%PDF-1.6%‚„œ”
1 0 obj<</Lang(en-US)/Metadata 2 0 R/Pages 3 0 R/Type/Catalog/ViewerPreferences<</Direction/L2R>>>>endobj2 0 obj<</Length 9999/Subtype/XML/Type/Metadata>>stream
<?xpacket begin="Ôªø" id="W5M0MpCehiHzreSzNTczkc9d"?>
<x:xmpmeta xmlns:x="adobe:ns:meta/" x:xmptk="Adobe XMP Core 9.1-c002 79.a6a6396, 2024/03/12-07:48:23        ">
   <rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
      <rdf:Description rdf:about=""
            xmlns:xmp="http://ns.adobe.com/xap/1.0/"
            xmlns:xmpMM="http://ns.adobe.com/xap/1.0/mm/"
            xmlns:stRef="http://ns.adobe.com/xap/1.0/sType/ResourceRef#"
            xmlns:stEvt="http://ns.adobe.com/xap/1.0/sType/ResourceEvent#"
            xmlns:dc="http://purl.org/dc/elements/1.1/"
            xmlns:pdf="http://ns.adobe.com/pdf/1.3/"
            xmlns:ExtensisFontSense="http://www.extensis.com/meta/FontSense/">
         <xmp:CreateDate>2024-08-01T11:18:40-04:00</xmp:CreateDate>
         <xmp:MetadataDate>2024-08-01T11:18:42-04:00</xmp:MetadataDate>
         <xmp:ModifyDate>2024-08-01T11:18:42-04:00</xmp:ModifyDate>
         <xmp:CreatorTool>Adobe InDesign 19.5 (Macintosh)</xmp:CreatorTool>
         <xmpMM:InstanceID>uuid:5d3a180b-4f12-264c-b9f3-d41edef9915b</xmpMM:InstanceID>
         <xmpMM:OriginalDocumentID>xmp.did:436bea68-88f9-4f60-9b76-86ef3f193c18</xmpMM:OriginalDocumentID>
         <xmpMM:DocumentID>xmp.id:72d583eb-7b08-4af6-831c-a9ade5f0bfe8</xmpMM:DocumentID>
         <xmpMM:RenditionClass>proof:pdf</xmpMM:RenditionClass>
         <xmpMM:DerivedFrom rdf:parseType="Resource">
            <stRef:instanceID>xmp.iid:6245aa2f-9433-4d5a-8905-346a914748fd</stRef:instanceID>
            <stRef:documentID>xmp.did:edc39fbc-0329-447b-8eed-47aa51f0b5df</stRef:documentID>
            <stRef:originalDocumentID>xmp.did:436bea68-88f9-4f60-9b76-86ef3f193c18</stRef:originalDocumentID>
            <stRef:renditionClass>default</stRef:renditionClass>
         </xmpMM:DerivedFrom>
         <xmpMM:History>
            <rdf:Seq>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/x-indesign to application/pdf</stEvt:parameters>
                  <stEvt:softwareAgent>Adobe InDesign 19.5 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
                  <stEvt:when>2024-08-01T11:18:40-04:00</stEvt:when>
               </rdf:li>
            </rdf:Seq>
         </xmpMM:History>
         <dc:format>application/pdf</dc:format>
         <pdf:Producer>Adobe PDF Library 17.0</pdf:Producer>
         <pdf:Trapped>False</pdf:Trapped>
         <ExtensisFontSense:slug>
            <rdf:Bag>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>3261192849</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>Helvetica Neue LT Std</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>OpenType - PS</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>3261192849</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Adobe Systems</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>HelveticaNeueLTStd-Cn</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>2.035</ExtensisFontSense:Version>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>3357634683</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>Helvetica Neue LT Std</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>OpenType - PS</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>3357634683</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Adobe Systems</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>HelveticaNeueLTStd-BdCn</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>2.035</ExtensisFontSense:Version>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>3454135</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>ITC Avant Garde Gothic Std</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>OpenType - PS</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>3454135</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Adobe Systems</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>ITCAvantGardeStd-BkCn</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>2.031</ExtensisFontSense:Version>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>3030352917</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>Helvetica Neue LT Std</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>OpenType - PS</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>3030352917</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Adobe Systems</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>HelveticaNeueLTStd-CnO</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>2.035</ExtensisFontSense:Version>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>4073973744</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>Helvetica Neue LT Std</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>OpenType - PS</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>4073973744</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Adobe Systems</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>HelveticaNeueLTStd-BdCnO</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>2.035</ExtensisFontSense:Version>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>3691150952</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>Helvetica Neue LT Std</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>OpenType - PS</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>3691150952</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Adobe Systems</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>HelveticaNeueLTStd-Bd</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>2.035</ExtensisFontSense:Version>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>2068535857</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>Symbol</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>TrueType</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>2068535857</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Apple Computer</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>Symbol</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>6.1</ExtensisFontSense:Version>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>1252007918</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>Arial</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>OpenType - TT</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>1252007918</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Monotype Typography</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>ArialMT</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>5.06</ExtensisFontSense:Version>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>1552261271</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>Arial</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>OpenType - TT</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>1552261271</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Monotype Typography</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>Arial-BoldMT</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>5.01.2</ExtensisFontSense:Version>
               </rdf:li>
            </rdf:Bag>
         </ExtensisFontSense:slug>
      </rdf:Description>
   </rdf:RDF>
</x:xmpmeta>
<?xpacket end="r"?>endstreamendobj3 0 obj<</Count 14/Kids[14 0 R 15 0 R]/Type/Pages>>endobj14 0 obj<</Count 5/Kids[5 0 R 6 0 R 7 0 R 8 0 R 9 0 R]/Parent 3 0 R/Type/Pages>>endobj15 0 obj<</Count 9/Kids[10 0 R 11 0 R 12 0 R 13 0 R 16 0 R 17 0 R 18 0 R 19 0 R 20 0 R]/Parent 3 0 R/Type/Pages>>endobj10 0 obj<</ArtBox[0.0 0.0 612.0 792.0]/BleedBox[0.0 0.0 612.0 792.0]/Contents 21 0 R/CropBox[0.0 0.0 612.0 792.0]/MediaBox[0.0 0.0 612.0 792.0]/Parent 15 0 R/Resources<</ExtGState<</GS0 22 0 R/GS1 23 0 R/GS2 24 0 R>>/Font<</T1_0 25 0 R/T1_1 26 0 R/T1_2 27 0 R>>/ProcSet[/PDF/Text]/XObject<</Fm0 28 0 R>>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page/PieceInfo<</InDesign<</DocumentID<FEFF0078006D0070002E006400690064003A00650064006300330039006600620063002D0030003300320039002D0034003400370062002D0038006500650064002D003400370061006100350031006600300062003500640066>/LastModified<FEFF0044003A00320030003200340030003800300031003100350031003800340031005A>/NumberOfPageItemsInPage 2/NumberofPages 1/OriginalDocumentID<FEFF0078006D0070002E006400690064003A00340033003600620065006100360038002D0038003800660039002D0034006600360030002D0039006200370036002D003800360065006600330066003100390033006300310038>/PageItemUIDToLocationDataMap<</0[410.0 0.0 3.0 -270.0 -360.0 -18.0 -346.846 1.0 0.0 0.0 1.0 0.0 0.0]/1[432.0 1.0 3.0 18.0 -359.889 270.0 -346.736 1.0 0.0 0.0 1.0 288.0 0.11058]>>/PageTransformationMatrixList<</0[1.0 0.0 0.0 1.0 0.0 0.0]>>/PageUIDList<</0 837>>/PageWidthList<</0 612.0>>>>>>>>endobj11 0 obj<</ArtBox[0.0 0.0 612.0 792.0]/BleedBox[0.0 0.0 612.0 792.0]/Contents 29 0 R/CropBox[0.0 0.0 612.0 792.0]/MediaBox[0.0 0.0 612.0 792.0]/Parent 15 0 R/Resources<</ExtGState<</GS0 22 0 R/GS1 23 0 R/GS2 24 0 R>>/Font<</T1_0 25 0 R/T1_1 26 0 R/T1_2 27 0 R>>/ProcSet[/PDF/Text]/XObject<</Fm0 28 0 R>>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page/PieceInfo<</InDesign<</DocumentID<FEFF0078006D0070002E006400690064003A00650064006300330039006600620063002D0030003300320039002D0034003400370062002D0038006500650064002D003400370061006100350031006600300062003500640066>/LastModified<FEFF0044003A00320030003200340030003800300031003100350031003800340031005A>/NumberOfPageItemsInPage 2/NumberofPages 1/OriginalDocumentID<FEFF0078006D0070002E006400690064003A00340033003600620065006100360038002D0038003800660039002D0034006600360030002D0039006200370036002D003800360065006600330066003100390033006300310038>/PageItemUIDToLocationDataMap<</0[410.0 0.0 3.0 -270.0 -360.0 -18.0 -346.846 1.0 0.0 0.0 1.0 0.0 0.0]/1[432.0 1.0 3.0 18.0 -359.889 270.0 -346.736 1.0 0.0 0.0 1.0 288.0 0.11058]>>/PageTransformationMatrixList<</0[1.0 0.0 0.0 1.0 0.0 0.0]>>/PageUIDList<</0 889>>/PageWidthList<</0 612.0>>>>>>>>endobj12 0 obj<</ArtBox[0.0 0.0 612.0 792.0]/BleedBox[0.0 0.0 612.0 792.0]/Contents 30 0 R/CropBox[0.0 0.0 612.0 792.0]/MediaBox[0.0 0.0 612.0 792.0]/Parent 15 0 R/Resources<</ExtGState<</GS0 22 0 R/GS1 24 0 R/GS2 23 0 R>>/Font<</T1_0 27 0 R/T1_1 25 0 R/T1_2 26 0 R>>/ProcSet[/PDF/Text]/XObject<</Fm0 28 0 R>>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page/PieceInfo<</InDesign<</DocumentID<FEFF0078006D0070002E006400690064003A00650064006300330039006600620063002D0030003300320039002D0034003400370062002D0038006500650064002D003400370061006100350031006600300062003500640066>/LastModified<FEFF0044003A00320030003200340030003800300031003100350031003800340031005A>/NumberOfPageItemsInPage 2/NumberofPages 1/OriginalDocumentID<FEFF0078006D0070002E006400690064003A00340033003600620065006100360038002D0038003800660039002D0034006600360030002D0039006200370036002D003800360065006600330066003100390033006300310038>/PageItemUIDToLocationDataMap<</0[410.0 0.0 3.0 -270.0 -360.0 -18.0 -346.846 1.0 0.0 0.0 1.0 0.0 0.0]/1[432.0 1.0 3.0 18.0 -359.889 270.0 -346.736 1.0 0.0 0.0 1.0 288.0 0.11058]>>/PageTransformationMatrixList<</0[1.0 0.0 0.0 1.0 0.0 0.0]>>/PageUIDList<</0 942>>/PageWidthList<</0 612.0>>>>>>>>endobj13 0 obj<</ArtBox[0.0 0.0 612.0 792.0]/BleedBox[0.0 0.0 612.0 792.0]/Contents 31 0 R/CropBox[0.0 0.0 612.0 792.0]/MediaBox[0.0 0.0 612.0 792.0]/Parent 15 0 R/Resources<</ExtGState<</GS0 22 0 R/GS1 23 0 R/GS2 24 0 R>>/Font<</C2_0 32 0 R/T1_0 25 0 R/T1_1 27 0 R/T1_2 26 0 R>>/ProcSet[/PDF/Text]/XObject<</Fm0 28 0 R>>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page/PieceInfo<</InDesign<</DocumentID<FEFF0078006D0070002E006400690064003A00650064006300330039006600620063002D0030003300320039002D0034003400370062002D0038006500650064002D003400370061006100350031006600300062003500640066>/LastModified<FEFF0044003A00320030003200340030003800300031003100350031003800340031005A>/NumberOfPageItemsInPage 2/NumberofPages 1/OriginalDocumentID<FEFF0078006D0070002E006400690064003A00340033003600620065006100360038002D0038003800660039002D0034006600360030002D0039006200370036002D003800360065006600330066003100390033006300310038>/PageItemUIDToLocationDataMap<</0[410.0 0.0 3.0 -270.0 -360.0 -18.0 -346.846 1.0 0.0 0.0 1.0 0.0 0.0]/1[432.0 1.0 3.0 18.0 -359.889 270.0 -346.736 1.0 0.0 0.0 1.0 288.0 0.11058]>>/PageTransformationMatrixList<</0[1.0 0.0 0.0 1.0 0.0 0.0]>>/PageUIDList<</0 994>>/PageWidthList<</0 612.0>>>>>>>>endobj16 0 obj<</ArtBox[0.0 0.0 612.0 792.0]/BleedBox[0.0 0.0 612.0 792.0]/Contents 33 0 R/CropBox[0.0 0.0 612.0 792.0]/MediaBox[0.0 0.0 612.0 792.0]/Parent 15 0 R/Resources<</ExtGState<</GS0 22 0 R/GS1 23 0 R/GS2 24 0 R>>/Font<</T1_0 26 0 R/T1_1 25 0 R/T1_2 27 0 R/T1_3 34 0 R/T1_4 35 0 R>>/ProcSet[/PDF/Text]/Properties<</MC0 36 0 R>>/XObject<</Fm0 28 0 R>>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page/PieceInfo<</InDesign<</DocumentID<FEFF0078006D0070002E006400690064003A00650064006300330039006600620063002D0030003300320039002D0034003400370062002D0038006500650064002D003400370061006100350031006600300062003500640066>/LastModified<FEFF0044003A00320030003200340030003800300031003100350031003800340031005A>/NumberOfPageItemsInPage 2/NumberofPages 1/OriginalDocumentID<FEFF0078006D0070002E006400690064003A00340033003600620065006100360038002D0038003800660039002D0034006600360030002D0039006200370036002D003800360065006600330066003100390033006300310038>/PageItemUIDToLocationDataMap<</0[410.0 0.0 3.0 -270.0 -360.0 -18.0 -346.846 1.0 0.0 0.0 1.0 0.0 0.0]/1[432.0 1.0 3.0 18.0 -359.889 270.0 -346.736 1.0 0.0 0.0 1.0 288.0 0.11058]>>/PageTransformationMatrixList<</0[1.0 0.0 0.0 1.0 0.0 0.0]>>/PageUIDList<</0 30617>>/PageWidthList<</0 612.0>>>>>>>>endobj17 0 obj<</ArtBox[0.0 0.0 612.0 792.0]/BleedBox[0.0 0.0 612.0 792.0]/Contents 37 0 R/CropBox[0.0 0.0 612.0 792.0]/MediaBox[0.0 0.0 612.0 792.0]/Parent 15 0 R/Resources<</ExtGState<</GS0 22 0 R/GS1 23 0 R/GS2 24 0 R>>/Font<</T1_0 25 0 R/T1_1 27 0 R/T1_2 38 0 R/T1_3 39 0 R/T1_4 26 0 R>>/ProcSet[/PDF/Text]/Properties<</MC0 40 0 R>>/XObject<</Fm0 28 0 R>>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page/PieceInfo<</InDesign<</DocumentID<FEFF0078006D0070002E006400690064003A00650064006300330039006600620063002D0030003300320039002D0034003400370062002D0038006500650064002D003400370061006100350031006600300062003500640066>/LastModified<FEFF0044003A00320030003200340030003800300031003100350031003800340031005A>/NumberOfPageItemsInPage 2/NumberofPages 1/OriginalDocumentID<FEFF0078006D0070002E006400690064003A00340033003600620065006100360038002D0038003800660039002D0034006600360030002D0039006200370036002D003800360065006600330066003100390033006300310038>/PageItemUIDToLocationDataMap<</0[410.0 0.0 3.0 -270.0 -360.0 -18.0 -346.846 1.0 0.0 0.0 1.0 0.0 0.0]/1[432.0 1.0 3.0 18.0 -359.889 270.0 -346.736 1.0 0.0 0.0 1.0 288.0 0.11058]>>/PageTransformationMatrixList<</0[1.0 0.0 0.0 1.0 0.0 0.0]>>/PageUIDList<</0 30618>>/PageWidthList<</0 612.0>>>>>>>>endobj18 0 obj<</ArtBox[0.0 0.0 612.0 792.0]/BleedBox[0.0 0.0 612.0 792.0]/Contents 41 0 R/CropBox[0.0 0.0 612.0 792.0]/MediaBox[0.0 0.0 612.0 792.0]/Parent 15 0 R/Resources<</ExtGState<</GS0 22 0 R/GS1 24 0 R/GS2 23 0 R>>/Font<</T1_0 27 0 R/T1_1 25 0 R/T1_2 26 0 R>>/ProcSet[/PDF/Text]/XObject<</Fm0 28 0 R>>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page/PieceInfo<</InDesign<</DocumentID<FEFF0078006D0070002E006400690064003A00650064006300330039006600620063002D0030003300320039002D0034003400370062002D0038006500650064002D003400370061006100350031006600300062003500640066>/LastModified<FEFF0044003A00320030003200340030003800300031003100350031003800340031005A>/NumberOfPageItemsInPage 2/NumberofPages 1/OriginalDocumentID<FEFF0078006D0070002E006400690064003A00340033003600620065006100360038002D0038003800660039002D0034006600360030002D0039006200370036002D003800360065006600330066003100390033006300310038>/PageItemUIDToLocationDataMap<</0[410.0 0.0 3.0 -270.0 -360.0 -18.0 -346.846 1.0 0.0 0.0 1.0 0.0 0.0]/1[432.0 1.0 3.0 18.0 -359.889 270.0 -346.736 1.0 0.0 0.0 1.0 288.0 0.11058]>>/PageTransformationMatrixList<</0[1.0 0.0 0.0 1.0 0.0 0.0]>>/PageUIDList<</0 30880>>/PageWidthList<</0 612.0>>>>>>>>endobj19 0 obj<</ArtBox[0.0 0.0 612.0 792.0]/BleedBox[0.0 0.0 612.0 792.0]/Contents 42 0 R/CropBox[0.0 0.0 612.0 792.0]/MediaBox[0.0 0.0 612.0 792.0]/Parent 15 0 R/Resources<</ExtGState<</GS0 22 0 R/GS1 23 0 R>>/Font<</C2_0 43 0 R/TT0 44 0 R/TT1 45 0 R>>/ProcSet[/PDF/Text]/XObject<</Fm0 46 0 R>>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page/PieceInfo<</InDesign<</DocumentID<FEFF0078006D0070002E006400690064003A00650064006300330039006600620063002D0030003300320039002D0034003400370062002D0038006500650064002D003400370061006100350031006600300062003500640066>/LastModified<FEFF0044003A00320030003200340030003800300031003100350031003800340032005A>/NumberOfPageItemsInPage 1/NumberofPages 1/OriginalDocumentID<FEFF0078006D0070002E006400690064003A00340033003600620065006100360038002D0038003800660039002D0034006600360030002D0039006200370036002D003800360065006600330066003100390033006300310038>/PageItemUIDToLocationDataMap<</0[463.0 0.0 3.0 -270.0 -360.046 270.0 -349.446 1.0 0.0 0.0 1.0 -195.0 -285.046]>>/PageTransformationMatrixList<</0[1.0 0.0 0.0 1.0 0.0 0.0]>>/PageUIDList<</0 15792>>/PageWidthList<</0 612.0>>>>>>>>endobj20 0 obj<</ArtBox[0.0 0.0 612.0 792.0]/BleedBox[0.0 0.0 612.0 792.0]/Contents 47 0 R/CropBox[0.0 0.0 612.0 792.0]/MediaBox[0.0 0.0 612.0 792.0]/Parent 15 0 R/Resources<</ExtGState<</GS0 22 0 R/GS1 23 0 R>>/Font<</C2_0 43 0 R/TT0 44 0 R/TT1 45 0 R>>/ProcSet[/PDF/Text]/Properties<</MC0 48 0 R>>/XObject<</Fm0 46 0 R>>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page/PieceInfo<</InDesign<</DocumentID<FEFF0078006D0070002E006400690064003A00650064006300330039006600620063002D0030003300320039002D0034003400370062002D0038006500650064002D003400370061006100350031006600300062003500640066>/LastModified<FEFF0044003A00320030003200340030003800300031003100350031003800340032005A>/NumberOfPageItemsInPage 1/NumberofPages 1/OriginalDocumentID<FEFF0078006D0070002E006400690064003A00340033003600620065006100360038002D0038003800660039002D0034006600360030002D0039006200370036002D003800360065006600330066003100390033006300310038>/PageItemUIDToLocationDataMap<</0[463.0 0.0 3.0 -270.0 -360.046 270.0 -349.446 1.0 0.0 0.0 1.0 -195.0 -285.046]>>/PageTransformationMatrixList<</0[1.0 0.0 0.0 1.0 0.0 0.0]>>/PageUIDList<</0 11429>>/PageWidthList<</0 612.0>>>>>>>>endobj47 0 obj<</Length 19277>>stream
q
/GS0 gs
0 TL/Fm0 Do
Q
0 0 0 1 K
/GS1 gs
q 1 0 0 1 46 711.6877 cm
0 0 m
310.199 0 l
S
Q
q 1 0 0 1 37 265.8877 cm
0 0 m
538 0 l
S
Q
q 1 0 0 1 46 248.0477 cm
0 0 m
296.641 0 l
S
Q
BT
0 0 0 1 k
/TT0 1 Tf
-0.018 Tc 10 0 0 10 46 714.5277 Tm
[(W)0.5 (h)0.5 (at )0.5 (are )0.5 (th)0.5 (e )0.5 (p)0.5 (o)0.5 (ssi)0.5 (b)0.5 (l)0.5 (e )0.5 (o)0.5 (r )0.5 (reaso)0.5 (n)0.5 (ab)0.5 (l)0.5 (y )0.5 (li)0.6 (kel)0.5 (y )0.5 (si)0.5 (d)0.5 (e )0.5 (effects )0.5 (o)0.5 (f )37.6 (ABECMA?)]TJ
/TT1 1 Tf
0 -1.568 Td
[(T)0.5 (he )0.5 (most)0.5 ( )0.5 (common )0.5 (side )0.5 (ef)18.6 (fect)0.5 (s )0.5 (of)0.5 ( )55.6 (ABECMA)55.5 ( )0.5 (are:)]TJ
0 Tc /Span<</ActualText<FEFF0009>>> BDC 
0.586 -1.694 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
/TT1 1 Tf
-0.018 Tc 0.018 Tw 1.8 0 Td
[(f)0.5 (at)0.5 (igue)]TJ
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.388 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
/TT1 1 Tf
-0.018 Tc 1.8 0 Td
[(f)0.5 (ever )0.5 (\(100.4\260)0.5 (F/)0.5 (38\260C )0.5 (or )0.5 (higher\))]TJ
0 Tc /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.388 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
/TT1 1 Tf
-0.018 Tc 0.018 Tw 1.8 0 Td
[(chills/)0.5 (shivering)]TJ
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.388 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
/TT1 1 Tf
-0.018 Tc 1.8 0 Td
[(severe )0.5 (nausea )0.5 (or )0.5 (diarrhea)]TJ
0 Tc /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.388 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
/TT1 1 Tf
-0.018 Tc 1.8 0 Td
[(decreased )0.5 (appet)0.6 (it)0.5 (e)]TJ
0 Tc /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.388 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
/TT1 1 Tf
-0.018 Tc 0.018 Tw 1.8 0 Td
(headache)Tj
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.388 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
/TT1 1 Tf
-0.018 Tc 0.018 Tw 1.8 0 Td
[(dizziness/)0.5 (light)0.5 (headedness)]TJ
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.388 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
/TT1 1 Tf
-0.018 Tc 0.018 Tw 1.8 0 Td
[(conf)0.5 (usion)]TJ
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.388 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
[<0047004C0049>0.5 <00BF00460058004F0057>0.5 <005C0003>0.5 <0056005300480044004E004C0051004A0003>0.5 <005200550003>0.5 <0056004F005800550055004800470003>0.5 <00560053004800480046004B>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.388 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
/TT1 1 Tf
-0.018 Tc 0.018 Tw 1.8 0 Td
(cough)Tj
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.388 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
[<0047004C0049>0.5 <00BF00460058004F0057>0.5 <005C0003>0.5 <00450055004800440057>0.5 <004B004C0051004A>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.388 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
/TT1 1 Tf
-0.018 Tc 1.8 0 Td
[(f)0.5 (ast)0.5 ( )0.5 (or )0.5 (irregular )0.5 (heart)0.6 (beat)]TJ
/C2_0 1 Tf
-0.017 Tc 0.017 Tw -1.8 -1.694 Td
[<002C00510003>-13.8 <00440003>-13.8 <0056005700580047005C0003>-13.8 <004600520050005300440055004C0051004A0003>41.4 <002400250028002600300024>55.2 <0003>-13.8 <005700520003>-13.7 <005600570044005100470044005500470003>-13.8 <00550048004A004C005000480051000F0003>-13.8 <00440003>-13.8 <004B004C004A004B004800550003>-13.7 <0053005500520053005200550057004C005200510003>-13.7 <005200490003>-13.8 <005300440057004C00480051005700560003>-13.7 <0048005B005300480055004C004800510046004800470003>-13.7 <0047004800440057004B0003>-13.7 <005A004C0057004B004C00510003>-13.7 <0057004B00480003>-13.8 <00BF0055005600570003>-13.7 <0051004C00510048>-17.2 <0003>]TJ
/TT1 1 Tf
-0.014 Tc 0.024 Tw 0 -1.1 Td
[(month)-0.6 (s from rando)-0.6 (mi)-0.6 (za)-0.6 (tion)-0.6 ( i)-0.6 (n the )55.4 (ABEC)-0.6 (MA)54.9 ( a)-0.6 (rm compared)-0.6 ( to)-0.6 ( the standa)-0.6 (rd)-0.6 ( reg)-0.6 (imens arm. )18.4 (Thi)-0.6 (s h)-0.6 (igh)-0.6 (er rate)-0.6 ( o)-0.6 (f early dea)-0.6 (th)-14.1 ( )]TJ
0.021 Tw 0 -1.1 Td
[(was mainly observed before receiving )54.9 (ABECMA)55.2 ( with the main reason being progression of multiple myeloma. )17.8 (There was)-14 ( )]TJ
-0.018 Tc 0 Tw 0 -1.1 Td
[(also )0.5 (an )0.5 (increase )0.6 (in )0.5 (t)0.5 (he )0.5 (rat)0.5 (e )0.5 (of)0.5 ( )0.5 (deat)0.5 (h )0.5 (f)0.5 (rom )0.5 (adverse )0.5 (event)0.5 (s )0.5 (af)0.5 (t)0.5 (er )55.7 (ABECMA.)]TJ
-0.012 Tc 0.029 Tw 0 -1.73 Td
[(A)0.5 (B)0.5 (E)0.5 (CMA)55.7 ( c)0.5 (an caus)0.5 (e a v)0.5 (er)0.5 (y)0.5 ( c)0.5 (om)0.5 (m)0.5 (on s)0.5 (ide ef)18.7 (f)0.7 (ec)0.5 (t)0.6 ( c)0.5 (alled c)0.5 (y)0.5 (t)0.6 (ok)0.5 (ine r)0.5 (eleas)0.5 (e sy)0.5 (ndr)0.5 (ome or)0.5 ( CRS)0.5 (,)0.6 ( whic)0.5 (h c)0.5 (an be s)0.5 (ev)0.5 (er)0.5 (e or f)0.6 (at)0.7 (al.)-11.8 ( )]TJ
/C2_0 1 Tf
-0.018 Tc 0.018 Tw 0 -1.1 Td
[<0036005C0050005300570052005000560003>-13.5 <005200490003>-13.5 <0026003500360003>-13.5 <004C00510046004F0058004700480003>-13.5 <00490048005900480055>55.4 <000F0003>-13.5 <0047004C004900BF00460058004F0057005C0003>-13.5 <00450055004800440057004B004C0051004A000F0003>-13.5 <0047004C005D005D004C00510048005600560003>-13.5 <005200550003>-13.5 <004F004C004A004B00570010004B004800440047004800470051004800560056000F0003>-13.5 <005100440058005600480044000F0003>-13.5 <004B00480044004700440046004B0048000F0003>-13.5 <00490044005600570003>-13.5 <004B00480044005500570045004800440057000F0003>-13.5 <004F0052005A>-18.1 <0003>]TJ
/TT1 1 Tf
-0.02 Tc -0.014 Tw 0 -1.1 Td
[(blood pressure, or fatigue. )18.2 (T)111.1 (ell your healthcare provider right away if you develop fever or any of t\hese other symptoms after)-20 ( )]TJ
-0.018 Tc -0.055 Tw 0 -1.1 Td
[(receiving )0.7 (ABECMA.)]TJ
0.001 Tw 0 -1.568 Td
[(ABECMA)55.5 ( can increase t)0.5 (he risk of)0.5 ( lif)0.5 (e-t)0.5 (hreat)0.5 (ening inf)0.5 (ect)0.5 (ions that)0.5 ( may lead t)0.6 (o deat)0.5 (h.)0.5 ( )18.3 (T)111.3 (ell your healt)0.5 (hcare provider right)0.5 ( away)-18 ( )]TJ
0 Tw 0 -1.1 Td
[(if)0.5 ( )0.5 (you )0.5 (develop )0.5 (f)0.5 (ever)55.5 (,)0.5 ( )0.5 (chills,)0.5 ( )0.5 (or )0.5 (any )0.5 (signs )0.6 (or )0.5 (sympt)0.5 (oms )0.5 (of)0.5 ( )0.5 (an )0.5 (inf)0.5 (ect)0.5 (ion.)]TJ
0.003 Tw 0 -1.568 Td
[(ABECMA)55.5 ( can )0.5 (lower one )0.5 (or more t)0.5 (ypes )0.5 (of)0.5 ( )0.5 (your blood cells \(red blood )0.5 (cells,)0.5 ( )0.5 (whit)0.5 (e )0.5 (blood )0.5 (cells,)0.5 ( )0.5 (or plat)0.5 (elet)0.5 (s\),)0.5 ( which may make)-18.1 ( )]TJ
-0.004 Tw 0 -1.1 Td
[(you f)0.5 (eel weak or t)0.5 (ired or increase your risk of)0.5 ( severe inf)0.5 (ect)0.5 (ion or bleeding.)0.5 ( )55.1 (Af)0.5 (t)0.5 (er t)0.5 (reat)0.5 (ment)0.5 (,)0.5 ( your healt)0.5 (hcare provider will t)0.5 (est)-17.9 ( )]TJ
-0.016 Tc 0.013 Tw 0 -1.1 Td
[(y)0.5 (our blood t)0.6 (o check)0.5 ( f)0.6 (or)0.5 ( t)0.7 (his.)0.6 ( )17.9 (T)111.4 (ell y)0.5 (our)0.5 ( healt)0.6 (hc)0.5 (ar)0.5 (e pr)0.5 (ovider)0.5 ( r)0.5 (ight)0.6 ( away)0.5 ( if)0.6 ( you get)0.6 ( a f)0.6 (ev)0.5 (er)55.6 (,)0.7 ( ar)0.5 (e f)0.6 (eeling t)0.6 (ired,)0.6 ( or)0.5 ( hav)0.5 (e br)0.5 (uising or)-16 ( )]TJ
-0.018 Tc 0.018 Tw 0 -1.1 Td
(bleeding.)Tj
-0.023 Tc -0.014 Tw 0 -1.568 Td
[(ABECMA)55.3 ( may increase your risk of getting cancers including certain types of bl\ood cancers. )18.2 (Y)91.8 (our healthcare provider should)-23.1 ( )]TJ
-0.018 Tc 0 Tw 0 -1.1 Td
[(monit)0.5 (or )0.5 (you )0.5 (f)0.5 (or )0.5 (t)0.5 (his.)]TJ
/C2_0 1 Tf
-0.002 Tc 0.002 Tw 0 -1.568 Td
[<002B00440059004C0051004A0003>-28 <002400250028002600300024>54.9 <0003>-83.2 <004C00510003>-83.1 <005C0052005800550003>-83.1 <0045004F0052005200470003>-83.2 <00500044005C0003>-83.2 <004600440058005600480003>-83.2 <00440003>-83.2 <00490044004F005600480010005300520056004C0057004C005900480003>-83.1 <004B00580050004400510003>-83.2 <004C005000500058005100520047004800BF0046004C004800510046005C0003>-83.2 <0059004C0055005800560003>-83.2 <000B002B002C0039000C0003>-83.2 <00570048005600570003>-83.2 <0055004800560058004F00570003>-83.1 <0045005C0003>-83.1 <0056005200500048>-2.2 <0003>]TJ
/TT1 1 Tf
-0.018 Tc 0 Tw 0 -1.1 Td
[(commercial )0.5 (t)0.5 (est)0.5 (s.)]TJ
-0.01 Tc 0.042 Tw 0 -1.388 Td
[(These are not all the possible side ef)18.1 (fects of )55.3 (ABECMA. Call your doctor for medical advice about side ef)18.2 (fects. )18.2 (Y)91.8 (ou may)-10 ( )]TJ
-0.018 Tc 0 Tw 0 -1.1 Td
[(report)0.5 ( )0.5 (side )0.5 (ef)18.5 (f)0.5 (ects )0.5 (t)0.5 (o )0.5 (FDA)55.5 ( )0.5 (at)0.5 ( )0.5 (1-800-FDA-1088.)]TJ
/TT0 1 Tf
0 -2.45 Td
[(G)0.5 (en)0.5 (eral)0.5 ( )0.5 (i)0.5 (n)0.5 (fo)0.5 (rmati)0.5 (o)0.5 (n)0.5 ( )0.5 (ab)0.5 (o)0.5 (ut )0.5 (th)0.5 (e )0.6 (safe )0.5 (an)0.5 (d)0.5 ( )0.5 (effecti)0.5 (ve )0.5 (u)0.5 (se )0.6 (of )37.7 (ABECMA)]TJ
/TT1 1 Tf
-0.01 Tc 0.042 Tw 0 -1.838 Td
[(Medicines )0.7 (are )0.6 (sometimes )0.7 (prescribed )0.7 (for )0.7 (purposes )0.7 (other )0.6 (than )0.7 (those )0.6 (listed )0.7 (in )0.7 (a )0.6 (Medication )0.6 (Guide. )0.7 (If )0.7 (you )0.7 (would )0.6 (like )0.7 (more)-10.1 ( )]TJ
-0.017 Tc 0.014 Tw 0 -1.1 Td
[(information about )55.5 (ABECMA, talk with your healthcare provider)55.2 (. )18.4 (Y)91.8 (ou can ask your healthcare provider for information about)-16.8 ( )]TJ
-0.018 Tc 0 Tw 0 -1.1 Td
[(ABECMA)55.5 ( )0.5 (t)0.5 (hat)0.5 ( )0.5 (is )0.5 (writ)0.5 (t)0.5 (en )0.5 (f)0.5 (or )0.5 (healt)0.5 (h )0.5 (prof)0.5 (essionals.)]TJ
0 -1.568 Td
[(F)0.5 (or )0.5 (more )0.5 (inf)0.5 (ormat)0.5 (ion,)0.5 ( )0.5 (go )0.5 (t)0.5 (o )55.7 (ABECMA.)0.5 (com )0.5 (or )0.5 (call )0.5 (1-888-805-4555.)]TJ
9 0 0 9 46 178.0277 Tm
[(Manuf)0.5 (act)0.5 (ured )0.5 (by:)0.5 ( )0.5 (Celgene )0.5 (Corporat)0.5 (ion, )0.5 (a )0.5 (Brist)0.5 (ol-Myers )0.5 (Squibb )0.5 (Company)74.5 (,)0.5 ( )0.5 (556 )0.5 (Morris )55.7 (A)18.4 (venue,)0.5 ( )0.5 (Summit)0.5 (,)0.5 ( )0.5 (NJ )0.5 (07901.)]TJ
-0.024 Tc -0.014 Tw 0 -1.547 Td
[(Marketed by: Celgene Corporation, a Bristol-Myers Squibb Company \(Summi\t, NJ 07901\), and 2seventy bio, Inc. \(Cambridge, MA)55 ( 02142\).)]TJ
-0.018 Tc 0.018 Tw 0 -1.547 Td
(ABECMA)Tj
0 Tc 0 Tw 6.3 0 0 6.3 83.0182 153.1847 Tm
(\256)Tj
-0.018 Tc 9 0 0 9 87.5446 150.1877 Tm
[( )0.5 (is )0.5 (a )0.5 (t)0.5 (rademark )0.5 (of)0.5 ( )0.5 (Celgene )0.5 (Corporat)0.5 (ion,)0.5 ( )0.5 (a )0.5 (Brist)0.5 (ol-Myers )0.5 (Squibb )0.5 (Company)74.6 (.)]TJ
-4.616 -1.547 Td
[(ABEMG)0.5 (002 )0.5 ( )0.5 (4/)0.5 (2024)]TJ
ET
4 M 
36.5 126.768 539 604.54 re
S
q 1 0 0 1 36 85.8146 cm
0 0 m
540 0 l
S
Q
BT
9 0 0 9 36 108.9146 Tm
[(T)0.5 (his Medicat)0.5 (ion )0.5 (G)0.5 (uide )0.5 (has )0.5 (been )0.5 (approved )0.5 (by )0.5 (t)0.5 (he )0.5 (U.)0.5 (S. )0.6 (Food )0.5 (and )0.5 (Drug )55.7 (Administ)0.5 (rat)0.5 (ion.)]TJ
-0.055 Tw /Span<</ActualText<FEFF0009>>> BDC 
0 -2.111 Td
( )Tj
EMC 
51.714 0 Td
[(Revised:)0.5 ( )0.7 (April )-54.5 (2024)]TJ
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-51.714 -1.671 Td
( )Tj
EMC 
-0.018 Tc 49.154 0 Td
[(2012-US-2400020 )0.5 ( )0.5 (07/)0.5 (24)]TJ
ET
/PlacedPDF /MC0 BDC 
q
236.563 55.624 138.874 19.075 re
W n
/GS0 gs
q 1 0 0 1 241.8615 56.0668 cm
0 0 m
-0.143 -0.296 -0.449 -0.487 -0.778 -0.487 c
-0.909 -0.487 -1.036 -0.458 -1.155 -0.401 c
-3.866 0.914 -5.299 3.23 -5.299 6.299 c
-5.299 9.764 l
-5.299 10.241 -4.911 10.628 -4.434 10.628 c
-3.958 10.628 -3.57 10.241 -3.57 9.764 c
-3.57 6.299 l
-3.57 3.905 -2.503 2.175 -0.4 1.155 c
0.028 0.947 0.208 0.429 0 0 c
-2.556 8.032 m
-2.556 7.542 -2.16 7.145 -1.67 7.145 c
-1.18 7.145 -0.783 7.542 -0.783 8.032 c
-0.783 15.104 l
-0.783 15.594 -1.18 15.991 -1.67 15.991 c
-2.16 15.991 -2.556 15.594 -2.556 15.104 c
h
0.187 8.237 m
0.187 7.748 0.584 7.351 1.074 7.351 c
1.564 7.351 1.961 7.748 1.961 8.237 c
1.961 17.746 l
1.961 18.236 1.564 18.632 1.074 18.632 c
0.584 18.632 0.187 18.236 0.187 17.746 c
h
2.93 7.583 m
2.93 7.094 3.327 6.697 3.817 6.697 c
4.307 6.697 4.704 7.094 4.704 7.583 c
4.704 16.119 l
4.704 16.609 4.307 17.006 3.817 17.006 c
3.327 17.006 2.93 16.609 2.93 16.119 c
h
5.674 6.454 m
5.674 5.979 6.059 5.594 6.534 5.594 c
7.009 5.594 7.394 5.979 7.394 6.454 c
7.394 12.222 l
7.394 12.697 7.009 13.082 6.534 13.082 c
6.059 13.082 5.674 12.697 5.674 12.222 c
h
f
Q
q 1 0 0 1 258.4387 64.1496 cm
0 0 m
0.002 0.053 l
1.118 0.437 1.809 1.108 1.809 2.307 c
1.809 2.49 l
1.809 3.866 0.691 4.998 -1.59 4.998 c
-4.746 4.998 l
-4.746 -5.739 l
-1.361 -5.739 l
0.856 -5.739 2.378 -4.625 2.378 -2.841 c
2.378 -2.733 l
2.378 -1.341 1.558 -0.322 0 0 c
-3.365 3.786 m
-1.787 3.786 l
-0.283 3.786 0.484 3.216 0.484 2.197 c
0.484 2.089 l
0.484 0.858 -0.581 0.463 -1.979 0.463 c
-3.365 0.463 l
h
0.964 -2.717 m
0.964 -4.046 -0.083 -4.543 -1.61 -4.543 c
-3.365 -4.543 l
-3.365 -0.672 l
-1.586 -0.672 l
-0.082 -0.672 0.964 -1.172 0.964 -2.548 c
h
6.89 2.39 m
7.288 2.39 l
7.288 1.132 l
6.966 1.132 l
5.678 1.132 4.834 0.488 4.834 -1.215 c
4.834 -5.739 l
3.546 -5.739 l
3.546 2.39 l
4.834 2.39 l
4.834 0.933 l
4.896 0.933 l
5.126 1.669 5.724 2.39 6.89 2.39 c
8.435 2.39 1.289 -8.129 re
9.865 4.214 m
9.865 3.586 9.579 3.292 9.079 3.292 c
8.578 3.292 8.293 3.586 8.293 4.214 c
8.293 4.842 8.578 5.154 9.079 5.154 c
9.579 5.154 9.865 4.842 9.865 4.214 c
16.87 -3.5 m
16.87 -5.065 15.705 -5.892 14.002 -5.892 c
12.284 -5.892 11.149 -5.156 11.057 -3.5 c
12.345 -3.5 l
12.391 -4.497 13.128 -4.819 14.002 -4.819 c
14.876 -4.819 15.582 -4.436 15.582 -3.592 c
15.582 -1.613 11.149 -2.978 11.149 0.227 c
11.149 1.562 12.13 2.543 13.925 2.543 c
15.567 2.543 16.656 1.731 16.778 0.151 c
15.49 0.151 l
15.413 1.102 14.754 1.47 13.925 1.47 c
12.99 1.47 12.407 1.04 12.407 0.227 c
12.407 -1.69 16.87 -0.509 16.87 -3.5 c
19.843 2.39 m
21.592 2.39 l
21.592 1.255 l
19.843 1.255 l
19.843 -3.239 l
19.843 -4.42 20.15 -4.665 20.932 -4.665 c
21.147 -4.665 21.392 -4.635 21.592 -4.619 c
21.592 -5.724 l
21.346 -5.77 21.024 -5.801 20.794 -5.801 c
19.199 -5.801 18.555 -5.172 18.555 -3.438 c
18.555 1.255 l
17.189 1.255 l
17.189 2.39 l
18.555 2.39 l
18.555 4.998 l
19.843 4.998 l
h
25.398 2.543 m
23.388 2.543 22.315 1.163 22.315 -1.076 c
22.315 -2.273 l
22.315 -4.512 23.388 -5.892 25.398 -5.892 c
27.407 -5.892 28.481 -4.512 28.481 -2.273 c
28.481 -1.076 l
28.481 1.163 27.407 2.543 25.398 2.543 c
27.177 -2.197 m
27.177 -4.129 26.502 -4.758 25.398 -4.758 c
24.293 -4.758 23.619 -4.129 23.619 -2.197 c
23.619 -1.153 l
23.619 0.78 24.293 1.409 25.398 1.409 c
26.502 1.409 27.177 0.78 27.177 -1.153 c
h
29.843 4.998 1.289 -10.737 re
43.559 4.998 m
45.746 4.998 l
45.746 -5.739 l
44.381 -5.739 l
44.381 3.51 l
44.304 3.51 l
41.558 -3.962 l
39.886 -3.962 l
37.172 3.51 l
37.095 3.51 l
37.095 -5.739 l
35.745 -5.739 l
35.745 4.998 l
38.039 4.998 l
40.745 -2.46 l
40.822 -2.46 l
h
52.011 2.39 m
53.315 2.39 l
49.711 -8.347 l
48.377 -8.347 l
49.282 -5.801 l
46.643 2.39 l
48.008 2.39 l
49.956 -3.945 l
50.018 -3.945 l
h
56.777 2.543 m
54.768 2.543 53.694 1.102 53.694 -1.076 c
53.694 -2.273 l
53.694 -4.512 54.768 -5.892 56.777 -5.892 c
58.388 -5.892 59.339 -5.003 59.661 -3.484 c
58.342 -3.484 l
58.111 -4.42 57.59 -4.758 56.777 -4.758 c
55.673 -4.758 54.997 -4.129 54.997 -2.197 c
54.997 -2.089 l
59.706 -2.089 l
59.706 -1.076 l
59.706 1.102 58.787 2.543 56.777 2.543 c
56.777 1.409 m
57.82 1.409 58.386 0.794 58.401 -1.076 c
54.999 -1.076 l
55.017 0.794 55.688 1.409 56.777 1.409 c
64.483 2.39 m
64.882 2.39 l
64.882 1.132 l
64.56 1.132 l
63.272 1.132 62.428 0.488 62.428 -1.215 c
62.428 -5.739 l
61.14 -5.739 l
61.14 2.39 l
62.428 2.39 l
62.428 0.933 l
62.49 0.933 l
62.719 1.669 63.318 2.39 64.483 2.39 c
71.385 -3.5 m
71.385 -5.065 70.22 -5.892 68.517 -5.892 c
66.799 -5.892 65.664 -5.156 65.572 -3.5 c
66.861 -3.5 l
66.907 -4.497 67.643 -4.819 68.517 -4.819 c
69.391 -4.819 70.097 -4.436 70.097 -3.592 c
70.097 -1.613 65.664 -2.978 65.664 0.227 c
65.664 1.562 66.646 2.543 68.441 2.543 c
70.081 2.543 71.171 1.731 71.294 0.151 c
70.005 0.151 l
69.928 1.102 69.269 1.47 68.441 1.47 c
67.505 1.47 66.922 1.04 66.922 0.227 c
66.922 -1.69 71.385 -0.509 71.385 -3.5 c
81.626 -2.901 m
81.626 -4.819 80.307 -5.892 78.282 -5.892 c
76.38 -5.892 74.815 -4.972 74.616 -2.917 c
76.042 -2.917 l
76.211 -4.129 77.07 -4.696 78.267 -4.696 c
79.632 -4.696 80.245 -3.883 80.245 -2.978 c
80.245 0.074 74.785 -1.69 74.785 2.314 c
74.785 4.031 76.15 5.151 78.052 5.151 c
79.892 5.151 81.426 4.246 81.518 2.13 c
80.092 2.13 l
79.969 3.433 79.141 3.955 78.037 3.955 c
76.732 3.955 76.165 3.187 76.165 2.375 c
76.165 -0.325 81.626 1.271 81.626 -2.901 c
87.447 1.409 m
87.384 1.409 l
87.036 2.126 86.375 2.543 85.53 2.543 c
83.52 2.543 82.6 1.163 82.6 -1.076 c
82.6 -2.273 l
82.6 -4.512 83.52 -5.892 85.53 -5.892 c
86.375 -5.892 87.036 -5.475 87.384 -4.758 c
87.447 -4.758 l
87.447 -5.739 l
87.447 -8.347 l
88.736 -8.347 l
88.736 2.39 l
87.447 2.39 l
h
85.683 -4.758 m
84.579 -4.758 83.904 -4.129 83.904 -2.197 c
83.904 -1.153 l
83.904 0.78 84.579 1.409 85.683 1.409 c
86.788 1.409 87.463 0.78 87.463 -1.153 c
87.463 -2.197 l
87.463 -4.129 86.788 -4.758 85.683 -4.758 c
94.653 2.39 m
95.942 2.39 l
95.942 -5.739 l
94.653 -5.739 l
94.653 -4.696 l
94.592 -4.696 l
94.285 -5.355 93.626 -5.892 92.598 -5.892 c
91.08 -5.892 90.144 -5.033 90.144 -3.116 c
90.144 2.39 l
91.448 2.39 l
91.448 -2.932 l
91.448 -4.236 91.985 -4.804 92.951 -4.804 c
93.887 -4.804 94.653 -4.175 94.653 -2.595 c
h
97.596 2.39 1.288 -8.129 re
103.818 2.543 m
102.961 2.543 102.308 2.126 101.963 1.409 c
101.901 1.409 l
101.901 2.39 l
101.901 4.998 l
100.613 4.998 l
100.613 -5.739 l
101.901 -5.739 l
101.901 -4.758 l
101.963 -4.758 l
102.308 -5.475 102.961 -5.892 103.818 -5.892 c
105.828 -5.892 106.748 -4.512 106.748 -2.273 c
106.748 -1.076 l
106.748 1.163 105.828 2.543 103.818 2.543 c
105.444 -2.197 m
105.444 -4.129 104.769 -4.758 103.665 -4.758 c
102.561 -4.758 101.886 -4.129 101.886 -2.197 c
101.886 -1.153 l
101.886 0.78 102.561 1.409 103.665 1.409 c
104.769 1.409 105.444 0.78 105.444 -1.153 c
h
111.218 2.543 m
110.36 2.543 109.707 2.126 109.362 1.409 c
109.3 1.409 l
109.3 2.39 l
109.3 4.998 l
108.012 4.998 l
108.012 -5.739 l
109.3 -5.739 l
109.3 -4.758 l
109.362 -4.758 l
109.707 -5.475 110.36 -5.892 111.218 -5.892 c
113.227 -5.892 114.147 -4.512 114.147 -2.273 c
114.147 -1.076 l
114.147 1.163 113.227 2.543 111.218 2.543 c
112.844 -2.197 m
112.844 -4.129 112.169 -4.758 111.064 -4.758 c
109.96 -4.758 109.285 -4.129 109.285 -2.197 c
109.285 -1.153 l
109.285 0.78 109.96 1.409 111.064 1.409 c
112.169 1.409 112.844 0.78 112.844 -1.153 c
h
99.027 4.214 m
99.027 3.586 98.741 3.292 98.241 3.292 c
97.74 3.292 97.455 3.586 97.455 4.214 c
97.455 4.842 97.74 5.154 98.241 5.154 c
98.741 5.154 99.027 4.842 99.027 4.214 c
f
Q
q 1 0 0 1 373.928 69.1798 cm
0 0 m
-0.73 0 -1.323 -0.593 -1.323 -1.323 c
-1.323 -2.053 -0.73 -2.646 0 -2.646 c
0.73 -2.646 1.323 -2.053 1.323 -1.323 c
1.323 -0.593 0.73 0 0 0 c
0 -2.832 m
-0.832 -2.832 -1.509 -2.155 -1.509 -1.323 c
-1.509 -0.491 -0.832 0.186 0 0.186 c
0.832 0.186 1.509 -0.491 1.509 -1.323 c
1.509 -2.155 0.832 -2.832 0 -2.832 c
f
Q
q 1 0 0 1 373.6636 67.896 cm
0 0 m
0.284 0 l
0.377 0 0.45 0.024 0.502 0.07 c
0.554 0.118 0.581 0.182 0.581 0.263 c
0.581 0.348 0.557 0.414 0.508 0.461 c
0.46 0.507 0.387 0.531 0.292 0.533 c
0 0.533 l
h
0.308 -0.223 m
0 -0.223 l
0 -0.834 l
-0.276 -0.834 l
-0.276 0.755 l
0.283 0.755 l
0.466 0.755 0.608 0.714 0.708 0.632 c
0.807 0.55 0.857 0.431 0.857 0.275 c
0.857 0.168 0.831 0.079 0.78 0.008 c
0.729 -0.064 0.657 -0.119 0.566 -0.158 c
0.923 -0.82 l
0.923 -0.834 l
0.627 -0.834 l
h
f
Q
EMC 
Q
endstreamendobj46 0 obj<</BBox[0.0 792.0 612.0 0.0]/Length 343/Matrix[1.0 0.0 0.0 1.0 0.0 0.0]/Resources<</ExtGState<</GS0 23 0 R>>/Font<</TT0 49 0 R>>/ProcSet[/PDF/Text]>>/Subtype/Form>>stream
0 0 0 1 K
0.75 w 
/GS0 gs
q 1 0 0 1 36 743.6949 cm
0 0 m
540 0 l
S
Q
BT
0 0 0 1 k
/TT0 1 Tf
-0.018 Tc 0.018 Tw 0 Ts 100 Tz 0 Tr 12 0 0 12 36 747.3099 Tm
(ABECMA)Tj
0 Tc 0 Tw 8.4 0 0 8.4 87.3439 750.4559 Tm
(\256)Tj
-0.018 Tc 0.055 Tw 12 0 0 12 93.3792 747.3099 Tm
[( \(i)0.6 (decabtag)0.5 (en)0.5 (e vi)0.5 (cl)0.5 (eu)0.5 (cel)0.5 (\))]TJ
ET
endstreamendobj49 0 obj<</BaseFont/JHWGPK+Arial-BoldMT/Encoding/WinAnsiEncoding/FirstChar 32/FontDescriptor 50 0 R/LastChar 174/Subtype/TrueType/ToUnicode 51 0 R/Type/Font/Widths[278 0 0 0 0 0 0 0 333 333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 722 722 722 0 667 0 0 0 0 0 0 0 833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 556 611 556 611 556 0 611 0 278 0 0 278 0 611 0 0 0 0 0 333 611 556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 737]>>endobj50 0 obj<</Ascent 1010/CapHeight 716/Descent -376/Flags 32/FontBBox[-628 -376 2000 1010]/FontFamily(Arial)/FontFile2 52 0 R/FontName/JHWGPK+Arial-BoldMT/FontStretch/Normal/FontWeight 700/ItalicAngle 0/StemV 136/Type/FontDescriptor/XHeight 519>>endobj51 0 obj<</Filter/FlateDecode/Length 323>>stream
Hâ\íœäÉ@∆ÔÛ9∂á¢µÌÿÇ≈v¡√˛a›>Äùâ]aá—|˚MLÈ¬å˘…˜£¢<ïÆ!˙Ω©pÑ¶u6‡–ﬂÉA∏‚≠ujùÄmÕ¯xÕ_”’^E$Æ¶aƒÆtMØ≤¢OJcò`q¥˝ó*zCÎn∞∏’¢ÍÓ˝vËFà!œ¡bCFØµ´;Ñhñ≠JK˘vúV§˘´¯ö<B2ø◊“åÈ-æ6jwCï≈tr»^Ë‰
ù˝óO≤kcæÎ†≤Ñã„òÒ^xœ|>o◊3S NÑÊçÜy'ºc>	üàµh5kµh5kµh5kıVxÀ,>ö}t*ú2K?ö˚—Öp¡|>ß‚ì≤O*>)˚§ZX•ûÁ1mû;0˜h¸Û ÁπÛƒ[áœø¬˜H≈W˝
0 mIûXendstreamendobj52 0 obj<</Filter/FlateDecode/Length 20198/Length1 47336>>stream
Hâåï	XWÄ´¶ª´a¬*Œtœ@O"aç´,´.!xÆ{It7ÒÇ"á†‚ô®dÉ.ºV@Tº5"*^ﬁ3xFW◊œ¨;¿‰±Ÿoø|Ÿ7_U◊´WıΩyø™Nü2-\!8à6¸Ωû–6ÃL¢cSb“r¯äÁ ‡ÒiÏÙtπmŸsÄ8*>mBJ€º3ãí&$œä/ΩΩ|"Ä4í˘‹‚b∆ﬂÙ|3†7ÛAhs¥≈˜ﬁƒT`BJ˙Ãˆ˘iÄê´…©±18pv@ *6øô33≠mΩ0ï)yRLJ\÷ëÙÉlæÄüêñ:5›7 ä^;÷”¶ƒµ«˚≤ˇ[wUup÷
Ωÿ)¸€û\-ƒ´<ùïF‰Ué¡7Bê˝$Ã¿Rù˘#ÜêÅ˝ÏMB}ÀGÿK«}ÄvªùÌk ªœ¥
∞uCo∆èYÿÖ	Aªì=U*GÃ∂»ÒâNŒjçãÎ[nÓû^ﬁ>æ~ù:wÒÔ™’I≤ﬁ®ﬂ~ß[–ª¡øÍ˛^è_˜ÏÚõ–ﬂˆÓ”˜waÔá—ØˇÄÅÉˇ~»˛¯ß?˝pX‰GÒóø~ÚÈ»Q£«|56:∆≈éèãüê011)9eRj⁄‰)S”ßMü1s÷Ïœøò3w^∆ó˚*s˛Çøg}ùù≥p—‚%πKó-_±2o’Í5ka˝ÜçõÚ
7oŸZT\≤m˚ÆtÁÆ›{ˆÓ€‡‡°≤√G è;^q‚‰)8]y¶ÍÏπÛ’.^∫|•jÎÍØ^ª~n›6ôÔXÄwgaG!Ê¢]%´F™vr‹0.ïõ∆ÕÂ≤πÖ\wô{ÕªÚ√¯ÇópVx*º"é|»ü$ÍKQdS¥â⁄$Ìimµ÷Æõß[ß˚^˜FÚë¥“ i®Ùâ4R-}&ÕëHïRΩdí^HØ§ŸM6»Fπª‹Cë˚ ar∏<PéíSÂyÚ
˘†^–{È˝ÙΩQﬂ]ˇ°~Ñ>Jü©_©/1®dp3x|]í°õ·]√Cå!.@‡†W@Q).äª‚≠tR∫*ÅJ∞¢Ñ)…JÜí©d)ïÂJÅR™ÏS ïcJ•rQπ¢‹R√å∆˛∆hc¨1ﬁòdLNû—›Ø∏K±ﬁ¶≤Ö⁄¬l·∂~∂Å∂Ω∂'6{”∏Êö_67µ¥4Ÿõ˜å›∞|®Ù™Q™]\ …•s≥πLFm1∑ô´·~‡ﬂ‚#˘,a©P#|G@FMGzä†h1RåZ≤∂R€¢]Ü._˜R©ì$KC§»vjc•ÈêT%]óÓH/•◊Ï≤{2jAåZOπOµDF-WŒo•Ê€Nm®~∏~4£ñ€AÕÉQÎl–µSã6åo•&ˇµ»jπJæ≤ΩÉZ5£vìQÎ€A-Œò»®Eß3j~≈≤mZ[oF-¬6¿6ÿVokjäjo•&∑d8®ŸÔ≥˙|¡§éı£˜ôts\ã£˚ _√¨†∂l™i∫ ∞g› Úy(¿˛≈P Î<ÄG¨∫≠>V/´á’ÕÍju±j¨j´≥U¥íU∞rVïû:ﬁ4Œg≤íIf„õª%ç3û%2ªÏY¶≥Á 4$6Ãj,∑^∫‹∏ÿ∫∫°§!œíg)¥‰ Xä˘~ñ…ñ±l÷√aÈe	462áô˚òCÕΩÃ=Ã›Ã≥øŸ€å¶Á&´È±È°Èû#ÀTe:a™0ï1Îåi´i∑iê©ø©ü)–d0ÈM∫kè7≤ç˜ã˜*X	Æ◊âk≈5mÁ§'Óz€µ÷Â© \lk◊b]ücú√àdí!d1ΩL8Ã¢]òÑR°x∏-€I«§áSOßÒN˘Œ µØ√´ˆló¡C¢˛òi÷ß’”‚mÌ€mı˙üÕ]‡uV˚,Ûóˆ˙IÊuTá=ÍˇàÎ∞‚5aöÑˇ	‡`3d¬|.
Ú‡,Ä≈ê`lw»fHøÇÂ|ã`d!≤ÔÈÿ€·ü^A!î¬9®Çù0b!∆C5ƒ¡Y8ó·\ÑK-ƒC-\Åÿ‡9,Ö´Pıê O¿
_C"LÑ$HÅdò˘ê
ì!¶¿TòÈ0f¿cò	≥a|s‡(ÉòsŸW˛Kx
œ‡Ê·*T!á<
`É&\çkp-ÆÉfhABù¿éÎqnƒMòèËåj‘†‚fx?‡‹äEXå%∏∑„,≈ù∏w„‹ã˚p?¸Æa6Ê‡<àá∞£+æÖG∞›–=–·.z°7≈cËÉæ∏ècû¿ìx
øA?Ïªav∆.x+—ª¢ux´‡¸Ó¡}îPF=,û√ÛXç"^¬ÀÄÅ®†Ø`÷b÷„U(«∑ÒÏÜA ‚5 ¶ZHãh1-°\ZJÀh9≠†ïîG´hµHkh-—:ZOh#m¢|*†B⁄L[h+Q1ü»'Q	m£Ì¥ÉJi'Ì¢›¥áˆ“>⁄O¯d>Ö“!*£√tÑ È(£„TA'Ë$ù¢oË4U“™¢≥téŒS5]†ãtâ.”™·õ¯fæÖ∑ ††8ÅÅQpúµ†°Z™£z∫F◊È›§[tõLd¶;d°j§ªtèÓ”zHèË[zÃj˝)YÈ˝Éû„uºÅ7ÒﬁFì∆St=DO—KÙ}D_—OÏ$v˝≈Æ¢V‘âí(ãz—†Ò“xk|4n?“\ﬂ¡]i¿ﬂ}ˆ˜Ï>œ˚ÏíP!@ =Å4,àÙN("**zàûtF±PQi	Uöw'**ŒâzÍ)V:“•Ñ	ÑöÑ»≠wsÏ_;;;ÛÃgvø_9(á§DÀ9*«‰∏úêìÓ≤´pïÆ ]q’Æ∆]u◊‹uW¢*
∂ïmmìmäMµi6›fÿLLñÜ“»æj«€	v¢ùd_≥Ø€…ˆ;≈æiﬂ≤o€©vöùngÿô∂»€Yvv∞38hÁªÌ\;œŒ˜Ø◊ˇä-≤ãÌ˚Æ˝õ˝ª˝á}/ÿÏˆ|‹oó⁄˜Ì2ª‹Æ∞ÿïvï]m?¥ŸèÌ˚â˝‘~f◊Jcâó&“T§ô$Jsi!-%IZIkIñIï¥HQ§ò:E^†;©3›E]®kdu£Ó‘ÉzR/ÍM}®/ı£˛4ÄR!¢¡4ÑÜ“›4åÓ°·t/›G˜”à»lIó…î,…ñ6“Vr‰îúñR)ì3í+yíOSiMß4ìä®òf—löCsiÕßwh-§%QçD1HTÂÍú:Ø˛P‘EuIU®JU•Æ®jï©j‘UuM]WY>[‡É&hà Ç° Q®u!b!ÍA}’@C’VÂ@#hÒ–öB4ÉDhÓ3⁄€>o$©\ï≠T>¥ÜdHÅTHÉt»ÄL)êv≤O˛ê˝rV Âúúßü ≤°¥Ö»Ö<»áh7¿çÙ3˝/¿ã0^Çó·x∆√òì‡5˙^á…Ùm†ç¥â6”⁄J€h;˝N;h'Ì¢›¥áˆ“>˙Éˆ”:Há®Ñ”:J«Ë8ù†ìtöJ©åŒ–Y*ßstû.–E∫Dó©Ç*©äÆP5ºS0c©ÜÆb÷£ktÎclàç®ñVÿ„YsÑë[&fYÿalä	ÿ±9Gπ◊ÂlÅ-1	[q,«q=Æœ∏!7‚∆œM∏)'p3N‰Ê‹Ç[r∑äNÊNÂ4NÁŒ‰,lç…úÕm∏-Áp.Áq>p;æÅo‰ˆ|ﬂå)ò ∑pÓ»∑Úm|;ﬂ¡ù¯NÓÃwqπ π+wã⁄(E9F%Í∏;˜‡û‹ã{sÓÀ˝∏?‡Å\»Éx0·°—h¥N¥n4ÜÔÊa|Á{˘>æüG¸ ?ƒ#˘a~Ñˇ¬£¯Qπƒ£˘1~úˇ Oì¸?Õœ≥<Ü«Ús0¶¡tò3°äaÃÜ9rÊ¬<òÔ¿Xã`1,·Á•B*•JÆ@ôº/Keô,óÚÅ¨îUò/’p ıx=Qø¶'Î)z™ûÆãıl=_/Ú`©^°WÍ’˙#ΩFØ’_ËØıwzΩ˛EoÑsz´ﬁ°˜Ë˝∫D”ßÙ]Æœ√y∏ ·\Ü
®Ñ*lè7·Õ≤Z>îè§FÆ 5π.µ.Ä+P5pÆ¡u®’ÅV¥÷(”àiòÖ∑`ºo˜ß;agÏÇ›∞ˆ¡8áÈÊx>àè‡h|ü¡Át*æÄ/˚\4'·Î¯æâo„4ú·3“,úÉÛ|Ø\®3q1æãÔ·r\Ö„g¯9Æ√/Ò¸ﬁ7õﬂp3n’Ÿ∏w·><àGt.û¿R,«ãXâ5XÎ{èıæÆâ5ıL#]j‚M3ﬂÇZ¯DüdZõìf2Lñicrt;ìg
L{ﬂênıiøìÈ¨…‹e∫òÆ¶õÈnzòû¶óÈm˙òæ¶üÈoòÅ¶–2ÉÕ3‘‹mÜ˘ù{dç|˙ˇ˘ËPãvˇõènFòëfîyT÷:p∆ÖÆéãs]óËí\äKs.ÀÂ∏◊ﬁup∑ªŒÆõÎÂ˙πB7‘w#‹H7 çvèÀÅh„hº⁄Ø®ÉÍê*Qáπ6BB®√Hà°	mH!áa(°£aù∞n∆ÜqaΩ∞æ:¢éF*"ïë™»ïHu§F6…fŸ"[eõlóﬂeáÏî]≤[ˆ¿I8ß°T÷kÇO‡M≥^kÉœÉÔ’±‡”‡≥‡˘1ò|L÷}|Ô‡;T5UMìüÙ =X—Cı@]^k%.´¢‘ç¢%ﬂF^æˇ›äïâuõ‹f∑≈mÖ∑do0?8¸;X©€ÇÈÍıúö©äT±z>¯ß'l∆ò±Êy¯QæêuÚ•|%_Àø‰˘VæÉü‡g¯~Öﬂ`lÑM∞∂¿Vÿ€· ÑCPá·ÖcpNxùΩ∆ÅXàÉts›B∑‘Iﬁ‰C8ˆN˚b?ÏÔïﬁè#/∑'ˆ¬ﬁﬁ⁄∏Ùﬁ6‡F‹‰Ì>ãcp¨W¸$>ÖOÎTù¶”uÜ◊¸"é√óº‰)ﬁÛdÔ˘-Ô˚ù©≥ºÍô:[∑—muéŒ’y:_x•ó2Vx±exœzß1^j‹üwzßâf¥∑˙òy\óÍ”~ïyówxôwzÈá∞{ΩÈﬁp™7úâ]Lé…ı¶ìΩÁlØ¯”¡tƒtL◊ÌÙ˙¢æÑÎÇÑˇÆeAB$%H¯ﬂU’uÖœπÔÓÇà≤˛ jﬂÚÑX4⁄®à®+Ï¢ñ™ jvQ”]ÑI5¶⁄$¯;8O⁄hbú§õ⁄ˇÚsQQ£¡tÏd≠µk¨I£1ô°±Vkt_ø∑ ëŒƒ˜ˆÁ‹{ÓΩÁˇ‹sà¨ã˜æëjÎ¢ç≥ˇ≈UÙ.}[ømœ.T÷ˇ@•ß”næMIt‰`ö@ín¢fıÌK‘ì¶“zT†˝©M£	®ÅìŸCıº¡Zh]°QÙm∂ˆÚ2kœ£Jø>ìL√i÷OC•~EªDAÎ∑Ku‘ôF“ÓEaT,ßÈxxë÷—!~∆∫™=·/Pç•±÷aÎeRΩ\„8”ÈO®Ë∞”ömUS?J#Sx¨”÷ÁîAAtoÄ'7…Ò‰Fïøí^ÊdÌ/Ä^B·x1K+pºJh:Íˇß…DgÒ!wÁb«Gãı+Î29© O’tÖáÚD±E∆[£≠≥4Éˆ—ê◊~õ‰π’1#2∆z’züi/j¸w˘∞cà„7wóZø∑ﬁ¢x3ô:ÂËi£C˘}#j≠ZO•†|UπéZ{ üF-ÒúxN;I!Ì,p˚˝é,≤ü–AËÊü®˘/°‚OÂs9bÊT'‚∏∂A€£ùí,∑Cﬂ•CG]ÔD˚†„Ï¿˘s1œ·yËY^ÂÛBâk‚¶åïÀÂ∑ÚÆ##r>Ú≠5…∫AΩ)Ö~ÇÆß∫˝C4˛ˇJ£ﬂ∫NˇAœë√UËc≤—5TGib≤®Î≈Ò&r√ZÌ∞*ÛÂ„Úò<ãxXéâ‹y=Úb‰Õ»	kØuæ”ÁgP!4∫^±ÖﬁC7ˆ1*–OÈÇÌ?8$óÒc†2üWÒ:ÙCG–}\Öî}”ƒH·’y‚–”≤Ëm∫¿Œg≈ß‚kqCshiàÄ'q'*≠Q˚õˆ•t…9PñìezÇ!x«!#lsÏtºÔhA‹T8kú_°¶^{ÙnÊ›œ"©ä®»n¯n,<i14±	›Ê€–≈ÙòG°ëO`Ö√
)Ëùﬂ#∏êãx"? 3πíóqrŸÀºùﬁ[ê 2†ûL1Vîä∞®D˝Vá™`ﬁ˝»eß≈—Œì4πc∞6A+”fhO@Ü⁄s⁄
hv≠∂C;Æù‘.k_iÕ∞ZíÏ'üíãÂ+r´‹#O É¸Ôf‹ìMéé;é;N·LqˆqBNŸÊº„åSå>·TÃıÿtÅô‡\ß˚ëåÏ'vàû≤ñõ1—ó%%@rÏPä®∏Nc¥Ï“’∆É∑Dë,{ÿ;ù^©∞†°|ÑjùBc"yûvÒ9q^˛YåB‚dπU{¬Ò°p”Nd£5‚]qÄÛiè»”≈Fç¯o£K˜_“:~úÁ”NnÊ\~ñás-ùΩ¥R^Ay÷f!πO‡¥TV–cÙ¿áG–9∫Ÿ$ª»gêüi=,˙}Œ€È6;¨k»n≤QY¶˛æíÏ¨7qVãxLFôÎ<N{ÿI3‹9Z.¶˙/]qÏáGÂ#ì^éTÀMÚk∏ïçCî—6ƒ]çCƒ\ÇóƒÿÕD§«!óATSU–≥»zk-em¥ñ[ã¨yÙˆﬁFrõ_CD4bG}Ä˜y˙ÑW#«=XŒÔ{"‘DWπ7ßÛƒC≥c!n¶®´9é9C€+h<˙º9Ã¶tïnr,lìLYÙ¯ÕÔö+Ç⁄A*‡™AÃ@œoìd>NYÌmD<Dl¥ OÃ§CtÜ'A¢Ÿ†ãsä†ÁübıÎ∞‡rﬁçô
dÌL˙rwÂ± Ùº8i=≤Vx:G_B€VîØ,‰O«Y7ÈQ™ ÖaTÃ∞¿;4ô’ßÖæ˚≥ãÚ9çˇà}!DhWÍK#_∞†¨»$+GTkq«Xò∑W*ç‚'¡E‰∏Kâ<ôÜF¶Äáì¨I≈èrÒä®¥Í¥ß#sÈ#⁄õxÂ¬üwÏTÔò—£ÚFÊé»>Ùë¸†ÅŸYûÃx(#ΩøëÊ÷–Øoü‘î‰ﬁIΩ{ˆËﬁÕï–µK|Á∏N±1Ná‘Sñﬂ(È*#§dÜ1~|∂=6¬òﬂ7R:¶
;ÆQz(∫LÔ∏“ãï?˚øïﬁ÷ïﬁˆïÏ“Û(/;K˜∫:Ê3ÙF.+	 ˛µœÍ™9
Oå¬k¢p¿n76Ë˛ﬁU>]qH˜´¬ÖU¶?‰√qù„
åÇ ∏Ï,jàÎ∞3 ïd‘4p“hé"…ü€ (∂òR)ÜœØíüÕÅ““˝·
U\˚R›Ó`vñ‚ÇŸFπ"#_%x¢K® JF9TLîå^mKC´ıÜ¨&≥æ—EÂ!O|ÖQûPZ8h”ËÊ]üJZ|±˜wCﬁΩ Pw?6U3˝Ω´u{höu∫j*	‹èu€ø¡ Œ¿^ë^2A∫J,*’AM¨ØI›ñƒñ™UæJ√oœÑÊË™ìëoTôsB0Mä©h "˜ÆîÔ>Î<•¯usj¿p´1©F0ÏÎ”–ìÃ)ãv'{ı‰éòÏ¨W∑V≈6tMh‚ª‹T∂„¢PtπMi◊,€‡Jü≠ÉìÄôrÏü 2gÁ`û có™ÄE™UßÇêÈ µÁÌ˝ ëÓ2tÛ¡åÊkg¬m3Œt◊≤A€O⁄]¯{∞ÚxTf¶Ì"1∞)xÕŒZÿ(Ü5.PC∑·`Ó ®ﬂÌ∂º∫—KÂ®%%Å÷±NÂ©ª»;»T"dcöÓaßŸò%˜0Ì€C<y·r¢Dõ—˛IpıÍ·Ø U‹ÎË V|Q©QTR–˝f®M∑ES;åZÒ9Ì∏6Hı(h©¢©ZßúŸæÿ‚ïL««uÍ
•¡)£¨*Wh|Îo0ŒÌ˛ﬁ=ç1±˜mj¥ZÏ]—øÔ∂µq©r=«#;å;poj‡Wfà¢©e¶◊WàdöÖÜ^hÜÃp£µ§‹–]ÜπOl[ÕËûA≠˝´SUa}BTq.úUP~É¡´Jºº™ÙlW{l«üôù}ÃÓ›yÔŒ˜¥èªÛÛÏ3ÁÛyync∏ÊQìì,ê&`óH%á ´RÉ’DR‘í&@ï†*I(M
ÿPù¥¢‰QıTî•-ñB¬CDçÎPÌı€≥U©{7ﬂÏÃéfæ˘}ﬂ˜õoVÆRäºº|≈ ¡dﬁöˆûû©àXˆ‡·«¥à⁄Ol
bédt7‚©…!Y§&FI‡M¬ù¡uàAvÍG˛∏:ñ.§´£ÈŒBe‡]—íå:£ŒZN¸Òw~\Á—°Á!W@œôÀHˇW§¢∫#VˆG$ÜSëK:ã´C$"ØÎ2˚⁄v0Bìî–Ÿ7Ë|„9kE#_Õ´yî…®i÷¬ÆÆ#”T˜Ù≠Ñx ]>/Y˚ááüy‚•ÛªzÁL´6ó]«ˇº	9$9k^2ªÔ1è\gi24—Kö,‘˝ı§^Ó%ΩÚ~@Ù®Cdíä‡ÔR-ùÏ∏§”)Èk˛†Õ“∆µ~û•MæpÌae‹sπi·ZΩ.OπH∏GªÊœ™\∑Î‹˛∑⁄;ﬁ6óºwÔÍ¶;¯7∏˘s ΩKwÕQÛÃk%êV˙2~dâ≈+:õ—¶	1bÆx^g±iö†ÉÄ÷}i¥æÅh@ç¥ëè…Õ∂ôhü±≠GÎ…Znﬂ'ı 7∏≤E∂¿Âd∆®»0d?b9$Y£4¬Â</H≤Õï≠%î`Hìk	«	îÂ›!àÑßpõîl>_Â»”∫∆•;N?Êpé‘Ë,Ãpíı3¬ÜI¢0ÇExÃîUœ¯„‡Fg!0fdGç¨ø∞¯—µÛø'ú2ÈŒº”’÷ú.ƒ„Èù|"æÛGv&¸V%™ÈÙŒN
dﬁÚßò∆Ïä˜ ∞'îÆéS ÇÜW4$*M@j¸§@gZOŒÒ“çr√Q7«ÒÁÃ˜˙øﬂf^$≥q[„Gqß9»èøB"ÖÀﬂ˜Úﬂ‰›(i…=≥•˜9∂6~I«(eQbM—ZØ+ÏY‚!IœqÒx ´´j]n)R^ã©®^Ëáõ@G¨˛∏€ …A¶h‡#ªıh2°'ñ&÷$ûOÙ'ˆ$'§H"ô âÚ™ä∏ìn‚ŒëüNmÈö Àä¢N’»é≈≥ù˘Q#_ä(´8€öç,ê–Ú˚BmXd hU˝'›m∞·ÑQÂøXïV'Â‡b √MMÅ‡D/$KÇ )R;[S3¶Oü¶’’◊UsŒËd£ÆzYÙªﬂÓ\πaıé=∆Ø6/2ø0Ì8ˆ«wø››±®È“1Ï:oÔ“∑}ƒáû:∞∫˜Ìx˝ôÌœûÕ⁄%B/öÔ¨˚[Ûg|a»‹ l∆‚ˆß≠X{∫xù_±DÎãw∞]Âªºá–/Ñ˜ŸeÓ≤Ú/é’≤ò-fo(on‚7±º$∫EüœÌÛ5êFÆñc¸~?˚ê˚ì¬g»zø£"<9(A‰NøV™eH∏tü*ï∫√•9:Vó·%e∏L˜¯µ≤éÈUÆ©2Wv◊Ò∫ãJSìï∏“SXƒebXLäêﬂÓ¡ä&Ì÷X¨clRçŸkq´∂^åñ$2∞aòhu9Uç¯º>Ä¨ú™∑55ùfp∏›¸ÀmÛoÊÀ¯áX√ˆ£œ¶ÃœÇol˛ıü?8º˘©xÚ´õ¯gx%˛>ﬁ{h’â_∫eﬁ7o›ﬁg!∑.z_Åá*hè>G‚©(’
Æ0èì¸qû<„h-PπÃj©oGìëÇï`ƒû¥ÎvŒNY?iﬁf˚_o+m+›9öMˇg„¡ÀBm<x8ˇê≥q<ƒiK≤’ıD'À^öøIF
Æïægæ˚çô˝¥.Ø–ﬁF¸∫¢puRù¬Qs0ùŒ*gird÷lçÂä#Éìµ~§2Ω &…ü≥€2ƒ°,ªI%UYXÆ&M4¬öÅ™˚ËZ∂^ﬁB∂“#Ïò|öÀcÏæÏ=D˜∞CÚEˆ°¸	πB?fü ◊…˙ª%€∑∞≠Úãd7}ëÌñ˜qÖ≤ñ¨ßΩ¨OﬁL∂Qq>È†ÛYá‹-u≥≤ËóõôE56[Œ8Déÿ®¿òÏ!AÍc‚AÈaBÅ\yõ(¶á-Ñ¢¬q∂T≤kä%Jªt(vM“ıöb	Ë˙•ÆZ/äƒ¡˘àâ(#…‚≈L⁄ÈÚµM0òÅõÛÍÂº’Që+Œ÷ß¬**1ñ‚h9«Q¢»rä#J`ŒF	±…¿Ú¢v`G€≠K–0ôiqIC„-Ü˜u-◊¯î®ã€%,ù›V8´D…ëô∫r "°Tÿ¢2ò∆ﬁ≤	éπ—l>W”w‘t0†≤Öl:ËWÅº°CΩñÂ’´É∂≥˘$sªª¿õ§‚»I%b—¥Qz≤≠ç¢x÷ /¬ÿJ‡åvæäﬂÖÀ®àœòyÛÔÊÁÊ?Ä¨˝‹ç˚Ëèº`„Ö≈4AÁ¢jî¬YΩOJï|»\TÒXÂ¬⁄œ‘´N6=∞ –]∑.–[∑£ÓÁÅ◊Çoá*ﬁ~Paª«+ºıBÉß'∞ÖÏ o
ßÖãÇÌúˆ©JB5©gìΩFè'¥Ω*"“6‘å◊êö!¬§£Lõ¬(§ÜNÑ˛¢°PnE:Ùñ°0®ˆxTØtf¢zÖ
¬‘¢9ÚÉ”T¥ŸÂ&ãû‡[©Üœ•F4¡]/W¶¥‘I,fÔ	€Ÿ‡_ËØf.—∞∂bÈßIåqkCtµ_ı·%æ’æ>Œh˝ﬁ#ìDµ(*õ7¨∞éO¥ÆYâ/ûIg¿`ÒQ#~ÕeEx|¬ÉöC8€ìüh°ö‚¯Æ÷ÿ(Æ+<wû;;;3ª≥ÛÙcÌ≈ˆ.fCçŸµ∞ïbcàm^\j046l©ÇM[ë–R <îÚj)j£Ç†î
b ;4Rí˛â@A•R%—RáZX"4‡°ÁŒÿ$Q§⁄⁄=ª3wˆﬁ{ÓwæÔ;˝ÁÛSÛK_.%[Y¨ß )î’é›M(IäWW''ÇéP™nDA<‚,[2&Vï™ÆNWßAAÄ˜ñM’±¬§´´P˚”ƒß◊ﬁø–DÂó9üAéöq§ı»ïñw˘aÛú’MÛ—íÍœK”Îõß%É˘ŸwÏÕn?Ô\¯≈ÕiÀ◊––∑m—é¶Ç≤‚Çπ”júOïâfº∂¶eb,]⁄)ﬂ
hÿ#ƒ°ãÑÚÙë])LNÁOœ'ï∂≈ﬂ¢∑òŸÇ/8∂äÆk¬U˘”Ë&±)<-/∑ü˜$ "°è·T|aAê	øıÂuFP$XNR1êçr;Ä:ânòœ*Ãx˘Ó3\˚œY¡Æá3±Xg·“DtÅ ‘-¥Ö∂√ﬂ°wòπ¶5K¥& Ë!Hù	ãka’¿Ú‡•l+≤6ˆ]uú·ããﬂ≥ï‘ãØµn⁄º¢}sixhØs◊˘Ø3‰‹Zú=Hé;:ª≥ÁwÁ¬⁄∞ ˆûÅJ∞àø€s Y%´ØîsJN_oæfΩCæ¯(¯ë˘ó‡MsÄÑ¥GlxRxí÷®4Íf6êpSî¥û6©µÃZy+≥EﬁnWéÈïs:/πÕO·xVQSRRƒW¨H çr(%^B4·áú)!Å∞a(a√8"πpz	ª¡≠bÉC¯*ä"˛ FgGÂÂsQ’ [Ë•+,ÿƒÉ¡ñÿ÷;	Oa!bÅÌË!OR]TUß:¨∂ E∫“π'}vn˝ÜUs:4§&|2‡‹C˙‡’êˇû8o˛ûW.^]Ò«´(Üh‡ñ≤cÿsœá‹-¡Õn{ºíe≥˛¨‚°ÂW çG<ﬂÈéêS®T`äñ≤©˙@£VoÌÁy’ÖãÄQÙŒI2Öﬂ(óƒ¬Hëe"o∆N‘g.¨}∂√Æáb0V\¥∏ﬁ°cEÃ±9NÒ–¬∂f£—™ë*…â‰◊°B/sO}o—yÁ±sµo#≤Üïä˙uÀ∂m^ÒÚ÷Éã≥(é|HB÷^2¯§ÛDÛ+Gèú?‹˚ù
˚çVT¢ ˝Ê"Ñ:i&ÔÁà˚Ç«ôc˛À¸eÒBûœß¢‰t∂¡?;r\<«ûÀ˚ÿˇß¿Mˇ_è∏/D±@.–l`ÕñB)Y˚@ª¶QöãÜH∆çíë‹adIô#µI§d*nú≥ÚS(©∏&≠∞ÿ3kc ΩòÔE≥¿ç∂t⁄)Ö∆å$ñ*
§˘-(&Nw©¿QT°y ™à,ç¨éÙDËàıŸ¢úÇÑè∞a‚Æmç≠öˆX5c⁄ﬁÄÇMÃ’XÖ≤ôa◊Ò(∞°‡≈¿ eÑ™qÏ
4ÎJ¥˚ 7¿v„˚ßœ˛Á›ØS£73h´;ΩdCñ$<©Ñß{jd˜G›V\|wë]¿Cº8´¬'®®é∆5¿±˘%2´N9˜ﬁ»!ı∆ Rÿaõ⁄∏ÏÖEqÍ’ñÔ’÷"ÙR≈Å√g˜¸∞êp>vÆ¨s˙·∫uu?r±ÔÃ•€\≠@≥ÏÂk∑íJ@Ï¨‹"vW“≈®Ñ,°&†$ô§lTG÷QãÂ¨ö-k)oÅ•ÆíÖÖï1©◊åM>◊$÷ÎMcÎü
˛ù†YB@∆ƒ∏§⁄x1`Ë¥Yäp÷EÄ{–R»M“!‡≈±„< îîy±2ÂÅ◊Ú]·[ ‡Ç+í„8H˛ÒÇ∆ô;Æ\àÂô∏ËxÀ À€Uâ*°/ÿ~"YU¨	œ™Ô¡H˝É√wF…z¯¡œoçÍ·.Œùºè§‹„CÿÖ·Œj2~qæ‡(≈wπu+Á‘\ŸäÚéDÆÇ≈,o0∫1™{UP¬#hTEC™DñÉPÜ’Øj˘54’W8∂ÂïtYX¸yˇÕıÀ˙‡√nƒ=ﬂyyóÛüœûlj[±s€ ˆMÒIZ$™Wñ,y˜‰Ÿ]F ˚˝€O¶øÈµwJ‰¶ﬂ:¸Î£Ωá‡lﬂa8	ºF±ˆ"¡C3!∆ÊÁd7öÔÁØÛ˜y¶ào„7ΩpÅ°Xé`h
XÃ&Æ∑·…V–Dña9⁄Or¿ôÓYDKS¥ÂÀx	M‡ˆ¡„±⁄·÷.Ø!éòÑ5â0vszYŒ]d—ÁÌ<y‹H«ﬂÇ„¸jÖÛ‹.√.«ÎcÊ0d7söÈgÆ3˜¶àic60ΩpÅÅ≈P 3T£+!,˙[+ô;ÈÕÀ\˙≤¡Î?Ë, ]'zlì·Eæï>˙çRæT∞ﬁW/„©0ƒI"†r≈t¬..Mù"–S¯@Ã´è)MÌ6{M≤”2…˚&2˝B, nªºO.q¡#Ω4U`#ÎüÎ°w[Â°{¡]≤köü©@4Jπ
«j!‹PÅSàêùuÓñŒù¸‚èêHÊÕ≠fëëìÌìÊlÓsäËÿ¡?‘≠‹¸SÏäû˛ã‹√/â]^L@˚ÀÂ)R£îï9K#LJ◊C	´»PHôœ˘π î≤e¬Ë5NTÑ~pî›2äió–XŒUπÄ MW|±å∞«öTÃPhµG=•Rmj∑∫[ΩÆ©°’buÇJÉ¿ø⁄;ÍMõNßÁ5ùÆôªÍL}⁄?)[;Û	¥í–âXwõß·Z<ÙZ()√ÊB§ïÑTL~i˚L0úU°í™dUYà\◊/ƒ‚çÊÚü5Øõ,ØøéÚËÿmg˛∆DA˛≠q…π”*ﬂF◊nﬂ8‚lá¸Ï ˝õG« 	m„ª°°}≈≥[K÷Üö»¶–]íìÒVC¥†~MU˝<VcöF`zët:z™#˝ˇ‡Å˜=ÇAüıM |3kÉﬂ¬A´'¸1ÿd‘€vu5˛HÕör%∑ÍD3≤ä^ ÃX3Y=ñ/9±èÏuÃ€Ì5≥rıCq¡>@¸"ÿÁˇ8Øˆ‡(´+~Ó˜›Ô€Õn!d≥dÂÅí«Ê±ÃbàR^	åR À–éhFf‚H)a ¿ Ñó 4ê0†Ä-€∆ZJx§8”∆2≠¬`ÅòN;Äÿ(˚ıwÓÓ2kÍ?ÌŒ¸ˆ‹Ô>Œ=Á|øsÓ˝ú‚°ÄÀz∆˚l¸gÚüùˇ	zÈ§JÎœ_ì&>GÌéXßK∏¥›„q§“8Ág,2ÓüÅ$úÿ2úâîÏIcú>ö‡\G1°™y“!‚bï.gå€'≈ìTƒﬂ≥~Æû~ˇCÅ'9§_®ö&L¥c¸|áÏı9„Ü≈e∆‚dú€Ìâw9 ∫„îñpJÕÔƒı∂LÍ¯îÕD*Æ	ÙèÕ%ë"B…±ø∑íô\É¶ıT!≈™íKKO˛B=´í¿ﬂ•	~¯KÙπå*>WU≈.ÜtÛÀ@||˛*8[åÍò‡6˚≈ü√Éàﬁ˝´Ôî$çßÂòJÎûu≈∏m\"˛»+†b·‘˙á6ã√∂√1Õ˝B^RûG/À)ÛiÆ1k”õıf„êÛP‹±åO2Ï+”ksV˘ÙeC÷˚vÂËK.u-ÛËyIïæ•n=/¡ÔÒ’G˚¸Z^?=”ó°gMó‰ÂÁ<Z\í∫6çØ#ëïù]RäH9:®ŒÓ|Ñ36nØWÛ^Ù˛Õ´{ßfsè£(kE÷ö¨Ü,ôuJK8◊≠ëBzJä0˙À·õRˆ¶h)y'±.6yÚSÔä'(t2ﬁˇ™™êYâõö=H?Ñé;ôï°¡~‹O
EºõÔ&Sﬂr"ç˚´4N∑>+ò'™B?‹Y™D∂Lp%j2-uÑñÎK·Nïö+1AÊdèH»ıi#pΩ…v£™%ö∂$ìnw⁄(îº¥Õπ¸•iwOãÍãÁÉç¡∆ÛEıˆ?m~SåxcüH;–¸$h;xcÃ˘kñçÙ¶≈‰,∏0π§≤$£xSâw‘î˙b„“È`√Y^z^,Ô8+Vúﬁ∂'xiˇæ‡ïƒà}˚Öwœ7A}úfÀy&0wUˇ~√;Á¿+kKÇ«≈ìÚ”Rs›úCDÜ∂©≥·‚ÁO˜/ºkO∂ˇˆ_+¬ÚCπbKoÔ∑˜„…Ó¬‹ÄW ∂GÇ•TOΩΩΩ/∆áÙD˝‚rÕpóÊ£ÖNÈÁiÖ¨°‡1€ögú°JÒwzcÀÅb}ñG®Û_¿s‰VÕo›«¸
`?êL“Å˘¿ú0fì∞Ê,–O≥%ØQµ≠ì&b/∂?^3*®cØõ~Z»˝ÿk#t§°Ω˝ªÕ⁄åˆvåœ„πJÚ˙
z„c—ﬁjTXñ≠ûlË#¥Ô£?	˚oaõ!”±ç¨±z–›?ƒ¯:»r»Ÿa{©ˆ5^£|e◊sÒYç˛Õ¿L`0Ò·ıôX7œıh;aWd,–O•bN°6ëﬁÇá˝ã√~ìÚ~<	ˆ+õæÂl_4`˚uË>ä≤≠/ÍøÉö¨Á®˜«>«kùÙ(‚døåÎ÷=xw	~µÜ\DYv≤Z`gëqí∂„9(T®!!w—≥˙ºÉìÙ¢πçˆ°ü¥,‡+©}Is$Â#~s°∞:?T|Xƒ6X_Bì◊…]ÄjÏ}6'éûß‡ΩŒ≈‹o9◊WÄgÉÌ¿Ûlˆœ1«{ø'*Çá1˜3Ï3ïÅ=á)¿˜–{•∞˛9Ëjü–{I „’àÈQ‡∑¿lCäga(]-§k-÷m»ÅÄË63ﬂÄÄüÁ`Ê;_¡Ê&ÛÉπaúQ\ù≈∂á|Pπ∞!ú3?≈˙˘@2‡5è–ìax1ó„≥ê9À˘—Õ‹bŒD§‚Ùr≈˚ˆì9%_3⁄i€†ˆ∑"íÛzkYÍ.eSìﬁEÃYÊ[Dr\òkúèúa9= ◊±·ãıC◊¡≈àåƒ‚ÅºHM–YanOª©T^¶R˝ïµê[‡ﬂªËÉ?≤5,É ÏÌ4Ô≤kwÙë€∂.QçΩ6…Vƒ¢ãv´∏vi©≤KF´u” q÷h’V´ˆ…æÌ°1ñåË±ˇµˇˇÅˆ±—JK–æetY¸Ÿ¬9aÎô@JD¢ˇ8∞cœ€ÌÀ≈)[9≈õDwÄgeÄ& óÌT$]@úF¢ø‹|\’›Ë?#∫©ÔÎÁ6•È7Q±óˆ1ŒÄıCNã‚—w8◊óK·k_…ú·∫i@&#Ôﬁ⁄ÄÀa|\ß èÛŸ¿ıYù®—@}àØVœ~û•]êØF¯Ÿáßc˙”÷óó}%ü-\ﬂ’ŸÇ<Öıˇπ>rç„…uéœæ»¸æ2j}#j«_TÓ§ p^è2ÅÒ–Ò~∏é¥·Ê|9z√¸ì’f+≤⁄ÙsVõπ√˙Ömπ’aû¥v¡Ô—Œ‘ˆP-„|äú•'>#Á®ëNK¬ı¨IÕ≈˛Í≠PuÄÃZ‰_5-Ñﬁ|ÆrÍªêwà'ÙΩ,—O‰UjÄÌ˝ıc°~9ãJπ& ïh£5ù«ùzÉü)o”J9ÌCê;iÄi£ïÊÔxç’©˙ÆÖ∆∏œ®§◊¡ªÒr=0ﬁ¶π¸Æÿ-◊:«Ô9Ô±Ø°›6áØRìÏÖœÌÒåí;üxÌ	´ó˝≥=LnCá<‡5¯bM	«cõäEªäQ£‚0b¡:Õ?´˚·ﬁdÏ•Uv5ŸG°>›%èµDÌı6Õ±T‹•:ØˇÖ¸Ë« ©ŒH¥˛≠¯ƒ≤Ù^‰P7Úã!0Ê¢d£õv"óÍT|BrÁèﬁM.Ê¸õ≠Ó›‡¯Azﬁl•çf;x◊Ö≥†Ô≠æ,ß¥7ÀVÎÃ-Å‚Ω—?C›O¯ú
Xqæÿ⁄iê-Ä˝1ámP˜?Ï´_áΩ[©µdíΩõﬁ4S(«#_áY!®ÁóÄ’¿∆T_|Hä·–±ä˚µ≈‘+4"Kp.»√»Ωù4Io∆◊ÿ‹n—À⁄xZßóÇw=83tZ≈œr,yıö™≠ŒüuÜÉÚ’º$ú„7h∫úáıÌ¥HßE∫Öˆ †|ƒ:„U?∆=Î)Ë	CÀ√öönn@{ºuÑÁ©=æ∂í≤ñ≤’∫(([#`õ˜GŸ‹Ø~>∞ΩhG€À∂>∞3l„˜Ÿß¸dΩXßÊ¸ï&!NWÄë!ú°’S+Üv˜vZ-∂YÔ!Æèı¡îËgπZ‘”)W”»qê∑Ä.`>ôKk°˚»¸]¿–~É⁄âÒÉ¿ØÅO#c—‡}æØ?Úãˇp_Ó1Vwˇ›{œ=gw•ÇtY ´†ªŸ"VPäÆ–¯÷uY›j!µ]åÅ`K≠1µ°*W!à‚RK#]bµmD%•`¥£`—[Í.§ >¶üﬂúôª◊≥{w≈«?Ω…'ø3sÁÒ;sf~øÔòM˘ÂlÖú°§ÀâÈÂü˛œ∂_-cÉà√cÃ&%3OJîX…»Ù^ÍkËó(gG»=¡l⁄VI¶'ü∫Éﬂòºuúîˇé˛{`O¯ºïgá®Â|ç“¸¸E¸˚<}oÜ´Ì˙? ß⁄=Ùö<2/§ûëÈ©wÃ‚y®ƒe)≥ÎπZéÛﬂâ˙Ö∂>Ò˝ÿ+„tÕìı<ü©¯rÚªˆTf‹∫|¸>D2I	ﬁ¶=$À‰ÉIJ®{¨ºs97o!™e,Î4%®∆óΩùÀa≠§ÁP^…ˇ˚Â[JÆ\-#m´∞∂√÷zìíﬁ+CïLˇUŸˆïºuΩL◊5≥Y˚⁄˛ˆ˚¯}û¸>Ùï`ÒË=4sµî%m˛ôMû€dùè%]µIúç1Ö∆¸Ç≥ÛlÖø|•Û∞œS¬^Ö>Ç¶˚z£≠˙{Óò€Âë∂Ö"-œâ¥Œ ëÉ[7P7çÁì±A)uuX≤QÀ;<œ·ø]∞»NWˆß<9Ó€∂÷çwR‹_˚AÌ¥åã˚∑,ÄU<ÔvYÀÿÂÿ√¥o§_-–:;ñÚÄ˝–˙
Ââ@ﬁoˇ¸lE∆¥é¶ˇjòßz§ã{Ëók‹?>´≈«Y#´9Ò7yá¯Ã÷œlÚÆ·øO÷ﬂ%:Y∑hæóîºªO∑wo˘ûü8¡¡`ëiCSFVG£e≠ÊV˝Ë¨’€ª≠ûLYMÈ,Î©~ÙRÌ¨˙{øΩÁΩå?◊ÀÖ¯Uc˝Úy$/∂¶ÀÂ*8¡A‹ìJ⁄ºä?ˇ!ˆÙ&øF[.Q$˛Mè1€…]Ωâπœ¶û1á±;($ó˚úÊckß€9ß}•Â£Õëü#ß^‰®K‡Îg:íˇèv|SIÊ‚£•ß‹˝πsyÅùüßøhŸÁyOÒD©P¢I¯=©≥.MÍÄû =È‹£-'uG^y£“Õˇ∂ú‘%æú§”ˇù˜^¨g 8oûƒπ;Z8ßÁ≥Õ˛ºzíÁ8wﬁ\9ºYŒÖ…ﬁ¶ñƒëëPÔÓ]√x&ö5øµJE—©†¸<«SÁ>Sü˙Z˙ør⁄o•;l€Àµ=ÌÁ‰æU}nı!kf}_¬∑8$£a·∫‹∑Ê…‹€2d^ΩÁfﬁ3áÎp!-X»rœõ´˜= Ω)˜&7 †ÏfY≈Ûl	∂Ñ¯^?&fOÀn5m·„∂Õ¸Wº)SâÛ3≥ôÏ3ÎâÈWfKπjÃïª5wBDﬂ{ÈªàÁÿﬁ—AY¡8ËßÊÄ®î<ÿ,”¬≥eu∑kÜü“ˆ'¨Ì”Ô  ‚¸`˛+uvT8ãy»W·Hõcé•ÓÑ@xØ}2jÉqr
ú¡ﬂÅÀ3G{çÌ{{˙,iÃ¥Hc∞AjÔ©íu≤ºx´,/‚}äk§!˙Ü4seY…xY…˝m%Â•öØ|^eÌ€˝3⁄m]4P.”˜fÏ·ŒV˚wNjÎﬂ8‚ÍfM˛ºæ_Q%kS≈˚oïïîóˆ§mÁtá`r>ÕÕôÅfGlÂ◊.«_ùÀ˘5r>„å·π‹ÆÌj95iÁ[as59;€ãqzYﬂÌ'}Òs±.mÖ¥ê◊&0ŸÓõ}2_˜Â±–◊’U[]p∂\»˜∫J≥§4X,UÈufKÆöI˜Q∞”ÓŸ≈Íß¢˚ÀÌπeÈá9£oH_}v…2æ—≠é_±O◊Í⁄§ﬁ˙¯<œ>6R≈ZÌÔÄ≥ï√Ïa.ÖıR´ÇãÌ˛ÏÔˆÊÄ‡c9/xÿÓô„yˇbÎÎR–µõ√Á∏ûx∆ôÚ÷Æ’÷}±\dﬂMïyÑ}À˙dV£Øˆ…Âæm—˜§:Zƒ~}åΩ3üyß»‡p%í“4Ù·bﬁ{2}ÁÀ¬ÙGR°§Ó4{”œ8¢dD*î9±GRÔÀôÌ2áıZ	?áÂºO≥¢Ìl€ı2√qäí^ó ˇOÉ˛z¸lÎ^r4;÷ÊA;Û.¥§ˇ≈‹C?ç_ˇé} ÙaØ&†œïéƒ˝∫‡R÷Í”T&°Ø⁄—I®W{RW_ñÑzµÁ$°˛ú.¸(‘ÆêÖÍONB˝…_ÇÖ∆ñÑ˙a›¯wAÍ/8
?
≠Û$‘Ô∆è©I®üöÙÉ¯Ù<Àı	Õü‰Í∞±gag√£<sÔ53]yõkwM˙3ÉÁ¬⁄êèÕáp?\‹ÅŒe˙≈}¸<ÊZûõ∞ﬂèÁ“æÌO«s[‹úÌkùØÑ?Âï’wÊnﬂœgÁ∆èˆM±é1˜πˆ‹º≈~∑üà˝Y‹^ˇ◊w¥˝Í¿p¸qºMﬂÌí‘˜ˆFûk¶ˆß‹ZÆâÁm„ûh˙√(˜ˇ¬é∏ €∏'.!Œ”\]îQ´±÷∆‹:Èõó´¨∆‡˘çw!ﬁg ¿«%™4Ü€˚$qﬂﬁ'_Cü†,√…#ª(øÀ∞è%nﬁ"#té‡#Ù
ckﬁUÕëŸ%+Vkl∂π˙lÕ%gIm8üI„àvJ}8ùxﬂeèâÆ°|5∫„óRF2Øhµ‘GØÛF¶êØ*}Ωø€Ü∑ì-ócº=fº‘ˇô˙[–RerÅŒù&”X≥”˝‹πuXØ˜\˚›u˝◊¡ë÷o√Ö÷g¸≈á`s±j']ìe!˛îk˛d›éRÚµDŒU´åàä—O ¬‚¥‹Õ†ùŒı[’uπµï9 ˝¬W•<˚Èg◊˙Aôæ…∫^áñvñ¸PMê≥ÎyØπ/ÿ∆X2$€O˙[Ì∞€é[?∆:ÙÃY≈û(KÍØ£r˙ÊeˆZ 7á{µö;Ûﬁﬂ⁄<Ωa◊=ªQ.ÆïÔGú>LXÔS¥[¬›vL∑˙k¢Lèn$∑nê)·©ÃV¢”œó ¢2=(˝UüE3Ÿõ™◊»—·ï]%úqS…˜y˚htÁª∆ùπ◊`ΩãUqΩ=õ‘µ›ÁÍg¡MPˇØˇôõ„Á∂ÉÒ¯ˆøõ‚ˆm´8k)NT˚AG|‚ŒÏ«˙ú∑Œ+¨¶ÔlùÆóÂN∑vo˙≥ê’3Ãw.Õ”√±ûÏlßb'¯2ÁÛ’’rfß◊—IK€´Ì¨5ú›„Ïv›k™ıí6OWwiÈ◊ÎŒô∑±Æ^P¿÷z}›ìÕÈÔ6ß◊{≤5∆húÚ6∫C"’†ﬁ∫8÷´√:]ﬁqJ⁄ª—io;´˙˝<÷˝Œ‹‘Ó–}ßÑÕ¶)lŒ∑ƒH»¸ï›· ⁄â5M—£VÔä›ﬁEøª»/ÉMS—‡|+}|^cûÑ-6|è√ÊL 4eRÃ≥‘4°’Û,πc©ΩüTuEÿ¿ºÃ3ç˘à‚—ã¯K–|◊hvâ⁄Èw•}«fÕÖ›≤ìyPE∑1œmÙ9¬<G¨mV¸∫˚uÙÎ¬ªΩoøó˜ŸœÔ∆˝¢ﬂë1Îª£w1Õ óıﬁ›˘û›j^Å=˙ÃYzÀ›K∞¶YI¯|ßı{?Ô—•1zûi€‰hf]ˇ◊ÂxûÜtoeÿ
Û8ò'πöÆ¨gQ	˜õ◊£ÛÕ=ôßÃ!EµTWÎ]e^aÓâV`w“gñΩ#©ˆzã≥Z¢Ò]q±ohÒÚ±ÄÁ!öÎãŸ€B¸yNf~ZÛôK\^Û?ˆÀ8 ´ä„gÔ›IIvÛZÅÏóÚJI“®ˆ!ÏÜñÅ∞)÷N≈HXIw3õÖ“VK∆‚°•ÄèÂQ†å≈0-›O-	–ÜBZ≠0*÷2⁄2ÖZq‘"„®”j>ˇÁ~_h,¥TùÈÃMÊ∑Á‹{œ}|˜qÓπhá‡/ä˝≈e/ÕÛw‚m;>ÈóˆoÙµ“ÂóıNÏg?;Û¨Úw˜GVS%˝FÙá^Ï-nºÕql∆°˜M'ˇ›qı˘^/"aºu	ﬂ÷Ñı™¯e∆∂â*Û<ƒÒÇ∫#Ç4›ªå÷"¶,‰¯É„u⁄h‚¬ó*ÃK‹ªq„iö´8ªN˚Üc"µNßiéÕÒûØ /¬O ◊¿y‘˝bŒFZÖ≤bé}∏é9.íß1è)rﬁ∏àúÂN»FØÑ¸ôûb‘W°Ôï»øÚ∞˙(»˚¿ù`èõ?ôæR¥ÂÉŒT¡ÓáéTqÃAË˘‚Eÿ≠§	‚<Ú¶Å|0›Öm ∆„≤:egä≥Ë„Sî/+\}
 NÇà@∏=/8ÔñıŸ‘Ωk„˚#MÕﬂàò™¨∂ª}1ª€sñ*Ωq
aM V≤óﬂCOªqN´=lE˙úxÜíå\Ü10=v∑‹\È;J7¯6êÈ”W|É©oÅò?à{¯34˛gbÈFÁM‘Àoª≈ﬁ6˚X∑ïÚ∆qJÒî+ª˝«©:o%ﬁΩà≤0tÍì¢@z’›Iÿ[‰·Ë≠”â»|oÿ„≥÷Á>O∂#ñ‹Nw∫æàc-æKä¯^á~Ôﬂ™CK∏}Ï:'∆∑˘<ÃÖo‡Ûõtœp“ªö„ΩÂ∆ÇløGÜÈÀê1ü§J∑Ó40<‡Œ·¥ª’gbéÄ∏w Ä~3ΩõÈW~E“ﬁ≠8_À·[j°◊^ú∆zŒr˘∑µòeºØ¬éâ”ŸÉ8<é:Ø_>ÌQ#Zëﬁxât!ç	†1™ÓÌóOã◊©äëò„Üã”Ës·ª/ìñõi8”∑ﬂ.ÏÈ˜˚˛”ˆ!é°ŸèÜ±nü œKËˆ≤ç≤ìÿKU∞{Pú√ô˝5Óáw(‚¯p¯√”ÿwèÉø´˝˜5ß=ƒÁ#·ÛO√¶ïÔéÅŸ∑"v]»q©Ï∂è∞ü„XQ≈Éàˇ∏Æq>|Ï,ı.õDsîØÖO≈Xép, Ô4ÂÉÚ~ˆ3ÏÉ<Á(˚Òg§≥HW9~âu±ßa-ÙŸ(üÓ¯)ˆAr>ÍÃGﬁ€éœR>ì}üC¯+üC˙˜.A‚$êœ8„ø#gaÉﬂ9Ω€¯nRæS8Ìä?°Ë¸vQÁˆv™‰3ªÿÂ‚%7æÏã1èº7}π∏6/ÙÁΩÂÚ÷ NCpﬂ‘"¶˘'∆ÊX˛¬ª´çÜÛùÌØﬁ+ Ô`-+.ƒ˘|ÁÒ=…ÎƒÎµöä‡S*.zHJÛ⁄˙∂ê¡wÊÈG‡˝‰|uOÛ<æ©|•áÓR}¿«π˚ŒØ‚~ﬂÒ€·{ˆK˝ﬁ~}oπ∞ª∑F„€æÖ{pïØã>Ìﬁ˜–vØÀcè€Ò∏‘ÚWÏíˆˇ-ÿô‰EDÔ€Ï‡ˇÏ3‡â+K>ÊÍ™}DˇBTpÜ(xŒ°Ë'≈©~út(9riJQøu}á4çF£—h4çF£—h4çF£—h4çF£—h4çF£—h4çF£—h4ö+Çá®`"ùßõÈÚì†’P#ëˇmÒ˘ê&*§'+âˇæ®~YP7Rr˛&zF∏∫§œÆÓÖﬁ‚Í~Ë+\=@wy6¿“„Õ„6=oπ∫áFâ;\]P°X·Í˘ª∫∫ÂÍ~ËØ∏:∆#l⁄MôTãˇÎ°≈i1% gRöR K˜R´ ôÇT:ˇ6!?©,™Q£¸‘ÄºE®ü•6ïJ@&`ΩøÕ∞åAO¢.€&ïM»™ˆöas7dÜñ /Mˇã±p´)’¢SØ©$R‹ªAs°5©î”s
π5™CµΩXç’†H-EiVçñ≠´wfmÌıF|q¬òôN•≥˜∂&å)ÈLk:”îM¶S’F¨•≈hH.Zúm3mâÃ≤DsıåiÛnõ]?6ñI6µå´K∑4œå∏,•…6£…»fööw7eñÈÖÔ€ΩëLYî5¶íŸD≥17€îM†r™π&ù1“(…“KSŸL2—V˝\Ó4çÊ—m4õÍilø≈Guh´63—?◊[Ñ	oQãˇ·Í\I´èÏ¶t›Ÿ£óÈO≈€cr=	‡£kÄGÅ§®‹c
ÃË>»‚R%s·±fó›Â∆Ò*‹7Ãˆ≤ìÊ”xdwÊ9ª”äﬁb*9˛&G÷\ßdnÄS(5#±!®V]mxlœ?‘IØH˘∏‹ëõAª–P0V*w¡≥EÒ{ÿ@bÙª-ªË-7«ãQÌ¥Úr˜;U≠
πµÇ¯Åv$8|î∆Ô6`	m vêê;‰ˆ\(äÂÀ≠¥˘m
z<AÎ≠êöõMV∞ƒå∆BÚõ4⁄+gRhv=™≠'Û˙‹∏Î‘÷[˘Öfˆk0Ë5»t˘(~=*lø∆*	sÛÊÇE™ﬁ˝π⁄	ébÖ ÕŸòÖÂ‰ë	ô¢·ë@VB.Ä˘ŸLjúQ+2€—ﬂdòOñe4≈1∆9è»[‰™PfKsÖN?Ks£Ø1Ò≈Sdπ2	 ö 9@rfƒÿ/£jÚWYyWÒ¯VÂBeÊA˘U†RXµ√jP$xPÊceÛ’óƒ≠ºs]l†å„3„òñ∆Ë¡,ßTC©ä…[ÂP
£lâFeêSe•íﬂï€i*‰k‘–Hœ~˘uUk7äÓ'9[kíUPhˆƒÚ‰$îÓïk± kUÁÎ¨Qü0)6Jé¶Z 0«+†≠PõæZV≠+’ÅïÍ¿†:∞˚HÆF…jÿ‘»˚®UﬁCÎ¿6Ëº≠ rò–.•åmv…¡≤⁄è©Ù wàïW»#+œó(≥rk`°9˘†l√>oCõQôµïõÈ˝Úı)◊ZÂ\°5áÌzPrñ√º$ÂPLOÃ0Yô+ãÏçEêÊç!èxQÁI?'xπ≈1§Y˛ÿï/πÚßé¥{ƒqÁPàü±<*ﬁ@cÛ≈oh4!ˆã√p˛qRÏ„QàWDMÜ¸“Õê]ê„!ªsUG#˚ƒ>cˇNÆ Ã+Á∆÷∏Jd§´™pï‚∞)ûáh(öxr‰!—CWC>YŸ#≤tÚb"›˘}Wxããß≈øH/üÿ6é+åœi.%[•™jUùïò%-≤¥(A
mÿ0óô†ÂA¥ÂdÏ†¥…)HFh˛H≤5;
(
‘LÅF›D√%¢R±
r,Ã£z*æ’Ås(z+‘o)ŸEu	∫“7ﬂpÊ˝ÊÕŒwπõÏº·ÙÎ)(«–∂·x¥}È∞ŒßÏ¥‹_äÏ$Bøp'—zøxY<ƒx\¸Aîùq9îËüÛˇ'Ç™lO;øwbzêug€î[b]¨€£1€≤#vÕµ¢ëhÕeZfƒåô53·wqπ'˝ü¢å1S`˜@6¥.n;ÓòJ¸Á§œK∞5îU™P©∆P˙{ø£Z\‹bê¿+–*¥›¿∂uÒ!ÙÙ1Ù	µî°
¥åªIDDDëà"à"à"à"E ^Å4Q Q Q Q ¢ ¢ ¢ ¢@ÑûoDÅà,à,à,à,YYYY"≤ ≤ ≤Dÿ l6õÑ¬aaÉ∞AÿDDADADADâàÇàÇàÇà%¬aÇ0AòDò L&ìÑ	¬$¬¬¬¬GÑÑÑÑè]ü
§â6à6à6à6mmmm"⁄ ⁄ ⁄bπÓj%æ“““"§§§§EHHH´{ÍeZÅm≥≠Bkêfw¿ÓÄ›ªCÏmØ
§YBÅP 
Ñ°@("BQQQQ%¢
¢
¢
¢JDï6n“ƒ˜ﬂîﬂ˚“à<Á≈≥V¨Ò)ÚUˆî|ÖÌë¬Í‰≥˘GÏ&˘á,FæÃ‰èºÃ§ó;26ê¡-`˙9Ù>t⁄ÄA’Cáˆ≈º=È0å{∆ÜÒ»8∂a¥1‡Y‹Ûlxyémx⁄a&∆D›GqkaüQπäÚÑá 8’‚byÁpüù«ﬂúò≥ø5üÖ¯„‚!˛Yà'zƒÎ‹Mw:ì≈&Œsˆâ¿π≈¡∏3››|˙È^ëMæ›±);
’°täA≥P≤ Im!ƒÁÏ…Óê€PöÄLùÇçå‡‚–†◊ﬁ}º÷¯¶èıË<¡S‡:¡(¨È`vÇ◊e¢áo≤†˛Uƒø¬ï{ ﬂp‰t—±?9Ú!Ïæ#Á`o;¡”∞+NØ2—«ﬂ`“≠—À]_ƒykø‰»7v—ëS∞∞ËËYËù‚9ˆnu©ó;ô¸é<õt‰YÌeA}·πáEhz« ÌÆ&ÙlãÁ‹‹>.øïøíOÅˇãÌÒ7≥ÈÜ=∂ö¸MªWnG~á‡ÑtΩ:œáz◊ïˆØdÕ∫-ã±∏µ)#OÀªë¶Õw0Ô€î¬ë7Õ¶x`ø$◊dTñ#OdI˛L^ìó‰€⁄yUnÎi≤<œâõ2ãä≥∞˘∫’§)æ&!mîgÕmΩæÏLg‹Xd[Ø õÌdˇ	÷7d5ı#÷‰Év»¯ŒX7ÆI„ú·7&ç„∆∞w»ÎÛˆ{Ox{Ω^Ø«Îˆ
/Û7˜€vòa€{|⁄<n]∫©Ó∫DÅí	ÓxyR/π2"≥ò‰µÛÀ\7’ø˝Mﬁ{Ò-uÃü‰j(√2óìÍL8”4ˆ/©X8£åÏï\ùÛªy¥*ÒÀ&gósMæØõnç©°W—…n›€búˇ÷ù|ûçé|ç]<˚ZÍà¢–-√œè—´„Í◊ô≈ú˙„x^ÕÍ ˛x>£n,öWs[b@Ù•S[¢_[>∑Â.äÅÙ%›Ó.¶Ú{BaÿÕ˝cAmÛ&ô©√p?IÍ0\£N\ 8‚&¥!Æ∑è(.–€GqnÆ„Í{f:U7Mä±€£ò=ãΩÉ6U( oÚúé‚9øIõ¢Å§DHDR«Ô:HrJ¶¶üáX›ê˘√êy Â‚œcd'f¯‘AÃ)ƒÑˇœc)Êçô  nz…ü.¯”KPA}˙¡ª£jÌ∫i÷W*∫√TÆ@·˙;Ôjø∂§*˛•îZÒßÃ˙ÃÓ›ª∫{∆ü™≥›ÙÂ\}◊^J93ˆL⁄-ïoƒœÁˇïÎˆaÆ‹˘#;ØÀÈ\Òƒ›	›◊π:WBÁä€q ï~OÔ˚lÆÓe…¸´W;ﬁ«{±ác˘‰àØxAoË≠s£+c_ªøœéáÛÍÑ?©˙ ›ID∫ﬂ3›’èÊÅn◊Ë πâ±Ø˘˝nóÕÉ˛$;XZ¶É2j˛bFM,æï”[EŸ◊éæf%}P˜(Køó¬?>óI¯{1íïé< GïJ•§ãJ∏ƒXFÖ3Íïãòâa U!ïG€ÈÉ6óã⁄Í==ÈÊ˛:√ò/Ît∫Êa¨†›ã∑.CT=UCËWÖr„‰¯Ï˚¡|¬{úXv¶gË-bπ1iÈ˜órczæ„x]’ÓúúòEÜF®v´„ˆ`ïuk=≤´Z’H5ÊAÎfç≤¶•ŒtÕ≈ ·“¡B†ZŒc±1-ùÔsÁG„î∏™+·p>\‚¥^ˇªÿ¸`—∂‘µD√ó.HßΩ‘W¢ìΩrÄU∫uVÍ“˘tX<?È? èê≈–endstreamendobj23 0 obj<</AIS false/BM/Normal/CA 1.0/OP true/OPM 1/SA true/SMask/None/Type/ExtGState/ca 1.0/op true>>endobj48 0 obj<</Metadata 53 0 R>>endobj53 0 obj<</Length 5767/Subtype/XML/Type/Metadata>>stream
<?xpacket begin="Ôªø" id="W5M0MpCehiHzreSzNTczkc9d"?>
<x:xmpmeta xmlns:x="adobe:ns:meta/" x:xmptk="Adobe XMP Core 9.1-c002 79.a6a6396, 2024/03/12-07:48:23        ">
   <rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
      <rdf:Description rdf:about=""
            xmlns:dc="http://purl.org/dc/elements/1.1/"
            xmlns:xmp="http://ns.adobe.com/xap/1.0/"
            xmlns:xmpMM="http://ns.adobe.com/xap/1.0/mm/"
            xmlns:stRef="http://ns.adobe.com/xap/1.0/sType/ResourceRef#"
            xmlns:stEvt="http://ns.adobe.com/xap/1.0/sType/ResourceEvent#"
            xmlns:illustrator="http://ns.adobe.com/illustrator/1.0/"
            xmlns:xmpTPg="http://ns.adobe.com/xap/1.0/t/pg/"
            xmlns:stDim="http://ns.adobe.com/xap/1.0/sType/Dimensions#"
            xmlns:xmpG="http://ns.adobe.com/xap/1.0/g/"
            xmlns:pdf="http://ns.adobe.com/pdf/1.3/"
            xmlns:pdfx="http://ns.adobe.com/pdfx/1.3/">
         <dc:format>application/pdf</dc:format>
         <dc:title>
            <rdf:Alt>
               <rdf:li xml:lang="x-default">bms_logo_cmyk_blk</rdf:li>
            </rdf:Alt>
         </dc:title>
         <xmp:CreatorTool>Adobe Illustrator 27.9 (Macintosh)</xmp:CreatorTool>
         <xmp:CreateDate>2023-09-25T13:28:08-04:00</xmp:CreateDate>
         <xmp:ModifyDate>2023-09-25T13:28:08-04:00</xmp:ModifyDate>
         <xmp:MetadataDate>2023-09-25T13:28:08-04:00</xmp:MetadataDate>
         <xmpMM:RenditionClass>proof:pdf</xmpMM:RenditionClass>
         <xmpMM:OriginalDocumentID>uuid:65E6390686CF11DBA6E2D887CEACB407</xmpMM:OriginalDocumentID>
         <xmpMM:DocumentID>xmp.did:5b0707f2-3331-4669-a1f8-b3bb5fecb5f7</xmpMM:DocumentID>
         <xmpMM:InstanceID>uuid:e9ccb478-a5e7-984e-a54c-e534a8c2b689</xmpMM:InstanceID>
         <xmpMM:DerivedFrom rdf:parseType="Resource">
            <stRef:instanceID>uuid:db5659f3-6411-f742-bf8f-b16bfaa386c3</stRef:instanceID>
            <stRef:documentID>xmp.did:4edd90c1-b301-4d0d-b22f-f129dd224159</stRef:documentID>
            <stRef:originalDocumentID>uuid:65E6390686CF11DBA6E2D887CEACB407</stRef:originalDocumentID>
            <stRef:renditionClass>proof:pdf</stRef:renditionClass>
         </xmpMM:DerivedFrom>
         <xmpMM:History>
            <rdf:Seq>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:b521286a-9a99-48db-800b-c0dd2945b62d</stEvt:instanceID>
                  <stEvt:when>2020-01-02T15:36:11-05:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator 24.0 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:5b0707f2-3331-4669-a1f8-b3bb5fecb5f7</stEvt:instanceID>
                  <stEvt:when>2020-01-30T11:01:24-05:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator 24.0 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
            </rdf:Seq>
         </xmpMM:History>
         <illustrator:StartupProfile>Web</illustrator:StartupProfile>
         <illustrator:Type>Document</illustrator:Type>
         <illustrator:CreatorSubTool>AIRobin</illustrator:CreatorSubTool>
         <xmpTPg:NPages>1</xmpTPg:NPages>
         <xmpTPg:HasVisibleTransparency>False</xmpTPg:HasVisibleTransparency>
         <xmpTPg:HasVisibleOverprint>False</xmpTPg:HasVisibleOverprint>
         <xmpTPg:MaxPageSize rdf:parseType="Resource">
            <stDim:w>415.562183</stDim:w>
            <stDim:h>104.989900</stDim:h>
            <stDim:unit>Points</stDim:unit>
         </xmpTPg:MaxPageSize>
         <xmpTPg:PlateNames>
            <rdf:Seq>
               <rdf:li>Black</rdf:li>
            </rdf:Seq>
         </xmpTPg:PlateNames>
         <xmpTPg:SwatchGroups>
            <rdf:Seq>
               <rdf:li rdf:parseType="Resource">
                  <xmpG:groupName>Default Swatch Group</xmpG:groupName>
                  <xmpG:groupType>0</xmpG:groupType>
                  <xmpG:Colorants>
                     <rdf:Seq>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>Black</xmpG:swatchName>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:tint>100.000000</xmpG:tint>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>100.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>Dark Gray (CMYK)</xmpG:swatchName>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:tint>100.000000</xmpG:tint>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>11.000000</xmpG:magenta>
                           <xmpG:yellow>7.000000</xmpG:yellow>
                           <xmpG:black>77.999997</xmpG:black>
                        </rdf:li>
                     </rdf:Seq>
                  </xmpG:Colorants>
               </rdf:li>
            </rdf:Seq>
         </xmpTPg:SwatchGroups>
         <pdf:Producer>Adobe PDF library 17.00</pdf:Producer>
         <pdfx:CreatorVersion>21.0.2</pdfx:CreatorVersion>
      </rdf:Description>
   </rdf:RDF>
</x:xmpmeta>
<?xpacket end="r"?>endstreamendobj43 0 obj<</BaseFont/JHWGPK+ArialMT/DescendantFonts 54 0 R/Encoding/Identity-H/Subtype/Type0/ToUnicode 55 0 R/Type/Font>>endobj44 0 obj<</BaseFont/JHWGPK+Arial-BoldMT/Encoding/WinAnsiEncoding/FirstChar 32/FontDescriptor 56 0 R/LastChar 174/Subtype/TrueType/ToUnicode 57 0 R/Type/Font/Widths[278 0 0 0 0 0 0 0 333 333 0 0 0 333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 611 0 722 722 722 722 667 0 778 722 278 0 722 0 833 722 778 0 0 0 0 611 722 0 944 0 0 0 0 0 0 0 0 0 556 611 556 611 556 333 611 611 278 0 556 278 889 611 611 611 0 389 556 333 611 556 778 0 556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 737]>>endobj45 0 obj<</BaseFont/JHWGPK+ArialMT/Encoding/WinAnsiEncoding/FirstChar 32/FontDescriptor 58 0 R/LastChar 176/Subtype/TrueType/ToUnicode 59 0 R/Type/Font/Widths[278 0 0 0 0 0 0 0 333 333 0 0 278 333 278 278 556 556 556 556 556 556 556 556 556 556 278 278 0 0 0 0 0 667 667 722 722 667 611 778 0 278 500 0 556 833 722 778 667 0 722 667 611 722 0 944 0 667 0 0 0 0 0 0 0 556 556 500 556 556 278 556 556 222 0 500 222 833 556 556 556 556 333 500 278 556 500 722 500 500 500 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 333 333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 737 0 400]>>endobj58 0 obj<</Ascent 1006/CapHeight 716/Descent -325/Flags 32/FontBBox[-665 -325 2000 1006]/FontFamily(Arial)/FontFile2 60 0 R/FontName/JHWGPK+ArialMT/FontStretch/Normal/FontWeight 400/ItalicAngle 0/StemV 88/Type/FontDescriptor/XHeight 519>>endobj59 0 obj<</Filter/FlateDecode/Length 533>>stream
Hâ\î›ä£@ÖÔ}äæúπåZ]ïÄÚ3πÿ6ª`¥ì&*∆\‰Ì∑ègòÖ?—Æ˙NIõÓ˚C◊N.˝9ˆı1LÓ‹vÕn˝}¨É;ÖK€%YÓö∂û>ØÊˇ˙ZI∑)\›πO “•ø‚Õ€4>‹”¶ÈO·9IåM€Ó‚û˛Ïéœ.=ﬁá·#\C7πÖ[Ø]Œ±–∑j¯^]ÉKÁe/á&ﬁoß«K\ÛÔâﬂè!∏|æŒ(S˜M∏U∆™ªÑ§\ƒcÌ ∑x¨ì–5ˇ›◊%óùŒı{5&eéáãxäº$/¡+Ú
º#Ô¿{Ú¸J~øëc”≤`Õ5ãåúÅsr.»X»ˆdV≤Ççl`z,ËY¿≥ÿê7‡-yYË p:Ñ°É¿AË p:Ña_A_a_A_·¨≥ŒJ0+·¨≥ŒJ0+œYyÃ ”Õ√Õ”Õ√Õ”Õ√Õ”Õ√Õ”«√«”«√GôWëWYSQSYSQSYSQSYSQSôWëWY_Q_9s≈ÃïΩtÓ≈9+Ê¨ÃÆ»ÆÃÆ»ÆÃÆ»ÆÃÆ»nÃn»nt68ùŒFgÉ≥—Ÿ‡lt68ùŒFgÉ≥—Ÿ‡lt68ﬂó·}≠P?_dp^	Œ:o‡º•g<aC}Ól≠¯p_˚∂æèc‹≤Ûgbﬁ´ÿ•mææ$C?∏∏
ø‰Ø  Àœendstreamendobj60 0 obj<</Filter/FlateDecode/Length 33234/Length1 65728>>stream
Hâåï	TTW@´˙ˇ_PVA±˚ˇn¯m$å! 0—!àÎ8ãëDgó à "*ÆâJ&»\ÇÓ
∏Äª‚ä"‚∆‚ﬁmÉk‘v–8éßÅŒk‡0ô3''ÛŒ©zUÔUùwﬁ˝øÍ•Nù.êD˛^Oh&&Q1I—)˘“ p˚,fF™‹∫ÌæÄFƒ•LHjı}û g«9<zt@{`¬·¯ÿËÒ7+ñ d,bA!Òl°5>„S˛ÒI©≥⁄¸« ¡◊ìc¢Öæı %≈Ãøï=+•uˇÂ2¶‰…—I±.Ôwf~ îí<-’ 9 ØÔ€˜S¶∆∂≈ˇS‡T
óâŸ ÄÉ∞VË≈n·€:s’ßrwTNƒ´ÏÉØá €)ò5Ä•:⁄ÛG C8»∂F°∂˘cÏ%ÜaQ8†ÕfcÁÑ˚i¿3≠l9–ìÒcvaB–∂»fï ÛﬂÉmrº@¢É£⁄…Ÿ•CGW7wOØNﬁ>ùª¯v’h%Yß˜ÛW›ﬁÈn‡ØzºÙ~œ^¡ø˘ÕΩ˚¸6Ù√∞æ·˝˙8hÔÜ¸˛¸”–èÜE|¸…˛Àßüç5zÃÁëc£¢a\Ã¯ÿ∏	Ò&%&MNNô2uZÍÙ3gÕûÛ≈ósÁÕO˚ÍØ_ß/»¯[Ê7Y-^Úmˆ“eÀW¨ÃYµzÕZXøa„¶‹º¸Õ[∂n+(‹æc'∑k˜ûΩ˚ˆ8xËë£«äKéü(=yÍ4ú-;W~æ‚BÂ≈KóØ\≠ÇÍö⁄k◊o‹Ñ€wå¶ªÊ:‡]√ÿEÉŸUEÜyhS…™ë™›ú7åKÊ¶sÛ∏,nó«]·ﬁ.¸0>CŒœÑ◊ƒë˘íD}(ílbí&A3IsVS©±iÁk◊iø◊æïº$ç4H*}*çîFKüKs•ÉRôT+•“k©YÓ(ÎeÉ‹CíÉÂ>r®&î#ÂdyæºB>§t:où^g–ı–}§°ã‘•ÎVÍ
ı*=È;Í›ı^˙.zIﬂ]ˇÆ~à>ZÎßÚsı”)†®g≈UÒT|îÆäø®+°J¢í¶§+ô "eπíßÏRäîbÂ∏R¶\RÆ*∑ï«ÜPC∏°ø! cà3L2$&ŒÏ·]–•@gUYC¨°÷0k?Î@Î~ÎS´≠q\Sﬂ¶WMçÕ~Õç∂F˚∆˛∞\®t™Q™=ú?¡•rs∏tFm	∑ô´‚~‡;|¶∞T®^ê£¶%ÖSî°F-QS¶i÷Ç6Mõ´}%Å‰#…“)¢ç⁄X)M:,ïK7§ª“+Èç≤;£¿®ıî{∑SK`‘≤Â‹jù⁄®’◊çf‘≤€©π1jùı⁄6jQ˙Ò-‘‰ü°—N-[…Uv¥S´d‘n1j}⁄©≈µ®¿TFÕª@∂¢Uc˝ÄQ∑∞∂÷Z#õ¬Z®…Õivj∂¨>_0©a˝ËC&›Ì◊<—Æ˘*f¥ñ`cU„E!èÕ5ˇ)ÀÜÄ¸ã° ñ˘ èYu[º,7KGãã≈Ÿ‚dQ[-¢Ö,ÇÖ≥®,Ã˛ç†~ìïL“Îﬂﬁ+¨ü˘<ÅŸGû˜f:´~.@]B›Ï˙bÀÂÅıK,´Î
ÎrÃ9Ê|ÛB Û6{~ù∑yäy,ÛÇÃ·Ê^f”`” S®©∑)ƒ‘ÀdÍn“õ|Mû&46-∆'∆GF{ßcπÒ§±‘xÑYÁå[ç{çÉå˝ç˝å˛FΩQg‘>\S¢˛∞π$Œ;Œ](e%∏^\'Æ◊¥ﬁìûRòÀójÁgp1-]ãu}éuy~#6êIöê…Ù2·(ãvfB˘‚—÷l-ì áû„rÕ ÍNˆUµ{õÜ_Í`ı'L≥>≠ûÒì’ñæ›∫¢^ˇ≥πvQg∂yÈøt÷O2«®#€ÌQˇG|hªÁÍˇ?lÜtX¿E≤◊Á1d¿X`;lW»bHøÜÂæá≈∞
2Ÿ{˙6¬¯ºÇ◊êª† a7åÉ»ÜÒP	±p.¿∏ó‡2|qPW°
ˆ¿hÄ•pj†‚·)X‡HÄâ0	í &C.$√HÅ©0¶C*ÃÄôf¡ò_¿\¯é@ÃáyÏïˇ
û¡s8Ü9∏
U»!èX°W„\ãÎ†	öëPD∞·z‹ÄqÊb:¢ù–Ûq3ºÅpn≈mXÄÖ∏w‡N‹ÖªqÓ≈}∏ã ¸Æc.ƒÉx„<ä.ÿèa1vDWtCw®á{ËÅûXÇ«—;·"<Å•xO·i<ÉﬁË{av∆.xÀ–ª¢µxÀ·-¸Ó√îPFÍÒ<V‡¨ƒãx	/„ÙCT–ÄW±
´±kÒc7|ªc <ÑGxù≤h!-¢≈¥Ñæ•lZJÀh9≠†ïîC´hµ‡Okh-l£u¥û6–F⁄DπîG˘¥ô∂–V⁄F|?â
i;Ì†ù¥ãv”⁄K˚h?—:»'ÚItà”:J«®òJË8ù†R:IßË4ù°≥TFÁ®úŒS]†J∫HóË2]°´T≈7ÚM|3o@@A%p/	¢‡ 8
j¡â™©ÜjÈ:›†õtãn”2íâÓíôÍ®ûÓ—}z@È=¶ÔË	´ıgd°ÁÙwj¿xo·mºÉF'w—Ut›E—SÙ;âﬁ¢èÿYÙªäQ+J¢,ÍD˝è4◊wêñEwzæûÈ~{>Xr^`aÛ.Ï¬î 9ÁúTÙ9#°
%Áú%yw¢  "`ù®ßú"$Áú3ÏÏÕ’’˝1MMMU◊ØfûG
Ia)"˘Â¥úë≥rNŒÀπ(ó‰≤\q]∂Àqè‹c˜ƒÂ∫ßÓô{ÓÚ¢ATE¡V∞mºM∞â6…&€õäÒRTäŸOÏH; é∂cÏX;Œé∑ÏD;…N∂SÏT;ÕN∑3ÏL;ÀŒ∂sÏ‹‡Pp⁄Œéÿ˘vÅ]Ë_ØE˛[bó⁄eˆ3˚7˚w˚˚yp48NáÉìvπ˝¬~iWÿïˆ+ª Æ∂kÏ◊v≠˝∆Æ≥ﬂ⁄ıvÉ›(≈•ÑîîRRZ H¨îïrR^‚§ÇTîxIêDIäÃäÃ¶ëa‘êQcjBM#É®5ß‘íZQkjCm©µß‘ë:QgÍB]©uß‘ìz—À‘õ˙Pﬂ»\IñIï4IóJRY2‰™\ìÎrCnJ¶Të™4ï¶—töA3iÕ¶94óÊ—|Z@ÈSZDãiYTG#Qb’muG›U'‘=u_=PŸ*G=Rè’ï™r’SıL=Wi>[‡É&hà Ç°JQ»˘!
@A(ÖU%(EUeï≈†8îÄíP
JCàÖ≤>£MÒy#Ne™*PAUÖä	êIê)ê*YRMéÀ	9)∑‰∂‹ëª¥“ *Ae»ÄL®U!™Au®Aø”v¬p¯F¿«	åÑQ0∆¿X˙∆¡x⁄A;iÌ¶=¥óˆ—~:@“A:DáÈ•ctúN–I:EßÈù•stû.–E∫DóÈ
]£ÎtÉn“-∫MwË.›£˚ÙÄR6Â–#zLO`Lƒ,@πÙb!zFœ±0¡¢XåÚ8`≈Ä≈±ké0≤aÀƒÃ!;,â•∞4ñ¡X,ÀQŒ«˘9Àayå√
\Är!.ÃE∏(„‚\ÇKr).Õe8ñÀr9.œq\!j8û8ëì8ôS8ï”∞"∆s:W‚ ú¡ô\Ö´rW„Í\ÉkÚ¸"&`"◊‚⁄\áÎÚK\èÎsn»ç∏17ë{rüõr≥®çRî£aT¢éõsn…≠∏5∑·∂‹é€sÓ»ù∏3w·Æ‹-çÊãÊè∆pwÓ¡=πøÃΩπ˜ÂW¯U~ç˚ÒÎ¸ˇÖ˚ÛõÚÄ[<êˇ oÛ;¸.ø«ÔÛ<àÛò
”`:ÃÄô0f√òÛ‰!Ãá∞>ÖE∞ñ¿RX∆C%[r‰ë<ÜÚÖ,ó/eÖ¨îØdï¨∆™Ún¡m=Rè÷cıx=QO’”ıl=W/‘K|XÆWÍUzç^´◊Èç˙{˝ìﬁ¨∑ËÌz‹—˚ÙA}Tü‘gıE}Uﬂ‘∑ı]∏˜‡><Äáê9k‚¯¢¨ëØe≠‰ Sy&œ%œû@.<ÖgÚt†ï≠unhƒ$L√ZXÎb=∫6¬&ÿ[`ÏÄ]∞á.ãΩÒU|‡€¯>—â8G¯\4
«‡8úÄìp
N√>#Õ¡y∏¿˜ ≈:ó‚g¯9Æ¿’¯n¿Ôp˛Ä?„ØæŸÏ¿=∏Oß„<å«Ò4û◊ôxØ„mºè9òãyæ˜Xü·Ûõ¶ê)¶Øõ¶åoAÂ|¢è3MÇI2)&ÕT2∫ö©b≤LMﬂêÍ˙¥ﬂ¿4“dõ&¶©iföõ¶•ieZõ6¶≠ig⁄õ¶£Èd:õ.¶´Èf∫õ~ßß¨ìıˇüèµh˜ø˘ò^¶ØÈg˙õ7e£g\ËÚπÇÆ®+Èb]úKpI.≈•πóÂj∫⁄Æûk‰öπVÆùÎ‰∫π^ÆØÎÁ˙ªn†úäèñP'’)uZùQg’9ŒÉPÖÍ0bhBR»aJË¬hò/Ã∆Ñ¬Ça°∞∞:Ø.D≤#9ëGë«ë'ë\Ÿ-{dØÏì˝r@˛îÉrHÀ9
W‡*\ÉÎ≤%X|ìÃïlæ~UÉı¡Ü‡7Ÿå
6„uﬂ;;¯’^MU”dõÓ¨ªËÆ∫õÓ®;Öœ√<	ÇáÍ≤(UC¥D‡ó»à‡GÒﬂ≠Xâën∑€„ˆ∫}0YéÉõ¡øÉÂ¡,ıR0]’WC‘L5KÕVCÉ™·¬fêlÜ¬V˘^6…Ú£¸$ˇíüÂŸ€‡wÿ¿ÿ	ª`7ÏÅΩ∞ˆ√8ß·úÖsp.¿E∏óΩŒ:^cGÏÑùuY]Nó◊qﬁ‰kÿ_˜N€b;lÔïˆ¡æ¯äó€[akoÌ7‹Ç[Ω∑ù∏w{ª‡ ÏøÉÔ‚{:Q'Èdù‚5à√Ò#/y¢˜<ﬁ{ûÏ}¨SuöW=SßÎJ∫≤Œ–ô∫äÆ™≥º“¯≥Ωÿxoyß1^j¡ˇﬁÈù∆öﬁÍ[f†æÆØ˘u√ª¨Ôe6Ù“œ‡Y<Áı&{√âﬁp*61&”õé˜û”Ω‚Z¶∂©É…ò¨´ÈÍ˙æ~Äõ˛√x’GGU\Ò;o7,IX>B6	 [ûI%õ	•ÑêÜ%õ]†!@æt7≤íí`+AEAÇZR°T€¢Ç““ó4–@•çT=ˆh€äÌD-ËIˇ†∂˚˙{õì˛—”ù}Ô›ô{gÊŒù;w~ó“§+˚)Mfëã»ºÑÁ≤ıç5öó-æıÂüâwˆ?DË¨ò˙wtÇıíÖè¬ﬁ¢T*¶Ω@¡;©ÖlTçñÕTé¢†}'K3;h±¿”Ÿ{Åìè—XÊ2?fﬁ(Œ†◊FJ¢	4ãiocÛÃïTCÁÂöFÛÄøõÿ:3dn7wò/¿+éä∑Ãõ4ú“ÅÏóP∑˘πÚû˘7Ú¢«3úÛl«∞√‰√,Î ˘c`ˆ=bëdÊRÛKh‡rÔ&I•‘Õ∫∏£◊”%ÊbÕ¬èQˆôÜ˘:§∆—"‰{Äiß≤Ÿ‹≠‘ò•f7ç≈´0Ínj«	8õß˜Y¢“kæ`ˆRÂ–\¨ßÉN≤.ªπ>6S`•â4úÂÙ[‰ßÄù_„ÀïD%qÒ1Û]Cì©
⁄ÓGœø≥/pì„.o †YD…∞À,k”¿ÚÈ¿ÿ=@
À˘s‚AJ¿åìQÍê©l¶g1˙9†ñ#@$=bü<(Ø€nã]0ì±#YÙ#‰NØ!Cp—?ƒû R˝ê˚˘b‹/≈N˘≤<mèb’˜!ﬂŸFë}åby¨å}õ5∞f÷Ç”∑∏ˇªÃgÒJ~?nö±BóE(Ú!πæ≈v9äΩ˚cÏ3◊‹Deáı–˛deì`…≥tû.2yN2äï[T±5(è#f¸,ûÈt`ñSÏ"˚xÏª‹E¿[fB—¯É¸Q‹ë{qÆ≠ì˝ˇ∑Hp¶¶äÀ°UãxÂ∞¯@¶À†¸\î] Û∏3*'î^[¢˝âJxÁ∆æõŸ7œ≈(÷€kèuòP
ˆ0VO–>ä≤˚Ω˜K:ÉÃÃÖ»fÖl,≥ò-c+ÿ*XÚIdu/∆u?Ñ<´¿UËúƒgÈ|∞Z_ÄrØÁ+pœÔ‡¸œ¸Ka«ù0B§àl1[,ı‚a±ZÏÜxwÒEÒOq≈î9^NêY“#gÀ≈r•|N^íóîDüèm€˜lõêˇ¸√˛{°}°ΩÃæˇà˝›Ñà°ßMÉ~ÏA@¶Ì|äLCl<	^Lu¢î√S˘÷ ◊≤~á≤ 6Éœ`Û©Wf¡÷oÚÁÅfàRV¬*hü‹7ömå|ü˘{∫"_≈⁄Nb‰U∂Dˆ8øjK§vF|:Ê|C‹-=‚mz_úgv˘S˙´t Ûº¬˜ãÖÇ„≤P	ë[Ï•Cb[KáyÄ»q=a+¸x>{q°íÂ≤	ìü/ö&>§t?˜√£‘J?dur)mß)¨ô.—K8ïSÿx£‘˘h÷A\æå’MG∆*î1Ù$[$ˆÿÆÚ≥¥íz§ÉŒâüC˚~Hî ^•ú5‡¨•M¥¬\O´ïê<Õñ‚⁄æá2ÂD∑fë+›¯~Q•1ÌN˜1ƒÅY¢-.xŒ<¯E"ƒîg'$<®g¸^D±ì‘a´‰ù¥TIfà:DÚÌX9Uõ/—ns)=`Ó /‚AãŸå–«Ù`ck®ân«…9«Ê)Aﬁ£M/◊˘Y^¡w›_X;ìπËSîC®*ø!]˛Ö*h¶π’¸º˚NDÿ›TKﬂ¢è∞ œ1√—ESbÛyõMXÔy*3˜õ„ôÉÃÔ“zï^¥+µ{∞«;çıÆ°z^n>,Ícç∞√S∞Ç÷Zâ¯≥ŸÁØ™úÂõY¯ÕÇ˘”Û¶M˝˙î‹…wO∫Àõ„…ûxÁ◊≤2Ô–&∏’Ò∑ﬂ6.#=Õï:6eÃËQ#ù#íìá;Ü%ÿmäúQN@FT#+b»,mŒØU◊¢hàjà*öÇCe5SáJ˙ ˘ùˇíÙıI˙$ôS-†oé–T£ªXS;YuYÙ∂b-¨W‚tiú~:N'Åvª—A∏äUÉE‘Ä|§ADä1\€pá_Û◊;º9‘Êr8(#Ukjc©Ö,N‘@~ßÑ$(e§k≈#M+∂40Df Zg,,ä3‹Ó∞7«`˛%Z≠AZë1¬!|√Ê7ÏÒi‘Fk5¥EmÀÈ“∑v:©6‚I¨”Í¢5!CD√÷#=ò∑ÿH}Ï#◊WU> jÃÕz¿’®ZU]oQçüîÖs›÷;∆ËÀ3É=à©∑¬à%*f„√!Émƒî™µkU}Î´◊VKdôj”ä¥}Y[ìÆTæ⁄›ûûÓ;j^†ÙÄ™WÜ4∑13CGã«µç!Ω|ıØ“|j⁄Pé7ßÕ9≤œ∞m…#˙âƒ§¡D˝ /N≈≈-™§|¿≤Ã“Hõá0‘%*4	iXSûı™œ#}Iƒ3Ù2Í∞#ç∆0DwÊ[ÌVC…tj™~ç‡⁄ïœÜ∂D˚[lôŒkdëñü∏¯∑h√„1≤≥-±˚±ß–±0^üÍÕy§ìkZìS≈Ê£Ö∞m4ú?	Êwª≠ﬁ“È£ZTåue°æ∫JµÌ‰õ‰	<bq∫nqR™,Œ∫[úÅÓû‹AA#≈H»¯èpéh»7ÿÿˇ¡ÆÔ„óTh%e’!5†G˙m[R9§÷«œ‡ıS∆hHd~ägà8NY3 lUBâÜÃƒﬂwÍ∫N{º2ﬁ¬‘†·åÃÈ{án˜ˇŸ©”Ïµz≈?_uÎW”»˜≠œR¢^¢.†0Æ í j]w·¡’˙&ú€ˇÅ«Se»≠˙™¬…Ãƒø”Ï ≥ûpÜ·É…¸ñ ¸ØØ©ø:D0£ü„gyß7'à@ßÎAMÍ=⁄iÆ´’Tß¶Â'¯	Ω)πÂ8ùÊ±-Fpk∂j`˘8úä⁄4÷Z÷Êc≠’°£N"µµ2‘Œ˜Gä¬ñ!πø24x˜‚G"Ï%Œ‚V!‡e;ë{§{d&^WﬁUt›)tùTŸÖkâöce<¢ú°ˇ∞]-¿MgxwÔeùÓ±wílIñeŸ*2Æ6»/5¢>⁄a⁄RúêLQ‹Jú∏Ni °òZ‹¶º2PL
MùB(∆˘ëÑ6ûq”÷3%3Ñve‰0◊√îHÓø'L¶èªπΩΩΩΩ›ˇÔ˚øè¢9ñ\¶cDM)è“éùFáµ<∏[ÜtX{q˛¬8Ó∏qhó7J'íôâ4ùH£˙D}bV%N‚1™jkjc¢ßáb¸Òû?4,‹≤ÆlN8ä£Ÿ'Ò=¨ç]Õ‹ˇc”ŒΩÔfã≥°ˇòˇ;ñ2ùLßƒ!SåL≥@>Ãa∏˜†√‹”°áR“ï{=∫nWF{T’Æ‹±tY&ç∫V¨Ì∏˘¿∆(ˇeß+åå™≤ú±|»tîd∂‡h¥tNŸ˙-ÉK>Ã>ÅØ„øˆÌ›πÙœ˜3W«≤ˇ»ÊÅïogØ·W‡ÔDFèı ‡‘ﬂà)º–ä`.Añq…ÑÉ$÷I_xvn´a“	 t:èÏK∆ì„£4ù†	TœJö¶ô46Ã¯¨ XuÃ„•≤öö⁄3√üöØ·Üá[_ã4¯û˘&Ã;ß»*Ú=¿ÒÀ∑Ü¨·HnÄ)√à¯Ö5–¡«Ø˘±7˙M“õ®¢!=´µ¬"´K<sI9Nıˆ2å˚°hÎ94ÕÚfl"g‚Iƒw¬˚Nﬁ∂r"ô?•sFı≥o·Øìƒ}£qì◊∫›qíöºfÖ‹Ò}&‹aÓ$G∏µª°7èC2wë[Ä[LŒü^#'ËxöÊ0hfFìÈyÜE4Í¡1åª:≤K|¬ù¡5N˛ù7Ñs¿á"‹xä0ä[≤?»Ó†™8Rì∑lÏY≈Ú1RX W(÷Ü* ¯a(Üa=lEÖßƒˇiFŸH7ÅEveÃÚ9ù"í≤DÖï¨Ì·êüçŸ#Ü|4 ¥Ï&!Á{ê"Û·2·“'Ø[ﬂÊ≈v≤√πCø§	…È%Û\<Û}_.\‰ZÊYÊ{≤∞Ejq.w=ÔiÒ}´p˘°∏÷π^o˜K{È%ÔUrEº‚¸H˜?4∑ÕaïÑ´*9®É8:äç6Jci–ÇçA¡ãØÂH|O∂F”Ãƒ…VîDuÏ¿p55π®Yõùüo˘≈piYƒEÛc≥k	óJbcÀHÁ⁄Óæ¥j‰»Âu?ÌÎ⁄∞°´ÎÂÛìdÛxŒÒÊ”Ÿ…´ŸlˆÉ˚œ‚CŸ}ü‹Öˇ–Ucœmg\˘ ºÿ…Ë§‚,’®j·7ë›‰@ú«$
ÑsX!xH∂≠óŸöf:êöºnG7Tn[Üh¿T≥/[>◊&6>~E∞TΩJòÚD•ÄCÇ%¡ÁÏ«	¸#îç÷(¯%ö;‡!—êÅ@¨/àc#Œ¸Éí—í∞!äR5Daå‹Ôô;≤hﬂﬂ*^‡_˙‚Ü‚wæ2‘Ã÷ñ .K∞∂ æ¯ÄKÉ™^óKlTï√ÆåYJ°tAF—÷!doÉﬁfy0E,Ö»°bj*5®∏<Ã aTëfñ÷≥Ú¸lF^ÚpB≈4â=°Â–25œuÀi∫Hc–Õ⁄ÿÿ›04ßì40u¥Ω¯ˇfc|fÛ±ŸÏ…¨öGÖG≈·}q@∫òw) }MiRi- 
mΩπﬁı™9hﬁﬂ(ºÎWﬁwûuëB†E4H≈˜&Ô"	»üw†Â 4Oá~w ‡œ¯A-Ú¸N“9z˙q)ÏÌe+@∂;tLπ≠`ºÕ∏é»B◊Yä—[Oö…j≤â§ü|„›ßrd]ôà2yq…$Í”ô‰®a2d°h◊fF5êöú“¢©®CIú¸~S”4OI§Ø©©ÆÍ€"qr	LîxÈ”ZR0Ìóo|ÚÎ/m=à˚\˜˛42Ò’∑~ˇÊ≤‡âsÀœΩ|˛∆ ñ◊Ót}¯ó€'ñº=xt«3≥Ä)ã'oÚ˘¿î(nz ú”ÁµòˇΩÑU£
<‡Ú∞¨ÍäîÂrO0¿ÀBπVØ“_à2Úá§CëuèT0ıÆ`'2„ııêD“Ä_˙Ω`∆È˘Ëlv1¸¶jæ:O›ÆÚÛåßåµÖ‹ì˘œ”UÓ˘?P◊π∑´;›ØSe!ƒŸºq*™∆KÊ≈0 ø™ÂH≈’=ä‚·Ω˝‰(Úëg≠2∞R 3U≥≠9¥:DB^∆‰–f©-bkS£ç∞x¸,{Èò·M·∫nﬂÓ«uêHŒYŒœ‘Íë˛Ÿ©)¡≤Qdö5MÊt+3 »	yí·ôÉB Ñh≈≠MÆ⁄|¶Y6pRÌ√ÍÜDâï(\Y‹Sºße”…77∆∏Mg[j˚™Ávπ{JnøÛ‚PÀ [;≤∑Æ¸nø‚=–˛€≠é∏A^‹∏|Î∂m°ﬁãﬂÌ^—|pf›üúÀ˛Û&Ì†B?Ëõä#VçπDyVyCÈR.)¬nÅ˙sû3Å„H9IêùúÑˆ!éwsœ©à(*/qd Â¡≠”íœC4$Û)≤Ú¨ »VQqï<•Ñr.1Ÿï1;C…)\k©íUÆí6óTK:atr™Ó*D(	é∞èŸ7P=√æ!ΩZ
Ô≤=}‘œ¬q&/	zì⁄:H«	#Œúè∑œåÚ2∫ÆÉªaüﬁáT»˘f$Á≤Âå≈π“qé/*J∞!ö ËcπÀW6/å+V$Æî‡>#n´ml;´qÃày¬g`≤7≥çz˝¬Öûl5n>∆ù˘t˛±ÏÍ=ô À˝%¬Ø@cÁ"ßaXü ÑöÙx&ì
ßŒÛ¡Ä™a$y!_ÿ;ªbG”4%åG@¢ÃyàÂ¶≠Ω∫]~›øÆhg—^◊[Æî+ GÖyóW˚ºüsT
ïŒ~–1¢É∫dèÈri∫[sπ5]Ö±\ÃKÎÑç¶¶[¸¿®≥:èGX¯Ä™Y!fû—LW”Mt7Â)â◊/Fﬁ”]-@Q]g¯ú˚‹«››{ˆ¡ ^.Æ.OAE,âõâc∆Ñäb0!hT∞¢Dì÷G}°¯¿à„hï§é⁄$¢Üƒ""X:jáh3)ì§¶iLjÏ√1—çéÕ®¨˝ˇ≥ªàùñŸÀ={Œ›{˛Û?æˇ˚T/Áçâ∑Ÿpˆ–±ƒA˜@Rço∑ü˙_≈íÙd±<.ó
dîP#Ï†\ ◊MY"Dë0‡còGÎÄm=Q6P+q…ÆdÍÖ∏‚e`¡ôøuÌ_º°£≠iVSÍ—◊πÀßãvù£¶Â;Ó˛~ÄÆS∑mÔ=‹“^<—Õ›~7¸ÍK·{ü^‹’˛WdmE9`ûü§”‚(Í%9h≠§<ñ™ál‘fÉV5LÆ«€,:%#Ulbå¡©∫G≈zÊyÉÛDÈVﬂg}Í±HVÙ´Ω…Q5	tírMJòdÃvŒ0j¯˘Ú|”"Á|cπiE‚&”ÊƒœMüπ5Ÿ@ßDjBö`Äá£d∂ „Bä0íqAC+Klÿ9å^™ƒ@Ëôc6üríS#ÎUH–(*T)ú‚÷id$js¶#ß”Çê{¢ß“≥‘≥÷#x‹∏Êq„vû.nƒ…åIÉJÏbÒ“¡£√ÚA¥+ß2®§fíå‡ÊƒN45°é∆	)ˇ‡§7sJMŸ33_·ûÈ©ÓxÌìÜøÖØ˝rÎ∑mWÚã_ü∂Ï≠√´VJÌãrärû˛◊_ÊÕ	ˇ˚è€˙Nß“’ÙË˘÷ﬂ=ºRq¨ºÎ¿æ˜ﬂÃºsãGàç‘ÜÏΩ6*¿á3	f¿2¨¬é
f≈VœÛ∫§òµhûÛ9LıÊíbà}%«OÑ€R∫»cÇ=ö≈”@’›Ìü¶ﬁC6Ü  ªwÅVi’ê¨®`$¬Kr`ú”ô?ó?’Óü:Œ—Õo∏≥U∏ﬂ÷¥'Ï?Ë˙™çﬁ§ﬂDù[
ò Ë!í√ëHv(dòûÖ	<åõôïÂL÷%1Uw⁄t≥Ç…Ü*†ì©àÍKLCGå8·Ä-:º|L|Ú±ß¯¡ÙÂG∏|‹≈ﬁËbÈÎz¨ûî"»∏˙
…ifà3Därç)G√£˚„ÜÜ„$nãøt18s±ì>>_l3ÿãfGà]XA˘c›4Õ=≈=%x]πë#ösË≤ÜÆñõÍ¨Àî∂ïûÌdm6õ÷[îÕ∂û?h‚ú√°R⁄ﬁ#o£å ñèûf(D˜Ã8òEáx∫˛¨ôöª∏ÍêöQÔP;J™Ést—]ùπﬁ˙<ÂaΩ}DΩkP“∏B.Œ’<zP“‹Ö⁄øÅº˛ËŸ*ÿ·∞iE+Ü·\≈≤:RW^NÉ¡±c¢t.∆Ãƒ≈©ñ°•C’.æ~ˆ‹Õö%ç;¬˜._ﬂ€ı ÊöÖõ∂VUoô0•πt}k€ÜµG¯ai˚¸ÚÍ¡™_§eˆnÈyD(=∑Û<ù±∞acÂº∆ÜáèäöãﬂY∑·XkLÀbNÍÄäÔE„mMÇ0RÉpè;C'/JúTå®Wc!’ò“—ºZfÜ5UwÿìÏ≈vﬁnè'%î2iSAUPÏ4√ëD£Wz3*rà‰2«@¥1˝TD—+*â!F<Óù°t÷<5ñ≈ˇg◊'˜˙Ø≠≤án3¡˜º;x—=+P≈/v/ÒUV˙÷ËMæÌzã˚®Ø«w”}›∏gƒ=Â>‡nsÛ“ÊK\
ˆ› $ì7ŸêåTΩÿ^âM6∑§óJ"ê‹ÅF$ù°ƒ
à¨=ŸVõ3ß;¶µ¡\“Bß5g\ 61ï˙áˆŒÏíä:ZQÌîOsc«§ ⁄¬ù@295ï√FIY ∏X.’∂πWœ-]S2éé˚ÕíŒáTæ∞≥’ €áﬂ˝í˚ËÌÂ?m?∫zÕ!Z™Æ¸…Ûkø®Uºe5‘Ù≈U™∂Ñˇ˛.¸M¯‰{g˘1otˆæŸê9”Úg≥Dì…x‡"ëd3'
|!ïWºÜp¯‚êÈ–>8T‚'®VqcÛ\<\›}}}|y_ﬂ√#}}Óc·ØÈFˆn;Ÿ Æ∑n¥Ó∂˛ zÀ*Ç/Éñ|ÀdKôeÅÂîÂÔŸj±À∏ß\(I¢]∞ÚY
àÖ3c=!¢$
ñÒ÷	b∂0Q‡Å
á1ì
Ô^v©2lW˙Uˆ%b$Q?Dê'ÀÍbÜ∆3Êûﬂ	ˆñÃ -««¨Æ€,Jò˚"xÊ— lYÏ[&vZ›IÌï—‹Ô:¢ÉÔYqàÀÂR<äÏ∂ö£VõöÁ®[¯fıCÒÇtNΩ•ZMb9-„J‘Ö÷ÍÂéÌé›,(ÇM∞ÛVãY–F&Iñõ$E¶Ñ¿6!V1d%ñ8û«9ŒÒÜ†ƒ√ØÃ∫(ötâó∫∏⁄êôòî!ér‹j∏∞ÜúäA»¸Ù·c·™¿7É„∫(YKîsÚUÖoV®ÇﬂUá¸±Ã≠ï◊…úº€Ò˘ü#éMÄ>^p•/AÖˆN,ÙıOºŒÖO£òïëÃØ1ÀÀÓ,%Ä€7™ΩΩˆﬁﬁF1rÔO=a-ùzBˇ—Ï:oíœ<∫¨Û{,År∫Ÿ"˛h…|\2LëdûÀ˚î{· ÒÅ7]¶∑˜Oûò'ûπ?ôˆÑ'q≥ÈﬁÓ◊vl«^ºx√àî∆¯`\7 &œY≠“LAò(TÍÕfÈ«æb≠≤P‹hïR‹fﬁõíÆª˝fsúSOOOK#â~¸ñ§Î1yÉíÇXU C–íúXíÑûóL¯vâ≈Zä«<êfå*â¯≈Çœ)ò.|JÒe˙uÉb	∏N"P‡≥0∏ﬂ¡ÇH8∏≤‡{IE∆^äP8¸´ ﬁ2ç})Íøô ÄîáYº X
°
≤µT±ú.#OK¢RÌ\Ä&ÁÊè√VÄd ÕG‰¡Ò^.ÿ˙Q}Uı¶ù≥÷ùo
Ô¶O≠ˇ√©ì7Eóº|vˆÑ{ö¬m‚ôÚÓ/øìó“≥Æ˙◊sFÛ”5wU—î•i  ¯ö…”6`ÖT=˙F|UºQπtj∑»œ—’aÁ˚6Tâ#É‰⁄ÊëZ≤‹øé4¯õIãxú€÷Õwÿ.⁄>!◊¸w¸ö›È◊¸~>]J’“ç§ÁleÒ≥\e	≈ˇ*ÁvgøﬂﬁíÿJﬂ‚Zµ?Ÿ„H<Ò©Ò™OÄ ¸∫=µÄµÆQ©ˇ!Ω⁄É£∫ ¯9Áﬁª˜ÏΩªwÔæ_ŸÕΩ$YíI◊Pπ#-#Ö@ÏXJ[B⁄ô⁄(èZ≠ZZ
ı14TëNß¶d “™@ÏXÑ"LßB«RÀ(†8Bô  6…≈Ôúª˛¡qì=˜€ª…Ó˘æÔ˜˝ŒÔó”}ã…`⁄#$”¢[œ¯BŒòDi4cPL=l74û^4ü+∆læëÈEXzŸœã	»/ÖÇfÒ2uâe£ °pÅÚöj1*gIìp(¿hZÏ∏ﬂ˛Ì˘KˆÈ◊v·©g¯ÜÉ5ØÏ¯Î¸∂/˛Ú/ÑT}2xÌΩÛ¯ëÓ≥«&l]øÕ˛§„Ä}Òo1Vﬁ‹3ÌÉ⁄ù∑&•x*u–È◊”>DaÀn\jq%…AÂV¢‹1~áCèSR¢4•ﬂ3ÙÆ°w£ΩÙù–+ƒ˘€ê´™ú˙úU'$eÍ¢©Ëä«1‚RòEpÖ#°H0"∏íB‘ƒñ-1qDÒõ™òÕéÉ«*úgçF¢∞YaV◊9 /bn∆ˇ~cﬁäÊgñœ˙v«Ò’v7Œuº^ı`„œûû’eø+ıáS3∑OºΩ›∂w,¨Ó™´z‚Ø.\óÜ¨∑3¸Í®¢üZaóî¶Tñë ≤B*Ó¥ä®Ã–ë“µÚWÑá≈%·›ˇ«∏zZ ä÷»6ﬂxı\ˆŒ9≠™Ñ¨√f·πM,⁄,dá˛(º ıwŸSv⁄ﬁ.6E Ìƒ’êÉ˝ÿ Ú÷…¯Vê¬&É*!	ıˆm©|„û¬⁄wm_iò?b˚#ˆŒ1MLª‹π˜N·£°Ûd˜p€˜ÁªÜüÄ=¥¡ÏÔáŸØ¿A+ë%√§u4~åq@(/Gf J*Pö·4ÿ0vE”ö *ﬁçqftEπ!ê◊ËVpxéA)úæ,˛ƒ;¿Oﬂ$˚≤¨}4ù 
V∏êU‚ôE-∑FπQœ_+‰õg∆˜ñ=öÃ_3æÑ'≥É Ëƒ≤dI¢$^"∏<Ω"ú)Õ–
1SVÛ¶LÒM¯„P–ê·’(©¬ƒ%* ;‰á%Ì6MT.¿Çÿ¬ô…Î(è'U¯ˇã="Q˘sË√%ÉÃà@ ı~a&i[gü‹˙ÅΩ•g/n˙p∆Î3ªÃ«{øæz‡õÊ}k0ÈXqÂd N<|vŸÚ˝¯±N·Â=Oˆ˝§rI{„ó_òΩvÀ€ˆçˆÖıÿ˝8PZ(–ª˚jà•ﬂ{ﬂ˝µ¸ZSÎ\'T:◊1cùkYÖsM•ùk,¡Ø†›ıZCzY⁄%Aó@¶¨C[—n$NDjB£+H
pÛe$?W9¸bX˛≥ÀÀEX^≥tG„pXnO5è†ù©ÛÁÓi!ìo^∫lÚpæX»…ÄG¬ˇ¡&
 «˙õr∞√“ì']œêo∏÷z◊˙]né¥ï≠',UL˚‹Óå¢–å L	€ÿÜTg.x‡WÏéa®RÛFA+ÿläAúa'Yë˛Qú¶3ÖiöË-frIœ/u2∫ƒEÍ•KYÿ> ;¬ò	1Èüiÿ%/Y4˝©1Õáøw¯8ﬁÎ¸Ó‘Â+ÑOá‚}Gü˙3c¶w∆Aûj≥<òàBZBîÈ·>≤›Ú…D∏g˙∫vÂªÓ¢¸yá∑úbõ·‰=(¯ø∫‡+6"‰Ú¡NtrŒ±z˚Önrí°ö◊œ'⁄ ·≤5ÜEû {[Úy7¬Ñ∫UQ7QTÔÇ^h¡gΩº:lÓBO!ì≈LÜúLòŸ<Œ √°C˙…ìá¸ z≤Y~RgQ≤€≈6eï Y.æ
|˘*ÒïØXe,"úaË£h∑UΩ¬Wπ(˙)+X)ã2ˆJ†÷«…# ¨¡±B·|aâ≥O„ˇêd
@≠ÊXﬁªäÂÁã0ÀÂÍD _(˘î…ìùdÚN6¸¡9%õ¥V"‚£!í§‚≥û=G†îûÈûÈ>a¨X·ØÕZƒgΩﬂ“÷x©J$öÛ÷i≥…·Ÿ¢çﬁ/j FÚ™∞Aﬁ@;ÖÌ≤+@|öV)ëê$ÍÒz+%
!ı<Ï{[`#(u+*L∞¶È¨O≠Åˆ 	ÙìN‰≈U{$Éˆ·*KÒ∏√Ú¨T±⁄IjXÖwHò∑ÄË[¢cΩèÃy”êZ•v	HÅtÓı7¿lƒ¡c\ÕOéŒ∏øÄ8qÎ≈π<∏(É>‚'Ñπé5œs”ò¢€Ê‚◊»ss0x
‹)Ó-fÏˆ¿{c‡Ω˝»{ÛF∑¶∞ª@*ÏÂ˚ΩfNoÊº}÷Á¥ÍzÓõ w'‰úí7É;AKÛ¿?Õ â÷’c”_Ê«eÿøó„ñ H|^Ä•ˆú]ˆ\©”é/5Ω&}6M<68I<;»Üq(∫Rvä„Áª*#E%Æ•1O|S√&ã(ÿ;C¶`Ù(ëÅ∫EB‹2√ÂíäÃ)1∏rJïúIÈf%8úÛÜäµImUó®Ì™§RPà}ôæÏﬁ§ÅXêw´A•a-gÛÏ‡R„JÅ)Y∞ò˘?ëw»ø˝H∏yˆMèøñ∞ Çõ´*Ÿ¡=Ë°÷¥§®wZéZ’NXùìG≈sLæ˜∆!¨vBv∑åáñZñìµ<ÉÏı’ﬁ Ñ)'LAf·çÓp°Y<bt†Ö5hz∑ÈÅÙø3dC√Vâ+°YÌÉÌL{/ÂÚëÙ>“Pµö>“C°d4ôE]©Q5)Óàˆjø”Ñh4ñ$F ÚœŒéZâπ“\˜£˙#˛¡y—±9âGì?åæJÙxZi’Œ ‹ÿy¡ö œ?Æp>ñŸ	¬™¡UN2kã…©'—û¬)_Üı–5Ç:‚%Eø‚ñ|ëπ◊¬¸¯0-Aô’"ì◊\w‘Î®¶˘k	ò¥Ø≈u«¥7zÏﬁÉ'Ï˛Œ#8u˙Cú|Ób«Ï”‰(n√?∞_?Û±Ωuﬂ<Ô7ˆu˚Æ≈…ΩX}≈>Ô¯q–ÌE1¥«øÿˇ’ô°œµË-!Qı§ÅaP4ÊË’@Ü*,o™∏∑†‡h¬H`¯Mƒºˇ´åΩ[Ö«Gc¸õ•/Â≈aÖ)jp&cô„Ê#÷çò¶‚[æÉå]ﬂ¯Ù˙ÊÀˆÔÌµ¯;omŒœ¨z¡~IÍ◊ã{€ÿ√√;¸£ïÛøˆ2‰¸fº™C£êeTÍJÊï>A€J¡rÚìÉØ2_ˇ√xµ«6uùÒ{ÓÀ˜^ﬂw¸∏vc'ˆuíìƒç€.ÅÖ(xÖZ-êÚ–†e¢⁄Äm©∂⁄≠[áê™ÅƒÄÇ¥cëZ÷jH›ƒZmÌ6î]AõJTâBú}ﬂµò¶I≥uœ˘rÓçÔ9Á˚ŒÔë@IÇÎP0ﬂ»ï¿[	Ã¬ÿï3úÖ˛_µ©¨Å◊§≤zπ◊ =‹ˇh†∆.›áÁırè˜ùíÍ¨»¨ÿÔ≤»”ëgƒÔ™€¥]“µC Q≠†]WØi:∞]Ã–|Ü°ö,ö’t<êx”–ô≥D1á¢AÑínz0H≈k›|Zñ¶©B‘V_Á±¥1U|%U¸Õ©≈u<Æòœ«;L¢÷˙sÃˇO<™Î¸’YïÚ[hQë0 πŒ¿Ωiπ& Tbs{‘Iná>ÑÈœ‹ˇ° ä”ëGÀi˙T√úä∞A˙]∆P}¬°ú¯d¬•:ëú^ÎÉk\„ÄÉ<19˚x8⁄`U3âÜr™sKk´.~òﬁ7Ù¡ˆﬂ˝°∑æÔ°±ë}Î5∆gˇùﬁupŒ°#≈fÓ‹‹˜∂Ω~π&ôò≥•ÿOZ~Bá◊3∫Öimﬂ6sın‘ÄÀ∆Æ±_Äøj¶˝NÍqÊqv≥ôeì©)L.ÚM¶«ÛPM˜ÑÆƒå‘fâgYÕ¢˙ΩUj⁄'‹ÔD%HVª§*Aùõä“√• Y	ÏJêBÂ>£z≈N–	&ïl”≤u]…Ó¶Gcè‘ı%üÚÆU÷©O¯VY€º€ïÌ⁄}KbSr7≥œªWŸßΩ®ÔJ|?˘#Â†v–-+µ∆∏mV€a—NÉ¥¶“aìù‹bS´‡p)ç€™˜V”’…Ä“M%IípàÆ2„¢çb4`\ÃÀÄèÀó,vyÇ2™ÈfÈ[Ì4&™‚Â‚ëöhµ‡·YÜÊI2Qc<≠n;Xv án®F◊†∫,´ìôGñìç‰e¬Éâ8ÈT5‚+Ò’0„Y¢M•I!\UÈæ4NM¡ˇKá'√öàm"}„-≥R‰&÷≤ÊûÚÖxB-e√öÔv‡˘W.îèî¿\˜3åÕÆ ÿ@∫Öp	:â˛{Uò_’•[K’ñ≤)€ûímkkÖ™zlÄ|pô¡ tãLG¬^vVyÏΩé-ò∑¨≥¯‘¸5O~ÔÀüπΩõ;ß?zÚpÆÉ|ºxÁˆ›w~˛nÒ÷k‰O˙˙=∏©´˚…∫‡äL˚ëU~≥rÕœ´˚_z~È‹÷÷uıùg∂nπ¥iÛÁX©Õ¿Á =‘^G·Ë(l8˚Œ±bÅﬁ4‡⁄BŒÚ1B71ÑÅ¯q°Eë◊Ö°å_VlÀï
H‹≠ÄB±$†ÒÖ¡◊Ów0∞ù†NÜÛWJ–ﬂ“7‚S‚˛∏AWkÿ}≈jN9~¸Î[8€√¿˛µ0[ı±#Ÿ⁄bv±pQ`X–PY∂Sò¡Œ∂jor◊5èL—FÅ>ö}6]—gÙ∏>£][K#
F\{ëèH,0/@/lÏ0≈éID™»A…ÖC©áR•R§q8îÿ≤•(¡°4áRﬁèÚÏfÚ7{ı|Ÿtñ‘ÄÀv*O¿jñTÄÎ:]j∞À/¨,ﬁ˘„Ôã_oº0Û¯éÀÉ‹πªß>)ﬁ=ÚQ>gÊﬁ}ÎÌ3ﬂπ@|∏G!äÚlEû#vÏ4ei”∂rTõë3€¨j¶—cŒ¥Sãå≈Ê"KUxU£À«ªU'·P∆üÂ≤r◊%œˆ/‰ K˝+πïÚ:ˇfn≥¸¨_„¸Ë¢L“N»0”ÒÉè'9ó´v¢^Ö˜'¡Æàä™i≤Ø 4˝Å†e˘c”8 äa/õˆŒ£~ê¬G”†á}ÑP'QøÂÛ˚-S≈®ﬂÑ–4dMãÈÜO◊SîÀœiÜ9Ü)qå•kö(
s≤L”0(!ÜıD2üäQ2¥~∏ä#Ûc1BH(T ˚OïH*ıéÇµáF≠9›´∫ÆéÛS≈⁄ 7¡˙å 2∫˜~£Ûüduè™A3m®›ﬂÄÛ—¿˘‡|ﬁ2%j©dáí0ÿ‡⁄!jÏùé%eÛ§¬»ÄÏp<pBû…«IkïkvZ´LË™Z¡ÿ)ﬁC»/äœæ˚◊D∏C"¡|8∑.“xı∑≈ıÁãÔß<A_Ò"‘ÕÙCØ|ë`>o‹⁄ö˘5àÎ¸±U3ÔA˘
*iTèL÷
‚TÜÌc◊Ã`¥‡5GÖÄA√`#¢Æ±‚xÎ#ß∂”f”BÉ‘§≤´…j~µ˜SûÂXÜ·è»Û"œàíÁHåI^ü$yyÜ§™ é21ö¯ áºÏÂ	@ÒËê#Jí»– LjÅ∂Qv§ù-»GÒzÂ≈<<ó>@”4éàPAæärqº.<…eH∫R)⁄T‘ÒÂê˛ÃW%è4í/uWâ¿ŸéL3Jiﬂ3)ì@ëpò^7⁄£B"uhfüBÇ"ê†”Ç, Ïπ±pT#§˝-"?qã(Ç"‡b¡#ù
°Y2ŒqÉ¥ñ¨+ÿ∫sÙ˝$>Ø˚¡oì»ï—≥Ù”Loq∆sœmzôú∏;0˙c‘≤≥∆Æ≥ˆT=’N7:EEl)·Ü¥“–êS⁄¸Ì’SzÚJæa≠≤¶ayÛ>ew˙ßÅüÖè*˛zîÅàR)DpW-æ:V?:_?∫Tˇ°ˇìz°+@¢»êÇòi∫Ó˘ƒ >å&'XôâŸõõÿ√~k‚#¬íÃ¬öÃVyè|Qæ≠‹ŒÌYï∞zS"ú˜Yè•7§Èt§IùÆPﬂP«TÓıÑ˙OïQeLêä‘å9SÒ≈~]Á˚TëSÂ5Z5¬Ù±AÎ_$‚°°∞K.›)irÑÒ¶WË+(ﬁMr2û@¨/K©%¨O∞òw¯{Ô#Ó.@‰1à‹%*¨ï(–K5ÂP∂n«Ïf˚ÑÕÂ–†F âuy–ZpÃQ¢uŸÊ‹;9˙ó9í‚‹¿_&≠⁄¶ƒ€¸%ûû¿OÁi^uÂ∑[äºÂÍn'√ªFâW]Æ„À˘ñé{Ó®FFÅj„Ê8ÅLÕ|ˆÚ∆pf˙Õ—aUt˘˘˛íº π“
K–U˝–Q˝IÆ‹hwøS≤)ˇÊ∫⁄Éõ8Œ¯Óù§ìt:›ùt∫Û…'ü_¬+¯!ŸF¿±!ÿÛ0äRÒì rÄö4¶
Ö6¥3…§°)N!îRõÑ$≈Cã[˛HaÏL 3qBa”í4OhÍ`ª˚≠∏ùët´”éˆvèÔ˜qìö?‘@@QµºQ¨ÉÛíñäôƒ∆Wúnh=3˝πÂÎ∫W„hÂûÌ[CmÎªˆÓ9^'π¥‹3Ü∂Ï¸Ü%eœÆ]Û€Q°ùıUoÌ™›Q´xÖ`~ÿΩ˛±âO•2R˚™≠•3«6ı}∑k‚x|µ–ê
gœH~oˆƒFÔ&å6âÔH(Ñõ≠ÉÿÓÛÌÂˆJª}≤Ÿf2¶ôkDç©∆FÛÄÈò‡è´Ò`çZL8¬"1°>lp>#¨◊´ÎÉÊßûn≠[ˇªˇkÌk˝ã–us»‘≥Ì≈b±Rbü,Zˆ±Œæ ﬁ∫kÎó<R¿ks0(” ÷È^>#øã«oÒIæô∑ô†≈SéÚte∏Ï£¢Ì êáÆSÚ¿´‰7a9ä(˘êçÜ†(fòLrjn√}ÿf‚…x6f1ƒ$ -‹∑B@/L©ÇiL¡>†
¶T!3æ=£SUXg¿∫XÅ%∞û5}‹ˇÑ`Ec|ñ4@Óêà˙Ë&‰%_“fïjD©ú<í<HÕb À-`I%DÄﬁ(◊Å˚›©∆ìÀZS÷‡7<≥éâ’ˇbÀâ76o9ao∏˚‚Ï?|nˆ‡'Ø·óœ÷ÔªÙ◊ÆóHU©∫…ˆø
‚≈'ö5bﬁÌ"yl°:¥±»Ê3x.√∞Òÿ‡ú∞{éÓûÛ¿Ó9	vœQÜ_∫|!ù∑œ' ‡]ZíiMwy∞iLÛO”Ê˘ÁiIR;»d_éHGÇß†ªòµlÉ}≥g£–,ıºÁzﬂ˝û«£zv{æ`XoÓ˜≈‚vë1±kk	ÇáJí«:ÄZ–u‘á\HyÙËÚË˘^'ıß‹L≤ø|æ»$Uá§
ãdQtfPLÇì'ç@~'áMn2«p^òƒπaGÌï+ÕåùŒ≈ï¥¯ç’ÛÚ™i¿êzÔı6“Ω±ÀèKâÚ¢›¡Ì)¨Å∂ëÛA+Ò∞ì ‰ÿ¯…–Ìﬂw˛ªÒÀΩon∂Í€Ô9~‰«?«ª¥:qªO`fGÎÎôÎû9˜Ò'˘‘ò*ÇŸ5¢Hô(≤ﬁ:‚flBXà	Oˆr•‹X»ÃwœUÊ´ôˆïÆÂJ“Ë0/€Ø¯ØÍ7¸7î€⁄øÙTy™iAÆ’A–.7ñ…∆™òr°ö©™î'çÖÓ¬j·Ü„üj?æ„ïpÄıÚíH…s2"íd˘å(FaYKRóå%Ÿíìr≥L§	úHTˆÅrdZ¥@™≤$S¡ 4√âÀ^8qÚ˝U©Ò|*†#oÚÂüÂ:πk‹gàfs,óE)G}öÀJSë¬FÀG´ßg≈ÍF(-ëö’;0Rtq	2Eç˜~§≥TÇ»¨ºòòq0¢9¨<“;~Â˘ÌW67\ﬁô|π¯›ÅÏõ∑ºqÏáMØÔ˛Õ˛Ô¬ÏOÁLaº˝UåÔ‚áæ–}Ò<`VM\4ãË,@0õgi&2$S%Ï	W=øí]gﬂ‡Z…;PÈ∂…¿ö£êüæOÌ˝ Ω†≠‘7A/5¶¯fßs|KÙπ∆Rﬂ≥¡•Fì£)pèπó!!ãÇ¶’©–)±™!êZ$FílôÜõCÌÃq`Ï7Î j Á.uº‰'Í—,ÅT]⁄:	Ä,-@˝á#`æ´`L¨M¿B–$ﬂﬁèä¡’öe÷ƒ¶ïÚ9+LÏRŸ#ê2(RiÅ#ï‚EêÈââ¢Y=µRä§ø‘√lÄT»*ÆD| ß˝¿Ö¥Ñ‚T„âI(ZÜdÖÀ°›ŒEã(˚t{‰÷È/ocÂÛ+ÿãÔﬂtø≥k˘˛Ånfég¸ÇΩ/ºâháOaìòΩ˛m?Rvk˚¸“ÓikéÒõÌ#Vñ‚¬¢^¨óËñæQ?Ë˘µ¶‡
ÖBõﬁ°€t8è¬†9÷#n`äøçu ˜!+C~À¶Ömàe~Il	±t|ÆVëa∆ ¨[ ›àLÜ√r! π éÀﬂ§˚Z§¿y¢tF£É–ÇG˝–v8C?É€Q∫á›ËA¶~ öÆI’+ıˆ&“—zÄ»ÅÙP•%”∂Zä$;\ú√Ií‰Úe"Ÿ!f‚"\4f«\Dt“ïÛ £Â±qD&ƒ÷¿’—@û¸Œ°C˛‡Œ-5K2«óÕ}¢≥ì}uj]¨j°Ô5wUrŸ˛˚´à"¶Œaø"ä»Bc+…Ûv%¬áïæRq∏Bz(¬èR"yèÛ LæJY¿-‚◊˝ÓªÔÿºH¡§ºI5"-Æ"ßbÙ‰H_ïS9z~Œ¸—kπÂ9ÀG'#ÕëÓÇõ9∑Ún»öÍ¸Å9y™–s¥íHŸ®Ñ÷ëf‘Å∫â≠Ã6´Ãn¢ª2◊∏’@4uá32∫4,iññ‘ö5[Ñ9S°∂¶Q[”⁄öFmMSÈoç¥≠¡,|O€ö°`&ê^€$‚0 5Ûœäù‚5qH¥ô‚dq6)tT1b∞s·ﬂD˛I§ﬁ&Roı¢»¶∞∑¢⁄ˆvßW˙?áËπ'‚È˝Ù¿5äIë¢§i™ñêD5L⁄Á¥Ú®¨–Íav´Z˘≤iõ∂Ì…‚-müı≠ˇËggû?∫Ú≥ñ?}ı´£€^8ˆˆÛM«ÁÑÀV,◊∂«ØæÇÒ˛WöÔ7|€ŸÙ;Ê£é≥œ]8áàÜ~Ç{ìT-/=çTB¸ ÈU°m°Ò:l+g+Ÿv¡FoM–ÙòÊî=≤¬⁄1;ßnOÿeE+bC.‹·¬*≠1™0∏
Èß∏†±ê·‡\4€πÇ0œE˚M8Hóê∏†¿∞ÆÀrÅﬂﬂá≥u’™†E-VkS˚Tf£⁄¢∂©C™Meî0’´%ëgË#˚AŸÑ9◊ë§vj∏©Ì∑4™“t¨t¬“»6¨–˛tDï%C#gm`z›p∏Fçtqh)F$Dzõ∏`<°Î•ÍÙ:º\ÿÎdb¡Itâ˛Àv’GqñÒ}wﬂ}˜„ˆÓˆæˆ6Ÿ‰r·ra µêi“hÆ WIIh)9A
jÄh¬G lm–*F∆’Q	-CùÍH∞ùÊè¢3|Qä⁄v 0§Xƒ‘å2±-‹≈Á}.ÅÉöè}ﬂ}o˜Ω›Á˜¸~œÔb&v	@jí®»πDÀ
˘b>ÑëÖ|ù};˙;~Wﬂ∑iÌ¬’Ç%¸˜ﬁÙ¡_dñã:∑-⁄≥=Û{‡‰n 
>◊ßÁR_—fÚ7h‘∫¥n≠GÎ◊µM¥≠M€©Ì_∫¢çizâK°¢§1iòÃ®Œî∏,–˝¥õˆ–~zÖ≤~:BEÅFÈ úQöÛ ‚bz7n„Fu˛≠ïçN(Â&ú«årÈ<Ü¥A}0zÎ!z\∆ÍÜ±DûÚÎ€Å äêQŸ›◊◊Goû?;DÀoøœÛﬁY˙ﬁŸ%~5Â∞úá`œ≤•ö‰uˇGeífßdºó‡èßOL¥â	§ÏG)ìﬂ∏X⁄¨ã~î&UhBé˙''5ﬁå¿Ëóq°R/¿
£T¶¨JõKÂ8{D_¢oñ6ÈÔK◊òràë+W‚j5{T´s7∫õh[¢4i€ÈV˘g⁄ÿüÈ_ÿª°¸ó}™Ü¸∫.KS4MÖMU„
*
ì(çÀzPñuÄ°*ÅÀLQ!3ù'ﬁî&SKyí œJ£ËÇ±’U
ª†–ª‚ÇáûH uB#d¿êöé9nb%¬H@ƒ?f:⁄f-∏P`∏ØñŒ˝ZûRqaZ ﬁkJ¸h"≤Ö©m¬/¿VÎWw Stª˘åv¬≈Tk’Z	èGˆ(Ózçîh/H¢fª}I»˘ˆ&¿˘ÀÕKR∫ˆpqµ¶◊`ó{ã´ax∑7ä√ë“j|Ñ&px‡ÛÑDÓ8!∞±˛ﬁ“j ±ø◊‚√Â^≥öÂ<3p8‚ ›úhöÒS˛Kî®Aæ-¨≈‹5⁄kÛõˇyƒ…]N“MhQ¯¨yI*â2ëºq#ªÜº}9{‡;Ú…;oíûlGfïXÚÌÏ2ûóœ√°
πxÌòåDîπ]®z4âc≤27Nõû'≈qL≈AVΩrâº_îi#Fd©Dnìw c2’“E)'d|'¥T˝ÈávJÃWµOÓ©Zqû™Â∞Œ˘u‹t‰®	ì1,t¬]é
Ù~érí&9öb5Zü[ÊëyæO>˘ŸúÒZ¡ ¡ƒ»On†ﬂ^=>>˝-µ¿ÂN∆È“ÆÜ?å Â—®V£1Õv¢ö$≈"E,ƒKßBX¨∞¿‘‚§+ﬁ„·p°'ﬁÂ#>äùâç]	Ø.ÏLÇ¸%}ú—a˛¢>˚˚∆‹«ı~¢KwÎ$ù2ÏxóC‹ŒπªùÉ€¡˘«)ﬂŒ¡j‡`ÉÈp.aræ1úﬂ¡çæü%à±8Ôu≈ÅÛOB˛ébbçWö;^V*à%'Ö'G…≤¯q≤ÂhÈ‹|ˇ0.û‡ºÕºï·º"îŒ4Ã^=Îz;tπ`Abëƒ@W.¥… ÉÜœ!~wh¢ ç[t¿74õ)~»ï%Ùã˘Í¿åCk:ˆïÏ8˝´7é∆öøÿˆ”æ%´û‹UCÀ_nXær……√«2ì≈_Æ[^ÛÚ¡Ã>±wÀñÖ?ˇIÊΩ	oqÚ≈"€SYbÒ◊ÊqÛöÙ˜¿à4`îKn-$ÃVìºbÿWÏ1õF’†'h˘¡[fπu∑«îŸË'lÙ.t.tÆªÆ¬Ö$pM¬+xÑ—U∏–U¿˘ß9@]Ë*\‹u†∫–∏∏¸πlN∫BÓ0Ï[l≥ªÌªﬂ¶∂$VÑ,‰Êhüœócﬁˇ7˙∆¬óg,Ë8˚S˛çJCÿM∑ﬂ√XxÕ∆}´3jÃ˝F›=∑a1ü¶´∫¢KÃ,˜1èCº∫‰)ª∏≠ÑBîπÔﬂqÁ´õ.≠8∞–‘˚¶¨ù∑·uZæÔÏ∂3∂g6à/~≥ıÒΩg3oBÉ%Ã˚àN›BY{,dÛ7	 ëd^N…|VÄ¯Ω¿òÀÊ©œ≤&ıÎ¨EUìfçø∆™¥gõı˛zk∂›,7kOõi⁄z⁄nï[µUf´ø’Zeo&!ç…Óe“3Ú3˙2cù¥Z^≠Ø3ÙpU| ¡2=æÉi†p7è_±±É5«WG˙∞ïÂÙ|¬q¿	PB†,ûú¶A1ï®")”A#¯˙ëXrÃ=eÇ··ÌùÈl æEàØÒÕ±ıG∞·l…Â@¶&´∏∏¶Ô!g∂'“£Ètñ–‘É‘Bø÷ŒÀñ∂H^§≠îWjî◊&~I¿¨–Ñö!ﬂ¸œ:¯˝Sk€Õó≥√'z;_Ï=˙ΩŒ^1@&ÔÈ»^Õúª˘]!Ó≥gŒ˛È‘ô”@ùŸZ
˙ÖYô⁄còèò_0ÎMZÌâä%—áåXÒå–å‚/∑Eª¢jM∏∆ôûÔ4©ÀåÊp≥≥F]k¥ò≠·µNÙBí}©Bd(8πãZ1ö0°JZcŒ°ÛÕ•ÊáÆõ≈Y”ÂÛHVQWy´»„<e:1ıîæBﬂ©”(BE8¡∑]Oπ8ê∫=~˛ŸÑ°˚±Dg«!‘yÆ≈x∞ıç$P!V¯„Ç–.àtì2Bh	©#çD"ºŒ°TcÇjL0Cà¡∑$úÃ;º bçA"WRP2∑ &âÛ!63∑ÜÓµsÈv@`‰|‰t“ºp
ÌÅ	QµBAë7nì}Rzùkˆ~c˜¿öMÉ€ñ˛x™ÔP«ñﬂºæq√ëlã¸÷ûzÍácØºñΩ˝“ì5ô€“¡sÔúπxÊÙ_9Áe[§+Ä°)ëô©=.1!N±Î≈≠´’‘tE∫#r2êtÍ"≥≥úEÅEŒsÅÁúëùëwŸEˇuv√¯ám>$N2°j±“xBúc,[ƒ˜åÏk÷çÇÎŒ—K®;XX‰R<,XD∏∞ßBàõÊÄóòﬁîwÖwßóFR.g—Û˙πzπ‚"Ωåá›k·gXHyËΩè5ó
d ^^áÍ±—Wˆ∂r^T∆Z&∑»XÜL.‰7*ìê€VŒ¯"üä#KìyU2›æ`8ì»√©P™˝<0B;Ò!ì|IN∏<_*“√Sˆ-~+˚Øo]ÿq™˝’LÈo∑l8t∏c”kŸQ}¨ÅL% ˇËÆˆÿ(é3>≥∑Øô€Ω}‹q{{Á«˘|/nõÿg·ñ@dãGi õ¢ñáph (¶5
âIîê™H§T!$Ç4M[-j)XAA	
R≠°Xä"ZU „~3Ási£Íˆfø›€πô˝øÔ˜;|ˇŸ£ÓŒ¸vx¯„OØ^˚îu∏Á 4ó *∫Ïœl
cSƒıbQú+.7à€EôX*Qâ∂àé*Úí@î‰_U±öJÜqXHYˇ_¡NrΩ˘÷çFÊ@Ù_å¢,bÂH˛bª„‚wDÏàŸ}ßwú√\¢ïÛÑvd^Ìπ»’ãª+ú¿Qò_hœôΩ©¥zÕÏ«õπ&R#fﬂŸ6∆±\GimÔÿUÊÖ“¯≠¿	¬¥Ä„ÔSë‘≤ÄÃKØH≠Oıëd_˙h¯7
Ëƒâ«úiÆ9RB¯æ òÕò∆∫‘.“EªÇ]Zóﬁ£ˆê⁄Ï—zÙ¡Ï`Œ»e”πÙ‘ÈÈUtep]v]~{˝ˆt˙ }K{=®·ó”ﬁ£ø÷ﬁÕΩó?ô˝$ÕWòh™b‘Wåt≈»ó’·ƒ3Ã®ØÈäQ∫¬∑k⁄W©πåF≈x2;E6V«áÑ¸î€¿ú_Îñ‹N˜áÓÔ›œ\Ÿpk›-ÓWÆXÎæ‚
ÓyàÕ»ãÜ®Fÿ„&ˆ±`‚+ Ù∞âÃx~$Zƒ<Ï!´àqcWıÊj°∫jä"≤m∞I`¸çò~òX¨j÷∆q<Ì˙·X±ôMobeÁ∆ #´7 rƒM≤ôníÕrπpt£ºK	´?R“òz™™˝Jÿ*lFÅï'˚õB•N¡∏}öM*ƒ˘RuπBqmÛÖf°‘‹ﬂ,4õ„4äï˘.OπdŸÀ ÌÃ``ÜÔ≤M$”`ÉoœHN ƒ]?…q#ƒÅA„†ê˙™"k›áY'Ü"üÄ‚Q¯öpÍ]Ã)ªµÕ[Ù '.Ã*çn≥€õ  @õü Ÿ·Äúw Ï…œ=TS/E≤ñiõa3 ßÙdëºí¿“C0‘D‡≤.Tü@©z]Sß“ŒÁï=1ÅjÕj∆≥<XYy`
‘+x{˜ÓE¿ÓÓ›÷nãñ°&óÕ5
≠≈ÈmÂ5∆πXƒnÊ‘Âfü-}dº∞ªogkÊ‡•7;Á<RxmŸûÛ´¨„⁄3õ˙z¢—¶ƒæ?Z±È“ûœæƒèV=’ª~ﬁ£ı±LÛ{wÏ ◊zÛwoå-ÌZ⁄V_U¶Èñ9}]´ﬁ˛¡á¨N”„ﬂ
ÈM‰†/Œ"
9Xü-Ÿ9`ÙªaMß8Ä¢&Ò
≠;4ÃJa›Œhx\Q'èØU∂*˝ ´äàÄ9Vé+î+ä¨∞fÕ∞J)7kn|;»0K)Î±	É£zôAó9Î˝`…‘¨Ã*ïsBä·È'6¸èHÖˆ;
¸ÿa?Zì!º’“b^f≤’Û2Û_∂’™|o$´∑"ÃıÇˇﬁ¨mnÿ∑Ô‰©Sa/_ÛŒ€ÊÏıGÑøÑïÕ˜_~iÏ‡¢Ü8Û—≥Äe7≈,¨ﬁy≈¡7däSí·h—`ªm±#E/å”j8™·p4`nÅõPK4sòúàs≠‚pï‚ÿÃóùÃáogRü8\ü8ﬁπ>q∏‡tò>—ô?∆|¡¡Œ‚8ã—&M‚ﬂƒÖ≠Ò√Ò„ÒÒ∏◊2d≤qåHí\!7âH*çÉL6¬W&î≠JÿˇÛ~A∏6![õ,vôˆúÙ6◊ËwEtÊ˜“¨rÁ‡EÕênËÇ¨®≤*© DD-Åt’J &C
ÖΩ–an]+MÇ”bA¬≥ÇòŒÏ@©ÔÛ5Ôvö¡¡†ıÙí%fæ58ˇ'ù≠œØèù|˘·é%À^Ÿ/¥ﬂª—ÅnAt(æ}BÊ.“w$QU∆2EQ%,Hiñ~Rìwcÿº1©¡∫€j‚L´ÑQ jßﬂu´ùÄÃ,™l ÈN¬Oú·â/|RSWDy8Ô$©LEaÄ´Î˛œÛçEîÑ¡–¶¢<…“v‘JÁ£∫ØV™OíxÉ∞I›Dv¢xá∞K›Iv–< <xAŸØæH~Öﬁ Ø——zùQN–ÀËz}NøF•˜–⁄ ØCc(JÛ(K€h'Ú)ë|;Zî Uä'd˛ÓﬁáΩ:bŸ7X)‚ |¡Óq:Àº¬Ô
í§!lM7<|áΩa5ïJ<î	øç*™ö!4BEA b¡6BÅ≤®™ `Y°$Ä∞‘§a-•˙æO˙â@Üp‚î/ıKÇñOíÇèS¡€aŸ4w«∫«∫„±—ënF5€(ÕbpYÇ“êΩÅ=cÏ¥àÁÅ"zPÙ¢Óïu∏%u¶∑Ö[0˛›˝Õ…‘∆ºØœﬁZÃéÌ€∏e˘OÖ˝êê2B“»[¨.g«Yd3f —GÊçJû–W5ù∑ÿ[@Q¡≤íZ˘áÉ!ìˇ ≠ïYñœØ©¿H6Ñeº°k2+(Õ¬ÇHEã≤´ttù·aÛ⁄∞y’fŸ«Ã:ŒD[`≈êÄ
å‡Ç8ï
¨’÷+`%y¸Ü∆or+Ü≈`á‘÷Õ™ÍÉÎo¸3µÈ¢(k$,'àkK"Â 	ÜT€D·@D©R¡jP∞•†z°"jUf®3CÛ≤Ø,RÁ÷{µ±‘~JYßn¥w…?S∂´gÂs∆i˚Ú=íZyî◊s°ºë≥õ"è†6{á˙º˙F‡êvø/º<™ùBßÂs°?ã◊‰/…-ÒñÒw˚é|óTe∂cçè&C|4¯hO§mÇÜ—Fñ™®≈»Ñòå)k}h¸öﬂ∆PJáÏ+p≠¶„HX¶A+K=kπ∏îvYõ≠>ÎEãZTÑ\d·(Ê?ÆÓÊ¥∂…ªª6Gÿß‹˝·H¯ëÄ$`)°TçBMÀ|_xRB6pñ'¸‘%?∂5©X∂ÌIJDíîƒ9£á"∫RAÓxTç¿t$MV
∞bã™ai!ùoœWUEa•cF(Ñh‰ü¶é◊Í[ı~=†·c>MvRºÖ˛Ç˛õÍ*n‚:√ÔΩïV{ÔjuÀ$ŸíÌ XÚÕÇâ7ÃU«dLRDQ8•B	‡¶√0&eö!	&”q”∑ù1¯¬@
h)§t†4t
)i«°ù∫tjπˇ[!íﬁπávˇ˜˝ﬂ˜="ígMæ—âW:79âìéDÕé⁄_Ñ‰b π:˚Ò]◊›%ñ%
4g2~5£IñÒ˛(≥¥‹^Á≤Œi’€O∏Ø7Ä mäv °hµ¥–>-≥˜èkö◊'á•0yÙx⁄HΩÿáRjXå‚	πOzˆ˛ &»8nÙ‚G
[ë¶Ÿ˚+ûôoÕﬁ8‡?ò’av¨57 +˜∂∫ÿ„H—;ˆ†	‰ÉztÛG◊˘¨Îú£7zÖ∞-åË†<uÅu∑À∫ÅJ†@ÇpFÈúò≠¶TBΩ"l-B±¯ƒÂ£§íœ2xvˆ»·Æ:[E◊°ˆ™…›Ÿæ#]≈WÄ`ﬁΩÈ<G~8≤Î¸Gd…˝´dCˇˇ. ”®†Cˇ¶—ür:‰Q±»⁄œVD™ñ#Wì	îNü•?™é’h¿`©˛Ã	Û’∑mosm nı∏˝8{‹q^ÂU”kÔëÉZû(n∆?π§˛-[⁄ëÁ)Ô‡]¬.Ò îŒäÁîﬂiWôO˘O‰k⁄-Aò\¢ÑtßÍó¡X∞î›⁄SYDd$rÑ/ hà6yÊñeœcñÂÌ6,ü
z.cUï5LëEF“V%™†ùFßy¢≈ÔFàgà|Z∆rLb‹íƒ<œ0ÑÖùÄ$!°Q«˙Ly£‘E,ø—@öÏ∂ïeÿA2’T¬ÃFmÑXŒtn∞6™ô·bZ°›“Üá>œ|œT+29¥f^÷N!˙¯™∫ç≥P˙†ÜÜB∑ñ´ÕÅ¢OÒè1Doqå!E}Öé{"ÜF9^81x3d<TútfJÄP@p*|Tzj†0¡*ﬁöm˚KGi®$÷{%˚S¸˙ı´≥_ê"úΩ7=5•‚~V˘œJg3^ëÏ3ÃóÄë ˛o#c∑ àL(†Í¨»∫L]ã¶Œa%êLØ˝m(pÜ,Ÿ»ÎUCX•/±"dπüSª∆îMXêpQ™R£ïC‚uØÏ◊≈B©PÆñ™Â*•Õ)ÈEÆﬁ¥ûv•=Kı•Æ•ûµÏKÚZÁ:˜:œ+ÚkŒ7Ù7\Ø∫w	˚ƒ˜µ#Œ√ÓøsˇG—ÓπGCc" ÎCy6ı)u´ ®ÅGèo=¨A&á£Uï4‡Jp∑À”7T	»0&
nQ\∫.I"KoÄBZà$C«B$4HÍ˙UàÖÈ$sM±N7uÚ]˝òNÙA<e@≈Q4-O†á¨hôa)%5JÃiT"ú—õT!6§Æ//ºàÇ7≤
∂ã "Ë˘µ·õÌff’P–ØY=‰ßááà‚ I–˙JR€,¸ Î)¿6~`õ#HΩçƒ—€¯qÆqè˛y†∆¢5ÜY÷Ô1úQèëC0xÄè´êz‹˙˝ ¬ÄTÅﬁ‰ûTR;√Áå€≈Ïä◊—qâøˆe_x≤ µ·π Ï˜ª¥¢ÇºÂÍ[—H€è6oxâ,ø∂{J∫â∫ú"‡ûÀÄ+wõ≤>H>‰àéÀu_%pË«&¸∏Vù0gAßòÒIÕ¿Ü0◊ìzn&ﬂ®-¿s…\n>?G{7ìfnø∑pÎ˘◊Ò+‹´¸=<LÚ\s	ﬁ‡~Œ]¡ö-5O%zrŸÃ◊L&Ú·!Ü	»¡†ã,YdO¿+
ãd$S [jûP2à’>C;{Ñ|!‰ÄÉ^z–ïﬂS0RLe°“™¸S±+Ù∫zHiA¬FåªnD+—(bêüN£Ä™µD(m$ûvØm–Ü¥⁄πô–ÜÈ‚é¿6%Q´›Ç-‚-'’¸ú’‘îS	XCK	,;´Ÿ_å„¡£«—X¬ËƒAEJÎDº*ç3÷⁄s@*BÆπ}0œ‡9oﬁdjŒz|ÜµÌºqC	zø"ñä*ÃÊG™"Ï®Æàxä»ﬁ5Û≤çÃÛ#ø]πv˛«õ«æ˘„ëÔ¨Áﬂ'ÅZô}‰WˆKHD>4ÈR…ˆ~ƒc~ãgêlÔa0¨¸ˆ~lœ	z‡∫øˆˇl≠E•C#ô!à ‘e)WeuEπ◊„¶ªØ7EdUe<? ∂v¨nŸ”±fu«äÊ˙iÕÕ”ÍõmG◊ÏŸ≥fM«ûñ˙ÊÊz(»Üò—/Ì∑·)T4U#o1´wÎ;Ω;Éª«^”/{/ØçÂéïO‚Ö≈„ãSâ≤Nfüÿ%$N'˛êæ«• íœ'[í$	ﬂ_ô$ãÕq•%Ó““íÒ%âo€KSeÂLu™¨®Çéπdqqú”_SéòuÙÏPEwDIt'*M&´√XØo
ﬂ∞”'Ùp¢FƒL¢M|nÚ0YåJ±w¿f÷TUG™√0ûÖ$"ã{m¡)n˙R‡…ﬁuñïjzZª€0ö–©≠ÖvòFØnà§ñ¢i8S;BU39b$-OÂ3†ŸV
(¢ºÅÅ§˝S◊ö≥jü¿±Çÿ‰∏S‚$66Óç16å=ë?©;Uwç√°ˆÒ–8†W´+¡.Yã‡1T—Ayv®–£ù¬„üÕõ1Xó€tèõÿÚ£§™R/Emƒ„÷mÂzU%)¿ŒHπóÆ∏√ÍÂÀ/å∆ÛÛùŒK]r˜(^vÓL∂Ì‘©l€ŸÛxŸ—ˆÏ•_v‚íé\ÚãÆÏÔ≥>Ï€—˙ÕMK¡≤ÈÕÔÕx∂≤`ZC˚Í¶¢Èﬂ≤_:ô}ÎÉìŸ]gŒ‡ú¸ /?˘rGˆìΩŸO;;q¢c/Nv‹ˇÇ)ˇb]z+ßR´⁄[ﬂâá≤ù¯√ß&!@vÛo2?áÏ?ö⁄›r«q«E>s|Ê"\‰ò„òãt;∫]§›—Ó";˛œ}’WuTÒ≥{˜~PﬁK}/Å°@ÅÜ	P_I⁄R>ÇP MÇ§ÙCB@¥v*ÑFB(DZ,Öì&Ã@-U ®£mLù~é°U•3"∂bPH√ıwˆ›* åˇ¯f~svœ›≥{ˆÏÔú›goà ˆä®lw⁄cr°≥0&Àú≤ò9°òåE;=î⁄ïå‘)∆ôñ"S<,àÈ√£ãÌïˆ€∞EtL,û≈Ò/HÔ1*eπ∞«8q)(n§ê›+viJÃEIÈ@99è2¢[îœ,¯ïÜ))ˇ&(“i≈üª•¢¬˚âπ"≠_Ó(T˛tÀ≤˚&µEÏPüA≥áåeàÁ˝ñ˙’˚;´„”≥&§œ.Ω‹B§&ß‰4≥UGÍH¡4©3Œôòéà…cˆ±®|œ~/*õÌÊ®‹gÔã ª!*7⁄£Úi˚È®\b/â GúGb≤»)Ú"ïÍjP¨) ±	Ö≤K8M6+≤().DJj<ÑxeÜ”«ÖBaWxπîFú≤L‰ìt¥Pn‚gOpå8T'"∫çÙ·u|‚À+É’ßä
ƒMÃçÊÊ§≈lÀŒÃÀùì‘.=‘{Ï!yπ∆G~C˝˙“å¨â∑Ã+∫‹‚{ëGlÉ9`€·y©ÒsNOá¯◊p<sÀ_™%œ^‹€ÒXÑú∫]0û- {‹•itOÑ.ÓΩ¯d$1O“/úky*9∂˚‰áÙUµå“Ä…v/˙ñYB≥ƒ*ìçÙ√ËEj-≈ÿFÙÔÇ<»∂_¸à%@O7x(‚>∆æ∆∂òc	œ£Â2*sz”b≥ƒÌ¿zõÕzÿévÉ:Nª≠±¥˝∞{]çÊ1∞Ÿl5“Ë_ƒ˜á°€9˝z¥Á¿.€kw±k)É%`AüÖy÷y˚Õ4QûZÊ~åΩ|s’Xc:‰`
∆D!Ô÷à™-næCR÷_√z`º''aû’¯ûª˛ËW°›~Xê©@_`†‹C∏AÈgê√±ˇ“ƒæÅzú˜‹π'¯Ô˘t5>NI÷¸9–OéuOBvIÚ-à™ &9T	YÙf»∑ië˙2	ƒÎÛ$é„Ù‡N5ü¶°/‡gëπü∂rò™±ÃÌP/Rùqñ∆‡€ì÷fÏc>‚=8O√Â_i®5ÄVÇ_„1ˇ*`;Ê¸≥Ê√|∫ÎÉÃQ'5á™ÅıXÎo~ú86ËØ¬πŒƒZüs>¿æòàs©≤?X8«úœ]î\ã±'0f˙tÏù9…6lèπx<l∏,©cj◊cê
Hc|hûy¿∑71O`ΩÄa¿I†(Ó ¶ ±6a]CÛúanj~Äfbﬂ4g{ÿÆœ3ë3ıﬁ\ºN_kï{ËÀsræ0g·ÀÀ˛‹úSÃ_j~ókﬁ ˚dNuJ‰û:MŸùÉ‡ñ/9Ô‡3Á√fYL5ê[¡„*Ê,˚ÁKésM«9·…x“^≥ué@D˝<ÆW˘“èEß|úv`Œ¨áPSÍhí˙M2û£á‘od—03:Ïc˜…”4”i¶úÂ}Ëøê[võX`6cüMàgΩÑòV®6yõj¶Ÿ‰û2I¥öMrÖn_%ÉÕâo,…ﬂ˛[˝ç@6õP3õ‹øòmÆã˝l‰ú∞Oãl†è/°ˇ1P	rã-Nπ8`Sƒ":,VtáY@£U3Œ'uπ }±˘1Ωn‘“Z’Ê˛NTR•l£j;çîõQ”∞ñ<LUûrIèÆ‡\êKæÙ˘î\Û=NıÜ¥êÔx8··<p<öNf›¿ıYﬂ®—@uÇØÓ≈N~∂“N»u>?<-3‰ePÍªı›œS¯±÷ﬂ?◊GÆq\#πŒqùÒ«eí˝3≤<Ê:¸6ïyy}õáB¯¯'/˜Qáqﬁ•ÆkMpwY˚››∆ÕÓnk$⁄¶ª˚~¢ÛNùÂ^ÚÓ”,ˇ.MË©´èö9¥»´g;tΩ˘åû◊˜hâˆØãµóVöÌ8w‘@ÌoùóÉà'¸.W Ê[i=ˆëa¨A>BÃ·òË≥ ÍŒ˜ﬂâ∆&ƒôÔ¢Z™2é‡Ω¿∂9‘Mﬂ˘T
ﬂ[µw*K÷ô•‘`ù¶ë™µ∂ôÊÛYÒ>ÿ>{g9Öù4‘â6°~Ñ1it∆’È–.Õ∂-«É
±∞&úùÜ1<_Ω∂)†õΩxÏ–±–ˆxã0á9ò”J£ô˙=qö~`S)r®ﬁÆ§z´9óFª1«Nÿ≥/∞Î°ÔÎM4˘UÉ⁄TÉöCöˇenª—Ñ˝<Å∫ïàQu7+√rΩ˜Ò*Qc◊p˛çt;sƒ⁄Ñ:ÃÔâMÙåL˜ZÂT]≠â:âu◊A˜]‰o6rw-Ï{{uõ∞ˆZËŸ6üﬂ2¸F‡|±(jUÍw i¯ùÇıçSToRx|ó≥	qXMCAi~4ﬁ
åH@˜WxXüÄ÷ERÙ5"Ù÷À˙ +t%r˘}M≠¢Ø©iå@Óv£°Í}‰Í⁄f§“<ımSh=˜Uî˚∞ˇ˝x[≤˛]öŒz˘˙[®L≈a_C_WÛhôÒ2∏˜[∫I=ä≥Üù˘=§?Ï?√ºƒq*3Jê[’h_p˜8Ω∆~∑î°&—PmóÌ´èÄœr
vUà3Öø‹æ¬_¯⁄ÈßÔ„5¸”˚‰ya«c‘6ä#NGÅ	yiÜ¨•&†N˛ûÓ1¶“∑≈n˜ ‚:!ÄI…}ï+ûÜ©\˙)∞
Ì!êø ˆ&˙xªÂ“`5Ê>˘
ˇ/`»ª)è%t€Å-¿o¸o…‡uÆ•OÜŸ”=xEˇU‹5Ä8Îd«#ŒyX/O›ÈdÄãÖk%≈ÏoRÃ»Ñ˛Vÿ˙fO‰”´‘ﬂ ˜◊ÛÈﬂøÏ§8$Ô—?»[˛Mí}Xzw√˚v£¿˘ÆÊÍ¯~Ji	Qä8ÏÖ,á)b,Ùá¢ı„ÈüÙﬂ◊˙¿˘Å+ƒ1ÍÉ˝‡π^Ø/_°y…y–…áç4é°Ú1ˆùV«∞ﬁ¿∑7ÆÓ´]◊A2∂≤O‡`Ê’}Î> d»˛µ€ ÁÄŒ˛ª® è’ˆaö»‡‹e»˝¯øt~œ•{IqÕ„∏[ﬂ˝ÛÒœ%x>Ø@ΩCì!oáYYËÀ‰úÊmPÁ◊íkç	‰FˆÕ˘ˇ‰Œ[@Êˇz-A‡*¨£xá‰„ŸÜ˜…l™"Í@-˘|8C‘°˚!?Ñ∑˜•, åv7ËÉ|â®˝⁄K°oK¿ï™'’yÔ Ë~‚Ÿ:ﬁ|E	˚ˆ_]<ÏMÿ∑7–˛;/÷À=∏™‚é„ø‹ÛJ@ê§ì§BÏ@Å653∂Rm≈H"•"rI°<¨è±•Äy¥(ñ"E
®¥tdÜ˙(à¥Xu⁄jGE©É£¬®1˜ÙÛ€≥ÁÊÊÑ$¢‹ôœ|ÔÓŸ=ªg_øÔœõ˛É>ÅÆ¶¸{‘[Ñ>=oûB˙&ÿK˙(ÈŸ0Åˇ+–Ù;P=©øJQ?“Êz⁄ı‰˜è/™xñiÙ≥›ÉﬁöºC|açÁ≥Mﬁ5‚˘ÔL={óh´—8pgzﬂ∑=˜Ó”—'VÊ3ìã[6„)œP≠^V˝≥ÒèVÕ˝Õ¯X⁄)éï˛®UÔ¨˛’˜7¯ûÈO-˝∫⁄ÙÀ∆ç‹≥5ÔcY›·ÎVgQÊ”TˇgO!Î˚8w£“gB]D¯"±´êX∑ès˜8˙È^ËÒ8¶≈gkõ3∂ìòv∫”ß#øDL≠≤LI–^~ÃñÀîd,>U:ã›_:ñ∑£s„ÙWM«q>¶‡áR•C¬=J“ó∂Òù§;ÛπßöN˙éSN'|IúN“ÊyrÌ≈~¶\ ≥$ˆ›©¢wwgã˜è˚ê‹«Ÿ˝f”å—èr·`cËFŒ¸ÿàQ·=‰›ñˇπTÂoì*“;Å∏ôyMÎ3ÙèyÀER'¬f“Hww_0e'X“ù≠Á‰∫Un¸!cfŒ¡⁄9.ÑûWòœµﬁ!i˚µQWÔπÓ§∏{∞S=_ÆÉm§Ir˚=8∑á»ü¯'⁄Ì¬˘>Í9À«x¬fû)3Çg5Óç2ús~Æ˚2Ô|+|ö3}éõë¬‡i v.$ÜV|uì.AKÉ≥ÂAﬁÛıój?$é'hÏ†›:Y≥({Ö˚°‹Îtï°ºßØ˚ñ[=◊kí©Ø¸A‘!Êë˜-tÄ—∑‰<w≤ÖãyﬂEkú-¨ë√‘%˛§äeØ3Zˆ∫[Âzﬁ∑ΩK£¨+8 ÎÚ”Rìª¨Úeï≥Ví∑6¯ç¨ı+•Aﬂ«UçâÒÃT^–Àƒ¸9§À≠V«ﬂúÙ¶ìeqycnªqΩ¸bÈá|?mk_;Û6ƒ¯%êÊ;\ÙD≤=£Tc¯|§2√∆¯õ≤1øN&”œãuLÕÿNñ±Œm‹˚4¶k˚õ– UÓù`«8Ÿó∏-∆•π=/{˛èá·:œë"]Wf-E‘zGÃ|]¶sÊucÍ¸áªu|7S>%eÓ1`i?÷W‹•§÷±GÁ≤WXÉÓJ<S£,≤P6‹dÍÕ6ıÜ˙„‡b˙UO;ç·€-»-Ñoªµ≤ƒ¿xÈ¸•ä√›Ëı©Áhk∞öÒªÅ>-cûØ∆âî3é˙›•Ó Úu}^	Ã?¸ät_ÛÌVÕX°^!˜:˝F<ï3HÑg˘ŒÖÍØ7[6xTjÇ!¨◊ÆR„ÌêæŒµ¯óøq÷ù≈‹ç`^e°Û¶Ùv/êiNI+y5·°º£(N]IΩG˛kË›§dRÍπäÒö≥a	ﬂ›dxØ Ïó_X¶+©∆ºo¸uòhˇ˜ä˛ì7Xv‚w4 ¶(æ	M©{iªZ“©«hc=}°ß;˚/uÆ±∞Ìs«≥«ZsiÍ™ûìÑ|’o&±˘ÂI»W≠NB~ıI˙—^πˆ˙—^~ø$‰˜;˝hÔΩ}íêﬂßÉ˛çLB˛»SËG{„‹7	˘};Ë«Ë$‰èNˆÉÛâ{lf?w”≠Ë´6ﬁAG°¨æÃ”¸Á~÷€Ù´∂‹Ôa5‹CµÖ3/úBôÙ∞	∆∂ê9àû%Ê∑ÆÑoC]‘ñ÷Õ<µm∞mfvDıõ∑Ÿ˛Ê§3_Éw¢ˆL€zˆÓA˚¿[~±mw{‘˜Ã ñÚ˙\ø—‘€ﬁBË¿èy^Åék!≥3"|
˝3¸¿3ˆo;˙ÕèÍªZŒ˘Ã]#ÀÙ<‘X4äòò}ãå2gÓã≠bïÒƒôÕÊº9˚.í*ø>‰~©Vﬂ†g∏7›î_Í•âMÇ?¡+ø_Ò‹øKôwX¶∏se®≥_<åÛñ6‹ﬂ…OÙ›zn´ÁpÓíÀaå∆0ŒMçÖ#9s∫<b¸Kw ªÔ“ﬂ˚dw∂≈ﬁÈ™Áy0àÙ
æeÉ‹Ï›"ÛÚÁ»>ˇ˙˙≤‘Ø*¸)2ÿ[ √„ª≠?G
º3VªÊ…¥Ç≥»o$Óæ#Cu/…∆Ï{q€Ÿq§ò|ù3ú^ÜëÀ0˜üW¬(”g˙ãs›J¸û…ƒÎü2&i”ü—?›á≈uÊãx«à›ó…Ä† Ôué,.(ïı˛	æ√ß≠JıuŸ±?◊iî~¡œ‰<ØA˙yµÃQ%æ˘m∆˘JÈ+g˚æ`öﬁ§∞	Ô∂¡ùa¸bOwãîÔ@Ï j¸éFYÌÕóe¨âAI_˚®¨ßÃ◊∆mdø’¯ô˝~´9~√å;˘#‹©ÙJX;¯é6j˚î»f .ç˝l∞OF∫IÍ˝;eúw9„R$„Çß§g0LJ’üÅÒus4F{ü‚E«I?÷˛•vøˇt/≥{¸FÚ_Å≠—~‘˝•˘foí◊º∆ÊˇnÖô—s}ﬁ˝o>Ωﬂ<ª5*ﬂÃ>ó1l)ı£ñ7"Ã=‰Ï\üj¸h‰≠[k÷◊õıS”©&¸g{™{ò5Rîı√±ül´+—qü˜{ÙÍû~Ï£ìJŸUxî€"5ﬁPı!´ËZSØó‘¨ØnG€ÛØ9>6⁄g±Fæ˙éÑ^eµ_ÏØ;”¨ˇn•ah”gf˝zgZ'∆wZñs‚Acµ˘Ö9Í∑π?Â™ôq¨èUˇ>B˝µª/⁄∫Ók†5uäs∑\s2|"âÃnçı˘Ì‚ˇñzê_ë$¸H°œøéˇ`9jŸ®8y"ä{wí#Éﬁ›NÇ?ÌB˛¿à‡`ÑÒˇ¿H¿ŒÔi‘◊Xÿ!∏%8fYÜJ<ÓÒ8∆„¬∑Ω√wœ»ˆ9nﬂæ˜´Œ„Wùó”ı›ı=ˆ‰aà’WN⁄oÊ«QÑûOî-≤¯åÎ„∞ûµ¨Tÿ+ÂÏ€„Œt÷‰÷i≥ñs7UlZ˜¢‚„ÏÇ“hpGz/B&ûl|ÇÈ—˙˙G„‰5…TÎΩÛ›Ù|WÏŸ◊∑`ål0gAùTËŸB‹’}~Æ˚Ñ‘∑ˆ|·8÷MôÓ‚§G˘ﬁçRìz.|¿õ«ôA¯åw;^ hkëÂ†e}‰˝¬ø†ﬂ7„<Xv£Á¬›∂∑¢ehÔx»˙mı±◊GdﬁçÚ[˙üΩŒ'|Gìî©opáHôÒ/3• ú£<«/ãù©râ∆Áªx+¸á˙≥Dä‹◊—ànåÀgsŒ˛ÆîEn-„ÍâÃ<Ì'h˘˝¶~π=h[Œ,ŒÒIEÍ(ÂxFΩ≈˙Ôôßæ»·F·]¡∫KŸ±·?ú’ËpÀ'0ó˛÷…Ã‘"Ë‘KUÍ%¸N	˘◊¡µ¸/Ea"¨Öõ‰<ìﬂƒ:˘åÚ‡∏§üG=ICUÍSÀ≤}ûW-È‘.I„â”º/*˜≤©·K:ÔI”V⁄©Ê}îKqSrpNâ˝ÔÛ¸ÍÌ√Åæº£—ªÃ≥∏LAKÔ}©ÈR/5~‹ÓÒ.	˜‰ëã‹I“É9ÌÁ3◊áÏ˝A}‘ã¿hÖÎH?õ⁄!SÁàå0¨	˜8˝¡™∑Mfz?êÅ^3˛‡ˇÏó{l««3{>∞â}g7LÏ€µ1Áÿ&>sÊ˝Úùy'‘∆∆!°$∆≈á9p|÷˘ •™¬¢D©⁄D1•Mì6¶àV!–ÇŒ9“Qπ!ÅR@¯É‚§R´¶M\E®	- ı;≥kÍÑóUïÊVüﬂcwfvnfˆ7øπÑu0@≥”˛N/ßU”˝ŒÏc{I¨•Y@úÌ÷8∫S◊∞Óö¯˘‘)ˆ*˙2Á#4:˝MZÑ9$|4§˘ ÕöÂ~DX”ƒDˆ∂« »pÓ–ÏoMÊπ#Ê””¯é+Yπ÷Ω®õ!æ=ÿırè˝9Xyú8C}é—JâÔ°	±!uñ⁄ﬂR¨ßüâµeÁÇ®ö⁄Àœäsmjó:ƒ»c◊˝Üu.M=~Í–ÓOpéô)`WR€√¸CÇˇ∂ÔÿBSS¿ÿsnÙ1ü~õ/Ã≠sÕ8™QN∞Ç ¥óD]kÆÔ‰;Î©D¿ãÒéq7Ò7„\∑gCQ◊sgüøN„rΩï‹Ë„?-\ˇﬂwÚ3±∂¿–zªæ¶oıˇªS"G^à}%È|-u˛‡˚àØªJ•Ï†ùØ}WÖo;Ü3Ëb*∂b8bc7yø<éÁ±ˆê˜[Ì—◊õjDlDúø&ˆ{ˇ˚⁄˝ß»Kµ±àˇ"ñ!W¥€Á§ZQ_‰˘à{ãEÏKõLÕ"÷äò*˜‰¢‚úÜx”&b?NU¸öÉÿy	âX§e#v‘†è5RKõóŸ1•Ü“y˛À,4WÍ∏åIYVÃ“Ì%D<√˛k≈´múø¯9+ÒÀ(3ƒ!˘Ò-±{ŒÁªÂﬁÙ+N Xà8-lqv±œO.Ò"^Ôî/ŸπÂû/È√C˙Ny°]gè]Á∆Ú+®…q
ÎdÊNÏ…oQi⁄#4Í˙πã®Jå⁄Ây•œEÚÔ<_ÏybüîÛÑ9jFNÙb_>8ŒSìò€¥ ÂàΩ„tú¶[,‰>-∆ÒO»À2∞Ô>$ﬂÅáˆGcù^±˚)Œ'yXßœ]?˚ùÂÜŒD≥Ø–.≠πP%’⁄˚˝ëaÁ€]±Œ¨àKeˇØaU5„måL@l‰á—7"Ç7"ì˙6Q˙√DàÓÈ" Z>! ~ÂÓÕÁnN.‚ÌX<œC˚„^$∫o%Q>2¸Çù¥°w⁄|F4æà®¯$ë›+qZîb<'ÊÉD|lQ9—b“Ÿ€3„3YÎÙ©D3>ƒpæJ4˚—‹ø∂ü±òèˆ`NaåcÍŒ=Ñ}‚Îß˙J¢F‰`M®◊å›myÇh%˙˘8∆aˆ‚o>{w≤˙û[Zu˜≥Ê{DÌ
ÖB°P(
ÖB°P(
ÖB°P(
ÖB°P(
ÖB°P(
ÖB°P(w9å(s
}B≥Èß4Ç8π…G9÷:
(>Q˝
R#Ò['•∞G–!xå¨ﬂVl€e±Gm€ª›∂ù∞7ÿˆzå=çíÃë.⁄d∂Õ(ü◊Ÿ6ß,æ∆∂5‹èŸ∂ˆV€v¬ﬁk€ËõvìA~™ƒ5÷2ZK!Ë%°N£'©Kﬁô/
[»V‹Àx§\5‚^;Í«®[z!ËJoÑlC… Ï0Íä≤aY¶ƒd{m(Ûtî÷„^Ñ÷|ÖæàV;eãVΩfxax‚Ì5¡jïûıÊN‹ı…ŸˆZŸWÉV√€Äß1Ÿ[Q∫b∑·Ø¨új,[2ñD:#±'ªB∆ºH¥+mçÖ#ùF∞£√h∑Øçuç°ÓPtc®≠¢Æv˘¢ÜÀÉ—pk«íe∑Û§2¬›F´ã∂∂ÖûhçÆ7"kn˘>#‹iƒ¨π3µM±÷Xï;€|ë®¡ì®±:≤°3á∫+˛áÛ[Gµ¥úQ=HÂ√f{	ﬁ*J∑c\;‰ﬂÆ‰W}ˆª∫Ï8A©⁄N7˘§e⁄˝}ﬁ±˙ô#Z) Æï∆ÀÙÉZâVü•⁄¯æú—~WÕ@DIi@F¿>êj—<∏ÔÜ‹L∞$¡‡D Ú»ßàÄ^0 ûhZ~‹–›¡-uÛi\⁄)†ëÈı†ÙÄ^‡îÂƒùÿí‡oÚI@ﬂVÖæèâ?'Uﬂ∫øt[-wÂc“Ì[˛®•ó,µÙ¸≈V±ôV±Iì≠€5ñ.ôhÈú	~SËåLˇ—`Æñã?ôãéwA2˛r1F:Ì–F”~¿5ß}'†ÂÙ{˝ΩIÕAL„√DÍ©£ãgf˚É<≈)át˛1ˇ»z¬?ÍÀ ˆ˜Î¯¥$Å∆?¿ı>ü6Û1Êê’†$¡i0ú| ◊{∏.ÛÀ‰‚ÔíTÉ–í`å‡ÔB∫˘%±H)Ïj¿˘%H7ÎHøÎ"øàÆ˝>>mÜˇ†4 }∂°O∞ç1˜ŸFNÆ?¡œ∆ØñbEy1”XQáµ"öKUZQ|¬$=°ççœÎ	˛á>£\ﬂ¨‰Áh?¿NÈh ´@p¬∫ Îô`+ÿˆ¨2H70¯	p\†J `$?«k¸t‹[£s˘)˛ç¡àˇõï–'˘1©Àﬂî˙8¥˙?˜ËÖÁÑ:nh7¥œ”¯Ø˚äsÙT0õ'1v:§TÉz–zÄì'yQºMœA#áÈƒHB…8˝YÍ_–ŒëXßºÛ∞ !º3Á¿ÇË5zΩ<‡›˛c∏Bx_ÿKÔ3œ√¬˚≠-∞ÑvlÑ%Ñ∑m,!º+Z`	·≠_"¡_y£∏DüVøûAﬂÑQ⁄ÑQ⁄ÑQ⁄DæI\t’!˙ˆrº¨#ˆR†º¥L71Û3ôπìô!f>≈Ã-ÃúÕÃ«ôYŒÃ|fzò`Êa6Ca≤¿Î_pg∆2Û3…Ãnfzô9Åô≈Ã4ÿ¥@Ç∆WIµ@™æ†¯Ë†ÁÃEÙqÒBåh!÷|!bBÚ4HI/ÄBFëU8œ#tQ_YµÂWÃÙGÇµº˚1˝Ùp`Ç˙±å˙—H?pAVÉpÇp¢t:ﬁ#•“™AÿÅSvgpäÿ]‹';Ê≥;]/<ﬁè´W!/∏Û›ÂÓZ≠'üπ<¨ﬁìÚiîõãàúì=2;¡2|ö˘ŸßôîLÁ/*¿DlµuO¸jÅû`/∆Ωáı‡hˆ#Ú8∞ÍÿÚ≤	–”©[˙S(§–ˇbº^€∂‚8˛ûÏEr“$NRS+ñÇ‚∞UÈ:B6wuqTGö:‘çΩ y¶81Üå]≤{[»ÅÖ—]=Ù/(+É'åÏÓ–Îrﬁÿ5á∂€“√†'Ô˜{íùïe∞áﬂ˚=}ü˜~Ô==Iœp*{vΩ+Ô@≥ŸÓÍö2†3ÿ™ßºñ_*»Å ’ﬂÂÁ ojß]ÂWPûıî_‰cÂÁõÅ O´3P9⁄óo)?ûrÙkp<È*hz WrI˘BÊéVËx‡¡ï1´lØ÷îO†?SﬁS˙Ï)õÚÂNH}Ämz ˚0=¨^á¡æ+Û†ZÜw¯i.†˚∆ö¯Xtƒ{‚á‚∫∏&.ãä∏$¶≈i^JJ3“iRí§	).	ëÇ·ô°∏uI4q,„ºû∞ƒ5æÙ®$¿ÄΩ≥ªR§6{—$ˆû ˛™hùº_coiE ÊmbWãÏñn‚põÂtõâÂœü“Ô\PôM@I’	Ë•£4õﬂr˙Ñ“π£Gi¥Ô=r]íZ|∏ô⁄ú/Ã}Ù±yI—àJ˝"•ﬁ®/±«v≈a?,πl+√%◊fﬂW‘∫”ßØËüñŸßÁh\ß+–W÷6Í±ÇÈ∫v@w8GTzÏòsŒIaFé®R&‰ûÑ\⁄∑Ç∏DÇd9óM$8ß»˘ﬁäe˙++úπ™è3ﬁUıüÃiòlñ3ãá‰î3ßãá»∞GdêåÃzç»ëÈ5éÏ\ 7#‰xåÛH1z¡»!3}6b¶œÄ—ˇojuùû‰›f›jiVC≥ZêÏ€á˚)v∏ß™~”Eá b´çΩÊ>⁄›sµñ…öö©˙˘˙%Ó:∫ÛöÈì∫Uu¸∫—2ªy#oiª¶{R*o‰ﬁàu<éµQæ§≥2v∂Å±JπK‹9tó0VcÂ0V…(ÒXÑÔÒ≤„K§Ën’C{"LM¬~m§ó›‚bÚÀﬂº˘Â‘Az ßïßdJwŸ≠»¶!£Î∆›w—œ∫f@ûç\©É¸rz@üFÆ$»sZëËÌé◊!)Îs3¸yê@jwp¡√R˜˛+Åœb∆ÆÈµ	±ŸıäÕ6Ô◊_Am‡îÿÌë65e√°¯à∑Qå≈∆ jwPK$"ﬂ˜øŸ-|
ÖÁ'‘»P¯s‚∆X∆Æ
*®÷`Æıö3Ä≥~<&ËQùz£>¢aÎ:	Ø	Œyî€ù®≠E;≤aKh‚çñdúp±ÙÒäµu˝Ô \¡ÉIendstreamendobj56 0 obj<</Ascent 1010/CapHeight 716/Descent -376/Flags 32/FontBBox[-628 -376 2000 1010]/FontFamily(Arial)/FontFile2 61 0 R/FontName/JHWGPK+Arial-BoldMT/FontStretch/Normal/FontWeight 700/ItalicAngle 0/StemV 136/Type/FontDescriptor/XHeight 519>>endobj57 0 obj<</Filter/FlateDecode/Length 426>>stream
Hâ\ì›j„0ÖÔı∫l/äGûi¡⁄§Ö\Ïõ›pÏIjhd£8y˚’Ò)]XC¢œ»öÛõ›v˚…?”–ÓmÚ«>v….√5µÊvÍ£[ñæÎ€ÈÛn˛oœÕËä|xªLvﬁ≈„‡Í⁄øÚÊeJ7˜‹ªw≈è‘YÍ„…ﬂ˝ŸÏÔ}±øé„áù-N~·◊kﬂŸ1˙÷åﬂõ≥˘b>ˆ∞ÎÚ~?›ÚôO¸æçÊÀ˘~IôvËÏ26≠•&ûÃ’ã|≠}˝ñØµ≥ÿ˝∑V<v8∂ÔMruâáãºd~$?Çü»O‡-yõyı6s^\ñ3Á%sI.¡+Ú
»\ë+∞íÃ‹Ä‹¿‹Ä‹B~”!¿!ºí_¡Ù	©òU!´bVÖ¨äY≤ÑŒg°≥¿YË,p÷‘÷‘!ò5eÆIÅø–_‡/Ù¯ÀÜº≥A/¬^Ω{Ù¢|/ä˜¢ÙTx*=ûJOÖß“S·©ÙTx*=ûJ7Ö€3sÛÇ!˘úåKûjˇ5ãÌ5•<ÜÛËœÛá…Î£}}„0˙|
?˜WÄ ¨¢“vendstreamendobj61 0 obj<</Filter/FlateDecode/Length 25691/Length1 54546>>stream
Hâåï	XTGÄ´ÊΩWf@9E≈ô˜f‡M"aç´Ñç.!x∆ÏÆëDwè à r*ûâJ6Ë"®¡≈ Ô[5 *^ﬁ3xF£âÎg÷`“|lˆ€/_∂Á´ÍÍÓ™ØªˇÈ™ó:eZ∏Bp>l¯€Ω†µôôDF'E•dÒeœ 0¿˝≥ËÈ©rÎ≤«
 qTl Ñ§÷qÊ#$LHúÓñæ@	Nﬂ∏ò®Ò7<^±ú9«±âVˇÁòÚèKJùŸ6˛ ËJbrtîjü<`·)6æë53•uΩ,ó)yRTRLFIÍ!6.‡'§$OMµ¿uÄr«π‰î)1m˛ÂaÏºµ¿qWT«@ 'aç–õ›¬∑µÁj VÂ·$®4"Ør4æÏ'aÊ Í‹rû°d`?{£P◊¸1ˆCq†›ng˚ÖR«n¿3≠lŸ–ãÒcveB–6…zï ·Ûﬂç-rº@¢ì≥Z„‚⁄°£õªáßów'üŒ]∫˙v”Í$YoÛWåoºŸ=‡≠¿ﬂıxªÁÔ{ız'¯ÔˆÈ˚«ê˜BﬂÎ◊¿¿AÉ?Ú·ü˛¸ó°ˇ¯ì·#˛˙∑O?9jÙòœ#∆FF¡∏ËÒ1±‚&∆'$&MJNô<ejÍ¥È3fŒö˝≈ósÊŒK˚ÍÔ_ßœ_èåÖôYã/˘&{È≤Â+VÊ¨Zùª÷≠ﬂ∞1/ø`”Ê-[ã∂mﬂ¡Ì‹µ{œﬁ}˚<t∏¯HIÈ—c«ÀNú<Âß+œú=Wu˛¬≈Kó´°¶∂Ó ’k◊·Ê-ì˘∂•x∑Pv— vUÇ`.⁄U≤j§jÁ«„íπi‹\.ì[ƒÂsó∏Wº+?å_ x
gÑ'¬K‚»õ|I¢æAv1IØM–ñk´¥v›<›Z›è∫◊í∑§ïIC•O•ë“hÈsiétP™êÍ$ìÙ\z)5ÀeÉlî{»=Â πØ"á Â9Yû'ØêÈΩßﬁGo–ı=ÙÈGË#ÙÈ˙ï˙"É @ÜéÉ∑°´A2t7ºebà2ƒ¯©¸‹¸Ù
(*≈EqSºîŒJ7≈_	TÇî%QIS“ïeë≤\…Wv*˚ïRÂòR°\P.+7ïá∆cò±ø1“må5&ìgÙ)ÏZ®∑©l¡∂[®≠üm†müÌ±Õﬁ8ÆÈ˝¶MçÕ~ÕçˆF«;c/,O*Ωjîj7ÁœÖs©‹l.ùQ[¬m‚™πü¯|8ü!,™ÖH√®ÈHOa)ÜkÅQK‘Vhõu†K”ÂÈ^H uñdiàﬁFm¨î&ñ*•k“mÈÖÙä=vF-ÄQÎ%˜ißœ®eÀy-‘:µQ™ÆÕ®e∑Ssg‘∫tm‘"„[®…øB-ºùZ∂íßloßV≈®›`‘˙∂Sã1∆3jëÅ©åöO°lCõ÷ˆ.£f`l´≥56F4Ö∂Pìõ”‘Ï˜X~>gRÀÍ—{L∫;Æy¢CÛ’Ã
hM¡∆Í∆ÛB>ÎkˇìñœÇûÛœáXÁ<dŸmı∂zZ›≠≠ÆV´∆™∂:[E+Y+gUY·â„?ÇÜ˘LV2Iox}ß®a∆”xf?Ì√tf√Ä˙¯˙Y•÷ã˜ñXW◊’ÁXr,ñ, ÀVG|Ωèe≤e,ı¥ÑYz[¸ÕÉÕÉÃ!Ê>Ê`sosOsw≥¡Ïkˆ2£Èô…jzdz`∫Îà2UöNò L≈Ã:m⁄b⁄cdÍoÍgÚ7LzìÓ~n√ÒÜ√ñ£±>±BK¡u‚Zqçò€zOzL°Æ∑\k\û¿E∑T-Vı9V¡˘1åÿ@&iB”ÀÑ#Ã€ÖI0àGZ£ùtLz:ırÔîÁlPwrÃ™=⁄d0¸FS©?aö’iıÙ_Ã∂‘Ì÷ı∫_ç]‡uF€(˝∑ˆ˙E‰uDª=Íˇi∑b5!ö∏ˇq‡`§√|.r‡!,Ä%êÎal7»dHøÜÂ¸ãad ≤ÔÈsÿ €·ü^BÏÑ≥P	ª`DC6åá*àÅ3p.¡y∏ ·;àÖ∏’∞&¿3X
W†Í ÉB<LÑHÇDòyêì!¶¿Tò©0f¿#ò	≥a|s‡K(Ü|òsŸW˛+xO°sp™êC∞A#Æ∆\\Ék°	öëPD'∞„:\èp#Êa>:£5ËÇ∏	^¡O∏∑‡V,ƒ"‹Ü€qÓƒ]∏˜‡^‹á˚Ò ¸Æb&f·A<Ñá±è†+v¿,≈éËÜÓËp=—è‚1Ù∆N∏ècû¿ìx
øEÏ{`/v¡ÆXéËã›Pã:<çï˛w·J(£xœ‚9¨¬Ûx/‚%ÙCT–àó±k∞Î
î‚¯&v« ∏*eR-¢≈¥Ñæ°lZJÀh9≠†ïîC´hµ‡Oπ¥∂“ZZGÎim§< ß⁄Dõim•B>ûO†"⁄F€iÌ§]¥õˆ–^⁄G˚È ‰˘$:Dá©òéP	ï“Q:F«©åN–I:EﬂR9U–i™§3tñŒQùßtë.—e™Ê˘&æô∑ ††8ÅÅQpúµ†°™•:∫J◊Ë:›†õtãLd¶€d°zj†;tóÓ—}z@È;zƒr˝	YÈ)}Oœ^«xo°I„!∫âÓ¢áË)zâﬁb'—GÏ,v}≈n¢V‘âí(ãz—†Ò‘xiº5?”\ﬂ¡]i¿ﬂ}ˆ˜Ï>œ˚ÏB®°§'ê@(Jë&Ω:"*zàûï2ÉàÇ"“ª(xw¢" "‡ú®ßû:“Ö–[Bá ∑ﬁÕ˝±ÌÏÏÃ3üŸ˝~ÀJûórRN…i9#gÂúúw∑\°+r∑›WÏJ‹]wœ›w•— ™¢`Îÿ∫6—&ŸdõbSmöM«D©$ïÌÎv¢ùdﬂ∞o⁄…väùjﬂ≤”Ï€v∫}«Œ∞3Ì,;€Œ±sÌ<;ﬂ.ˆyvap–.≤ãÌˇz-ıØÿ˚vô]n?∞≥∑ˇ∞áÇ√¡ë‡òOÄGÌ
˚ë˝ÿ~bW⁄OÌ*ª⁄Æ±üŸµˆsªŒ~a◊€v£Të8©*’§∫‘êx©)µ§∂$H©+âí$…íôôGm"„®-µ£á©=uàå¢é‘â:SÍJ›®;ı†û‘ãzS •æ‘è˙” HÉh0°Gh(=J√"$U“$]2$SÍI}…írQÚ•@.I∂4êÜ4Éf“,öMsh.Õ£˘¥Ä“"ZLKË]ZJÔ—Ú®éF¢ƒ´+Í™∫¶˛P◊’uS™"u[›Q≈*]ï®ªÍû∫Ø2|∂
¿M–Bï	¢P BîÉX(T=®ïT}ïï°
ƒAU®’°ƒCMü—ﬁÒy#Ae´PG5Ñ∫êIê)ê
iê.9“Hé»rT.Àπ*◊h+d@&‘É˙êŸ– B4Ç∆–Ñ~¶_`º„·Uò Ø¡Î0&¡&L¶_a
L•ﬂhmß¥ìv—n⁄C{Èw⁄G˚È §Ctòé–tîéQßtíN—i:CgÈùßãîOtâ.”∫J◊Ë:›†õtã
©àn”*Ü∑`∆`9*°ªãÂÈ›«
X+ae*ÂÄV¡8÷ad√ñâôCvX´au¨ÅÒXì£\ÜÀr÷¬⁄òÄu∏«ryÆ¿πWÊ*«UπWÁœ5π◊ÊÆ5ú»IúÃ)ú iúŒX9ìÎq}Œ‚ln¿9áqcn¬M˘~ì0ôõqsn¡-˘!n≈≠π∑Âv¸0∑óÎrÉ;p«®çRî£aT¢é;qgÓ¬]πwÁ‹ì{qoÓ√π‹ó˚qçFÀDÀFcx ‚¡<Ñ·°¸(„«¯q~ÇáÛì¸ˇÖG”rìGÚ3¸,ˇïü„Á˘~ë_‚óyèÊ10f¬,òs`.ÃÉ˘∞  -Xãa	ºK·=xñ¡r+ÖR$∑Â»G≤B>ñOd•|*´d56îb∏WÙD˝Üû¨ßÍizÜû•ÁÈzâ~ﬂwÄz•^•◊Ëµzùﬁ®ø“ﬂÍÙf˝ãﬁWınΩO“Gı	}F_–óÙ}Æ¡u∏7·B‹∆¶¯ >(k‰3Y+%rWÓ…})u‹Åb(ÅªpÓC©¥“†µé@ÅFL¡lÜÕ±%∂Úß€`;lè±3v«ﬁÿÈö8«ßp$>á/·ùå„pÇœEìMúÇo·€¯ŒƒŸ>#Õ«Ö∏ÿ˜ ˜t:.√C¸W„Á∏øƒM¯5~á?˙fÛÓƒ›:˜‚<ÇyxJg„9Ã«+xã∞K}Ô±>√ó5ÂLySYÁõ8S√∑†Z>—'ò∫&…§ò4ìaÍô,›»409¶©oH-}⁄oc⁄i2õˆ¶ÉÈh:ôŒ¶ãÈj∫ôÓ¶áÈizôﬁ¶è…5}M?”ﬂ0Õ ø3X÷…˙ˇœGáZ¥˚ﬂ|Ã3Ã7#Ã”≤—Å3.te\¨´‰™∫xó‡í\äKs.ÀÂ∏¶ÆπkÂ⁄πéÆ´ÎÈr› 7ƒs√›7“=+«¢U¢qÍ®:¶Ú‘quBù‰“0U°#!Ü&¥!ÖÜ°Ñ.åÜe¬≤aLX.åÀá‘)u:R)ä‹é‹âGJdáÏî]≤[ˆ»^˘]ˆ…~9 ÂúápÚes∞.¯ﬁ6õUN∞1¯2¯Qù	÷ÇüdK0)¯!ò™ª˚ﬁŸ€w®^jÜö)[u_›O˜◊tùﬁK%n©s¢T—ÅÔ#Çoƒ∑b%F πnß€Âv√t9,	.ˇVs’C¡,’ZçQs‘\5Oç˛©∆õQf¥[‰+Ÿ$_À7Ú≠¸KæìÔÂÿ
?√/+¸€`;ÏÄù∞v√ÿ« é√	8	ß‡4úÅ≥pŒÎl·5ˆ¡\Ï´kÍZ∫∂N&ü¿·¯§w⁄{b/ØÙQÜèyπ]∞+vÛ÷~¬Õ∏≈{€Ü€qá∑˚2é¬—^ÒÛ¯æ®ìuäN’i^Û+8_ıíßyœSΩÁÈﬁ˜k:]gx’st¶ÆßÎÎ,ù≠ËÜ:«+Ωâ∑∞–ã-¿KxŸ;çÒRcˇº”;ç7#Ω’gÃ≥:__Ù´¿ªlÌe∂ı“è„	<Èı¶z√…ﬁp:∂7Y&€õNÙû3Ω‚f¶πiÅ©ò™È∆˙ÜæâõÇÍˇ]’#I¡¯Æ‡®™3¸ˇÁû›Ñ`yÜ$@ÔÊíH≥	5BÄ%Ÿ§)êr7Ä›Õ£ì ïXU√s¬\“
äå§ñy˘8ÅT;tÖR
R§®Çí*•PÑΩ˝Ó&D“πwˇ9ˇ9ÁˇÁˇ˚YÓ}#’÷gˇã+Ë]˙∑~€û]®¨ˇÅJOß›|õË*»°THín¢fıÌK‘ã¶—zT†©MßB‘¿âÏ°zﬁ`-¥.”hzÅ6[{xôµ¯ÁQ•ﬂüI¶4	Îß£Rø¨]§†ı[ä•:ÍL£h
˜°0*ñSt<ºHÎË ?c›’^ø(ó∆—8Îêuá“©^ÆqúÓÙ'TÙ˚Ÿiï[’4ÄR»Îîı9•Qù≈‡…√ÕrπQÂØ§ó9Q˚†ó–_D8^Ã÷ÚÔÅR!Õ@˝ˇ4ôË,>‰\Ï8Ì∏f˝ ∫DNÍIÉ¿S5]Ê,û(∂»xkåuÜf“^˙ Ú⁄o≥ú)∑:fF∆ZØZÔSo⁄Éˇ]>‰Ê¯Õ›•÷Ô≠∑(¸ÖF&ÅNzöCËP˛EﬂàZ´ñ&–TP>å™\G≠=àO°ñxN<ßù†¡êv6∏}ä~G
ŸG˚È tÛO‘¸QÒ'Ûèπ1Û™ì
qL€†5j'%ÀÌ–∑A©–—D◊;—>Ë;p˛√\ÃsxzñW˘úP‚™∏)cÂr˘≠ºÎHãúã|kM≤nP_J¢ü†Î©Önˇçˇø“«Ë∑Æ”–sds˙Ölt’Qäò,jƒz±Eºâ‹∞V;$≥dû|\ïg´c¬1ë;ØG^åº9nÌ±é√w∫‚¸4*ÄFó¬+∂–{Ë∆>F˙)ù∑˝Áè‚R~TÊÛ*^á~Ë0∫è+êí¢oä%|†:O¸zZΩM∑ ÿ9‡å¯T|-nh-$ÓD•5i”æî.ô&À°r≤,EO0ÔxdÑméùé˜◊7ŒÁW®©Wƒπõ~˜≥E™"*≤æOZMlB∑˘6t±=Êh‰X·ﬂ∞Bzßá¿˜H.‡"û»èÚ,Æ‰e\á\ˆ2o@ß˜$Ä®'SÑGåSEXT¢~´CU–àwrŸ)qZ¥ÄÛÕ@Ó™j•⁄LÌ	»∞@{N[ÕÆ’vh«¥⁄%Ì+≠VKê‰Sr±|EnïçÚ82»œÒn∆=ŸÏ8Ó∏„∏„Œ$g?Á‰îmŒÛ1Œò·1≈ËN∆\è≠AòŒu∫Ôâà¡báË%kπ˝YR7HÓÅ¶"*Æ”X-ªtµÒ‡≠∑Hî=ÌùNØTÿøÄ˜S¶Zß–òHû£]|Vúì£—≈Ü8Qn’ûp|(‹¥ŸhçxWÏÁ<jπbÜÿ®_‰mt˛˛KZ«èÛ|⁄…-ú√œÚÆ•ì¢è6ïWPÆµYHÓƒÖ|ç¿-ïÙ=·ëtñ.G6….Ú‰ß&ZãæAüÛv∫ÕÎ*≤õÜlFñ©áøØ$;ÎÕFú’"ëAÊ:èQ#;âbF8«»≈tç˛Kó˚‡Qy»§ó"’rì¸¬ae"¬e¥qWE„1·%0∂G≥Èq»%√’≈TJÙ,≤ﬁZKY≠Â÷"k}ÑΩ∑—á‹Ê◊MÿëK‡}û>·’à√ÒñÛ˚ûH5”ÓÀ©<Ò–‚XàõiÍ™Éé£Œ°–ˆ
⁄ è>oéÉÂtúÆ–MéÖm)ÉøŸ‡=@sEP;@˘úD5àŸA»„ymíÃ«)À†ΩçàÁàçk»≥Ë ùf¡	ê®ÙcqNÙ¸S¨~\Œª1SÅ¨ùN_CÓÆú-Äû'≠G÷jOgÈKh€äÚïÅº‡„8Î&=J†0úäπxáF"≥˙¥#–˜@vQß±/ÑÌJ˝i§„îôdeãjÌ ÓÛØ·ˆJ¶—¸$∏Ë9ÓRoûLYë)‡·kRÒﬂ£\º"*≠:ÌÈ»\˙à∂√&^π0∆Á7Õ;vÃË‹Q9#≥Gd=Ú£aC283√ì˛√A••4R‹˙ÙÔóúîÿ7°OÔ^={twuÎ⁄%æs\ßÿßCjÇ)√oÑtïR2Õò0!”aLÑÔõ)S◊(=]¶w\È≈ ü˝ﬂJoÎJo˚JvÈπîõô°˚]ızóñ ˇ⁄gu’Ö'F·5Q∏`∑tﬂ*üÆ8§˚U¡¬*”Ú·∏ÜŒq˘F~e\f5ƒuÿêJ0j8aGë‡œi€L©$√ÁWâÜœÊ@i©˛pÖ*.	¯}…nw03Cq~πQ¶»»S›<—%î%£ú˘*&JFØ∂•°’zCF≥Yﬂ‰¢≤ê'æ¬®œ
(-¥it˜ÄÆO%,æ–˜ª!Ôë®ªõ¨ô˛æ’∫=4Õ:]5óÓ«∫Ìﬂ`g`ØH-ô ]%M’AM¨ØI›ñƒñ™UæJ√oœÑÊË™ìëgTôsB0Mí©h "˜Æ§$Ô^Î%˘usZ¿p´±…F0ÏÎ◊–ãÃ)ãv'zıƒéòÃåW˜V≈6tÌ÷ƒwπ®l«E°Ër*ö“ÆY∂92
·J/◊¡I¿ÄLŸˆOe6ôÂŸXÜ'»ÿ•*`ëj’)?d∫rÏy{ør§∫›ºA £Âj«ôp€å3’uÉl–ˆìvW˛¨<ïûnªHL>l
«D«Yôõƒp£∆•„Í£bË6Ãıª›∂ÅW7y©µ§$–:÷©,yyáxÇJÑlLÛ=LÔÈ6f…=L˚ˆêOn$\N‘[≈¶µ∫π˙ÙÙWÂ(ÓÛ te+æh™QTR–˝f®M∑E”:åZÒŸÌ∏6HıÃh…¢…Zßú’æÿ‚ïL≈«uÍ
•¡)£¨(WhBÎo0ŒÌ˛ﬁ=M1±˜mj≤ÆŸª¢ﬂmk„RÂx:éGuw‡.ﬁ‘¿ØLE”JM3ÆÆ 	»4Ω¿ô·&kIô°ªsØÿ*∂ö5˛–=É6Y˚V'´Ç˙ Ñ®‚8´†ºÉWï4xy’ˇÿ.◊‡&Æ+éﬂ{wÔÆvıZ≠¨áec≠ld	aÀ"
^lB ◊Ê¿Nñ7Ü ”†L†	ƒM:a¶<J˘Ä;	R¿<jHÜêÑN€°d¶è)xÑL2ƒ5L∞÷=W0ô2≠ˆÆV⁄—ûÛ?ø˚øgg∑œ?≠ §Ω>g~¡§iQc[[5"¨6X¶E‘xÇ`S{IÉÓFî79$ãºâQ±E†&·Œ‡J$AwÍG˛ò2ò…gZïÅLK>É‡≥2√ÿD»rÖa¿∞‚i\ˇêN—}§Ò˝–+†’ÊL≤í^F
ö¨;"Œw9bë0í§ZŒ‚r$!#";tY˙Œ∂W„<·{…Æ„Æ˝´Ÿç\~ ß‰PCÉíQ‡^ÿ¿ï§Nq◊ßj	Ò©>/Y˛—ûÓ•s∑Ùo[Òx]Ö9Û&æszHrı¨y…ú˜Õ;ÊÅΩ,í&àD/D2U˜Wë*yY!ÔE8D…¢ x´
ã	A∆ÖòNXæ£{m,uUã&óøˆh0Ó	\]ípµ^’S$ÓâŸì∆óvl˚p˜ªçÕáÕô=‹˚œ∫oÔÒò/Ã≤{ónõÊ}…D‹Eû%›†çJ`VıTC·4x≤ÂπITAJ¿œ≈¸˛5˛X´rÕhQnhLŒõpÉ⁄I˙·bÛ&DâVAk∏ï~ãom÷£Ç‚p'©¢®…Ò˛Ò≈:} ”8$
í◊çÙ‚`“	W‘^6Æ‘ŸK~’£¸Ú{A/w„Rπî)RHÒj^‚Ñú!E¡J±∂øâÖ1`¥‰Z°&-95=&«4 )Ú◊î¸#¶¶”c»à≈†@u…˙˙T}]≤≤¢\√ı#kkxOë 
¡ì€√x÷†?º˘π’€KL”äKn‹¡eœnãÂ°=‹ê≤Ω‹˝ipÏc≥÷mÿ®ˇ>¿¯›[”⁄Mµê.a¥‰}@Æå'ûF‚]J•ìB±w∏_ó"uIAáŒÆË3BU£Pîè“à<∆6•hÉmZEñst•eÖ¸%Áú&`&'K/J:G±TA‚yç
Eî
Yåò ≥[X#íròpú¿KΩ¯åÓDBy#ãÕÁ†^≤X∑q·˘∞s∏óå‘•†ÑRßD§>2ÒpÖ§QLã≠ñ>T6_<hdå¨?ﬂ˙ƒÚI7`ÇÅæôñúƒŒ‰c±Lç«∫6ûÔä˚ŸAT2ôÆÛÁè	§iŒ¸RR≤'Q¨†l>jù›|¥‹Á4‚ÜÕ/˜õ†‘–1Å«^m8ubØPàÉá‹G?4?ËÃüz…º@√ÈË≈∏≈<N˚Ü~A¥¸UÊª@˘%†º‡çÆË?ã‚ïé£7¯AûóBIàåÖΩj–3›Cû#‚ÒUîáU∑E+
cDJ™÷
ù’©:b√6PÚ∏dMo¬,àÎÒÒEÒµÒŒ¯ˆxw‹¢≈q/*◊êÊN∏âªóºqºzÏÏb1jQåÏ`,€í0r7bª+=∆»ÇÅüFû·Œûi‹§'¿ù«‹iH∏.¬†(Ç˝≠ú†’1Y]d∏C5eÑ—ÍÖFS hiªjkRıåÁ™ 
@¯·Ie≈.2Ìá∫⁄ü[∏uªÒ€ı”ÃÎ¶GŒΩ˝…ºÊi£/ƒjw¨q∂˛“E⁄7‚ô=WéUùyeŸŸ¨›B¯Ê{Tö˜‰§ß$ö?mæ(Ÿå÷∆g¢Ãﬂ§¿ßËÔzÎVi[—6Ô>Ùk·ÈsÓsÎ9),El˚®¢Qﬁutù¥ïZD∑ËÛπ}æQ$ Ö©°{ËnÈ3Óc+m¿”¡[f)_Ö˛ù &πÀü,e‡öU›ÁØÊ-›°&Õùx∫;uè?ÈÏ≈Ω\≠ñ9Ám«\t˛*ê(≈•û™n;≈†ò9X8ﬁ<^≤Èa]≤ÃfPì¸@Ã»^ã±#˚`0{¿Üa`*r)(§˘º>Z…l¬•xkkÍ˘l4ˇ¸µ˘/Ûuº'±˝¿≤ÛüÅ˝Îﬂ˛”ß›ÎííßøΩÖﬂ¬Ì¯ßxÁæG'?øÂ+Û{Û´Øw1'‹Ñ.B∏WÙ⁄L˜'}À˘Â6ı•}Sºmﬁï^öˆ’ótïÏ°ª¨4ËbX∫’∞S±W±¯êIñïÓÓa-îëêK
ïÑBF°ˆ£˛Ä À2ãF>oaYÿVÒ ¢	ÑqÌ #˛∏Ë’ﬁE’©éñÕKﬁ…_∆ëøúö≤0ìY3{¬I⁄WZyŒº˘óìõªó6GÉ¸π°:á:˜„ÉOu®∆»N¸o!S+⁄Æ?n°ºh	jê‚=B	•«áa¡ó•∞¡R3G¶»»ä≠Õû∞ÎvŒŒKfK Ÿ˛?£B3-ôÅÃèL+
ÛiDö¬|ÇiEôVGõ®uÖ<°á˚NæaËπö◊∏Z⁄wœ|ˇÆôΩ—/¬œ·∏»‰qeÕes≈ıñı∂◊,[lØ˘∂îHÇO(Q}jIƒÒGë2ÀÎ”¸©›∫äˇ9ø¡ˇB‡î„îÚâ˝ÇÚÖrSqp•Ç∆à÷ÉÅ4,`2«ﬁ“jAR‘jÛt7v3¢›åË®∑⁄…Aœ°/ÑØ´‘π$®i	hÂârR^\’-cßî2'3≤Cõˆ=B6H»eû¸Äp <Ábùçe
¶RÄ◊Ö\@y˘H(∏ö™Ø’¯áú{8O’qdìaÓ;y√<x∏ˇÙ/ˇÜ]∏v¥˘è‡°Œs◊ø<cºﬂDJÓÊ{€∑}ÑW\æéó-úz˝bjÕ∆¡;Ê}Û˛‘d‰…¸8Z`‡m=,ÒTÊà$áyıá9	î¢≈Pã&¸ï—Mﬁ–Àu˚˚";∑÷ﬁi'án{øù∑Î ˙¡Ë ±ÓQ»ü¸›Â’U«Ò{˜û«ΩªlíM≤˜nVnöÊaíÌ≤©<Bsïê“2`îàvã0ùiõ0*8£!XAhQC!<2µ>¶‘ê»4∂XDgÑQ¶<áWÏàˆ•<≤w˝ùª	•Œ∏èﬂπÁŒù›s~Á˚˚˝>øÏ8˜e	∏ hÇö ÖT´Üˇ—ƒÑ,Óæ∑°:‹ÇÍ¸sπc˙ë‹õ¯”∑[Ò∫‹Zÿ”f˜ÿ—û¥6êŒdtîU’¡Ë5GÀ3öÓÈmz∑>¢Îìıezá˛ÅNªu»NòhìÛ¿∑˚¥ç´úß6ufT{ñ>8qò´∆∑“@\Á*X≠ZﬂfTßπ›
Îÿæ}[˘mÒn†‚b)uÇ	ÖÇ §‡R\H>àyIfD3à	† • 0êDn¬”¿∞0Õ49„ ∂OıÎÛ8^1Çﬂı¸D(~Â#ø€Jr±B2ΩÎv¸¨|Ü_@ÇXí~;r<∏‡ÍÇGö¯q¢lSÅ
◊e‡\~◊œkÅ$hsñzvçQ+zhØ—G˜—a æk¸Çé“:0M~d‡SüœÂ˚·¢⁄ò-øF6êdáÿ)_%G»I"MNì1IfÀœº
x%;≥ÌÅå¸Ë@±ŸlÊGΩíIf3MÖ ¿X—fÍö≈Õ∞í”ìÏ¬./åD0¬C¡8˛\∏§Y+†

,îhuR¿˜aE;@Iã—rÁp´øŒRbÓÎ¯≈‹o∆÷·}ˇÒÁ¬In—4√Üì¥pÃ3MR√kL@l?ﬁÌâäôÈŒúï	v<>zØT‘√]0úÛ%Ò	t#e	Æ†1YV·)‘–<¨§À≈”r5^C_Ø É‚àº!nÀ≤=¥GÏëÔàìÚ,>GﬂÁÂ5<JØà˜ehµX#ü«õÈÛb≥Ï¡l©π?MWàïÚ¯õîµ‡˘¥EÃóK¯±T≤òlgLö≥dsòlQCYäZ.X·hΩ…ò≤Íci#l•É&Û6 ò ª√Ès/\õ1ïÅ[ªΩà∫09ÅérÑ‘∏“WsìRU¡ŸY|Ê∫∫ÃœÚ¶¬ø∏îë&4J≈¶îiÇ·√œãblÅ„ì√(<àB¿MÙûÒ≥Ö‡-_ÙxFO3è≠Âà≠ÖS2]”¬Éx∫WQÎ¡ÉöiÈ…
·gB*E˛›y=ôå4˝3“‰ÿë\gÆ≥…âE â·F‰r',>DG! Óa‰q.Y™‰˘ë˝¶´‡7ºÇ®Oj†Z®©†™¢-Ë(íà°c˛uˇ¢…ˇ+ pååﬁn•ﬂπ”•æ†©^»U†)Å˛‡Ö1∏M 9-Ü‹ﬁ’îˆUT€V£˜ Ïà§á4¡	«ò˛_™vL’éi⁄8˝Ä –∂g∂ôÀL“avõ∏œ6±k¶L≥ˇ— .√ãeD˙c9[ﬁì≥°]Ä¨=ë∂ad;Eæê7fÃ¯^Ω⁄<x®†#ï√G<™‡nA#√áÑRM–T$Éî1'x™˚Wf#Ô6ÉçÕvÍ3|ùîë4Òm%ÎyÔ„˝¸21éìS¸á¶∂Åg»,˛Y˛Ÿ√˚»|yìõÖfmZc{”Çfmƒ5§3ÿUÜE·ŒvOT÷g„`Çß[?·¬«å≈0)gSp-õÖß±ÖÿcO‚≈LDqú-¿sŸN∂ó˝ü«£¯ªÖÕZ\«ckÿFˆ6T∆_ïúxiRh◊%®
Öäzëãó¢ˇln?`*˘”ÌVrl¨EQf;–À5†óIZ\{Ÿ{bªæù˜ZΩa ÛI,V[#V≥’EkJ7–M|ìµ!ºæxStcÈ∆Úç±é≈äA	Ni±ub•+ôˆTF jﬂêHìÈÿ√sS	/±,—ëËNÙ%7ÒA'"µ}öxõ
Œ|Û@E◊€w%`—l¿¢◊õØ´ ñÌÑ~&›ä"êpk(™ 0`§}N˙ó+6†¥ﬁÔÚá¸√~zÍ˛˝ó.:4ÇœåÙvÙ'g˙œ˙;˝˚œvØºÂÁÛ˘±õwÉN=Q¿¥U^UÉH—îﬁ&:†«ÌÃ@:Æ¶3çãÚráÆU⁄FS=i0•¥µ™⁄¡¥àÑ€pÓ∆=òbõÁ^+Ïe˛ÁñÓ«ﬁÙv†–,@òπÀ[.
Œ555©Q1&zœ_@øÔ/§o›ºyÁaX’V8ù˚aU∂ˆÇ7ùq&X§úóâG¯#Ç-ã#€"€ãzKwï˝<r®ÏlÈ„ÜaÜ,⁄ V]",”ùR	, •x[|Yútƒª„ÿçß‚}Ò·8ç# 
◊NŸ√6±U–9ˇîÆÂ: åí ¢(t‡˜áA_ë0Æ∫Oµç[QùYÚ√ouu;®.µÓ‹Î<ﬂMÄ‡ÆMˇ¬3+∂ΩNícæÛ¬∂ˆ/Ôz¢ÎÜÚ:”4ˆ¢™g(Ô'I“pÕi&’dzŒÃ‘‹Ó…=cø›„ö'úDF⁄`¨âô¶f∫äºˆ≤DÜ∫`î√r¥RÒI≠Z∞øÀk÷á‚ñ¸–“OË'Â	ÎÇv*⁄ª÷˚⁄!ˆ“üË{ÂO≠£t@?*Zø•¢ûﬁß7H◊⁄E∑Íª‰è,^H08
áïø¬ïÖ§(‡
R•ZÚÓÅB≠⁄Ìï™ ıîöô`:ÉÚ$ÇÍæ¸®:i,~‡-ìÍÓ`>5`@qÃßΩ'âfπ¡ÿEZA0ßM5M)∆\.¢újZ÷xÉ?!ñÜµà.M&∏¡”≤≥M„a–o‘´AîÚ§kôC^É‚òZ.à∏”}iú⁄{A.Îƒr9«ŒecA∂WÔVß»¯;X=|ä´©¢µ‡ﬁ™ıÒ°ê}É¢’9û±îÈÃV¢ ®X%ï
Ü–rˇe‘pYhBC¯ª˝w¸ø¯AKE‰_cÄøP¡Ê›Ñ¿{4?JÎÈ√ZïñFùﬁJÊ
=QÊ<üWÒhıü#ÔâáÏV{IÕWÌ5j^≤∑:?s«O8ˇe∫Ícõ8œ¯Ωg˚Ï;˚>|æO;61qÏáÜƒóÑêÄ%@¬J£Í∫:Aºn*1"†¥ïèé≠ÉÜ÷v*
$PB+Ì?S+¶±©˚®“¢îFç¶àÜ5vˆºÁ§ù%ﬂ„ª˜=ﬂΩœ˚{~øﬂÛA¿CQ¨¨P∫£ ÂîæìÏ#CRw)œ-„oåTWy+ÿà¬àòsÀ‡†çë©i	‚M_¿Ò∆‚ "ÇBrq–V†a¬UÃi$Òtÿ,Ú&√f@ÄÉÊ7¬C‰ÌNÀT`Ï¿òaÿä0£fò¶‰UE]Âtõö„9„!¡=LÉÅ09≈¯€dlÇ 9≤ “î(w©Ëü*jSª‘™M’ô•≥]8ÌÏXõÓx·lƒ™c»6 D4>ëéè‡∂'/¿z†2à≤©±YçÄlÇ∆˙»Û2O•·ÿk'H+õ&“Y´≠MT+älì5£( Éìt]ÅñÙî,_¿•⁄¥e:~Ô√wáZmÅ“¸Án¡i[y>}˛f«ÎØæ∑∫}GÎzÙlÌÁë∫ŒÊ’ÀÇõ¸‰âS'RáØÂá~˙ÚÍ¢:›’“2ph√+≠E•≈EÎñ7‰Ôâ’Z¨±°£:ZŸ)?h8|¬EƒÈaBúû4´‹ıuÅRÏ†:ò•CK}Â§jÏlÉØ&∞‹ﬁ ∂˙ñN8O“åá¯~ÿÑáS¬{·sªyÇQ√.OÖÑr“ÂáPπÈA=D/<O&˘Œ6ÆÀ5~∂V»>¬ä’à5˜cD6ç“–û∏ª©n¶[È÷2Eé4h≥’°AÍDê1HXLˆ•~£dëæo‡N>üﬁ¯é)OÓNÔ?∞uKÙ„'ÚÚèÛ„˘øoLıìÛ.¥ıúyÛÍπ”òKüÜµ'°t‚ﬂÊ∫N>%¶îm|FÃ({¥›˙k‰kûª¬]Ì/¬}mîuç˙FÂI ∑–∑P^%ÆRZ¥î'„q.Îî:Õ∂”±ì?ËË„Îóƒã ∞xU°9°«AQ2∏ãØË!√äº◊`Ø#;¡@ŒDØõ0a*a¬<"qpzËÀC≈™·´(LT≤¯nÅÚúaI˜wRπfl≠(Ωf,>1'íπâÙ 67èCÑÑË ßé(ŒìÖ™⁄:6 E{U˛!˜›∂ÃûΩ/¥wÀHäO¸q4ˇ)cw>%ø®~j˝Ò7nˆo‹Q˘˚;(äÏ‡åK/b¥r∑y7«Ã˘bäJ1)±Äñ_4&i∫'‘"Ÿœ"Ÿ–WŸö=´‰f˝$MK\‹5–ú89∂ÇQÀ96ä0Rxû≈ÿ	ªÙ`g„7+Ã>* ∆RÉÇ√!“∞2¿
õ°2LF,†ÖJß¬·öôÇ◊Q¡œ˝?TÏõÛ_/}g√µ¸◊˘;˚êû+õ_⁄|Ë¿÷ÁˆoL°≠B˙	RòÍycıˆÁØù;Î]
ÎçV$¢˝zò†NZ‹ı'ÈSÏ/ÑKéãÃ˙;‰wπ$¥í\Aµ0m°KÏUÍ™ˇ}Êœ}ÊØûIÁW,[ƒ…&0Ñlr^Éóo… 6ŸBC(iENÖHæbzxNlÁ6q$ßâÆÍ%Dœ	Vú[^àÒ˘Ö®Y—‰ÅN¡%Ñ Ø›%äêÊ+v∑®·tG‹N"å*Âà*C]°°3!{àªLñ7 ·3l«OcPM`;ŸÙLß)ifôî‘Ã†`sµeúì9«‹q˚
ÃÒÀ¿$qÜ™qòù:1#b÷àı¯•T._°ô%÷È“p“íπ‘f–¥ıxŒÑ,q¯°~<gB≤
ÕIe#ê3xxê÷ÑÂ∑Ä-Üx1X,åq¬∂‹ó◊ÄìR…ˇ"≠vÙÌ¸√ó3H˙”©úi€∑yŸÜòmW«3çç}ßÚ‘π¡„‚˘˜Û7˜¸d%˙˛K{õö^ƒº°A|ÄBô’µv4œ^,{Sˆ^Õ·≤ﬂ“HYÒíí®x9Oú)—.ﬁç∫‹”–»·ç`(‰Â4≠ üÜ¯ﬂq¯k '1t"	ÕR;ÙäeB•∑ÀKzáê›d9_îî∫à≥ mÖT0&hè°ËÍÆa2Cˆ(u
ÚT,≥>BhP&ÈlcæI8‘WÛô—!_+á”b9!ó Ωñh˝ı'¥Î≈h”í≈5˜ÓÂÙ€£Ì}ûä¸A®_◊˙Ò‘5€ìVÌÁ◊Ÿ7Y¢≠5ü€<$E€S’«ˆVŸãQ	Yb[Äd¬f¢&≤…∂ëOI©“éÚÿ™¯IÔ§Ol`JCY¢¢ïmVZÀö+∆=9ï9öÌˆ∞Óy6∆)™<üı®ä]ã‡
¥*¿:Áµ@r≈Ì)ƒ≤yÖ()-ƒ*£P¥∞ÑøÀÅ	g√ÅcÊ„Ñªeß¶SÛ ›QøÜIá÷uøˇh™
2"	ã˙ÇoÿgbÜÑ1!72+Vπâô.rVˇ	ÎÂ¨á¿ÊXEÿ∂ÿÚ·Ø”%ÃJ\÷‚->#eJ∑ñw«3ïV9’°®≥∫_6`µ:Ëä¡(¯§oπl7ZÍ
ñulØ+ı±?æ}œs›zØ9óÙ‹8öˇœ'S˚7m=rh€ñ˝-±Ör(¨Tï<˚˙[ÉGˇå‹»ˇªüO≠x˜˙˜áèp‰˛ﬂû>˜´gOC≤^ÖÆ.ºÆfúGsP=ﬁHaZÊ˝zåhßCqD»NÔ6Ø!“'yEüM"èì¥9iÜëdF!7u—fqƒxõF”4¢!Õ∞% ‹àqL;´ë=⁄∏F~©!çê¢äl—Ã=+£q…∫ö,$>˚É8Ó•÷‚∂*˛hÊ¨–Ä£Éú™ñΩrYm®6!R(ñ‹Q¯'zÛ–ÕÕ˝m¡¸É‚uã[∂'Ú¿|zfeœ°£π„d’≈5Õá˚r_¿¢€?ÉB|~⁄†”⁄9L–fI/ì4ÈvöÏ•/”∑ÈèË/i«zΩó>6 I8Ï6P1ì¯à¯‹ôOD9(ßù!ù†ô√√Æªf÷ıÌ:íVy⁄^—ˇËÆ˙‡¶Õ3ÆWüñ,Ÿ≤,[˛«r"≈q¿icR“F¥¡2J Ñ÷,πR+6k§mÖ∞2∫ÖÑîñ◊È∆ç4°\≤ÌÆŸ⁄Ì±]Ÿ⁄˛Q∂ÓF/tW∏AXW"Ôëú1nq§◊Ø$KzûÁ}~yë∏)Èµ^∂ü¢†9ÜÇ‰IDö7ø^Hj_üÖ
ÌÜ
5√:±ç`DÓ≥!¡Sm[™m¡iÜ	/≠≥≠ÙqÓÓ}ˆ4wñ„Íâò õ•sl°©ìÏ9ÚyìºNSè2è:ZÈm‰^ÚUÚ’K˜2Ω.JJtíLR%t	S‚H	µd-≈Å&e9÷¡QK–§ì"iàs:Gpúì∆ü6BT Qe≥Z¿ùj«P^8»W?;)±≠∏É‚x[ : ÚBXæíÅ.ŸÂÿ&æÁ®öÍ&"˜˛ KcSˆß€ä⁄RÅñ·â!∆≥—¥“ÏB?2ˇl^ÃŒ8⁄b>7ÒmÙŸnÛ<˙v5ÎG0
rî∞jI’Qx;5@çRg®À•Z®T† $$°!l™jXêºßjìu*œ◊à˙ı≤¨ÌF˜ *ÍhŒñÄ_7¡≥ÄÖxÌÁ”D⁄ë§„5¯<«º@Mú/ Râz∂%—û8úxÉ> ¸úõ~õHúIúO∏∞D*Q'ﬁIúK–	#IW√º›>I11í	M≥hcêcb6{êåËÒË·HD”9XznQì<∆ LãmÄÖ4ågw(¨Mã¿±‘A8v¢H”tKqbònã∂⁄çYﬁ:\™sa´Ç≠POÎ∆¶S˙á˙9ùpÎQΩ]'0Ω@/”s:©ãˇQ5e¢ÚêòÃce’8=P“x[ì5LµÆh∑oı% G!üõí-°§7Ê≥¸ëbª$≈o∑≤~´ïowıvDté∂(Ày|ÛëbËÌi˙í9kföc”´gÕ]3√#µ˝o.khX÷¸xMœD#ﬁ¸˙Ã™˘ùLœæ∫≤4€qp‚&‘løÖvP3?vÿ0^≈ª“±∆Aì™%÷8j‹_àmCõáq	4ÔtÇT≈ëÊ«lh√PnÚˇ†çsjºÀ Ø ∑éGWÄÂÓF8;S˜Ä\æ1¶TnÏ.H≥ì@G6öcÖK*|?	@Au~‘‘ª8äO?∂zv]«†%µC'Y”Ò¨ÖkKAøˆB§∏ùnc˛E4Ê∏·Ω·#O·)\
RAoó{ó˚›x›„ËÊáŸOøRc?·«®1˙¢ uú∆ˇHøÎ¯OmvÏ¶;Ñ«^ÖN≈JëL2r%j	o„aWªÀû‰M^^¥O±ªVlÕæ6@"ã˙Pì7-AXòOÉW®›¡sK˜L∫ä“Ê_æbﬁÿÉ
¨_ﬂ’µ~˝\›ãË=Ê©ÀWÕw;r˝Ø˜˜˜ÍÔ∑‚Ì4øKvCº"¯ì^cÊlÔ|/.•âJ°“õ◊ÑﬁöWa÷Ú∏Sæeú˘*ÏÄ˛π”œ˙ùN—ÌöÚ≥ûÑÀÂ÷D—6*Œˇu¥ã.UA!≈˜xZõõ,æ∑<Ì>tT“äy“‘ZVÂv‘ùà.ˇ’wFnﬁY±o1îÿˇrÎ/Ï|Ú©ó†¥u´ÃøõÊ∏˘i∂a‚bdËóØ=r‰.#*Ïÿ˚ç‚n
±.TOµRõ)"%≠p≠qmîHéuÛQﬂ«Áxºö_Ã„¸0˛#¡0∞æ	úÊä1VdÀÿç,…ÜvHá%ºY⁄!óŒH§$b"Ï¯qºı!=’#(í°mw,ÁÒ¶‡¢ºÖL¿ÍÆº?üä6¨v@©Ø»,Yπ‚-Ó˛ŸêáòΩ¶o	R⁄É˙¨˝»∫öñ∆«æÒ‡ú•)RÎ^Wìπ>sÓ/Ã´c¨gb,¡oå“:Ó–èÔëz‰nΩ´Ñe‰¨åKøF\ßbü«ˇ-å´tBhV]ŒnÈ®:¬3s„Façˆî∫J€%Ìíw™/≤⁄<:Î\(,vgc´åZ®k|&ñQ3ÒL!CsîáçùWU5Œ™FÈ˜¯≠Ú}[õK^ÚuîÙ˙∫JN®'‚B;⁄ßÏ,y≥d†îVb~#O˚çH4ı£s ˘À±∫¢}Exëòñ.
ïZË† Í÷ï¢≤Rî*E•”ce"ÀQõDf{ÑKÚºƒ
¿K…≠√V o⁄ÇBmª4â …6k8|	ÀS©ë°¢ëiÍ¨X6∂5*´–ZeqH¡…PL≈ãΩèáöIDfãùu! zo…◊©≠©-<Ç©π”ñ‚éÁGu8w~hz°5??-ÃœÉ!{nÑ·À:ÕR≥jè3ı=ıcïé©º@í!lR”cÂñ∫RfT£Ihœ’¢¥5”Ä˚0TÜTá»‘éÆ C"ÃZi_Èı√ïã05ìWH‹
¡o¿≠˝Âä˜U∏©bd*“äëú	ª¢Ï‡æn%™4+RiÄﬁÓ™ÂB¯dm…kMy.ªê¥¶◊íìÏfyR+˘ìçyG’MM∂≠-Ã}`∞N©⁄];»√ó'ÖJ^Ê+≠ØÉ|%dËüo9+mÎä‡˜Äáﬁ"ø-˙3@u:,:f˚QyªÍì¡ ‡¥2í÷?˘tEëÏ[`˚÷ˆ≥üü˝∏ÿº·i^±°¨ ¢°ﬂ5Æ∏v˘”	îJ.m(é§
|≤ßˆ°Â˜¸ˆÂŒ˚z8ÍèO˜EZ÷Ó|Â/–E—‹E|?ıp¬üåD÷çK∏p-t5∫ô†~¶H^).£ ¡2√¨tª1•OPàFBã:ËCda>ö±†”≈;Ÿó¬¿%6JX&∂8@hä‘‡´ñÀ«e¢Enó"üëØ»&ãrÅ\&ìr0¥µoJL‘T NÃú¡‰‹ËÏ∆º√Ω÷T%^≥.¿+ .\zdÑß|“·6!∞≥≤ùS≈Jö)ıƒ3Âô"˛Ã®SèËO<˜Õg*ùÏÛœ£©ù7óΩêåÑœñî/ôw_˙¸Goòª!??î©'ˇÀwµ«6y]Òsøó˝=Ï¯€±	âì@‚a≤ºúá”PªÑîî4°–4î°"^™D®‘¡TuàGcàAaL)i“:Mc+eLöê —∫v¨HQºJÏ˝ÓµÉXµÕÚÔû˚¯Ó„ú{ŒπÁî">ÿùÃt/tÔPe]jMRìªMjs&ŸDÊ„VL?æ‹\C◊ºπ•>qÈÙã(¡œ“∞˘ˇ%ËˆG·ÅùŸô˝'@ô'Ê;—AwQ≠&ÿ¨Eh ÿÆ´„Uπ£Ò7ãóˆ?ÀÇÖ”≠+∆±‡ﬁÛÁˆÔêﬁNÂ]_ƒ‘ï7ŸI§‡”D4|ölT“ßFB1/4^ÿyÅ„Ú1PëÃÑCç±]
”d”n7,õ‰ëCz»(¶rÛåi¡∂áí˛—·òA™ôKAs,ç3c‘hn =„íÊ∞ƒZ¶à)åt¶ëAâDÆ1 √¬¯®§«$C1]ó$¶°Æ«|F^~$f:
ïé§Cq!óë0¶"	î*ì¶"≈M%°LUdÂC©⁄∫déUK,"≥†u
∫‰ Õkø›çó™;ÿ—≤`“?D[ƒß<8ıƒé L;äã€)~E¨»®´Ø´˜"9ûzÅïùmhN◊YQ
“˛˚-˛Úr© #S˘@djIe…*H÷ M2l™>ä¸RÅ‚VC∂\Ω¿p[ñ'*Gµ3.«µVπU€)Ô‘t'Átı¯…°©(™¢õÜbç¢ê‚Wsı†·≥¨ä(ejπ1 ¨*™Wü‘ü¶…“dµ’ˆåæäV+´‘’˙jcïµÅzïjØﬁkl∞Æ–ÂízIøb\≤n—-Â¶zSøe‹¥Ó”}ÂézœvGøo‹± ’¡Ù_í˙®∆òRäBL_-É∑¨ë1‚-ç{‡`#Wèì«AÕ$äÏ€"f>é$N‰ß>TÃ$oôú∏§ÛKÁ9˜®‹äõ¯Ω©®·¡t˚1Õ–AüMVÀdÖ1K∂Hbä%´Üi”Ìö›fSUE·˙aP2*ú	ß‰ÑRÿü“ôì¬ê˘+dIíôs ÃÇéS'X(´ÑÇÌ√°º··Pp8/£îπ˛D6Gq5â·Ô%π≈)°îqﬁ¬á„% Ó˘Ã§#éÔuƒ¡=∏}3iÒû!∏}9C–∫~‘‰≠Î#èÄxEx\ƒıÀÀˇ¨HñYWÍsü9Œrﬁ?œ|©wS_ÄéµJÉﬂ^ïﬁû-s¶¶)”°e^DTÊÂÔnûï≥˚91/4^®~ÙI¸
aΩHKáÈ‘\y5≈+)ÿÅØwÇéAv¶ó„®pF(Ï´ÙÕÛ…C0qÒ*ó∆8MzÚb>YâÀ…º`l≠Ã¬≤§.âñƒ$ﬁÚ∞8%ÛÎba™‰QrÓ©¨Wè∂QrRèFóØhw}}˘AwEFÙ∞>∑»ÖËmNWyF‡›mG\xÒ(U\ÙazV>ÙæÏb¯uâ'XMût:‹	ØÀD·…K@ßáé°¡ÈQ¥3kueƒms %≈ee‹q÷;Y4uèï§66èmûπˆπi¡âµÛÁ!zßÙÂCÈD˜¸	≈Ókéû.∏ÃÙ›Ù5ı+ı2ÂP!5P3$◊ƒ˙ÿA€AΩ/Gç{Í¸u!yjÕ‘ò‰˜ziü‹ßæcæ„8˝$jˇQÈöö◊bÚ¢—cªk‰ÖﬁÖæE!πŒ?;∂0 ◊y‚°xÅ¸ΩX\™s ï±®\’o©´Øoòÿ‹Rº˙q»’K¨™∫∫amòÖÂı⁄Õ'˘´Ïÿaá##ã»ë∂jﬁc$™ñU≠´⁄R•TJ•I#øw¢ºPKsFU¥9º7,Ö1ÚAnØú4˜õí±çˆ·;›M¸Âπ”Õ´∑Òƒ¬=ÚNnôAwº%sj‡(€éò∏ïÒTó¶Ø7@£3øÂ‘›Õ™è/WRê◊Iµ1œò@±"˘r=JMıOmL√‹à¸ëœÊj6ø?‡J ˚î∏›‚)„âoâÙÕi∂‰‚˘‘ˆ≥gS€œ_dK˛∞'ı◊æ_∞1oÔc%˙Rü§lø¸<˙ú	=ã∆FJÙöyOjô›mﬁ‹)k›‘¨^>ù⁄réO=œñû=«ñùﬁ±'uyˇæ‘µÿò}˚Ydœ∑)π\≤’,NŒz-«YÙ}kÊÅıØ∑§é≤?˘ÎKäk‹ß©“ÊıS$^ i˙∆¥ˇÌø—4ö”èîe€<x8Ï"ªO¯&f ∂'S‘Ï¢ºÍ ¨ÛÿœQ´eª§x˝4(üßeJyÄßm£©K=C≥ŸgÙ"∆ñÕÚh Wﬁ£¯~%⁄=†oJÒÙ0æÔˆ5@;P
ÃffÒ<Êú˙±∆K|Ao–€öÄΩÿ¸ xKÌ§Ì˚©ß˘º{˝kî†˛3Ùˇ\Îß≠®ÔƒxˇVP>øì¶`|<Ío™ùÈ¥mŸ–G®£ﬂè˝∑Ò3Éñbˇ•'}ıqX˚åo ù˙Bˆºy¢~Éœºr7Ú:‰ÛcÙo¶o s >øÛ
—ﬁÑ∫âsÈ†‡TàäÒMì4ÅéÄñcˇÊ,ﬂ$¯èx¬˘≈ô˛;fÛ=úâÛıO‡Á«Œˆ]l˙Ù–$πF‹ÁŸ<!]†âêKäÛ•~öæÀΩªæ~® ÀTeßt?ŒôPh'⁄’@ì@1e7˝P˛w0@Øj;h˙I™Ó–XÈ
ic©ÚõÖıg∞ÊGB^ÊgHZ®|ä»£áÊK∞˜π9qŸ†›ä{ùÖor{Ä\◊ã!Éù¿
~>Ï_¡eé{øÀ:SÒÌuÏ”∆Å=¿{Ê^i%Ê/«ZLÏìπá0æ2=¸¯?√Ñûe!÷Í'YÍOÍB¿`+◊7`Áﬂ`ﬂB_°3\7π~p›Pœ]}ûü=√É∞Ö7≤6Û
ÊœÇ@D{è^Ã"Çoπ|ÊsùÂˆ2≤6◊-Æ3#TËÙR°˜g9ü\ß£o©'i?Éÿ∫5Bπ›a›5ú >q¶]Ú%⁄¬uñÎ€Âr·∫∆Ìë€Dñ>˜Ø„≥62ÛÑÆCGËà,—ã¥kvj[°ßˇ¢Â*u»Sá∫t¯;Å>£\Ç˚7˜ÂúEuÛÌﬁ›˝HA4@y…CÇ`häX∞bA[,è4 †≈)"lßåvF§ÃP¬ÀÇ<(ÉïRD;–Sã}HÏHGÉ•hä÷ÅLë∑øsø›±!Pˇqg~sÓΩ{Ô›sÔû{Œπ◊…àtÖ‰Ò/G0vUBñ*Aej*ﬂ˙•)g/*e≠›◊JÁSôÚºÚ}ORØxÂŒ,[n ì§*2ÔT*ŸÔ.µ˝rpﬁ e2Âº 0d=OËô™S}†S,ifCœÙu©“ÙÉ©]¡hi·ãúÑi¶PxÖr£©ê[L+)dü∫—>⁄ø›˙›%Ãø/U-ã˘_øZI˜}|#ﬂrﬁ >ÄŒè¸^ñùcsI[äelØI©6£~È!€pÓv√8Ò.Taèw¿Ì‘?€¯ÄèÜ≈{è◊€Á+≤˘xlü	;Ìô∞œ ióI©±E˝ªç-úSÙXØ_˝£˙8ıëÍÁ4ˆ≈˝ì2k¸
|«?¨>(„£sù} ü9ˆF~dŸ¸IŒË1ˇıpOpK∏«=ÓÒWÖÉ√˝˛≥·÷ùWS+2æLœSKuü4.∆q‘Î.ì#∂⁄ˆÂ˚6éé±~@¸G8Se"Û˛Y„™ûCwÁé˝dæ9fì¸ÿT…toÓnÀ¥õÔÀpıâf&e⁄ÒÈ˙˛+Ó˚æ»úêô&èÚ&dô\Â2”Q«Ñm€ëÃ;mÛ∆Àìÿ]æô/øˆv»X˝W∫ÁÜÄ˛{Œ|€ÙlY6\%´Õi÷\¡˜YYfÌI«ÓOÎ˙Çõ‰kûÀ˙¥Ëo≠täˆc•›ã
ªG+¨≥:ß»ÊBæ⁄˚ï<öŒë’ÈkÒO5“6¿óÿoÌêª“Övﬂçç◊s>™±±—R‚µ?±ˆø%›”ú°jŒóí‚]+i„UKg©ƒÓOF.‘Û„VK+µ÷WlÛâjl¸iô·óÀ"øª´$TÚﬂ™YÀÉÚ- KMyXKﬂ!Ã!˙m⁄GŸ¸D„Ta¯W=/AÖ‰Ö|ü>™ÉÕˇ¯Æ˚/Ù]&%¯íAÈjy ◊;ï§4iÏ ﬂ»`Îè¡,Xî¡∂µ»HnïÀ‰QmwÓó˝h·àÑ)=Ê∑úΩ2‰˛FrÃdÚádéì/Û‹·ÿ›qbÜ+èj›ÙíÓqÊû≤Ògûó#7⁄~≠â„«d§«¯
ôdûëInH9V`èåÛv…xÔ>Ú¨	Ã·ÙcL3È/§ún—~ˆß¬÷äyD
Ï∏,¨Æ1™ÛÜ,ùW∞™üc™/Âl}U◊z=#œßü]ßŒÀ8€Áü2à}z∫e‰ß£ú≈RÎù√‰·2+µ2‹ÕæMpGv›ÃJï¿H0fñ¨CˆF~ ï∞ˆ¬áÊôÀ‹/ wÍΩ@q˛àÔBÚ˛i¯ºøÀFøsæˆlÃ—pwv›+ê˛ä”üﬁÎ‹w∂ˇ:Èk∆˜	w+ÓL…Q¸+%/HKûSE˚∆%Í^y“L£oë∏MÈt!x˙dÌcaˆ„ˇÅl}ºï%;©‰|ı÷¯¸YÙª¯øè¡vˇ◊Àı÷Üéëì·K©Ω2!ıNxÓ+ô∫¥µ˚πNÆäˇÌ%∂=Òˇ∞ï~∫Á…v ﬂV‚zÚø6Ugﬁ)ŸƒvH°bﬁ¶?$ÎƒÉB≈WÎ’∞^ˇ›∆(ñæÏ”PSå.UÎ~…WúÈ‘KyTÆUÍÎ≈íßh_ÖΩÌ¢∞◊ªßJ:+nÔälˇÅJ÷æé’}u+t¨oˇOlÁ…ˇ√X1/„èﬁ#g.ñ∂Iô}fìÁ6Ÿ˚íÛıIúç>çÕ˘eÇ≥s ˆ¡üæ–Ô`Á)¡V°Öê”ΩNæ±ù\ı)ÓòØ bë3%"µ/à‘›ã"◊m•m4ÂÓ»è!ó∂)H¢QÌ;îßÛÓÑı¶ù<Âïm®…å=≥1öØ[fºé;M∂S€/3ævîQ~∞≤⁄óêÀë5ÙﬂŒ∏qHrÄ∫9»æ‘GˆP˜7ÍÅ∏_7 ﬁÙ¨#ç©Àg¸:ò©˘»yÓ°üØl‰˛q±ß¬lŒâæ…;ƒEÀ¯6!ìwç¯ˇ7%„ªDÌ9ﬂ%ÎÓs¡;N,˘üüDúÑèÃ¸9e`ÛhrYõsk˛IõoW⁄|2es H≤ü™«ö;k˛ä\cÔyAüá‰NÙcıä„Hñouz…˝–:ø'ÉÈÛwÙ˘/æß9ÒµÜ‹râ"ôgBÜUbWs|ÓÛ©ΩaÚ ıˆƒ≤fqLã}k€0¶}°ıKçëóSGDLI∑OéHæœè∏FI∆‚K•©ÿ}Ÿ±ºëùß?k=éÛ1ÕJÅ¢wa√º4ô4Uo*œΩ‘z2Ô»™ÔP.ﬁ÷ìyI\O“‡}C€À‰3m9o1âsw©pNo5”¬7„ÛÎê<«ıÁ-™˚è…m0$ñ©M“?íã¢{W ƒ¿gﬂ“uRêﬁ*‘üÉﬂg|N8.˚¬E©g…•ˇß.Á”π‘s–ˆ1Æ){N⁄≠ÊÁ6?dœ¨ÓK¯'%nÇ´a¸§˛_sá‰€˚]"Øﬁs›˜¬Ê™i,lLrœõ°˜=ÍÕ©7«∑ÛwHØB (œCÊ sÔS‡á¯Ï—ﬁæåø”ˆπáw≈Ê∞«œOˆ\ôféÑ[ÈΩ\Æ3‰	çù0vcÁSnál|$+ôg+„◊‰O»hêt†m°∆aòDﬂ˚ÿ€ÒŒª“?ﬂëwπëÏÌOÂ;ƒ+?œ∆ò+ikmÑuë0ŒÙìû–üwﬂÑª›”ÃΩ¡é]Ë‹,€›ZŸn∂ Ê€ï≥Yñ7€'À”¨ßŸY|]÷ö≤,gÄîr+•æT„UWŸ˚O„2π€Ê†Ωå’u3w◊H«kNÊVø~¯’˛·ÜÏÔ∆„“ÉŸõ"÷øOJ©/m*∑aû°7úÑ£…Ôilv€á3RfG1˛Å˙ò?FæÀ<}(˜≤{ªNÆ7yˆ{+m¨&f{W0œVwª«I]‚o±/gÀÖ‚‹ÜXª9"s‘∆®˜ÖñQ[±Õ…ù¸ØêÎÕì\≥@äúÕ·Àı}»ô‘éÃk÷f®ûä⁄WdsÀúMú—7••ñÕ!Y∆?ö1;›®{k™eë’±^ƒéC)bØéûÖ≥UOx‘îÛ-Ö˝R}" Ã(küm"€lgN…wÃ&k3W≥˛fV◊•†{7ÌÒ˛å3KªW’Ï˚a◊HNÂñc∑Ïèªé¸Íà‹˜Mﬂ"≈¡|Ïu∂3áÔïé~)úî\ˇÚ√¨{cÁHâÛ±(©«√*«PF≈)0dÊ¯I˝[Óq_ïÈÏW)¸ñ≥ûäˆ≥}∑»Ω=gs™3Ô˜@\˛j¶l€Dúàÿò˝¬w°÷9Œ∑;3øÉ^ftr[`´	31¬Öˆ®?≈‹≈^ùÀ‡$åUôüÑvï›íDÌmì–ÆÚ÷$¥ﬂz=Î◊òçµwOB{˜œAè∆ÊÌíÑˆ.–oX⁄á]ÇçÌs◊$¥wΩÄ√ì–><©˛i<œı9çüƒÍáë;ê7#ß¡Ô(sÔ'Gı˝QøùEü∞cƒmp/}à«·`å:ã~ÎˇÏópU≈«œª˜›{ì˚∑IJx§°ÖêF–
»“°Ä
%$P∆öñ@`¬$iKãSS3¸¶C™µ¸ê¡a5Ril°U¨©î•AÑ|aZ…€~œÓﬁ‰˘Ú´?¯ß3õÃÁù≥˜Ó››ªw˜úÔäÍø±~ˆÎ™/~6˙ÜÍ[¢˚å˛\èıUzLô«éæ£T≤oå#Z´tåÿ¶ÎO–˝æ§∆[°ÍÛ}~G˘‹K≠l?Å8ﬁÃÔ6ß{t?¸J3E_”sπSı€ås¢H£ı˝Í÷∏@«pN|Ò∞ísuÇEƒñc≠åπaÍì´§∆Äˇéw.FúHÉ]h8¥ëƒ∫Åc∏<O"ÓÀÛ‰–'–
í·»#'Q˛⁄¯)÷aOƒÕ* ‡>Çü@Ø†mŒª¨9Ïì4õëZ„àÃ’9úíÓ£˘ÓxåÈ&•†˝TÔ≠u û™≥l7ØÂ%–+iÆÎQe¬vZÎù¬}õ¶"_Â˙◊˝≥≠˚#!úQ‘Õ∑›∆”¸ƒ_‚z¥T
›œ˝y„® svèﬂwÀ<ÏÂsÆ¸Ó<ˇª¡ÀD∑æêc∆xa˚¿¶ \Ã⁄âÁ‰8Uc<£8bﬁ˙‘√Ñ}uã2ºDËãÉTùh—Vo!Íq_œ≥Ækô˚—ˆU‡æO£ú'iÄúÎ©Ã=çy}ZZ[‰áµﬁ‰Ï≈{’–∂‡1¥UC!g %KÌP/€V÷oc7ÙÃUzk"%^◊¯:™Eﬂºã5-–“á~∂ú;cﬁ_⁄Ω!Á›yÖÊó—WÉMZ∆YL^=’∏ır,ê˙k-Gn}ô¶∫uîÎ‰Bßœ†‹Ñ
y/R2Î3o1÷&Î5‰h7D£ùg	{\‰‚˚á}Ï◊˚{ÆﬁsÄΩ:v‰©Îro‚ZÛ6}})X¬Í>ﬂ´ïﬂ|]µ/Ô≠Rıõ9VaØ∞£¢◊5Õ‡üzœ~ ~Ã<oñöæ≠’∫û~¨ukÁ6Nvdy„;ﬂ£áïûlkg¬NÀÿüÔ+XÀâæéé∑®[#µù¥‚™∂gµ˝Ø5÷zÒ6FW∑k;“Ø≠:VÔ3ﬂ*]˝tvæØØª≤-˙ª€¢◊ª≤sÖ‡8Â[oy¨A}´„X˜V´uyÎ˘)ﬁnÇN;ßu,Î˜Èò˜uÿs3;É◊„6äà€k#Å˝6rt;∏i®óF‰Ìo_´Â≥bg∏‹‰ó!"í0$÷Rc~F!Ç:p\¿; "v ˝lhıã‹±QûOÚ⁄√≠Aø5Ëß ˝!ä{«1^DŒwùÕN^œ}[æc#Á¬N9Å~†ûB?O·ô&Ù”$m#„œª?è˛º‡›.ÀÔÂèŸÔ_∑˚ø~G¥π∂3:˛.¢ëπ]Ô›Ÿÿùﬂà˜¿Yˆ±óŒËs	¨hd‚∆º^é˚ﬁxÛºüQ7¢iƒº~˛ƒ1Jsº>‚µec0ËGÉ~‚◊A£Fóy/2Ó%q õ!ŒÚ>∞_7÷RÌÕèW$ﬁ√<ÎmÜ=Ågñ 3kØ3ÿ´Iﬂ˚“ﬂA˛B,Ä‚\ü∞kõﬁ§≈ü◊|béé¡;—!^ÙuPæ•yÓúmª#&˝A\b–WïÊ∏f£“~‚-+5œÚ˙ÆXÏLJc‡èGËE‘hΩÕ:∂LΩ¨Æ∑éÀèΩA(aúu	ÔVàÔ›KÍó≠€VJÖÊYÀzAÊà^4=XIÎ°){≤˛`Ω ˜B9çÖ.Ã”§c^ÚÉõ†hé‰
ÍÌü1¨â‰wj†ŸÓpö<_e\Dú¥ˇ"xˆ4gU„^_÷>‹ÎA÷EvÊ1≈ﬁâ3.î≥˝3ÿE–Ü]EŸÅ2h‘s˜É4\
˚(x˛ÿ«¡C`Øæ˛= v˙£->ìézïïX
Î]ÖB∏n˝ı™h¨¡µi 	L◊pùC–x|oä¨óm]APíù™˝\‹;†@∏Ω àË{~ù)≠uúø“‘§-–T˝¿QÎ‰à⁄¿JÊSo|” _2 Á°Wµé¬n≥¿vîoXá)ÃÿïsD‘⁄œmùctØ≥â≤›ÅÙC'ôÓ«Y «ÌÖ<¸M @¸-]†ŒDQ>€À≈-|∑*ª„8/yE€Z˜˜îôXÖs/TÜNæµˆ ÿ@ÅÃùÑµEVo{î"s>ˇ‡ΩÊÎ\Ô[¥Œ€-πÉ“±àµÁí>ú◊·ﬂÀk«IS–≤èò¢4æ‡˝0±Å˜oXÔ·ppΩ¿kKkAÆø◊HﬂáΩ«⁄Çy∏è“Ù≥”¿t=á3–Óv's¨Q»Å ˛D~-sˇ∂îÉ€±øCl…Çü’∂åÔ9KÛπoÎe”d&xıò|kÅœ«3∫.ªΩic≠@yK;Âû4“K†ëÚŸπ]ó≠îŒÿyò„º∂eÙ?âiyÔ. ˆs4åÒ◊[ÀöÓË˝ƒõ¨°9ézÉŸı‡->Éµ,pÔ4÷R:Í=i›¿û=É¸Q1Ò∞ÎÓ‡Sπ˛ûVÌAüﬂâò=ç:+8G∞Êÿ
Ì∫òu©]+Í8Œ±Vîz˙èüï@Á#∆ŒíÁ≤I4[∆ZƒTå•éµ(ü”dJí∏g8nP é3÷'(W†úÆ‚˚V%v√z¯ﬂ¿˝È*Nq≤‚ôÖ∏÷§bñåô€x"^Ÿì¡î?÷ YaÅ}Xç√˙à≤±6)8ÁDüÁ‹$cß•⁄µ˛Ü~‡ÛŸEÓ€πî∆{ır∫“KZ_˙≥.æ‹ï.Dù„±ƒﬂ∑/‚‰S
ÚM4M3∆5êµ|Àπ´úÜqŒvÔíÁw-S[t>Á<Œì¸ù¯{≠°>à)©mŒ6ïÚ∑uj(ƒπÛÙkp2∆.T»<ÕÛxY∆  =,˚@å”ÎŒï∫Üœw|vÿ-ﬁâ9˚˘gπÅzme‡›6#V;Ø”LùÔ°Ì®ÊÜ«≠".-ˇ¯;V…qú∏=XáXÒ‰ _πß†Jé"k<°Hƒú%!St™Ë~M—k2QüID}ß∂√¢~á¢ˇwt'J∆gH˘QÍX¢¡h?ÑæÄ–¿V˝òhæÙùI‡&—àãD_<Ø»®#ÖÎ£øDîŸóhÚÂWﬁV‹5„ˇìq„É¡`0É¡`0É¡`0É¡`0É¡`0É¡`0Ü€BÄ®«8ä–D⁄@.Y‘õ∆Pë€d%e¢û¥ø6ÒﬂR˘ÀæGµ(H˝ç◊æM˝ÛµÑø\˚.¸’⁄˜Ë·¿&‘πÕ¿uÌhÑ5_˚ı¥Vkﬂ∆ıu⁄¬?†}˛µèÒXÇvQà≤)ˇw√Àßb*Ç}êJ©T–JZ!Ø‰¢Tüq=,kd‚N-«àÚpm	ûØ†rY*Ç-BÌJ¸.BÕ¯a<Àu√≤N!®êÌ-BùG`ÀhÆï“‚ˇb,‹jâlQ=WÄR%Ó=Ds‡ íÍπW«»B≤Ìb9÷}•Ô‚nÖ-◊Œ‹ Œ ∫;î_\z∞¥§¥bÂä¢PniŸä“≤¬äpiIf(g˘ÚP^xIqEy(Ø®º®¨≤hQÊåiÛ˛E}«6u‹q¸ﬁ]sRøÑ`\B∏W¿185qMòaH…{)É≠ä°cÑM®,±Ç36hI ÑâÈ∫MÎ™5DÜ⁄º‹‘YÇ‚Æ´TmÍbmöJ'MıÏØQ—?¶˝7eﬂ;[[ˇË§Vö&-Ë{ﬂﬂªªœ›Ô›ùœfo*ŸbûË=Ì8Ÿ∑Ø˚≥U©ÿ<q Ï5≥ÉΩ}«ø’;¯ú9çˇ8Ωy¢ﬂÃ¢Ì`ˇâÏÒ>Û@∂7{p_Î¿†9ÄñAÛÿ¿PvƒÒS[ˇá€˝˘2˘*ŸKR$IZ>±˘Q“â±N¢œ>Ã/πob¡O™ÕˇlÃ≥◊ˇÌ°¨\/d9Lﬁ'üÚ7€=b˚ÿ-2·éBiB9àã›ru_‹ √Îîã@K|nπÄ‡ã€T}ÙÒë6Méêm®ûeı¥kÌé+ﬂ∂´Ï≠O(ﬁr≥ﬁÁˆZ`≠%˛J‘]Å&°E»ÉÑ¶…á–2ƒÿMvMÏ··Ú€Ïn6Â¥1dÔrÉ<¨‘T!´ÎnıJ9˝uE5≤Î†¸(höÅñ†d Â$¥1D◊–vçPvç]7ÏˆÜ(˚	Òk·˝«Æ°÷Ê◊ø*nŸ˚!IAî8l)@√æÏ%B—=)¢O®%L∫5µq˝«êÙ√î9îöz∂ ŸÃ]ê√O¯ÎwVƒ⁄ Åk„)¨¬wà∆é≥~≤ëpvæ~ﬁ? ˙àOÂiπ~#>Ç˘:–ΩÉ≠&[–l≥ >ÁúÌfkI£Í6$jÀÛâÕë8ﬁ¯IT]¸ÃG⁄‡^¶ã87Áô•ˇ¢[˝àÃÔ¢0V«Ô≤L'Ë5Ç^k∏ˇ.´¡Œ÷®7Èv´}Ò	{%Î∆kvcY8r‘∞ ˝j†~ÅÅÏ:ˆ%∂é–ˆk"´·{ÿzÂ?cW…¯O›Êuº0œ^V‘˜Â†òæΩ|¥⁄]_mº`W≥v¥:l0Æ&üpõwƒâ›Ã6ìD±∆√àÜ’°E4ä]≈NçbßFë‘(Naó–r	}ZŸíaß…4âX´’:ßÇMõ„sÏQƒ¬ÛXJµk›ÍZôYP‘ØR›ÇÓ ⁄x«]v
Á¸∆¥X÷]åÃ≥àzï«›`£2«ı.[SﬁÄπ%wŸ:,Ñ\ò&∂^¨ÊéÕÒ,2'˝- E¢†î€Mó,˝∑Ø‚ø+˚rÅÀ
˙{È%{˝;BˇL&Q:Oﬂ∆ÂœÈüh^fA?†s§~œ}9¯6¯/≈cÔÚ<Õª0‰˛™‰À“∑EKk%‡°J∞¶±‘‚và˛äæE÷aà˜·õ‡o—Ÿ _Ñ·ö%Ô¬o”Ìd¸ˇ5]êGúæIÔêpW‘ °KõioR~JµÚ˙ù&k—ıu—ºµ7›ÊM‹?èÒ4zÉfEØ∑kËU≠G˚:Â»=È§û^	9»ÑX0˘ù†V0aÖ¨®5≈b°X46≈Ãê5Êîit»$≈Áóé°Lì‚Ù@4A/â™ÑcˇÔ$ﬂãíî9•QfTDPˇj˝XEÙÈÇ(∆8C#–ã¯¡6Aœ@g°Á°TMÇN„6…Ä»Ä»Ä»(""""£àåö}íDDDDZiiiiE»|” “äHÅHÅHÅH)""""•àààî",Ñ•Ñ¬a)¬aÅ∞SDDDDL111Eò L&S&Ñ	¬TÑ	¬a*¬ aÄ0@ä0@ Ü"µ?Cê$J J J Jä(Å(Å(Å()¢¢¢DOœ≤¢˝ê"ê"ê¢Bä@ä@ä@ä
)))V^=´É‚ÿúÉÜ°H≤∞∞∞≈‘ÒÇ$ÎÄp@8 E8 GÑ£ààààú"r r r rä»©É;I‚Û œΩ5ÙE≠«ãÔZ:¢mQ>L(?GÓ)ÅÃ*ûL)?KŒ+?C OìfÂOyñpØ&x¬optAG†höÅ!]EK–á–2›nm®ÚÎ]˙§>£/Í+fÙíN˝û.œ§g∆≥ËY1„)y®i7Rü∫Gqµê+™F˘¬ó u–6Ã€Ü{v;˛µ—6´Ó#ÛaD[ähãm&¢]âhv5›´U©õŒ$	äƒµkes;ø%ö√Ì∏ô∆Ô<X√EÛx^[(€´˛ öÖ¶†ÛPäCQ(qUAˇkCe»(=ôr
‡b}ù◊ö£>m }«G™Â<·Õ‡ÊE8ÀãpÏM> ÌjÌ	À_E⁄mÏ‹4|F˚h~Ωl∑üá›ºˆ¨oÖ·˜∏Ì”^%—Óä¿{Kﬂ/¯3Ëˆ¥‡[`-"‹,{G0Q≠[¥r™Põ 3m|lÉ‡;eo/	Àç◊<$™“[Ig.z8ßıTi÷#¸#˛2 ¸ØXXèÃ|l)î◊û±j¯BÙ5t∂π∞kd|?ÃV‹ë~õOÖ.ÒW1ñ∫√_·[˘x4ÔEıe‰}IM!¯y3Oß≠U|Ñ«x6züü‚OÒ^æü?BΩ‡_Á2MrHÎ°”wx
~o|o(ØR‹√øÀ-Ê;ÕπædGy‹DtAÆ âógÎ	ÂÂ?ò»kuVDˇXü–Îù˙.}£æA_Ø7ÈﬁzØ·≠ıÆÙ÷xΩ^è∑ KΩƒ€ê_.Y-«∂¡cHÛT…≤J≈ï%
îÑj^äˇ<9´Xí&tjIßpå$èöŒﬂlÃk5OÕY±±SsÍì$Ÿ›ÈÏhIÊıÂ˝N¢%ÈË©√=≥ö6~µΩò◊HwO^[ñUù˙'—H.\nú#öˆËÖÀáë`‡€¡é˙ˆ∫ù{vJëÆî-ˇ˛~2lr~î<–„¸ºÈêó¡Ú?I/É›¥Å ÔRH"E
EòZ¶i-äâr*ÿµO\ö“É]Â ©,%ß"Ÿnn¥=VΩÙÇr\c©*ë*U‚%xÄæG;≥∆ê™æua{Ê€˘W≥fKvó}ÍâÁ÷\ÿr¶1Úhlkû
{Ê+ÙßáÜÿ/é¡nŒF°l['"b{¢#kqU\pŸ©rÆöÕq.Mëñ¢i¢»ôê%gñ2π√¿éÅ±FP≠rJ©Öµ$ëOÏ1OT.R+sÑ¬ˇ:û®Lπ´oyÖ4÷HÉk•ËÜ)GÃ·qÃ£¸gstÖÜ™?Zòédˆ%”Åﬁg_ﬁ_ÿ«QF>Dñ™ˆ/ﬁ^¢8ÃóÉç$C‘EBxÅaU2≤0_[¡¢„3µ£ö“¿∞√vÀ“˛“˙º÷≤Z	…ZòÃB≠∂ñ÷0‹F-µ4‘jw⁄\Àº¬}ˇ“
∂ânø8èl(Ïfa˜ã[øø?|éz~Z)åä∑iBo»Æb≥{íŒr–1T”jÜ‡{Ü°<∏˜V°¬Ë¥Rº•7´–>∏$ùƒ•%uY„¨À*Ω7n÷$Øôãçáƒº2‡˜Ô∫K7±yIÕ˜}?|≈%§ÀûÙ∫ÏŸÃ$ì©æaÉÔiÏK•∏/ÿŸ1øˇ˛	A&A=î√+Ö*P¡NN]a≤5…xT¬£“…ªˇ Œq¬ı¨ÆÚSƒu¯P∆Ûã÷ëÖ„*⁄ŸQÂ¬&E+G∂sPÉã±<ÆçõyRõ4∑¿˚m
ŒÚ•≥˙4E<≈çóû≈Üi°ﬁ◊ŸÉû‡Ö¢ÿäKyΩ˛-6çãæ.¨ª ÍÚÙ^º ëﬂ]%Åïà‘˝xòøƒÉ>%âÓ÷õw ûù_endstreamendobj54 0 obj[62 0 R]endobj55 0 obj<</Filter/FlateDecode/Length 426>>stream
Hâ\ì[ãÍ0Fﬂ˚+Ú8Û0ÙñÀR–™‡√π0Œ¸Ä⁄FO·òñX¸˜'ÕLAaë‰€{•ªiΩﬂÏ]?âÙ∑⁄Éùƒ©wù∑◊·Ê[+éˆ‹ª$/D◊∑”É‚{i∆$á˜Îd/{wíÂR§aÒ:˘ªxYu√—æ&È/ﬂYﬂª≥x˘™Ø"=‹∆ÒØΩX7âLTïËÏ)˝h∆üÕ≈ä4{€waΩüÓo·Ãˇü˜—ä"rN3Ì–ŸÎÿ¥÷7ÓlìeûJ,w·©Î∫oÎ≤‰ÿÒ‘˛i|‹^ÜÌYVdU§5Ù’–⁄Au§<É6Pm#2íÃ!êÜJËR’%’™K™ó‘ì‘+…Tdñd*2À§!R)íŒ4ùIR4)íMä4êÑËS”ß§Ç¶Ç\A¬A„ ©Æ’∑–‚>5˜©”¯)ÓSsüA3“‚çﬁò¬¡‡†p08(
ÉÉ¬¡‡†p08(
ÉÉ⁄@´ôÚ≈|üÖ™Èl˝0“áÒ{ÃŸ<à·{œ)ooﬁáèUúÏy¶{güﬂ›8å"úö…? ñ„Kendstreamendobj62 0 obj<</BaseFont/JHWGPK+ArialMT/CIDSystemInfo 63 0 R/CIDToGIDMap/Identity/DW 1000/FontDescriptor 64 0 R/Subtype/CIDFontType2/Type/Font/W[3[278]11 12 333 15[278 333 278]36 37 667 38[722]40[667]43[722 278]48[833]53[722 667]57[667]60[667]68 69 556 70[500]71 72 556 73[278]74 75 556 76[222]78[500 222 833]81 83 556 85[333 500 278 556 500 722]91 93 500 191[500]404[604]]>>endobj63 0 obj<</Ordering(Identity)/Registry(Adobe)/Supplement 0>>endobj64 0 obj<</Ascent 1006/CIDSet 65 0 R/CapHeight 716/Descent -325/Flags 4/FontBBox[-665 -325 2000 1006]/FontFamily(Arial)/FontFile2 66 0 R/FontName/JHWGPK+ArialMT/FontStretch/Normal/FontWeight 400/ItalicAngle 0/StemV 88/Type/FontDescriptor/XHeight 519>>endobj65 0 obj<</Filter/FlateDecode/Length 30>>stream
Hâö yÄÅoFõˇÔÔÄë'‡ 0 *‰endstreamendobj66 0 obj<</Filter/FlateDecode/Length 23337/Length1 52494>>stream
Hâ\U	|MgˇüÔ˚Ó{ëÖPd”∫œïî,EBmô//t≤®ƒXﬁì<I‘JµUïË´≠~™ï™éQ5’&î›∆åFStfl’°˝’2Û˚©Àªsn¢ÜπÁwÔwæÛù˝úÔ‹Y3g˚Ü!—}D~∑T4?˚¯ı?7KoﬁR¿Q0©¢tjÛﬁYhWKßÃô4$m„@ƒx¿≥°ÃÔ+9yË‚G@ﬁ-fz≤å	Õ¸˘›˘”πlÍ¨ {˚†Áâ)”ã}rÒ¯?À∫˛‘T_eEÛ˘~˚£OÛMıGÙxº'ÔŸ’Ωb¶ˇﬁ˘¡ë@ÿ«êr≠ÜÜ≠ZKc/„öW˘&â6!ös(a?Í≠®t≥h[æ «≠#∫uG;Ã•4gÌÃYñ≈v¥èlÎP⁄^ƒ´mEåJ@4`]‚˜≤ΩÀ≠ÀˆπΩäòø˛ﬁ‘‡*«¯>°Î,ı!ˆ†áÖ,l¿<¨E√îWê«†1}-≈XuËÜM\áMh`ﬁ—XÄΩhO—÷˜Xà%Ú8K-A:a Fb:V–0k6∆‚¨ZåﬁÜi®†≠Bk•µ∆z[∞G≤ÓrecQÃ–`]’NYC
Kºéı8KkZÏ‚åÊ Ôëoc&™Â8EV©uã=p·yˆA!t@$±v?.Q4Õìn÷≤Ÿ2≠œò´∆°’ÿKΩh∞pic≠´ÌŸF%k]èùÿÕPœ≈¸Ü¬µÎ÷ª÷uƒ Oq<u8BdÓ¢‡ Œò∆YÍäæ|2„è8J”µp-UÀ‘^∞N†-z`{ªï%ˇA7≈ÜÖÚïmBKŒÀkv∂Ò9ŒS,u£Ù¥Ë*¶ãçr&BÿbÜîsæﬂdÌg(âvãp—(7´ÌÍ∂„—‡9´%W$o·m§éTßgÈ%˙öæn1Aº%.»µjõ:ÊÙq‘„1+∞7©ı°\˙ï—<™¢◊h=5–Q∫,äÒå∏&À‰π_b»Wœ™≈⁄RÌU«Â`a≥‡W¡õV™µπ‹ãÿ˚◊±ë#€ÉFúf8ã§Qµd–…E£h.√ZAø°⁄FulÂ(]†ÔÈ_tÉn08DúpâNÜò)ûk≈—»pT¸(˛#£d'ô${…tY$ß≥WUr5√.y^≈™FeqûSµu⁄;Zç∂]˚DªÓwæÇê/Ôlæõx˜L¡e¡u¡ù¡:Î<⁄qc9ëŒﬁ˚&sΩ◊q«}à„Œπã•D †aúô	4ôfP%gÚe™¶-MæÔ†}ú•ìtç}éö|~BÙÉƒÜÒ¬/fà’bç®_ã[“)√d+ŸN& ¡rúÙÀYré\'M˘•¸ªº íw,™:™N*A%©¡jÇö≠6™KÍí6V;¨}ÁuLu,u‘;˛È|“ô·ÈÃuésÆrÓvûÒrw~ä]¯=xËú\$=rVä4#éà#‹œP"sw™®°eb>’âŒZ•£øËO√q]%pÆøÔàüDôCC)ìEèfmé∂Í}^“’ß∏¢ˆqlGXs•#úàképÏ$àælÛsŸ]%…√¯Fû%ß⁄Ñø™Pä¢+b´…]∞_ehÖp…ÿ!g–|Ï Ùv»rÓ„·Ù>œÖJ•KRÁ.Í-ø≈b<#N·
ﬂ„exÉJT)V"çÊ·ﬁ„[—UõÊHt¥£?ârèPÑ⁄∆—ı•Œ$µ∂xô∆…j«5q≥—®BqF˛ñΩo;dé∫ÆÂQﬂÄ˘Xä÷"Ã—
’1*Ö§ßœÉv-Ê…TÂ‚u!Oï±<”vÛÌﬁÀs`†ÃaJ4wŒ0ÓãQ<!™ﬁ‰9°∏É ˘éèÊ)vuéQèR≠%Ò‘·y|8òá1÷{Xoïböµ)<™¨y¨±ﬂajhIp.*ﬂú34LÀçZ∂ï"‚¥»ÎÆ/g;û¢Ò√ﬁd¨®ì»« kπıÓÓ.<a◊c"~âãÂU∂0D@Zp∏®µ≤e«{π÷V´#Ö¢ÃöÇ¸Ø‹‚‘‡s&qçM:∆ÒŒÖ_‰Y≥§?XŒyX≈Y»‰lÕÊ˘ÛJ¶{T¡¿ÃøHÔﬂØoüﬁΩz¶•ˆËﬁÌâî‰§ƒÆ]OàÔltrÈ{¥C\lLtT˚vmi”:≤UÀà∞–!Ná¶§ ${ålØn&xMï`íbÔ|º¶Œ§ÏáyL›€ƒ¶?Ãô…úì˛è3≥ô3Û>'EÍÈHOI÷=Ün6dz=ç…-d|EñQ§õWöú&|u¡∏À≈∫'∫,K7…´{ÃÏÁ o´´unhJ2jC√cÃå2*j)*ÉöÂÈW+¡Nô±Fñ«å1≤lLÔÒïò#s=Yq.WQJ≤IÓbc¢	cêŸ*©âÓ&3¶√m:õÃËÂv4xUØM>X^ââﬁ§£ƒ7∂–îæ"€FÎ$∂õeFΩp1˙[Vﬁ∆]Xı‡iúx¢Àu{TÈÊØs<uŸﬂ¢"÷¡≤">€»f”À9âCÛu∂&ñö¥ÑMÍv$vTÕÒ˘èMÒN÷Õ∆ £,0ŸÀ•âò»õ„⁄õπ«:áXè((4\ÊÄ8£»ó’°∂-ys~ì©«<|íí\Ÿ∫9±µ-[›C¬#D¸˜œö∞&vöw?≥d{d<≈aÍ≈:{RhpL}Ïèø≈}òçü"b)≥Ñ+Rn∂p{ë˝l∫-ojÒëÜ∏Ó „ èS|˜(é¯»∞QªOÓ∑üˇåõIIfb¢›"N7◊î}¸/ÈU€‘u≈ÔΩÔ”ˆ≥}Ìƒ¡I∞y∆ƒ	1iHBLÛ⁄åt%2ê@úb`|¨kB∑N›á»P5µT+)c ‰§ôH3¥iÍ≤≤Vm∑n+lKH5ee`gÁæÁ∞¶TìføwœπÔ‹˜Ó9øsŒΩ˜<¨˜U,x6E¸˛.™¯P`ª!V_	˚|Ã¡˚R⁄ùdœ v£Ø¢ç≈gëVå%I'ìOK\mL“3-yzß"πaX4\I9‡≤”Çºe€Íì∏‡sƒõyÛjÛ évuY¢3ámsÎåû!Ø{ Àq…º∆vÆò‰8RÃÈR u≥Nªí‰K‡ı†˛JJí!*ı'XmJ“Œ/mÃÏÛ˝è/•¶n±∑tÚﬂ◊rj&ÎÉ3˚KfÙg®ß$8P∂ Ê÷éD¬<C°fL¯xé@ƒ£÷vü⁄òDmêô%p•¶ÜÎÿ+Nj Y# Òg< ug,ŒÒ1¯±Ë¨X–]"—‰Wõùâ©©ûç~ï˙dÑå$∫ñuNNjjp_q≤i∞⁄ÜÎ!)zÙåÔ]yF√{Ww¥P®ˆ∂∂ü%ò4v>c@í∆÷ˆO{OOâX"X?ﬁ
Pî 	!ü√Á(Å√ñw_ÂÜÔk∫áT~∂%ÙùÏJ“)ºÉ(Z™ôKÌQß$Sö¬°sËàM™9§#∂ıà£ú q‹I«OˆªÉt"ûôH”â4jà4D™‚8GÕ‚⁄≈!QÇøãb|Â‡Ô£C;ü+]Í‚`vÂûƒ∂õdÓ]é%Ω˛ÀÏú¨:c˛ÕöRF (1ô)FN”¿|Ñ√@˚—nΩ‚°üR“Ãdø›Æ3c˝V´Œ|¨ŸÕf“f∑Õ±€IgN« ¸>£gû9jJ¿NGIf'Á.-˝÷Œ°éË[Pó]≈8îËx˚^ÊÉõŸ€Y¥¸EˆCº™3Zqﬁ†ûS∏E`.B6„2:H¨ìÍø'∑ß·“Ë≥º˙"h2£Èç†÷“4Õ§±√ÆZZrÂãRimÌ‚£-k´√µ‹Ëh˜æ@¥p√0Ô#8Eû$€¡è¥¬.“≈ë(é¬î~DäÑ.P»w=ÔÆ†cqzUF”UQ7π»ÁzÑÃ«©ÛÁôè°Ÿ⁄s®Ds¶lƒPÒ4‚˚@ﬁ«ÎZNƒ„ÄS⁄PjpttgPÕ!!5ßÑlxÎl≥ÉHjÍvéôàå◊bä"∂ô÷
z[I“≠Ú6S'›Àı“ﬂ
øáÈ-jëÖîJ-tõ%IÔ(w¨wl&^·≠ºçÉ„Ü¿Ûä’&ãí§ /CM ¡”hvE!mHïî|écœ\ÏßÚJ>ºeÚ
ÇÏ91E∫4íï‰
ƒÑ±Es**⁄,q´Z†Ù∏¬sΩ<ÊSkñeX∫¢pΩ
VXü⁄•∑$Ú=©G"“˚{ÔÎﬁÎ.Ñ.wö¶ã
i:ç‹ë¢t√XÑy5ΩGx(¸.Ω¥Á!∑Nôk√épxΩt…vÈ“¡†~ÕIÀÍÊ§∂ü∑s≤4’)öö¨É_ÔË÷6Ù„ˆs>.œ«JEâ#°?êˆøû»º¸Íüø^jö;;$ﬁm¬CŸ/ê|h‡õœÔcô~N≠7¿S‰AÂ8o Ò‡ì«,±çÁõ¸k¸[¸œòvõƒØ}CË2=cŸ%Ï≤à•&Œ]ZÓ-òLyNoy˘¸˘h∂«∏ÕÒzHvDÖÂúòö∫¶ÖX“âNñq¢»êeˆuQ˜µòœ‚@l-	(≥ŸäôçSX\∏ÿ(•hÅ«´bñÚ*ìÉO'Ù,÷6òª˝∫ìFdÃ-ÕÃæã‚¡%ÎXà ≈#ô»
ΩMèèÇ,≈3v;√ïöâÑ+apvŒ
≥ƒáOÑæÍÇño¨µ?ˆU/Æ≠]T¯a}¨^¸01¯C$p¸Õg∂l˝¡k{ﬁÿü=ÄóÓ¨[ﬁ‹Ù˝W≤∆€◊;Í[Óœûcõ◊ø*ÍŸz¶≥ä[Â(ÿ}¸È˘˜˙$•Ó©¶UœU±Ï€2ıO·YX·<ËùÛõ»ìÇSS◊˚&`ﬂuÌÀåSQµuT_˜Ù†›û^tX8¡˝Ã:¿ı[cΩå∆<w<õ”„x∏r±ÃQ>[ùÛòuM˛Z◊ö¬m¬Sûo;˜9s/Ÿœ>éèë„éwmyP◊—|ZƒCf~x∂,skeajGò/ŒÛ*\±ó7—Ä}9
®„¢9≥™åeÖi#z7≠c´ x0M––é≥•°!Ì–¡ƒª– ﬁÅgâºÓ< Œ9/TÕœí øπ"qÂ;B’µ|ˇ»“ÏØ>Jgﬂ˘4n˘^∞‰bh‰¿œˇ±n˚µ˛ÙÔÑT}rÔ¸µ∑?¬mgÆæY—˜„£ŸO~ÙzˆFbà!w"˙:D¥‘\¢‡ïeIBœ¬”lÚZê,1´<‘Y#µrÀU≥j%Ê"+o˙?¬LYÚÑax.Œ¢z†≈£„c¡œ∆¨ìüÀóªèÚÛÓø¬ÔøÀÌOeNf≠ßò«`˝ú´€«duãÚ\5<Á5ô˚ÃóÕƒ,bëeAV%	íÏ¶Æ+0∑5ãûgTœ≥‘‘UÕ≠Á÷s-ﬁc≈Vb1Ïdò·£üg∞f—-ñsQ˜Ôiª'µÇú›™´÷kßµÀ /âπÉÒÓÈd3“ç∆ç.≥\ﬂL√Ò CZp˚°=6BÓéådDa0ÛÈ∏€DŒe¢†„EÄb'†¿°ﬂù«PZ¥>W∑¥Fß°ÉV,4hŸ|É˙KÍÒ‘]§S≠‹JkT°W8-pú
€√∞◊&_	o∫Çn!¡©¬√^ƒÈ√u$ë;áŒ«”Ë‹úFgB£∆ﬁ¢£sî/ˆ©ïŒ™g{`â«∫wD2ÒiH É !«≈∂Éç/"$⁄¡FJ∆Œv4@2|[G^∂Y˙v	ìj›‘ ß8ôX∞+ú	a"õ,6$õàŸ"2m-îihˇ]`£,îΩ÷ü≥cr⁄é˚Üï†’®ﬁÄj√√Ù?ÑW}l«ﬂô˝∏›ª›ŸΩÂ|ﬂÿwæΩΩ;ü€ÿÿé‚C.‘ÆQêp	PhµÿÅ&Ö~ë§IERHÊdTïF®•M"¢¥"©T¢YÖ¥A•©Uï˚˙fÓH˝£{⁄7ogˆvwfﬁ˚˝~ÔÉ.y˙≤YñØY.rV¢Â‘∏ÿ<%fyffEfe{	ÍaÜºDCì‹Óf÷5M˝2ç¢ÍŸ"Rcn≥EgFTyHR≤ïNú>ç9Ï!qg¬Zı8«^ƒI”1…À!:óÒ»Dnèî'S(œÜ≥ÁEÎ≤Gdaó:®^Å•T;’NùœI≠û¨‚Wª¥›dHì=XîÛZ+YÜó\éºTõO‹Ø„7¯#Æ#Ú	˛ß.…ƒ:!ç"ˆâ"ñUMkepeuπæ9 &dYq{ û1Ë>ıô&6GÒ	NCMÁƒ»Â&«≠*Óò£æËAûQò$A¡Eê 
»Îòæ›@F˜\àâ}‚Ä!äO{i Ö®N,<Ñdc*¸˝ã±hX„°_î’C˚òÙÄ‰ﬂâÒsN-M@^wç)å%gTK√≈¢ü%n⁄!N/?œì˙x^+Ç€ñ'≥€ò{>Ωπ|y…{A£p˝»Ü^»y‰¥∂°8$>J ÔÎ»B´˝°9h-/NıúûZ%éN|˛ù«ªﬁ‰Ô˝gëÓƒ·O1s« Å<π WãÓ9q”CêŸ}™f£ºµHâE≥.f-HbÜÿ9„ÃQßœ¥cK7ÜÕp¥wÜkS-^z=3’bTZΩ“¬¯«√3ÌÚ8‹oTZ:ÓtÇì$ã£ãc+<k¢[£_Svì=˙~˜À˙k⁄IΩ®ﬂ"7u2!Ê’}^ØÓ’U≈å‡xÿÔñLØ°©bPQ¸Åp®:@a'D£:‡‚µî∞∏`P◊â\mì∑$ ˇú/C4¯ZıìQÖòµ›∞x´6¯…¨ÇÌ“ˇb{Ö”Ì'‚¥2©U‡<4§∫âSÖŸ≤0“	í◊ëYY-PŸáÆÇçé[vÙºnÃÛöÛh|†~M§ÙâÂΩµ°º	'q¢y£÷gúUï` ˆ>$»˛¿å?ßÏD¬›Lñ%‚«¡ÀÔÌ˝ÌÔñ¶ªü(çø”˝‹ \|…ü—±˝Gû|Ì¯T£8∫Ï û∑ÆÕLZOÓúÍGMﬂ|eÆ«5πìon€Û≈MÉî◊în
ı’à´ú‘z~Ω∞É^í©9|>˙æ”ıƒÃÖ5¨E©|ØkÕÃïÈ3HÇñ7tΩ≠i'9Ìÿ”Nj⁄I∞≠(ﬂ\ví”é=Ì§(«,¢^Z≥-lÒ©d´ﬁíXê\ÿT¨'—ù|÷≥E{ÜlÙmÓÒÏ’ˆÍ˚åù÷é‰ –s@;®øjÏ∑æë¸ÆvD?RU]AÒ\‹6#vX±3»Ê∏Lÿf7Ÿ‹H.-∑'r Ç#Iøñ´N%QRÙãTÖóÎ≤ÍúR]ÌÁôñÀÇ:.¿Yi
àBl√ÌÚ/‚‰í—<bÍÅàÏíK(i’BH±H.Ï–∞;F·€~.«Ù%„2≈PÍC€—a$°":„Ã»—W“W√/Vl.É2≈“_ﬂ&wgËßiÙôlò≤MJ—t»úrÛ~˘g~ôÊB®i}Y§ñéQ·o‹fµ¿ëj OèQ3NgaLÎ1ZÙ>˙D1*Ùœh´∆ÕÂhKŸV ∂Á¥¥∂6CTVîlï/‡,H%–πˆö⁄⁄+˚∂ùZ—µ¶}ÍŸ/m~˙Îüˇ¯›AqTˇŸ…3«Ús—VÏú¯—Øß˛˘˙»xÓ’ïÛw,X¯t"∞.€v|√∂_~uÛ{/ëo}˚•’ÀöõüI∑üﬂµÛÍéÁ?•ë™ *.Tt£GÀ˙¡1ERâÍ%7'*≤à∞ÿp˝}„˙˚ﬁÊf ˘òVScƒ±DT«•˘§ªAmT˚‘ÚÂ∞zIΩ£zbjóäPò∏7§%√#;:Xï
ˇv+JL} BAÊƒ∞Ë√XT‡Uü∆‹¿qd¥ÀLF•Û]2êÀpçê£a'ù_ã—!|cL{º1±Kƒç¿ká≈K‚Qn{yÿ”w¢Ãm˝c∞ˆÙ∞g ;·–Ì`«#î¡ b(ÉAÉ ¸Âé:«È†˛qN1mÄ‚A=Ãe•≤4‹÷ ®å+]ö€€K1
ÿ©–GÕefjF¯±…+¢}≥jjsËï_MÇTõ¯h`˚Ó›B$¨πTYsmëïyº–ÆK7áÕ@L˘¶C¿B`xj ¡8˙ÿiGHÉ1m!#◊πà∞	mí6y>ëQ‡yIv)í§Hº‚V!Òïò€„sÉÆ„%Ößp‡ßΩ|#Xn$©	ÒòCû"9ä€≠vùq–QTeπ„ÄR°àŒ;ö«£∆8~˘2|à-˙yGAàÛM≥É„aÙ†V∏·F•–¡¡çºßë˝WY≈è M Õ_8*,¿gô˘°YŸ¨{!“=aﬁπ|y» ≥‰L ñ=
À˛∂¨*™0ZÁ¯“8bõB≥1VP@}N œ≥!
¯Ω˜≥.Ó}∞A^‹>˘Óg(ﬁµp˛WPÙ∆‰ºï_:µËÖvFßÔO~èH[\∫%DÖGπ4◊ÜsNΩ¢)u!-\ó—ÍÍ@ŒUµEÊ’u÷¥B›ms]_„Am0ÛCˇõ·ìZUöR-%FÄ‡[eF˛IËTz$t1}9t5˝a’ı¥º¿è™)
y)@ö&ÉIñs(+wSØ&PÃ÷◊µ‰Ö|}ßx}è‹õ›(oŒÓRá‘ﬂ®wµªYo[AÇ—`µf«}¡µômúâ6êrà%%"%ß…ﬂ	OT∫AÑ¬›3B_\eR7Q)YI◊¡í((‚S#¡¯¢QGo
3V_òrœéÚûÃ:c'±MN∆-
ò∫˙¨\ÏX›w∏É…3gú≠8t<Ùu{ëE´˙`´àW;$Âp∂a«ÏF˚¥-Ê©Í¢84vmÑ9M¥œ—™-ç˘Ky¸„< Ë∑=FüHk¨_HW%\#uHX"L‚∞PîÇL€®Ùc$¶ˆ%¬té¡ Ÿ¶π˜kÕ¬πÆ˛‡¶≠;Æ'ŸVdYñdÀíÂ»Q~ôÏà~ù!ö@I·GÄ2‹ôﬂZàS`°+GÉ¡`+Ì]{]YG:(£î.°•Ì»±ëé?:∏§WË]”2∏5Ÿh◊@ÆŸñídÔ˚úî‹.∂ı$øXzÔÛ˝¸¯¶∞àá%,†Ë=#ô%wwÉ∏wÖK{∫dH*√ÛSiõJÏJê({
®TDõH˙dÚW+ Qgf–D„UüOQµº1åÉu”xàù Ob‚kœ◊6_òÛÏ‹íÕùP¥Ï¿Óù¡ˇñéÉNWKúñ{¡–V_ﬁ∫≤¯ôM;&∏∑¶¸Ì}Û˜ÃW‹B ?‰‹ÚÿÙ'S˛‘°
k’ºÒΩﬂÌõ>›,4§¬™¢π…,ò˛#\—˚qEõ–+RA‘hEvóòo/±óŸÌ•fãIõfÆ5fuÊ”1ÕW„ÅJµ2ê»HÀ≈Ñ˙T†6„ia£∏E›h3?sujù˙ﬂΩﬂhﬂË_oõC¶ûm/ãî	ˆR—≤Wä’ˆıˆŒ‡[ø‰í|nõÉ¶2ãú>√Õ˚Û;x$Òü‰yõiëÜì‘(Ôn>˚Fív/©!π°x‡6)∏bû¸6$G)R|îçÑœ(¢È6Ñ≥@jAΩ»f¢R¥ 1X—I—‚¡C+ÂÖH© 	˛y†T)-!Tô™¬≠ëÓã∏“≥ÊLùoIU‘«´§|«ÄGI:¿/y*qN´T=ï …ì£2ˆ¸,⁄'Qyπ∂|\ê?sË±ﬂù´?ª∫9e~˚«õÈXÕã;Œºπ}«{Î¿Éº—≥É˜?}Ωr±Ê–µøv\πÜ]•zË”Éı*ÄV;yÃΩ[D"è,™ö™£ Ê1x÷oÿx‰ˆ±∞zñ¨ûu¡ÍY	Vœí
øv˝J:”\N√ÁB¶1€;[[Ï]¨%ΩIÌ(}îyM8!ù∏2›YKobjÌ€]uB£p“ı>˜ÅÛ}óKuÌw}I3Ó‹ä[≈›"#",1÷Œ	<T?÷™â∫Mı‚ "ä<ıË¸Ë˘Ó¢Oπôx}˘|ÿƒÆÉ∞ÂÄ,ÇŒ\ÇIÄ`ÚÑ·Àogë…ñ≤4ÎÜI¨&±D^Ÿâô±À˛0!=F%M˛D}≈‚º
‚Á¸ºß˛~∏ßû¨ì]ûZ$%∫ã$8å€ìHnSrÃqÌ˚¥»1Ò≥¡{øÔ¸w˝Wﬂ˘¬l÷wØ8p˙ƒOkâˆi∂£ rûAÙûÊ727?}ÈìOˇÚòråŸ-ÃH3≤∆:·§mBHà	èˆ•ƒXF/q.RËµˆu‹%i¥ô◊Ì7º7ıno∑rO˚óﬁMòßöf8 t≠ wŸÒtæ0^ùFótôPÆ<a,s.6›é™˝Ëæ[B>∆ÕK"f$œ ¶$√˚£à
…bHí:d$…ñúîeLM®â4Ae0G&¶TïPA2!,æ˙-ûäw\v√é„ÛªÑ•2§ËYÄéºÕìëmgo±C¨ Z¿2l)9¢”lV∫	lƒñX‚>¨û´≈¥D™™g`4È‚dä.¿,ÔG<√π,ïSZå≈8ÊRÒåô≤ÓÚÓ€kØÔMæRÙﬁ@ˆôÌ;ﬁ<ı„Ü7ˆˇÊw«è!ÊÁg“Ó˛r⁄sı£?_Èºz0´¿*öÖyÊ√ò-∂4ì2|8S%Ï	ÆÜ_«l∂oÂ÷Ò>pA≤l<∞¡(h¿gÅÁ3{ø“∞MÙL”'3=UÅô∆BœJ}ë± ÛL`ï—‡hı—}~âRë(hZµöTÎTF5ƒ#RìDKí-”p≤T+}*vDÕ⁄0æKò/{1{4K¿ÆK∞Ä[‡ˇ∞•ÃÁ
∆≈Z$L|ˆ^hLé÷L∞YôjT g≠¸q±§≤G!e§“3F*¡#5Z·™ÅÆ˘Ó|˙H˜SJà˚£p!W">êäìv ‡B	b°(U?B1âäS≤¬Ê®Ä CLîy™5r˜¸WÉ˜êÚ≈‰FÔ8ﬂ›∑Ê@'Ω–5eÈ¡ÁﬂBKµ„Áêâ≈ﬁÖ
ˇ6¯_)ªπu#zyˇÏç'±äx1ÑçˆO(	Vñ¬!Q/“'Ëñ^ßu˝ZxK»ÖBãﬁ¶€tÿè¬ÄfåK4ú»GáØçqPŒc
RÜºñMŸ(Ü~	Àl‚ƒ)18Za√å°ênMtK¿4ÀÖ$(Áq®»p\∆ƒ!÷•¿~RÈåFˇ Üá˝ív‹Ø_@≠T’áú‘H¶°I◊q)é{úûD:Z`:LïÒﬁŒﬁi)íÏ‡XGNHÁ…§dáòâ¬(<nœ∆<©è y%—íÿdhC±¨Å™˘¢æ<˘›c«ºÅΩ;*WfN)^Ùx{;Û⁄·‘ÊX˘2œÎŒÚ‰Í√◊cFÃ\»|çëEçC[≠$œ€ïR*˘2≈¡ı`Ñ£DÚ¶Úìîy|π≤î]Œo‰˚ù|ÓÒyëÇy3
*éDö"Ï§úIcK#Â|yNŸÿ%9K∆nb◊‰¨õå4F:Ó‰‹ÕªW k™√˜˙ÏπB√À'ë≤©	ƒG©6™É¬±ïﬁe€CtñÂ.ßÍãÜ¢Œêﬂﬂ°!I≥¥§÷®Ÿ"xÀÈöë5ç»öˆΩ¨iD÷4ï|á—HÀÃr¿yZ÷4Û†Ëµm"
Qπf˛E±]º%â6S,`£#åÄ≠òø&K"—6ëhõ®á#€r@ﬁ¬ÛG…€˝Èˇn†´/é…”¸ÈÇcúÙùÿî4M’“≤ ≥ÜNÎúVïBΩ£ƒn}3_<{€Æ~7⁄—ÚyÔñèq·πìÎ>o˙”◊ø:πÎ˘SÔ<◊pjy`a®xÌä…-áP¸Ê´~µÒaÌ⁄ﬁf∆}‹vÒÍ•+ó†˝E1w∞k)h’yJ≈ÖÔ√Ω*¥-$^ál%L”*ÿ»•iö”2dó¨0vDâÜùUxß+ƒY—I±!µqH%£Z WH>ÄÄÉ∆BÜç„H∂„0è#˝&l$ß $˜Âú@¯˛ÿ[næ
\‘bìb-jØJ◊©Mjã:§⁄TZ	æZ~Ü^º*WŒm T;7‹‘ˆ[ˇ£ªZ`£∏ÆËºô7oÊÕ~òŸÔÿÎœ⁄Îµ€,Iõ8v\º%S	aÿä -W∂˘¶‘ài”R5"≠⁄)Ç*ë€Xh™ZI>ä€|⁄¶‚'JDY-r	∞vÔª≥ÜÖ¥˛Ã{ÛvÊÌÃ=˜ú{nYÍÿJ]|µD≥ΩÂ¯AIFZ h9õÇÛ≤Ê"ãtu¢•»qà∏*XÁÿA—ı";ΩÃ´≈ΩÃ!x)1;$ 5IT:.1
Z1adA´≥o[ˇ¶ﬂ4ˆm\;Ôáu`	ˇµ7}ËÁôeÚ¡Œ≠Û˜td~ú‹@¡G‡˙4È\r)Tº¡\ﬁ≈nﬁœ/ÚaÆIºò∑ÚÌ|vÈ„F1è•QY·LŸF$¶2j0-ÆJt?=@ªi?ΩDY?¶≤D£t Œ(uº≤ºÄﬁç≈∏QC|+Ee£„ FÖ	1£ÇDÜà!m“å^;DO»X˝ñÒ/RæΩ-·üZT *ª˚˙˙ËıwﬂΩ§Â∑?y	Ô¨‹Ñwv…_KFò„!ÿB∂ò+<ˇVGò¬›‚)ôË%ƒ„„>>ÅîΩñ4≈çîÕÜÏcQIïM»Q_EÕå>Jp!πV•*e’ºÅ™qˆ∞±»ÿ¨l4>RÆ0Ì0#1VÆ≈ıˆØ˜Ãı4”f∂HkÊÙyıß¸mˆg˙!dühˇaüÈAüa®äBe∆4Œu8·∫◊X@”òBi\5™j ’	Ñ_eöô)Ù8ôê‰*±TKuqVEå≠ÆñﬂÖﬁó‰8ÙD©óÊBÜ ……ò„&V"lÅ$DLÚa¶£mñ–ÇKynœÂíÜÁrîJ”^CP‚Giê-Lm~∂:+\”©>í†Ê)ÌÑ&ö©◊Èu
{ˆ(ûFNä˘NEÊ∂«™ÇúokúüH-J|ba◊Î ∞ΩÖ50ºﬂ≈°ß§°¯<)ëÄ;NHl¨ø∑§@ÏÔâ·BØY√úœ‹8Ù∏úõÕ@3qc“wû=ÇoÍ wçÙ⁄‚ÊˆDúÀI∫-äòµ!/I%!1¢A&í◊>]C~aÙ‡w‘ìwﬁ$›£õ2+Â‚oç.y˘™ëãWé©HDUÿÖÍ«™p¨öÍåì&;ci«dduÇZ¨ÓW/™t.ÜU•XmU∑´c*’2d≈2±
Z*¯~âÙC;%Á™⁄Õ{™Vò£j÷éÔ–≥¶√°&L∆∞–Iw9*5—˚9*HöH84≈j‘Ó,ã»º–ßûºıd∂V∞r1Ú«íh&∂◊èg'¿†ø&Á∏<Uq:H˘Â«Qıu$*áıhå€ë(WîXQä“©Àœ3çÅ8ÈäàÀÒp8ﬂÔ≤àE±3±±+U√ÖùI@º§%/j…ÿü∏±?aB¿-°˜„]J÷≠ìt“m«ª"$Ç€EÓn¡Ì‡¸”§%∂ã`5à`É\¬"qãç·¸n˚Ö$π2'ΩÆ\,	˛)»ø¬œÒœçòÑ≤ïÊŒ∏ºë`…q†:î,ã'[éñ4‰˙á¨xÇÛ6sVÜräP:”4s’å´m–ÂÇIâE]Ö–é$w¿_p[‚Û«R÷¢æ¡G±ôß,°_Ã-Pß^≥i_Ò∂”ø|Ìh,5≠ı'}ãV>µ£ññø‹¥l≈¢ìoÀT»øX∑¨ˆÂCô}rÔñ-Û~ˆ„Ãﬂ∆Ω≈U»óÈH˙UÖ˘Â_õ«Õ+ ?¸√ àüQ!πuê0œõ‰s¿ædèŸ4™ºÅêºa!è·Ò∫Ωe6˙	ΩÖ]Ö]ÖÎÆ´p!	\•xÖà0∫
∫
8ˇÃ‘ÖÆ¬%\ °çãã¿ü´…§À√∂ÂV˚Ä›m˜€‘V‰ `π9“gYÛ˛∑±00Vé±†Y&ˆ'}ï¶∞9ínªá)∞öç˚V·g‘X¯ç˙°{n#ƒ,nËÜf(Ã,∑ò7B&æ,»Ì∂RQæ#|ƒùØn<ø¸‡<”Ë{hÌ¨ıGh˘æ7f∂Œô“ëY/ø¯ÕñØÏ=õy,i∆ÿ5Z(z§<≤ˆX–o‚&"…&JÆ≥<¸¿ßyÓ6K_»öıØ≥’∫^e÷˙jCSÌôf£Ø14”N©)˛åôˆ•Cœÿ-j_i∂¯ZB+ÌÕ$»ôÍY¢<´>k,qØSV©´åun#\@5$#PAè¡4–ÑõGèØŸÿ¡öŸ’·>le≈=ÉòpÇTÄ‡/ãWM“à§ôZTS¥…A#ƒ˙WãbUì`Ó-ì‹^—ﬁ˘êŒnƒ∑ Òı"ækQ§"úÑ-Ö»“‰¸™j!ÆÈ{»ômâÙH:ùÉ%t ıC µ–Øµâ≤≈Á´Û˘
uß¢6âK¸f5Ä&—¸KπÊ∆°ÔΩıw⁄z˝•ã£C'z;_Ï=∫´≥Wˆìä=õF/gŒ]ˇ.)"û≥gŒ˛È≠3ß·Å:GW”@–'ë…=nÛaÛÀf£IÎ£›Qπ8˙Ew¨pJpJ·Ù¬÷hWTØ◊FfágGöı%ÓT8Y£ØuØ6[¬k#˝—˜ÁÌÛ˘Ôã.E«¢°Mòâ‡TZk>IgõãÕè]◊GMóÂUBBÂC^ó‰Õ+0ài$çÂ∆vÉF¬(¬	æÌj“%Ä4ÏÏ˘≠qC˜)bâŒN@hà\ãâ`àøRÆÙ≈%©\9@∫…0°≈§ûÃ%
u’ò†TcÇB‹bK"»,∞√K± n±1H$‡JÚä™míh2b3sc^;ónF¡GAG)-
ß‘Ê’P0 ã∆≠¬Rr–Î<Tª˜ª÷lº∏uÒè±o⁄Ú˙ëÎ{FW´ø˚˛”Oˇ`Ïï_çﬁ~È©⁄ÃmÂ–πSg>8s˙/BKwﬂ-Èù‰„_Úìí≠¢O–˘Ù9∫Å2nÈ\Áø≈=í¢_2¯∫t¢óF˝ƒ/óZˇøW∫Î*n&≠IcòÚ˜’.ß]b9v≤…◊pÍsÌ“†ôæ—>Ò—Åˆ+Rçdæ”ÈÌ8%b’N“„’'¨â∏h Iª^ù∂∫~…“i”ß?æ4PDÀ∂Õ™=R—Pøº=ÛæàB˝ÿ5•¢0I	'∑““@i-üÕgî-,]U˙mæáÔ,;Ï}‚Á€·Iç?´yÅ,õSàaßÙO)W ùÚ¨˘/Ÿ’≈uÖÔùù◊Ω;≥Ûÿewg◊èµΩ/võÿkå®ë◊X<JyπE-·–*–@c$ì(è&®"QSë&Q	Q‘`0∆&•Ej5ï¨X°	ä•¢°Xä" è"pœπkª§µgÓúôù;sÁ<æÔ;zÎ„}·>£œ ¨B>[»Œùü]œ◊Ö7Á7˜4Ï…ˆgèÚ◊åóã«5Ô-~“x≥VÒL˛√|º8£yÍgåÜ#;c+}»Ù=h4ÃŸ£l‡÷t¨◊9ÉÀ©L~én™NçHÔı^#:ø÷ÎÙzºyÔyüx™Â’z;º/<π÷{—ìºõ9êÔ
Qç·Ì6®d”qh)®M%ää2/SˆàS¶¥icıˆj©∫jé&„2DS58”Œ}D1¿rUS∏6ESY/à&À-8Ωã‘KVF¨+/é9‚ep¶ó¡YûhQº∏‡Éi√i-[Ç©g´:∆K¥Ño¡%$|å0p7ÜqR)%^UW(ï7µ\lë:[˙[§õRö%…ä≤)ó©x@\ Åáã»d-QÍñXûï¡€,‰„æ”ä‡-—PZı_Ã4Pﬁ˝àŸPΩª∫ßã~vªó2∆Kª¸Ó{‘◊$®.º©sró€—\—– ‚ …‰|¢¬”A·æö%÷òwl◊é⁄!µﬁÃ§	+ji™‹CMNÎ"iRﬂ`˙\û¶≈„™/ßI≠]çåÓc7V∞◊ÒK˛°Cá»= E{wÔÍç∂«+PS»ö§∂Ú¸ˆ
Aç	÷è%@$j§
≠‰;O[œ<y`_[ÓËGØˆ,^Pzi’¡ÎùS∆€Ù≈„ÕÈ√:∂f€G?˘ú.™zl˜£.jHÊZ>¥|È˛b≠øÏ…≠…ïW∂7TUGy∂uÒÅçÎèˇ‡]¨”Ï‘7RIyï$»g£ÑC6‰À#ªå~èjòúÜH‹fæ≈Å$BaÀÆ'ı‘tsù“ÙáÿCõ¥ùZøˆKM&¿—Økß¥ã⁄∏¶jHàUZÖÑÒÕbñVQ˛”_´hµ
˚#ÀÄ•NãÄä~—ŒK}$IÁn˘üvÄ~îò}ÌÊB§j0‰ù÷V˚clê|?ó@ˇÂ€úÜ∂Vßê¨¡â°Î%;ıΩÖ?ﬁﬁx¯ô≥g£~±Ê∑«ÌÔ>˙ÜÙìÁ®∂˝ÓÛœ›9⁄›òù$`ŸÑúá∑˜åí¯ÜAè(e¢Ò≤Ö´muce?J≥z4n–h<`ÓÄõHk<óL†pM	Uúz8·¢¢¡A$|'fïpB(·¬ªP¬	—⁄$P	õËè©Ωò†âÂ)—y¢N}ùív¶^OùJM•‰îëc≥ƒ¡(a6Œ&òÃfàÉÕofﬂ ˘Ç/òP¡L}‚rÔ[Õ'◊‰ˇÀ]`Ù{Á¬
sà"J…vƒ¥LI’tUWtêº≤ë&¶Ó§	
ﬁRÈP0Ã≠k°)@pZHx,à˘há:|˙√7{ÏPÿy|≈äzmhŸO{⁄ûê^æsÊ˘˚óÆXı‚©„ˆàÑ(t¢√ÈçAIZ≤zmêPt¬uï™ú(LW®§d1˝îfˇÍò}uRŸóö>◊¶PRÔtpƒw”È`––îu$@∫3p§”G∏„≥Ä’‘ïI°pX}ÆL‚0¿Ÿï‡≈¶2…¿`sIëÂyi„À»RæÜÆë÷ÈkŸ∫E⁄¶oc˚»^∫W⁄ØÔc{˘ êû=£—üeø!Ø∞ó¯ª‰~Åú”˘«‰C~Ö| ø"ˇ‡∑…Mﬁü√ì$Œã$œ€y	8S7^V U É™¯vﬂÉüNPåÜëÅ°Ëº&ÑzE\ï≈CÿöØ˙‡ÿ«¸1ü4wväP¶ÉvÆÈzéÒcúÑ$	ÑIåRX…¢ÎíDUç≥°J≥Açz=÷œ$6B”g•_ë∞ñëZæÒ7Ã¶…îwß˜No*9y≠•™çŒÖóùP∫Jì?pÉÅ¶$÷Å Ò}–ﬁ˜∂W§w]mç∆Û€£≠î˛˛Óˆ?^À’&˝ØFÔ>.ÁÔﬁ∫cıœ§#êê*! 9»WÆÆd«(q¡	¢’TATÍ¥öΩ4dòÇbØa¥úåQ˘·‚Pƒ? µ¢Â‚ú;!JPCTµ¿¶°bAïd.;Oú†sÄu∆∆ÏÀcˆ%≥åå3MXi®¿-…sπÙà≥¡y¡	9øë©	ÅÚå· Ï∞⁄∫≤]U]@∏˛:8Wõ-À™¡¢jöyÆ"Y≥pDwm≈¥*=ÆÜ^)ßït?R&m⁄wÙ"Üñ™Å÷≠wÖóXKùG‹÷J˜1m≥æ’›Ø˛\€£è™Á≠a˜_ÍmV;ER4ë¢UpõcHªªWZ%tÃ8AﬂñﬁˇŒ8KÜ’Ûëø»ó’œŸu˘∫ıO˜¶˙oVVq≈Üm1Fƒhâ—ùN€4èX≤K]”söïã`√—B&5rÊ»‘Â†Q ÑÏ+âÆ¿§±® √Nû˚Œjy%ﬂËlw8œ:‹·2‰"Ü£òˇ∫∫W»⁄fˇ&lxn_√ˇ
˚√ñb!E¿“∆π6n;‡{◊Ö∏†Y∂p+í˘≥£ÈÕq]_—bä¢E Œ933Õà]ÆœıL' l•âjÆ¨[é1≈Ú\¿q]◊4,◊≤"¬c∑lìn2wö˝f»°'ûÈ·täK|D˙~¿z∫√y ë<€
›§ÏÑ‚
Aqù8KoEomí»ÎæŸ€õ]YoÚÀŸ ≤ßˇ·”Èt’9bËæ∑‡æ}Ä¨àÿh{!Óh„ﬁu™v’⁄!3cd§?LMÄ¶ù ë©Ò!2œ ∏ê£t¡Ùﬂ∫ÆSÂUPq˙‘¯†6èäu´∫NµÆX/ÆNjô UÆ÷à´†aêÇl@´Ò”⁄<|‚i≤@:_y”Ï√gÁ%ƒ<gj‚œ»Ç? l–%≈”.ª§v(¡h|—∫ô6°µ"tÉPûD*°Bàv›}ˇ¸…Nπı‰ËÒ∂E√Ô›zˇ‰‹ø¿¸˙öÛWÈ?dWpT’>Á‹ªwÔsÔ›ªªIˆ%dC»“Eíziî+"œ±`$îh(àÇX0ED†`kÈL–°HÈeò¡B ©ÿ©∂òétò°≈÷!±Tå}L¥√cw˚ùõ]†6ôoˇsÓyˇÁ˚ÁôlÁ˚Áÿ‚[óY˚±€‡iLƒ°¡”XÙœÖ81©&âLëòdÄë¶óëõ’èî¡R/˛ò65SQG‚Òß1ÍÃ3;ƒyW`∑y wJ:ÂﬂTL∑ƒâ	!%bƒ¨::N€H†…’ˆ„b≥øYõ¯	ÌT;µn÷£øß˝.{Î≤GÂ∆ü¨>’.ó¶;hñH,$Ó›ºdJÑDUlÑ;^0nàã∏ªXíø¨(Tíü( Â3œjöÜ•!©`Ü&Ëñ*ôÃT≠3‰å¬¨J¢Ñ	Qfú1®Q©a]TE&·%†ÎDùeS{™±^O©ÊIYÔ™à›Æ‘(mê©á=ÏÜ
ÎYjt95ÿÓ=T[ÉbÖ’gÙ‹Ú?|Ê±¢•¿÷ñÔYÔæ}”‹"{,¸Ö‡‘mê
§Ë
î%çÎ[K:z™‘ ^?RÓX‹«´á¶ ≈M8≈à”‹≤ídÉ@ú⁄Rz∆¢öPìæî€ı—œF%FVΩî˚›~ÂÚ∏‹ﬂYöÊnLÆôP{+ßgœ”iÕπú´<˜®8£ˇ)p$©ÜMAQ”ñ4)‰⁄ÊPÕ’á∏≠ŒƒÆƒ Œ≈¢ú8˝^ÿà5‘‰áXûp“·&Û∞*∏ÜãöÆcÒøÆÿ%Fô]•UÈUFΩ^o‘vµ¥ùM)i∂õCÕë•ˆ“–“»Ziç±6∏.º.≤Ÿ¯~páΩ#¥-‹©–ﬁ∂Nﬂ
¢˛-¸πëµnÑÛâ˚äå*	iâ∏hN4_23zg˚ﬁ˛p-ç5M›ÇØDÊáBï∂F≈‘·+55¨ij»∂u]ì¯$a%Xu‚dÇ%zÿ¯c&t·Ü{ÿWoª6{“>i3ªáN8n“y$ÆÚ&O[ÓPΩFü•çz^g:z≠6°6æ+>¥é ÀÆƒs$B±øÃËçZΩ-+˚ceVøW"e¸·Pdî&AñeJmÒ¯ØÄ∑)É∑9AÙ¸5¢ÂØ—{}M8ˇ·Ò±éöÎ`e«"N0q
ÏÅßA˙Ñ™xé;ñˇﬂMa™êø˛˙»Ü)•¡·>-∑¸ÙïLjHÊjWnŸC√j⁄õ∆‰ñ¸¬Jã∑öI1ù›ı‹∆ˆ5¨ı÷{á'4œÊYNæÁ"x†á]√ÓaøïôMG€•c‡Cœª

ÙAd≠®ùvß°0Ç•ïjÀ°é:ïNbì‰© ,k>ù√Ê»ÛîFk]» O+/–’Ú v∫Yﬁ¶‹†,ïá”rFq‰üÀó®ü[K∑√‡^ëÑ\t+lá≤qä dU≠§·èQƒEâ-epDuÅAûÇ*^4œT÷CÕ.CütÇ}ã‚Gc	oÙßåΩJn‡€ÅÅ|>no
¨&ÍzJ:ã¨ y"ê2˛ôDMku9wôôÓ3¨~+ÀΩkÄ_nœîLÉ’á'b_ê«¸B™iﬁÕ‡ΩH‡•c∏Õc#Ëpô—¢ˆdÆK‘Nws-rUzÈ f⁄‚›Ω˜ar%ƒµÓ∏£»%Òxrv§‘Òû]jâ√¬@¨‰Æc©≠£REy]yÑ˙ÎkÀ#i∂ømnnñ∞(˚ŒäµO”Î;Y⁄˘|ˆâî◊p≈§?œ˘> %IöpÔ/ë5#™ —ıeƒH»4ƒ2B¬∂ÉAQ§XD≈ã*èπ…≤h4ëHÚ<Q3ë∫&-ûì&3]§©Iù?:Qˇƒ°·˘˜”‰…d>)$cC^UﬂDí∂Ì–â`8qâOë‘ÏdLË…˜zy1
üz9.
ˇÓ‚”°p≥K”Ó4I^ì´Ú©ÖË}Ìç^≤Rx=Œº\~PÏmôi}1¯æÙæœ¨/JY≈Æ∞◊~/oÛûõÅÄ)˘~+NêU∆)≤ÈçkÉuµucÍkGó˙áW§§H§6R§uµÔÀÓΩ{∑˛x·úD›»ñâÁœ”¶ÆÆ.·µÌKˆ(ÌT¶}˜ëÌ∑ø#^øp·VDÓΩ1èêmbÖpì0∂—%%ë0©HL^œZüπ∏&ó;ﬁùÀ≠π(‹\uqJîu∑}∞ä€%Ïá´&D?~“l¯\éÀÑˇÌªZı.#>˚ÍÕ√Ÿ%ëuTÙÁ# ˇÉπô‰aã‹<|sù58œ=FùT¯ƒú;xì]"Oàm$Lı'…Ûæ&2ón!ÛÿA“Œ!$â+"´–˜ ÍAæ≈«¢ˇc¿_Ä†	àæÕ  ≥y}≈«bég˘<ûl#Û‰!dÖØ)ü≈zæ≥d1∞Â}‚Ur@r»r‘˜c‹Iëê±º∆tHI'æøéˆÖ¯∂r.Ío†<„j
e≈ˇ
âr	H¯>Ûl/ú∑Jxá‘ãm˘èpñfÃ9xk4BN¶£Or∞Öû%[ÈŸ¸>¥CíMXˇL,»)òg3⁄«c‹0‘7°√>$H(“ÏÅì∑!´q˛«œú%OÒ3ﬂ9ˆ_ÿ”ˇcpè”Ô÷¸5P¡ú|§rœﬁæåM_¬T°ñlÄl‚¿£ÏY.~ÉPËkóØè‡◊”á¿‚"2uä}Œˆuë›ºÃ–ñœäØìΩ¬ ˘⁄÷I8«"Ë˚´¿§ö}JÓó*…ã‡◊DÃøÿÉ9Øy|XDÊ`˝Qêµbü«°óÅXÎE=q›†æ˜˙M¨uõ€∆œ&„^6 À¯~∞~5◊9øw⁄îs–∑}Ês‡{©úùsíè·„1WeÅá˚ÓJ≤}^Å^ˇ
)æá"<ûÄ∂3ò'
H@Ù˚ÄV`0HcmÇuèØ‡Á¶«p√w:ƒﬁ<ŒûaèwüÉ6ÛFa.æNπtà¥PŒÁ‰ˆ¬9ãΩ¸≤87∑)Œô¢Ù¯›ÍÒ˛3~NŒ©;∂'^'ì˘<∑äí€ˆÃÌ°É=F∂BÓè7qŒÚ˝%◊ÁößÿDA6‹s÷œF B*
\ﬂTîE]‹ëOë˝ˇÂæ\É´™Æ ºÓ9˚‹{1íÑ"®ëá +T´5)bÑ`ÒôƒF*®)mç¯¿«h«B,oG(Ç"84—(0L≈éJ—äSßA©¥3˙òæ†£ëú~kﬂs‚eáCÌüﬁôo÷ŸÎÓ}ˆ:{ØΩ÷⁄ºsbÚNb Jmí—˛3rß˘ßåÚ»†`:æáæº#rSzác/Øß˝ú#ó*©Üƒ›¡æ≥ûılêX”LÉwÅiHA}x(êƒÆ†ﬁõjü[HóƒéÃ*ïÏˇ⁄´?º=A=1≥><4Ñ!ﬂ≥PœDÍHbÙâ%˙_A-\úæ$±4]ìÿí*ó‹§»1∏œî»∑É˘ñŸ¡˛‰Á9ËÀÉø»õ˛rWC∏7Q+µ^ÉÃJÂÀﬁbsy{d∫¢ÔGﬁüÂGß¯úÎK±å˝’ïÛ#üÍçLr˛vGå8«Ò£±¯dÕüm~ F√¨åøÜü7˚Á.y˘dÏüéü÷8˛yéÎóÆ¥πÖ¯üSÏòø∆Gçq#5Œiúâ˚ª2k¸<Ø?÷8¸ÅTEÁ˙Çà2l‹ù}‚0˚]Ü…“pmrS∏ŒÔÆKÒ¸	·Zæ˚—ÊúzkÿÂ”q.ÕË•SúGÉa29äg´mº9*ãl≠∞ˆuHÆóiA#˚N¥ˆÆåŒ Îâ›5f"kæLÊÛ=¸ŸúGÙ0^◊ƒÓÖHwÕö˝≈¨≥Ê¢2›ˇîzA«ì.6_K%∂Ô≤:r™J’ïÚRÚàôrbÌ©÷Ω“ÔP{tÔ”KÁt>q¢AÜö_“'_:“o•]ÉYk˝B«÷PP±©ª$Öœé£èæoïS"]£ıXm◊¬éßQ÷µ‡ù…|π…÷G‰≈†\*9C´Rµ≤ä€Ép.÷ÒéóWÆ∂0Æ¿ÊÎ≈rÁk±i1G¨ˇWÖç~=ﬂÛ(q¸Z÷®^∫µ¨aç˝ˆQ&cgÎ˘ÒÎ§Ø˙Hr1qXÎâ≈2œ\"◊$kd∫qíyüD7ÉÛ;Ñ≥;óÒΩ£∏-Ã=Ωé-÷ZFk=/©Èñ¨µuÄX¥Na~ˇê¨ÚÀd~¸›Ùb÷a¶ƒ•µh<Üf∞Ì©Û3X]nF&Œ˜sÂg™˜Ü…GÃ–I$‘∫’<!?1R‰ÂÏvëÅÊ˜ú’œdπü#Ã{≤‹lë˘⁄6›§øøÅÔﬂDm©˙Â’{—^*UÊJ∆œë{Õy–ﬂ˚Ét4ìÿk∆O·'Öå? {#§ Ø‡lÕ‚˘≥ÌgÁÿV*f¥¥„≤∞∂∆86{c˘™2ˆ{ı˘{±µŸŒÿ∆”ÿgøSﬂÀ8ÌcñÀï¨”>∏(#õnÙH=¨Ù˛(W˚ﬂì«Î¬m¨k©√ËÏ∂ûxô·Ú<¡Û•»_√˙Lõ⁄m∏|
3y˜[»çz/Pºë2B%∫∞ﬁèˇÀFÁ9ù>õ†g∏Ìîˆfr$éÖ€∑?Î<Ç˘FòÔÑ€|±LINìº‘#íÁ˜C„úv–ìÛ¥Y
}	ˇ›ñMgÇﬂê¨u,…˛∆x?êﬂ¯
ÏÀí}TFπ·¨m;[ÿﬂiªæó¸å…πâ=·>dEbè‰˙„É@{ ÌnÒz∆˚Ñ˛Y´wˆ_]sWÔ∂›}m´Ìmî	Ÿƒ~–ÏÂ*≈”‹vzó\•$ﬂ·øwZ∂Õ⁄6®íã˝ej>ÿØe;yΩÙSºBl-–1ú9hnHå Ìk«wñk=ªä∑â˚4ˇ?\ÆQ≤÷uÑÆ´ø,Ûº?Òæ∏˚É}%f∑åAˆE^éºYÀÏ3Îû[W«í”ıqŒ∆ê÷ﬁ˘ˇgÁ=ÿ	Ô˛ØÁJæ
πê‹GRLŸ@}rõL9I,˘b0¨!›Ç¸Ÿªi tÊπ∫!_i<ŒÛÙBœÙîïQ]Ÿ›Î—ÿtÙæõ3„+Ú˘1XüﬂXwÛ¸/ ü7˛	˘r)˝3nÚ7ôˇON†˝lß}Ñˆ=p+œO#ÛëóB7Ë ¯%ä÷#-Ó°_ª<˝˝„´Jjñª∞≥7rÚq˜ÒïeºümH˜ÆÔ[2àÓ-ef∏3ÌßÓ€ê}˜9”'ñÏgS6¶<<IMyé÷—ZÀj˝lÎ«H⁄˚õ≠côW$/ñÿ”AÎW≠ùµ~EÍ˚g'kO9vM¥vEy#;∂&é…
»Öûë¨°œg^øp7±'ˇ>Œ›hµB˚\®»~HÓ !◊ΩI‹=é¸Äv/‰Ò8ß≈±µEåm#ß}›ÌˆÊ»≥»©EZ”«\1Fqsq{i+wüu.o%GgÁÈˇ∂Á˘òWIëí*	∑)n]⁄¢h£›Vù€ﬁ∂[w¥ªÌ‘%q€•≈ˇÆÔ≈ıLÅ4„úªˆ¢w≥˘À⁄?∂¡=«ÕÁ-j≥F◊dCËÂ–óà‘ˇa/ GÖ—MM!EÈW•àˆf o6˝Y≠ˇ!_L,ÒNÑ'iˇúvÆ˘¿ˆΩ5¢∫-v˝VÎs[≤f6>≠ˆÀ`∏∫¬k09ﬁkΩC2˜^è¨´˜\S7ª¡©€î√ÂxïvÌbq^≤qªD÷Ú<ŸŸë¯~#L"ñﬂÏO&j˚îÒ_©yHFÁÔ5ºÛ@¯61}≤iíú‘92õ‹9ù⁄õˇó0vÌ|d˜TYÕ{∂0˛IÕ…£‰¡JÚaÕÃ[!+†Üæ◊õ£≤»Ô$£xO°9 yë4 öØíÉCŒC7 Ÿﬂ 2‘åóQPÃ˚Æ‘\„◊„#e,˘«ÀìÌ˛8Ÿn^ë)ºoC«:Y—aß¨HWKizö,I÷…ˇyôéÓ˘‘SÚ|Úô≠ÔàÛ™Êƒ¯ôb*ëÍes˛d⁄ë≥[X˚∆Àu‰Âó≤Áç«•K…•G˘~ÊV[€™m»ÒÛ†öÔ0»Ó|∫F^]¯ªåîG9˛ëÊú_!„±≥X◊‘ÆÌxπ—ü ΩOs∫ŒøπGn7≥ Zc◊ñx.÷ÂdkµP\õ\	£uü-"›‘Ø¨/e(Ÿ˝£{tÊÁË˛á[u},è“ﬂìÊÄ©ù
˛’Ê*ﬁ
ŒËΩú|–<KÕT'3"ËÆ±„Ó±„F%oÜbÏöƒ<u·¡/ëô_4Â2œ¬zÈ˛yy·V‰Ô}Ê∫\rÏ˙=àMÛŸÁâ‘C"¨£~ww”Ω˙Á-¿˛√c¥Ì∑G“ÆU	„r∏◊È7RS˘ÉD¯/Ì_°ıÎıMΩ!•©¸µìî•–øè˙e±ÓõÏ]˚ö#”˝˝rûπLÓÚªHµí(w'é ©‘Ô0˙Ω»ghœñ*Ôcπùı™Ö{`ﬂ›hyèZ8/˜G¸PÒÍÁÛˇü·˚—sØÃ3∫ÀÂuK¸é:Yì˝¬˝–Ë-bÓëRÌmaéïÿ¬<~.ÁœÅ1wFÙèÊπ÷Tr∆NÂj∆™ÏÇ^ÂE.ëæ¿Ω ë.ËGû∆é÷˙µfGk˙æ.Ë˚~v¥ˆﬁ]–_x˚∆∫†€;Z[ÁBÙÖg∞cú˙qÆƒ'Ó±MÔr7}˘IîÔ!ØC‚}MoÛÃ˝"úµ?â˙˝ñ¬spFFÛ¬	Ù˘˚eõeu∆Òˇsø“" în-ÉˆI$¿ËÄZÇÇÿÇºTÖRG*OK´–∫∂≤âF|80ŸåC 0¡¶3ëÈ,&d3"8ÉnëÏ√åÚa‚Õ`yÈΩˇuŒπü>m°›&ˆ·¥˘=◊9˜}ﬁÓÛr]ˇ≥ñˆsÚ<ô◊N€1⁄¡Pq?—f2í,‘}I›∂C∫oÖÈ≥Ìe]ˇ“fº˘∂oëS∫?’∑¯ﬁV⁄Î»S~ùÈ˜%=ˆ∂ÕÌÂÂΩ|£™˜R;ëKÊÛ}!me;mø’Do–æH> oë£&]`ÊCæ˘Ui´›/‡º∑ƒJ¨˜*fﬂèŸ Áæ€!V)ç¡8≥G˘ªàæoJÇ>‘!€P&∫A|∏_£ Ø˜SåM†>°VPz·$|ÔM‰˚c©◊ÄiÓ+‘≈3ËoŸá˜K‹.mãﬂÕ·>Å9§Bb˝¶ƒ¬€Ës◊fT˙ÂZñË}¬Ò˛
áyg[Á/BoÒÁ·hÊ7Ú[v‚'˛˝X›k%_r¨'PÀxU,≈DˇÃåÔ∂¡Jd˘◊P€;ÅeYÉ˘|„Ó)LÀZK]˜*8g‚æ”Ûb üÀöQÈµqÊ⁄∏ˆã»l5féó:ÃÛä®«®ôTºæÉsíR„˘æƒOo/<˜!¿ˇÇ±{FÑY‘^c∞.+;ÇØ¯˚*]óû˚bwÜÖÀqΩø√¸*ÆQuÛﬂ8œê[˙ˆ√·2Ñ˛íËµ€NØNÈ≈ﬁ~‰)Ì¿ÿï∂q˚åˇ6pOåÓ¨kbï÷æZ„™∏èÙ˜–J¸Lø±zCÕ;üó{π(Úsπw®;∫X3¶0{Xv}¨g√√(]⁄ÁQ¸ï˛ŒK*√70 úÅ<—ga®t›Jâ—˛◊‘¢ï∆Ω?’ú˜9K3Ão·Ûøê˙< ˘íÁÍlÚŸ•-Ê˘]‰RØﬂÀªhçN_˙B∑Øﬁ=†À_‚9å6p⁄—£Üè4ÍíÃ‘©Jèjm›—¶uΩ⁄?”{¥ùÙÁï¨úaÓëú¥éıdWªô∂.ŒSÁ}ƒ3˙Î&IÎËŒñeü¶FyP[•≈Ó6ˆ9Ÿk¢ı:€¥ÆæÇΩí~Õ–±˙ú≈VÎÍ«;Ÿ;,÷◊=Ÿ¥˛Ó`£»‰˚¶ızOv!≤îÓ46|í˛ê4∂Êyøtπ?eZµ&pçé˝^.˙⁄€A-⁄≤ÔÑ‡ÓÅé,‹M∏Ûrå$B∏¢#FÁ_ë‡Á¨Gzv&:#pÃk¢gßø‹ xõ:ùQ»›Ì2€ÿ/È5J”(˝ﬂúÑ<¡Ω(H,Ï™!¸¬∞>&äÑxﬁ„yåÁÖﬂväﬂ]ós‹øi˜õÆ„7]ó´ı››ç=û…èIl·≤„Ê˙(Œhƒ?±lé!‡º"˚…€ÜÕœ  û€π5‹O$≥Nó}$Ô¶Ç…ÀY*ª0Oüﬁë>”`ÒÂÊ'¨—˚/ÆÁ…øÄj£Ω>ÊwÙˇ.ﬂ74´;ï/XàBÒ-åªrŒãΩﬂ£∂£Êã*πoÚÂl0N˙,ﬂﬂo¡tÁè—s˛j˙Ñ/££˛j¬æ33Ï–⁄/˙Ìçjû'‚5⁄Ωôn[ Hˆ◊LvΩ-:∂I”ˆâ~ﬁ>Æÿ˜∫Á¯ê/∫¡ª˘Jø‘c-…wOÛ=ıøaù[çRâÓxj+Í—Í, 9ﬁá¥ö>úó
wO∆˘.¬c^Áâà&RÎtÑ1@ Qıø8B˙rÔ¶ˇ+
ù”,«w¨∑N⁄bµË"ó7
.˜≈<ñù˝…}Üv¶·i‡x¢ﬁy£‹Zî8ÔQÔ‰Ú˘èH#”y¥˝»b≤ï¨¬ıÍ˘ÓìÛ,O\è˘wh}§HâÛµaÉFﬁ' êr^Aäö8≈ˆtπ™é&@*Ò’W -c{,Á¶‰RQ∏π&˝„¨wò
ÑÌ%NÎ∂‘ª∏LV{ˇòû]ãÈAy"jıK£÷ƒßò‰-AÆi2ék}‹‹DGΩK8[—vÊﬂv^∆R¡˝Âä-Q´;úÎøÄz2F˘ó®>‡>8âI˛Wx÷üÇA„ÿ»^∫â»›Æ÷ké.rﬂU:'¢„â=K¡"‰fΩâ\C| ∂Œ~Bõ®RÒ‹”Hàz€ØÔÆ9kJÁÜ”(œÒt¢}ë÷ZY7[Œ”sUå›ç!Z«…™ç≥…y®§o»fùyÊœ„~⁄){ÀhAVç8ñ{m4¡µ:(0uo◊˜“ËAÚRŒv∑Ús£ê8=-d‰[Ö´ù˜∆xoôÃÙ‰ÆyÆgâ°√⁄O·f¡õ¬r¬åt∑H]Ω÷=ÂÉπ.8CŸ«†À‰◊^∑äwC©[–sﬁ9àÎµﬂÜwÕÛõn“ﬂ›Sæ˜â˜[zO_È˚õ#—»”W˚¢ÃøJ6—øÓ<DﬂΩfÙ⁄noûÌﬁAga®ˆ·ÙçÕ(†ˇ*6pÔQ˜ÎˆêCﬂT&æë~˛¢ƒˇ÷≤›¢K›<˙Òe‘ä¶}π'Õî˙¢ÛÈ˜fâÔÛo@ï¯ZÒ©*fPã =ç˛&%æ≈9Ü±ŒEÌÉ'_‰ˆßÔ(„ÀîUig§Ò)e»r∆Ú[6k‹~—1Âì˙jüÂÇÌ˝N¸„ØˆWC‹A⁄9Ôk‰|»21g…g(·Yx]#1ßmØäMÁµüTæê~Z“rw1˜ß~rÈ/J{“KF[ÓÔd≈∂']hÍÏ7u∫ñ_ÇJÔ8˜…Æùƒ‰∑]zßÔ]¿Xôˇî∫ØÃ‰{— Ì:_bûƒIµN\£*j¢”Htæx'P)kÎﬂÇª8OG»˚v©F≈iô«O®À≤wg´>Ë„ÿ~.˜ÈY3Nπü‰süÆOﬂ˝‚ª\|◊ nÚ∂cóªúZ®3Mº=„~ªKê}¶=.F˛Ï„Æ™»‡(g¶/)øz∏g6Pâ—Ñ?kß◊F ´•#◊lÔJøl†ˇ¡vrF¥3x˜|õ;7ü>ˇ;‹„É©"8_ÖÁ∏ÏÆ„∏Ü>§Œı1ê”2¯˚ı0f£¶òÒ‰ÜõÅqw8mS&sæßÄrS?∑¸?pk b±\U∂Z,ã≈b±X,ã≈b±X,ã≈b±X,ã≈b±X,ã≈b±X,ã≈Úë ˙å√?1	€¬¡µÉÖÄWÁÅœ<–/Ú◊Ö¸›•~%¢ïπÙﬂ∏ƒPìv—7±ÿ§=¶óõt¿ÙΩ&‚éƒ£,ô≤§ÕƒIìN`∞Sn“˙:µ&ÌÚyãI{Lo4ÈÄÈ&ÕÒ8G±Iî†òˇ„ôZÄ:‘–ŒA#HÓ√=Í…TÊöòñﬂj>ØW%FÛM)V?â˘|∂úı[–¨r5¥5,Ωäø)ñ,e∫ûu•lΩ*SMZT{)ñYI€Ñª˘¨µˇ√X§’’¢ÆW≈\=s“{ïLU´úÓπÅO«®í™Ì:5÷$ñ1w/ﬂ∂®—JÈ—{ì%≈≈„ìÍjís[Óªß&9µ±Èû∆¶Íñ˙∆Ü—…“+íÛÎó◊µ4'Á◊4◊4≠™Iç.ü˘É∑ï6’WØò≥†ª‹ø©/ﬂÿ&Œ;é?œsÆ}	v<pBsÒ]‚¯hrÄ©°3üÉΩ–ZUI©ùe$!x#¿¬Hìá4§°∂§Í$∂1iA}1U´*.Á)s§d ÷©Y7–÷1â˛KªΩX_t)}±éWﬁ˜π3P4:M{1iw˘¸~øÁ˘}ü{û{û«w€)£yeX)ú>ò˚Êâ# ÿ◊ø∞?eÙòR@Óôc£Ö‹A•∑0\»°Ò±Éë± 2'îë±ÒcÖ£π¸¶ˇ·˙>EvìgIÈ!i¢}nµüFØ\˝ÃÎQ{çˇùÚøÕ˝ﬂÓÆ“'<ZTÎÂÎWÖV≤ò–jiçÚå∞^h¥⁄eΩ$Ñä˛µQob£†‡±≠;ÆÄy‡"ÉBı>ÿ3¿ W¿<∏‹x–Ì¨∆¿$XÊ°Qê,Eˆ%÷Î–vû$^°é¨Ä2à›`LÄI‡∂uºfúÛ‡;£u÷K[0ˆ:Î9€ç⁄≈aß85ªX|6Î¯ß˜8>˘§#€·»€ÍToÍt¸˙é˜á£˜’5—ÖD@‡&¯qX ~Iºîô\÷0¡]©—±EçNŒ.B&P,î\^®USMT≥2[!~"≥ø±èù˚∏∏∫6:ôxä}HÆÄy ∞q~¿> gÿ2üsÿ8òÛ‡Xn∂åÛ}úÔ±˜àóΩK" ¡$ò+¿√ﬁÖı±w¯Ûﬁ∂<é∆ﬁÅı±∑q[o√zŸMD7ŸMÌVl{t∆¥H%ê√ï†Æ°¯—˚Ωuª;J≈JcGÕ	Õ§Élö≠crI®∑vé %ˆÁ¢¢…óõŸ[ƒxì¡˙Äz¿8‹àn ∫A"∏LÄ]Î
[oÇd3–AŸu›îÿ5KÌîˆ;ˆkRáˇ-^F‹ø…^∑˝oÿØlˇ|~âΩneíXÖ<Aº>Ç¸CÏ≈ø\N‘≤yÃùq–¡p≥y÷lî˝∏»Y	î˘»ˆ?!/ãD?,ÎÍ.l@Öu«à`&ïIïÈÍ≈¢»çz·%D‹®ﬂy7Í∑Œ"‚F=z7Í¡√à∏Q˚q£v˜!Ç)±ˇºeΩÎ>BïÑóù¬,ù¬,ù¬,ù".väü‰∂ãèÌGV[fÏíÆµ∂…∆,5ÆRc/5^¶Féß©qñ;©±ü5$j©°Scén√TTˇŸ}≈Ìz=5ñ®Ò5Ú‘P©¶F5”K¨…zrãÌR∂+&¯è˛â<}º¨	3⁄Ñ=ﬂÑg¬<Ï5P∂K:DJ≥#^‰æπÿw õvD«ªŸ".b…˚¿ÖZƒ6ZƒEq/lÇ∞ ¿u3>a[/lƒ¡ 8VÄ€Œ
`d¨2ƒ+ˆ¿"ïAwÛ[ƒŸå≥â5Èç>…ß˘vıiw∞d1‡Û _+÷ñhÕÙg5ˇ¯¨ÜT%™ÿ6A±/V¸ÑuªQ.—XÍúúXKøOÇ.Ï:∫ù®4øç‰ÌÚ„DπﬂäØÆW·£ñ¥Õºñ∫Aû•´y´i˘∂Ù˘#©ƒ˛Uöìˇ§î\‘íˇàöWßÂ∑§ÛÚëíàö´jâ¬Õ*∂tF⁄&ø∂dKœ"q…íOs7-[ÍíèHv"Á$ˆÁQ“ΩÚ^µ_ﬁçÎ%•≤û«5ßÂ∏¥_ﬁÈ®Ám¶ÂÕÇÊÑml´dw
⁄|&V¢áÙûãûåß€ÛeO‘≥¡”‰ë=çûœ—/˙ƒ’‚√bµ(än—%2ëàkJÂe]#X∫5nwn∑.;ˆ1n˘3ËQë·o~IH≥to'Mõ#$}@1ˇﬁ*—Í=˝ÊC°Nj˙”$›◊in”“%OyØ”“¶ßÁ´ô)J/dQk≤Ôñ(ÈÀîhôWùk0˝ª23Ñ“⁄s/4pˇËπ≤YR8Øè˚;j∑%˘ 3T±⁄Ω£˛æ∏—ºòÓÕò?mÃöQî≥iÛ{Ω @fÜ~J?I%gË-Ó≤ô°É~ö⁄ÀÎÖéd6õ.—}∂é(Ùtÿ1∑lùà3◊E:∫Ké.åˆ–µp]U	€∫pUï≠sQÆõ ∑§íS--∂¶N!y[ìØS>ØY
C€öÄAñlÕR¿‡≥√ñH$A…ñ–GàdK$˙à-ŸwO©HŒﬂïú∑{Ë=ç‰hjñÔhjñ°—˛”#◊©i¥ÿûHÂB©°P*ÜÃÁN™7çä25íÂ	≈‘°#á∏ŒôŸP.iéÑí T˚¿“<›JNëÅT_fj@œ%≠vΩ=Nfã]=[c˜ıu˛n_[{p±~±≠ºØÆÿ“1ûÓ‚}≈x_1ﬁWóﬁe˜EÏ=ﬁìôIgv◊Ä„ãlU5ˆÎPCS∂3‡;ﬁaoﬁˆ¶˙”≥¯ZyÖ¨“≤Ê√°N≥‘∆ƒ∆O·7≈S´QÌ≠§ÍO∑75Ã“W*)™kCùD+åÁ«I}j4È¸Âq†™0Œ'‹±Z˛ã‰R¶>úÃIõmΩi3æß?3ÂÒ†vàﬂíπ„N›™U©Ry¡©‹Ñ ºRÓ
y›N^WUU˛Î˙èW¸.˛+0ÿ\ëÍAä>≤ÇL˜1<
˙˙qØ˝ôY|KÒ◊C>ãÃSçÊÔ\£2lM#Nô{æCaºUÊ¢PÒNK4…ﬂôíªü,ÌÓå4Ìü Y*oendstreamendobj22 0 obj<</AIS false/BM/Normal/CA 1.0/OP false/OPM 1/SA true/SMask/None/Type/ExtGState/ca 1.0/op false>>endobj42 0 obj<</Length 10800>>stream
q
/GS0 gs
0 TL/Fm0 Do
Q
0 0 0 1 K
/GS1 gs
q 1 0 0 1 37 678.9441 cm
0 0 m
538 0 l
S
Q
q 1 0 0 1 37 613.4568 cm
0 0 m
538 0 l
S
Q
q 1 0 0 1 46 594.7451 cm
0 0 m
326.771 0 l
S
Q
q 1 0 0 1 37 391.4516 cm
0 0 m
538 0 l
S
Q
q 1 0 0 1 46 372.7397 cm
0 0 m
85.575 0 l
S
Q
q 1 0 0 1 37 324.8843 cm
0 0 m
538 0 l
S
Q
q 1 0 0 1 46 306.1725 cm
0 0 m
130.814 0 l
S
Q
q 1 0 0 1 37 116.199 cm
0 0 m
538 0 l
S
Q
q 1 0 0 1 46 99.4672 cm
0 0 m
210.471 0 l
S
Q
BT
0 0 0 1 k
/TT0 1 Tf
-0.018 Tc -0.03 Tw 10 0 0 10 259.007 714.5277 Tm
[(MEDI)0.5 (CA)74.4 (TI)0.5 (O)0.5 (N )0.5 (G)0.5 (UI)0.5 (DE)]TJ
0.018 Tw 9.5 0 0 10 250.8274 700.3159 Tm
(ABECMA)Tj
0 Tc 0 Tw 6.65 0 0 5.6 291.4747 703.7299 Tm
(\256)Tj
-0.018 Tc 9.5 0 0 10 296.2526 700.3159 Tm
[( )0.5 (\(u)0.5 (h)0.5 (-BEK-mu)0.5 (h)0.5 (\))]TJ
0 Tc 6.834 0 Td
( )Tj
-0.018 Tc -11.377 -1.187 Td
[(\(i)0.5 (d)0.5 (ecab)0.5 (tag)0.5 (en)0.5 (e )0.5 (vi)0.5 (cl)0.5 (eu)0.5 (cel)0.5 (\))]TJ
/TT1 1 Tf
-0.005 Tc 0.067 Tw 10 0 0 10 46 658.5723 Tm
[(Read this Medication Guide before you start your )55.3 (ABECMA)55.1 ( treatment. )18.1 (The more you know about your treatment, the)-5.1 ( )]TJ
-0.014 Tc 0.022 Tw 0 -1.187 Td
[(more active you can be in your care. )18.2 (T)110.9 (alk with your healthcare provider if you have questions about your healt\h condition)-14.2 ( )]TJ
-0.011 Tc 0.038 Tw 0 -1.187 Td
[(or treatment. Reading this Medication Guide does not take the place of t\alking with your healthcare provider about your)-11 ( )]TJ
-0.018 Tc 0.018 Tw 0 -1.187 Td
[(t)0.5 (reat)0.5 (ment.)]TJ
/TT0 1 Tf
0 Tw 0 -2.537 Td
[(W)0.5 (h)0.5 (at )0.5 (i)0.5 (s )0.5 (th)0.5 (e )0.5 (mo)0.5 (st )0.5 (i)0.5 (mp)0.5 (o)0.5 (rtan)0.5 (t )0.5 (i)0.5 (n)0.5 (fo)0.5 (rmati)0.5 (o)0.5 (n)0.5 ( )0.5 (I)0.5 ( )0.5 (sh)0.5 (o)0.5 (u)0.5 (l)0.5 (d )0.5 (kn)0.5 (o)0.5 (w)0.5 ( )0.5 (ab)0.5 (o)0.5 (ut )37.6 (ABECMA?)]TJ
/TT1 1 Tf
-0.004 Tc 0.07 Tw 0 -1.925 Td
[(ABECMA)55.5 ( )0.5 (may )0.5 (cause )0.5 (side )0.5 (ef)18.5 (f)0.5 (ect)0.6 (s t)0.6 (hat)0.5 ( )0.5 (are lif)0.5 (e-t)0.5 (hreat)0.5 (ening )0.5 (and )0.5 (can )0.5 (lead )0.5 (t)0.5 (o )0.5 (deat)0.5 (h.)0.5 ( )0.5 (Call )0.5 (your )0.5 (healt)0.5 (hcare )0.5 (provider )0.5 (or )0.5 (get)-3.8 ( )]TJ
-0.018 Tc 0 Tw 0 -1.187 Td
[(emergency )0.5 (help )0.5 (right)0.5 ( )0.5 (away if)0.5 ( )0.5 (you )0.5 (get)0.6 ( any )0.5 (of)0.5 ( )0.5 (t)0.5 (he f)0.5 (ollowing:)]TJ
0 Tc /Span<</ActualText<FEFF0009>>> BDC 
0.586 -1.781 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
[<0047004C0049>0.5 <00BF00460058004F0057>0.5 <005C0003>0.5 <00450055004800440057>0.5 <004B004C0051004A>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.475 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
/TT1 1 Tf
-0.018 Tc 1.8 0 Td
[(f)0.5 (ever )0.5 (\(100.4\260)0.5 (F/)0.5 (38\260C )0.5 (or )0.5 (higher\))]TJ
0 Tc /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.475 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
/TT1 1 Tf
-0.018 Tc 0.018 Tw 1.8 0 Td
[(chills/)0.5 (shivering)]TJ
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.475 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
/TT1 1 Tf
-0.018 Tc 0.018 Tw 1.8 0 Td
[(conf)0.5 (usion)]TJ
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.475 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
/TT1 1 Tf
-0.018 Tc 1.8 0 Td
[(dizziness )0.5 (or )0.5 (lightheadedness)]TJ
0 Tc /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.475 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
/TT1 1 Tf
-0.018 Tc 1.8 0 Td
[(shaking )0.5 (or )0.5 (t)0.5 (wit)0.5 (ching )0.5 (\(t)0.5 (remor\))]TJ
0 Tc /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.475 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
/TT1 1 Tf
-0.018 Tc 1.8 0 Td
[(f)0.5 (ast)0.5 ( )0.5 (or )0.5 (irregular )0.5 (heart)0.6 (beat)]TJ
0 Tc /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.475 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
/TT1 1 Tf
-0.018 Tc 1.8 0 Td
[(severe )0.5 (f)0.5 (at)0.5 (igue)]TJ
0 Tc /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.475 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
/TT1 1 Tf
-0.018 Tc 1.8 0 Td
[(severe )0.5 (nausea,)0.5 ( )0.5 (vomit)0.5 (ing,)0.5 ( )0.5 (diarrhea)]TJ
-0.011 Tc 0.039 Tw -1.8 -1.781 Td
[(It is i)-0.6 (mpo)-0.6 (rtant that you te)-0.6 (ll your hea)-0.6 (lthcare)-0.6 ( provide)-0.6 (rs that you have recei)-0.6 (ved)-0.6 ( )55.5 (ABECMA)54.8 ( and to sho)-0.6 (w them your )55.5 (ABEC)-0.6 (MA)44.2 ( )]TJ
-0.018 Tc 0 Tw 0 -1.187 Td
[(Pat)0.5 (ient)0.5 ( )0.5 (W)37.6 (allet)0.5 ( )0.5 (Card.)0.5 ( )18.6 (Y)92.1 (our )0.5 (healt)0.5 (hcare )0.5 (provider )0.5 (may )0.5 (give )0.5 (you )0.5 (ot)0.5 (her )0.5 (medicines )0.5 (t)0.5 (o )0.5 (t)0.5 (reat)0.5 ( )0.5 (your )0.5 (side )0.5 (ef)18.5 (f)0.5 (ect)0.5 (s.)]TJ
/TT0 1 Tf
-0.037 Tw 0 -2.537 Td
[(W)0.5 (h)0.5 (at )-36.5 (i)0.5 (s )0.6 (ABECMA?)]TJ
/TT1 1 Tf
-0.015 Tc 0.019 Tw 0 -1.745 Td
[(ABEC)-0.6 (MA)54.9 ( i)-0.6 (s fo)-0.6 (r th)-0.6 (e treatme)-0.6 (nt of mul)-0.6 (tip)-0.6 (le myel)-0.6 (oma in)-0.6 ( p)-0.6 (atie)-0.6 (nts wh)-0.6 (o have recei)-0.6 (ved at l)-0.6 (east tw)-0.6 (o ki)-0.6 (nd)-0.6 (s of tre)-0.6 (atment reg)-0.6 (imen)-0.6 (s)-15 ( )]TJ
-0.018 Tc -0.003 Tw 0 -1.187 Td
[(t)0.5 (hat)0.5 ( have not)0.5 ( worked or have st)0.5 (opped working.)0.5 ( )55 (ABECMA)55.5 ( is a medicine made f)0.5 (rom your own whit)0.5 (e blood cells;)0.5 ( t)0.5 (he cells are)-18.2 ( )]TJ
/C2_0 1 Tf
0.018 Tw 0 -1.187 Td
[<004A0048005100480057>0.5 <004C00460044004F004F005C0003>0.5 <005000520047004C00BF004800470003>0.5 <0057>0.5 <00520003>0.5 <0055004800460052004A0051004C005D00480003>0.5 <0044005100470003>0.5 <00440057>0.6 <0057>0.5 <00440046004E0003>0.5 <005C0052005800550003>0.5 <00500058004F0057>0.6 <004C0053004F00480003>0.5 <0050005C0048004F0052005000440003>0.5 <00460048004F004F00560011>]TJ
/TT0 1 Tf
0 Tw 0 -2.537 Td
[(Ho)0.5 (w)0.5 ( )0.5 (wi)0.5 (l)0.5 (l)0.5 ( )0.5 (I)0.5 ( )0.5 (recei)0.5 (ve )37.6 (ABECMA?)]TJ
/TT1 1 Tf
-0.008 Tc 0.051 Tw 0 -1.925 Td
[(ABECMA)55.4 ( )0.6 (is )0.6 (made )0.6 (from )0.6 (your )0.6 (own )0.6 (white )0.6 (blood )0.6 (cells, )0.6 (so )0.6 (your )0.6 (blood )0.7 (will )0.6 (be )0.6 (collected )0.6 (by )0.7 (a )0.6 (process )0.6 (called )0.6 (\223leukapheresis\224)-8 ( )]TJ
-0.018 Tc 0.018 Tw 0 -1.187 Td
[(\(LO)0.5 (O)0.5 (-kuh-f)0.5 (eh-REE-sis\).)]TJ
-0.014 Tc 0.023 Tw 0 -1.655 Td
[(Y)91.6 (our )0.6 (blood )0.6 (cells )0.6 (will )0.5 (be )0.6 (sent )0.5 (to )0.6 (a )0.6 (manufacturing )0.5 (center )0.6 (to )0.5 (make )0.5 (your )55.7 (ABECMA. )0.5 (Based )0.5 (on )0.5 (clinical )0.5 (trial )0.5 (experience, )0.5 (it )0.6 (takes)-14 ( )]TJ
-0.023 Tc -0.014 Tw 0 -1.187 Td
[(about four weeks from the time your cells are received at the manufactur\ing site and are available to be shipped back to your)-23 ( )]TJ
-0.018 Tc 0 Tw 0 -1.187 Td
[(healt)0.5 (hcare )0.5 (provider)55.5 (,)0.5 ( )0.5 (but)0.5 ( )0.5 (t)0.5 (he )0.5 (t)0.5 (ime )0.5 (may )0.5 (vary)74.5 (.)]TJ
0 -1.655 Td
[(Bef)0.5 (ore )0.5 (you )0.5 (get)0.5 ( )55.7 (ABECMA,)0.5 ( )0.5 (your )0.5 (healt)0.5 (hcare )0.5 (provider )0.5 (will )0.5 (give )0.5 (you )0.5 (chemot)0.5 (herapy )0.6 (for )0.5 (t)0.5 (hree )0.5 (days )0.5 (t)0.5 (o )0.5 (prepare )0.5 (your )0.5 (body)74.6 (.)]TJ
0.004 Tw 0 -1.655 Td
[(W)0.5 (hen your )55.4 (ABECMA)55.5 ( is ready)74.6 (,)0.5 ( your healt)0.5 (hcare provider will give )55.4 (ABECMA)55.6 ( t)0.5 (o you t)0.5 (hrough a cat)0.5 (het)0.5 (er \(tube\) placed int)0.5 (o your)-18 ( )]TJ
-0.02 Tc -0.014 Tw 0 -1.187 Td
[(v)0.5 (ein )0.6 (\(int)0.6 (r)0.5 (av)0.5 (enous)0.5 ( )0.5 (inf)0.6 (us)0.5 (ion\))0.5 (.)0.6 ( )18.6 (Y)92.3 (our)0.5 ( )0.5 (dos)0.5 (e )0.5 (of)0.7 ( )55.7 (A)0.5 (B)0.5 (E)0.5 (CM)0.5 (A)55.6 ( )0.6 (may)0.5 ( )0.6 (be )0.5 (giv)0.5 (en )0.5 (in )0.5 (one )0.5 (or )0.6 (mor)0.5 (e )0.5 (inf)0.7 (us)0.5 (ion )0.6 (bags.)0.7 ( )18.6 (T)0.6 (he )0.5 (inf)0.7 (us)0.5 (ion )0.5 (us)0.5 (ually )0.6 (t)0.6 (ak)0.5 (es )0.6 (up)-20.2 ( )]TJ
-0.018 Tc 0 Tw 0 -1.187 Td
[(t)0.5 (o )0.5 (30 )0.5 (minut)0.5 (es )0.5 (f)0.5 (or )0.5 (each )0.5 (infusion )0.5 (bag.)]TJ
/C2_0 1 Tf
0.018 Tw 0 -1.655 Td
[<003C>92.2 <005200580003>14.5 <005A004C004F004F0003>14.5 <004500480003>14.5 <0050>0.5 <00520051004C0057>0.7 <00520055>0.5 <004800470003>14.5 <00440057>0.6 <0003>14.5 <0057>0.6 <004B00480003>14.5 <0046004800550057>0.7 <004C00BF>0.5 <004800470003>14.5 <004B00480044004F0057>0.6 <004B0046>0.5 <0044005500480003>14.5 <0049>0.6 <00440046>0.5 <004C004F004C0057>0.6 <005C0003>14.6 <005A004B00480055>0.5 <00480003>14.5 <005C>0.5 <005200580003>14.5 <005500480046>0.5 <0048004C0059>0.5 <004800470003>14.5 <005C>0.5 <0052005800550003>14.5 <0057>0.6 <0055>0.5 <004800440057>0.6 <0050004800510057>0.6 <0003>14.5 <00470044004C004F005C>0.5 <0003>14.5 <0049>0.6 <005200550003>14.5 <00440057>0.6 <0003>14.5 <004F004800440056>0.5 <0057>0.6 <0003>14.5 <005600480059>0.5 <004800510003>14.5 <00470044005C>0.5 <00560003>14.5 <00440049>0.6 <0057>0.6 <00480055>-18 <0003>]TJ
/TT1 1 Tf
0 Tw 0 -1.187 Td
[(t)0.5 (he )0.5 (inf)0.5 (usion.)]TJ
-0.008 Tc 0.049 Tw 0 -1.475 Td
[(Y)92.2 (ou should plan t)0.5 (o st)0.6 (ay wit)0.5 (hin t)0.5 (wo hours of)0.6 ( t)0.6 (his locat)0.6 (ion f)0.6 (or at)0.6 ( least)0.5 ( f)0.6 (our weeks af)0.5 (t)0.6 (er get)0.5 (t)0.6 (ing )55 (ABECMA.)0.6 ( )17.8 (Y)92.2 (our healt)0.6 (hcare)-8.2 ( )]TJ
-0.018 Tc 0 Tw 0 -1.187 Td
[(provider will )0.5 (check )0.5 (t)0.5 (o )0.5 (see )0.5 (t)0.5 (hat)0.5 ( )0.5 (your )0.5 (t)0.5 (reat)0.5 (ment)0.5 ( )0.5 (is )0.5 (working )0.5 (and )0.5 (help )0.5 (you )0.5 (wit)0.5 (h )0.5 (any side )0.5 (ef)18.5 (f)0.5 (ect)0.5 (s )0.5 (t)0.5 (hat)0.5 ( )0.5 (may )0.5 (occur)55.5 (.)]TJ
/TT0 1 Tf
0 -2.339 Td
[(W)0.5 (h)0.5 (at )0.5 (sho)0.5 (u)0.5 (l)0.5 (d)0.5 ( )0.5 (I)0.5 ( )0.5 (avo)0.5 (i)0.5 (d)0.5 ( )0.5 (after )0.5 (recei)0.5 (vi)0.5 (n)0.5 (g )37.6 (ABECMA?)]TJ
/TT1 1 Tf
0 Tc /Span<</ActualText<FEFF0009>>> BDC 
0.586 -1.781 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
/TT1 1 Tf
-0.018 Tc -0.014 Tw 1.8 0 Td
[(Do not)0.6 ( drive,)0.5 ( operat)0.6 (e heavy machinery)74.6 (,)0.5 ( )0.5 (or do ot)0.5 (her act)0.5 (ivit)0.6 (ies t)0.6 (hat)0.5 ( could be dangerous if)0.5 ( )0.5 (you )0.5 (are not)0.5 ( ment)0.5 (ally alert)0.6 (,)0.5 ( f)0.5 (or at)-17.8 ( )]TJ
-0.021 Tc 0 -1.187 Td
[(least eight weeks after you get )55.2 (ABECMA. )18.1 (This is because the treatment can cause temporary memory and coordinatio\n)-21.2 ( )]TJ
-0.018 Tc 0 Tw 0 -1.187 Td
[(problems, )0.5 (sleepiness,)0.5 ( )0.5 (conf)0.5 (usion,)0.5 ( )0.5 (dizziness,)0.5 ( )0.5 (and )0.5 (seizures.)]TJ
0 Tc /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.475 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
/TT1 1 Tf
-0.018 Tc 1.8 0 Td
[(Do )0.5 (not)0.5 ( )0.5 (donat)0.5 (e )0.5 (blood,)0.5 ( )0.5 (organs,)0.5 ( )0.5 (t)0.5 (issues,)0.5 ( )0.5 (or )0.5 (cells )0.5 (f)0.5 (or )0.5 (t)0.5 (ransplant)0.5 (at)0.5 (ion.)]TJ
ET
4 M 
36.5 36.5 539 694.808 re
S
endstreamendobj41 0 obj<</Length 18943>>stream
q
/GS0 gs
0 TL/Fm0 Do
Q
0 0 0 1 K
0.5 w 
/GS1 gs
q 1 0 0 1 36 669.488 cm
0 0 m
126.06 0 l
S
Q
q 1 0 0 1 162.06 669.488 cm
0 0 m
125.94 0 l
S
Q
q 1 0 0 1 36 715.6799 cm
0 0 m
126.06 0 l
S
Q
q 1 0 0 1 162.06 715.6799 cm
0 0 m
125.94 0 l
S
Q
BT
0 0 0 1 k
/GS2 gs
/T1_0 1 Tf
-0.017 Tc 0.048 Tw 8 0 0 8 36 727.248 Tm
[(T)74.2 (able 11:)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
5 0 Td
[(Duration of Response in the KarMMa Study)-17 ( )]TJ
/T1_1 1 Tf
0.022 Tc -0.198 Tw 7.6 0 0 8 36 706.368 Tm
(CAR)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
(=)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
[(chimeric )-417.4 (antigen )-417.4 (receptor; )-417.5 (CI)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
(=)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
[(confidence )-417.4 (inter)-18 (val; )-417.5 (CR)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
(=)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
[(complete )-417.5 (response;)22 ( )]TJ
0 Tc 0 Tw 7.6 0 0 8 288 706.368 Tm
( )Tj
-0.012 Tc 0.049 Tw 7.6 0 0 8 36 697.868 Tm
(PR)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
1.005 0 Td
(=)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0.617 0 Td
(partial response; sCR)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
7.718 0 Td
(=)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0.617 0 Td
[(stringent complete response; )37.2 (VGPR)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
12.728 0 Td
(=)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0.617 0 Td
[(ver)-17.7 (y good partial response;)-12 ( )]TJ
-0.198 Tw -23.302 -1.062 Td
(NE)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
1.024 0 Td
(=)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0.617 0 Td
[(not )-245.8 (estimable)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
4.916 0 Td
(.)Tj
0.012 Tw 5.32 0 0 5.6 36 683.532 Tm
(a)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 41 680.868 Tm
[(Response is defined as achieving sCR,)37.1 ( CR,)37.2 ( )37.2 (VGPR,)37.2 ( or PR according to IMWG criteria.)]TJ
0.012 Tw 5.32 0 0 5.6 36 675.032 Tm
(b)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 41 672.368 Tm
[(Median and 95% CI are based on Ka)-9.7 (plan-Meier estima)-9.7 (tion.)]TJ
-0.021 Tc 0.036 Tw 8 0 0 8 36 651.2081 Tm
[(Response dura)-10.2 (tions were longer in pa)-10.2 (tients who achieved a stringent CR as compared to)-20.9 ( )]TJ
-0.018 Tc 0 -1.044 Td
[(pa)-9.8 (tients with a PR or )37.2 (VGPR \(T)74.2 (able 11\).)37.1 ( Of the 28 pa)-9.8 (tients who achieved a stringent CR,)37.2 ( it)-17.9 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(is estima)-9.8 (ted tha)-9.8 (t 65% \(95% CI:)37.2 ( 42%,)37.2 ( 81%\) had a remission lasting a)-9.8 (t least 12 months.)]TJ
-0.013 Tc 0.071 Tw 0 -1.764 Td
[(The median dura)-10.3 (tion of response for )36.7 (VGPR pa)-10.3 (tients \(n=25\) was 11.1 months \(95% CI:)24 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(8.7,)37.2 ( 11.3\).)]TJ
-0.003 Tc 0.121 Tw 0 -1.764 Td
[(The median )0.5 (dura)-10.3 (tion of response for PR pa)-10.3 (tients )0.5 (\(n=19\) )0.5 (was 4.0 months \(95% CI:)34 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(2.7,)37.2 ( 7.2\).)]TJ
-0.021 Tc 0.036 Tw 0 -1.764 Td
[(W)0.5 (i)0.6 (t)0.5 (h)0.6 (i)0.5 (n)0.5 ( )0.6 (t)0.5 (h)0.6 (e)0.5 ( )0.5 (r)0.6 (e)0.5 (c)0.6 (o)0.5 (m)0.6 (m)0.5 (e)0.6 (n)0.5 (d)0.5 (e)0.6 (d)0.5 ( )0.6 (d)0.5 (o)0.5 (s)0.6 (e)0.5 ( )0.6 (o)0.5 (f)0.6 ( )0.5 (3)0.5 (0)0.6 (0)0.5 ( )0.5 (t)0.6 (o)0.5 ( )0.6 (4)0.5 (6)0.5 (0)0.6 ( )0.5 (x)0.6 ( )0.5 (1)0.6 (0)]TJ
0.021 Tw 5.6 0 0 5.6 177.7221 578.142 Tm
[(6)0.5 ( )]TJ
0.036 Tw 8 0 0 8 181.7144 575.478 Tm
[(C)0.5 (A)0.6 (R)0.5 (-)0.5 (p)0.6 (o)0.5 (s)0.6 (i)0.5 (t)0.5 (i)0.6 (v)0.5 (e)0.6 ( )37.5 (T)0.5 ( )0.6 (c)0.5 (e)0.6 (l)0.5 (l)0.5 (s)0.6 (,)37.5 ( )0.5 (a)0.6 ( )0.5 (d)0.6 (o)0.5 (s)0.6 (e)0.5 (-)0.5 (r)0.6 (e)0.5 (s)0.6 (p)0.5 (o)0.5 (n)0.6 (s)0.5 (e)-21 ( )]TJ
-0.014 Tc 0.064 Tw -18.214 -1.044 Td
[(rela)-10 (tionship was obser)-18 (ved with higher ORR and sCR ra)-9.9 (te in pa)-9.9 (tients who received 440)-14 ( )]TJ
-0.003 Tc 0.118 Tw 0 -1.044 Td
(to 460 x 10)Tj
0 Tc 0 Tw 5.6 0 0 5.6 72.3761 561.4421 Tm
(6)Tj
-0.003 Tc 0.118 Tw 8 0 0 8 75.046 558.7781 Tm
( compared to 300 to 340 x 10)Tj
0.003 Tw 5.6 0 0 5.6 169.1937 561.4421 Tm
(6 )Tj
0.118 Tw 8 0 0 8 173.8495 558.7781 Tm
[(CAR-positive )37.4 (T cells.)37.2 ( Overall response)-3 ( )]TJ
-0.001 Tc 0.132 Tw -17.231 -1.044 Td
[(ra)-10.4 (te of 79% \(95% CI:)36.5 ( 65%,)36.5 ( 90%\) and sCR ra)-10.4 (te of 31% \(95% CI:)36.6 ( 19%,)36.6 ( 46%\) was)-1 ( )]TJ
0.01 Tc 0.184 Tw 0 -1.044 Td
[(obser)-18 (ved with 440 to 460 x 10)]TJ
-0.01 Tw 5.6 0 0 5.6 137.9505 544.7421 Tm
(6 )Tj
0.184 Tw 8 0 0 8 143.1261 542.0781 Tm
[(CAR-positive )36.8 (T cells.)36.9 ( Overall response ra)-10 (te of)10 ( )]TJ
-0.014 Tc 0.065 Tw -13.391 -1.044 Td
[(65% )0.5 (\(95% CI:)36.9 ( )0.5 (51%,)36.9 ( 78%\) with )0.5 (sCR ra)-10.1 (te )0.5 (of 25% \(95% )0.5 (CI:)36.9 ( 14%,)36.9 ( )0.5 (39%\) )0.5 (was obser)-18 (ved in)-14.1 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
(300 to 340 x 10)Tj
0.017 Tw 5.6 0 0 5.6 82.7431 528.0421 Tm
(6 )Tj
0.011 Tw 8 0 0 8 86.8511 525.3781 Tm
[(CAR-positive T )-36.8 (cells.)]TJ
0.004 Tc 0.156 Tw -6.356 -1.764 Td
[(One hundred and thirty-five pa)-10.2 (tients underwent leuka)-10.3 (pheresis.)36.7 ( F)17.8 (ifteen out of the)4 ( )]TJ
-0.015 Tc 0.061 Tw 0 -1.044 Td
[(23 )0.6 (pa)-10.2 (tients )0.5 (who )0.6 (received )0.5 (trea)-10.2 (tment )0.6 (outside )0.6 (of )0.6 (the )0.6 (recommended )0.6 (dose )0.6 (range )0.5 (of )0.5 (300 )0.5 (to)-15 ( )]TJ
-0.022 Tc 0.036 Tw 0 -1.044 Td
(460 x 10)Tj
0.022 Tw 5.6 0 0 5.6 61.4625 497.2321 Tm
(6 )Tj
0.036 Tw 8 0 0 8 65.4508 494.5681 Tm
[(CAR-positive )36.8 (T cells experienced a response in addition to the responses noted)-22 ( )]TJ
-0.013 Tc 0.069 Tw -3.681 -1.044 Td
[(in )36.8 (T)74 (able 9.)37 ( )36.8 (The IRC assessed overall response in the leuka)-10 (pheresis popula)-10 (tion \(n=135\))-12.9 ( )]TJ
-0.02 Tc 0.036 Tw 0 -1.044 Td
[(was 64% \(95% CI:)36.7 ( 56%,)36.7 ( 72%\) with stringent CR ra)-10.2 (te of 24% \(95% CI:)36.7 ( 17%,)36.7 ( 32%\),)36.7 ( )36.7 (VGPR)-20 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(ra)-9.8 (te of 21% \(95% CI:)37.2 ( 14%,)37.2 ( 29%\),)37.2 ( and PR ra)-9.8 (te of 20% \(95% CI:)37.2 ( 14%,)37.2 ( 28%\).)]TJ
/T1_0 1 Tf
0.017 Tw 0 -2.61 Td
(15)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3.375 0 Td
(REFERENCES)Tj
/T1_1 1 Tf
0.01 Tc 0.183 Tw -3.375 -1.719 Td
[(1)27.2 (.)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
0.649 0 Td
( )Tj
EMC 
0.476 0 Td
[(Lee DW)74.1 (,)37.1 ( Gardner R,)37.2 ( P)18.1 (orter DL,)37.1 ( et al.)37.1 ( Current concepts in the dia)-9.9 (gnosis and)10 ( )]TJ
-0.01 Tc 0.086 Tw 0 -1.044 Td
[(mana)-10.3 (gement of c)19.6 (ytokine release syndrome.)36.6 ( Blood 2014; 124\(2\):)36.6 ( 188-95.)36.6 ( Erra)-10.4 (ta in)-10 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(Blood:)37.1 ( 2015;126\(8\):1048.)37.2 ( and 2016;128\(11\):1533.)]TJ
0.009 Tc 0.177 Tw -1.125 -1.764 Td
[(2)26.2 (.)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
0.649 0 Td
( )Tj
EMC 
0.476 0 Td
[(K)20.3 (umar S,)37.3 ( P)18.4 (aiva B,)37.3 ( )37.2 (Anderson KC,)37.4 ( et al.)37.3 ( Interna)-9.6 (tional Myeloma )37.1 (W)18.4 (orking Group)9 ( )]TJ
-0.017 Tc 0.042 Tw 0 -1.044 Td
[(consensus )0.5 (criteria )0.5 (for )0.5 (response )0.5 (and )0.6 (minimal )0.5 (residual )0.5 (disease )0.5 (assessment )0.5 (in )0.5 (multiple)-17 ( )]TJ
0.048 Tw 0 -1.044 Td
[(myeloma.)37.2 ( Lancet Oncol 2016; 17\(8\):)37.2 ( e328-46.)]TJ
/T1_0 1 Tf
0.017 Tw -1.125 -2.61 Td
(16)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
(HOW SUPPLIED/STORAGE AND HANDLING)Tj
/T1_1 1 Tf
-0.005 Tc 0.11 Tw -3.375 -1.719 Td
[(ABECMA is supplied in one or more infusion ba)-10.2 (g\(s\) \(see belo)-10.2 (w\) containing a frozen)-5 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(suspension of genetically modi\037ed autologous )37.3 (T cells in 5% DMSO.)]TJ
-0.007 Tc 0.1 Tw 0 -1.764 Td
[(Each infusion ba)-10.1 (g of )37.2 (ABECMA is individually packed in a metal cassette.)36.9 ( )37.1 (ABECMA is)-7 ( )]TJ
-0.013 Tc 0.067 Tw 0 -1.044 Td
[(stored in the va)-9.7 (por phase of liquid nitrogen and supplied in a liquid nitrogen dr)-17.7 (y va)-9.7 (por)-13 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(shipper)74.2 (.)37.2 ( )37.2 (An RFI Certi\037ca)-9.8 (te is af\037xed inside the shipper)74.2 (.)]TJ
0.017 Tw 1.192 -1.647 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.508 0 Td
[(50 mL infusion ba)-9.8 (g and metal cassette \(NDC 59572-515-01\))]TJ
0.017 Tw -1.508 -1.512 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.508 0 Td
[(250 mL infusion ba)-9.8 (g and metal cassette \(NDC 59572-515-02\))]TJ
0.017 Tw -1.508 -1.512 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.508 0 Td
[(500 mL infusion ba)-9.8 (g and metal cassette \(NDC 59572-515-03\))]TJ
-0.002 Tc 0.124 Tw -2.7 -1.629 Td
[(Ma)-10 (tch the identity of the pa)-9.9 (tient with the pa)-9.9 (tient identi\037ers on the cassette\(s\) and)-2 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(infusion ba)-9.8 (g\(s\) upon receipt.)]TJ
0.001 Tc 0.141 Tw 0 -1.764 Td
[(Store )36.6 (ABECMA frozen in the va)-10.4 (por phase of liquid nitrogen \(less than or equal to)1.1 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
(minus 130\260C\).)Tj
0 -1.764 Td
[(Tha)-9.8 (w )37.2 (ABECMA prior to infusion )]TJ
/T1_2 1 Tf
[([see Dosa)-9.8 (ge and )37.2 (Administra)-9.8 (ti)]TJ
(on \(2.2\)])Tj
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
ET
q 1 0 0 1 333 572.8505 cm
0 0 m
97.882 0 l
S
Q
q 1 0 0 1 333 535.2139 cm
0 0 m
59.11 0 l
S
Q
q 1 0 0 1 333 497.5772 cm
0 0 m
31.641 0 l
S
Q
q 1 0 0 1 333 476.9589 cm
0 0 m
62.773 0 l
S
Q
q 1 0 0 1 333 447.8314 cm
0 0 m
74.376 0 l
S
Q
BT
/T1_0 1 Tf
-0.017 Tc 0.017 Tw 8 0 0 8 324 727.248 Tm
(17)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
[(P)54.2 (A)55.2 (TIENT COUNSELING INFORMA)55.2 (TION)]TJ
/T1_1 1 Tf
-3.375 -1.72 Td
[(Advise the pa)-9.8 (tient to read the FDA-a)-9.8 (pproved pa)-9.8 (tient labeling \(Medica)-9.8 (tion Guide\).)]TJ
-0.003 Tc 0.117 Tw 0 -1.765 Td
[(Advise pa)-9.7 (tients tha)-9.7 (t the risk of manufacturing failure is 2.1% [8/384 in the c)20.3 (linical)-2.9 ( )]TJ
-0.01 Tc 0.084 Tw 0 -1.045 Td
[(studies].)37.1 ( In case of )0.5 (a manufacturing failure,)37.1 ( )0.5 (a second )0.5 (manufacturing )0.5 (of )37.4 (ABECMA may)-9.9 ( )]TJ
-0.007 Tc 0.097 Tw 0 -1.045 Td
[(be )0.6 (a)-9.6 (t)0.5 (tem)0.5 (pte)0.5 (d.)37.4 ( )0.6 (In )0.6 (addit)0.5 (ion)0.5 (,)37.4 ( )0.5 (wh)0.5 (ile )0.6 (th)0.5 (e )0.5 (p)0.5 (a)-9.6 (tie)0.5 (nt )0.6 (a)-9.6 (wa)0.5 (its)0.5 ( )0.5 (th)0.5 (e )0.6 (prod)0.5 (uct,)37.4 ( )0.6 (ad)0.5 (diti)0.5 (onal)0.5 ( )0.5 (a)0.5 (ntic)0.5 (ance)0.5 (r)-7 ( )]TJ
0.001 Tc 0.136 Tw 0 -1.045 Td
[(t)0.5 (r)0.6 (e)0.6 (a)-9.5 (t)0.6 (m)0.5 (e)0.6 (n)0.5 (t)0.6 ( \()0.5 (n)0.6 (o)0.5 (t)0.6 ( t)0.5 (h)0.6 (e)0.5 ( l)0.6 (y)0.5 (m)0.6 (p)0.5 (h)0.6 (o)0.5 (d)0.6 (e)0.5 (p)0.6 (l)0.5 (e)0.6 (t)0.5 (i)0.6 (o)0.5 (n)0.6 (\))0.5 ( m)0.6 (a)0.5 (y)0.6 ( b)0.5 (e)0.6 ( n)0.5 (e)0.6 (c)0.5 (e)0.6 (s)0.5 (s)0.6 (a)0.5 (r)-17.4 (y)0.5 ( a)0.6 (n)0.5 (d)0.6 ( m)0.5 (a)0.6 (y)0.6 ( i)0.5 (n)0.5 (c)0.6 (r)0.5 (e)0.6 (a)0.6 (s)0.5 (e)0.5 ( t)0.5 (h)0.6 (e)0.5 ( r)0.6 (i)0.5 (s)0.5 (k)1.1 ( )]TJ
-0.003 Tc 0.122 Tw 0 -1.045 Td
[(of adverse events during the pre-infusion period,)36.6 ( which could delay or prevent the)-3 ( )]TJ
-0.017 Tc 0.011 Tw 0 -1.045 Td
[(administra)-9.8 (tion )-36.7 (of ABECMA.)]TJ
-0.003 Tc 0.117 Tw 0 -1.765 Td
[(Inform pa)-9.7 (tients of the risk of early dea)-9.7 (th:)37.3 ( In a c)20.3 (linical stud)-9.7 (y)55.3 (,)37.3 ( a higher proportion of)-2.9 ( )]TJ
-0.001 Tc 0.13 Tw 0 -1.045 Td
[(pa)-10.1 (tients experienced dea)-10.2 (th within the \037rst nine months from randomiza)-10.1 (tion in the)-1 ( )]TJ
-0.012 Tc 0.071 Tw 0 -1.045 Td
[(A)0.5 (B)0.5 (E)0.5 (C)0.5 (M)0.5 (A)0.5 ( a)0.5 (r)0.5 (m)0.5 ( c)0.5 (o)0.5 (m)0.6 (p)0.5 (a)0.5 (r)0.5 (e)0.5 (d)0.5 ( t)0.6 (o)0.5 ( t)0.5 (h)0.5 (e)0.5 ( s)0.5 (t)0.6 (a)0.5 (n)0.5 (d)0.5 (a)0.5 (r)0.5 (d)0.5 ( r)0.6 (e)0.5 (g)0.5 (i)0.5 (m)0.5 (e)0.5 (n)0.6 (s a)0.5 (r)0.5 (m)0.5 (.)37.5 ( )37 (T)0.5 (h)0.5 (i)0.5 (s)0.5 ( h)0.6 (i)0.5 (g)0.5 (h)0.5 (e)0.5 (r)0.5 ( r)0.5 (a)-9.4 (t)0.5 (e)0.5 ( o)0.5 (f)0.6 ( e)0.5 (a)0.5 (r)0.5 (l)0.5 (y)0.5 ( d)0.6 (e)0.5 (a)-9.5 (t)0.5 (h)-12 ( )]TJ
-0.017 Tc 0.056 Tw 0 -1.045 Td
[(was mainly obser)-17.8 (ved before receiving )36.8 (ABECMA with the main reason being progression)-17 ( )]TJ
-0.005 Tc 0.107 Tw 0 -1.045 Td
[(of multiple myeloma.)37.2 ( )36.7 (There was also an increase in the ra)-9.7 (te of dea)-9.7 (th from adverse)-5 ( )]TJ
-0.017 Tc 0.011 Tw 0 -1.045 Td
[(events )-36.8 (after ABECMA.)]TJ
0.048 Tw 0 -1.765 Td
[(Advise pa)-9.8 (tients to seek immedia)-9.7 (te a)-9.8 (ttention for an)-9.8 (y of the follo)-9.8 (wing:)]TJ
0.017 Tw 0 -1.649 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.021 Tc 0.036 Tw 1.125 0 Td
(Cytokine Release Syndrome \(CRS\):)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
12.256 0 Td
[( Signs or symptoms associa)-9.8 (ted with CRS,)37.2 ( inc)20.3 (luding)-21 ( )]TJ
-0.01 Tc 0.083 Tw -12.256 -1.064 Td
[(fever)74.1 (,)37.1 ( hypotension,)37.1 ( tachycardia,)37.1 ( chills,)37.1 ( hypoxia,)37.1 ( headache,)37.2 ( and fa)-9.9 (tigue )]TJ
/T1_2 1 Tf
[([see Dosa)-9.9 (ge)-10 ( )]TJ
-0.004 Tc 0.116 Tw 0 -1.064 Td
[(and )36.8 (Administra)-10.3 (tion \(2.3\),)36.6 ( )36.8 (W)17.7 (arnings and Precautions \(5.2\),)36.6 ( and )36.8 (Adverse Reactions)-3.9 ( )]TJ
-0.017 Tc 0.017 Tw 0 -1.064 Td
(\(6.1\)])Tj
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
-0.017 Tc 0.017 Tw -1.125 -1.514 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.019 Tc -0.001 Tw 1.125 0 Td
[(Neurologic T)74.2 (oxicities:)]TJ
0.036 Tw /Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
7.411 0 Td
[( Signs or symptoms associa)-9.8 (ted with neurologic events,)37.2 ( inc)20.2 (luding)-19 ( )]TJ
0 Tc 0.136 Tw -7.411 -1.064 Td
[(encephalopa)-10.2 (thy)54.7 (,)36.7 ( confusion,)36.7 ( seizures,)36.7 ( tremor)73.7 (,)36.7 ( a)-10.3 (phasia,)36.8 ( delirium,)36.7 ( and somnolence )]TJ
/T1_2 1 Tf
-0.012 Tc 0.075 Tw 0 -1.064 Td
[([see Dosa)-10.2 (ge and )36.8 (Administra)-10.2 (tion \(2.3\),)36.8 ( )36.8 (W)17.8 (arnings and Precautions \(5.3\),)36.8 ( and )36.8 (Adverse)-12 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.064 Td
(Reactions \(6.1\)])Tj
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
-0.017 Tc 0.017 Tw -1.125 -1.514 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.013 Tc -0.013 Tw 1.125 0 Td
(Infections:)Tj
0.199 Tw /Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
4.01 0 Td
[( )0.5 (Signs )0.5 (or )0.5 (symptoms )0.5 (associa)-9.9 (ted )0.5 (with infection )]TJ
/T1_2 1 Tf
0.162 Tw 18.95 0 Td
[([see )0.5 (W)18.1 (arnings )-36.5 (and)13 ( )]TJ
-0.017 Tc 0.048 Tw -22.96 -1.064 Td
[(Precautions \(5.7\) and )37.2 (Adverse Reactions \(6.1\)])]TJ
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
-0.017 Tc 0.017 Tw -1.125 -1.514 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.02 Tc 0.036 Tw 1.125 0 Td
(Prolonged Cytopenias:)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
7.868 0 Td
[( Signs or symptoms associa)-9.8 (ted with bone marro)-9.8 (w suppression,)17 ( )]TJ
0.01 Tc 0.183 Tw -7.868 -1.064 Td
[(inc)20.1 (luding neutropenia,)37.1 ( anemia,)37.1 ( thromboc)20 (ytopenia,)37.1 ( or febrile neutropenia )]TJ
/T1_2 1 Tf
-0.01 Tw [([see)10 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.064 Td
[(W)18.2 (arnings and Precautions \(5.8\) and )37.2 (Adverse Reactions \(6.1\)])]TJ
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
-0.017 Tc 0.017 Tw -1.125 -1.514 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.004 Tc 0.115 Tw 1.125 0 Td
[(Secondar)-18.1 (y malignancies:)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
9.335 0 Td
[( Secondar)-18.1 (y malignancies,)36.9 ( inc)19.9 (luding )37.3 (T cell malignancies,)33 ( )]TJ
0.005 Tc 0.157 Tw -9.335 -1.064 Td
[(ha)-9.7 (ve occurred )]TJ
/T1_2 1 Tf
[([see Boxed )36.8 (W)18.3 (arning,)37.3 ( )36.7 (W)18.4 (arnings and Precautions \(5.10\),)37.3 ( )36.7 (Adverse)5 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.064 Td
(Reactions \(6.3\)])Tj
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
-0.017 Tc 0.048 Tw -1.125 -1.63 Td
[(Advise pa)-9.8 (tients for the need to:)]TJ
0.017 Tw 0 -1.649 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.002 Tc 0.143 Tw 1.125 0 Td
[(Contact Bristol-Myers Squibb a)-9.9 (t 1-888-805-4555 if they are dia)-9.9 (gnosed with a)2.1 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.064 Td
[(secondar)-17.8 (y malignanc)20.2 (y )]TJ
/T1_2 1 Tf
[([see )37.2 (W)18.2 (arnings and Precautions \(5.10\)])]TJ
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
-0.017 Tc 0.017 Tw -1.125 -1.514 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.01 Tc 0.183 Tw 1.125 0 Td
[(Ha)-9.9 (ve periodic monitoring of blood counts before and after )36.5 (ABECMA infusion)10 ( )]TJ
0 Tc 0 Tw 30.375 0 Td
( )Tj
/T1_2 1 Tf
-0.017 Tc 0.048 Tw -30.375 -1.064 Td
[([see )37.3 (W)18.2 (arnings and Precautions \(5.8\)])]TJ
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
-0.017 Tc 0.017 Tw -1.125 -1.514 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.009 Tc 0.086 Tw 1.125 0 Td
[(R)0.5 (e)0.5 (f)0.5 (r)0.5 (a)0.5 (i)0.5 (n f)0.5 (r)0.5 (o)0.5 (m)0.5 ( d)0.5 (r)0.5 (i)0.5 (v)0.5 (i)0.5 (ng)0.5 ( o)0.5 (r)0.5 ( o)0.5 (p)0.5 (e)0.5 (r)0.5 (a)-9.5 (t)0.5 (i)0.5 (ng)0.5 ( h)0.5 (e)0.5 (a)-9.5 (vy)0.5 ( o)0.5 (r)0.5 ( p)0.5 (o)0.5 (t)0.5 (e)0.5 (n)0.5 (t)0.5 (ia)0.5 (l)0.5 (l)0.5 (y)0.5 ( d)0.5 (a)0.5 (n)0.5 (g)0.5 (e)0.5 (r)0.5 (o)0.5 (u)0.5 (s)0.5 ( m)0.5 (a)0.5 (c)0.5 (h)0.5 (i)0.5 (n)0.5 (e)0.5 (s u)0.5 (n)0.5 (ti)0.5 (l)0.5 ( a)-9.4 (t)-9 ( )]TJ
-0.022 Tc 0.036 Tw 0 -1.064 Td
[(least eight weeks after )36.8 (ABECMA administra)-10.2 (tion )]TJ
/T1_2 1 Tf
[([see )36.7 (W)17.8 (arnings and Precautions \(5.11\)])]TJ
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
-0.012 Tc 0.048 Tw -1.125 -3.926 Td
[(Manufactured by:)37.2 ( )]TJ
/Span<</ActualText<FEFF0007>>> BDC 
( )Tj
EMC 
6.568 0 Td
[(Celgene Corpora)-9.8 (tion,)37.2 ( a Bristol-Myers Squibb Compan)-9.8 (y)]TJ
0 Tc 0 Tw 19.713 0 Td
( )Tj
-0.012 Tc 0.011 Tw -19.713 -1.126 Td
[(556 )-36.7 (Morris Avenue)]TJ
0 Tc 0 Tw 6.855 0 Td
( )Tj
-0.012 Tc 0.048 Tw -6.855 -1.126 Td
[(Summit,)37.2 ( NJ 07901)]TJ
0.057 -1.711 Td
[(U.S.)37.2 ( License No.)37.2 ( 2252)]TJ
-6.625 -1.981 Td
(Marketed by:)Tj
0 Tc 0 Tw 4.724 0 Td
( )Tj
-0.012 Tc 0.048 Tw -4.724 -1.126 Td
[(Celgene Corpora)-9.8 (tion,)37.2 ( a Bristol-Myers Squibb Compan)-9.7 (y \(Summit,)37.2 ( NJ 07901\),)37.2 ( and)-12 ( )]TJ
0 -1.126 Td
[(2seventy bio,)37.2 ( Inc.)37.2 ( \(Cambridge,)37.2 ( MA 02142\).)]TJ
-0.017 Tc 0.017 Tw 0 -1.967 Td
(ABECMA)Tj
0 Tc 0 Tw 5.6 0 0 5.6 348.8143 246.2804 Tm
(\256)Tj
-0.017 Tc 0.048 Tw 8 0 0 8 353.1979 243.6164 Tm
[( is a trademark of Celgene Corpora)-9.8 (tion,)37.2 ( a Bristol-Myers Squibb Compan)-9.8 (y)55.2 (.)]TJ
-3.65 -1.405 Td
[(P)18.2 (a)-9.8 (t.)37.1 ( https://www)37.2 (.bms.com/pa)-9.8 (tient-and-caregivers/our)37.2 (-medicines.html)]TJ
0.017 Tw 0 -1.765 Td
(ABEPI.004/MG.002)Tj
/T1_2 1 Tf
0 Tc 0 Tw -36 62.565 Td
(\()Tj
-0.017 Tc 0.017 Tw 0.224 0 Td
(Continued\))Tj
ET
endstreamendobj28 0 obj<</BBox[0.0 792.0 612.0 0.0]/Length 527/Matrix[1.0 0.0 0.0 1.0 0.0 0.0]/Resources<</ExtGState<</GS0 23 0 R>>/Font<</T1_0 67 0 R>>/ProcSet[/PDF/Text]>>/Subtype/Form>>stream
0 0 0 1 K
0.75 w 
/GS0 gs
q 1 0 0 1 36 748.9131 cm
0 0 m
252 0 l
S
Q
BT
0 0 0 1 k
/T1_0 1 Tf
-0.008 Tc 0.008 Tw 0 Ts 100 Tz 0 Tr 8 0 0 8 36 750.2881 Tm
(ABECMA)Tj
0 Tc 0 Tw 5.6 0 0 5.6 70.5595 752.2021 Tm
(\256)Tj
-0.008 Tc 0.055 Tw 8 0 0 8 74.9928 750.2881 Tm
( \(idecabtagene vicleucel\))Tj
ET
q 1 0 0 1 324 748.8025 cm
0 0 m
252 0 l
S
Q
BT
0.008 Tw 8 0 0 8 443.2326 750.1775 Tm
(ABECMA)Tj
0 Tc 0 Tw 5.6 0 0 5.6 477.7921 752.0915 Tm
(\256)Tj
-0.008 Tc 0.055 Tw 8 0 0 8 482.2253 750.1775 Tm
( \(idecabtagene vicleucel\))Tj
ET
endstreamendobj67 0 obj<</BaseFont/LXQSRG+HelveticaNeueLTStd-Bd/Encoding/WinAnsiEncoding/FirstChar 32/FontDescriptor 68 0 R/LastChar 174/Subtype/Type1/ToUnicode 69 0 R/Type/Font/Widths[278 0 0 0 0 0 0 0 296 296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 685 704 741 0 648 0 0 0 0 0 0 0 907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 574 611 574 611 574 0 611 0 258 0 0 258 0 593 0 0 0 0 0 352 593 520 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 800]>>endobj68 0 obj<</Ascent 975/CapHeight 714/CharSet(/space/parenleft/parenright/A/B/C/E/M/a/b/c/d/e/g/i/l/n/t/u/v/registered)/Descent -218/Flags 32/FontBBox[-166 -218 1078 975]/FontFamily(HelveticaNeueLT Std)/FontFile3 70 0 R/FontName/LXQSRG+HelveticaNeueLTStd-Bd/FontStretch/Normal/FontWeight 700/ItalicAngle 0/StemV 144/Type/FontDescriptor/XHeight 517>>endobj69 0 obj<</Filter/FlateDecode/Length 323>>stream
Hâ\íœäÉ@∆ÔÛ9∂á¢µÌÿÇ≈v¡√˛a›>Äùâ]aá—|˚MLÈ¬å˘…˜£¢<ïÆ!˙Ω©pÑ¶u6‡–ﬂÉA∏‚≠ujùÄmÕ¯xÕ_”’^E$Æ¶aƒÆtMØ≤¢OJcò`q¥˝ó*zCÎn∞∏’¢ÍÓ˝vËFà!œ¡bCFØµ´;Ñhñ≠JK˘vúV§˘´¯ö<B2ø◊“åÈ-æ6jwCï≈tr»^Ë‰
ù˝óO≤kcæÎ†≤Ñã„òÒ^xœ|>o◊3S NÑÊçÜy'ºc>	üàµh5kµh5kµh5kıVxÀ,>ö}t*ú2K?ö˚—Öp¡|>ß‚ì≤O*>)˚§ZX•ûÁ1mû;0˜h¸Û ÁπÛƒ[áœø¬˜H≈W˝
0 mIûXendstreamendobj70 0 obj<</Filter/FlateDecode/Length 1794/Subtype/Type1C>>stream
HâlT}PT◊è›ΩÀóa}Y›}¨(e¯‹]êÄãX´çBx»*ÏÍ≤·´"-µâÑƒ*~LHì@å—®’®®•å§j«äë 1,£&4ÜÛÏΩãMúÃtÓÃ=˜úwŒÔ¸ŒπÁ]ñëª0,À.L›úëπ!9dµXT*⁄Õy¶u‚´bÍ∆L{~ÿä|ßÉVR≥“<π¥¿ì«8¥<ªˆ,O!Ò^Rú˜¿Â}∆≈	£c#í¨ª*lÊÌÖvA˚“K°tèçú›ç°Ç!2“ $Ê[sE!≥¢ƒ.ó)ñ<´mó’f≤ã˘·BbQë0\"ÿƒ—VÍ4˛HI0ó&¡n3Âã≈&€N¡Z §ö-V{≈.QH¢(·4hªô‚⁄ƒ|¡lÏÖ¢êû.¨ßËª`≤‰åN/(0Áâ≥∆bSÖ@9˝4:O¥ŸMTZ)åMÿÒ™Õ\íoŒ≥õ≠ñí¿-¶bÒˇ∞∞⁄3≠†à¬[JDÒ≈Á‰‚‹’·´27:ï(!_,`ñ.∆çet.ÃÜ	gòrf5√¨aò4ÜIgò,¶Éa|iw©a=ÛÛ7∆¡äÏ«ÏòÀ"ó£.ﬂ bdM≤Q˘&yÖºA~]°T§(ÏƒM®Îñu≥tÏñ’…•˝3Î˚	4b?è	pP	
ÿÀÉSq4+${ˆ	Hu"ıŒ:5ø‡Så.}∂∏åÌùRg¨ºU9òé¡˛ŸçÜ/pÅ‹I"ö¡ à8˙€†y9Âåî„˛+π ÈÏë[¿5ËNn„‚–Äå(D}"
Ón[)¡MZS∆ÓõIóÌÛ#π
FºI˙êäÇoŒd+0ö‹≈ï|«£
L#‹£:‡`Û4,ŒÁËiM°Ëz’S(Ö[<,'ü}lYëòUñ¶≈xÇz‰xxBÄØX<ñÛY‘;Zï4–yÍ MòqÅÜcf›Ç»’û™‰Ù\€F-	˛ï‡'ïÉ{Ù≤ô4…¬Cl9˙M†^çª—c±sÅJÿI‡V”b(	´ŒJ	Qc¿&Ó•"‡Ó?≤V“rÁÍ¿è˙rFa){Ÿ_È#s‘¯8|a“™w—ÙΩm•3Ÿe‘+H≤Bı§á⁄IéZÃ°RjT48!h&w48™µóI’
™r;™&„Ü&}ﬁdÉNuQÚÑ≠|—ÎFîmÀ=“€sˆËÖÕÖÉ›ıÌmÆ∏Ó)µÈ‘[}ÍÓÛ5Î2‚£ˆjç’F+∫˘‹˝Õ„kÉ«/]‘® Î+T6˝÷…ﬁ∂◊.]Úá∑î0ÁæàÆËëáÛˇ†·TMá?Ñ˚”∞∂Ãßèf˛=Õ|Eµßœ‘Due∞Aπ°Îö˝é˙? ÅêÅ≤ë¿µkK6jk·Íà‰Âÿ Gƒ«ƒ|˛ÂÉ”üﬂø:>JCãô¶òÙt2È<|≈É_ ?ENçÒ!ËÅ—Ò] L˛û–‚BíZ#öR‘ÀÿÌ;ù_ˇ˝tQFãˆ'‰úmyÌ99ieGõ®√#µ‰/;”;÷©14y‘jUWp—§£<ÿﬂ~ı§¶Å‘¬&~©56ÃX0:<˙˛ΩáùÀbûÛ˚Ÿ8∏L≥Ô9)û;∆CK·Á∏Rçz›1£æE9ƒÄ€hpgµËMv÷l+‹†éœ97˛∫v\~∂°„Ê∏˙FóòtÑ≈Õì‡:}>ÌC´ÜﬂÅZ5¨z$]ñZy§ù^U´¸ƒ¸Î∑ì’∏89ÙG› ∫Cƒ¿@G_ó∂!ô$÷oœäWoyÂDÔ^-toèóß‘P”	Å£Zl„£¨√∑áN›º7Òﬁ/cÛV≈iπ∂R©µÏpc˚i˝æ†ìZÈï–Ï[x⁄7–Ó˘H˛›Ÿ3¬U—∏ò«¡ üΩmŒQ£◊≠ÉvÚÙ‰üáﬂ1-’‡E™ﬂR¬<qC“”¨€5˚âjËü®Vrxè áìÏÑÛŸ;ÂL˙%ˆì¿;eﬁÌ™?–Æôrˇû™7ˆ®_Æ>|Y-ﬂM.RrUU ~,≈îΩ»,}ËÏê€ân«+	)∂Û£∏Hı[Júwf)Ñ|2nˇáöF¢*Oö<j∂f∂IjñIáùë¥U,~Ô¸ëX¯^Å¡~ÂhUÄÅ˛èYï˜‡ƒupπ>rè=6ÛG rÿ)Ÿ1x∆c9§`‰–ïAPeòK0áÆ\Çeö)_˙¸z”GB†B/˙Ù.GŒ•É°GoòÀ50E~í{»&+:.kMó;á¸ø^RßAY√ﬂ$g.ÔÀﬁ\∏o´6ëpï«g≤è„éV¯EÅ„-S-é°VÂˇåá]°£˘õf«øªMªÉŒc˙êß'ËézŒ©˜‰‡OÛ§Ô¯ˇ
0 "ë‘Mendstreamendobj27 0 obj<</BaseFont/JHWGPK+HelveticaNeueLTStd-BdCn/Encoding 71 0 R/FirstChar 31/FontDescriptor 72 0 R/LastChar 174/Subtype/Type1/ToUnicode 73 0 R/Type/Font/Widths[240 240 0 0 0 0 778 0 0 296 296 390 0 240 370 240 332 480 480 480 480 480 480 480 480 480 480 240 0 0 600 0 0 0 556 556 537 574 481 463 556 556 258 463 537 463 740 574 556 519 556 556 519 480 538 519 760 537 520 0 315 0 315 0 0 0 481 500 463 500 463 296 500 500 240 0 500 240 758 500 480 500 500 333 444 296 500 444 704 462 444 426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 500 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 800]>>endobj25 0 obj<</BaseFont/JHWGPK+HelveticaNeueLTStd-Cn/Encoding 74 0 R/FirstChar 27/FontDescriptor 75 0 R/LastChar 215/Subtype/Type1/ToUnicode 76 0 R/Type/Font/Widths[463 497 240 463 463 240 0 0 0 0 759 0 0 241 241 352 600 240 352 240 278 480 480 480 480 480 480 480 480 480 480 240 240 600 600 600 0 0 500 519 519 556 463 444 537 537 204 426 500 444 704 556 556 481 556 519 500 463 519 462 722 481 0 0 259 0 259 0 0 0 444 463 426 463 444 259 463 463 204 204 444 204 722 463 444 463 463 296 407 259 463 406 648 406 406 389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 240 0 0 500 500 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 800 0 400 0 0 0 0 463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 600]>>endobj26 0 obj<</BaseFont/JHWGPK+HelveticaNeueLTStd-CnO/Encoding/WinAnsiEncoding/FirstChar 32/FontDescriptor 77 0 R/LastChar 121/Subtype/Type1/ToUnicode 78 0 R/Type/Font/Widths[240 0 0 0 0 0 0 0 241 241 0 0 240 352 240 278 480 480 480 480 480 480 480 480 480 480 240 0 0 0 0 0 0 500 519 519 556 0 444 537 537 204 0 500 444 704 556 556 481 0 519 500 463 519 462 722 0 0 0 259 0 259 0 0 0 444 0 426 463 444 259 463 463 204 0 444 204 722 463 444 463 0 296 407 259 463 406 648 406 406]>>endobj77 0 obj<</Ascent 932/CapHeight 714/CharSet(/space/parenleft/parenright/comma/hyphen/period/slash/zero/one/two/three/four/five/six/seven/eight/nine/colon/A/B/C/D/F/G/H/I/K/L/M/N/O/P/R/S/T/U/V/W/bracketleft/bracketright/a/c/d/e/f/g/h/i/k/l/m/n/o/p/r/s/t/u/v/w/x/y)/Descent -272/Flags 96/FontBBox[-171 -272 1068 932]/FontFamily(HelveticaNeueLT Std Cn)/FontFile3 79 0 R/FontName/JHWGPK+HelveticaNeueLTStd-CnO/FontStretch/Condensed/FontWeight 400/ItalicAngle -12/StemV 84/Type/FontDescriptor/XHeight 536>>endobj78 0 obj<</Filter/FlateDecode/Length 505>>stream
Hâ\îQk‚@ÖﬂÛ+Ê±}(—‰ﬁ;-¡j>l[÷›ì—¨I„Éˇ~Á‰îV–|!Œ=Ø˘f∑›ı›‰Úè84˚0πc◊∑1\ÜklÇ;ÑS◊gÀ¬µ]3}ﬁÕüÕπ≥<ﬁﬂ.S8Ô˙„êUïÀ¶áó)ﬁ‹›∫·>Àﬂcb◊ü‹›ÔÕ˛ﬁÂ˚Î8˛Á–On·V+◊ÜcÙ£ﬂÍsp˘|Ïa◊¶Á›t{HgæøÒÎ6WÃ˜K 4C.c›ÑX˜ßêUãÙZπÍ5ΩVYË€ˇû[¡cácÛßéYU‡ÀãE∫$~$?Çü»O‡yﬁí∑‡Ú¯ïúB´í3KÃ,ó‰%∏ ‡í\ÇÖ,`%+ÿ»ˆd¶g	œíû%<À5yùXò+»Ê
rÖπÇ\aÆ Wò%»f	≤ÑYÇ,añ Kû…œ`ˆ#ËGÿè†a?Ç~Ñ˝˙Qˆ£ËGÈ¶pS∫)‹în
7e'äNîû
O•ß¬SÈ£Q:(å=z0Œ7Ã7Œ7Ã7Œ7Ã7Œ7Ã7Œ7Ã7ˆ`Ë¡ÿÉ°cÆ!◊ÿÉ°£ÉÕÏ¡–É±Cû=xÙ‡ŸÉGûûûûûûûûûûûûûûûûûûûûÈÇE¯¸≈c%“Ê∫Ø}kÆ1¶Uõ◊{ﬁ1lW◊áØÄq]:ÖwˆOÄ Åd˛µendstreamendobj79 0 obj<</Filter/FlateDecode/Length 4278/Subtype/Type1C>>stream
HâlUkPWÓfËÀà0 ùf—÷t*`A¡G 1
»*2(®(å–‡ù—ô¬Kç#A‹ıQ+à†Qâèàõ‘u]â∆e–u‚cyâ,nY‹”x¯±=ÏÊ±U©Æ[}œΩÁ;˝›Ôûsö¶úù(ö¶ﬂNåOõì<˜ùxiuæd—gÎÊIÎ•§T≠%gBúaæ√√WÊiy∏ÛF7'y§á—xÙÕï7ëåÏÓ!Oˆ›HˆåÂ‰ÂM˚≈◊öÙy+-bhTTHê8)$díõc\!â⁄B≥EZcŸF”Z£IgërÇ≈ÿ’´≈AÄY4If…îÔX¸ôä®7ã:—b“ÂHkt¶˜EcÆò§7-Ök%1Nâ¨ÄÚÙJ\ìî#Í¢e•$.÷ã…JtÉE‘rƒ‘ü—ÛssıŸ“‡‚]°®p˙t∂d≤Ëî∑Q	cW≠7ÈÕ9˙lãﬁh0ˇ‹†[#˝£I‘+'X≠Ñ7ò%ÈóÌ9kVƒOú≠Mu·béîKQ¥ÚPCh ]C˘™(ƒPa5ù¢ﬁ•®ô5ãPI•u°¢Q©*â⁄N]£^(0ñ¢ÀË≥NÓN;ún®T«UÌŒÖŒoÅIc	KíÕ‰GóÒ.3]
]ˆπ<WèVoT_8§b»Ÿ!Ø\WìkïÎ_á¶=·∆∫ô›˛Ï>ÕΩ‘˝S˜áÓ?j245ˇˆ»Ú8ÏÈ‚9ﬂsØÁÂa^√Ê€	 ÂﬁFºÂÌ˝…€	Ïƒ&ﬂÖ=tÒ
c`∑À Y>8áwQ±â|ôsÃ–ai–®AN…„]@?±´‡Eˇr=–;√ı∂
'¿à‰‘!ô‡∑∆úÇàì0Ò&L'Æ˛©≠™JL‚¿ºÄìv
&BDpÍ•‰Ù€ÖcVbƒ*úòÑìëF÷X˛ö˛∆©Óz7êmÊÕŸ
§¢·ft>t´˙˛⁄6f"—àPfß_CïÍ5îq∞ù∞3∏ù¸{\Ïsr¯µ√vÁ˜–‰’ÜRŒJ‰˝EL—îZÂ6+˝CúnS¡á•hØBå?!¿Ã˙:HA-è⁄TÃ¡êUNœ3`
hy	ﬁprÚ4¯≈eFﬂ¡Ì¿˜Û–)©#‡Å'Õ°|πÓ:®‚·®
‚Â:ﬁ!»‘1O	åÔOgÊìˇîM°€‘örª|’FÀô]*y©ù√k‰‡Ö”_ü?	C€|∫o]ªv(ıwï;Ä≈H«∆Ñ‡£–Næ⁄Û90@Û˜+Êmägdd≈/ô≥ƒg¬ú‡P#˙®e—q@8e˝([ΩæÔÇMù∫∂˛ œ8ˆ—9“^óY(†õ)~]?µ¯^sïF 63´∑öq*§0Úi'p«ˆ‚¡óŸó¢´’.ˆöã7˜ﬂQ≥≠≠6ˆa èøãçD˜u
ôÀ˙¸Y7´rQb©0´$saüI	 ⁄&K¥U^¢íÂÆÇÃ∆á∆ìò›\—tˆí<åVÙ8—ÃCRmc¶ëó≤ƒL§ﬁkÖ`;}∑>ÈP¡[îªˇ1s`g„Â|«æ®EB\I6:˚Ûvu◊ÔQ®ßl¸òŒC¿cPÅœ1è/|:ö_ö^∏2O(´∞ÅéÅä¡<π=ˇëR¨^è;aKWf+À_…_rlﬂ…›˚aFÒ®KAF¨–ı:\ È<¯tˆ¡®:Åïax]Vz3.ZW îë}cÿæ˙=0\˘ÎGñ'o∞Ôq¨|∑∫æÛˇ‚ì–ÿb!∂8+4åg˚¬∂uﬁ≠Lê;îúØÇÚ HXËˇDøﬂ4t ’/Iåmœ[@∑ºæ˚¨ÒRı˜>É‘œY°ƒÍeÎ¯c¥+∑⁄gá4.¯ÉZTCa∑A›]+Í1~;˝ÿÉ∫≥Á´Ô´Ÿ GR≠ËÃ£sd≥P˝È≤fÉöÌ1¶%Á9<.…ZÓÔµK‚KÖÑ“Ï≈s˘ƒ¢Fkï–RuÊb≥¬•ÅdÓIÕ˘õè˘«ìî‹â,\ñ≈G‹|R#8X•ÿ‡ë’ÎaGVlÈ`{üBà¢Á™≠%8
¢x–5Å"N	0Ó¯gJq•ÛËÍã£€ã√çgC¿É∑_ΩÚY≠PA6j=Û∂.«˜–ïüo9ﬂ¥OÄ/@—≥7¶8w“~¬éé{’¬ΩÍ≥Ì
Øˆ]ìbäÖ¡ áé‚œPAò<Ü˚_˝#5∞ÛßπÊk%'”mÚUyÅ◊πí}∞Ei=êŒ¿d/¶3œIvˇr]	€}júíÆ5¯í¡T¢π^nÉCVÿdÛí_,Ìa_Å∫π>Ú‡™ò/Ã.]ñÃ£«¡"Å=ﬂ¬ÿ/Ñ⁄vSK‰!•nn◊^iÆjV≥› ‘MkP<çƒ«˝ã<;ñ["†ìyÚÊ\~úÚïRõ‹c£_u¡ùJ+P[x~Æø»£¶F@‘óÇ2îôÜÔ⁄7{jâúÄx4Î1é„qq,j1^îQäZ»‰!§<ÅØ4ΩÂ6πEi/{{T––Ô≠h·Î1 ﬂ6¯ñq1Ü`?qêzÅÙ'ƒü`ÒŸ]é&•Mâ¢Zõ,v∫IÆQ5y∑ì;–∆@Õ`1’ê`a‡î√`à∆^j[–Ÿ‡åÕÀqíˆ¢¸Oπí´ﬂ}‚P˜+™©+∂·ò«€o5ﬁ8°\;[í?û±íVŸÖ¡u§$éÅ—ÑΩîüç„PÛ"¥ÌOåŸ(hÏ
ª^;ú+Pÿ˝C’?T˘QÖëﬂ„πˇ0^≠QQ]Wò…xØhê∞Ç«‰j5J|Ä≠DÉ&*Ejâ|TBaPt—‡HG)y1´`blB$b	B:j§†®d‰ﬂB€Ë>≥ŒX∫œ≈X◊j~Ù«]Îû{Œﬁg?æΩø}ñ!6¡a∫»¶<∫≈ø√2ƒ˘Ï.ÏYv±∆éB∞[v	¶`ÊßÀ°.xƒ’ôÂù:ÿ{ØÏPÏ°»&–PgÖ7E÷ 	b+<‚bZ}ª≈ÅÀH(CÌÂ–úÅX¯.dË¡ï©4ñ!Ωéäâ:õùç*∂ë_Ïb"däGüA≥0C|¡\W‹&Ê*™N≤Bk3^ñ@õ˘s
√'qÛhè*V∂ˇ⁄Üíè≠må¯≈TYÔ† S–;QrcˇÏÅk=JÍmâVøàù4ƒN(Å–VíQ∞®:ÇX(IFtÿÔd£ò'6Dœ®p|˚µåÿó`.Í±Tnö{ræázd)FÙ∑Ç6Â5_≤È˙≈Ñ˘ñ@W≈JlÂS˝#¸…o∞P˛J¿:{Ìnˆ}U?Wq	Æ≤x¶.˝Õ)â)”£ˆÁj]ã€Ûv…ª~Ï_=xaÎŸ%F,µÓ#_v∂€bè ñ…Ì.ô_Ù≥ÿQ·çµˆzÃ}ôÅiå√≈^hÌU“ZÆÁÚ∞Kl4aæAÃŸ7E
bo∂öÖ€ŒKˆı&Lùﬂy£P‚x⁄ÙŸLòC˙¡˘+Óˇy»gÃÓ4|`{ıP›©Vb>¬[íÊÄ=~]Ø§n5,í´$HLÚ¿Gd‰©á"÷Ωe|¢¢≥Gy¢‘H8µo√8czz8ﬂ<°˚0ìc¨˚Ñâöu+¶íÒµ?ó<˚jˇG}ˇ0s¿fáº„CD∏Ö˘wÁ˘/≥Z0ˇª®Ö˜?8§'¶––6ç-‹e!–v®¬`í”QFq£'"‘¢®ê•Xo¢ñRzS+≤yQÄ¥ÄÖ± ì≈hR‘PQY√'=1ﬂ$L¡√b˙˘;Ûy·X$ÉN>M˙à)æxÄy<5‚q|GI{mä)∞Ój‡%ì„π^X£™÷–·ÍÃBë·pÁmræ,&T'Ì
ﬂõ‰∑çŸm|ı]ÕÍê‰wl''V-Ì#ﬂ4˚˙§‹J~üzJ_IäK˚≥§ºF·„=È:≤Â@q…©ÍÑÛπ≈ôa#˝W0˚-ld±jUÌÚùaÀ…2]ıπ\)Á´√≈üû.m3VWŸ⁄oB~ªß•I—“⁄[J˙¶n ”√Pﬁ}=ﬂcÓlˆ”Äı'¶Å3ÅQ&z´HÚwlû∑ÄL8c~(ê`ÂÁﬂï◊ëÔ≥ﬂ—!:x£§≥Z`V¢„µ.ÿYÜû.Çb5å¨®Óh'Ω{∆éKê–∏ç”›àWF~ñ®]¶ˆW≤4åˇ_vÖ[Eÿ‰8∞Ÿ*1ØÀò *“p˛‘©"9“rDa≠	fòxãŒ¨ÑP∏¶6*çU`”MZóÓê“cÑV_µÒ∏ Cè¿8>i˛èSö¿ÂØπË‘∫¥è9d|98t Û≥0ÏòõL ∂(n¿è Nf±ènB*≈ÃªãyÕ¬…Ï‚¸§F,hñà≥WØôΩ]⁄ xÒå∑ãˆƒo°ì[kÃ›†-Wµ¡Uß~Çó‚#gN#9†Ë*íûEGı¨jPœUmZå≈N6⁄áΩ∆ﬁà∆t3Öi‰€Ûg*0ZoAu=rw ,—#6’f°lT
®ıU8ƒw6¿å„rµ“8ûù⁄´¨G7ÆSQh?tÈ”3‰ÍŒEk”§∑≠"´7©É–úW˙ÑΩNV˘FGD„ x“¯– )ÖV%˛„æ¢t F‘ "≠¬ù¬µY,æœœhÂ#~¢¢û&)°∫‘∞¬9ü§3=∫Úı¬s2eô≈jÌ2ﬂaáëyû÷s›º≈{öÊÜÛËQ◊Nò€´:”¸Ãvs·≈≤r˘€˝Îsè∆íÂA¬6Jˆn.[LBˇ·˝ÕËùÍ&qé8 ˘û©Ω™ìˇGÄ∆˛W≈ÂAàE∫–§∏“È› N;õº9á9É;∑ã‡ìÒÁkre*83w¬‹1g‹ó‡≠ûiË€£>5}∑HÔﬁâÃ6N¬g˝ƒﬂƒêªﬁj°≥∏u‡V;ªU7ë¬∞òÏÀèwﬂ!Ìôûlxoˇ<Ω»o<˛Wâƒﬁ≈y÷,~©ÿÔ>8XÛ5©Ê¢àÑ©[A`*¥n›6Ó¿D3:¿<0ë?xõ”ÎT«xZ‡∂–Stµ˙Rq„}Ÿí*Ôpá†:fH”e&ë•kWØå‚.ﬁ‡È
¡π.H∆6L_Q7ÁÇõF‹¶Øöò ≈3eÛ∂∆Ñ∆Ñf≠vgû±ƒsœwÀCÃ.◊≈2~§ÔV=ÚõTÚxIÈ“í%%˛πyÕ∂máöå‰BN§O
Ø…ÙÍjR‹ø≠Ñ`Z•~Vl<?ﬁ⁄¸ª»üKôí
.˚RS3∂ìà›ÖßJ|@∫√À÷M¨Çi‹ÿ¡óËÿéßE®…CV‚ïÏÛQ8ôó{ÒÛlâÉ¿CúmuvƒèÅ±§ÆÈìZyûã≈2«¨¸Ω#8P'$(wß˚"‰ba»¸dù/Û”|ôüıÁj®ﬂC$ßõTùÕuà∞ÒF^‚ÙêÛì?ı√|Ì∑˙aáÅt‘"Û”B\gà‹sYÄº0‚˘)Gäo5êì®»¢z%DA•ö≠eï\⁄¢öXæÕÑJÅ˛∑ ±† ‚∂≥Ö&À®DÖûï0[ßﬁ&ƒ$'ƒØ'ö‰˝ô;%Ëæ¸¸å*“¬‘ä3–ßÙ2ó_,ª£t'%ﬂûœñÁ√¯| ç]Fk}ˆ–§BKx!€îkã_˙å÷ªπ√L√Õ/7fee}bg◊Xf0ÿç†Ò#iÑ˙? É_u¿endstreamendobj74 0 obj<</BaseEncoding/WinAnsiEncoding/Differences[27/uni03BC/greaterequal/uni00A0/f_l/f_i]/Type/Encoding>>endobj75 0 obj<</Ascent 932/CapHeight 714/CharSet(/uni03BC/greaterequal/uni00A0/f_l/f_i/space/percent/parenleft/parenright/asterisk/plus/comma/hyphen/period/slash/zero/one/two/three/four/five/six/seven/eight/nine/colon/semicolon/less/equal/greater/A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X/bracketle\ft/bracketright/a/b/c/d/e/f/g/h/i/j/k/l/m/n/o/p/q/r/s/t/u/v/w/x/y/z/quoteright/bullet/endash/registered/degree/mu/multiply)/Descent -212/Flags 32/FontBBox[-164 -212 1000 932]/FontFamily(HelveticaNeueLT Std Cn)/FontFile3 80 0 R/FontName/JHWGPK+HelveticaNeueLTStd-Cn/FontStretch/Condensed/FontWeight 400/ItalicAngle 0/StemV 84/Type/FontDescriptor/XHeight 536>>endobj76 0 obj<</Filter/FlateDecode/Length 623>>stream
Hâ\‘Õä‚@‡}û¢ñ›ã&±Í÷-åNÉã˘aúy MJ'0∆„¬∑ü:u§F–ú¸y>.Iïõ›v◊wì)å◊f'sÍ˙vå∑Î}l¢9∆s◊3k⁄Æôû{˘∑πÜ¢L7Ô∑)^v˝ÈZ,ó¶¸ôNﬁ¶Òa^÷Ìı_ãÚ˚ÿ∆±ÎœÊÂ˜fˇj ˝}˛∆KÏ'Sô’ ¥Òî˛ËÎa¯v∏DSÊ€ﬁvm:ﬂMè∑tœÁøC46ÔœàiÆmºá&éá˛ãeï>+≥|OüU˚ˆøÛÛo;ûö?á±XŒÍtqÂÍÕ*ÂM ÷™Gﬁ‚xµÆêø‰¨öæ˘∫˜œ˝E⁄∑Uﬁ∑∏÷zf¸áù3œëÃ˘˙5ÛπfÆë7ÃË∞ÏOõîŸü6)≥;mä•cØCØõ1œê-≥EvÃYòôNßSfEÃô~ø£ﬂ¡ÔËw;˙¸é~ø£ﬂ¡ÔËwùß–)p
ùß–)p
ùß–)p
ùß–)p
ùß–)p
ùß–)p
ùß–)Ÿ…9ÊÏ9gè9{˙=¸û~øßﬂ√ÔÈ˜{˙=¸û~øßﬂ√ÔÈ˜{:=úû6õ≤W—´ÏUÙ*{Ω ^EØ≤7?À™œÁôΩä^eØ¢W9∑¸<+Á¶òõ“£(Áñﬂ•M≥Ì˘~`n˙|70∑¿πÃ-–‡Ù¯˝˛@Ä?–‡Ù¯˝˛@Ä?–‡Ù¯Ë≤’«>gãﬁÖÚ8z◊ÙØ·ØiÆaÆi®aÿ≤7m∞®<W,/i4kWs«¥lÂ•2ØWX©∫>~¨¶√u0È.|ã U≠@Ãendstreamendobj80 0 obj<</Filter/FlateDecode/Length 5003/Subtype/Type1C>>stream
HâlT}TWü!ôI$0√†FùA∂Å(Çµ¢â¥≠… AH0	XDZ¸™xXË—™’„“Z=Vˆî∂ànQ∫Äñ¢´K‘ö•ä£]\≠‚πÉ/ÎÓ€zˆ¨Ã}Ôæ{øπÔ>ìza8éO\òî± ÌÕ◊í¯¸bﬁfÃ÷ßÚE| RùÕö`Ú8∞á„§¬§ë4äFπœ6>ã&≠è∞rÙ˘	cn©0ôHÉ…1?l<∆`ì(<°»d‘hÁ&¨±zo·◊ÈÛ=GöxMNV~Nñ1¡\Xb1Æ…µq11öi\§F…≈Ã´yNWbµÒV.Ÿîm∂ö-"Å!åãœœÁÜVŒ¬[yK±Á˜Ä9£ï”s6ãﬁ¿Ë-k9sób4ôm%Ö<ó ≤Ñâ†5F´'g4q∂\û{+L∆•âÏ&ß7∏•ø£Á‰≥˘·√}	'∆ÙøËlﬁb”ã´Y§±pyE£’`Ã∂Õ&Îo‰&}ˇä(ÃŒ(fê/“õ¨<ˇ“º†`uRXx¢n©GôŒ¯L,)éa$Ü…«`ì«`≥1lÜÕáô1ÃÜa˚0Ïs;Çaµæ]ä≠t`ñä]«Æ≈◊‚5x+~ˇÓ5∆+◊kß◊-…
…áí.ÈÈ˚R7ëOl#ÍàÀƒ#í"S»?Àºdq2Él´ÏÅ‹_"_.Øê*ø6¬wD÷à}#Üº≥ºœz;¥"^ÒGEª¢OÒ|‰ˆë?èö2™lî}‘êrùÚ®Ú{Â|"|Ê˘‘¯t˙2æ≈æ?éVå.}xÙMïLµHµY’¶˙ßÍ9≈P9TçﬂLø<øø^øüiÜ^ıQe≥0–åã2∞YR)*Ü“‹$T£vÕÅè	Ë'áN”‡Q‹ªdnrÂÊ Q'ÖV⁄≥CM©Ñeg†ˆÃª°:Â ox$’
Û%≠´hÎÈ©nkk´÷≈ƒTËtÏn˜˙G.ÂÛI™∑Ôﬂöˇ˜°Z›!POÉ‚◊√á∏ê)>˛$,’+Ñ†ªØ∂)Ö¡ßxßK“)“çV2{Û˙‹Ã;≤æC;/]Uﬂ
ó)≈®g?Û_è€+Å%C+Èi»?MGZ5älEQ˜Õ|G∆C¿Ñ(5Ñ◊¬å0éyâ≤W“äRË˚‡ﬂ”A´Ü»à
öyõÏDﬂ†@•F·&4cÚ‡ÖÎ!]ƒùì@ê‡¢πEKÄ0∆Ü6Á8~qLiÆèΩƒWEÌ‹jãe 'ã°–é√gv	|ÊoáBQC¢HFÖ®0
IeÂã˝_ù` ÏË∆œ@Ö‰Ï†°¢UºD∏ûÜìJd⁄U<¥a=æ	Z$õ h;	á6…§≤¥Ã.‹≤„«úûS[Àh–Ì¸ÊñC:“!]92 öΩ•ÉéE$<£A≥&ÿN4Y4ÖlCCÿ6ÄFYz∞X®=∑Ê©¿‘K]æ(‘“öª∂ó§Íá2À®À€Éc #?î+K+ªÖÔx£÷:%¬¬n˝@Ói:z¢°Ó·≠±?]:˘`ÍÛÎÄü¡):R3NÚx5Ä_˝"9ıçúUÈ+ò%+àŸ‚#–Xµ¿ß_Ÿ∑√!ª™¡9«˘ˇ‹ô‰§∫ !	˙Ëì§ÛxF4ô∫.É•ö g≠ÌÍ`µõ…¸Ωh§√Ñé;@?»ly˝ S%£±Œöo.\QˇdDS—òÙh4J¸}ÎÓæ˛Káó-d®´ÿºº∑‚ë:ãÙd±Å˚› ^∞z·"]ÖÆ£$2v=v£ÿ^àΩÓx]‡g Üc∞CX7~‹	6ß§zÈ´€â?5¥˛ÌvmÃ	•HZ÷_œh…Ù#àÖŸ0µ$0Bz'Ω˝NIÆâŸQuÙTu£À/ræ·ÄtªÍk'òú	NjêÑx·k∫Æ&¢§ﬂÑl(
ÔGK ì°aÏ•Aò„›E>o¨Z∂Æå›—F÷ÔÇy‡ÕP¬π∫ïi¨ÿ.∫≥ÊŒ=—˝^MD|º5BÀRÇ÷zßìnØª?&Lï‹4\##“ÉıYìM»Î}N˛Ä‹S¿˜$‡çO€˙Z‰ˇpO}ë˜I;l¥´Íù…NHı∏2Ë∞F$-hAﬁ?˚l‘QÜ∏R˚Â©´j ÌHä§â…àå˝Ú›+&ÜzeŒNõ¶¶ K–—Ø]ëîlZ˛ÊBs≥˝‚—øv∞‘c$sß—7Î.ÙÙ‘•DGÁ•ƒƒ‰]∏…ˇ=›7<UJ‘I¨“@hËº˝h"ƒÄ~ÿ 
Ç ƒ+Ô)ª`2öà∆ù◊ÄO˜∑ßèÏg´t‰ö≠h>ã4∞8ÔT;+ŒHW*∫áñ‹ÓÍ:|€…RŒ√ëq¨8z–ÙÎìH{Êœ]-√óÜW24Ωp{≤Øo™%M`•ÖjTJÿeÓ8»ƒœ≥ıú(üÄ∑˚Ø~]¢ü›]M¢C“õó[DîÁDú∏$ÀÑ8î·?B˘ëxq3‡QÂz’aumãøã<ôºG∂†L¬E¢•C+	‰MR˝mAty= –RRy®“ÌPÓPµ;¡‚Jtâ˜*˙ÈAÚ⁄>$qmJãFí⁄ñë“s¶8µYq≤ÑéO::‘¿F4Ü1»L:Ëë}ı´‚ë◊ÃÕ9lêH^ÊÓ;Tﬂπ`èkÜãzDı¡‚´6Ωbc07)KA-v,ÊÄ∏(YÍ—›#â≥™X	‹ˆ‘4-œ_≠$îÙ“AKıÉÊ4¯¬¯èYÂπJáp—ÅˇóÓ™Åä‚∫¬ÆÀæ!¶n(√@eÌåDÖ(Tå`WD¢"ÆAåA©£¢·W4Í≤Ÿí5hA¿4H´àöQÖR◊ÿ¨W†cX)6¡h˝ª≥Á-«ﬁY–Dœ…9ú3º}{ﬂ~˜æÔ˚ÓùK6ÿ◊ßÑ@ª'áa¡ªQ‡<ı»E'ù†ìƒõ ]#a”M]B‘i+Ï∂¬;VE ÷S˙µïûÅ›Pn•ÂHû£Váä®„∞†=?}«=œÓü‹jânÅB‘Âß3≥l£¥U*ÂéÌÄp∫Úi1µ4†SYø:◊v@06w¢Ybhz8¯0lC¿{‘ó™ü-œ6ˆö7´XPüD ˝V0e!–£Ωn∆ÆDMT¶†ÅdÙÉûˆ€∞/ò*3Ì…YCxÌ…AD±’bó•®·utëëOﬁç]ÙN}ﬂ§]ƒL=˚º~G˙ÄÂe˝tÏ$w!ñˆ´n∫M
Üup^5ÅP˝Q•áÒ¯8É’Ó6ÙuIm•ßÌn¯)¨¬S\z≠6)¿¶lE(.FS\T6|ÿ]T∆ÑG_!t¨£]•«á‘Æ¬%ﬁ*åòò)]Ö—»bÃ∂Ã∆&!¬ÆìÆ»q\U¡H91∂ÃqKœ–|Èñäås“LÅ◊PÉl8l_«=•N-R'ja	R`n,°	B∏®ˇBΩ—QC∂‡„π Í<¨x3™¬"W|sü≥Õ† 0ÚFåÇï4»%–yÉ|Ô9ª‚è¬Àœ·êﬁ~Ékl
7´,{›Û˙ÒgÅù?Yz0˝óüõQò˛ú"Ü@Nﬁ1=#V–µ.ãU©"≤o,ÅS¨Ÿ≤§»‡æÅ	+ôæ,úP"|Hï∆5%K˜ÁçzH2K∑UÏº^ÍﬂÏl[s>™ƒE˚‡ﬂ’›VoPÕFGÊÈ9ã§ªaEÂqB0Q™ˆ∞mF‰ÿ¬˚ÿ+Ï5)V˙î/}‘◊t¥ÜÍ6P/ù¿^°˚°^†…ﬁ3c"xˆ&Âv|◊)–8BÔ¬»·Ÿ+∞èˆ“_¡rÔo?ØÔ‡Ÿkbu:k“ƒÕ™ÄÖ8¨≤ªq0◊ÍXën6ßs»Ã=á,¥)œ¡é˙ôg‡T2Ê_7·∑ºT‰(b¸6ƒ˛.xm„y…®◊ÓÜ Ïu◊K©ÏFòÂ	.Ê¢Á‚∏B«8Ï2”∆Hv\´!” ûTÒÑjŸó≤Ò0—Ûa◊‹ìÆ™å‰6RÌ?G∂ïRÖ£√}•.ïÒu˛O∏@∂ÁJ∆(•+!st1}ån„·ºLO»⁄Yèa‹«¶^¥ÇzB HMË|≥Ωƒ¨∞ZïVH!“Ïk/πk¶ë?€ªgUÇeK#uwJ|uÄõq[Õ—≠ﬂLnvØ±Õ!\dOÉª4Ç˚Ä9`¯ÆÔ¬gÎíπ≤y™Z´bÊdæ7À€ˇÃ¬;ÁöjŒVÛh?ôsäÎG4ïU≈Ô(¥2ªvÓ–Ák“ïU41∑©ñzƒ≈R5”ç€≥4)fqv›ó˚*´À¯∫É%ák]’i≤J”,0-ÀΩYÑÂ6∂y[…›/ÿk≠°TùˆjŒŒ≥y3h%◊IÿF≥ëIŸ€ê“¢∑Û‡˛‡íÉ/#„c„◊/œÙ∞]+€ñæœ•YqƒãE•ƒK/pˇÿ˙dH:DYÃoûå¡ﬁßÄπ¡kIÙñô·æEHàˇ‚”¶V.ä„üAá’r—ΩÑË¿£¢€⁄[Ó3ñ™ÛÇ&ÖeuÉu“bNK∑Î…ôÏ¯öDıœ¡ó#vñ™Ämi®Øﬂ+ªvûÆìëÀoö!ÿ¨8nÉ•»]∏∆U0Gˆ¿0[«ÅŸ˘ıåM«eÄ…É±8>ÿ˜(å˙
ß‰kC«¿≠ﬂ0
pK3±(:Eeßß(•ıô€…ÒÚ}«¯ñd˙öï”Ö˘a:+£NCZ‡õô4±%⁄ÇIΩ.buÿÎê.m‚úœô:Yª=Œ$ˆ{Xÿ¬Öˆz§û9ïüT≠°£W·44~ˆöÄ›Ù\µ©\0Fê‘‚ité¿+Vh‹)h	ıﬁú°V√:Z ÿ)Uiì\Iﬁsî®lFîÑX€>3}˚ÁπoÚ"JnLª·Â≠[ë¡^£‹ê§⁄¨ˇ˝†h±àR≠ñtªà?8∑Ë|Kb¶}%Ó∫∑ä¨	∆Iµú÷—L)q˘∆˜x6;úaME••˙RÕénÏ%.Z—ŸöÒXX&£QBÙp†Ödπ5-¢ï^
”$ã†#óEò@ÀQÅO[„ {≤V∂ 9'πéÌ"Ãíˇ<F≥çÌŒƒƒ∂ON\~íaûYÊÈì∏:i3ﬂñõ˙Iî&n…ÜeÇû∞]Ì°Ã`≠‰sù•bMøX+gèq◊‰8‰ï4€¨®±A™MYÉD•˛u‘a“	ßL¸WÉ2i“*4{…:njÓp◊Ú;7zÀ¸®+uÕÒõÇóE3·˜i⁄‘eóSó†ﬁoª%sÂ≥BPòÔÛ3p»°¿Hñ0≠?´·ºÜ≠'(TîçNJI…óÎ7Àâ˝¸‹AEuA7û;6«ÁUYG<å@÷›⁄Ñ∆±C>ÌI°€•”3ıÉÙc©äQﬂc‘Ñ≥¶ö3Ú8§¶IX¥Tqk÷!ŸIÿ6¨Ùëõ_◊ù™ﬁ≥´Ë#û-Ìfÿ∂‚ÌÔs5ﬂz#~≥™¶_¬¶8´Ê˛WÒ"LgãŒ^•í^‚⁄ã
aù¨ôñËGïó≤/fÏÕãÊºpÔôQ€6Ü‰¸˝"Í0∆H50ÔŒïfP=‘úWÖÕIW•˚∏›˚jkIu[yj§¨œBãÙäŸ)N‰(Í–AHDÂüz˛VUl‹À_fäﬁ+–ÁhV‰óù†ˇñyLF\ÉÓ≥)Î	§ 'ø		[vÚÃ]óNÚ—:‹ò˘Ü1‡”t·PcïÏÀˇgΩ¸Cö√8Œq›Œjç–nà≥õJ°ÀÃ¨b”rk0ò“˙CƒÅê¯GâÖ"Yö9±-D.…Ëá(ëÉ(6¨`09®Ü$¨êbgë‘Ûé˜Çû;˙#Ç æ‹=Ô˚œÀ˚æ˜|û˜¢å}¯€QÌÄé3Ç¨÷ºÜ4!≥:«*’FdO%i‘)vpX9—K<
"l,_Ä≥òDÿ
Ò ¬VUè∆°"Ù‘vªCÜ#¯© pXo;∞ç ≥Î%"50É†•3Ë¯∫æ”.Ìﬁ∞f†∆0¢ç∂Ä-¥ù6…˘íNëÖ∫A°øç;πØß”“€πduÛ◊%ih÷ÚÂ∂º8iÖZÚ
ùjÙπóoŒΩ¯“SŸG§SÄ~Ω¶Vpn»eËBD‰^”∑ºi"fòÑYàl#·å∆ÚNa2@ÿ‰[÷•(Ÿ¨¢∏≤6õÀeù”ﬂóˇ›óˇG€2èPh¬:(MÜß,˙>hâ˛ô∂’‰–<¯ÁôÑˆf‰Ö‡H{sπt:óÛ¶Ø◊!ŒõìÒx2Ô:¥'ûMr ˜RPúZK1d∞ÀÄI{ØÃ¬<o`§N6–›‡„‰X‚·RI.∏Z§uô∂
Pº¬?yÚ{ŒÑ}V™ˆ4NÍÑ  	∫≈ûìQ8NÉ"^%ZOK¡
(Õ÷£J©ï6†4[o5mL?≥D¸,Èô‚s‘∫:Ê¥z{Õ¡ ∏©Æ9lA3˜ﬂ÷2r+¡êäõ$ãÇèáu⁄ƒa˝æNOr>ûî√9.¡è–!°VùÂMz
’à∏p:Sò]ÜZ˙W.¬Uµ{3€¥„∑ºﬂØ˝ì≥∆¶¢O[têÚÌmï`üdÄª±1ı˘Mæo"ﬂ>Aª«p‰sL]ﬂ.ÔXﬁôäF£˜ç∆‘ù—Q„.Ì!!·ß  ∏?ˇUendstreamendobj71 0 obj<</BaseEncoding/WinAnsiEncoding/Differences[31/uni00A0]/Type/Encoding>>endobj72 0 obj<</Ascent 961/CapHeight 714/CharSet(/uni00A0/space/percent/parenleft/parenright/asterisk/comma/hyphen/period/slash/zero/one/two/three/four/five/six/seven/eight/nine/colon/equal/A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X/Y/bracketleft/bracketright/a/b/c/d/e/f/g/h/i/k/l/m/n/o/p/q/r/s/t/u\/v/w/x/y/z/bullet/registered)/Descent -224/Flags 32/FontBBox[-164 -224 1066 961]/FontFamily(HelveticaNeueLT Std Cn)/FontFile3 81 0 R/FontName/JHWGPK+HelveticaNeueLTStd-BdCn/FontStretch/Condensed/FontWeight 700/ItalicAngle 0/StemV 140/Type/FontDescriptor/XHeight 538>>endobj73 0 obj<</Filter/FlateDecode/Length 554>>stream
Hâ\‘›j£@{üb.€ã¢q˛-H M[»≈~∞Ÿ}ÄT']acƒÿãº˝ŒÒî.¨êxD«˘qd¶‹ÓûvC?áÚ˚tn˜i«~Ë¶t9øOm
ØÈ≠äU∫æù?Æñˇˆtã2ﬁ_/s:ÌÜ„πhöP˛»7/Ût7õÓ¸önãÚ€‘•©ﬁ¬ÕØÌ˛6î˚˜q¸ìNiòC÷Î–•c~—ó√¯ıpJ°\Ü›Ì∫|øüØwyÃø'~^«ÍÂzEL{Ó“e<¥i:o©h™|¨CÛíèuëÜÓø˚nˆzl¶¢YΩ‰á´jS≠ã¶Æñ\/Yô˘û˘˘Å˘y√ºAﬁ2oëüòüêüôüë9W>M‰\s≈Û
πfÆë#sDfA¶-¬çŸêùŸëié0Gö#ÃëÊs§3¬)4BÉ¿ 4BÉ¿ 4BÉ¿ 4BÉ¿ 4BÉ¿ èÃè»ÏP–°–&ãç
:v(ËPŸ°¢C•_·W˙~•_·W˙~•_·W˙~•_·W˙~•_·Wöf•S·4£¡`0£¡`0£¡`0£¡`0£¡`0ˆfËÕË±≈√ﬁΩ{3ÙÊÏÕ—õ”Ï0;Õ≥”Ï0;Õ≥”Ï0;Õ≥”Ï0;Õ≥”Ï0;øª„ª?‡=uUcÆù˘Ñ˚±2±tÛ>˜Öˆ}öÚñ∞lCÀ^Ä]†“ÁN5û«êG·W¸` ÙWÂendstreamendobj81 0 obj<</Filter/FlateDecode/Length 4692/Subtype/Type1C>>stream
HâtT}PT◊ÀÓﬁƒ«≤èGq—∑O≈:≤e›0÷bTD*âÑÈ≤<pvqwÅä!“∆(¨NM1Çµ∆ê*~E%⁄(j!ZïÑ`¶Sùç∫ûááLzÛ’Ø?ﬁ˝zÁ¸ÓÔ¸Ó9G¡®|ÖBaHIZΩ,cπ1I*.ó‹6´eÖT&•Æ rD..Xbü0ëß*‰`ï<-Ä«ht?=Û4[- 1A7¶ÜƒÍ%b|”evõŸo^‚(›Ë¥≠uãœ-X`˛ôe6GâÒé|IÃ⁄ËrK%.1Ÿnu8KNã[*0âÒ≈≈‚ÑÉKtJ.…YÓ=¸ûëhsâ—Ì¥H%Áz—Q(¶⁄Ï˜∆RI\BQL‘©»FqùRÅh≥ãÓµíòm 2â›Ó-ˆq’˜ﬁÈÖÖ6´4qXbŸ(RNˇÓmïúnù∆)Æ+s⁄\6´€Ê∞ªæ∑[J§ˇ¡¬·m4Çb
owI“øóï‰'ôÊ&f≠ÚnÊâR!CS0a?f2À3#îâaòE≥ÿóId‹”∆(j&Õ´n≥ÇπKŒVlSº´8ØP<ÙY‰ìÔsRiV⁄ï∑TÀUUj¢.WÔRøØíCﬁ%√^≥PÛñÊäÊæ°æ+|mæÙ˝÷¯]ÚèˆÔÔü‰;)j“¶IG'›	`≠ﬂL^2πyÚcˆ9ˆ˚U`P`J`^‡Ÿ¿Øµâ⁄6Ì7AÉ˛4¨õ•K◊Ì’p°\<g·ûp∞ØÆ[ÌV–1º[Yßík«2∆k	4‡_x\;’0LPƒs<x7„;4„$obãêÓâ|ñ˜Æ–ªcYË©Ä ãwÿS°k˜‹ÒÄñ‹âjn†ZÓÅd˛zcggg£uiLç’j≠È¶◊»∑•Å¥mΩ¿ø°µ®›êÜº@˝∆c`¯ˇxˇê{Øz«¯i˛.ë#∆j’QÑ≈d¸E˘”ê
E7Ñ*aÂX?ÕåDQè‚1å¸ÕÇáDÉ±ò¢«Í!ˆ üÅQ¯¡ıÀS}Ü∆É»c¨cãëèF#ı˚Ã« D=ààúfÅù'ü¨Ä‘Õt[	&zkêÌt∆kçõŸ∑Ê÷£[3˚N≈=zˆ	≤V5kÿ:0+zË5=`Ê—|vì¶∞≤hÌkBÇÊ…Ô[oyÙ¢aE®≈	ËPûÄ<˙C¯ˇß#ÑÇY√‚¨ÂcïäZ¯\Y[≈Éä ›´QEÿÜ™˘‡àb/ÑÉ¬ï0_‡!e˜˘ÀΩoÊc¢∞HÉ)/g•¶m:
âÜ‰±Òå	‚†h$√–ò3åqXTç)ò#∞oóÀµ#@h®)^¨¡ê±úÈöÿ™Ã¢»∞W"a:Õ$∂°TÚ6ÔÖDP#˘EPÒÿLv¥Ô?rÏß7Cán∏¯O=∞	◊q„Ò'B)ö[ØÔ∏¸∑∞ì≠ˆå≈’ÎSW2≥’3"rÊ°N/'MDõG6ñCÌàÆ¶qœ†≥¬π¡f∞ÚµÎèÜi˜>‰ÅÄ{w◊^17Í5‹Òæ›Gœˇ]Aq0ıÒ	h îÙÌ:’€’Rö,pÉôeŸÈBn$·>9Eõ2S”~ª:!µÍ‰Ì≠oƒ0õî]°hàﬁåzﬁ‡Q$4æu=¡Ì„A<l«Ÿî—Ï~P-ì≥q¡Õ„Èj ˙>∏@ï{PÈºäò(ﬂ”rÏX
?Æ&‹–Üq^<·Nwnoi=vuÔ:Ùõª·•Ã¥W?Í2†ksÄ>{§ú|sAUß
‹–
À¶¬R√V≤~ÆÜ¶gÍ¥{¿4¢k¢œIu·Ë=è9YŒñ[yò∂’t|VæRÉYòãÒ≠/∏«u˝sò\ÓÍ“r]Ö.√÷ÚËçÅÅìOÌYüm¿ü‚%˛ãñ√ÓÒ˘…∏’Ù''U8¥mBπ¥ä9IŸBB-ú—†3“±®„|¡HˆAn?8¿¯ÇèfÇ&Müú	öÙÈ™Á≥'Â6A.ˇ¸úBìÓÖ0eËÆı⁄¬7˙~£ÕmWœË¡sû÷"ìÖÜú∂îÅ
a´Ü{∏pì5!Jœç“‹æ∆_Ÿw®´kﬂ∫Â…éuã„–_Ó·fÏÁ˚˜Ù\Ω∫'{YRÂ™îî ˙Ñ	"&¥?#¬Q"ëzçÑ<N≠˛’WaJ#¨Ñó ﬁ	QËï£ñöq>r]ë†ÎÌ⁄ˇﬁ~CΩçÃ‹'p£k*ﬂ9GM™°óˇtÁ≈k}ª2û]0ñI+≥ !xK§Ô 6ƒ[≤J@R}ªb!6hG®ñ]rÉ≤ŒÒrh«ﬁS}ªbi"¡nÇ∂ÆBW'ü„>ÆSA9F5¨$áêN3«Ú‘òH∏·;®ÂÎ…GxSMSï¨Û¿˙˚êÓ—u?Î¥Ä"8π;jMÑòFAu/ÁbÃ.o¡»◊õˇ¸·«zò6ˇ˙¯ÅÈ¸Yr˝êsYRQiå!üÃVıR∑À]ÆËË\g¢!ã∞´<rªG◊A—óRtÅ 9Ã=êk‰˛—À`ƒ|,.Eñ`I;ö†X‡Ü!Û0Lì√	ö§“’i%G†Úˆ‹∏!pÆæù7”¿é÷y‰m≈
öJ;…Ö® ê’CªÛÔ†∞¶aÆ´'ÿ]"‡Ûáh˙:ø¨HùmXNÿ∆:™’*˙≈–JcVv”∂¸uû	˛∏ó˛ÿBÁ-ÙÁNoG≠¢⁄^˛±mΩÒÚèm∆gR´<KÀ·¸∆£;Ní@ò„·∫h9◊À€xòµ|£05q÷u`(¸ãÔ*çäÍ»¬"æzê1}œ&=›ÊuTÇéKƒ—Mı  ´ò∆(AE¬*söµ’—C@ç∏4Çä(((@≈%Çƒ$8B2&ì¡0aÒ>RÕ9sÎ5h2gf~pËzU∑Í´{Ôwø[ﬁ¢–ÿﬁt¨µJõKÑÙÂÉíí&=ˆ‰Ö∆%¡7ªg`Qx|Ã˜:E°È⁄±e°Z9»ù(|eLªúÒË,ù‡A;¡yh-u¶e‘ –i
öP¨Zõ¬‹cNlrx-^∆0846≈¶ skõ1„≈Q«ón€∂ÌtóXBU±<wf:Ãóª7a¶(‡m÷Ωû{
OçÊØÙ¿Tää°±“LÖÎu%®µújâ¬Ä^ñz≠fRà˙kü‘kÖáÂÚ‡lsTì”+ò˜R{.¡“Œ1Å§v.◊“*Dæô8[r8#yM ·hQÙè¬Q¡F¥Å§í≤ry≤dq‡éF*ã¡H®ßd‡Xl0˝lX˙≠A,’0§…4à=ÅE7‚·u;íÖòûNd˙Í·C”€XÉûnnÜ/!XT‘aj!nP¿¸— ‘‹'0ÒØÌ0Ìi¯SÍ¢•{‰¨k#˜Ãx{Fmd)áÈOÍá∆ZiÄ8ÑBA'ù›Æ\ÚGÆ±cﬂﬂ·Eı¿
GP)Ã…-è√πªÌ±tÁq8yRZ•¸Ô8Y¶¥@§ï–ÓHπWÒ<	B•'J·I˘º:f˘í®8≠?°Œ%.j!Çtü\;æ9(WªõæíìêóhJ˘-∏Ó%â¶èk≥ø6¬åÃÊﬂ≤√
§ß∞Êˆc‘Ëwn≤
pÑ(Í¨¸.¡É‘≤còƒLzK YœS’Ì•∞Pæ◊G0„˚Ñ:ıÀˆÁW∂ıƒyu]·πœE·~Ki‘2-àG	ºÚzjÒD7/‘ãﬂ\Ö	Ôã¬ècN%ØP˚ØOxij}ªXÃÀ”ã§îôpê5V/Ä´•úÒ´+cÓk≤ü!À9ñÎªx∂Q®:ˆ`{Và“.t¡.ﬁ+=tŸ≤Ù+_‡ògqf	ñ'Ì∑ÕC#p^À¡J¬ÚäC˘ûd9ŒeÈ8ßÄ”üÄ]ƒñ;Ó ∞WqÇ§[*@ÒÔ∂p8 'f&·å…B4ƒ·By‡aåRlØTbãÂlXI}Ë0s…?`◊?È.ôd>0ãaê£sà+ÕòùGıVC¿ `WZº9ZÖwÆ‚a•‰Õ89ïñ„Q≥†úS`ÙÚ∞È€nÍ´Ñ¥Å…C~Ohy>	∂8ªWû˝Ÿâ¶M}2Ï7À¶°/@/â˙á}éfPQkvZB∫†á7%{e_WbÆk(⁄π…êπ]|Sœ	ç3ì"#]‘ÔT-˙ÒN≠©ı§à≈Nø;m∑>?›€,CeVÈE5úÊ˚c;®˚∑ı‘A‹ä%;¶ç Ä˜í7nÃ¨:w°‰DÎA±pwi˛ìù¢‘08˚<∑«‘Ê◊@2—e%J∞?ÿv£Ì†?µßˆ€¸˝˝∂µÅΩHEä3*l¢ÆÊÚ·5˙fpóøË¬æ•\X¥~]º÷z6√v6e∏Î$¨+“rËWÇ∞ºá
Tp]Iìhlñupπ˛ &â®ÃÛıQ+∑µ†P9hÎ∏º?(L¸ºSœ‡-Å◊vcûüø≈è¡√z%RΩë‘«Gáiñ;™ó–Duó›ÅkÆ)æXÅéc¯¿„ò–˜Kà9 JmÇ1tıK†jı>¨:pjÎÑóˆà‘Å,ﬂô°Yù~Ûñ∂ûˇf\1Ò’ñ´˚#Â±g“(†Ô/Y)é]∂∑À	D)†ªÔçFRi:XõüˇIv>“Ûoº–õª%9gãfná”µ~ﬁ≥:yE)ı˝Û<pnÑÔÕfïM§/cUûÇYQùRµR®Ú7Ú≠I∫¢:=ïN£é4ºÂ-{ææÏ¨YõÎEÇS÷â¬ŸÙåΩ˘[µBÚ÷¸ù¶"5˙V8;˚Nrt¡≠ª0YîˆÒB-ßµ®§ön¥Æ°/ª¶˚ÆZµ˝ŒWËsºA Û∏Kà∂x"meÂçÁäÙ!¢Ö«;M·W7.X•˚}DíhÑq4¨N˘k»%4∫ƒ.^çüÔåCÎÿ|©º VßXXÖFÑ9|”m‡i3-`˜ÕQ¸≠•úQzëmÃH9∫+/ˆqU'ÛÉÈh˝õ0Qhí—>%7ÕÁk∂¨-„Ÿòˇ’X“ˇZw’uEx|†^4íñÃàJ_Õ™u)k¢±”zZ®ä∑˙attÉpˇ¯A¯LˆDxrh<Ó%‹ø≈¨ŸSP—gcFãià€å)K˝¶¡‚<Ê6ˇÑÛè¯â.Œ““π!”®ØñU∫±{t¥c÷©”ÇÉﬁ˝Ëå≈p–ŸzpÑß£P˙ˇE-(d"Ës…∫Új˝ÂÇjÖ+GC6Ë√„Œ˛´Ú-π˝©g€ﬂexüÎ9ŸpÛqr0ßzç¸≈∏≈!#≥ÚÎruq}9va
ÍåtïAÆ,¬Ê="‹Ö.˛^ÛÒ¶ÇÏl˙ïœŸπ#gß&0jsXÛ˝ô{UåÏ=«Rp†„—˜é÷ˇ¬•‡•LÂùÎﬂ≈±˚S+p=ûü_é°q7sÜí2uM≈—Íœ'Üà‡PB˙ZÈKtrêÁ‹•µ∫ÆD‘Ω˛hÓƒJ3¢’ÎÙÎu[*≈"I˚—Ä'£≠LŸƒ.dÚëﬁ@4‘Êhå9iŒÀ´‰≥wlœﬁÆ˘`GaùŒ#ß±øykëíSû%J*|Õ0L~:D¸ì‚uëi≈Õ¢ƒchX∂L∫§˚Ó⁄≈cW Yäë9a≥GÚ±ÖTò•4í%íí√û¥ñjÊ–H’≤¶A
>m®F/9Ç+>K>ÚVÉÉ.¢€%GT»/,éÃ!`«,0@áV‡#Ò¬I:ù,ìælÄªeZœ˝T
∂ÖiºÚmpìO}ïö)Z¡Å3ÈØnÍ≈~Q®¿˜£â≠PƒPØÈg+‰Í•l%0°≤¸.h¡I fõ{[Ï§7$;y«xè˜>NMX≠˘7«e“0Ña⁄&_˝âﬂd:tHA)ò—°É…,:;ÈR8YA\Ñ“•∏Xá§CtR°..Í\p”BiA0õôäƒN·Mπ^ÂÓn;ÓÆ—h›4Jrˇ
˙P2w©Ã›R	Öj5å‘d¶ê'O5©Ú;H3C§π!ôfh«q∆±ö¶mõÜƒg=¡≈‡wûd∏ßàPå∆Pr¸FlÍ*]1¶ä˙#6∞•ˆºóßè‚◊¡Î∫¡;<⁄÷ﬂƒ„Û’·—YÛ∏¥+®™ìã,8åÖseë√pNé•¿„ëÖì…íFefnìôÁeC z0≠¥`-∏˜æΩYØùøÏL´:Ò8ôx≥±øò,¡X¯æÎ∫~W”&l∑Ì∫⁄JKìhÆ¶Á˙ü  ˛L endstreamendobj24 0 obj<</AIS false/BM/Normal/CA 1.0/OP true/OPM 1/SA false/SMask/None/Type/ExtGState/ca 1.0/op true>>endobj37 0 obj<</Length 78626>>stream
q
/GS0 gs
0 TL/Fm0 Do
Q
0 0 0 1 K
0.5 w 
/GS1 gs
q 1 0 0 1 36 378.576 cm
0 0 m
232.781 0 l
S
Q
BT
0 0 0 1 k
/T1_0 1 Tf
-0.017 Tc 0.06 Tw 8 0 0 8 36 727.248 Tm
[(In the )36.5 (ABECMA arm,)36.5 ( the median dura)-10.4 (tion of response \(DOR\) was 14.8 months \(95% CI:)20 ( )]TJ
-0.014 Tc 0.064 Tw 0 -1.044 Td
[(12.0,)37 ( 18.6\) in pa)-10 (tients with partial response \(PR\) or better)74 (.)37 ( In those pa)-10 (tients with CR or)-14 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(better)74.2 (,)37.2 ( the median DOR was 20 months \(95% CI:)37.1 ( 15.8,)37.2 ( 24.3\).)]TJ
0.049 Tw 0 -1.764 Td
[(A higher proportion of pa)-9.8 (tients in the )36.8 (ABECMA arm compared to the standard regimen\222)55.2 (s)-17 ( )]TJ
0.048 Tw 0 -1.044 Td
[(arm died within the \037rst nine months of randomiza)-9.8 (tion as sho)-9.7 (wn in F)18.2 (igure 3.)]TJ
/T1_1 1 Tf
0 -2.413 Td
(Figure 3: )Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
5 0 Td
[(Kaplan-Meier Plot of Overall Sur)-17.8 (viv)16.2 (al \(Intent-to-T)74.2 (reat Analysis\) at)-17 ( )]TJ
0 -1.063 Td
(Second Interim Analysis)Tj
ET
/PlacedGraphic /MC0 BDC 
EMC 
BT
/GS0 gs
/T1_2 1 Tf
-0.01 Tc 0 Tw 0 8 -8 0 48.3982 532.127 Tm
(Overall Sur)Tj
0.01 Tw 4.257 0 Td
(viv)Tj
0 Tw 1.082 0 Td
(al Probability \(%\))Tj
0 Tc 8 0 0 8 120.251 490.3094 Tm
(T)Tj
-0.01 Tc 0.452 0 Td
(ime from Randomization \(Months\) )Tj
/T1_3 1 Tf
-0.028 Tc 0.028 Tw 7.2 0 0 8 38.9632 481.6605 Tm
(Pa)Tj
-0.009 Tc 0 Tw 0.897 0 Td
(tients at Risk)Tj
-0.01 Tc 0.01 Tw -0.861 -2.786 Td
(Standard)Tj
0 -1 Td
(Regimen)Tj
-0.029 2.306 Td
(ABECMA)Tj
ET
0 0 0 0.25 K
[7 7]0 d 
q 1 0 0 1 68.4059 580.24 cm
0 0 m
215.355 0 l
S
Q
BT
0 Tc 0 Tw 7.2 0 0 8 61.544 512.339 Tm
(0)Tj
ET
66.689 515.076 1.717 0.131 re
f
0 0 0 1 K
0.288 w 2 J []0 d 
68.406 515.076 -1.717 0.131 re
S
BT
7.2 0 0 8 58.0882 525.353 Tm
(10)Tj
ET
66.689 528.09 1.717 0.13 re
f
68.406 528.09 -1.717 0.13 re
S
BT
7.2 0 0 8 58.0882 538.253 Tm
(20)Tj
ET
66.689 541.111 1.717 0.13 re
f
68.406 541.11 -1.717 0.131 re
S
BT
7.2 0 0 8 58.0882 551.279 Tm
(30)Tj
ET
66.689 554.136 1.717 0.131 re
f
68.406 554.136 -1.717 0.131 re
S
BT
7.2 0 0 8 58.021 564.4125 Tm
(40)Tj
ET
66.689 567.161 1.717 0.13 re
f
68.406 567.161 -1.717 0.131 re
S
BT
7.2 0 0 8 58.021 577.4294 Tm
(50)Tj
ET
66.689 580.178 1.717 0.131 re
f
68.406 580.178 -1.717 0.131 re
S
BT
7.2 0 0 8 57.9912 590.4449 Tm
(60)Tj
ET
66.689 593.199 1.717 0.13 re
f
68.406 593.199 -1.717 0.129 re
S
BT
7.2 0 0 8 57.9912 603.4693 Tm
(70)Tj
ET
66.689 606.224 1.717 0.129 re
f
68.406 606.224 -1.717 0.129 re
S
BT
7.2 0 0 8 58.0879 616.5714 Tm
(80)Tj
ET
66.689 619.237 1.717 0.13 re
f
68.406 619.237 -1.717 0.131 re
S
BT
7.2 0 0 8 58.0879 629.6012 Tm
(90)Tj
ET
66.689 632.266 1.717 0.131 re
f
68.406 632.266 -1.717 0.131 re
S
BT
-0.06 Tc 0.06 Tw 7.2 0 0 8 54.9944 642.6146 Tm
(10)Tj
0 Tc 0 Tw 0.9 0 Td
(0)Tj
ET
66.728 645.286 1.651 0.13 re
f
68.378 645.285 -1.65 0.13 re
S
BT
7.2 0 0 8 84.2193 501.733 Tm
(3)Tj
ET
85.875 509.609 0.129 2.39 re
f
86.004 509.609 -0.129 2.39 re
S
BT
7.2 0 0 8 110.022 501.733 Tm
(9)Tj
ET
111.659 509.609 0.13 2.39 re
f
111.789 509.609 -0.13 2.39 re
S
BT
7.2 0 0 8 97.1205 501.733 Tm
(6)Tj
ET
98.792 509.609 0.129 2.39 re
f
98.921 509.609 -0.129 2.39 re
S
BT
-0.06 Tc 0.06 Tw 7.2 0 0 8 121.4115 501.733 Tm
(12)Tj
ET
124.606 509.609 0.129 2.39 re
f
124.735 509.609 -0.129 2.39 re
S
BT
7.2 0 0 8 147.2145 501.733 Tm
(18)Tj
ET
150.397 509.609 0.13 2.39 re
f
150.527 509.609 -0.13 2.39 re
S
BT
7.2 0 0 8 134.313 501.733 Tm
(15)Tj
ET
137.494 509.609 0.129 2.39 re
f
137.623 509.609 -0.129 2.39 re
S
BT
0 Tc 0 Tw 7.2 0 0 8 159.9 501.7335 Tm
(21)Tj
ET
163.247 509.609 0.13 2.39 re
f
163.376 509.609 -0.13 2.39 re
S
BT
0.02 Tc -0.02 Tw 7.2 0 0 8 172.7295 501.7335 Tm
(24)Tj
ET
176.148 509.609 0.129 2.39 re
f
176.277 509.609 -0.129 2.39 re
S
BT
7.2 0 0 8 185.631 501.733 Tm
(27)Tj
ET
189.053 509.609 0.13 2.39 re
f
189.183 509.609 -0.13 2.39 re
S
BT
7.2 0 0 8 198.532 501.733 Tm
(30)Tj
ET
201.958 509.609 0.13 2.39 re
f
202.088 509.609 -0.13 2.39 re
S
BT
7.2 0 0 8 211.434 501.733 Tm
(33)Tj
ET
214.864 509.609 0.13 2.39 re
f
214.994 509.609 -0.129 2.39 re
S
BT
7.2 0 0 8 224.3345 501.733 Tm
(36)Tj
ET
227.761 509.609 0.13 2.39 re
f
227.891 509.609 -0.13 2.39 re
S
BT
7.2 0 0 8 237.2365 501.733 Tm
(39)Tj
ET
240.667 509.609 0.13 2.39 re
f
240.797 509.609 -0.13 2.39 re
S
BT
0 Tc 0 Tw 7.2 0 0 8 250.21 501.733 Tm
(42)Tj
ET
253.569 509.609 0.13 2.39 re
f
253.698 509.609 -0.129 2.39 re
S
BT
7.2 0 0 8 263.111 501.733 Tm
(45)Tj
ET
266.47 509.609 0.13 2.39 re
f
266.6 509.609 -0.129 2.39 re
S
BT
7.2 0 0 8 276.0131 501.733 Tm
(48)Tj
ET
279.372 509.609 0.13 2.39 re
f
279.501 509.609 -0.13 2.39 re
S
BT
-0.06 Tc 0.06 Tw 7.2 0 0 8 80.9693 454.9335 Tm
(12)Tj
2.243 Tc -2.243 Tw 0.9 0 Td
(81)Tj
-0.04 Tc 0.04 Tw 3.103 0 Td
(14)Tj
-0.08 Tc 0.08 Tw -2.202 0 Td
(12)Tj
2.233 Tc -2.233 Tw 0.88 0 Td
(01)Tj
-0.02 Tc 0.02 Tw 3.113 0 Td
(03)Tj
0 Tc 0 Tw 3.373 0 Td
(81)Tj
-1.792 0 Td
(91)Tj
3.583 0 Td
(75)Tj
1.792 0 Td
(59)Tj
1.792 0 Td
(45)Tj
5.375 0 Td
(18)Tj
7.407 -0 Td
(0)Tj
-0.06 Tc 0.06 Tw -29.117 0 Td
(13)Tj
0 Tc 0 Tw 0.9 0 Td
(2)Tj
-0.04 Tc 0.04 Tw 0.882 1.861 Td
(24)Tj
0 Tc 0 Tw 0.92 0 Td
(0)Tj
2.643 0 Td
(208)Tj
-1.792 0 Td
(223)Tj
-0.08 Tc 0.08 Tw 3.623 0 Td
(19)Tj
2.223 Tc -2.223 Tw 0.88 0 Td
(01)Tj
0 Tc 0 Tw 3.103 0 Td
(69)Tj
-0.1 Tc 0.1 Tw -2.172 0 Td
(17)Tj
2.273 Tc -2.273 Tw 0.84 0 Td
(51)Tj
-0.04 Tc 0.04 Tw 3.133 0 Td
(61)Tj
-0.1 Tc 0.1 Tw 1.392 0 Td
(14)Tj
0.432 Tc -0.432 Tw 0.86 0 Td
(31)Tj
0 Tc 0 Tw 1.332 0 Td
(03)Tj
5.165 0 Td
(44)Tj
-1.792 -1.861 Td
(24)Tj
0 1.861 Td
(48)Tj
-1.792 -1.861 Td
(32)Tj
-0.02 Tc 0.02 Tw 0.01 1.861 Td
(75)Tj
0 Tc 0 Tw 10.98 0 Td
(0)Tj
-1.792 -1.861 Td
(3)Tj
0 1.861 Td
(4)Tj
-1.792 -1.861 Td
(4)Tj
-0.08 Tc 0.08 Tw -0.2 1.861 Td
(13)Tj
-1.792 -1.861 Td
(11)Tj
0 Tc 0 Tw -0.04 1.861 Td
(30)Tj
0.02 Tc -0.02 Tw -23.552 0 Td
(254)Tj
0 Tc 0 Tw 0.501 3.989 Td
(0)Tj
ET
72.972 509.611 0.13 2.389 re
f
0 J 
73.102 509.61 -0.13 2.389 re
S
283.761 652.682 -215.355 -140.682 re
283.261 512.5 -214.355 139.682 re
f
0 0 0 0.8 K
0.375 w 2 J [6.5 1]0 d 
q 1 0 0 1 73.2034 645.366 cm
0 0 m
3.514 0 l
3.514 -0.403 l
3.889 -0.403 l
3.889 -0.944 l
6.528 -0.944 l
6.528 -2.042 l
7.389 -2.042 l
7.389 -2.931 l
13.597 -2.931 l
13.597 -4.042 l
13.806 -4.042 l
13.806 -4.944 l
18.903 -4.944 l
18.903 -6.028 l
19.208 -6.028 l
19.208 -6.958 l
23.042 -6.958 l
23.042 -8.069 l
23.694 -8.069 l
23.694 -8.958 l
25.972 -8.958 l
25.972 -10.014 l
30.833 -10.014 l
30.833 -10.972 l
36.778 -10.972 l
36.778 -12.042 l
37.681 -12.042 l
37.681 -14.056 l
38.278 -14.056 l
38.278 -15.111 l
38.889 -15.111 l
38.889 -16.083 l
41.222 -16.083 l
41.222 -17.069 l
41.736 -17.069 l
41.736 -18.069 l
42.333 -18.069 l
42.333 -20.153 l
43.028 -20.153 l
43.028 -21.153 l
45.986 -21.153 l
45.986 -22.167 l
46.764 -22.167 l
46.764 -23.236 l
47.944 -23.236 l
47.944 -25.25 l
52.25 -25.25 l
52.25 -26.319 l
55.528 -26.319 l
55.528 -27.333 l
56.778 -27.333 l
56.778 -29.375 l
57.319 -29.375 l
57.319 -30.319 l
60.444 -30.319 l
60.444 -31.444 l
61.042 -31.444 l
61.042 -32.514 l
61.306 -32.514 l
61.306 -33.569 l
63.889 -33.569 l
63.889 -34.583 l
65.681 -34.583 l
65.681 -35.833 l
65.861 -35.833 l
65.861 -36.736 l
66.708 -36.736 l
66.708 -37.639 l
66.917 -37.639 l
66.917 -38.68 l
67.111 -38.68 l
67.111 -39.764 l
71.444 -39.764 l
71.444 -41.167 l
71.861 -41.167 l
71.861 -41.917 l
72.722 -41.917 l
72.722 -42.958 l
74.792 -42.958 l
74.792 -44.042 l
77 -44.042 l
77 -45.097 l
80.639 -45.097 l
80.639 -46.125 l
82.139 -46.125 l
82.139 -47.25 l
83.208 -47.25 l
83.208 -48.25 l
88.417 -48.25 l
88.417 -49.347 l
89.833 -49.347 l
89.833 -50.417 l
96.861 -50.417 l
96.861 -51.445 l
98.903 -51.445 l
98.903 -52.806 l
100.361 -52.806 l
100.361 -53.945 l
102.375 -53.945 l
102.375 -55.195 l
106.861 -55.195 l
106.861 -56.542 l
115.639 -56.542 l
115.639 -58.056 l
118.43 -58.056 l
118.43 -59.847 l
119.805 -59.847 l
119.805 -61.611 l
163 -61.611 l
163 -65.903 l
206.361 -65.903 l
S
Q
0 0 0 0.8 k
q 1 0 0 1 74.5718 645.5059 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 87.3818 642.5907 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 94.6935 638.5647 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 116.252 628.3978 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 126.6935 620.2688 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 134.985 614.1439 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.129 -1.366 l
-1.129 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 156.583 598.2269 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 135.7765 612.9375 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.563 0 l
-2.563 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 176.833 590.4769 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 177.437 590.4769 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.318 l
-1.448 -0.318 l
-1.448 -1.365 l
-1.129 -1.365 l
-1.129 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 179.8745 590.4769 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.318 l
-1.448 -0.318 l
-1.448 -1.365 l
-1.129 -1.365 l
-1.129 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 180.416 590.4769 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 182.1245 588.9565 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.129 -1.366 l
-1.129 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 183.2285 588.9565 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 184.2495 588.9565 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 185.208 588.9565 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 185.5315 588.9565 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 186.131 588.9565 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 187.2765 588.9565 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.563 0 l
-2.563 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 188.839 588.9565 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.563 0 l
-2.563 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.129 -1.366 l
-1.129 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 189.464 588.9565 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.563 0 l
-2.563 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.129 -1.366 l
-1.129 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 190.881 587.4355 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 191.235 587.4355 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 191.403 587.4355 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 192.2765 587.4355 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.563 0 l
-2.563 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.129 -1.366 l
-1.129 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 193.089 585.6644 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.563 0 l
-2.563 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 193.9665 585.6644 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.563 0 l
-2.563 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 197.583 583.894 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 199.3955 583.894 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 200.041 583.894 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.129 -1.366 l
-1.129 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 200.677 583.894 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 201.323 583.894 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 203.339 583.894 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.563 0 l
-2.563 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.129 -1.366 l
-1.129 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 204.339 583.894 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.563 0 l
-2.563 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 205.2975 583.894 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 208.36 583.894 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 209.6625 583.894 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.563 0 l
-2.563 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.129 -1.366 l
-1.129 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 214.871 583.894 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 215.4015 583.894 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.563 0 l
-2.563 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 216.2975 583.894 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 217.4345 583.894 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.563 0 l
-2.563 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 218.1725 583.894 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 219.214 583.894 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.563 0 l
-2.563 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.129 -1.366 l
-1.129 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 220.985 583.894 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 225.86 583.894 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 233.714 583.894 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.563 0 l
-2.563 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.129 -1.366 l
-1.129 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 235.2555 583.894 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 239.291 579.623 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 240.2285 579.623 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 242.7925 579.623 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 244.584 579.623 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 247.1475 579.623 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 247.916 579.623 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 249.0825 579.623 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.129 -1.366 l
-1.129 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 252.562 579.623 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 254.7495 579.623 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 264.4575 579.623 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.129 -1.366 l
-1.129 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 268.166 579.623 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.563 0 l
-2.563 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 272.062 579.623 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 279.52 579.623 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.563 0 l
-2.563 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.129 -1.366 l
-1.129 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 173.437 592.6895 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 174.719 592.6895 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.318 l
-1.448 -0.318 l
-1.448 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 171.9945 594.0605 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.563 0 l
-2.563 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 173.1575 594.0605 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 165.083 595.1019 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 166.3645 595.1019 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.563 0 l
-2.563 -0.318 l
-1.448 -0.318 l
-1.448 -1.365 l
-1.129 -1.365 l
-1.129 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 167.8855 595.1019 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.563 0 l
-2.563 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 170.594 595.1019 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.318 l
-1.448 -0.318 l
-1.448 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
0 0 0 1 K
[]0 d 
q 1 0 0 1 73.1794 645.4158 cm
0 0 m
2.244 0 l
2.244 -0.477 l
3.857 -0.477 l
3.857 -1.084 l
5.073 -1.084 l
5.073 -1.505 l
6.429 -1.505 l
6.429 -2.066 l
6.709 -2.066 l
6.709 -3.072 l
7.083 -3.072 l
7.083 -3.609 l
7.948 -3.609 l
7.948 -4.638 l
8.486 -4.638 l
8.486 -5.246 l
9.351 -5.246 l
9.351 -5.713 l
10.309 -5.713 l
10.309 -6.181 l
10.613 -6.181 l
10.613 -6.742 l
13.068 -6.742 l
13.068 -7.186 l
14.284 -7.186 l
14.284 -7.701 l
14.681 -7.701 l
14.681 -8.262 l
15.219 -8.262 l
15.219 -8.753 l
15.71 -8.753 l
15.71 -9.314 l
15.967 -9.314 l
15.967 -9.828 l
16.388 -9.828 l
16.388 -10.366 l
18.188 -10.366 l
18.188 -10.903 l
18.749 -10.903 l
18.749 -11.418 l
19.404 -11.418 l
19.404 -12.446 l
20.058 -12.446 l
20.058 -12.891 l
22.607 -12.891 l
22.607 -13.381 l
23.892 -13.381 l
23.892 -13.966 l
24.079 -13.966 l
24.079 -14.457 l
24.617 -14.457 l
24.617 -14.948 l
25.669 -14.948 l
25.669 -15.509 l
26.674 -15.509 l
26.674 -16.023 l
27.586 -16.023 l
27.586 -16.397 l
28.264 -16.397 l
28.264 -17.122 l
28.428 -17.122 l
28.428 -17.496 l
29.012 -17.496 l
29.012 -18.151 l
29.573 -18.151 l
29.573 -18.572 l
29.76 -18.572 l
29.76 -19.062 l
30.111 -19.062 l
30.111 -19.577 l
32.917 -19.577 l
32.917 -20.138 l
33.314 -20.138 l
33.314 -20.605 l
34.366 -20.605 l
34.366 -21.184 l
34.74 -21.184 l
34.74 -21.704 l
37.686 -21.704 l
37.686 -22.125 l
37.943 -22.125 l
37.943 -22.78 l
38.294 -22.78 l
38.294 -23.201 l
40.538 -23.201 l
40.538 -23.808 l
41.052 -23.808 l
41.052 -24.276 l
41.824 -24.276 l
41.824 -24.72 l
42.128 -24.72 l
42.128 -25.305 l
42.876 -25.305 l
42.876 -25.842 l
43.203 -25.842 l
43.203 -26.317 l
43.624 -26.317 l
43.624 -26.894 l
43.904 -26.894 l
43.904 -27.385 l
44.091 -27.385 l
44.091 -27.806 l
45.167 -27.806 l
45.167 -28.414 l
48.136 -28.414 l
48.136 -28.905 l
48.346 -28.905 l
48.346 -29.489 l
49.889 -29.489 l
49.889 -29.887 l
50.1 -29.887 l
50.1 -30.471 l
50.263 -30.471 l
50.263 -30.986 l
50.427 -30.986 l
50.427 -31.944 l
51.012 -31.944 l
51.012 -32.529 l
51.713 -32.529 l
51.713 -33.043 l
52.648 -33.043 l
52.648 -33.464 l
53.069 -33.464 l
53.069 -34.095 l
55.173 -34.095 l
55.173 -34.562 l
56.646 -34.562 l
56.646 -35.007 l
58.75 -35.007 l
58.75 -36.105 l
59.475 -36.105 l
59.475 -36.713 l
59.685 -36.713 l
59.685 -37.625 l
60.153 -37.625 l
60.153 -38.209 l
61.789 -38.209 l
61.789 -38.677 l
62.818 -38.677 l
62.818 -39.262 l
63.94 -39.262 l
63.94 -39.753 l
69.2 -39.753 l
69.2 -40.828 l
71.421 -40.828 l
71.421 -41.225 l
72.403 -41.225 l
72.403 -41.88 l
83.251 -41.88 l
83.251 -42.348 l
85.659 -42.348 l
85.659 -43.353 l
86.243 -43.353 l
86.243 -43.984 l
92.766 -43.984 l
92.766 -44.498 l
94.262 -44.498 l
94.262 -45.55 l
96.109 -45.55 l
96.109 -46.158 l
104.595 -46.158 l
104.595 -46.719 l
107.097 -46.719 l
107.097 -47.538 l
111.258 -47.538 l
111.258 -48.8 l
114.461 -48.8 l
114.461 -49.571 l
115.817 -49.571 l
115.817 -50.343 l
116.682 -50.343 l
116.682 -51.138 l
117.22 -51.138 l
117.22 -51.909 l
119.09 -51.909 l
119.09 -52.774 l
127.74 -52.774 l
127.74 -53.663 l
129.143 -53.663 l
129.143 -54.598 l
132.018 -54.598 l
132.018 -55.767 l
132.836 -55.767 l
132.836 -56.959 l
140.738 -56.959 l
140.738 -58.525 l
166.361 -58.525 l
166.361 -60.629 l
169.494 -60.629 l
169.494 -63.341 l
177.7 -63.341 l
177.7 -68.064 l
197.712 -68.064 l
S
Q
0 0 0 1 k
q 1 0 0 1 133.208 609.9626 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.563 0 l
-2.563 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 138.952 605.8112 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 139.936 605.8112 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.563 0 l
-2.563 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 163.903 601.6035 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.365 l
-1.13 -1.365 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 164.4655 601.6035 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.365 l
-1.13 -1.365 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 167.949 601.103 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 168.138 601.103 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 168.7095 601.103 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.318 l
-1.448 -0.318 l
-1.448 -1.366 l
-1.13 -1.366 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 155.604 603.7255 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 173.6585 599.417 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 174.3665 599.417 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 175.075 599.417 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 175.7835 599.417 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 176.6165 599.417 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 177.7625 599.417 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 178.062 599.417 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 178.3615 599.417 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 178.661 599.417 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.563 0 l
-2.563 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 178.557 598.8774 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.563 0 l
-2.563 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 178.958 598.8774 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 179.1805 598.8774 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 179.4025 598.8774 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 179.625 598.8774 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 179.8475 598.8774 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 180.07 598.8774 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.563 0 l
-2.563 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.129 -1.366 l
-1.129 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 180.2925 598.8774 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 180.9255 598.8774 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 181.1295 598.8774 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 181.3335 598.8774 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.129 -1.366 l
-1.129 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 183.064 598.2104 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 183.272 598.2104 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.318 l
-1.448 -0.318 l
-1.448 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 183.4805 598.2104 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 183.689 598.2104 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.318 l
-1.448 -0.318 l
-1.448 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 184.043 598.2104 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 184.2095 598.2104 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.318 l
-1.448 -0.318 l
-1.448 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 184.971 598.2104 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 184.971 597.5024 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 185.6275 597.5024 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 185.6275 596.9189 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 186.0445 596.7109 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 186.2525 596.7109 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 186.461 596.7109 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 186.6695 596.7109 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 187.326 596.7109 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.563 0 l
-2.563 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.129 -1.366 l
-1.129 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 187.437 596.7109 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 187.548 596.7109 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 187.659 596.7109 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 187.7695 596.7109 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 188.333 596.7109 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 190.2225 596.0439 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.563 0 l
-2.563 -0.318 l
-1.448 -0.318 l
-1.448 -1.365 l
-1.129 -1.365 l
-1.129 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 191.306 593.7524 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 191.416 593.7524 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.129 -1.366 l
-1.129 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 191.5265 593.7524 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.563 0 l
-2.563 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.129 -1.366 l
-1.129 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 191.637 593.7524 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 191.747 593.7524 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.563 0 l
-2.563 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 193.4995 593.7524 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 194.541 592.8359 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 195.958 592.8359 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 196.063 592.8359 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 196.583 592.8359 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 196.7495 592.8359 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.129 -1.366 l
-1.129 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 196.916 592.8359 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 197.083 592.8359 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 199.002 592.8359 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 199.48 592.8359 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 199.6465 592.8359 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 199.813 592.8359 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 199.98 592.8359 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 200.541 592.8359 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 200.7615 592.8359 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.563 0 l
-2.563 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 200.9825 592.8359 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 201.4405 592.8359 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.563 0 l
-2.563 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 202.0955 591.9189 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.563 0 l
-2.563 -0.318 l
-1.448 -0.318 l
-1.448 -1.365 l
-1.129 -1.365 l
-1.129 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 202.264 591.9189 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.563 0 l
-2.563 -0.318 l
-1.448 -0.318 l
-1.448 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 202.931 591.9189 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 204.4725 590.8564 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 204.828 590.8564 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 205.4945 590.8564 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.563 0 l
-2.563 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 206.0155 590.8564 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 206.578 590.8564 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 207.297 589.6505 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 207.8595 588.548 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 208.579 588.548 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.563 0 l
-2.563 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 208.958 588.548 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 209.562 588.548 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 210.083 588.548 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 210.2395 588.548 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 210.3965 588.548 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 210.9785 588.548 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 211.812 588.548 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 212.458 588.548 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 212.96 588.548 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.563 0 l
-2.563 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 213.094 588.548 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 214.3755 588.548 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 215.0215 588.548 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 215.8865 587.048 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.563 0 l
-2.563 -0.318 l
-1.448 -0.318 l
-1.448 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 216.845 587.048 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.318 l
-1.448 -0.318 l
-1.448 -1.365 l
-1.129 -1.365 l
-1.129 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 217.585 587.048 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.563 0 l
-2.563 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 218.4505 587.048 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.318 l
-1.448 -0.318 l
-1.448 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 220.149 587.048 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.318 l
-1.448 -0.318 l
-1.448 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 233.4405 587.048 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.563 0 l
-2.563 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 234.7225 587.048 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 234.889 587.048 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.563 0 l
-2.563 -0.318 l
-1.448 -0.318 l
-1.448 -1.365 l
-1.129 -1.365 l
-1.129 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 235.5475 587.048 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 236.171 587.048 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.318 l
-1.448 -0.318 l
-1.448 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 236.61 587.048 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 237.6195 587.048 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.318 l
-1.448 -0.318 l
-1.448 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 238.568 587.048 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.563 0 l
-2.563 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 239.318 587.048 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.563 0 l
-2.563 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 240.4225 587.048 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 242.485 584.9855 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 242.986 584.9855 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.563 0 l
-2.563 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 244.1725 582.2355 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 244.268 582.2355 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.318 l
-1.448 -0.318 l
-1.448 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 245.0485 582.2355 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.563 0 l
-2.563 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 245.454 582.2355 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.563 0 l
-2.563 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 245.746 582.2355 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 246.736 582.2355 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.563 0 l
-2.563 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 247.465 582.2355 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 248.861 582.2355 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 249.09 582.2355 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 249.4235 582.2355 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 249.52 582.2355 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.563 0 l
-2.563 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 249.687 582.2355 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 250.7055 582.2355 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 251.166 582.2355 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.318 l
-1.448 -0.318 l
-1.448 -1.365 l
-1.129 -1.365 l
-1.129 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 251.4245 582.2355 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.563 0 l
-2.563 -0.318 l
-1.448 -0.318 l
-1.448 -1.365 l
-1.129 -1.365 l
-1.129 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 255.312 577.548 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.318 l
-1.449 -0.318 l
-1.449 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 257.4575 577.548 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.318 l
-1.448 -0.318 l
-1.448 -1.365 l
-1.129 -1.365 l
-1.129 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 258.8745 577.548 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.318 l
-1.448 -0.318 l
-1.448 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 259.8535 577.548 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.318 l
-1.448 -0.318 l
-1.448 -1.365 l
-1.129 -1.365 l
-1.129 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 260.7285 577.548 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.318 l
-1.448 -0.318 l
-1.448 -1.365 l
-1.129 -1.365 l
-1.129 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 264.166 577.548 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.318 l
-1.448 -0.318 l
-1.448 -1.365 l
-1.129 -1.365 l
-1.129 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 264.291 577.548 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.318 l
-1.448 -0.318 l
-1.448 -1.365 l
-1.129 -1.365 l
-1.129 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 267.291 577.548 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.318 l
-1.448 -0.318 l
-1.448 -1.365 l
-1.129 -1.365 l
-1.129 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 267.77 577.548 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.318 l
-1.448 -0.318 l
-1.448 -1.365 l
-1.129 -1.365 l
-1.129 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 268.1035 577.548 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.318 l
-1.448 -0.318 l
-1.448 -1.365 l
-1.129 -1.365 l
-1.129 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 269.166 577.548 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.318 l
-1.448 -0.318 l
-1.448 -1.365 l
-1.129 -1.365 l
-1.129 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 269.291 577.548 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.563 0 l
-2.563 -0.318 l
-1.448 -0.318 l
-1.448 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 269.52 577.548 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.318 l
-1.448 -0.318 l
-1.448 -1.365 l
-1.129 -1.365 l
-1.129 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 270.937 577.548 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.318 l
-1.448 -0.318 l
-1.448 -1.365 l
-1.13 -1.365 l
-1.13 -0.318 l
0 -0.318 l
h
f
Q
q 1 0 0 1 170.0595 600.0835 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 170.33 599.417 cm
0 0 m
-1.129 0 l
-1.129 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.129 -1.366 l
-1.129 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 170.601 599.417 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 171.341 599.417 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.449 1.047 l
-1.449 0 l
-2.564 0 l
-2.564 -0.319 l
-1.449 -0.319 l
-1.449 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
q 1 0 0 1 75.4947 645.5141 cm
0 0 m
-1.13 0 l
-1.13 1.047 l
-1.448 1.047 l
-1.448 0 l
-2.564 0 l
-2.564 -0.319 l
-1.448 -0.319 l
-1.448 -1.366 l
-1.13 -1.366 l
-1.13 -0.319 l
0 -0.319 l
h
f
Q
BT
-0.01 Tc 0.01 Tw 5.4 0 0 6 187.4355 605.6519 Tm
(ABECMA)Tj
-2.395 -6.058 Td
(Standard)Tj
0 -1 Td
(Regimen)Tj
/GS1 gs
/T1_0 1 Tf
-0.012 Tc 0.048 Tw 7.6 0 0 8 36 434.9932 Tm
[(Da)-9.8 (ta cutoff da)-9.7 (te:)37.2 ( )37.2 (A)-9.8 (pril 28,)37.2 ( 2023.)]TJ
-0.001 Tc 0.105 Tw 0 -1.225 Td
[(74% )0.5 (of the planned )0.5 (OS events ha)-10.1 (ve )0.5 (occurred.74 pa)-10.1 (tients \(56%\) )0.5 (crossed )0.5 (over from )0.5 (the)-1 ( )]TJ
-0.012 Tc 0.048 Tw 0 -1.063 Td
[(standard regimens arm to the )37.2 (ABECMA arm.)]TJ
-0.011 Tc 0.06 Tw 0 -1.225 Td
[(T)0.5 (he)0.5 ( O)0.5 (S )0.5 (c)0.5 (ur)-17.5 (ve)0.5 (s )0.5 (c)0.5 (ro)0.5 (ss)0.5 ( )0.5 (a)-9.6 (t)0.5 ( )0.5 (Mo)0.5 (nt)0.5 (h)0.5 ( 1)0.5 (5 )0.5 (o)0.5 (f )0.5 (th)0.5 (e)0.5 ( s)0.5 (tu)0.5 (d)-9.6 (y)0.5 ( )0.5 (re)0.5 (n)0.5 (de)0.5 (ri)0.5 (ng)0.5 ( )0.5 (th)0.5 (e )0.5 (o)0.5 (ve)0.5 (r)0.5 (al)0.5 (l )0.5 (h)0.5 (az)0.5 (ar)0.5 (d )0.5 (r)0.5 (a)-9.6 (t)0.5 (i)0.5 (o )0.5 (un)0.5 (r)0.5 (el)0.5 (ia)0.5 (b)0.5 (le)-11 ( )]TJ
-0.012 Tc 0.048 Tw 0 -1.063 Td
[(to estima)-9.8 (te the trea)-9.8 (tment effect on OS.)]TJ
/T1_4 1 Tf
-0.017 Tc 8 0 0 8 36 379.576 Tm
[(Rela)-9.7 (psed/Refractor)-17.8 (y Multiple Myeloma )37.2 (After )37.2 (Three or More Prior Lines of )37.2 (Thera)-9.8 (py)]TJ
/T1_0 1 Tf
0.013 Tc 0.197 Tw 0 -1.629 Td
[(Ef)0.5 (fica)0.5 (c)20.4 (y )0.5 (o)0.5 (f )37.5 (ABE)0.5 (CMA )0.6 (was )0.6 (eva)0.5 (lua)-9.6 (t)0.5 (ed )0.6 (in )0.5 (K)0.5 (arMM)0.5 (a )0.5 (\(N)0.5 (CT033)0.5 (61748)0.5 (\),)37.4 ( )0.5 (a)0.5 (n )0.5 (o)0.5 (pen-)0.5 (labe)0.5 (l,)50 ( )]TJ
-0.006 Tc 0.106 Tw 0 -1.044 Td
[(single-arm,)36.7 ( multicenter stud)-10.3 (y in adult pa)-10.3 (tients with rela)-10.3 (psed and refractor)-18.3 (y multiple)-6 ( )]TJ
-0.003 Tc 0.121 Tw 0 -1.044 Td
[(myeloma who had received a)-10.3 (t least 3 prior lines of antimyeloma thera)-10.3 (py inc)19.6 (luding)-3.1 ( )]TJ
-0.004 Tc 0.115 Tw 0 -1.044 Td
[(an immunomodula)-10.2 (tor)-18.2 (y a)-10.2 (gent,)36.7 ( a proteasome inhibitor)73.8 (,)36.8 ( and an anti-CD38 monoc)19.7 (lonal)-4 ( )]TJ
0.008 Tc 0.175 Tw 0 -1.044 Td
[(antibod)-10.1 (y)54.9 (.)37 ( )37.4 (The )0.5 (stud)-10.1 (y )0.5 (inc)19.9 (luded )0.5 (pa)-10.1 (tients )0.5 (with )0.5 (ECOG )0.5 (performance )0.5 (sta)-10.1 (tus )0.5 (of )0.5 (0 )0.6 (or )0.5 (1.)45 ( )]TJ
0.004 Tc 0.151 Tw 0 -1.044 Td
[(Th)0.5 (e st)0.5 (ud)-9.5 (y e)0.5 (xc)20.4 (lu)0.5 (de)0.5 (d pa)-9.5 (ti)0.5 (ent)0.5 (s w)0.5 (ith)0.5 ( a c)0.5 (re)0.5 (a)-9.6 (ti)0.5 (nin)0.5 (e c)20.5 (lea)0.5 (ra)0.5 (nce)0.5 ( of)0.5 ( le)0.5 (ss t)0.5 (ha)0.5 (n or)0.5 ( eq)0.5 (ual)0.5 ( to)4 ( )]TJ
-0.003 Tc 0.117 Tw 0 -1.044 Td
[(45 mL/minute,)37.4 ( alanine aminotransferase >2.5 times upper limit of normal,)37.3 ( and left)-3 ( )]TJ
-0.009 Tc 0.089 Tw 0 -1.044 Td
[(ventricular ejection fraction <45%.)37.1 ( P)18.1 (a)-10 (tients were also exc)20 (luded if absolute neutrophil)-9 ( )]TJ
-0.004 Tc 0.113 Tw 0 -1.044 Td
(count <1000 cells/mm)Tj
0 Tc 0 Tw 5.6 0 0 5.6 104.8534 302.3575 Tm
(3)Tj
-0.004 Tc 0.113 Tw 8 0 0 8 107.5183 299.6935 Tm
[( and pla)-9.9 (telet count <50,000/mm)]TJ
0 Tc 0 Tw 5.6 0 0 5.6 206.7859 302.3575 Tm
(3)Tj
-0.004 Tc 0.113 Tw 8 0 0 8 209.4509 299.6935 Tm
[(.)37.1 ( P)18.1 (a)-9.9 (tients had measurable)-4 ( )]TJ
-0.011 Tc 0.081 Tw -21.681 -1.044 Td
[(disease by IMWG 2016 criteria a)-10.3 (t enrollment.)36.7 ( Bridging thera)-10.3 (py with alkyla)-10.2 (ting a)-10.3 (gents,)26 ( )]TJ
-0.003 Tc 0.117 Tw 0 -1.044 Td
[(cort)0.5 (icoster)0.5 (oids,)37.4 ( )0.5 (immu)0.5 (nomodul)0.5 (a)-9.6 (tor)-17.6 (y)0.5 ( )0.5 (a)-9.6 (gents,)37.4 ( )0.5 (pro)0.5 (teaso)0.5 (me )0.5 (inhibit)0.5 (ors,)37.4 ( )0.5 (and/or)0.5 ( )0.5 (anti-CD38)-3 ( )]TJ
-0.006 Tc 0.102 Tw 0 -1.044 Td
[(monoc)20.4 (lonal antibodies to which pa)-9.6 (tients were previously exposed was permitted for)-6 ( )]TJ
-0.018 Tc 0.036 Tw 0 -1.044 Td
[(disease control between a)-10.1 (pheresis and until 14 days before the start of lymphodepleting)-18 ( )]TJ
-0.017 Tc 0.017 Tw 0 -1.044 Td
[(chemothera)-9.8 (py)55.2 (.)]TJ
0.06 Tw 0 -1.764 Td
[(L)36.8 (ymphodepleting chemothera)-10.2 (py consisted of c)19.7 (yc)19.8 (lophosphamide \(300 mg/m)]TJ
0 Tc 0 Tw 5.6 0 0 5.6 253.4982 246.4624 Tm
(2)Tj
-0.017 Tc 0.06 Tw 8 0 0 8 256.0922 243.7984 Tm
[( IV infusion)-17 ( )]TJ
-0.016 Tc -27.512 -1.044 Td
[(d)0.5 (a)0.5 (il)0.5 (y)0.5 ( )0.5 (fo)0.5 (r)0.5 ( )0.5 (3 )0.5 (d)0.5 (a)0.5 (ys)0.5 (\))0.5 ( )0.5 (a)0.5 (nd)0.5 ( )0.5 (\036u)0.5 (d)0.5 (a)0.5 (ra)0.5 (b)0.5 (in)0.5 (e)0.5 ( )0.5 (\()0.5 (30)0.5 ( )0.5 (m)0.5 (g/)0.5 (m)]TJ
0 Tc 0 Tw 5.6 0 0 5.6 159.9059 238.1066 Tm
(2)Tj
-0.016 Tc 0.06 Tw 8 0 0 8 162.5016 235.4426 Tm
[( )0.5 (IV)0.5 ( )0.5 (i)0.5 (n)0.5 (fu)0.5 (s)0.5 (io)0.5 (n)0.5 ( )0.5 (da)0.5 (i)0.5 (l)0.5 (y )0.5 (f)0.5 (o)0.5 (r)0.5 ( 3)0.5 ( )0.5 (d)0.5 (ay)0.5 (s)0.5 (\) )0.5 (s)0.5 (t)0.5 (a)0.5 (r)0.5 (ti)0.5 (n)0.5 (g )0.5 (5)0.5 ( )0.5 (da)0.5 (y)0.5 (s)-16 ( )]TJ
-0.008 Tc 0.096 Tw -15.813 -1.044 Td
[(prior to the target infusion da)-10.3 (te of )37.4 (ABECMA.)36.7 ( Fludarabine was dose reduced )0.5 (for )0.5 (renal)-8 ( )]TJ
-0.02 Tc 0.036 Tw 0 -1.044 Td
[(insuf\037cienc)19.7 (y)54.6 (.)36.7 ( P)17.6 (a)-10.3 (tients were hospitalized for 14 days after )36.7 (ABECMA infusion to monitor for)-20 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(potential CRS,)37.2 ( HLH/MAS,)37.2 ( and neurotoxicity)55.2 (.)]TJ
0.004 Tc 0.155 Tw 0 -1.764 Td
[(Of the 135 pa)-10.1 (tients who underwent leuka)-10.2 (pheresis for 300 x 10)]TJ
0 Tc 0 Tw 5.6 0 0 5.6 236.1182 198.9232 Tm
(6)Tj
0.004 Tc 0.155 Tw 8 0 0 8 238.8297 196.2592 Tm
( and 450 x 10)Tj
0 Tc 0 Tw 5.6 0 0 5.6 285.312 198.9232 Tm
(6 )Tj
-0.017 Tc 0.048 Tw 8 0 0 8 36 187.9034 Tm
[(CAR-positive )37.2 (T cell dose cohorts:)]TJ
0.017 Tw 1.192 -1.648 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.003 Tc 0.118 Tw 1.508 0 Td
[(11 \(8%\) did not receive the CAR-positive )36.9 (T cells either due to dea)-9.9 (th \(n)]TJ
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
27.164 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
0.719 0 Td
[(2\),)34 ( )]TJ
-0.006 Tc 0.106 Tw -27.882 -1.063 Td
[(adverse )0.6 (event )0.5 (\(n)]TJ
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
6.342 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
0.713 0 Td
[(1\),)36.8 ( )0.5 (disease )0.5 (progression )0.5 (\(n)]TJ
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
9.777 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
0.713 0 Td
[(1\),)36.8 ( )0.5 (consent )0.5 (withdra)-10.3 (wal )0.5 (\(n)]TJ
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
9.628 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
0.713 0 Td
[(3\),)31 ( )]TJ
-0.003 Tc 0.118 Tw -27.887 -1.063 Td
[(physician )0.5 (decision )0.5 (\(n=3\),)37.2 ( )0.5 (or )0.5 (inability )0.5 (to )0.5 (manufacture )0.5 (product )0.5 ([manufacturing)-3 ( )]TJ
-0.007 Tc 0.1 Tw 0 -1.063 Td
(failure \(n)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
3.408 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
0.711 0 Td
[(1\)].)36.8 ( )36.9 (T)73.8 (wo pa)-10.1 (tients died after receiving lymphodepletion and prior to)-7 ( )]TJ
-0.013 Tc 0.069 Tw -4.119 -1.063 Td
[(receiving )36.7 (ABECMA.)37 ( Dea)-10 (ths were from septic shock and general physical health)-13 ( )]TJ
-0.017 Tc 0.017 Tw 0 -1.063 Td
[(deteriora)-9.8 (tion.)]TJ
-1.508 -1.513 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.016 Tc 0.06 Tw 1.508 0 Td
[(24 \(18%\) either received )37.4 (ABECMA outside of t)0.5 (he 300 to 460 x 10)]TJ
0 Tc 0 Tw 5.6 0 0 5.6 246.8101 122.7465 Tm
(6)Tj
-0.016 Tc 0.06 Tw 8 0 0 8 249.4063 120.0825 Tm
[( CAR-)0.5 (positive)-16 ( )]TJ
-0.008 Tc 0.094 Tw -23.976 -1.063 Td
(T cells dose range \(n)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
8.006 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
0.709 0 Td
[(23\) or received CAR-positive )36.8 (T cells tha)-10 (t did not meet)-8 ( )]TJ
-0.017 Tc 0.048 Tw -8.715 -1.063 Td
[(product release speci\037ca)-9.7 (tions for )37.3 (ABECMA \(non-conforming product; n)]TJ
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
25.363 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
0.691 0 Td
(1\).)Tj
0.017 Tw -27.561 -1.513 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.004 Tc 0.151 Tw 1.508 0 Td
[(Th)0.5 (e e)0.5 (ffi)0.5 (ca)0.5 (c)20.4 (y)0.5 ( e)0.5 (va)0.5 (lu)0.5 (ab)0.5 (le)0.5 ( p)0.5 (op)0.5 (ula)-9.5 (t)0.5 (io)0.5 (n co)0.5 (nsi)0.5 (st)0.5 (s of)0.5 ( t)0.5 (he)0.5 ( 1)0.5 (00)0.5 ( p)0.5 (a)-9.6 (t)0.5 (ie)0.5 (nt)0.5 (s \(7)0.5 (4%)0.5 (\) w)0.5 (ho)4 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.063 Td
[(received )37.2 (ABECMA in the dose range of 300 to 460 x 10)]TJ
0 Tc 0 Tw 5.6 0 0 5.6 216.9695 85.1232 Tm
(6)Tj
-0.017 Tc 0.048 Tw 8 0 0 8 219.5612 82.4592 Tm
[( CAR-positive )37.2 (T cells.)]TJ
0.005 Tc 0.158 Tw -22.945 -1.629 Td
[(The overall manufacturing failure ra)-9.8 (te for pa)-9.9 (tients who underwent leuka)-9.8 (pheresis)5 ( )]TJ
0.013 Tc 0.196 Tw 0 -1.044 Td
[(f)0.5 (o)0.6 (r)0.5 ( t)0.5 (h)0.6 (e)0.5 ( 3)0.5 (0)0.5 (0)0.5 ( x)0.5 ( 1)0.5 (0)]TJ
0 Tc 0 Tw 5.6 0 0 5.6 91.3274 63.7315 Tm
(6)Tj
0.013 Tc 0.196 Tw 8 0 0 8 94.0853 61.0675 Tm
[( a)0.5 (n)0.5 (d)0.6 ( 4)0.6 (5)0.5 (0)0.5 ( x)0.5 ( 1)0.5 (0)]TJ
-0.013 Tw 5.6 0 0 5.6 142.7537 63.7315 Tm
[(6)0.5 ( )]TJ
0.196 Tw 8 0 0 8 148.025 61.0675 Tm
[(C)0.5 (A)0.6 (R)0.5 (-)0.5 (p)0.6 (o)0.5 (s)0.5 (i)0.5 (t)0.6 (i)0.5 (v)0.6 (e)0.5 ( )37.1 (T)0.6 ( c)0.6 (e)0.5 (l)0.6 (l)0.5 ( d)0.6 (o)0.5 (s)0.5 (e)0.6 ( c)0.6 (o)0.5 (h)0.6 (o)0.5 (r)0.5 (t)0.6 (s)0.5 ( w)0.5 (a)0.5 (s)0.6 ( 1)0.6 (.)0.5 (5)0.5 (%)13 ( )]TJ
0 Tc 0 Tw 17.497 0 Td
( )Tj
-0.017 Tc 0.053 Tw -31.5 -1.044 Td
[(\(2 )0.5 (out of )0.5 (135 )0.5 (pa)-9.8 (tients\).)37.2 ( )0.5 (Of )0.5 (these )0.5 (two )0.5 (pa)-9.8 (tients,)37.2 ( )0.5 (one )0.6 (received )0.6 (CAR-positive )37.4 (T )0.5 (cells )0.5 (tha)-9.8 (t )0.6 (did)-17 ( )]TJ
-0.011 Tc 0.08 Tw 0 -1.044 Td
[(not meet product release speci\037ca)-10.2 (tions for )36.7 (ABECMA,)36.8 ( and in one pa)-10.2 (tient there was an)-11 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(inability to manufacture )37.2 (ABECMA.)]TJ
-0.014 Tc 0.066 Tw 36 86.406 Td
[(Of the 100 pa)-10.3 (tients in the ef\037cac)19.6 (y evaluable popula)-10.3 (tion,)36.7 ( the median a)-10.3 (ge was 62 years)-14 ( )]TJ
-0.019 Tc 0.036 Tw 0 -1.044 Td
[(\(range:)37.4 ( 33 to 78 years\),)37.4 ( 60% were male,)37.4 ( 78% were white,)37.3 ( 6% we)0.5 (re black,)37.4 ( and 2% were)-19 ( )]TJ
-0.022 Tc 0 -1.044 Td
[(Asian.)37 ( Most pa)-10 (tients \(78%\) were Interna)-9.9 (tional Sta)-9.9 (ging System \(ISS\) Sta)-10 (ge I or II.)37 ( High-risk)-22 ( )]TJ
0 Tc 0 Tw 31.5 0 Td
( )Tj
-0.003 Tc 0.117 Tw -31.5 -1.044 Td
[(c)20.3 (ytogenetics \(presence of t\(4:14\),)37.4 ( t\(14:16\),)37.3 ( and 17p13 del\) were present in 37% of)-3 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(pa)-9.8 (tients.)37.2 ( )37.2 (Thirty-six percent of the pa)-9.8 (tients had presence of extramedullar)-17.8 (y disease.)20 ( )]TJ
0 Tc 0.135 Tw 0 -1.764 Td
[(The median number of prior lines of thera)-10.1 (py was 6 \(range:)36.8 ( 3 to 16\),)36.8 ( and 88% of )]TJ
-0.017 Tc 0.044 Tw 0 -1.044 Td
[(the pa)-9.7 (tients received 4 or more prior lines of thera)-9.8 (py)55.2 (.)37.2 ( Ninety-\037ve percent of the pa)-9.8 (tients)-17 ( )]TJ
-0.007 Tc 0.096 Tw 0 -1.044 Td
[(w)0.5 (e)0.5 (r)0.5 (e)0.5 ( r)0.5 (e)0.5 (f)0.5 (r)0.5 (a)0.5 (c)0.5 (t)0.5 (or)-17.4 (y t)0.5 (o)0.5 ( a)0.5 (n)0.5 ( a)0.5 (n)0.5 (t)0.5 (i)0.5 (-C)0.5 (D)0.5 (3)0.5 (8)0.5 ( m)0.5 (o)0.5 (n)0.5 (o)0.5 (c)20.5 (l)0.5 (o)0.5 (na)0.5 (l)0.5 ( an)0.5 (t)0.5 (i)0.5 (b)0.5 (o)0.5 (d)-9.5 (y)55.5 (.)37.4 ( E)0.5 (ig)0.5 (h)0.5 (t)0.5 (y)0.5 (-)0.5 (\037)0.5 (v)0.5 (e)0.5 ( p)0.5 (e)0.5 (r)0.5 (c)0.5 (en)0.5 (t)0.5 ( w)0.6 (er)0.5 (e)0.5 ( t)0.5 (ri)0.5 (p)0.5 (l)0.5 (e)-7 ( )]TJ
0.007 Tc 0.167 Tw 0 -1.044 Td
[(c)20.3 (lass refractor)-17.7 (y \(refractor)-17.7 (y to a proteasome inhibitor [PI],)37.3 ( an immunomodula)-9.7 (tor)-17.6 (y)7 ( )]TJ
-0.009 Tc 0.091 Tw 0 -1.044 Td
[(drug [IMiD],)36.6 ( and an anti-CD38 monoc)19.6 (lonal antibod)-10.4 (y\),)36.6 ( and 26% were penta-refractor)-18.4 (y)-9 ( )]TJ
-0.014 Tc 0.064 Tw 0 -1.044 Td
[(\(refractor)-17.9 (y )0.5 (to )0.5 (2 )0.6 (PIs,)37.1 ( )0.5 (2 )0.5 (IMiD )0.5 (a)-9.9 (gents,)37.1 ( )0.5 (and )0.5 (an )0.6 (anti-CD38 )0.5 (monoc)20 (lonal )0.5 (antibod)-9.9 (y\).)37.1 ( )0.5 (Ninety-two)-14 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(percent had received prior autologous stem cell transplanta)-9.7 (tion.)]TJ
-0.001 Tc 0.13 Tw 0 -1.764 Td
[(Most pa)-10.1 (tients \(87%\) trea)-10.1 (ted with )37 (ABECMA received bridging thera)-10.1 (py for control of)-1 ( )]TJ
0.003 Tc 0.148 Tw 0 -1.044 Td
[(their )0.5 (multiple )0.5 (myeloma )0.5 (during )0.6 (the )0.5 (manufacturing )0.6 (process.)37.2 ( )37.6 (The )0.5 (median )0.5 (time )0.6 (from)3 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(leuka)-9.8 (pheresis to product a)-9.8 (vailability was 33 days \(range:)37.2 ( 26 to 49 days\).)]TJ
0.041 Tw 0 -1.764 Td
[(Ef\037cac)20.2 (y was established on the basis of overall response ra)-9.8 (te \(ORR\),)37.2 ( complete response)-17 ( )]TJ
-0.01 Tc 0.083 Tw 0 -1.044 Td
[(\(CR\) ra)-9.7 (te,)37.3 ( and dura)-9.8 (tion of response \(DOR\),)37.2 ( as assessed by the Independent Response)-10 ( )]TJ
-0.007 Tc 0.099 Tw 0 -1.044 Td
[(committee \(IRC\) based on the Interna)-10 (tional Myeloma )36.7 (W)18 (orking Group \(IMWG\) Uniform)-7 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
(Response Criteria for Multiple Myeloma.)Tj
-0.013 Tc 0.066 Tw 0 -1.764 Td
[(E)0.5 (f)0.6 (\037)0.5 (c)0.5 (a)0.6 (c)20.5 (y)0.5 ( r)0.5 (e)0.6 (s)0.5 (u)0.5 (l)0.6 (t)0.5 (s)0.5 ( f)0.6 (o)0.5 (r)0.5 ( t)0.5 (h)0.6 (e)0.5 ( d)0.5 (o)0.6 (s)0.5 (e)0.5 ( r)0.5 (a)0.6 (n)0.5 (g)0.5 (e)0.6 ( o)0.6 (f)0.5 ( 3)0.5 (0)0.6 (0)0.5 ( t)0.5 (o)0.5 ( 4)0.6 (6)0.5 (0)0.5 ( x)0.5 ( 1)0.5 (0)]TJ
0.013 Tw 5.6 0 0 5.6 481.4766 548.222 Tm
[(6)0.5 ( )]TJ
0.066 Tw 8 0 0 8 485.7286 545.558 Tm
[(C)0.5 (A)0.6 (R)0.5 (-)0.5 (p)0.5 (o)0.6 (s)0.5 (i)0.6 (t)0.5 (i)0.5 (v)0.6 (e)0.5 ( )37.2 (T)0.5 ( c)0.5 (e)0.5 (l)0.6 (l)0.5 (s)0.5 ( a)0.5 (r)0.6 (e)0.5 ( s)0.5 (h)0.6 (o)-9.5 (w)0.5 (n)-13 ( )]TJ
-0.017 Tc 0.041 Tw -20.216 -1.044 Td
[(in )37.1 (T)74.2 (able 9 and )37 (T)74.2 (able 10,)37.2 ( and the DOR results are sho)-9.8 (wn in )37.1 (T)74.2 (able 11.)37.2 ( )37.1 (The median time to)-17 ( )]TJ
0.048 Tw 0 -1.044 Td
[(\037rst response was 30 days \(range:)37.2 ( 15 to 88 days\).)]TJ
ET
0.5 w 0 J 
/GS2 gs
q 1 0 0 1 324 469.7542 cm
0 0 m
127.44 0 l
S
Q
1 w 
q 1 0 0 1 324 499.6661 cm
0 0 m
127.44 0 l
S
Q
q 1 0 0 1 451.44 499.6661 cm
0 0 m
124.56 0 l
S
Q
0.5 w 
q 1 0 0 1 451.44 470.0042 cm
0 0 m
0 29.162 l
S
Q
q 1 0 0 1 451.44 469.7542 cm
0 0 m
124.56 0 l
S
Q
q 1 0 0 1 451.44 459.0023 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 451.44 448.2504 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 451.44 437.7485 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 324 437.4985 cm
0 0 m
127.44 0 l
S
Q
q 1 0 0 1 451.44 437.4985 cm
0 0 m
124.56 0 l
S
Q
q 1 0 0 1 451.44 426.7466 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 451.44 416.2446 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 324 415.9946 cm
0 0 m
127.44 0 l
S
Q
q 1 0 0 1 451.44 415.9946 cm
0 0 m
124.56 0 l
S
Q
q 1 0 0 1 451.44 405.2427 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 451.44 394.7408 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 324 394.4908 cm
0 0 m
127.44 0 l
S
Q
q 1 0 0 1 451.44 394.4908 cm
0 0 m
124.56 0 l
S
Q
q 1 0 0 1 451.44 383.7389 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 451.44 373.487 cm
0 0 m
0 10.252 l
S
Q
1 w 
q 1 0 0 1 324 372.987 cm
0 0 m
127.44 0 l
S
Q
q 1 0 0 1 451.44 372.987 cm
0 0 m
124.56 0 l
S
Q
0.5 w 
q 1 0 0 1 324 326.0751 cm
0 0 m
127.44 0 l
S
Q
q 1 0 0 1 451.44 326.0751 cm
0 0 m
124.56 0 l
S
Q
BT
/GS1 gs
/T1_1 1 Tf
8 0 0 8 324 511.7661 Tm
[(T)74.2 (able 9:)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
5 0 Td
[(Summar)-17.7 (y of Efficac)10.2 (y Based on Independent Response Committee)-17 ( )]TJ
0 -1.062 Td
(Review According to IMWG Criteria \(KarMMa Study\))Tj
-0.012 Tc 7.6 0 0 8 472.2537 490.3542 Tm
[(ABECMA-T)74.2 (reated P)24.2 (opulation)-12 ( )]TJ
0 Tc 0 Tw 7.6 0 0 8 557.4395 490.3542 Tm
( )Tj
-0.012 Tc 0.048 Tw 7.6 0 0 8 456.5837 481.8542 Tm
(\(300 to 460 x 10)Tj
0 Tc 0 Tw 5.32 0 0 5.6 504.6969 484.5182 Tm
(6)Tj
-0.012 Tc 0.048 Tw 7.6 0 0 8 507.1855 481.8542 Tm
[( C)18.2 (AR-P)24.2 (ositive T Cells\))]TJ
0.012 Tw -0.406 -1.062 Td
(N=100)Tj
0.048 Tw -23.697 -1.479 Td
(Overall Response Rate)Tj
/T1_0 1 Tf
0.012 Tw -0 -1.344 Td
(\(sCR)Tj
0 Tc -0.21 Tw /Span<</ActualText<FEFF200A>>> BDC 
5.32 0 0 5.6 336.4426 453.4344 Tm
( )Tj
EMC 
0.029 0 Td
(a)Tj
0 Tw 7.6 0 0 8 338.8965 451.7704 Tm
(+)Tj
-0.012 Tc 0.012 Tw 0.588 -0.125 Td
(VGPR)Tj
0 Tc 0 Tw 1.95 0.125 Td
(+)Tj
-0.012 Tc 0.048 Tw 0.588 -0.125 Td
[(PR\),)37.2 ( n \(%\))]TJ
18.585 0 Td
(72 \(72\))Tj
0.364 Tw /Span<</ActualText<FEFF00090009>>> BDC 
-23.671 -1.344 Td
(  )Tj
EMC 
[(95% )316.2 (CI)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 353.4153 442.6825 Tm
(b)Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 355.8135 440.0185 Tm
[(\035)-47.8 (\(%\))]TJ
0.048 Tw 19.619 0 Td
[(62,)37.2 ( 81)]TJ
/T1_1 1 Tf
0.012 Tw -23.805 -1.344 Td
(sCR)Tj
0 Tc -0.21 Tw /Span<</ActualText<FEFF200A>>> BDC 
5.32 0 0 5.6 335.4028 431.9305 Tm
( )Tj
EMC 
0.029 0 Td
(a)Tj
/T1_0 1 Tf
-0.012 Tc 0.048 Tw 7.6 0 0 8 338.0535 429.2665 Tm
[(,)37.2 ( n \(%\))]TJ
21.822 0 Td
(28 \(28\))Tj
0.364 Tw /Span<</ActualText<FEFF00090009>>> BDC 
-23.671 -1.344 Td
(  )Tj
EMC 
[(95% )316.3 (CI)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 353.4153 421.1786 Tm
(b)Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 355.8135 418.5146 Tm
[(\035)-47.8 (\(%\))]TJ
0.048 Tw 19.619 0 Td
[(19,)37.2 ( 38)-12 ( )]TJ
/T1_1 1 Tf
0.012 Tw -23.805 -1.344 Td
(VGPR)Tj
/T1_0 1 Tf
0.048 Tw [(,)37.2 ( n \(%\))]TJ
23.671 0 Td
(25 \(25\))Tj
0.364 Tw /Span<</ActualText<FEFF00090009>>> BDC 
-23.671 -1.344 Td
(  )Tj
EMC 
[(95% )316.3 (CI)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 353.4153 399.6748 Tm
(b)Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 355.8135 397.0108 Tm
[(\035)-47.8 (\(%\))]TJ
0.048 Tw 19.619 0 Td
[(17,)37.2 ( 35)]TJ
/T1_1 1 Tf
0.012 Tw -23.805 -1.344 Td
(PR)Tj
/T1_0 1 Tf
0.048 Tw [(,)37.2 ( n \(%\))]TJ
23.671 0 Td
(19 \(19\))Tj
0.364 Tw /Span<</ActualText<FEFF00090009>>> BDC 
-23.671 -1.344 Td
(  )Tj
EMC 
[(95% )316.3 (CI)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 353.4153 378.171 Tm
(b)Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 355.8135 375.507 Tm
[(\035)-47.8 (\(%\))]TJ
0.048 Tw 19.619 0 Td
[(12,)37.2 ( 28)]TJ
0.022 Tc -0.198 Tw -23.805 -1.479 Td
(CAR)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
(=)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
[(chimeric )-417.4 (antigen )-417.4 (receptor; )-417.5 (CI)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
(=)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
[(confidence )-417.4 (inter)-18 (val; )-417.5 (CR)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
(=)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
[(complete )-417.5 (response;)22 ( )]TJ
-0.01 Tc 0 -1.062 Td
(MRD)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
1.78 0 Td
(=)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0.621 0 Td
[(Minimal )-257.9 (Residual )-257.9 (Disease; )-257.8 (IMWG)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
12.033 0 Td
(=)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0.621 0 Td
[(Interna)-9.8 (tional )-257.8 (Myeloma )-220.9 (W)18.2 (orking )-257.8 (Group; )-257.8 (PR)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
15.228 0 Td
(=)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0.621 0 Td
[(partial)-10 ( )]TJ
-0.012 Tc 0.048 Tw -30.905 -1.062 Td
[(response; sCR=stringent complete response; )37.2 (VGPR=ver)-17.8 (y good partial response.)]TJ
0.012 Tw 5.32 0 0 5.6 324 340.8391 Tm
(a)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 329 338.175 Tm
(All complete responses were stringent CRs.)Tj
0.012 Tw 5.32 0 0 5.6 324 332.3391 Tm
(b)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 329 329.675 Tm
[(Clopper)37.2 (-P)18.2 (earson exact CI.)]TJ
ET
1 w 
/GS2 gs
q 1 0 0 1 324 303.5132 cm
0 0 m
175.5 0 l
S
Q
q 1 0 0 1 499.5 303.5132 cm
0 0 m
76.5 0 l
S
Q
0.5 w 
q 1 0 0 1 499.5 292.2612 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 499.5 281.7593 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 324 281.5093 cm
0 0 m
175.5 0 l
S
Q
q 1 0 0 1 499.5 281.5093 cm
0 0 m
76.5 0 l
S
Q
q 1 0 0 1 499.5 262.2574 cm
0 0 m
0 19.002 l
S
Q
q 1 0 0 1 499.5 252.0055 cm
0 0 m
0 10.252 l
S
Q
1 w 
q 1 0 0 1 324 251.5055 cm
0 0 m
175.5 0 l
S
Q
q 1 0 0 1 499.5 251.5055 cm
0 0 m
76.5 0 l
S
Q
0.5 w 
q 1 0 0 1 324 204.5936 cm
0 0 m
175.5 0 l
S
Q
q 1 0 0 1 499.5 204.5936 cm
0 0 m
76.5 0 l
S
Q
BT
/GS1 gs
/T1_1 1 Tf
-0.017 Tc 8 0 0 8 324 307.1132 Tm
[(T)74.2 (able 10:)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
5 0 Td
(MRD Negativity Rate in the KarMMa Study)Tj
/T1_0 1 Tf
-0.012 Tc 0.012 Tw 7.6 0 0 8 324 294.7812 Tm
(MRD)Tj
0 Tc -0.21 Tw /Span<</ActualText<FEFF200A>>> BDC 
5.32 0 0 5.6 337.2422 297.4453 Tm
( )Tj
EMC 
0.029 0 Td
(c)Tj
-0.012 Tc 0.048 Tw 7.6 0 0 8 339.6003 294.7812 Tm
[(-nega)-9.8 (tivity ra)-9.7 (te)]TJ
0 Tc -0.21 Tw /Span<</ActualText<FEFF200A>>> BDC 
5.32 0 0 5.6 381.0934 297.4453 Tm
( )Tj
EMC 
0.029 0 Td
(a)Tj
-0.012 Tc 0.048 Tw 7.6 0 0 8 383.5472 294.7812 Tm
[( in all trea)-9.8 (ted pa)-9.8 (tients \(n=100\))]TJ
18.998 0 Td
(21 \(21\))Tj
-26.833 -1.344 Td
(95% CI)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 344.4153 286.6933 Tm
(b)Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 346.8135 284.0293 Tm
[(\035)-47.8 (\(%\))]TJ
0.048 Tw 23.965 0 Td
[(13,)37.2 ( 30)]TJ
0.012 Tw -26.966 -1.344 Td
(MRD)Tj
0 Tc -0.21 Tw /Span<</ActualText<FEFF200A>>> BDC 
5.32 0 0 5.6 337.2422 275.9414 Tm
( )Tj
EMC 
0.029 0 Td
(c)Tj
-0.012 Tc 0.048 Tw 7.6 0 0 8 339.6003 273.2774 Tm
[(-nega)-9.8 (tivity ra)-9.7 (te)]TJ
0 Tc -0.21 Tw /Span<</ActualText<FEFF200A>>> BDC 
5.32 0 0 5.6 381.0934 275.9414 Tm
( )Tj
EMC 
0.029 0 Td
(a)Tj
-0.012 Tc 0.048 Tw 7.6 0 0 8 383.5472 273.2774 Tm
[( in pa)-9.8 (tients achieving CR or)-11.9 ( )]TJ
0 Tc 0 Tw 7.6 0 0 8 461.7431 273.2774 Tm
( )Tj
-0.012 Tc 0.048 Tw 7.6 0 0 8 324 264.7774 Tm
[(sCR sta)-9.8 (tus \(%\) \(n=28\))]TJ
26.833 0.531 Td
(21 \(75\))Tj
-26.833 -1.875 Td
(95% CI)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 344.4153 256.6895 Tm
(b)Tj
7.6 0 0 8 346.8784 254.0255 Tm
(\035)Tj
-0.012 Tc 0.048 Tw 23.956 0 Td
[(55,)37.2 ( 89)-12 ( )]TJ
0.012 Tw 5.32 0 0 5.6 324 244.8576 Tm
(a)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.036 Tw 7.6 0 0 8 329 242.1936 Tm
[(MRD nega)-9.8 (tivity was defined as the proportion of pa)-9.7 (tients with CR or stringent CR who are)-12 ( )]TJ
0.06 Tw 0 -1.062 Td
[(MRD nega)-10.2 (tive a)-10.2 (t an)-10.2 (y timepoint within three months prior to achieving CR or stringent CR)-12 ( )]TJ
0.048 Tw 0 -1.062 Td
[(until the time of progression or dea)-9.8 (th.)]TJ
0.012 Tw 5.32 0 0 5.6 324 219.3576 Tm
(b)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 329 216.6936 Tm
[(Clopper)37.2 (-P)18.2 (earson exact CI.)]TJ
0.012 Tw 5.32 0 0 5.6 324 210.8576 Tm
(c)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 329 208.1936 Tm
(Based on a threshold of 10)Tj
0.012 Tw 5.32 0 0 5.6 403.9097 210.8576 Tm
(-5)Tj
0.048 Tw 7.6 0 0 8 408.2061 208.1936 Tm
[( using ClonoSEQ,)37.2 ( a next-genera)-9.7 (tion sequencing assay \(NGS\).)]TJ
ET
/GS2 gs
q 1 0 0 1 450.06 141.3678 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 450.06 130.6159 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 450.06 119.864 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 450.06 98.3602 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 450.06 87.6083 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 450.06 76.8563 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 450.06 66.3544 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 450.06 47.3525 cm
0 0 m
0 18.502 l
S
Q
1 w 
q 1 0 0 1 323.9999 182.0316 cm
0 0 m
126.06 0 l
S
Q
q 1 0 0 1 450.06 182.0316 cm
0 0 m
125.94 0 l
S
Q
0.5 w 
q 1 0 0 1 450.06 152.3697 cm
0 0 m
0 29.162 l
S
Q
q 1 0 0 1 323.9999 152.1197 cm
0 0 m
126.06 0 l
S
Q
q 1 0 0 1 450.06 152.1197 cm
0 0 m
125.94 0 l
S
Q
q 1 0 0 1 450.06 109.3621 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 323.9999 109.1121 cm
0 0 m
126.06 0 l
S
Q
q 1 0 0 1 450.06 109.1121 cm
0 0 m
125.94 0 l
S
Q
q 1 0 0 1 323.9999 66.1044 cm
0 0 m
126.06 0 l
S
Q
q 1 0 0 1 450.06 66.1044 cm
0 0 m
125.94 0 l
S
Q
1 w 
q 1 0 0 1 323.9999 46.8525 cm
0 0 m
126.06 0 l
S
Q
q 1 0 0 1 450.06 46.8525 cm
0 0 m
125.94 0 l
S
Q
BT
/GS1 gs
/T1_1 1 Tf
-0.017 Tc 8 0 0 8 323.9999 185.6317 Tm
[(T)74.2 (able 11:)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
5 0 Td
[(Duration of Response in the KarMMa Study)-17 ( )]TJ
-0.012 Tc 7.36 0 0 8 472.8771 172.7197 Tm
[(ABECMA-T)74.2 (reated P)24.2 (opulation)]TJ
0 Tc 0 Tw 7.36 0 0 8 553.4328 172.7197 Tm
( )Tj
-0.012 Tc 0.048 Tw 7.36 0 0 8 457.7019 164.2197 Tm
(\(300 to 460 x 10)Tj
0 Tc 0 Tw 5.152 0 0 5.6 504.2957 166.8837 Tm
(6)Tj
-0.012 Tc 0.048 Tw 7.36 0 0 8 506.7058 164.2197 Tm
[( C)18.2 (AR-P)24.2 (ositive T Cells\))]TJ
0.012 Tw -0.406 -1.062 Td
(N=100)Tj
/T1_0 1 Tf
0.048 Tw 7.6 0 0 8 323.9999 143.8878 Tm
[(Dura)-9.7 (tion of Response)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0.012 Tw 5.32 0 0 5.6 383.2364 146.5518 Tm
(a,b)Tj
0.048 Tw 7.6 0 0 8 389.1436 143.8878 Tm
[(\035)-47.8 (\(PR or Better\))]TJ
0 Tc 0 Tw -8.572 -1.344 Td
(n)Tj
-0.012 Tc 0.012 Tw 24.415 0 Td
(72)Tj
0.048 Tw -24.415 -1.344 Td
(Median \(months\))Tj
0.012 Tw 24.067 0 Td
(11.0)Tj
0.048 Tw -24.067 -1.344 Td
(95% CI)Tj
/Span<</ActualText<FEFF200A>>> BDC 
2.669 0 Td
( )Tj
EMC 
20.349 0 Td
[(10.3,)37.2 ( 11.4)]TJ
-23.018 -1.344 Td
[(Dura)-9.7 (tion of Response)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 383.2365 103.5442 Tm
(b)Tj
-0.012 Tc 0.048 Tw 7.6 0 0 8 385.6347 100.8802 Tm
[(\035)-47.8 (for sCR)]TJ
0 Tc 0 Tw -8.11 -1.344 Td
(n)Tj
-0.012 Tc 0.012 Tw 24.415 0 Td
(28)Tj
0.048 Tw -24.415 -1.344 Td
(Median \(months\))Tj
0.012 Tw 24.067 0 Td
(19.0)Tj
0.048 Tw -24.067 -1.344 Td
(95% CI)Tj
/Span<</ActualText<FEFF200A>>> BDC 
2.669 0 Td
( )Tj
EMC 
20.668 0 Td
[(11.4,)37.3 ( NE)]TJ
-23.337 -1.344 Td
[(Median follo)-9.8 (w-up for dura)-9.8 (tion of response)-12 ( )]TJ
0.012 Tw 0 -1.062 Td
(\(DOR\))Tj
0.048 Tw 22.587 0.531 Td
(10.7 months)Tj
/T1_4 1 Tf
0 Tc 0 Tw 8 0 0 8 541.8843 38.3513 Tm
(\()Tj
-0.017 Tc 0.017 Tw 0.224 0 Td
(Continued\))Tj
ET
endstreamendobj40 0 obj<</Metadata 82 0 R>>endobj82 0 obj<</Length 28335/Subtype/XML/Type/Metadata>>stream
<?xpacket begin="Ôªø" id="W5M0MpCehiHzreSzNTczkc9d"?>
<x:xmpmeta xmlns:x="adobe:ns:meta/" x:xmptk="Adobe XMP Core 9.1-c002 79.a6a6396, 2024/03/12-07:48:23        ">
   <rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
      <rdf:Description rdf:about=""
            xmlns:dc="http://purl.org/dc/elements/1.1/"
            xmlns:xmp="http://ns.adobe.com/xap/1.0/"
            xmlns:xmpMM="http://ns.adobe.com/xap/1.0/mm/"
            xmlns:stRef="http://ns.adobe.com/xap/1.0/sType/ResourceRef#"
            xmlns:stEvt="http://ns.adobe.com/xap/1.0/sType/ResourceEvent#"
            xmlns:illustrator="http://ns.adobe.com/illustrator/1.0/"
            xmlns:xmpTPg="http://ns.adobe.com/xap/1.0/t/pg/"
            xmlns:stDim="http://ns.adobe.com/xap/1.0/sType/Dimensions#"
            xmlns:stFnt="http://ns.adobe.com/xap/1.0/sType/Font#"
            xmlns:xmpG="http://ns.adobe.com/xap/1.0/g/"
            xmlns:pdf="http://ns.adobe.com/pdf/1.3/"
            xmlns:ExtensisFontSense="http://www.extensis.com/meta/FontSense/">
         <dc:format>application/postscript</dc:format>
         <dc:title>
            <rdf:Alt>
               <rdf:li xml:lang="x-default">ABECMA_Figure 14.2.1.8.1_v2</rdf:li>
            </rdf:Alt>
         </dc:title>
         <dc:creator>
            <rdf:Seq>
               <rdf:li>(Steve Burgos)</rdf:li>
            </rdf:Seq>
         </dc:creator>
         <xmp:MetadataDate>2024-03-28T12:44:25-04:00</xmp:MetadataDate>
         <xmp:ModifyDate>2024-03-28T12:44:25-04:00</xmp:ModifyDate>
         <xmp:CreateDate>2024-03-28T12:44:25-04:00</xmp:CreateDate>
         <xmp:CreatorTool>Adobe Illustrator 28.3 (Macintosh)</xmp:CreatorTool>
         <xmpMM:InstanceID>xmp.iid:7a4671d5-92a2-45de-a0b1-f1dba88ec67f</xmpMM:InstanceID>
         <xmpMM:DocumentID>xmp.did:7a4671d5-92a2-45de-a0b1-f1dba88ec67f</xmpMM:DocumentID>
         <xmpMM:OriginalDocumentID>uuid:5D20892493BFDB11914A8590D31508C8</xmpMM:OriginalDocumentID>
         <xmpMM:RenditionClass>default</xmpMM:RenditionClass>
         <xmpMM:DerivedFrom rdf:parseType="Resource">
            <stRef:instanceID>uuid:42655d90-0d6e-4642-bd6c-40e6af2288d3</stRef:instanceID>
            <stRef:documentID>xmp.did:219fc2f0-4faa-4a85-821f-13aab714f2b5</stRef:documentID>
            <stRef:originalDocumentID>uuid:5D20892493BFDB11914A8590D31508C8</stRef:originalDocumentID>
            <stRef:renditionClass>default</stRef:renditionClass>
         </xmpMM:DerivedFrom>
         <xmpMM:History>
            <rdf:Seq>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:d599b828-ed96-4490-81fc-c4d51bcca240</stEvt:instanceID>
                  <stEvt:when>2015-02-04T10:49:55-05:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator CC 2014 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:1bd14a16-0efe-40e4-8a1b-b6dc42b79d8b</stEvt:instanceID>
                  <stEvt:when>2015-02-05T08:36:22-05:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator CC 2014 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:25efb995-0525-4acf-947a-7121f5005ef3</stEvt:instanceID>
                  <stEvt:when>2015-02-05T08:45:51-05:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator CC 2014 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:570b4bfa-630e-4a2e-9933-8a586722f5ce</stEvt:instanceID>
                  <stEvt:when>2015-09-09T15:16:34-04:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator CC 2014 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:6b6ce731-ff56-4b03-909d-ed8fb56ccba3</stEvt:instanceID>
                  <stEvt:when>2015-09-10T11:49:56-04:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator CC 2014 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:6577cbb3-82e5-4b41-8272-5ed3fb87fe8b</stEvt:instanceID>
                  <stEvt:when>2015-09-10T12:15:15-04:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator CC 2014 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:7a7d1989-3367-4b49-a2d9-60d4e7d92179</stEvt:instanceID>
                  <stEvt:when>2015-11-03T14:03:36-05:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator CC 2014 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:3f80f38d-f9a5-4154-819d-7b0dd9020509</stEvt:instanceID>
                  <stEvt:when>2015-11-23T13:07:39-05:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator CC 2014 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:2f2b22f4-1b1d-4c29-83a1-c3676cdb1311</stEvt:instanceID>
                  <stEvt:when>2015-11-23T13:19:09-05:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator CC 2014 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:ee43bc4a-76bc-48cb-861f-1d7db6aef4b4</stEvt:instanceID>
                  <stEvt:when>2018-01-09T16:09:06-05:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator CC 2017 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:71260198-f0a5-4516-8f77-f4314126aff7</stEvt:instanceID>
                  <stEvt:when>2018-01-09T16:10:17-05:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator CC 2017 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:35ab0b4a-5b47-4f3e-bf33-db6b679288c7</stEvt:instanceID>
                  <stEvt:when>2018-03-28T20:02:37-04:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator CC 2017 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:580913a1-971d-44b9-ace5-bf195458ff57</stEvt:instanceID>
                  <stEvt:when>2018-04-17T12:48:26-04:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator CC 22.0 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:a162dd44-4f4f-464e-b01a-66f8e5e8a5e7</stEvt:instanceID>
                  <stEvt:when>2019-08-20T09:12:32-04:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator CC 23.0 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:b615bd2b-2b8b-4d77-bde4-bbcc92e06eaf</stEvt:instanceID>
                  <stEvt:when>2019-12-02T14:56:25-05:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator 24.0 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:1edaa293-2a6e-48cc-96e7-99e7e0181e48</stEvt:instanceID>
                  <stEvt:when>2020-06-14T07:25:39-04:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator 24.0 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:a426361b-c649-4336-8dcb-79537c3a08e3</stEvt:instanceID>
                  <stEvt:when>2022-05-13T14:53:19-04:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator 26.2 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:5d77a624-6024-4ee0-89ea-bec841d9ebbc</stEvt:instanceID>
                  <stEvt:when>2023-10-25T13:00:57-04:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator 28.0 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:219fc2f0-4faa-4a85-821f-13aab714f2b5</stEvt:instanceID>
                  <stEvt:when>2024-03-28T12:39:10-04:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator 28.3 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:7a4671d5-92a2-45de-a0b1-f1dba88ec67f</stEvt:instanceID>
                  <stEvt:when>2024-03-28T12:44:25-04:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator 28.3 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
            </rdf:Seq>
         </xmpMM:History>
         <illustrator:StartupProfile>Print</illustrator:StartupProfile>
         <illustrator:CreatorSubTool>Adobe Illustrator</illustrator:CreatorSubTool>
         <xmpTPg:HasVisibleOverprint>False</xmpTPg:HasVisibleOverprint>
         <xmpTPg:HasVisibleTransparency>False</xmpTPg:HasVisibleTransparency>
         <xmpTPg:NPages>1</xmpTPg:NPages>
         <xmpTPg:MaxPageSize rdf:parseType="Resource">
            <stDim:w>7.185000</stDim:w>
            <stDim:h>6.030851</stDim:h>
            <stDim:unit>Inches</stDim:unit>
         </xmpTPg:MaxPageSize>
         <xmpTPg:Fonts>
            <rdf:Bag>
               <rdf:li rdf:parseType="Resource">
                  <stFnt:fontName>HelveticaNeueLTStd-Cn</stFnt:fontName>
                  <stFnt:fontFamily>Helvetica Neue LT Std</stFnt:fontFamily>
                  <stFnt:fontFace>57 Condensed</stFnt:fontFace>
                  <stFnt:fontType>Open Type</stFnt:fontType>
                  <stFnt:versionString>Version 2.035;PS 002.000;hotconv 1.0.51;makeotf.lib2.0.18671</stFnt:versionString>
                  <stFnt:composite>False</stFnt:composite>
                  <stFnt:fontFileName>HelveticaNeueLTStd-Cn.otf</stFnt:fontFileName>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stFnt:fontName>HelveticaNeueLTStd-BdCn</stFnt:fontName>
                  <stFnt:fontFamily>Helvetica Neue LT Std</stFnt:fontFamily>
                  <stFnt:fontFace>77 Bold Condensed</stFnt:fontFace>
                  <stFnt:fontType>Open Type</stFnt:fontType>
                  <stFnt:versionString>Version 2.035;PS 002.000;hotconv 1.0.51;makeotf.lib2.0.18671</stFnt:versionString>
                  <stFnt:composite>False</stFnt:composite>
                  <stFnt:fontFileName>HelveticaNeueLTStd-BdCn.otf</stFnt:fontFileName>
               </rdf:li>
            </rdf:Bag>
         </xmpTPg:Fonts>
         <xmpTPg:PlateNames>
            <rdf:Seq>
               <rdf:li>Black</rdf:li>
            </rdf:Seq>
         </xmpTPg:PlateNames>
         <xmpTPg:SwatchGroups>
            <rdf:Seq>
               <rdf:li rdf:parseType="Resource">
                  <xmpG:groupName>Default Swatch Group</xmpG:groupName>
                  <xmpG:groupType>0</xmpG:groupType>
                  <xmpG:Colorants>
                     <rdf:Seq>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>White</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>Black</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>100.000000</xmpG:black>
                        </rdf:li>
                     </rdf:Seq>
                  </xmpG:Colorants>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <xmpG:groupName>Grays</xmpG:groupName>
                  <xmpG:groupType>1</xmpG:groupType>
                  <xmpG:Colorants>
                     <rdf:Seq>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=0 M=0 Y=0 K=100</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>100.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=0 M=0 Y=0 K=90</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>89.999400</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=0 M=0 Y=0 K=80</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>79.998800</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=0 M=0 Y=0 K=60</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>59.999100</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=0 M=0 Y=0 K=50</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>50.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=0 M=100 Y=100 K=0</xmpG:swatchName>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:tint>100.000000</xmpG:tint>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>100.000000</xmpG:magenta>
                           <xmpG:yellow>100.000000</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=0 M=0 Y=0 K=25</xmpG:swatchName>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:tint>100.000000</xmpG:tint>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>25.000000</xmpG:black>
                        </rdf:li>
                     </rdf:Seq>
                  </xmpG:Colorants>
               </rdf:li>
            </rdf:Seq>
         </xmpTPg:SwatchGroups>
         <pdf:Producer>Adobe PDF library 17.00</pdf:Producer>
         <ExtensisFontSense:slug>
            <rdf:Bag>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>3261192849</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>Helvetica Neue LT Std</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>OpenType - PS</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>3261192849</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Adobe Systems</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>HelveticaNeueLTStd-Cn</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>2.035</ExtensisFontSense:Version>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>3357634683</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>Helvetica Neue LT Std</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>OpenType - PS</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>3357634683</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Adobe Systems</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>HelveticaNeueLTStd-BdCn</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>2.035</ExtensisFontSense:Version>
               </rdf:li>
            </rdf:Bag>
         </ExtensisFontSense:slug>
      </rdf:Description>
   </rdf:RDF>
</x:xmpmeta>
<?xpacket end="r"?>endstreamendobj38 0 obj<</BaseFont/JHWGPK+HelveticaNeueLTStd-BdCn/Encoding/WinAnsiEncoding/FirstChar 32/FontDescriptor 83 0 R/LastChar 122/Subtype/Type1/Type/Font/Widths[240 0 0 0 0 778 0 0 296 296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 740 0 556 519 0 556 519 480 0 0 0 0 0 0 0 0 0 0 0 0 481 500 0 500 463 296 0 500 240 0 0 240 758 500 480 0 0 333 444 296 500 444 0 0 444 426]>>endobj39 0 obj<</BaseFont/JHWGPK+HelveticaNeueLTStd-Cn/Encoding/WinAnsiEncoding/FirstChar 32/FontDescriptor 84 0 R/LastChar 116/Subtype/Type1/Type/Font/Widths[240 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 480 480 480 480 480 480 480 480 480 480 0 0 0 0 0 0 0 500 519 519 0 463 0 0 0 0 0 0 0 704 0 0 481 0 519 500 0 0 0 0 0 0 0 0 0 0 0 0 0 444 0 0 463 444 0 463 0 204 0 444 0 722 463 0 0 0 296 407 259]>>endobj84 0 obj<</Ascent 932/CapHeight 700/CharSet(/space/zero/one/two/three/four/five/six/seven/eight/nine/A/B/C/E/M/P/R/S/a/d/e/g/i/k/m/n/r/s/t)/Descent -212/Flags 32/FontBBox[-164 -212 1000 932]/FontFile3 85 0 R/FontName/JHWGPK+HelveticaNeueLTStd-Cn/FontStretch/Condensed/FontWeight 400/ItalicAngle 0/StemV 75/Type/FontDescriptor/XHeight 500>>endobj85 0 obj<</Filter/FlateDecode/Length 2646/Subtype/Type1C>>stream
HâlUPGûawg—Ë™å£∏»ÃD$*·GTDÇ" ≤ h‚œ
ã. Æ.ÑR$˛R¢5ö≈X"ßòC∏äøQ	 ±jπ¢Æäé¶bY§ﬁ‡#U◊KÍruU©©ÍÓ◊›Ô{Ô˚˙ı4M)›(ö¶Ω„c”&/ökÿêo∞3ıâÜè	©:k÷¥hìkÉèÏEÀ„îÚ¯aúÏ=lÜ·∫∑Eo√TÚƒr“®õ„ﬂôÂA)\Pch:,⁄º±–b\ªŒ*ÖáNÉÉ≈®,ÛÉ®+Ã≥rÛƒ8S¶Ÿ≤—l—[Yb‘Ü‚†Cûh1‰,˘Æ…?íçy¢^¥ZÙYÜ\ΩeΩhŒå&≥µp£Aå&(ƒi≠ë‡ZY¢—$Z◊ƒ¥ ]ÄòL–MVQo SˇN Œ6f'sıÖ"…ÈˇΩ3´ûÙfcs>∂Û≤åôV£Ÿî˜_pì>◊'Yò-¢ë0ÿ@‡My√ˇñÊÆâx?FóÍ2¶ãYÜÏ?ö¢…GçBMp£|)*Ä¢Ç(*Ñ¶>†®4KQÒï@Qâ4•s£"7µòJ¶*©¥'Ωõnt‚∂ŸÌ¥‚=≈Wä; i m jÂ3ïóÍS’∆Ã4´«™w´O™ü∏œpœu?1D=$¢ÿvQÓΩHìv‚EÖM)ÔÍOÿ≈¿ÿƒ·\¯R=äxÖó1PÆ`Véa.õë/sÆ∫,ViäÌÚ3;}FÇI€ä9–Ä,x>(Å‘°Æ≥0Á¿–	»¿[˜¬†Ä⁄ã»íˇvÙA
©Ì‡˛º¶2_ÆnNÇ˘`Í`Ô‹í´9ò2P›¡∞µ˝IjˆŒNøí‡ÓõSæÍ†$X/)‰x'á◊ô˝ç'˛^WÛÀ3œG∑œ^J{s∞§f'ÈQÀKL˝†˙AU\bDˆÍîÂ¸íÂ™9£Ç–S+ã·ßÌ€Û·;ªGù4W˙å9*≈JÏ˝àÖNÓ,#’ßá·∞ƒMÈ€X2k˝˝V!‰3f√ú)0æµ∏Wóf√ó©Ÿ™≠‚o-wµèå}8«¶Ñ·p˝ÚæŒû€«ñ∆ÛÏj~N⁄<û@Øb]àt»ÜÕ4‘u(†Væ≈ï·cåe"Àπ9∞#; Ú±c∂lUª2ÏµCÄìÆó¿*)ö†É{∞Sım›Âœ´√#¢∑†“oZqO-¬§GÊ¿‰&PÄ'¯Gwº˚·GÖÎL|iŸ	–´†Ãâw	?q@ä›„{	LR¥ƒ rî¸=WSﬁé˙O—ä3—Ô.ÅûÌœ€}‡„ø¿´ón*JØ1µÂ0ÜÚ¨‹\≥2Y }ük´ËzI∂ø¨ää 
X9$Ø´MpÎÄì>#OVúë8x»ƒ•¯È}VM0°€'¢˚+Ê L™ÉëgÅn¯ıZg›%˜{ì)üµCë›£Väì ë4ÏõZHÁ–B §‹{~Œ¸iÊ	ûÌΩ[}Í‹-01vT¢2&ô»S+ÓöxˆÕLsfÚT-€´d˜œÍÂ±q¶eã‚ÕÌ∑N\hÿ7®HÊû÷¥¥∑◊$ÑÖÂ$ÑáÁ¥<Â]¡Sƒ%P¥K"∂˜r9á–¬Aø¨0|ãIïªÙAœÖ–«›ÑŒÆ?$îÈòµ€p}zìrŒ5	‰Z‹ÁÊO#€ß>øˇÿsI`{•c¡ÛM1)Ñºzm€Ï±U>»>‹:¶õπ*(`.aÜ™õ¡‘˛ï* ∞=◊|π2ÊæRa*£Ÿcs@•JMX∫c∫…Y˘B◊«<l1¯«¨OpÕ¡R¸€ÇIR÷≠êJÅ™‹z∏ÆµUBPC èfFäÊ˛Õt÷ÆéB∑–œ≤_^ÏêvxúÔÜ˝›3∫ŸŸJπÈªä¸D/‘l-"¸“iˆıã„1≥ ÑnƒùâÌËÎÖÀr»˝è≈ÿ*‘¡*ÅÌÅ¿+0ºæ46'ÏsÇ’I7ë:#èr‚9ÿN¨ ™ûv®§TÊ˜+ªËfIû*)ö«H˝ 2ÇS™$“ı+Ueø)•˛ï8ôAüÅU)È‰159D ´DAáºn@Ç´@30¸_m0Ùb[,`¸Ôtü’fDLM[µHò@ÿ«ªÿ3(eÅãpüÀ˜.º√∞ÚŸ∑˚ó{QQ∂Æ|È◊E„~eÚ~rdÁ£Ì†Ò‹yc›•≈ÂÓD“æßG™⁄ùZPÕ'U»„Wê>¶Ωq’‰ß⁄“ÖÈ‰ﬁ˝ÆÈIiN7J—›ÏC9M>Œ¡ÿ“≈∑qº∆ôqlú¿ﬁ√Ø°Ü‡Jmd⁄≤<˚πùèÖß^ò≥_√FÁŸ{pªp¨–>h®o„ŸáUÈ§ú€ó4√À|p≥{TKÛ: ∫É˝<‰°‹ıa[g˜µøöñ≠¥˝%±ÄGïQ≈6∆‰ØOüßùr.Èóãó´œWÒeõ≥ªﬁv ´ÚËÓœ˜
ÕÍ];wîñxm≤U‡≤˙öÌÜ‚ËÙ4‘n‰ÿ∆‘••¶ú˘±ÒPe’∑¸ôÔ⁄ O÷∏k2äKö‰0Ñmv˝hVt∞`Tr0˙Hª≥´‚]‘ÖDlná—<úëS∏P‹Z ú+»®˛–ßígFâÁQlSc}˝Å$V˜XÌ"kÏ0›N◊J∞î<=£·!wD}j?PR€·˘IºI-≈qß’†.ÚÑo¬˜Qã	Wa,¯ûÜq◊˘P&≥$tˆDålÁˇ#æàﬂ>gøs]˛°u42–°N˜ø›æıΩGë(ÿïLï¶ÊuﬂÅ./¸ÍªˇQQk6·[ÓùÏ[b6JˇñI ™.SGS˙ﬁe;Ê ˜∫≤•ı[¸f ñıÒ©Ûˆ¥Àõ≥˝ñö˘]¥{çÙwÜ´Gøõ»Û˝>,◊î|Õx¸>0ïﬂˇ±∆úÌ.À˝◊Êl|Æ`ôÔQÂåáÄU√úÔèDøõèc’d˚ªõµÛá≠˘ﬂ∏˚ﬂ=Ÿ.‹ˇÆ˘{.Î[`ûIj)˘‡‘˝Ô $"#ºÁ–T6∂˚'o∫–Áë$˜á»eG·
∞üÍ˛ˆ[1$:5¶XÓDU⁄b_È‡¸®R˘N6·;ß¨Ÿ˘"`Ê∫ˇ›˜æéC`#oûXπ„:ö`}r@}7@˙~Á5¶›Ø-_^‘*|®Ô˚s∂'Á7n]6µ£k≤úåªÏ¬'˙õÎ{´§˝≥"äA6Æ∏¨ÏÄÌ
ó≥BKÓ;ﬁˇnuﬂÂ>0ó∞˛‡=’’˙ù·∑Å¥ûm¥˙oÊsgJÂÖüú)=[„,eÔ[W`YyÏ0^CzK˜zÂ–w÷Øûãº≥ÖÁBœÈß§Æü¥Ïƒ‹4w9æﬂì[/ˇ–8Àx˚>ÛÌkDm=o˛acs]ê˛h›¬˛ﬁirÿªö;+•„Êlìˇ˛Ê≈YΩÔ†*xÊœ∏ôøCf~Wô…ˆ}È§Gì˛öÃ^5Ág‹úﬂY”9Ä"Ô'˝y9ùÛ,◊}Ó„'N\Œ√s|q?Ôèë”D QÑâÆendstreamendobj83 0 obj<</Ascent 961/CapHeight 700/CharSet(/space/percent/parenleft/parenright/M/O/P/R/S/T/a/b/d/e/f/h/i/l/m/n/o/r/s/t/u/v/y/z)/Descent -224/Flags 32/FontBBox[-164 -224 1066 961]/FontFile3 86 0 R/FontName/JHWGPK+HelveticaNeueLTStd-BdCn/FontStretch/Condensed/FontWeight 700/ItalicAngle 0/StemV 140/Type/FontDescriptor/XHeight 500>>endobj86 0 obj<</Filter/FlateDecode/Length 2148/Subtype/Type1C>>stream
HâtU{PSWæó‰û‘…"óÀ–†7◊ö:*≥¨µhEGÖU†<D-PC$<Lb 5ï’È»√Wáç≈
X@iKãä–E[ãÎÍ«µÆ≠Ó
≠÷?÷¯ªxÚ«û´;ŒÆì…yﬂ˘~øÛùsiJÈG—4≠Y∂4cIÚ;KMÖNì√l–'ö6òñß•:åëq∆xãºd≤NK!Ji¬8^ö8.«`«ì”O“iÍÔ§„ØM∏L)d≤Pz2='ﬁZ\f3ØÀsàøü=[˜Ü≠”Eãå÷ìòZfwòäÏbÇ≈`µ[mzá…%.(,} ªh3ŸM6ß<¯\éh∂ãz—a”MEz[ÅhÕóõ-VGY±Iå',Q¥ŒLxm&£h∂àé<ìòï%&vãC‘[åb⁄stRnÆŸ`ÚÈÀD¢ÈE¥¡dsËIm%461ÉÕl7ö≥’bFn—ô˛è
´M4ì
	Ω≈n2˝wzIQŒ“®ãS”‰ŒL—h }Y™)ö¸(DQ4EQ:ö˙ÉGSã¸®öZ°†Rï‘ööHRM≠†í©;¥öN¶kÈaø`ø≠~í‚UEÉî© C ;ÃDf>ìŒg°XTÜÓ±ZVœÓ`/±û¸Ω“˝^öî⁄^≈•T1ñÏ≠@PãœÛxÏa`aüÂAÓxw≥^îÌk√<L˙H:√À-,˜T∏[ïÆaÿ8¨óãÜí‡VœëÇ.ó˙ Åˇk›—£GÎÁn7€èﬁ&mÁ1ﬂ≤Ç ®Â"¿ØøàÉp–˙ò∏Âﬁπ0ÚÚû∫ˇ%‰æ,ﬂÌ=≈ﬂE“Ù±
&©[Œ'°%t/Ñ) e,õüÜuzâE5ªp‰¨<("
	w¨b€Åø¬3 ÇÀVﬁ¬Ìò«±j[à˘AP@◊ë ™A‘C‰4–	*04:•!–“g!Lí°gCIc®Áb@Ijià©ÒAÿX66#≠∑ö©DØK’ŒG™fóGjı–†Ö5†Ut¿èãZqBa+DAC.ƒÖ≈8
	†ÖT˜ﬂnﬂv/¿©8Õ7kñÎ§	*W£:=P‰!aka&·Í%çŒÎ&¸k¶>^˝O—‡ù¥ì¯AtµÕ∞(ŒhN—ºC4hˇC»ÒÀ––b¥ú+•G<˜Ë2∫‘ëü0œX¥XìÑ∞÷;Ö'ã˙']GÁ?5ß÷hÍƒjkm±ª‰U–ÌB≈ÓÌG™æØÑàÕ}”˛‰_√rèn6t~˚≥TÒq†Ä?A*ó/Ê‡&≤ë⁄ßU¿LÁFö¿Œ[XˆÌ|xK‡ÆÅÓﬁeà¯…⁄è©Vúd[>h=°Ój8vI‡Æ˜7ój@8Ä`bT?¡f-ƒ¸ üWB»˚w˜Á¸œÌÀ‘IzÎ˚ÛKè	ç¨j%9¶§a.…M=qùw¥dTÅ¨*√5öÏîÁÌ—‡6√,Ò_ÑqNàï¯}lWS[W˜~[Œ:◊¶úr!÷…p=o¨œ…ô¢éˇbˆ/ﬂq|&‘ ŒYWVÁ‹ª—¬ê´Ω¢πW_≤˜/„ò…≥Ù8H¯ÄÂz`'ŒÂìﬂ≥ÁÊn˛‚ÿ…¶÷Åz°°ÆyÔ'nUæÀ3„<ˆ¿¨í‡n‡u∏Õ∞öx®º0XüÑp¿ñ§§ƒ-É `ìô0ƒù:W√Æ>‹ÈÏÊÃ-»ÑÃå[ò…»sÆµh*¡âÙıÁœ©ÁˇF=x·ubíè"|‘ƒ±vV¢„ñº∆åpBÉ35‹)úy&òæŒ∆ﬁ√$h’"◊(Ã˝BFÈ¬<â‹)™˘vfØ
øâ≠Xç…iÔ!∆ŒÑ–¡+0~ßÄÉP¬∂“º¨U/~£9Œ˛†ld{?>◊Ó£¨ŸµÇäWÚË?Vî©#√° H…}ªµªÎèÏ›ª£j/±¡ñ©±Ÿ´m·—i”5âã"Ø∞™|ÇMë#•Â$ÜÅ†Ë&hCÉ-ázéÌw¶^ñ∞Mf=´zﬁ|7”ëµ^®ÑMrñp7Åvî¸H|rö¿NÀõvêâÔî¯l≈Xv…Ûi9CH‰-ÔÕ¯é-¯È?dw ∑Òct±Ìâ#˚lŸÇwú‹g_ËK·Ïø◊û”-[mIq
ï®sV˚Úw◊ñ¨…”T"Óf?˚-§g¸$"Ó˙KB‚æˆµ⁄æ“B∏∏Îﬂ»ËïÆQI5J∑ƒT¢ªçú:NÍû
sjàÓ˚ï8,)ÎW<ßBÉ£”ß‚Â‰^ÖÇﬂÆóˆßëÉSó••.˘¯ë'2ìËàÅ0óœü‹W≤ƒ˝ÜŸ´}üûtÔ´™rylı∂≠’€¬SåÊ´¬WWe—>¡ÕÑ«ëÇü÷‹›fX»ó≤⁄„K`¯ˇc òõ'f"∆¥1Y˚\M-ÍŒ√:æ˛∏8]Ä†&t?y è«Ø•∆Eœ?í9\LÓ˙˝<¶ıèÕõÚ‘k≠N}¶≠ΩGÿœ™>|'»gû‚a©É'Œ¿àL»Í≥∂⁄⁄√¬/l’÷Ú™Úp√÷Ü.ú Ó"o≠¿>Ω,RJ…Ûló¬˜Ú´N¨Ä«P“zKfNYcü ±X )üt:Û«ÛΩœíoC¥œBÙNi±J!íØDÛ$û¡Zo3ÑKåÏöhº°Ù‰È“nºê@“ﬁâ'5*U…Ky˝…«‚m…ﬂáè ¯˜∂óZWÖoŸR]≥E£wÄÜ@IîTäÉ°í
î∏ A\c<^%VÇû≈¯£rπ«≤›8≈Øπ¥Ï˛i∑∑ª±a,ªÁ◊˚ìëáªΩ£ıû@^πR_øk◊Æˇh˙jû˜@z‚‰âyx{x¯æÔ˘±R ¿ kë»Öendstreamendobj33 0 obj<</Length 58805>>stream
q
/GS0 gs
0 TL/Fm0 Do
Q
0 0 0 1 K
0.5 w 
/GS1 gs
q 1 0 0 1 36 478.9081 cm
0 0 m
225.641 0 l
S
Q
BT
0 0 0 1 k
/T1_0 1 Tf
-0.017 Tc 0.017 Tw 8 0 0 8 36 727.248 Tm
[(P)18.2 (edia)-9.7 (tric)]TJ
/T1_1 1 Tf
-0.013 Tc 0.067 Tw 0 -1.539 Td
[(The pharmacokinetics of )36.8 (ABECMA in pa)-9.6 (tients less than 18 years of a)-9.7 (ge ha)-9.6 (ve not been)-13 ( )]TJ
-0.017 Tc 0.017 Tw 0 -1.044 Td
[(evalua)-9.8 (ted.)]TJ
/T1_0 1 Tf
0.048 Tw 0 -1.715 Td
[(P)18.2 (a)-9.8 (tients with Hepa)-9.8 (tic/Renal Impairment)]TJ
/T1_1 1 Tf
0 -1.539 Td
[(Hepa)-9.7 (tic and renal impairment studies of )37.3 (ABECMA were not conducted.)]TJ
/T1_0 1 Tf
0 -1.715 Td
[(P)18.2 (a)-9.8 (tients with Other Intrinsic F)20.2 (actors)]TJ
/T1_1 1 Tf
0.036 Tw 0 -1.539 Td
[(G)0.5 (en)0.5 (de)0.5 (r)74.5 (,)37.4 ( )0.5 (ra)0.5 (ce)0.5 (,)37.5 ( a)0.5 (nd)0.5 ( )0.5 (et)0.5 (hn)0.5 (i)0.5 (ci)0.5 (ty)0.5 ( h)0.5 (a)0.5 (d )0.5 (no)0.5 ( )0.5 (si)0.5 (gn)0.5 (i\037)0.5 (ca)0.5 (n)0.5 (t )0.5 (i)0.5 (mp)0.5 (ac)0.5 (t)0.5 ( o)0.5 (n)0.5 ( )37.4 (A)0.5 (BEC)0.5 (M)0.5 (A )0.5 (ex)0.5 (p)0.5 (an)0.5 (si)0.5 (o)0.5 (n )0.5 (pa)0.5 (r)0.5 (am)0.5 (e)0.5 (te)0.5 (rs)0.5 (.)20 ( )]TJ
0.004 Tc 0.155 Tw 0 -1.044 Td
[(P)17.9 (a)-10.1 (tients )0.5 (with )0.5 (lo)-10.1 (wer bod)-10.1 (y )0.5 (weight had higher )0.5 (expansion.)36.9 ( )0.5 (Due )0.5 (to )0.5 (high )0.5 (variability )0.5 (in)4 ( )]TJ
-0.018 Tc 0.036 Tw 0 -1.044 Td
[(pharmacokinetic cellular expansion,)36.7 ( the overall effect of weight on the pharmacokinetics)-18 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(of )37.2 (ABECMA is considered to be not c)20.2 (linically relevant.)]TJ
/T1_2 1 Tf
0.017 Tw 0 -2.048 Td
(13)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
[(NONCLINIC)18.2 (AL TOXICOLOGY)]TJ
0.017 Tw -3.375 -1.558 Td
(13.1)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
[(Carcinogenesis,)37.2 ( Mutagenesis,)37.2 ( Impairment of F)20.2 (ertility)]TJ
/T1_1 1 Tf
0.01 Tc 0.187 Tw -3.375 -1.584 Td
[(Genotoxicity assays and carcinogenicity studies in rodents were not perf\ormed)10 ( )]TJ
-0.017 Tc 0.011 Tw 0 -1.044 Td
(for ABECMA.)Tj
/T1_0 1 Tf
-0.008 Tc 0.096 Tw 0 -1.764 Td
(In vitro)Tj
/T1_1 1 Tf
[( expansion studies with )0.5 (CAR-positive )37.4 (T cells \(ABECMA\) from \037ve )0.5 (pa)-10.2 (tients and)-8 ( )]TJ
-0.003 Tc 0.117 Tw 0 -1.044 Td
[(two healthy donor drug product lots sho)-9.6 (wed no evidence for transforma)-9.7 (tion and/or)-3 ( )]TJ
-0.013 Tc 0.07 Tw 0 -1.044 Td
[(immortaliza)-10.3 (tion of )36.7 (T cells.)36.8 ( )36.6 (A genomic insertion site analysis of the lentiviral vector was)-13 ( )]TJ
-0.012 Tc 0.075 Tw 0 -1.044 Td
[(performed )0.5 (on )37.5 (ABECMA samples from )0.5 (twenty )0.5 (\(20\) )0.6 (individual )0.5 (pa)-10 (tient )0.5 (donors.)36.9 ( )37.5 (There )0.5 (was)-12 ( )]TJ
-0.016 Tc 0.06 Tw 0 -1.044 Td
[(no evidence for preferential integra)-9.7 (tion near genes of concern or preferential outgro)-9.7 (wth)-16 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(of cells harboring integra)-9.8 (tion sites of concern.)]TJ
0 -1.764 Td
[(No studies on the effects of )37.2 (ABECMA on fertility ha)-9.8 (ve been conducted.)]TJ
/T1_2 1 Tf
0.017 Tw 0 -2.048 Td
(14)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
[(CLINIC)18.3 (AL STUDIES)]TJ
/T1_0 1 Tf
-3.375 -1.67 Td
[(Rela)-9.7 (psed/Refractor)-17.8 (y Multiple Myeloma )37.2 (After )37.2 (T)74.2 (wo to F)20.2 (our Prior Lines of )37.2 (Thera)-9.8 (py)]TJ
/T1_1 1 Tf
0.005 Tc 0.161 Tw 0 -1.629 Td
[(Efficac)19.6 (y of )37 (ABECMA was evalua)-10.3 (ted in KarMMa-3 \(NCT03651128\),)36.7 ( an open-label,)42 ( )]TJ
-0.014 Tc 0.065 Tw 0 -1.044 Td
[(multicenter)73.8 (,)36.9 ( randomized,)36.9 ( controlled stud)-10.1 (y in adult pa)-10.1 (tients with rela)-10.1 (psed and refractor)-18.1 (y)-14 ( )]TJ
-0.013 Tc 0.07 Tw 0 -1.044 Td
[(multiple myeloma who had received two to four prior antimyeloma thera)-10.2 (pies inc)19.8 (luding)-13 ( )]TJ
0 Tc 0.133 Tw 0 -1.044 Td
[(an immunomodula)-9.7 (tor)-17.7 (y a)-9.7 (gent,)37.2 ( a proteasome inhibitor and dara)-9.8 (tumumab,)37.2 ( and were )]TJ
-0.01 Tc 0.086 Tw 0 -1.044 Td
[(refractor)-18.3 (y to the most recent prior antimyeloma regimen.)36.7 ( )37.1 (The stud)-10.3 (y inc)19.7 (luded pa)-10.4 (tients)-9.9 ( )]TJ
-0.005 Tc 0.11 Tw 0 -1.044 Td
[(who achieved a response \(minimal response or better\) to a)-10.2 (t least 1 prior trea)-10.2 (tment)-5 ( )]TJ
-0.015 Tc 0.06 Tw 0 -1.044 Td
[(r)0.5 (eg)0.5 (im)0.5 (e)0.5 (n )0.5 (a)0.5 (nd)0.5 ( )0.5 (ha)0.5 (d )0.5 (E)0.5 (CO)0.5 (G)0.5 ( p)0.5 (e)0.5 (rf)0.5 (o)0.5 (rm)0.5 (a)0.5 (nc)0.5 (e )0.5 (s)0.5 (ta)-9.5 (t)0.5 (us)0.5 ( )0.5 (of)0.5 ( )0.5 (0 )0.5 (o)0.5 (r )0.5 (1)0.5 (.)37.4 ( )37.5 (Th)0.5 (e)0.5 ( s)0.5 (tu)0.5 (d)-9.5 (y )0.5 (e)0.5 (xc)20.5 (lu)0.5 (d)0.5 (ed)0.5 ( p)0.5 (a)-9.5 (ti)0.5 (e)0.5 (nt)0.5 (s)0.5 ( w)0.5 (i)0.5 (th)-15 ( )]TJ
-0.008 Tc 0.096 Tw 0 -1.044 Td
[(serum crea)-10.3 (tinine c)19.6 (learance <45 mL/min,)36.6 ( serum asparta)-10.4 (te aminotransferase \(AST\) or)-8 ( )]TJ
-0.007 Tc 0.098 Tw 0 -1.044 Td
[(alanine aminotransferase \(AL)94.1 (T\) >2.5 times upper limit of normal,)37.1 ( and left ventricular)-7 ( )]TJ
-0.014 Tc 0.064 Tw 0 -1.044 Td
[(ejection fraction \(L)74 (VEF\) <45%.)36.9 ( P)18 (a)-10.1 (tients were also exc)19.9 (luded if absolute neutrophil count)-14 ( )]TJ
-0.011 Tc 0.078 Tw 0 -1.044 Td
[(<1000/\265L and pla)-9.8 (telet count <75,000/\033L in pa)-9.8 (tients in whom <50% of bone marro)-9.8 (w)-11 ( )]TJ
-0.007 Tc 0.1 Tw 0 -1.044 Td
[(nuc)19.8 (lea)-10.1 (ted cells are plasma cells and pla)-10 (telet count <50,000/\033L in pa)-10.1 (tients in whom)-6.9 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(\03450% of bone marro)-9.8 (w nuc)20.2 (lea)-9.8 (ted cells are plasma cells.)]TJ
0.001 Tc 0.136 Tw 0 -1.764 Td
[(I)0.6 (n)0.5 ( t)0.6 (o)0.6 (t)0.5 (a)0.6 (l)0.6 (,)37.5 ( 3)0.6 (8)0.6 (6)0.5 ( p)0.6 (a)-9.4 (t)0.5 (i)0.6 (e)0.6 (n)0.5 (t)0.6 (s)0.6 ( w)0.5 (e)0.6 (r)0.6 (e)0.6 ( r)0.5 (a)0.6 (n)0.6 (d)0.5 (o)0.6 (m)0.6 (i)0.5 (z)0.6 (e)0.6 (d)0.5 ( 2)0.6 (:)0.6 (1)0.5 ( t)0.6 (o)0.6 ( r)0.6 (e)0.5 (c)0.6 (e)0.6 (i)0.5 (v)0.6 (e)0.6 ( e)0.6 (i)0.5 (t)0.6 (h)0.5 (e)0.6 (r)0.6 ( )37.3 (A)0.5 (B)0.6 (E)0.6 (C)0.5 (M)0.6 (A)0.5 ( \()0.5 (N)]TJ
/Span<</ActualText<FEFF2009>>> BDC 
27.849 0 Td
( )Tj
EMC 
0.125 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
0.6 0 Td
( )Tj
EMC 
0.125 0 Td
[(2)0.6 (5)0.5 (4)0.6 (\))0.5 ( o)0.5 (r)1 ( )]TJ
0.006 Tc 0.163 Tw -28.7 -1.044 Td
(standard regimens \(N)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
8.531 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
0.737 0 Td
[(132\).)37.2 ( )37.3 (The standard regimens consisted of dara)-9.8 (tumumab,)43 ( )]TJ
-9.268 -1.044 Td
[(pomalidomide,)37.2 ( dexamethasone [DPd],)37.1 ( dara)-9.9 (tumumab,)37.2 ( bortezomib,)37.2 ( dexamethasone)6 ( )]TJ
-0.011 Tc 0.081 Tw 0 -1.044 Td
[([DVd],)36.7 ( ixazomib,)36.7 ( lenalidomide,)36.7 ( dexamethasone [IRd],)36.6 ( car\037lzomib,)36.6 ( dexamethasone [Kd],)26 ( )]TJ
-0.003 Tc 0.12 Tw 0 -1.044 Td
[(or elotuzumab,)36.8 ( pomalidomide,)36.7 ( dexamethasone [EPd]\),)36.8 ( selected by Investiga)-10.2 (tor prior)-3 ( )]TJ
-0.004 Tc 0.111 Tw 0 -1.044 Td
[(t)0.5 (o)0.6 ( r)0.5 (a)0.6 (n)0.5 (d)0.5 (o)0.6 (m)0.5 (i)0.5 (z)0.6 (a)-9.5 (t)0.5 (i)0.6 (o)0.5 (n)0.5 ( c)0.5 (o)0.6 (n)0.5 (t)0.5 (i)0.5 (n)0.6 (g)0.5 (e)0.5 (n)0.6 (t)0.5 ( u)0.6 (p)0.5 (o)0.5 (n)0.6 ( t)0.5 (h)0.6 (e)0.5 ( p)0.6 (a)-9.5 (t)0.5 (i)0.5 (e)0.6 (n)0.5 (t)0.6 (\222)55.5 (s)0.5 ( m)0.5 (o)0.5 (s)0.6 (t)0.5 ( r)0.6 (e)0.5 (c)0.5 (e)0.6 (n)0.5 (t)0.5 ( a)0.5 (n)0.5 (t)0.6 (i)0.5 (m)0.5 (y)0.6 (e)0.5 (l)0.5 (o)0.6 (m)0.5 (a)0.5 ( t)0.5 (r)0.5 (e)0.6 (a)-9.5 (t)0.6 (m)0.5 (e)0.5 (n)0.6 (t)0.5 (.)33 ( )]TJ
0.001 Tc 0.137 Tw 0 -1.044 Td
[(Randomiza)-9.6 (tion was stra)-9.6 (ti\037ed by a)-9.6 (ge,)37.4 ( number of prior antimyeloma regimens,)37.4 ( and)1 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(presence of high-risk c)20.2 (ytogenetics abnormalities.)]TJ
0.007 Tc 0.167 Tw 0 -1.764 Td
[(P)18.3 (a)-9.7 (tients randomized to )36.6 (ABECMA were to receive lymphodepleting chemothera)-9.8 (py)7 ( )]TJ
-0.018 Tc 0.036 Tw 0 -1.044 Td
[(consisting of c)20.3 (yc)20.3 (lophosphamide \(300 mg/m)]TJ
0 Tc 0 Tw 5.6 0 0 5.6 160.2011 274.3221 Tm
(2)Tj
-0.018 Tc 0.036 Tw 8 0 0 8 162.7864 271.6581 Tm
[( IV infusion daily for 3 days\) and \036udarabine)-18 ( )]TJ
-15.848 -1.044 Td
(\(30 mg/m)Tj
0 Tc 0 Tw 5.6 0 0 5.6 64.16 265.972 Tm
(2)Tj
-0.018 Tc 0.036 Tw 8 0 0 8 66.7487 263.308 Tm
[( IV infusion daily for 3 days\) starting 5 days prior to the target infu\sion da)-10.2 (te of)-18 ( )]TJ
-0.015 Tc 0.06 Tw -3.844 -1.044 Td
[(ABECMA.)37.1 ( Up to 1 c)20.1 (yc)20.2 (le of DPd,)37.2 ( DVd,)37.2 ( IRd,)37.1 ( Kd or EPd bridging thera)-9.8 (py)55.2 (,)37.2 ( dependent on the)-15 ( )]TJ
-0.018 Tc 0.036 Tw 0 -1.044 Td
[(pa)-9.7 (tient\222)55.3 (s most recent antimyeloma trea)-9.7 (tment regimen,)37.3 ( was permitted for disease control)-18 ( )]TJ
-0.017 Tc 0.044 Tw 0 -1.044 Td
[(between a)-9.8 (pheresis and until 14 days before the start of lymphodepleting chemother\a)-9.8 (py)55.2 (.)]TJ
-0.004 Tc 0.111 Tw 0 -1.764 Td
[(O)0.5 (f)0.5 ( t)0.6 (h)0.5 (e)0.5 ( 2)0.5 (5)0.5 (4)0.5 ( p)0.5 (a)-9.5 (t)0.5 (i)0.5 (e)0.5 (n)0.5 (t)0.6 (s)0.5 ( r)0.5 (a)0.5 (n)0.5 (d)0.6 (o)0.5 (m)0.5 (i)0.5 (z)0.5 (e)0.5 (d)0.5 ( t)0.5 (o)0.5 ( r)0.5 (e)0.6 (c)0.5 (e)0.5 (i)0.5 (v)0.5 (e)0.5 ( )37 (A)0.6 (B)0.5 (E)0.5 (C)0.5 (M)0.5 (A)0.5 (,)37.5 ( 2)0.5 (4)0.5 (9)0.5 ( \()0.5 (9)0.5 (8)0.5 (%)0.5 (\))0.5 ( p)0.6 (a)-9.5 (t)0.5 (i)0.5 (e)0.5 (n)0.5 (t)0.5 (s)0.6 ( u)0.5 (n)0.5 (d)0.5 (e)0.5 (r)0.5 (w)0.5 (e)0.6 (n)0.5 (t)-4 ( )]TJ
-0.017 Tc 0.017 Tw 0 -1.044 Td
[(leuka)-9.7 (pheresis:)]TJ
0 -1.647 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.008 Tc 0.091 Tw 1.125 0 Td
[(F)18.5 (i)0.6 (v)0.5 (e)0.6 ( \()0.6 (2)0.5 (%)0.6 (\))0.5 ( p)0.6 (a)-9.5 (t)0.6 (i)0.5 (e)0.6 (n)0.5 (t)0.6 (s)0.5 ( d)0.6 (i)0.5 (d)0.6 ( n)0.6 (o)0.5 (t)0.6 ( r)0.5 (e)0.6 (c)0.5 (e)0.6 (i)0.5 (v)0.6 (e)0.5 ( l)0.5 (e)0.6 (u)0.5 (k)0.5 (a)-9.4 (p)0.6 (h)0.5 (e)0.6 (r)0.5 (e)0.6 (s)0.5 (i)0.6 (s)0.5 ( d)0.6 (u)0.5 (e)0.6 ( t)0.5 (o)0.6 ( p)0.6 (a)-9.5 (t)0.6 (i)0.5 (e)0.6 (n)0.5 (t)0.6 ( w)0.5 (i)0.6 (t)0.5 (h)0.6 (d)0.5 (r)0.6 (a)-9.5 (w)0.6 (a)0.5 (l)0.6 ( \()0.5 (n)]TJ
/Span<</ActualText<FEFF2009>>> BDC 
28.644 0 Td
( )Tj
EMC 
0.116 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
0.591 0 Td
( )Tj
EMC 
0.116 0 Td
[(2)0.5 (\))0.6 (,)29 ( )]TJ
-0.006 Tc 0.101 Tw -29.468 -1.062 Td
[(a)0.5 (d)0.6 (v)0.5 (e)0.6 (r)0.6 (s)0.5 (e)0.6 ( e)0.6 (v)0.5 (e)0.6 (n)0.5 (t)0.6 ( \()0.6 (n)]TJ
/Span<</ActualText<FEFF2009>>> BDC 
6.202 0 Td
( )Tj
EMC 
0.118 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
0.593 0 Td
( )Tj
EMC 
0.118 0 Td
[(1)0.5 (\))0.6 ( o)0.6 (r)0.5 ( f)0.5 (a)0.6 (i)0.6 (l)0.5 (u)0.5 (r)0.6 (e)0.5 ( t)0.5 (o)0.6 ( m)0.6 (e)0.5 (e)0.6 (t)0.6 ( l)0.6 (y)0.5 (m)0.6 (p)0.5 (h)0.6 (o)0.5 (d)0.6 (e)0.5 (p)0.6 (l)0.5 (e)0.6 (t)0.5 (i)0.5 (n)0.6 (g)0.5 ( c)0.5 (h)0.6 (e)0.5 (m)0.6 (o)0.6 (t)0.5 (h)0.6 (e)0.5 (r)0.6 (a)-9.5 (p)0.6 (y)0.5 ( t)0.6 (r)0.6 (e)0.5 (a)-9.4 (t)0.5 (m)0.6 (e)0.6 (n)0.5 (t)-6 ( )]TJ
-0.017 Tc -0.115 Tw -7.032 -1.062 Td
[(criteria )-162.8 (\(n)]TJ
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
(2\).)Tj
0.017 Tw -1.125 -1.512 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.001 Tc 0.126 Tw 1.125 0 Td
[(T)74.4 (wen)0.5 (ty-fo)0.5 (ur \()0.5 (10%\) pa)-9.6 (t)0.5 (ients did not recei)0.5 (ve )36.5 (AB)0.5 (ECMA e)0.5 (ithe)0.5 (r due)0.5 ( to)0.5 ( dea)-9.5 (th \(n)]TJ
/Span<</ActualText<FEFF2009>>> BDC 
28.608 0 Td
( )Tj
EMC 
0.124 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
0.722 0 Td
[(4\),)36 ( )]TJ
-0.003 Tc 0.118 Tw -29.454 -1.062 Td
(adverse event \(n)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
6.412 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
0.719 0 Td
[(4\),)37.1 ( physician decision \(n)]TJ
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
9.281 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
0.719 0 Td
[(7\),)37.1 ( failure to meet lymphodepleting)-3 ( )]TJ
-0.017 Tc 0.048 Tw -17.13 -1.062 Td
[(chemothera)-9.8 (py trea)-9.8 (tment criteria \(n)]TJ
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
12.548 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
0.691 0 Td
[(6\) or inability to manufacture product \(n=3\).)20 ( )]TJ
0.017 Tw -14.363 -1.512 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.018 Tc 0.036 Tw 1.125 0 Td
[(Three \(1.2%\) pa)-10.2 (tients received CAR-positive )36.7 (T cells tha)-10.2 (t did not meet product release)-18 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.062 Td
[(speci\037ca)-9.7 (tions for )37.2 (ABECMA \(non-conforming product; n)]TJ
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
19.565 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
0.691 0 Td
(3\).)Tj
-0.01 Tc 0.086 Tw -21.381 -1.629 Td
[(The overall manufacturing failure ra)-10.3 (te for pa)-10.3 (tients who underwent leuka)-10.3 (pheresis was)-10 ( )]TJ
-0.012 Tc 0.071 Tw 0 -1.044 Td
[(2.)0.5 (4%)0.5 ( \()0.5 (6 o)0.5 (ut o)0.5 (f 24)0.5 (9 pa)-9.5 (ti)0.5 (en)0.5 (ts\))0.5 (.)37.4 ( Of)0.5 ( the)0.5 (se)0.5 ( six)0.5 ( pa)-9.5 (tie)0.5 (nt)0.5 (s,)37.4 ( t)0.5 (hr)0.5 (ee r)0.5 (ec)0.5 (eiv)0.5 (e)0.5 (d CAR)0.5 ( po)0.5 (sit)0.5 (ive)0.5 ( )36.6 (T ce)0.5 (ll)0.5 (s)-12 ( )]TJ
-0.017 Tc 0.04 Tw 0 -1.044 Td
[(tha)-9.8 (t did not meet product release speci\037ca)-9.8 (tions for )36.6 (ABECMA,)37.1 ( and in three pa)-9.7 (tients there)-16.9 ( )]TJ
0.048 Tw 0 -1.044 Td
[(was an inability to manufacture )37.3 (ABECMA.)]TJ
-0.001 Tc 0.13 Tw 0 -1.764 Td
[(Most pa)-10.1 (tients \(85%\) trea)-10.1 (ted with )37 (ABECMA received bridging thera)-10.1 (py for control of)-1 ( )]TJ
0.003 Tc 0.148 Tw 0 -1.044 Td
[(their )0.6 (multiple )0.5 (myeloma )0.6 (during )0.6 (the )0.5 (manufacturing )0.6 (process.)37.2 ( )37.6 (The )0.5 (median )0.5 (time )0.6 (from)3 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(leuka)-9.7 (pheresis to product a)-9.8 (vailability was 35 days \(range:)37.2 ( 24 to 102 days\).)]TJ
-0.015 Tc 0.06 Tw 0 -1.764 Td
[(In overall stud)-10.2 (y popula)-10.2 (tion,)36.7 ( the median a)-10.2 (ge was 63 years \(range:)36.8 ( 30 to 83 years\),)36.8 ( 61%)-15 ( )]TJ
-0.006 Tc 0.103 Tw 0 -1.044 Td
[(were male,)37.1 ( 65% were white,)37.1 ( 9.3% were black and 3.1% were )36.8 (Asian.)37.1 ( Most pa)-9.9 (tients)-6 ( )]TJ
0.005 Tc 0.161 Tw 0 -1.044 Td
[(\(80%\) were Revised Interna)-10.4 (tional Sta)-10.4 (ging System \(R-ISS\) Sta)-10.3 (ge I or II.)36.6 ( High-risk)5 ( )]TJ
-0.002 Tc 0.125 Tw 36 86.379 Td
[(c)19.8 (ytogenetics [presence of t\(4:14\),)36.7 ( \(14:16\),)36.8 ( and 17p13 del] were present in 42% of)-2 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(pa)-9.8 (tients.)37.2 ( )37.2 (T)74.2 (wenty-four percent of pa)-9.7 (tients had presence of extramedullar)-17.8 (y disease.)]TJ
-0.012 Tc 0.076 Tw 0 -1.764 Td
[(The median number of prior lines of thera)-10.3 (py was 3 \(range:)36.7 ( 2 to 4\).)36.8 ( )37.2 (Thirty percent had)-12 ( )]TJ
-0.017 Tc 0.06 Tw 0 -1.044 Td
[(received 2 prior lines,)36.9 ( 37% had received 3 prior lines of thera)-10.1 (py and 32% had received)-17 ( )]TJ
0 -1.044 Td
[(4 prior lines of thera)-10.1 (py)54.9 (.)36.9 ( Ninety-\037ve percent were refractor)-18 (y to an anti-CD38 monoc)19.9 (lonal)-17 ( )]TJ
0.042 Tw 0 -1.044 Td
[(antibod)-9.8 (y)55.2 (.)37.2 ( Sixty-six percent were triple c)20.2 (lass refractor)-17.8 (y \(refractor)-17.7 (y to a PI,)37.2 ( an IMiD and an)-17 ( )]TJ
-0.019 Tc 0.036 Tw 0 -1.044 Td
[(anti-CD38 monoc)20.2 (lonal antibod)-9.8 (y\),)37.2 ( and 5% were penta-drug-refractor)-17.7 (y \(refractor)-17.7 (y to 2 PIs,)18 ( )]TJ
-0.012 Tc 0.072 Tw 0 -1.044 Td
[(2 IMiD a)-9.7 (gents,)37.3 ( and an anti-CD38 monoc)20.4 (lonal antibod)-9.6 (y\).)37.4 ( Eighty-\037ve percent of pa)-9.7 (tients)-12 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(had received prior autologous stem cell transplanta)-9.7 (tion.)]TJ
-0.006 Tc 0.102 Tw 0 -1.764 Td
[(The primar)-17.6 (y ef\037cac)20.3 (y measure was progression free sur)-17.7 (vival \(PFS\) as determined by)-6 ( )]TJ
-0.001 Tc 0.131 Tw 0 -1.044 Td
[(Independent Review Committee \(IRC\) based on the Interna)-10.2 (tional Myeloma )37.3 (W)17.8 (orking)-1 ( )]TJ
-0.02 Tc 0.036 Tw 0 -1.044 Td
(Group \(IMWG\) Uniform Response Criteria)Tj
0 Tc 0 Tw 5.6 0 0 5.6 439.0051 626.5421 Tm
(2)Tj
-0.02 Tc 0.036 Tw 8 0 0 8 441.5834 623.8781 Tm
[( for Multiple Myeloma.)36.6 ( Other ef\037cac)19.5 (y measures)-20 ( )]TJ
0 Tc 0.134 Tw -14.698 -1.044 Td
[(inc)20 (luded overall response ra)-10 (te \(ORR\) and overall sur)-18 (vival \(OS\).)37 ( Ef\037cac)19.9 (y results are )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(summarized in )37.2 (T)74.2 (able 8,)37.2 ( and Ka)-9.8 (plan-Meier cur)-17.8 (ve for PFS is provided in F)18.2 (igure 2.)20 ( )]TJ
0.014 Tc 0.202 Tw 0 -1.764 Td
[(The estima)-9.7 (ted median dura)-9.7 (tion of follo)-9.6 (w-up a)-9.6 (t the primar)-17.6 (y PFS analysis was)14 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(15.9 months \(95% CI:)37.2 ( 14.1,)37.2 ( 18.0\).)]TJ
ET
/GS2 gs
q 1 0 0 1 324 307.3955 cm
0 0 m
104.4 0 l
S
Q
q 1 0 0 1 428.4 307.3955 cm
0 0 m
74.13 0 l
S
Q
q 1 0 0 1 502.53 307.3955 cm
0 0 m
74.13 0 l
S
Q
1 w 
q 1 0 0 1 324 551.0261 cm
0 0 m
104.4 0 l
S
Q
q 1 0 0 1 502.53 551.0261 cm
0 0 m
74.13 0 l
S
Q
0.5 w 
q 1 0 0 1 324 529.6142 cm
0 0 m
104.4 0 l
S
Q
q 1 0 0 1 502.53 529.6142 cm
0 0 m
74.13 0 l
S
Q
1 w 
q 1 0 0 1 428.4 551.0261 cm
0 0 m
74.13 0 l
S
Q
0.5 w 
q 1 0 0 1 428.4 529.8642 cm
0 0 m
0 20.662 l
S
Q
q 1 0 0 1 502.53 529.8642 cm
0 0 m
0 20.662 l
S
Q
q 1 0 0 1 428.4 529.6142 cm
0 0 m
74.13 0 l
S
Q
q 1 0 0 1 324 518.8622 cm
0 0 m
104.4 0 l
S
Q
q 1 0 0 1 428.4 518.8622 cm
0 0 m
74.13 0 l
S
Q
q 1 0 0 1 428.4 508.3604 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 502.53 518.8622 cm
0 0 m
74.13 0 l
S
Q
q 1 0 0 1 502.53 508.3604 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 324 508.1104 cm
0 0 m
104.4 0 l
S
Q
q 1 0 0 1 428.4 508.1104 cm
0 0 m
74.13 0 l
S
Q
q 1 0 0 1 428.4 497.6085 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 502.53 508.1104 cm
0 0 m
74.13 0 l
S
Q
q 1 0 0 1 502.53 497.6085 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 324 497.3585 cm
0 0 m
104.4 0 l
S
Q
q 1 0 0 1 428.4 497.3585 cm
0 0 m
74.13 0 l
S
Q
q 1 0 0 1 428.4 486.8565 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 502.53 497.3585 cm
0 0 m
74.13 0 l
S
Q
q 1 0 0 1 324 486.6065 cm
0 0 m
104.4 0 l
S
Q
q 1 0 0 1 428.4 486.6065 cm
0 0 m
74.13 0 l
S
Q
q 1 0 0 1 428.4 476.1046 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 502.53 486.6065 cm
0 0 m
74.13 0 l
S
Q
q 1 0 0 1 502.53 454.3508 cm
0 0 m
74.13 0 l
S
Q
q 1 0 0 1 502.53 422.095 cm
0 0 m
74.13 0 l
S
Q
q 1 0 0 1 502.53 411.3431 cm
0 0 m
74.13 0 l
S
Q
q 1 0 0 1 502.53 400.5912 cm
0 0 m
74.13 0 l
S
Q
q 1 0 0 1 502.53 389.8393 cm
0 0 m
74.13 0 l
S
Q
1 w 
q 1 0 0 1 502.53 379.0874 cm
0 0 m
74.13 0 l
S
Q
0.5 w 
q 1 0 0 1 324 475.8546 cm
0 0 m
104.4 0 l
S
Q
q 1 0 0 1 428.4 475.8546 cm
0 0 m
74.13 0 l
S
Q
q 1 0 0 1 502.53 475.8546 cm
0 0 m
74.13 0 l
S
Q
q 1 0 0 1 502.53 465.1027 cm
0 0 m
74.13 0 l
S
Q
q 1 0 0 1 324 465.1027 cm
0 0 m
104.4 0 l
S
Q
q 1 0 0 1 428.4 465.1027 cm
0 0 m
74.13 0 l
S
Q
q 1 0 0 1 428.4 454.6008 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 502.53 454.6008 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 324 454.3508 cm
0 0 m
104.4 0 l
S
Q
q 1 0 0 1 428.4 454.3508 cm
0 0 m
74.13 0 l
S
Q
q 1 0 0 1 428.4 443.8489 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 502.53 443.8489 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 324 443.5989 cm
0 0 m
104.4 0 l
S
Q
q 1 0 0 1 428.4 443.5989 cm
0 0 m
74.13 0 l
S
Q
q 1 0 0 1 428.4 433.097 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 502.53 443.5989 cm
0 0 m
74.13 0 l
S
Q
q 1 0 0 1 324 432.847 cm
0 0 m
104.4 0 l
S
Q
q 1 0 0 1 428.4 432.847 cm
0 0 m
74.13 0 l
S
Q
q 1 0 0 1 428.4 422.345 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 502.53 432.847 cm
0 0 m
74.13 0 l
S
Q
q 1 0 0 1 502.53 422.345 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 324 422.095 cm
0 0 m
104.4 0 l
S
Q
q 1 0 0 1 428.4 422.095 cm
0 0 m
74.13 0 l
S
Q
q 1 0 0 1 428.4 411.5931 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 502.53 411.5931 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 324 411.3431 cm
0 0 m
104.4 0 l
S
Q
q 1 0 0 1 428.4 411.3431 cm
0 0 m
74.13 0 l
S
Q
q 1 0 0 1 428.4 400.8412 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 502.53 400.8412 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 324 400.5912 cm
0 0 m
104.4 0 l
S
Q
q 1 0 0 1 428.4 400.5912 cm
0 0 m
74.13 0 l
S
Q
q 1 0 0 1 428.4 390.0893 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 502.53 390.0893 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 324 389.8393 cm
0 0 m
104.4 0 l
S
Q
q 1 0 0 1 428.4 389.8393 cm
0 0 m
74.13 0 l
S
Q
q 1 0 0 1 428.4 379.5874 cm
0 0 m
0 10.002 l
S
Q
q 1 0 0 1 502.53 379.5874 cm
0 0 m
0 10.002 l
S
Q
1 w 
q 1 0 0 1 324 379.0874 cm
0 0 m
104.4 0 l
S
Q
q 1 0 0 1 428.4 379.0874 cm
0 0 m
74.13 0 l
S
Q
BT
/GS1 gs
/T1_2 1 Tf
8 0 0 8 324 563.1261 Tm
[(T)74.2 (able 8:)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
5 0 Td
[(Summar)-17.7 (y of Efficac)10.2 (y Results from KarMMa-3 \(Intent-to-T)74.2 (reat)-17 ( )]TJ
0.017 Tw 0 -1.062 Td
[(P)24.2 (opulation\))-17 ( )]TJ
-0.012 Tc 0.048 Tw 7.36 0 0 8 446.1408 541.7142 Tm
(ABECMA Arm)Tj
0 Tc 0 Tw 7.36 0 0 8 484.7892 541.7142 Tm
( )Tj
-0.012 Tc -0.115 Tw 7.36 0 0 8 453.1063 533.2142 Tm
(\(N)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
(254\))Tj
0.048 Tw 7.012 1.062 Td
[(Standard Regimens Arm)-12 ( )]TJ
0 Tc 0 Tw 7.36 0 0 8 575.8254 541.7142 Tm
( )Tj
-0.012 Tc -0.115 Tw 7.36 0 0 8 527.3613 533.2142 Tm
(\(N)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
(132\))Tj
0.048 Tw 7.6 0 0 8 324 521.3823 Tm
[(Progression Free Sur)-17.7 (viv)16.2 (al \(PFS\))]TJ
/T1_1 1 Tf
/Span<</ActualText<FEFF0009>>> BDC 
0 -1.344 Td
( )Tj
EMC 
0.592 0 Td
[(Number of events,)37.2 ( n \(%\))]TJ
16.479 0 Td
(149 \(59\))Tj
10.004 0 Td
(93 \(70\))Tj
/Span<</ActualText<FEFF0009>>> BDC 
-27.076 -1.344 Td
( )Tj
EMC 
0.592 0 Td
[(Median,)37.2 ( months [95% CI])]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 398.843 502.5424 Tm
(a)Tj
7.6 0 0 8 401.205 499.8784 Tm
(\035)Tj
-0.012 Tc 0.048 Tw 5.384 0 Td
[(13.3 [11.8,)37.2 ( 16.1])]TJ
10.472 0 Td
[(4.4 [3.4,)37.2 ( 5.9])]TJ
/Span<</ActualText<FEFF0009>>> BDC 
-26.015 -1.344 Td
( )Tj
EMC 
0.592 0 Td
[(Hazard Ra)-9.7 (tio [95% CI])]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 389.6802 491.7905 Tm
(b)Tj
7.6 0 0 8 392.1434 489.1265 Tm
(\035)Tj
-0.012 Tc 0.048 Tw 11.47 0 Td
[(0.49 [0.38,)37.3 ( 0.64])]TJ
/Span<</ActualText<FEFF0009>>> BDC 
-20.436 -1.344 Td
( )Tj
EMC 
0.592 0 Td
(One-sided p-value)Tj
0 Tc 0 Tw 5.32 0 0 5.6 379.0586 481.0386 Tm
(c)Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 490.6212 478.3746 Tm
(<0.0001)Tj
/T1_2 1 Tf
0.048 Tw -21.924 -1.344 Td
(Overall Response Rate \(ORR\),)Tj
/Span<</ActualText<FEFF2004>>> BDC 
11.388 0 Td
( )Tj
EMC 
0.321 0 Td
(n \(%\))Tj
/T1_1 1 Tf
/Span<</ActualText<FEFF0009>>> BDC 
-11.709 -1.344 Td
( )Tj
EMC 
0.592 0 Td
(n \(%\))Tj
16.479 0 Td
(181 \(71\))Tj
10.004 0 Td
(55 \(42\))Tj
/Span<</ActualText<FEFF0009>>> BDC 
-27.076 -1.344 Td
( )Tj
EMC 
0.592 0 Td
(95% CI \(%\))Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 360.1644 448.7829 Tm
(d)Tj
7.6 0 0 8 362.6276 446.1189 Tm
(\035)Tj
-0.012 Tc 0.048 Tw 12.127 0 Td
[(\(66,)37.2 ( 77\))]TJ
9.77 0 Td
[(\(33,)37.2 ( 50\))]TJ
/Span<</ActualText<FEFF0009>>> BDC 
-26.98 -1.344 Td
( )Tj
EMC 
0.592 0 Td
(One-sided p-value)Tj
0 Tc 0 Tw 5.32 0 0 5.6 379.0586 438.0309 Tm
(e)Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 490.6212 435.3669 Tm
(<0.0001)Tj
0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
-21.924 -1.344 Td
( )Tj
EMC 
0.592 0 Td
(CR or better \(sCR)Tj
0 Tc 0 Tw 6.285 0.125 Td
(+)Tj
-0.012 Tc 0.012 Tw 0.588 -0.125 Td
(CR\))Tj
0.048 Tw 9.84 0 Td
(98 \(39\))Tj
10.238 0 Td
(7 \(5\))Tj
0.364 Tw /Span<</ActualText<FEFF00090009>>> BDC 
-27.544 -1.344 Td
(  )Tj
EMC 
(sCR)Tj
0.048 Tw 17.305 0 Td
(90 \(35\))Tj
9.89 0 Td
(6 \(4.5\))Tj
0.364 Tw /Span<</ActualText<FEFF00090009>>> BDC 
-27.196 -1.344 Td
(  )Tj
EMC 
(CR)Tj
0.048 Tw 17.425 0 Td
(8 \(3.1\))Tj
9.77 0 Td
(1 \(0.8\))Tj
0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
-27.196 -1.344 Td
( )Tj
EMC 
(VGPR)Tj
0.048 Tw 17.305 0 Td
(55 \(22\))Tj
9.77 0 Td
(13 \(10\))Tj
0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
-27.076 -1.344 Td
( )Tj
EMC 
(PR)Tj
0.048 Tw 17.305 0 Td
(28 \(11\))Tj
9.77 0 Td
(35 \(27\))Tj
0.019 Tc -0.115 Tw -27.076 -1.479 Td
(CI)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
[(confidence )-319.1 (inter)-18 (val; )-319.2 (CR)]TJ
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
[(complete )-319.1 (response; )-319.1 (MRD)]TJ
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
[(minimal )-319.2 (residual )-319.1 (disease;)19 ( )]TJ
-0.015 Tc 0.036 Tw 0 -1.062 Td
(PR)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
1.079 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
0.695 0 Td
(partial response; sCR)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
7.71 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
0.695 0 Td
[(stringent complete response; )37.2 (VGPR)]TJ
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
12.67 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
0.695 0 Td
[(ver)-17.8 (y good partial response.)]TJ
-0.012 Tc 0.012 Tw 5.32 0 0 5.6 323.9999 355.4395 Tm
(a)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 328.9999 352.7755 Tm
[(Ka)-9.8 (plan-Meier estima)-9.8 (te.)]TJ
0.012 Tw 5.32 0 0 5.6 323.9999 346.9395 Tm
(b)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 328.9999 344.2755 Tm
[(Based on stra)-9.8 (tified univaria)-9.7 (te Cox proportional hazards model.)]TJ
0.012 Tw 5.32 0 0 5.6 323.9999 338.4395 Tm
(c)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 328.9999 335.7755 Tm
[(One-sided p-value is based on stra)-9.8 (tified log-rank test.)]TJ
0.012 Tw 5.32 0 0 5.6 323.9999 329.9395 Tm
(d)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 328.9999 327.2755 Tm
[(T)74.2 (wo-sided )37.2 (W)18.2 (ald confidence inter)-17.7 (val.)]TJ
0.012 Tw 5.32 0 0 5.6 323.9999 321.4395 Tm
(e)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.003 Tc 0.092 Tw 7.6 0 0 8 328.9999 318.7755 Tm
[(One-)0.5 (sided)0.5 ( )0.5 (p-v)0.5 (alue )0.6 (from)0.5 ( )0.5 (Cochr)0.5 (an-M)0.5 (ante)0.5 (l-Hae)0.5 (nsze)0.5 (l )0.5 (\(CMH)0.5 (\) )0.5 (tes)0.5 (t )0.5 (str)0.5 (a)-9.6 (ti)0.5 (fied )0.5 (b)0.5 (y )0.5 (str)0.5 (a)-9.6 (ti)0.5 (fica)-9.6 (t)0.5 (ion)-3 ( )]TJ
-0.012 Tc 0.012 Tw 0 -1.062 Td
(factors.)Tj
/T1_2 1 Tf
-0.017 Tc 0.048 Tw 8 0 0 8 323.9999 281.0455 Tm
(Figure 2: )Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
5 0 Td
[(Kaplan-Meier Plot of IRC-Assessed Progression Free Sur)-17.8 (viv)16.2 (al)-16.9 ( )]TJ
0 -1.062 Td
[(\(Intent-to-T)74.2 (reat Analysis\))]TJ
ET
/PlacedGraphic /MC0 BDC 
EMC 
BT
/GS0 gs
/T1_3 1 Tf
-0.01 Tc 0.01 Tw 5.4 0 0 6 485.3015 175.2231 Tm
(ABECMA)Tj
-5.485 -4.427 Td
(Standard)Tj
0 -1 Td
(Regimen)Tj
/T1_4 1 Tf
0 Tw 0 8 -8 0 336.3981 134.3916 Tm
(Progression-free Sur)Tj
0.01 Tw 8.071 0 Td
(viv)Tj
0 Tw 1.082 0 Td
(al Probability \(%\))Tj
0 Tc 8 0 0 8 408.2509 105.6126 Tm
(T)Tj
-0.01 Tc 0.452 0 Td
(ime from Randomization \(Months\) )Tj
/T1_3 1 Tf
-0.009 Tc 7.2 0 0 8 326.9631 96.9636 Tm
(Number at Risk)Tj
-0.01 Tc 0.01 Tw 0.056 -2.926 Td
(Standard)Tj
0 -1 Td
(Regimen)Tj
0 Tc 0 Tw 4.368 6.705 Td
(0)Tj
2.164 -6.239 Td
(75)Tj
4.813 0 Td
(32)Tj
-2.409 0 Td
(42)Tj
4.808 0 Td
(25)Tj
4.811 0 Td
(10)Tj
-2.405 0 Td
(13)Tj
1.924 Tc -1.924 Tw 5.057 0 Td
(76210)Tj
-0.06 Tc 0.06 Tw -17.29 -0 Td
(13)Tj
0 Tc 0 Tw 0.9 0 Td
(2)Tj
-0.01 Tc 0.01 Tw -4.866 2.029 Td
(ABECMA)Tj
0.02 Tc -0.02 Tw 6.321 -0.006 Td
(206)Tj
-0.08 Tc 0.08 Tw 4.863 0 Td
(14)Tj
0 Tc 0 Tw 0.9 0 Td
(9)Tj
-0.08 Tc 0.08 Tw -3.299 0 Td
(17)Tj
3.448 Tc -3.448 Tw 0.88 0 Td
(81)Tj
-0.02 Tc 0.02 Tw 4.348 0 Td
(10)Tj
0.02 Tc -0.02 Tw 4.581 0 Td
(40)Tj
0 Tc 0 Tw -2.395 0 Td
(62)Tj
0.04 Tc -0.04 Tw 4.797 0 Td
(22)Tj
0 Tc 0 Tw 2.424 0 Td
(14)Tj
1.925 Tc -1.925 Tw 2.644 -0 Td
(42)Tj
0 Tc 0 Tw 4.809 0 Td
(0)Tj
0.02 Tc -0.02 Tw -26.958 0 Td
(254)Tj
ET
360.468 127.072 0.13 2.39 re
f
0.288 w 
360.598 127.072 -0.13 2.389 re
S
0 0 0 0.25 K
0.5 w [7 7]0 d 
q 1 0 0 1 356.4058 197.7926 cm
0 0 m
216.29 0 l
S
Q
BT
0 Tc 0 Tw 7.2 0 0 8 349.5439 134.2621 Tm
(0)Tj
ET
354.689 137 1.716 0.131 re
f
0 0 0 1 K
0.288 w 2 J []0 d 
356.406 137 -1.717 0.131 re
S
BT
7.2 0 0 8 346.0881 146.3931 Tm
(10)Tj
ET
354.689 149.131 1.716 0.13 re
f
356.406 149.131 -1.717 0.131 re
S
BT
7.2 0 0 8 346.0881 158.4291 Tm
(20)Tj
ET
354.689 161.286 1.716 0.131 re
f
356.406 161.287 -1.717 0.131 re
S
BT
7.2 0 0 8 346.0881 170.5741 Tm
(30)Tj
ET
354.689 173.432 1.716 0.13 re
f
356.406 173.432 -1.717 0.131 re
S
BT
7.2 0 0 8 346.0209 182.8201 Tm
(40)Tj
ET
354.689 185.568 1.716 0.131 re
f
356.406 185.569 -1.717 0.131 re
S
BT
7.2 0 0 8 346.0209 194.9786 Tm
(50)Tj
ET
354.689 197.727 1.716 0.13 re
f
356.406 197.727 -1.717 0.131 re
S
BT
7.2 0 0 8 345.9911 207.1211 Tm
(60)Tj
ET
354.689 209.876 1.716 0.129 re
f
356.406 209.876 -1.717 0.129 re
S
BT
7.2 0 0 8 345.9911 219.2411 Tm
(70)Tj
ET
354.689 221.996 1.716 0.129 re
f
356.406 221.996 -1.717 0.129 re
S
BT
7.2 0 0 8 346.0878 231.4964 Tm
(80)Tj
ET
354.689 234.162 1.716 0.131 re
f
356.406 234.162 -1.717 0.131 re
S
BT
7.2 0 0 8 346.0878 243.6317 Tm
(90)Tj
ET
354.689 246.297 1.716 0.131 re
f
356.406 246.297 -1.717 0.131 re
S
BT
-0.06 Tc 0.06 Tw 7.2 0 0 8 343.0221 255.7015 Tm
(10)Tj
0 Tc 0 Tw 0.9 0 Td
(0)Tj
ET
354.756 258.372 1.65 0.13 re
f
356.406 258.372 -1.65 0.13 re
S
BT
7.2 0 0 8 376.1249 119.1946 Tm
(3)Tj
ET
377.78 127.071 0.13 2.39 re
f
377.91 127.071 -0.129 2.391 re
S
BT
7.2 0 0 8 410.7774 119.1946 Tm
(9)Tj
ET
412.415 127.071 0.13 2.39 re
f
412.544 127.071 -0.13 2.391 re
S
BT
7.2 0 0 8 393.4309 119.1946 Tm
(6)Tj
ET
395.102 127.071 0.13 2.39 re
f
395.231 127.071 -0.13 2.391 re
S
BT
-0.06 Tc 0.06 Tw 7.2 0 0 8 426.5369 119.1946 Tm
(12)Tj
ET
429.73 127.071 0.13 2.39 re
f
429.86 127.071 -0.129 2.391 re
S
BT
7.2 0 0 8 461.1789 119.1946 Tm
(18)Tj
ET
464.361 127.071 0.13 2.39 re
f
464.491 127.071 -0.13 2.391 re
S
BT
7.2 0 0 8 443.8629 119.1946 Tm
(15)Tj
ET
447.044 127.071 0.13 2.39 re
f
447.173 127.071 -0.129 2.391 re
S
BT
0 Tc 0 Tw 7.2 0 0 8 478.3304 119.1946 Tm
(21)Tj
ET
481.677 127.071 0.129 2.39 re
f
481.806 127.071 -0.13 2.391 re
S
BT
0.02 Tc -0.02 Tw 7.2 0 0 8 495.5704 119.1946 Tm
(24)Tj
ET
498.989 127.071 0.13 2.39 re
f
499.118 127.071 -0.129 2.391 re
S
BT
7.2 0 0 8 512.8829 119.1946 Tm
(27)Tj
ET
516.306 127.071 0.13 2.39 re
f
516.435 127.071 -0.13 2.391 re
S
BT
7.2 0 0 8 530.1969 119.1946 Tm
(30)Tj
ET
533.624 127.071 0.13 2.39 re
f
533.753 127.071 -0.13 2.391 re
S
BT
7.2 0 0 8 547.5084 119.1946 Tm
(33)Tj
ET
550.939 127.071 0.13 2.39 re
f
551.068 127.071 -0.129 2.391 re
S
572.696 264.981 -216.29 -135.52 re
572.196 129.961 -215.29 134.52 re
f
0 0 0 0.8 k
q 1 0 0 1 510.5614 149.0206 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.333 l
0.387 -1.333 l
0.387 -2.278 l
0 -2.278 l
0 -1.333 l
-0.946 -1.333 l
-0.946 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 526.1624 149.0206 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.333 -0.945 l
1.333 -1.333 l
0.387 -1.333 l
0.387 -2.278 l
0 -2.278 l
0 -1.333 l
-0.945 -1.333 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 499.0884 152.4551 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.333 l
0.387 -1.333 l
0.387 -2.278 l
0 -2.278 l
0 -1.333 l
-0.946 -1.333 l
-0.946 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 505.0045 152.4551 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.333 l
0.387 -1.333 l
0.387 -2.278 l
0 -2.278 l
0 -1.333 l
-0.946 -1.333 l
-0.946 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 473.4234 157.2986 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.333 l
0.387 -1.333 l
0.387 -2.278 l
0 -2.278 l
0 -1.333 l
-0.945 -1.333 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 459.9084 161.4936 cm
0 0 m
0.387 0 l
0.387 -0.946 l
1.332 -0.946 l
1.332 -1.333 l
0.387 -1.333 l
0.387 -2.278 l
0 -2.278 l
0 -1.333 l
-0.945 -1.333 l
-0.945 -0.946 l
0 -0.946 l
h
f
Q
q 1 0 0 1 454.0064 161.4936 cm
0 0 m
0.387 0 l
0.387 -0.946 l
1.333 -0.946 l
1.333 -1.333 l
0.387 -1.333 l
0.387 -2.278 l
0 -2.278 l
0 -1.333 l
-0.945 -1.333 l
-0.945 -0.946 l
0 -0.946 l
h
f
Q
q 1 0 0 1 441.8659 166.7006 cm
0 0 m
0.387 0 l
0.387 -0.946 l
1.332 -0.946 l
1.332 -1.333 l
0.387 -1.333 l
0.387 -2.278 l
0 -2.278 l
0 -1.333 l
-0.946 -1.333 l
-0.946 -0.946 l
0 -0.946 l
h
f
Q
q 1 0 0 1 436.3219 171.9166 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 430.4424 175.0826 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.278 l
0 -2.278 l
0 -1.332 l
-0.946 -1.332 l
-0.946 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 425.2534 175.0826 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.333 -0.945 l
1.333 -1.332 l
0.387 -1.332 l
0.387 -2.278 l
0 -2.278 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 433.1549 173.3011 cm
0 0 m
0.387 0 l
0.387 -0.946 l
1.332 -0.946 l
1.332 -1.333 l
0.387 -1.333 l
0.387 -2.278 l
0 -2.278 l
0 -1.333 l
-0.946 -1.333 l
-0.946 -0.946 l
0 -0.946 l
h
f
Q
q 1 0 0 1 418.9679 176.3621 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 422.7684 176.3621 cm
0 0 m
0.388 0 l
0.388 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.388 -1.332 l
0.388 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 389.1369 193.0766 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 384.3029 203.1486 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.333 -0.945 l
1.333 -1.332 l
0.387 -1.332 l
0.387 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 382.5239 204.1801 cm
0 0 m
0.388 0 l
0.388 -0.945 l
1.333 -0.945 l
1.333 -1.332 l
0.388 -1.332 l
0.388 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 381.5754 208.3526 cm
0 0 m
0.388 0 l
0.388 -0.945 l
1.332 -0.945 l
1.332 -1.333 l
0.388 -1.333 l
0.388 -2.277 l
0 -2.277 l
0 -1.333 l
-0.945 -1.333 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 381.2014 208.3526 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.333 -0.945 l
1.333 -1.333 l
0.387 -1.333 l
0.387 -2.277 l
0 -2.277 l
0 -1.333 l
-0.945 -1.333 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 377.6694 214.9111 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 364.9171 256.5463 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.333 -0.945 l
1.333 -1.332 l
0.387 -1.332 l
0.387 -2.278 l
0 -2.278 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 366.5926 248.9136 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.278 l
0 -2.278 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 368.3425 242.6585 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.333 -0.945 l
1.333 -1.332 l
0.387 -1.332 l
0.387 -2.278 l
0 -2.278 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 371.1071 238.4975 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.278 l
0 -2.278 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 360.3524 259.674 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.278 l
0 -2.278 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 413.4574 177.3871 cm
0 0 m
0.388 0 l
0.388 -0.946 l
1.332 -0.946 l
1.332 -1.333 l
0.388 -1.333 l
0.388 -2.278 l
0 -2.278 l
0 -1.333 l
-0.945 -1.333 l
-0.945 -0.946 l
0 -0.946 l
h
f
Q
q 1 0 0 1 400.4699 181.3511 cm
0 0 m
0.388 0 l
0.388 -0.945 l
1.333 -0.945 l
1.333 -1.332 l
0.388 -1.332 l
0.388 -2.278 l
0 -2.278 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
0 0 0 0.8 K
0.375 w [5 2.5]0 d 
q 1 0 0 1 361.116 258.5913 cm
0 0 m
2.508 0 l
2.508 -1.805 l
2.836 -1.805 l
2.836 -3.118 l
3.924 -3.118 l
3.924 -4.021 l
4.272 -4.021 l
4.272 -5.333 l
4.97 -5.333 l
4.97 -7.016 l
5.339 -7.016 l
5.339 -10.031 l
5.667 -10.031 l
5.667 -10.954 l
6.016 -10.954 l
6.016 -12.903 l
7.042 -12.903 l
7.042 -16.001 l
7.411 -16.001 l
7.411 -17.026 l
8.088 -17.026 l
8.088 -20.185 l
8.826 -20.185 l
8.826 -21.231 l
10.201 -21.231 l
10.201 -22.216 l
10.857 -22.216 l
10.857 -26.934 l
11.267 -26.934 l
11.267 -28.514 l
11.637 -28.514 l
11.637 -31.611 l
12.58 -31.611 l
12.58 -33.704 l
12.929 -33.704 l
12.929 -34.75 l
13.975 -34.75 l
13.975 -35.714 l
15.391 -35.714 l
15.391 -37.847 l
16.047 -37.847 l
16.047 -39.94 l
16.416 -39.94 l
16.416 -43.243 l
16.765 -43.243 l
16.765 -44.884 l
16.97 -44.884 l
16.97 -45.909 l
17.811 -45.909 l
17.811 -49.315 l
19.124 -49.315 l
19.124 -50.299 l
19.534 -50.299 l
19.534 -51.386 l
20.909 -51.386 l
20.909 -54.525 l
21.627 -54.525 l
21.627 -56.638 l
23.637 -56.638 l
23.637 -58.976 l
24.027 -58.976 l
24.027 -60.043 l
24.724 -60.043 l
24.724 -61.13 l
26.816 -61.13 l
26.816 -63.551 l
27.165 -63.551 l
27.165 -65.972 l
27.534 -65.972 l
27.534 -66.628 l
29.935 -66.628 l
29.935 -68.064 l
31.658 -68.064 l
31.658 -69.069 l
32.376 -69.069 l
32.376 -70.197 l
33.094 -70.197 l
33.094 -71.387 l
33.36 -71.387 l
33.36 -72.618 l
34.776 -72.618 l
34.776 -73.603 l
35.207 -73.603 l
35.207 -74.998 l
36.889 -74.998 l
36.889 -76.003 l
39.268 -76.003 l
39.268 -78.362 l
42.407 -78.362 l
42.407 -79.449 l
47.617 -79.449 l
47.617 -80.823 l
48.684 -80.823 l
48.684 -82.28 l
57.853 -82.28 l
57.853 -83.326 l
63.29 -83.326 l
63.29 -84.659 l
69.936 -84.659 l
69.936 -86.403 l
73.998 -86.403 l
73.998 -87.798 l
76.131 -87.798 l
76.131 -89.542 l
77.834 -89.542 l
77.834 -91.285 l
79.7 -91.285 l
79.7 -93.008 l
83.024 -93.008 l
83.024 -94.732 l
83.783 -94.732 l
83.783 -96.475 l
85.465 -96.475 l
85.465 -98.26 l
99.804 -98.26 l
99.804 -100.332 l
111.414 -100.332 l
111.414 -102.383 l
119.066 -102.383 l
119.066 -104.845 l
129.159 -104.845 l
129.159 -107.204 l
145.446 -107.204 l
145.446 -110.691 l
188.135 -110.691 l
188.135 -121.502 l
S
Q
0 0 0 1 k
q 1 0 0 1 545.95 145.1711 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.333 -0.945 l
1.333 -1.332 l
0.387 -1.332 l
0.387 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 532.7894 152.0841 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.333 -0.945 l
1.333 -1.332 l
0.387 -1.332 l
0.387 -2.278 l
0 -2.278 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 515.7444 156.6561 cm
0 0 m
0.388 0 l
0.388 -0.945 l
1.333 -0.945 l
1.333 -1.332 l
0.388 -1.332 l
0.388 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 514.0439 160.4356 cm
0 0 m
0.388 0 l
0.388 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.388 -1.332 l
0.388 -2.278 l
0 -2.278 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 506.7349 163.2386 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.333 -0.945 l
1.333 -1.332 l
0.387 -1.332 l
0.387 -2.278 l
0 -2.278 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 513.345 163.2386 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.278 l
0 -2.278 l
0 -1.332 l
-0.946 -1.332 l
-0.946 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 482.8409 173.9861 cm
0 0 m
0.388 0 l
0.388 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.388 -1.332 l
0.388 -2.278 l
0 -2.278 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 489.7539 173.9861 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.278 l
0 -2.278 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 495.9785 172.2236 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.333 l
0.387 -1.333 l
0.387 -2.277 l
0 -2.277 l
0 -1.333 l
-0.946 -1.333 l
-0.946 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 496.7219 172.2236 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.333 -0.945 l
1.333 -1.333 l
0.387 -1.333 l
0.387 -2.277 l
0 -2.277 l
0 -1.333 l
-0.945 -1.333 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 498.0714 172.2236 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.333 l
0.387 -1.333 l
0.387 -2.277 l
0 -2.277 l
0 -1.333 l
-0.945 -1.333 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 498.4279 170.1581 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.333 -0.945 l
1.333 -1.333 l
0.387 -1.333 l
0.387 -2.277 l
0 -2.277 l
0 -1.333 l
-0.945 -1.333 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 475.8649 178.8531 cm
0 0 m
0.388 0 l
0.388 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.388 -1.332 l
0.388 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 477.0039 178.8531 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 463.7365 183.0131 cm
0 0 m
0.387 0 l
0.387 -0.946 l
1.332 -0.946 l
1.332 -1.333 l
0.387 -1.333 l
0.387 -2.278 l
0 -2.278 l
0 -1.333 l
-0.945 -1.333 l
-0.945 -0.946 l
0 -0.946 l
h
f
Q
q 1 0 0 1 464.0834 183.0131 cm
0 0 m
0.387 0 l
0.387 -0.946 l
1.333 -0.946 l
1.333 -1.333 l
0.387 -1.333 l
0.387 -2.278 l
0 -2.278 l
0 -1.333 l
-0.945 -1.333 l
-0.945 -0.946 l
0 -0.946 l
h
f
Q
q 1 0 0 1 464.4574 183.0131 cm
0 0 m
0.387 0 l
0.387 -0.946 l
1.332 -0.946 l
1.332 -1.333 l
0.387 -1.333 l
0.387 -2.278 l
0 -2.278 l
0 -1.333 l
-0.945 -1.333 l
-0.945 -0.946 l
0 -0.946 l
h
f
Q
q 1 0 0 1 465.1424 183.0131 cm
0 0 m
0.387 0 l
0.387 -0.946 l
1.332 -0.946 l
1.332 -1.333 l
0.387 -1.333 l
0.387 -2.278 l
0 -2.278 l
0 -1.333 l
-0.945 -1.333 l
-0.945 -0.946 l
0 -0.946 l
h
f
Q
q 1 0 0 1 466.1834 183.0131 cm
0 0 m
0.387 0 l
0.387 -0.946 l
1.332 -0.946 l
1.332 -1.333 l
0.387 -1.333 l
0.387 -2.278 l
0 -2.278 l
0 -1.333 l
-0.945 -1.333 l
-0.945 -0.946 l
0 -0.946 l
h
f
Q
q 1 0 0 1 467.8829 183.0131 cm
0 0 m
0.388 0 l
0.388 -0.946 l
1.333 -0.946 l
1.333 -1.333 l
0.388 -1.333 l
0.388 -2.278 l
0 -2.278 l
0 -1.333 l
-0.945 -1.333 l
-0.945 -0.946 l
0 -0.946 l
h
f
Q
q 1 0 0 1 469.6804 183.0131 cm
0 0 m
0.388 0 l
0.388 -0.946 l
1.333 -0.946 l
1.333 -1.333 l
0.388 -1.333 l
0.388 -2.278 l
0 -2.278 l
0 -1.333 l
-0.945 -1.333 l
-0.945 -0.946 l
0 -0.946 l
h
f
Q
q 1 0 0 1 469.9474 181.5626 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 454.2934 188.1941 cm
0 0 m
0.387 0 l
0.387 -0.946 l
1.332 -0.946 l
1.332 -1.333 l
0.387 -1.333 l
0.387 -2.278 l
0 -2.278 l
0 -1.333 l
-0.945 -1.333 l
-0.945 -0.946 l
0 -0.946 l
h
f
Q
q 1 0 0 1 455.4894 188.1941 cm
0 0 m
0.387 0 l
0.387 -0.946 l
1.332 -0.946 l
1.332 -1.333 l
0.387 -1.333 l
0.387 -2.278 l
0 -2.278 l
0 -1.333 l
-0.945 -1.333 l
-0.945 -0.946 l
0 -0.946 l
h
f
Q
q 1 0 0 1 458.8429 187.2036 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.277 l
0 -2.277 l
0 -1.332 l
-0.946 -1.332 l
-0.946 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 459.5589 186.0651 cm
0 0 m
0.387 0 l
0.387 -0.946 l
1.333 -0.946 l
1.333 -1.333 l
0.387 -1.333 l
0.387 -2.278 l
0 -2.278 l
0 -1.333 l
-0.945 -1.333 l
-0.945 -0.946 l
0 -0.946 l
h
f
Q
q 1 0 0 1 460.9704 184.0451 cm
0 0 m
0.388 0 l
0.388 -0.945 l
1.333 -0.945 l
1.333 -1.333 l
0.388 -1.333 l
0.388 -2.277 l
0 -2.277 l
0 -1.333 l
-0.945 -1.333 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 450.5504 191.3091 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.277 l
0 -2.277 l
0 -1.332 l
-0.946 -1.332 l
-0.946 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 451.5809 191.3091 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.333 -0.945 l
1.333 -1.332 l
0.387 -1.332 l
0.387 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 451.9469 191.3091 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 452.3369 191.3091 cm
0 0 m
0.388 0 l
0.388 -0.945 l
1.333 -0.945 l
1.333 -1.332 l
0.388 -1.332 l
0.388 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 442.8789 195.4931 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 443.2694 195.4931 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.333 -0.945 l
1.333 -1.332 l
0.387 -1.332 l
0.387 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 443.6719 194.7126 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.333 l
0.387 -1.333 l
0.387 -2.278 l
0 -2.278 l
0 -1.333 l
-0.945 -1.333 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 445.2939 193.0536 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.333 -0.945 l
1.333 -1.332 l
0.387 -1.332 l
0.387 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 446.0869 193.0536 cm
0 0 m
0.388 0 l
0.388 -0.945 l
1.333 -0.945 l
1.333 -1.332 l
0.388 -1.332 l
0.388 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 447.1239 193.0536 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 437.7304 198.6511 cm
0 0 m
0.387 0 l
0.387 -0.946 l
1.332 -0.946 l
1.332 -1.333 l
0.387 -1.333 l
0.387 -2.278 l
0 -2.278 l
0 -1.333 l
-0.946 -1.333 l
-0.946 -0.946 l
0 -0.946 l
h
f
Q
q 1 0 0 1 438.0719 198.5741 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 438.8694 197.8956 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.277 l
0 -2.277 l
0 -1.332 l
-0.946 -1.332 l
-0.946 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 439.2109 197.8406 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.278 l
0 -2.278 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 440.2964 196.5236 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.333 -0.945 l
1.333 -1.332 l
0.387 -1.332 l
0.387 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 440.6014 196.5236 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 440.9304 196.5236 cm
0 0 m
0.388 0 l
0.388 -0.945 l
1.333 -0.945 l
1.333 -1.332 l
0.388 -1.332 l
0.388 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 441.2479 196.5236 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.333 -0.945 l
1.333 -1.332 l
0.387 -1.332 l
0.387 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 436.6614 199.3236 cm
0 0 m
0.387 0 l
0.387 -0.946 l
1.332 -0.946 l
1.332 -1.333 l
0.387 -1.333 l
0.387 -2.278 l
0 -2.278 l
0 -1.333 l
-0.945 -1.333 l
-0.945 -0.946 l
0 -0.946 l
h
f
Q
q 1 0 0 1 434.2379 199.3236 cm
0 0 m
0.387 0 l
0.387 -0.946 l
1.333 -0.946 l
1.333 -1.333 l
0.387 -1.333 l
0.387 -2.278 l
0 -2.278 l
0 -1.333 l
-0.945 -1.333 l
-0.945 -0.946 l
0 -0.946 l
h
f
Q
q 1 0 0 1 434.9209 199.3236 cm
0 0 m
0.387 0 l
0.387 -0.946 l
1.332 -0.946 l
1.332 -1.333 l
0.387 -1.333 l
0.387 -2.278 l
0 -2.278 l
0 -1.333 l
-0.945 -1.333 l
-0.945 -0.946 l
0 -0.946 l
h
f
Q
q 1 0 0 1 435.6284 199.3236 cm
0 0 m
0.387 0 l
0.387 -0.946 l
1.333 -0.946 l
1.333 -1.333 l
0.387 -1.333 l
0.387 -2.278 l
0 -2.278 l
0 -1.333 l
-0.945 -1.333 l
-0.945 -0.946 l
0 -0.946 l
h
f
Q
q 1 0 0 1 437.0784 199.3236 cm
0 0 m
0.387 0 l
0.387 -0.946 l
1.333 -0.946 l
1.333 -1.333 l
0.387 -1.333 l
0.387 -2.278 l
0 -2.278 l
0 -1.333 l
-0.945 -1.333 l
-0.945 -0.946 l
0 -0.946 l
h
f
Q
q 1 0 0 1 429.8314 202.1981 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.333 -0.945 l
1.333 -1.332 l
0.387 -1.332 l
0.387 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 430.2164 202.1006 cm
0 0 m
0.388 0 l
0.388 -0.945 l
1.333 -0.945 l
1.333 -1.333 l
0.388 -1.333 l
0.388 -2.277 l
0 -2.277 l
0 -1.333 l
-0.945 -1.333 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 430.5214 201.9906 cm
0 0 m
0.388 0 l
0.388 -0.945 l
1.333 -0.945 l
1.333 -1.332 l
0.388 -1.332 l
0.388 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 430.8264 201.8811 cm
0 0 m
0.388 0 l
0.388 -0.945 l
1.333 -0.945 l
1.333 -1.333 l
0.388 -1.333 l
0.388 -2.278 l
0 -2.278 l
0 -1.333 l
-0.945 -1.333 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 431.1314 201.7711 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.333 -0.945 l
1.333 -1.332 l
0.387 -1.332 l
0.387 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 431.5704 200.8521 cm
0 0 m
0.388 0 l
0.388 -0.945 l
1.333 -0.945 l
1.333 -1.332 l
0.388 -1.332 l
0.388 -2.278 l
0 -2.278 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 431.9599 200.4626 cm
0 0 m
0.387 0 l
0.387 -0.946 l
1.332 -0.946 l
1.332 -1.333 l
0.387 -1.333 l
0.387 -2.278 l
0 -2.278 l
0 -1.333 l
-0.945 -1.333 l
-0.945 -0.946 l
0 -0.946 l
h
f
Q
q 1 0 0 1 432.2704 200.0721 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.333 -0.945 l
1.333 -1.333 l
0.387 -1.333 l
0.387 -2.278 l
0 -2.278 l
0 -1.333 l
-0.945 -1.333 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 432.9414 199.9206 cm
0 0 m
0.387 0 l
0.387 -0.946 l
1.332 -0.946 l
1.332 -1.333 l
0.387 -1.333 l
0.387 -2.278 l
0 -2.278 l
0 -1.333 l
-0.946 -1.333 l
-0.946 -0.946 l
0 -0.946 l
h
f
Q
q 1 0 0 1 433.3009 199.9206 cm
0 0 m
0.387 0 l
0.387 -0.946 l
1.332 -0.946 l
1.332 -1.333 l
0.387 -1.333 l
0.387 -2.278 l
0 -2.278 l
0 -1.333 l
-0.945 -1.333 l
-0.945 -0.946 l
0 -0.946 l
h
f
Q
q 1 0 0 1 429.0779 204.5091 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 429.4434 204.5091 cm
0 0 m
0.388 0 l
0.388 -0.945 l
1.333 -0.945 l
1.333 -1.332 l
0.388 -1.332 l
0.388 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 425.5385 207.2291 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.277 l
0 -2.277 l
0 -1.332 l
-0.946 -1.332 l
-0.946 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 426.9164 207.2291 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 427.7214 207.2291 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 423.4714 210.7051 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 424.2344 210.7051 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 417.2919 213.5351 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 417.6669 213.5351 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 419.6304 212.7791 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.333 l
0.387 -1.333 l
0.387 -2.278 l
0 -2.278 l
0 -1.333 l
-0.945 -1.333 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 421.7189 212.5181 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 422.5484 212.5181 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 422.8089 212.5181 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 414.4619 213.8591 cm
0 0 m
0.388 0 l
0.388 -0.945 l
1.333 -0.945 l
1.333 -1.332 l
0.388 -1.332 l
0.388 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 416.5279 213.8591 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.277 l
0 -2.277 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 407.2164 219.0295 cm
0 0 m
0.388 0 l
0.388 -0.945 l
1.333 -0.945 l
1.333 -1.332 l
0.388 -1.332 l
0.388 -2.278 l
0 -2.278 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 407.8984 219.0295 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.278 l
0 -2.278 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 406.1564 219.8073 cm
0 0 m
0.388 0 l
0.388 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.388 -1.332 l
0.388 -2.278 l
0 -2.278 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 399.5404 224.992 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.278 l
0 -2.278 l
0 -1.332 l
-0.946 -1.332 l
-0.946 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 398.4974 224.992 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.278 l
0 -2.278 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 396.4984 226.3012 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.333 -0.945 l
1.333 -1.332 l
0.387 -1.332 l
0.387 -2.278 l
0 -2.278 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 395.0389 227.0655 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.278 l
0 -2.278 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 385.6864 231.901 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.278 l
0 -2.278 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 379.8204 237.7776 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.332 -0.945 l
1.332 -1.332 l
0.387 -1.332 l
0.387 -2.278 l
0 -2.278 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 370.7654 246.8309 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.333 -0.945 l
1.333 -1.332 l
0.387 -1.332 l
0.387 -2.278 l
0 -2.278 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
q 1 0 0 1 364.5574 258.2735 cm
0 0 m
0.387 0 l
0.387 -0.945 l
1.333 -0.945 l
1.333 -1.332 l
0.387 -1.332 l
0.387 -2.278 l
0 -2.278 l
0 -1.332 l
-0.945 -1.332 l
-0.945 -0.945 l
0 -0.945 l
h
f
Q
0 0 0 1 K
[]0 d 
q 1 0 0 1 361.116 258.2197 cm
0 0 m
2.586 0 l
2.586 -1.016 l
3.738 -1.016 l
3.738 -1.869 l
4.32 -1.869 l
4.32 -2.14 l
4.645 -2.14 l
4.645 -2.532 l
4.956 -2.532 l
4.956 -3.507 l
5.661 -3.507 l
5.661 -5.2 l
6.08 -5.2 l
6.08 -6.974 l
6.392 -6.974 l
6.392 -7.638 l
7.069 -7.638 l
7.069 -8.707 l
7.475 -8.707 l
7.475 -9.06 l
8.071 -9.06 l
8.071 -9.385 l
8.477 -9.385 l
8.477 -10.075 l
8.789 -10.075 l
8.789 -11.091 l
9.195 -11.091 l
9.195 -11.497 l
9.696 -11.497 l
9.696 -12.499 l
10.102 -12.499 l
10.102 -13.542 l
10.847 -13.542 l
10.847 -14.964 l
11.511 -14.964 l
11.511 -16.047 l
11.985 -16.047 l
11.985 -16.345 l
12.621 -16.345 l
12.621 -17.361 l
13.312 -17.361 l
13.312 -18.065 l
13.637 -18.065 l
13.637 -18.471 l
14.341 -18.471 l
14.341 -19.148 l
16.751 -19.148 l
16.751 -19.514 l
17.144 -19.514 l
17.144 -19.852 l
17.482 -19.852 l
17.482 -20.53 l
18.187 -20.53 l
18.187 -20.868 l
18.891 -20.868 l
18.891 -21.545 l
19.649 -21.545 l
19.649 -21.857 l
19.879 -21.857 l
19.879 -22.534 l
20.57 -22.534 l
20.57 -22.886 l
21.667 -22.886 l
21.667 -25.039 l
22.033 -25.039 l
22.033 -25.378 l
22.371 -25.378 l
22.371 -26.095 l
22.737 -26.095 l
22.737 -26.393 l
23.387 -26.393 l
23.387 -27.409 l
25.459 -27.409 l
25.459 -27.774 l
26.163 -27.774 l
26.163 -28.465 l
27.192 -28.465 l
27.192 -29.508 l
29.25 -29.508 l
29.25 -29.86 l
29.657 -29.86 l
29.657 -30.916 l
32.379 -30.916 l
32.379 -31.62 l
32.771 -31.62 l
32.771 -32 l
34.085 -32 l
34.085 -32.934 l
35.52 -32.934 l
35.52 -33.245 l
36.224 -33.245 l
36.224 -34.071 l
36.577 -34.071 l
36.577 -34.356 l
39.353 -34.356 l
39.353 -35.087 l
40.057 -35.087 l
40.057 -35.412 l
40.734 -35.412 l
40.734 -36.143 l
41.411 -36.143 l
41.411 -36.468 l
42.102 -36.468 l
42.102 -37.511 l
43.469 -37.511 l
43.469 -38.567 l
44.16 -38.567 l
44.16 -39.624 l
45.284 -39.624 l
45.284 -40.314 l
47.898 -40.314 l
47.898 -40.653 l
49.672 -40.653 l
49.672 -41.33 l
50.403 -41.33 l
50.403 -42.413 l
50.809 -42.413 l
50.809 -43.442 l
51.432 -43.442 l
51.432 -44.472 l
52.217 -44.472 l
52.217 -45.514 l
55.63 -45.514 l
55.63 -45.826 l
58.582 -45.826 l
58.582 -46.476 l
60.817 -46.476 l
60.817 -46.869 l
62.211 -46.869 l
62.211 -47.6 l
62.631 -47.6 l
62.631 -48.643 l
63.552 -48.643 l
63.552 -49.347 l
63.958 -49.347 l
63.958 -50.349 l
64.324 -50.349 l
64.324 -51.067 l
64.649 -51.067 l
64.649 -52.082 l
67.791 -52.082 l
67.791 -53.802 l
68.386 -53.802 l
68.386 -54.953 l
68.739 -54.953 l
68.739 -56.957 l
69.307 -56.957 l
69.307 -57.556 l
69.854 -57.556 l
69.854 -58.114 l
70.313 -58.114 l
70.313 -58.475 l
70.954 -58.475 l
70.954 -59.214 l
71.196 -59.214 l
71.196 -59.379 l
72.27 -59.379 l
72.27 -60.097 l
76.019 -60.097 l
76.019 -60.5 l
77.001 -60.5 l
77.001 -61.398 l
79.216 -61.398 l
79.216 -62.777 l
80.228 -62.777 l
80.228 -63.825 l
82.304 -63.825 l
82.304 -64.311 l
82.598 -64.311 l
82.598 -64.801 l
82.882 -64.801 l
82.882 -65.622 l
84.401 -65.622 l
84.401 -66.33 l
86.523 -66.33 l
86.523 -67.357 l
87.886 -67.357 l
87.886 -68.049 l
92.1 -68.049 l
92.1 -69.093 l
92.421 -69.093 l
92.421 -70.161 l
93.427 -70.161 l
93.427 -71.158 l
94.853 -71.158 l
94.853 -72.217 l
98.685 -72.217 l
98.685 -73.286 l
99.361 -73.286 l
99.361 -74.324 l
100.063 -74.324 l
100.063 -75.382 l
101.396 -75.382 l
101.396 -76.363 l
109.033 -76.363 l
109.033 -77.773 l
112.865 -77.773 l
112.865 -79.173 l
113.903 -79.173 l
113.903 -80.546 l
116.356 -80.546 l
116.356 -82.302 l
117.032 -82.302 l
117.032 -83.686 l
118.768 -83.686 l
118.768 -85.426 l
129.86 -85.426 l
129.86 -87.172 l
137.518 -87.172 l
137.518 -89.222 l
140.281 -89.222 l
140.281 -91.644 l
141.019 -91.644 l
141.019 -93.746 l
145.109 -93.746 l
145.109 -96.157 l
153.119 -96.157 l
153.119 -98.946 l
154.498 -98.946 l
154.498 -102.721 l
167.697 -102.721 l
167.697 -107.281 l
178.092 -107.281 l
178.092 -114.19 l
186.091 -114.19 l
S
Q
BT
/GS1 gs
/T1_1 1 Tf
-0.012 Tc 0.048 Tw 7.6 0 0 8 323.9999 49.3159 Tm
[(Da)-9.8 (ta cutoff da)-9.7 (te:)37.2 ( )37.2 (A)-9.8 (pril 18,)37.2 ( 2022)]TJ
ET
endstreamendobj36 0 obj<</Metadata 87 0 R>>endobj87 0 obj<</Length 27198/Subtype/XML/Type/Metadata>>stream
<?xpacket begin="Ôªø" id="W5M0MpCehiHzreSzNTczkc9d"?>
<x:xmpmeta xmlns:x="adobe:ns:meta/" x:xmptk="Adobe XMP Core 9.1-c002 79.a6a6396, 2024/03/12-07:48:23        ">
   <rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
      <rdf:Description rdf:about=""
            xmlns:dc="http://purl.org/dc/elements/1.1/"
            xmlns:xmp="http://ns.adobe.com/xap/1.0/"
            xmlns:xmpMM="http://ns.adobe.com/xap/1.0/mm/"
            xmlns:stRef="http://ns.adobe.com/xap/1.0/sType/ResourceRef#"
            xmlns:stEvt="http://ns.adobe.com/xap/1.0/sType/ResourceEvent#"
            xmlns:illustrator="http://ns.adobe.com/illustrator/1.0/"
            xmlns:xmpTPg="http://ns.adobe.com/xap/1.0/t/pg/"
            xmlns:stDim="http://ns.adobe.com/xap/1.0/sType/Dimensions#"
            xmlns:stFnt="http://ns.adobe.com/xap/1.0/sType/Font#"
            xmlns:xmpG="http://ns.adobe.com/xap/1.0/g/"
            xmlns:pdf="http://ns.adobe.com/pdf/1.3/"
            xmlns:ExtensisFontSense="http://www.extensis.com/meta/FontSense/">
         <dc:format>application/postscript</dc:format>
         <dc:title>
            <rdf:Alt>
               <rdf:li xml:lang="x-default">ABECMA_Figure 14.2.1.1.1_v3</rdf:li>
            </rdf:Alt>
         </dc:title>
         <dc:creator>
            <rdf:Seq>
               <rdf:li>(Steve Burgos)</rdf:li>
            </rdf:Seq>
         </dc:creator>
         <xmp:MetadataDate>2024-03-26T14:24:57-04:00</xmp:MetadataDate>
         <xmp:ModifyDate>2024-03-26T14:24:57-04:00</xmp:ModifyDate>
         <xmp:CreateDate>2024-03-26T14:24:57-04:00</xmp:CreateDate>
         <xmp:CreatorTool>Adobe Illustrator 28.3 (Macintosh)</xmp:CreatorTool>
         <xmpMM:InstanceID>xmp.iid:28cf9802-00b9-4db9-930d-0c70a7aa1ad4</xmpMM:InstanceID>
         <xmpMM:DocumentID>xmp.did:28cf9802-00b9-4db9-930d-0c70a7aa1ad4</xmpMM:DocumentID>
         <xmpMM:OriginalDocumentID>uuid:5D20892493BFDB11914A8590D31508C8</xmpMM:OriginalDocumentID>
         <xmpMM:RenditionClass>default</xmpMM:RenditionClass>
         <xmpMM:DerivedFrom rdf:parseType="Resource">
            <stRef:instanceID>uuid:bf20eddb-7668-b944-af3c-6092ffe3dd16</stRef:instanceID>
            <stRef:documentID>xmp.did:80ff2305-408d-420b-b0a1-2a90bf2f6abe</stRef:documentID>
            <stRef:originalDocumentID>uuid:5D20892493BFDB11914A8590D31508C8</stRef:originalDocumentID>
            <stRef:renditionClass>default</stRef:renditionClass>
         </xmpMM:DerivedFrom>
         <xmpMM:History>
            <rdf:Seq>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:d599b828-ed96-4490-81fc-c4d51bcca240</stEvt:instanceID>
                  <stEvt:when>2015-02-04T10:49:55-05:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator CC 2014 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:1bd14a16-0efe-40e4-8a1b-b6dc42b79d8b</stEvt:instanceID>
                  <stEvt:when>2015-02-05T08:36:22-05:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator CC 2014 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:25efb995-0525-4acf-947a-7121f5005ef3</stEvt:instanceID>
                  <stEvt:when>2015-02-05T08:45:51-05:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator CC 2014 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:570b4bfa-630e-4a2e-9933-8a586722f5ce</stEvt:instanceID>
                  <stEvt:when>2015-09-09T15:16:34-04:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator CC 2014 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:6b6ce731-ff56-4b03-909d-ed8fb56ccba3</stEvt:instanceID>
                  <stEvt:when>2015-09-10T11:49:56-04:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator CC 2014 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:6577cbb3-82e5-4b41-8272-5ed3fb87fe8b</stEvt:instanceID>
                  <stEvt:when>2015-09-10T12:15:15-04:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator CC 2014 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:7a7d1989-3367-4b49-a2d9-60d4e7d92179</stEvt:instanceID>
                  <stEvt:when>2015-11-03T14:03:36-05:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator CC 2014 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:3f80f38d-f9a5-4154-819d-7b0dd9020509</stEvt:instanceID>
                  <stEvt:when>2015-11-23T13:07:39-05:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator CC 2014 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:2f2b22f4-1b1d-4c29-83a1-c3676cdb1311</stEvt:instanceID>
                  <stEvt:when>2015-11-23T13:19:09-05:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator CC 2014 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:ee43bc4a-76bc-48cb-861f-1d7db6aef4b4</stEvt:instanceID>
                  <stEvt:when>2018-01-09T16:09:06-05:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator CC 2017 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:71260198-f0a5-4516-8f77-f4314126aff7</stEvt:instanceID>
                  <stEvt:when>2018-01-09T16:10:17-05:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator CC 2017 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:35ab0b4a-5b47-4f3e-bf33-db6b679288c7</stEvt:instanceID>
                  <stEvt:when>2018-03-28T20:02:37-04:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator CC 2017 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:580913a1-971d-44b9-ace5-bf195458ff57</stEvt:instanceID>
                  <stEvt:when>2018-04-17T12:48:26-04:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator CC 22.0 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:a162dd44-4f4f-464e-b01a-66f8e5e8a5e7</stEvt:instanceID>
                  <stEvt:when>2019-08-20T09:12:32-04:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator CC 23.0 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:b615bd2b-2b8b-4d77-bde4-bbcc92e06eaf</stEvt:instanceID>
                  <stEvt:when>2019-12-02T14:56:25-05:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator 24.0 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:1edaa293-2a6e-48cc-96e7-99e7e0181e48</stEvt:instanceID>
                  <stEvt:when>2020-06-14T07:25:39-04:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator 24.0 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:a426361b-c649-4336-8dcb-79537c3a08e3</stEvt:instanceID>
                  <stEvt:when>2022-05-13T14:53:19-04:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator 26.2 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:28cf9802-00b9-4db9-930d-0c70a7aa1ad4</stEvt:instanceID>
                  <stEvt:when>2024-03-26T14:24:57-04:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator 28.3 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
            </rdf:Seq>
         </xmpMM:History>
         <illustrator:StartupProfile>Print</illustrator:StartupProfile>
         <illustrator:CreatorSubTool>Adobe Illustrator</illustrator:CreatorSubTool>
         <xmpTPg:HasVisibleOverprint>False</xmpTPg:HasVisibleOverprint>
         <xmpTPg:HasVisibleTransparency>False</xmpTPg:HasVisibleTransparency>
         <xmpTPg:NPages>1</xmpTPg:NPages>
         <xmpTPg:MaxPageSize rdf:parseType="Resource">
            <stDim:w>7.185000</stDim:w>
            <stDim:h>5.961235</stDim:h>
            <stDim:unit>Inches</stDim:unit>
         </xmpTPg:MaxPageSize>
         <xmpTPg:Fonts>
            <rdf:Bag>
               <rdf:li rdf:parseType="Resource">
                  <stFnt:fontName>HelveticaNeueLTStd-Cn</stFnt:fontName>
                  <stFnt:fontFamily>Helvetica Neue LT Std</stFnt:fontFamily>
                  <stFnt:fontFace>57 Condensed</stFnt:fontFace>
                  <stFnt:fontType>Open Type</stFnt:fontType>
                  <stFnt:versionString>Version 2.035;PS 002.000;hotconv 1.0.51;makeotf.lib2.0.18671</stFnt:versionString>
                  <stFnt:composite>False</stFnt:composite>
                  <stFnt:fontFileName>HelveticaNeueLTStd-Cn.otf</stFnt:fontFileName>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stFnt:fontName>HelveticaNeueLTStd-BdCn</stFnt:fontName>
                  <stFnt:fontFamily>Helvetica Neue LT Std</stFnt:fontFamily>
                  <stFnt:fontFace>77 Bold Condensed</stFnt:fontFace>
                  <stFnt:fontType>Open Type</stFnt:fontType>
                  <stFnt:versionString>Version 2.035;PS 002.000;hotconv 1.0.51;makeotf.lib2.0.18671</stFnt:versionString>
                  <stFnt:composite>False</stFnt:composite>
                  <stFnt:fontFileName>HelveticaNeueLTStd-BdCn.otf</stFnt:fontFileName>
               </rdf:li>
            </rdf:Bag>
         </xmpTPg:Fonts>
         <xmpTPg:PlateNames>
            <rdf:Seq>
               <rdf:li>Black</rdf:li>
            </rdf:Seq>
         </xmpTPg:PlateNames>
         <xmpTPg:SwatchGroups>
            <rdf:Seq>
               <rdf:li rdf:parseType="Resource">
                  <xmpG:groupName>Default Swatch Group</xmpG:groupName>
                  <xmpG:groupType>0</xmpG:groupType>
                  <xmpG:Colorants>
                     <rdf:Seq>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>White</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>Black</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>100.000000</xmpG:black>
                        </rdf:li>
                     </rdf:Seq>
                  </xmpG:Colorants>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <xmpG:groupName>Grays</xmpG:groupName>
                  <xmpG:groupType>1</xmpG:groupType>
                  <xmpG:Colorants>
                     <rdf:Seq>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=0 M=0 Y=0 K=100</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>100.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=0 M=0 Y=0 K=90</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>89.999400</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=0 M=0 Y=0 K=80</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>79.998800</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=0 M=0 Y=0 K=60</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>59.999100</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=0 M=0 Y=0 K=50</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>50.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=0 M=100 Y=100 K=0</xmpG:swatchName>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:tint>100.000000</xmpG:tint>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>100.000000</xmpG:magenta>
                           <xmpG:yellow>100.000000</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=0 M=0 Y=0 K=25</xmpG:swatchName>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:tint>100.000000</xmpG:tint>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>25.000000</xmpG:black>
                        </rdf:li>
                     </rdf:Seq>
                  </xmpG:Colorants>
               </rdf:li>
            </rdf:Seq>
         </xmpTPg:SwatchGroups>
         <pdf:Producer>Adobe PDF library 17.00</pdf:Producer>
         <ExtensisFontSense:slug>
            <rdf:Bag>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>3261192849</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>Helvetica Neue LT Std</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>OpenType - PS</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>3261192849</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Adobe Systems</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>HelveticaNeueLTStd-Cn</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>2.035</ExtensisFontSense:Version>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>3357634683</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>Helvetica Neue LT Std</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>OpenType - PS</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>3357634683</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Adobe Systems</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>HelveticaNeueLTStd-BdCn</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>2.035</ExtensisFontSense:Version>
               </rdf:li>
            </rdf:Bag>
         </ExtensisFontSense:slug>
      </rdf:Description>
   </rdf:RDF>
</x:xmpmeta>
<?xpacket end="r"?>endstreamendobj34 0 obj<</BaseFont/JHWGPK+HelveticaNeueLTStd-Cn/Encoding/WinAnsiEncoding/FirstChar 32/FontDescriptor 88 0 R/LastChar 117/Subtype/Type1/Type/Font/Widths[240 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 480 480 480 480 480 480 480 480 480 480 0 0 0 0 0 0 0 500 519 519 0 463 0 0 0 0 0 0 0 704 556 0 0 0 519 500 0 0 0 0 0 0 0 0 0 0 0 0 0 444 463 0 463 444 0 463 0 204 0 444 0 722 463 0 0 0 296 407 259 463]>>endobj35 0 obj<</BaseFont/JHWGPK+HelveticaNeueLTStd-BdCn/Encoding/WinAnsiEncoding/FirstChar 32/FontDescriptor 89 0 R/LastChar 122/Subtype/Type1/Type/Font/Widths[240 0 0 0 0 778 0 0 296 296 0 0 0 370 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 740 0 0 519 0 556 519 480 0 0 0 0 0 0 0 0 0 0 0 0 481 500 0 500 463 296 500 500 240 0 0 240 758 500 480 0 0 333 444 296 500 444 0 0 444 426]>>endobj89 0 obj<</Ascent 961/CapHeight 700/CharSet(/space/percent/parenleft/parenright/hyphen/M/P/R/S/T/a/b/d/e/f/g/h/i/l/m/n/o/r/s/t/u/v/y/z)/Descent -224/Flags 32/FontBBox[-164 -224 1066 961]/FontFile3 90 0 R/FontName/JHWGPK+HelveticaNeueLTStd-BdCn/FontStretch/Condensed/FontWeight 700/ItalicAngle 0/StemV 140/Type/FontDescriptor/XHeight 500>>endobj90 0 obj<</Filter/FlateDecode/Length 2243/Subtype/Type1C>>stream
HâtUmTWûÅd®'ãCŸD'£FJ¡î˙V¥UµHP‘5ê AH I@QVOèÄ|he◊≈B,"¥“Ú%Et≠X◊na]uWkW∞Z˜ú5æÉ7?ˆN‹⁄ˆÏzr2˜ÛyÓÛæÔsgHB‚Fê$©\≥*!2Êù¿U˙LõﬁjH’FÎﬂ◊G≈«YuAÀtÀç‚ñÇÇ|%¬îI¨0uí
E÷ggû≠ó
ø÷N˛fä◊[>ÑªHÊGŒ -7eÁô[”≠¸ÎaaÍ◊¯µ:Ñ[gJ—Ûqy´>À¬Ø6¶öÃŸ&≥÷™◊ÛogfÚ.ÄÖ7Î-z≥Mú|!á7Xx-o5ku˙,≠yoJ„£Fì5/[œ/«,¡¥’ÄyÕzo0Ú÷t=ø>8.òè¡ÏF+Ø5Í¯¯hMZö!UÔöÃ“ÊÒX”Ø—©z≥Uã[¶1ÛÔõù!’j0-?ëµY˙ˇ£¬dÊ8ÇLLo¥Ëı?/Gf•¨
ûª2.^Ã„u˙¥ó•ö Òè†¬ì$dLØƒnƒ2íX!%÷∫qb3Ip8’D°!Óírrπïl Ô∏≈∫π=pœrîLóÿ%Ì“PiéÙ†¥âÚ¢"©˝‘e:å∂”ÌÙ-Œ#r_Ø∞óƒOUØ˚>âP4„,¢†]`—8(Ö1
ÒË‚¿˘!Ì§í]}XÇòŒ≤bâ#Z(^)Å¸≠¯®∂˚s|Á o¸`F
Ö>XÕ˛π¢ΩΩΩ"5bÒﬁ‘‘‘ΩÌ7∏i{Yƒ6¨onÿú!‰çºs÷"ñc∫
ùãaÏÂˇK»|^¯°Û4{èÊLIC(è⁄û˘Ÿ…^wáÿâdv6RkQ‚ÂàÔDAèêösP°òâ…√ÂﬁÏm‰^‡Ä¬¿âd…mÿåX.G·ôàEÅˆ‘ùºx-Õ5'ÀÄ|"ª†≈Ω˛≈"/h/Zﬂ◊⁄ÑaPëÁ¿_	œ˘·ŒpåsX
‹
√“2Á0¯O$#•rñJã©ôB©eP2®µA´≤8
Ãï{ØÓ¥éR0Âü√t”S4KâˆS†ö∆R◊SW,”bïÔ`l∆ˆ?Üáèà‚A≈∞Ax¬2OÆR_µd¨^¢ÀZ©‘PHÂú≈‚M˝#åR>1ƒï)+–‘RSyvï˝∑†>@eWÌm+˘∂wÙÕ˛£GÕ<πY›z˘ÅdÀáêá>≈8Ñcü:|í‹•ñCÃa∆Í¿¬i‰y),‰òo@}ˇ*ﬁ5ı#¢Gâ‹OI£vÎíwVw|≈1£˝ı∫UJ‡éP05∏˘¢)"êΩÚß‡˚«‹{êÒôeç\£5Ω∑4˜‰0WKÀFqÇ«pÊa1ŒŒ!\fúzµsTxV-ñ‡Ø„16Å≥˝c‹ß¸çÂ˛å¬Oˆ0›Y◊ÿŸ]cNŸZ∞=•ê∑Iôû◊rRRf…óü˚·J[’¿ß\≈ÿ*Ú*lï˘‡O4’˜ ·s˙aÊU:cÅys;i¶ˆ£46Ê]KZ⁄éßÍé‚™+Í+?ÆÚê8ÊﬁáßX`˜Èf«ÏÄ(®c¡Û–‡≈¡C‰â<wi4—ª¡ìC¬+˛s˙|Ω©©’÷ß ÈŸ€êâ	∑ë4!›∂≈®,‚®_2ˆÇyÈô/˛ƒ≠q1C†ã;çC∂bÍ§1Ω6AÅCQ¢í9çœÜÇ¥Øµ∂∑	á,,á≈∑¿wúl¿Ã”∞wÖ’P 6”∂4Eõê·ZD¡Xõﬂ‡5òºüCﬁ‘Í=πÈIäç˘Cóî'È[íZ∫˜£Û˝ÁüVé/ÆVÃ¯˜èãÏ>#XÎÿàpBÃﬂ∆ﬂÏ°ö´µUVÓ+©ƒ.xD3cefK©Yømé2zE–5ZÜ¢æ{T›∏{Æ√ß€ÎUá∏ñùpMhaôöbz '±FØ@srQ ÚAõ˙ﬂ∑ÆìÌç ≤*ﬁÆç„òˆ¸Ì*w*ÀŒ =U5rÑ›>˜Jx¬¸K_√tN8H3ùË8jcaÊN_ÏØﬁå^UÁG≠[WxÂ/úÎè”MäÖÙŒΩG ‘`√Òûé€zŒI„àf–éç=Û◊%Zìr∏bÿ.V
-ƒ–˚l’3vFº/\ë`º◊O;&íÌ/ñ≈2·k‚ëbƒ‚â>œˇæSò”ÆÉüRCçM]máÕ…úsí8¶5Ùø∑úWØŸdåµq≈Tˇé§Ê(≈∫-ˆÕÈ bäπŸè¸iŸ/Èq@ÃËK"bæt≈¥…≤¡à©ò—K"x¥`\êçìçÄe7bÁ!Mw ,*Á §ÔGlrM“èhQëÖ¨@Q¯f˚Å€ÅWj‚±y‰yÒqë‹ 7N∂Àˇ◊aæ5PÃ◊0B_Ô˚‰T’·íí*¨é.›≥ªtè"VgH0â|q]‘–·“‡Sﬁhé¿ÁyÀ‹´á6óVùåÑπ‡Ò˜êﬁ‹÷5Ô80¥Qöt∏†ÆAﬁ⁄t§ÂÀè≤◊s‡]G=å@ì—Ù∏e!K€G≤ÒÀÊa∫ÙÿÔÍ∑ßÀ∑òl⁄DssWCÀ¯/=ÏÚoˆˆ6'∫à≈ ÚHü6ñó7q?–%ªK
©ª´;ï–Ö¡à£]˜UàµøHv.|+~∞–•…1&¶‰’ˆqç8ßòÒigÔ\Ë=zÓ∏x!;\"˜+›!Çÿbjâ¿Jëä•≥E
Û(P-R—3(‚±Ï˘÷n¡P‡€‹ —ßî‡'îà[V8=wÊM¡√Öƒ¯w˜Êö6*vÌ*-€•î’Ô	ÉÑ<*»‹è˙	ˇb ùˇ˜˚k˜k˜‘ı¸˚˜a˚k˚‘}ô˘^ô˚Rô˜"ô˜•í‚í¸¬ìzú˘^ú˚jó˜•íÔí¸Èó	ı
˜—óóëëëó´Ôëëëëìëëå¯à¯' «√Ïnendstreamendobj88 0 obj<</Ascent 932/CapHeight 700/CharSet(/space/zero/one/two/three/four/five/six/seven/eight/nine/A/B/C/E/M/N/R/S/a/b/d/e/g/i/k/m/n/r/s/t/u)/Descent -212/Flags 32/FontBBox[-164 -212 1000 932]/FontFile3 91 0 R/FontName/JHWGPK+HelveticaNeueLTStd-Cn/FontStretch/Condensed/FontWeight 400/ItalicAngle 0/StemV 75/Type/FontDescriptor/XHeight 500>>endobj91 0 obj<</Filter/FlateDecode/Length 2774/Subtype/Type1C>>stream
HâlUPGûawg¡Ë™åÉ∏ËÃ(Qƒ\£† ¡ "ÇF¡¨∫®ª∫lNIë¯É‘ﬁF%j4ëà±D.béüKPT41ÂXµ\EWÉîé¶byXoë∫ÎÂÍrï™‘Tu˜ÎÓ˜ı{ﬂ˚zö¶î^M”„«ß/J~gjºqcæ—f 6$ﬂ7&¶Ím9”cÕûÅr -èQ cárÚ∏°~éÎ_oÆíﬂ.'éº6ˆçÎæî¬ÂG“·±ñÕÖV”∫ı61,""tö8#4tÜìcyœ(ÍÛl∆MybÇ9€b›l±l∆ú1f„Fq–!O¥Ûå÷|œ‰o¡à¶<— ⁄¨Ü„&ÉuÉhY+&öÃ[·f£KPBà”:¡µsDìY¥≠7äi!˙1ô†õm¢¡ú#¶˛ÊΩtÌZS∂qprì°P$1˝ﬁ;€hµHo!0V1˜}´)/«îm3YÃyˇ76ˇ 
ãU4ë6xsû—¯ˇÂEõﬁã˘Sú>’cÃsåkˇòhä&5“áö‡EM¢®ö“—‘€4µê¶‚)j1E%RTMÈ‘x¬5µÑJ¶*®´¥?ΩónÙÚÒ⁄ÍuF1EÒ©‚¶r∫rß≤J˘X•U´∫3”¢‘u∑∑ó˜Loáw≥˜ø}≤|˙‹,≤_î{/“§}Û¢¬Æî˜Ù'Ïa‡clÊp|¢ÇEºÃÅ«(S0ôÉcòáƒf‰KúgÑKÉïö"ß¸ÿI◊JP )`g˙CêS‡ÌbHA=Íã1C1Ú¶Ä^@^s∫& ‘~ú@ñÇwa RHÌÇ@Ê5˘rUÀRX‡ÊNˆÊuπäÉ©Uù[”ü±TÕﬁ,	ä(û±€[cwÀﬂªË	6H
y±õ√òÉçß˛^W˝Àcˇ˚7Œ˛ îˆ⁄`âh'ÍCQÀKL˝«†˙neBR‘⁄5)+˘e+Uëãb¬–_+ã…Œ8wÂ√óNﬂ:iûÙ¯ó‚%∂Ω‚·wñëÍ”√qh“ñtÅm,û≥°ΩM–}ƒl<Ñs ∆∂u˜<£iÓÁºCÕ6Pw ˇ÷zK{ﬂ‘áìqtJ8#ß_:®Á∆âÂãyˆ.µ 7m>O†≥í.Dªd„VÍ:P#_Á¯ „ôË2.`t'D?pÕïç≥’û{ù‚¶Î%∞IäfË‰Óñ®é÷]∫˙§*"*v*É¶ı‘:&Â$
	ìõA˛€9˛›UÖÎÕ|©„T‡p„Õ¡ÑrAä”˜k	ÃR¨ƒ rå¸5W]„0¢ga–\<€˛7˙`åYÚáG≠Yæ•H(Ω¬‘î¡¬≥rKuf≤@
›Œ›)ÔzF∂?+ãâ…”	¨¨ÀÎ∫#x :‡¶kÂ…äZyÄÉ{L\XJê!0kÇΩ>Ωü3áabå8t√´+èÍöºoLL˘¨∂;}k§	íH√æ¨Åt.§ΩA∫Ó˘9˚«Yßx∂˜V’Èswµ¿ƒ9Qâ ∏d¢OØæeÊŸó≥,Ÿ…”¥l/d…zÓU+„Ã+ﬁYlπËº~ÍBõ¿æDı@2˜∞∫µ££:1<<71""∑ı!Ô9<≈?yäıPƒˆ6A(ó{«AÇf¡§"¢r?Ëøhé√1◊Ba∏˚€À'è=≥n'.D¬OÔ“‹sÕπÌ‹¸¬”…ˆÈÖO⁄€O<ë∂W:1cæ†)"B»p¡Ûˆ≠æ;‰√ÏΩ~›Ãe»PA”Ñ™nS˚3U8Ña{ÆL‚ÃS|Æ¬TF≥œÓÇ
'ª|õ%∞v«uìZMÇÆèπ◊jé€ê"‡PFÀ¡rÇ;~ÑâRŒu]Ö@Ñ*∑}Q◊÷¶!¨!ÑG#≈rˇd’¨âAØŸ≠&"ó¸≥À˜|7Ï~´õÌëÉ†îõπg{êÄöm†%DD|N:ç¿æxz2néCËf@,IÍ¿I∏"ó‹ˇxåØD=d	lÑ^Üâ†…∞ª·Äln∫ôËÿOÈ∆sp  ›XNX=„P1H©»ÔWv—-í<MR¥¯I˝J3~U™$“ı+Ué_ïR&Nf0p†UUJ:πUELÕ7v2%_ná±ÑKB Qâ]’Ï'1ÏFπ›°Ü¬ÅvÎœ‘1Ï—ÅûR5À=*dH≤§∑\∞oê…Oæ}ƒn¡+ü˝nWpô∞éıeÀ?€>Êì¯Éc%˜wÅ∆ø‰Í˙¶%eﬁÑ—æá«*;‹ZP- "‰qõá“>¶£1k!Ú”ÏÈ¬LrÌ˛KÈWRd7J±›Ï=9M>…¡Ë“%7pl &XptÇ¿ﬁ∆œ†|0Sù∂b!œ>An˜£Çé¡iﬁÇπ/`X#DÏm8Ç]8VkÔ6‘ﬂ·Ÿ{ùïÈDMãúÀZ‡Y>x9}´§˘ù€…~æÚnü˙˚£Ó+5Ø»¥ˇ9©ÄGïI≈6∆ÂoHüØùznÈ//UùØ‰õ∑∑ﬁ~:†‚¯ﬁøÏZ‘{Jvól±W‡í˙ä˝9Œ∆QÈi®··S‹Ã±ç©ÀW•¶‘~◊x§¢Ú(_˚Âù≤Ø™Ω5EÆeÕr∏¬∑˙~ﬂ	´%ˆëK˜ØÚW]Óc8
5[uQaÖøÄœnèƒ
Ó√^p:‘Ÿá≥õ`DåÜ©†,$oŒƒ¥ÛÍ°vÃf~L~`´;	p£éu∏ª «¢fª.$jkå‚°VN·f„éRÊ\AF’ª8µê<_Jå:è*`õÎÎˇ√e’Ü4Ö·-€Ωe∂§Î˝—&˜*Ÿá∂∆Õdÿ«ƒ&3≥§LeÜÈÇ"KM¶¢fÖ‰k8QLkYZ4£/√F∞≤ç·L0K]r`
}XH?ÍΩrt∂ËG¡˘sŒ·yœÛæÁ}Œs∫xíqÉ6@á+•~HıKŒ√Qbiq0Õﬁ†ÔwÇd~™WìÀU–ÛZvê∫6sI´ƒ;∞Î‹*BtÛ lx≈	‘…f!=…±súº Î¸=)nÕõ$D˜!8åòY®´ÿÀu;UBHÉ‚<ÛrGŸtäôÕ2—CÕ≈OÚî8æå<,õ4ù¯8Q–Û˛·ﬁíI¨ª∞ÑxHIyÔ»U^†∞¬¨Ÿ•…‘(§ÚrÏ#/ÆÀ¯}QÍAD=Ht	‘‹J¥HJóŸÅB£‘M,«A–Àí)|õe&Q-¸“#–RíqèÏ—bÅTÖ3!ÿqÒÃàèD•(‰Ì{<qÌ@)¢»î˛gK˚Ã?qb~Qyq5Á≠7ÙÂ(è9WX√õ(ÊÉ/ùñ¸çKz#1√ÓH»ÔΩ·˜ˇ≈à‡8Çõ„pP£q ‹Våó‡‡#µÊ—Pgk[«\ü£Øı EKΩ2˜ÃâÇÍâwƒD»E„_ÌE∞iëüL\«˙⁄Z@ÇU u—5^;V√3c5˛Ü˝äåú¶ÛiuØ«»ΩÊ[∞≤óﬁ∫AˆC{+€IÙ¶ujª}äw[ø∑«ê≈…qGÀ§∏’/†®ÄËb’⁄ôEeﬁ<|‡¥Z∫∏	∫ÌÚ%Sù≤§ŸÒåáØü¸)†"¨˛tsïÒoƒÌ+§˙‡Y}FÎ¯SN§ÑP,≠3'@‚ãó#Œ∞Dku§aÌÀz;Œ∑CíùÇ;∂†-‰Ó†ÎÀz>›Ωä¨,ŸBüªW˚£—O{{˚@LåßœjçY+^àªÿﬂ ’∂’endstreamendobj31 0 obj<</Length 32166>>stream
q
/GS0 gs
0 TL/Fm0 Do
Q
0 0 0 1 K
0.5 w 
/GS1 gs
q 1 0 0 1 36 617.3839 cm
0 0 m
41.95 0 l
S
Q
q 1 0 0 1 36 543.2521 cm
0 0 m
51.766 0 l
S
Q
q 1 0 0 1 36 507.9628 cm
0 0 m
39.372 0 l
S
Q
q 1 0 0 1 36 441.6742 cm
0 0 m
24.239 0 l
S
Q
BT
0 0 0 1 k
/T1_0 1 Tf
-0.017 Tc 0.057 Tw 8 0 0 8 36 727.248 Tm
[(It is not kno)-9.8 (wn if )36.8 (ABECMA has the potential to be transferred to the fetus.)37.2 ( Based on the)-16.9 ( )]TJ
-0.011 Tc 0.077 Tw 0 -1.052 Td
[(mechanism of action,)37.2 ( if the transduced cells cross the placenta,)37.3 ( they may cause fetal)-11 ( )]TJ
-0.017 Tc 0.043 Tw 0 -1.052 Td
[(toxicity)55.2 (,)37.2 ( inc)20.2 (luding plasma cell a)-9.8 (plasia or hypogamma)-9.8 (globulinemia.)37.2 ( )37.1 (Therefore,)37.2 ( )37.2 (ABECMA is)-17 ( )]TJ
-0.016 Tc 0.06 Tw 0 -1.052 Td
[(not recommended for women who are pregnant,)37 ( and pregnanc)20 (y after )37 (ABECMA infusion)-16 ( )]TJ
0.002 Tc 0.142 Tw 0 -1.052 Td
[(should be discussed with the trea)-9.7 (ting physician.)37.3 ( )36.6 (Assess immunoglobulin levels in)2 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.052 Td
[(newborns of mothers trea)-9.8 (ted with )37.2 (ABECMA.)]TJ
-0.015 Tc 0.06 Tw 0 -1.772 Td
[(T)0.5 (h)0.6 (e)0.5 ( )0.6 (e)0.5 (s)0.5 (t)0.6 (i)0.5 (m)0.6 (a)-9.5 (t)0.6 (e)0.5 (d)0.5 ( )0.6 (b)0.5 (a)0.6 (c)0.5 (k)0.6 (g)0.5 (r)0.5 (o)0.6 (u)0.5 (n)0.6 (d)0.5 ( )0.5 (r)0.6 (i)0.5 (s)0.5 (k)0.6 ( )0.5 (o)0.6 (f)0.5 ( )0.6 (m)0.5 (a)0.6 (j)0.5 (o)0.5 (r)0.6 ( )0.5 (b)0.6 (i)0.5 (r)0.5 (t)0.6 (h)0.5 ( )0.6 (d)0.5 (e)0.5 (f)0.6 (e)0.5 (c)0.6 (t)0.5 (s)0.5 ( )0.6 (a)0.5 (n)0.6 (d)0.5 ( )0.6 (m)0.5 (i)0.5 (s)0.6 (c)0.5 (a)0.6 (r)0.5 (r)0.5 (i)0.6 (a)-9.5 (g)0.6 (e)0.5 ( )0.6 (f)0.5 (o)0.5 (r)0.6 ( )0.5 (t)0.6 (h)0.5 (e)0.6 ( )0.5 (i)0.5 (n)0.6 (d)0.5 (i)0.5 (c)0.6 (a)-9.5 (t)0.6 (e)0.5 (d)-15 ( )]TJ
-0.01 Tc 0.087 Tw 0 -1.052 Td
[(popula)-10.4 (tion is unkno)-10.5 (wn.)36.5 ( )37.4 (The estima)-10.4 (ted background risk in the U.S.)36.5 ( general popula)-10.4 (tion)-10 ( )]TJ
-0.003 Tc 0.117 Tw 0 -1.052 Td
[(of major birth defects is 2% to 4% and of miscarria)-9.7 (ge is 15% to 20% of c)20.3 (linically)-3 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.052 Td
(recognized pregnancies.)Tj
/T1_1 1 Tf
0.017 Tw 0 -1.88 Td
(8.2)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3.375 0 Td
(Lactation)Tj
/T1_0 1 Tf
0.048 Tw -3.375 -1.543 Td
[(Risk Summar)-17.8 (y)]TJ
0.044 Tw 0 -1.637 Td
[(There is no informa)-9.8 (tion regarding the presence of )36.8 (ABECMA in human milk,)37.2 ( the effect on)-17 ( )]TJ
-0.013 Tc 0.066 Tw 0 -1.052 Td
[(t)0.5 (h)0.5 (e)0.5 ( b)0.5 (r)0.5 (e)0.5 (a)0.5 (s)0.5 (t)0.5 (fe)0.5 (d)0.5 ( i)0.5 (nf)0.5 (a)0.5 (n)0.5 (t)0.5 (,)37.5 ( a)0.5 (n)0.5 (d)0.5 ( th)0.5 (e)0.5 ( e)0.5 (f)0.5 (f)0.5 (e)0.5 (ct)0.5 (s)0.5 ( o)0.5 (n m)0.5 (i)0.5 (l)0.5 (k)0.5 ( p)0.5 (r)0.5 (o)0.5 (d)0.5 (u)0.5 (ct)0.5 (i)0.5 (o)0.5 (n)0.5 (.)37.5 ( )36.8 (T)0.5 (h)0.5 (e)0.5 ( d)0.5 (e)0.5 (v)0.5 (e)0.5 (l)0.5 (o)0.5 (pm)0.5 (e)0.5 (n)0.5 (t)0.5 (a)0.5 (l)0.5 ( a)0.5 (n)0.5 (d)0.5 ( h)0.5 (e)0.5 (a)0.5 (l)0.5 (t)0.5 (h)-13 ( )]TJ
-0.017 Tc 0.054 Tw 0 -1.052 Td
[(bene\037ts of breastfeeding should be considered along with the mother\222\)55.3 (s c)20.2 (linical need for)-17 ( )]TJ
-0.019 Tc 0.036 Tw 0 -1.052 Td
[(ABECMA and an)-10.1 (y potential adverse effects on the breastfed infant from )36.9 (ABECMA or from)-18.9 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.052 Td
[(the underlying ma)-9.8 (ternal condition.)]TJ
/T1_1 1 Tf
0.017 Tw 0 -1.88 Td
(8.3)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
[(F)20.2 (emales and Males of Reproductive P)24.2 (otential)]TJ
/T1_0 1 Tf
0.011 Tw -3.375 -1.543 Td
[(Pregnanc)20.2 (y T)74.2 (esting)]TJ
-0.021 Tc 0.036 Tw 0 -1.637 Td
[(Pregnanc)20.3 (y sta)-9.6 (tus of sexually active females with reproductive potential should be ver\i\037ed)-21 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.052 Td
[(via pregnanc)20.2 (y testing prior to starting trea)-9.8 (tment with )37.2 (ABECMA.)]TJ
0.017 Tw 0 -1.723 Td
(Contraception)Tj
-0.01 Tc 0.081 Tw 0 -1.637 Td
[(S)0.5 (e)0.5 (e)0.5 ( t)0.6 (h)0.5 (e)0.5 ( p)0.5 (r)0.5 (e)0.5 (s)0.5 (c)0.5 (r)0.5 (i)0.6 (b)0.5 (i)0.5 (n)0.5 (g)0.5 ( i)0.5 (n)0.5 (f)0.5 (o)0.5 (r)0.6 (m)0.5 (a)-9.5 (t)0.5 (i)0.5 (o)0.5 (n)0.5 ( f)0.6 (o)0.5 (r)0.5 ( \036)0.5 (u)0.5 (d)0.5 (a)0.5 (r)0.5 (a)0.6 (b)0.5 (i)0.5 (n)0.5 (e)0.5 ( a)0.5 (n)0.5 (d)0.5 ( c)20.5 (y)0.6 (c)20.4 (l)0.6 (o)0.5 (p)0.5 (h)0.5 (o)0.5 (s)0.5 (p)0.5 (h)0.5 (a)0.5 (m)0.6 (i)0.5 (d)0.5 (e)0.5 ( f)0.5 (o)0.5 (r)0.5 ( i)0.6 (n)0.5 (f)0.5 (o)0.5 (r)0.5 (m)0.5 (a)-9.4 (t)0.5 (i)0.5 (o)0.5 (n)-10 ( )]TJ
-0.006 Tc 0.105 Tw 0 -1.052 Td
[(on the need for effective contraception in pa)-10.2 (tients who receive the lymphodepleting)-6 ( )]TJ
-0.017 Tc 0.017 Tw 0 -1.052 Td
[(chemothera)-9.8 (py)55.2 (.)]TJ
-0.014 Tc 0.065 Tw 0 -1.772 Td
[(There are insuf\037cient exposure da)-10.2 (ta to provide a recommenda)-10.2 (tion concerning dura)-10.2 (tion)-14 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.052 Td
[(of contraception follo)-9.7 (wing trea)-9.7 (tment with )37.2 (ABECMA.)]TJ
0.017 Tw 0 -1.723 Td
(Infertility)Tj
0.048 Tw 0 -1.637 Td
[(There are no da)-9.8 (ta on the effect of )37.2 (ABECMA on fertility)55.2 (.)]TJ
/T1_1 1 Tf
0.017 Tw 0 -1.88 Td
(8.4)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
[(P)24.2 (ediatric Use)]TJ
/T1_0 1 Tf
-0.008 Tc 0.091 Tw -3.375 -1.592 Td
[(T)0.5 (h)0.5 (e s)0.5 (af)0.5 (e)0.5 (t)0.5 (y)0.5 ( a)0.5 (n)0.5 (d)0.5 ( e)0.5 (f)0.5 (\037c)0.5 (a)0.5 (c)20.5 (y)0.5 ( o)0.5 (f)0.5 ( )36.8 (A)0.5 (BE)0.5 (C)0.5 (M)0.5 (A)0.5 ( i)0.5 (n p)0.5 (a)-9.5 (ti)0.5 (e)0.5 (n)0.5 (t)0.5 (s)0.5 ( u)0.5 (nd)0.5 (e)0.5 (r)0.5 ( 1)0.5 (8)0.5 ( y)0.5 (e)0.5 (a)0.5 (r)0.5 (s o)0.5 (f a)-9.5 (ge)0.5 ( ha)-9.5 (v)0.5 (e)0.5 ( n)0.5 (o)0.5 (t)0.5 ( be)0.5 (e)0.5 (n)-8 ( )]TJ
-0.017 Tc 0.017 Tw 0 -1.052 Td
(established.)Tj
/T1_1 1 Tf
0 -1.88 Td
(8.5)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
(Geriatric Use)Tj
/T1_0 1 Tf
-0.016 Tc 0.06 Tw -3.375 -1.592 Td
[(In the c)20 (linical trials of )36.9 (ABECMA,)37 ( 141 \(40%\) of the 349 pa)-10 (tients were 65 years of a)-10 (ge or)-16 ( )]TJ
-0.021 Tc 0.036 Tw 0 -1.052 Td
[(older an)0.5 (d 16/349 \(4.6%\) pa)-9.6 (tie)0.5 (nt)0.5 (s )0.5 (were 75 years )0.5 (of a)-9.6 (ge or o)0.5 (lde)0.5 (r)74.4 (.)37.4 ( In KarMMa stud)-9.6 (y)55.4 (,)37.4 ( all \037v)0.5 (e)-21 ( )]TJ
-0.013 Tc 0.071 Tw 0 -1.052 Td
[(cases of Grade 3 neurotoxicity occurred in pa)-10.3 (tients \03465 years of a)-10.4 (ge \(66 to 74 years\).)24 ( )]TJ
-0.014 Tc 0.064 Tw 0 -1.052 Td
[(No c)19.9 (linically important differences in effectiveness of )36.5 (ABECMA were obser)-18 (ved between)-14 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.052 Td
[(these pa)-9.8 (tients and pa)-9.8 (tients younger than 65 years of a)-9.8 (ge.)]TJ
/T1_1 1 Tf
0.017 Tw 0 -2.055 Td
(11)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3.375 0 Td
(DESCRIPTION)Tj
/T1_0 1 Tf
-0.003 Tc 0.116 Tw -3.375 -1.727 Td
[(A)0.5 (B)0.5 (E)0.5 (C)0.5 (M)0.5 (A)0.5 ( i)0.5 (s)0.5 ( a)0.5 ( B)0.5 (C)0.5 (M)0.5 (A)0.5 (-)0.5 (d)0.5 (i)0.5 (r)0.5 (e)0.6 (c)0.5 (t)0.5 (e)0.5 (d)0.5 ( g)0.6 (e)0.5 (n)0.5 (e)0.5 (t)0.5 (i)0.5 (c)0.5 (a)0.5 (l)0.5 (l)0.5 (y)0.6 ( m)0.5 (o)0.5 (d)0.5 (i)0.5 (\037)0.5 (e)0.6 (d)0.5 ( a)0.5 (u)0.5 (t)0.5 (o)0.6 (l)0.5 (o)0.5 (g)0.5 (o)0.5 (u)0.5 (s)0.5 ( )37 (T)0.5 ( c)0.5 (e)0.5 (l)0.5 (l)0.5 ( i)0.5 (m)0.5 (m)0.5 (u)0.5 (n)0.5 (o)0.6 (t)0.5 (h)0.5 (e)0.5 (r)0.5 (a)-9.5 (p)0.5 (y)-3 ( )]TJ
-0.017 Tc 0.043 Tw 0 -1.052 Td
[(product consisting of a pa)-9.7 (tient\222)55.2 (s o)-9.7 (wn )36.7 (T cells tha)-9.8 (t are har)-17.7 (vested and genetically modi\037ed)-17 ( )]TJ
/T1_2 1 Tf
-0.003 Tc 0.118 Tw 0 -1.052 Td
(ex vivo)Tj
/T1_0 1 Tf
[( through transduction with an anti-BCMA02 chimeric antigen receptor \(CA\R\))-3 ( )]TJ
-0.006 Tc 0.106 Tw 0 -1.052 Td
[(lentiviral vector \(L)73.7 (VV\).)36.7 ( )37.4 (Autologous )37.3 (T cells transduced with the anti-BCMA02 CAR L)73.8 (VV)-6 ( )]TJ
-0.009 Tc 0.087 Tw 0 -1.052 Td
[(express the anti-BCMA CAR on the )37.2 (T cell surface.)37.4 ( )37.3 (The CAR is comprised of a murine)-9 ( )]TJ
0.006 Tc 0.163 Tw 0 -1.052 Td
[(extracellular single-chain variable fra)-9.9 (gment \(scFv\) specific for recognizing B cell)6 ( )]TJ
-0.001 Tc 0.127 Tw 0 -1.052 Td
[(ma)-9.6 (tura)-9.6 (tion antigen \(BCMA\) follo)-9.6 (wed by a human CD8)]TJ
/C2_0 1 Tf
0 Tc 0 Tw <005F>Tj
/T1_0 1 Tf
-0.001 Tc 0.127 Tw 21.157 0 Td
[( hinge and transmembrane)-1 ( )]TJ
-0.014 Tc 0.065 Tw -21.157 -1.052 Td
[(domain fused to the )37.3 (T cell c)19.9 (ytoplasmic signaling domains of CD137 \(4-1BB\) and CD3)]TJ
/C2_0 1 Tf
0 Tc 0 Tw <00630003>Tj
/T1_0 1 Tf
-0.017 Tc 0.037 Tw 0 -1.052 Td
[(chain,)37.2 ( )0.5 (in tandem.)37.2 ( )0.5 (Binding )0.5 (of )37.5 (ABECMA )0.5 (to )0.5 (BCMA-expressing )0.5 (target )0.5 (cells )0.5 (leads )0.5 (to )0.5 (signaling)-17 ( )]TJ
-0.01 Tc 0.083 Tw 0 -1.052 Td
[(initia)-9.8 (ted by CD3)]TJ
/C2_0 1 Tf
0 Tc 0 Tw <0063>Tj
/T1_0 1 Tf
-0.01 Tc 0.083 Tw 6.346 0 Td
[( and 4-1BB domains,)37.2 ( and subsequent CAR-positive )37 (T cell activa)-9.9 (tion.)27 ( )]TJ
0.004 Tc 0.154 Tw -6.346 -1.052 Td
[(Antigen-specific activa)-10 (tion of )36.8 (ABECMA results in CAR-positive )36.9 (T cell prolifera)-10 (tion,)41 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.052 Td
[(c)20.2 (ytokine secretion,)37.2 ( and subsequent c)20.1 (ytolytic killing of BCMA-expressing cells.)]TJ
-0.007 Tc 0.098 Tw 0 -1.772 Td
[(ABECMA is prepared from the pa)-9.8 (tient\222)55.1 (s peripheral blood mononuc)20.1 (lear cells \(PBMCs\),)30 ( )]TJ
-0.014 Tc 0.061 Tw 0 -1.052 Td
[(w)0.5 (hi)0.5 (c)0.5 (h a)0.5 (re)0.5 ( o)0.5 (b)0.5 (ta)0.5 (i)0.5 (ne)0.5 (d)0.5 ( vi)0.5 (a)0.5 ( a)0.5 ( s)0.5 (t)0.5 (a)0.5 (nd)0.5 (a)0.5 (rd)0.5 ( l)0.5 (eu)0.5 (k)0.5 (a)-9.6 (p)0.5 (h)0.5 (er)0.5 (e)0.5 (si)0.5 (s)0.5 ( pr)0.5 (o)0.5 (ce)0.5 (d)0.5 (ur)0.5 (e)0.5 (.)37.4 ( )36.8 (T)0.5 (he)0.5 ( m)0.5 (o)0.5 (no)0.5 (n)0.5 (uc)20.5 (le)0.5 (a)0.5 (r c)0.5 (e)0.5 (ll)0.5 (s)0.5 ( ar)0.5 (e)-14 ( )]TJ
-0.01 Tc 0.081 Tw 0 -1.052 Td
[(e)0.5 (n)0.5 (r)0.6 (i)0.5 (c)0.5 (h)0.5 (e)0.5 (d)0.5 ( f)0.5 (o)0.5 (r)0.6 ( )37 (T)0.5 ( c)0.6 (e)0.5 (l)0.5 (l)0.5 (s)0.5 (,)37.6 ( t)0.5 (h)0.5 (r)0.6 (o)0.5 (u)0.5 (g)0.5 (h)0.5 ( a)0.5 (c)0.5 (t)0.5 (i)0.6 (v)0.5 (a)-9.5 (t)0.5 (i)0.5 (o)0.6 (n)0.5 ( w)0.5 (i)0.6 (t)0.5 (h)0.5 ( a)0.6 (n)0.5 (t)0.5 (i)0.5 (-)0.5 (C)0.6 (D)0.5 (3)0.5 ( a)0.6 (n)0.5 (d)0.5 ( a)0.6 (n)0.5 (t)0.5 (i)0.5 (-)0.5 (C)0.5 (D)0.6 (2)0.5 (8)0.5 ( a)0.6 (n)0.5 (t)0.5 (i)0.5 (b)0.5 (o)0.6 (d)0.5 (i)0.5 (e)0.5 (s)0.5 ( i)0.5 (n)0.5 ( t)0.6 (h)0.5 (e)-10 ( )]TJ
-0.013 Tc 0.066 Tw 0 -1.052 Td
[(p)0.5 (re)0.5 (se)0.5 (n)0.5 (ce)0.5 ( of)0.5 ( I)0.5 (L-)0.5 (2,)37.5 ( wh)0.5 (i)0.5 (ch)0.5 ( ar)0.5 (e)0.5 ( th)0.5 (e)0.5 (n t)0.5 (ra)0.5 (n)0.5 (sd)0.5 (uc)0.5 (ed)0.5 ( wi)0.5 (t)0.5 (h t)0.5 (he)0.5 ( r)0.5 (ep)0.5 (li)0.5 (c)0.5 (a)-9.6 (t)0.5 (io)0.5 (n)0.5 (-i)0.5 (nc)0.5 (om)0.5 (p)0.5 (et)0.5 (en)0.5 (t)0.5 ( le)0.5 (nt)0.5 (i)0.5 (vi)0.5 (ra)0.5 (l)-13 ( )]TJ
-0.012 Tc 0.075 Tw 0 -1.052 Td
[(vector )0.6 (containing )0.6 (the )0.5 (anti-BCMA )0.5 (CAR )0.5 (transgene.)36.9 ( )37.5 (The )0.6 (transduced )37.6 (T )0.5 (cells )0.6 (are )0.5 (expanded)-12 ( )]TJ
-0.011 Tc 0.077 Tw 0 -1.052 Td
[(in cell culture,)37.3 ( washed,)37.3 ( formula)-9.7 (ted into a suspension,)37.3 ( and cr)-17.7 (yopreser)-17.7 (ved.)37.3 ( )36.7 (The product)-11 ( )]TJ
-0.005 Tc 0.11 Tw 0 -1.052 Td
[(must pass a sterility test before release for shipping as a frozen suspe\nsion in one)-5 ( )]TJ
-0.009 Tc 0.088 Tw 0 -1.052 Td
[(or more pa)-9.9 (tient-speci\037c infusion ba)-9.8 (g\(s\).)37.2 ( )37.1 (The product is tha)-9.8 (wed prior to infusion back)-9 ( )]TJ
-0.008 Tc 0.094 Tw 0 -1.052 Td
[(into the pa)-9.9 (tient )]TJ
/T1_2 1 Tf
[([see Dosa)-9.9 (ge and )37.3 (Administra)-9.9 (tion \(2.3\) and Ho)-9.9 (w Supplied/Stora)-9.9 (ge and)-8 ( )]TJ
-0.017 Tc 0.017 Tw 0 -1.052 Td
(Handl)Tj
0.048 Tw (ing \(16\)])Tj
/T1_0 1 Tf
0 Tc 0 Tw (.)Tj
0.001 Tc 0.14 Tw 0 -1.772 Td
[(The )37.3 (ABECMA formula)-10 (tion contains 50% Plasma-L)36.9 (yte )37.3 (A and 50% Cr)-18.1 (yoStor)]TJ
0 Tc 0 Tw 5.6 0 0 5.6 262.9769 107.7626 Tm
(\256)Tj
0.001 Tc 0.14 Tw 8 0 0 8 267.463 105.0986 Tm
[( CS10,)38 ( )]TJ
-0.017 Tc 0.048 Tw -28.933 -1.052 Td
[(resulting in a \037nal DMSO concentra)-9.8 (tion of 5%.)]TJ
/T1_1 1 Tf
0.017 Tw 0 -2.055 Td
(12)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
[(CLINIC)18.3 (AL PHARMACOLOGY)]TJ
0.017 Tw -3.375 -1.835 Td
(12.1)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
(Mechanism of Action)Tj
/T1_0 1 Tf
-0.007 Tc 0.097 Tw -3.375 -1.592 Td
[(ABECMA is a chimeric antigen receptor \(CAR\)-positive )36.7 (T cell thera)-9.7 (py targeting B-cell)-7 ( )]TJ
-0.017 Tc 0.054 Tw 0 -1.052 Td
[(ma)-9.8 (tura)-9.8 (tion antigen \(BCMA\),)37.2 ( which is expressed on the surface of normal and malignant)-17 ( )]TJ
-0.001 Tc 0.129 Tw 0 -1.052 Td
[(plasma cells.)36.9 ( )36.6 (The CAR construct inc)19.9 (ludes an anti-BCMA scFv-targeting domain for)-1 ( )]TJ
ET
q 1 0 0 1 324 204.4944 cm
0 0 m
139.53 0 l
S
Q
q 1 0 0 1 324 68.3589 cm
0 0 m
57.378 0 l
S
Q
BT
0.127 Tw 8 0 0 8 324 727.248 Tm
[(antigen speci\037city)55.4 (,)37.4 ( a transmembrane domain,)37.4 ( a CD3-zeta )37.4 (T cel)0.5 (l activa)-9.6 (tion domain,)36 ( )]TJ
-0.007 Tc 0.101 Tw 0 -1.046 Td
[(and )0.5 (a )0.5 (4-1BB )0.5 (costimula)-10.2 (tor)-18.3 (y )0.5 (domain.)36.8 ( )37.4 (Antigen-speci\037c )0.5 (activa)-10.2 (tion )0.5 (of )37.5 (ABECMA )0.5 (results )0.5 (in)-7 ( )]TJ
-0.011 Tc 0.08 Tw 0 -1.046 Td
[(CAR-positive )37.2 (T cell prolifera)-10.1 (tion,)36.8 ( c)19.9 (ytokine secretion,)36.8 ( and subsequent c)19.8 (ytolytic killing of)-11 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.046 Td
(BCMA-expressing cells.)Tj
/T1_1 1 Tf
0.017 Tw 0 -1.875 Td
(12.2)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3.375 0 Td
(Pharmacodynamics)Tj
/T1_0 1 Tf
0.008 Tc 0.176 Tw -3.375 -1.586 Td
[(F)19.7 (ollo)-10.3 (wing )37.4 (ABECMA infusion,)36.7 ( pharmacod)-10.3 (ynamic responses of CAR )0.5 (activa)-10.3 (tion )0.5 (and)8 ( )]TJ
-0.009 Tc 0.091 Tw 0 -1.046 Td
[(anti-tumor ef\037cac)19.6 (y were evalua)-10.4 (ted.)36.6 ( P)17.6 (eak eleva)-10.3 (tion of plasma c)19.6 (ytokines,)36.6 ( chemokines,)28 ( )]TJ
0.003 Tc 0.147 Tw 0 -1.046 Td
[(and soluble immune media)-9.7 (tors occurred within 14 days of )36.7 (ABECMA infusion and)3 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.046 Td
(returned to baseline levels within one month.)Tj
-0.01 Tc 0.083 Tw 0 -1.766 Td
[(Ra)-9.8 (pid decreases in tumor markers associa)-9.8 (ted with c)20.1 (linical response,)37.2 ( inc)20.1 (luding serum)-10 ( )]TJ
0.087 Tw 0 -1.046 Td
[(levels of soluble BCMA,)36.5 ( and bone marro)-10.4 (w CD138)]TJ
0 Tc 0 Tw 18.299 0.125 Td
(+)Tj
-0.01 Tc 0.087 Tw 0.59 -0.125 Td
[( cells,)36.6 ( as well as minimal residual)-10 ( )]TJ
-0.001 Tc 0.127 Tw -18.889 -1.046 Td
[(disease \(MRD\) nega)-9.6 (tive responses,)37.4 ( were obser)-17.7 (ved within the \037rst month follo)-9.7 (wing)-1 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.046 Td
(ABECMA infusion.)Tj
/T1_1 1 Tf
0.017 Tw 0 -1.875 Td
(12.3)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3.375 0 Td
(Pharmacokinetics)Tj
/T1_0 1 Tf
-0.001 Tc 0.132 Tw -3.375 -1.586 Td
[(F)19.6 (ollo)-10.3 (wing )37.5 (ABECMA )0.6 (infusion,)36.6 ( )0.6 (the )0.6 (CAR-positive )37.5 (T )0.6 (cells )0.5 (prolifera)-10.4 (te )0.6 (and )0.6 (undergo )0.5 (ra)-10.4 (pid)-1 ( )]TJ
-0.013 Tc 0.071 Tw 0 -1.046 Td
[(multi-log expansion follo)-10.4 (wed by a bi-exponential dec)19.6 (line.)36.6 ( )36.6 (The median time of maximal)-13 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.046 Td
(expansion in peripheral blood \(T)Tj
0.017 Tw 5.6 0 0 5.6 415.5948 564.9337 Tm
(max)Tj
0.048 Tw 8 0 0 8 424.1089 565.6736 Tm
(\) occurred 11 days after infusion.)Tj
-0.01 Tc 0.083 Tw -12.514 -1.766 Td
[(ABECMA can persist in peripheral blood for up to 1 year post-infusion.)37.1 ( )36.6 (A summar)-17.9 (y of)-9.9 ( )]TJ
0 Tc 0 Tw 0 -1.046 Td
(T)Tj
-0.017 Tc 0.017 Tw 5.6 0 0 5.6 327.5664 542.4343 Tm
(max)Tj
0.011 Tw 8 0 0 8 336.0804 543.1743 Tm
[(,)37.2 ( AUC)]TJ
0.017 Tw 5.6 0 0 5.6 351.3284 542.4343 Tm
(0-28days)Tj
0.048 Tw 8 0 0 8 370.2247 543.1743 Tm
[(,)37.2 ( and C)]TJ
0.017 Tw 5.6 0 0 5.6 390.6052 542.4343 Tm
(max)Tj
0.048 Tw 8 0 0 8 399.1192 543.1743 Tm
[( from KarMMa and KarMMa-3 is provided in )37.2 (T)74.2 (able 7.)]TJ
ET
/GS2 gs
q 1 0 0 1 324 471.0508 cm
0 0 m
54 0 l
S
Q
q 1 0 0 1 378 471.0508 cm
0 0 m
55.44 0 l
S
Q
q 1 0 0 1 324 450.1266 cm
0 0 m
54 0 l
S
Q
q 1 0 0 1 378 450.1266 cm
0 0 m
55.44 0 l
S
Q
q 1 0 0 1 324 430.1547 cm
0 0 m
54 0 l
S
Q
q 1 0 0 1 378 430.1547 cm
0 0 m
55.44 0 l
S
Q
q 1 0 0 1 378 471.3008 cm
0 0 m
0 37.662 l
S
Q
q 1 0 0 1 378 450.3766 cm
0 0 m
0 20.424 l
S
Q
q 1 0 0 1 378 430.4047 cm
0 0 m
0 19.472 l
S
Q
q 1 0 0 1 378 410.6827 cm
0 0 m
0 19.222 l
S
Q
1 w 
q 1 0 0 1 324 509.4627 cm
0 0 m
54 0 l
S
Q
q 1 0 0 1 378 509.4627 cm
0 0 m
55.44 0 l
S
Q
q 1 0 0 1 504.66 509.4627 cm
0 0 m
71.22 0 l
S
Q
0.5 w 
q 1 0 0 1 504.66 471.0508 cm
0 0 m
71.22 0 l
S
Q
q 1 0 0 1 504.66 450.1266 cm
0 0 m
71.22 0 l
S
Q
q 1 0 0 1 504.66 430.1547 cm
0 0 m
71.22 0 l
S
Q
1 w 
q 1 0 0 1 324 410.1827 cm
0 0 m
54 0 l
S
Q
q 1 0 0 1 378 410.1827 cm
0 0 m
55.44 0 l
S
Q
q 1 0 0 1 504.66 410.1827 cm
0 0 m
71.22 0 l
S
Q
0.5 w 
q 1 0 0 1 324 304.4908 cm
0 0 m
54 0 l
S
Q
q 1 0 0 1 378 304.4908 cm
0 0 m
55.44 0 l
S
Q
q 1 0 0 1 433.44 304.4908 cm
0 0 m
71.22 0 l
S
Q
q 1 0 0 1 504.66 304.4908 cm
0 0 m
71.22 0 l
S
Q
1 w 
q 1 0 0 1 433.44 509.4627 cm
0 0 m
71.22 0 l
S
Q
0.5 w 
q 1 0 0 1 433.44 471.3008 cm
0 0 m
0 37.662 l
S
Q
q 1 0 0 1 504.66 471.3008 cm
0 0 m
0 37.662 l
S
Q
q 1 0 0 1 433.44 471.0508 cm
0 0 m
71.22 0 l
S
Q
q 1 0 0 1 433.44 450.3766 cm
0 0 m
0 20.424 l
S
Q
q 1 0 0 1 504.66 450.3766 cm
0 0 m
0 20.424 l
S
Q
q 1 0 0 1 433.44 450.1266 cm
0 0 m
71.22 0 l
S
Q
q 1 0 0 1 433.44 430.4047 cm
0 0 m
0 19.472 l
S
Q
q 1 0 0 1 504.66 430.4047 cm
0 0 m
0 19.472 l
S
Q
q 1 0 0 1 433.44 430.1547 cm
0 0 m
71.22 0 l
S
Q
q 1 0 0 1 433.44 410.6827 cm
0 0 m
0 19.222 l
S
Q
q 1 0 0 1 504.66 410.6827 cm
0 0 m
0 19.222 l
S
Q
1 w 
q 1 0 0 1 433.44 410.1827 cm
0 0 m
71.22 0 l
S
Q
BT
/GS1 gs
/T1_1 1 Tf
8 0 0 8 324 521.5627 Tm
[(T)74.2 (able 7:)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
5 0 Td
[(Pharmacokinetic P)24.2 (arameters of ABECMA in P)24.2 (atients with Relapsed/)]TJ
0 -1.062 Td
[(Refractor)-17.8 (y Multiple Myeloma)]TJ
-0.012 Tc 0.012 Tw 7.36 0 0 8 326.7853 483.1508 Tm
[(Pharmacokinetic)-12 ( )]TJ
1.27 -1.062 Td
[(P)24.2 (arameter)]TJ
7.586 1.062 Td
[(Summar)-17.8 (y)]TJ
0 Tc 0 Tw 7.36 0 0 8 419.4749 483.1508 Tm
( )Tj
-0.012 Tc 0.012 Tw 7.36 0 0 8 394.0275 474.6508 Tm
(Statistic)Tj
0.048 Tw 7.331 3.188 Td
(KarMMa Study)Tj
-1.693 -1.062 Td
[(T)74.2 (otal [300 to 460 x 10)]TJ
0 Tc 0 Tw 5.152 0 0 5.6 497.8459 494.3148 Tm
(6)Tj
7.36 0 0 8 500.256 491.6508 Tm
(])Tj
-0.012 Tc 0.048 Tw -8.165 -1.062 Td
[(C)18.2 (AR-P)24.2 (ositive T Cells)]TJ
-0.283 -1.062 Td
(\(Quantified by qPCR\))Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.152 0 0 5.6 497.5503 477.3148 Tm
(a)Tj
7.36 0 0 8 500.0283 474.6508 Tm
(\037)Tj
-0.012 Tc 0.048 Tw 2.209 3.188 Td
(KarMMa-3 Study)Tj
-1.28 -1.062 Td
[(T)74.2 (otal [300 to 510 x 10)]TJ
0 Tc 0 Tw 5.152 0 0 5.6 569.191 494.3148 Tm
(6)Tj
7.36 0 0 8 571.6011 491.6508 Tm
(])Tj
-0.012 Tc 0.048 Tw -8.165 -1.062 Td
[(C)18.2 (AR-P)24.2 (ositive T Cells)]TJ
-0.534 -1.062 Td
(\(Quantified by ddPCR\))Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.152 0 0 5.6 570.6414 477.3148 Tm
(b)Tj
7.36 0 0 8 573.2174 474.6508 Tm
(\037)Tj
/T1_0 1 Tf
7.6 0 0 8 324 462.4589 Tm
(T)Tj
-0.012 Tc 0.012 Tw 5.32 0 0 5.6 327.4261 461.7189 Tm
(max)Tj
0.048 Tw 7.6 0 0 8 335.5942 462.4589 Tm
( \(days\))Tj
0.012 Tw 7.897 0 Td
(Median)Tj
0 Tc 0 Tw 7.6 0 0 8 415.8317 462.4589 Tm
( )Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 395.3014 453.9589 Tm
(\(Range\))Tj
0.048 Tw 7.992 1.062 Td
(11 \(7-28\))Tj
0 Tc 0 Tw 7.6 0 0 8 482.0625 462.4589 Tm
( )Tj
-0.012 Tc -0.115 Tw 7.6 0 0 8 460.2911 453.9589 Tm
(N)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
(99)Tj
0.048 Tw 8.828 1.062 Td
(11 \(4-31\))Tj
0 Tc 0 Tw 7.6 0 0 8 553.4075 462.4589 Tm
( )Tj
-0.012 Tc -0.115 Tw 7.6 0 0 8 529.8585 453.9589 Tm
(N)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
(207)Tj
0 Tc 0 Tw -27.087 -1.553 Td
(C)Tj
-0.012 Tc 0.012 Tw 5.32 0 0 5.6 327.8517 440.7947 Tm
(max)Tj
0.048 Tw 7.6 0 0 8 336.0198 441.5347 Tm
( \(copies/mcg\))Tj
6.182 0 Td
[(Geometric mean)-12 ( )]TJ
-0.031 -1.062 Td
(\(geometric CV%\))Tj
8.762 1.062 Td
(256,333 \(165\))Tj
0 Tc 0 Tw 7.6 0 0 8 488.7474 441.5347 Tm
( )Tj
-0.012 Tc -0.115 Tw 7.6 0 0 8 460.2911 433.0347 Tm
(N)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
(99)Tj
0.048 Tw 7.948 1.062 Td
(117,557 \(215\))Tj
0 Tc 0 Tw 7.6 0 0 8 560.0924 441.5347 Tm
( )Tj
-0.012 Tc -0.115 Tw 7.6 0 0 8 529.8584 433.0347 Tm
(N)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
(207)Tj
0.012 Tw -27.087 -1.434 Td
(AUC)Tj
5.32 0 0 5.6 335.4106 420.8228 Tm
(0-28days)Tj
0 Tc 0 Tw 7.6 0 0 8 353.6398 421.5627 Tm
( )Tj
-0.012 Tc 0.012 Tw -3.9 -1.062 Td
(\(days*copies/mcg\))Tj
0.048 Tw 7.764 1.062 Td
[(Geometric mean)-12 ( )]TJ
-0.031 -1.062 Td
(\(geometric CV%\))Tj
8.414 1.062 Td
(3,088,455 \(190\))Tj
0 Tc 0 Tw 7.6 0 0 8 491.3906 421.5627 Tm
( )Tj
-0.012 Tc -0.115 Tw 7.6 0 0 8 460.291 413.0627 Tm
(N)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
(98)Tj
0.048 Tw 7.6 1.062 Td
(1,098,862 \(228\))Tj
0 Tc 0 Tw 7.6 0 0 8 562.7356 421.5627 Tm
( )Tj
-0.012 Tc -0.115 Tw 7.6 0 0 8 529.8584 413.0627 Tm
(N)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
(205)Tj
0 Tc 0 Tw -27.087 -1.524 Td
(AUC)Tj
5.32 0 0 5.6 335.6867 400.1308 Tm
(0-28days)Tj
0.109 Tw /Span<</ActualText<FEFF2009>>> BDC 
7.6 0 0 8 354.3665 400.8708 Tm
( )Tj
EMC 
0.125 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
0.725 0 Td
[(area )0.5 (under )0.6 (the )0.5 (cur)-17.9 (ve )0.5 (of )0.6 (the )0.5 (transgene )0.5 (level )0.5 (from )0.6 (time )0.5 (of )0.6 (dose )0.6 (to )0.5 (28 )0.5 (days )]TJ
0.003 Tc 0.121 Tw -4.845 -1.062 Td
[(p)0.5 (os)0.5 (t-)0.5 (i)0.5 (nf)0.5 (us)0.5 (i)0.5 (on)0.5 (;)0.5 ( C)]TJ
-0.003 Tw 5.32 0 0 5.6 369.5504 391.6308 Tm
[(m)0.5 (ax)]TJ
0.121 Tw /Span<</ActualText<FEFF2009>>> BDC 
7.6 0 0 8 377.9539 392.3708 Tm
( )Tj
EMC 
0.128 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
0.603 0 Td
( )Tj
EMC 
0.128 0 Td
[(t)0.5 (he)0.5 ( m)0.5 (ax)0.5 (i)0.5 (mu)0.5 (m)0.5 ( tr)0.5 (an)0.5 (s)0.5 (ge)0.5 (ne)0.5 ( l)0.5 (e)0.5 (ve)0.5 (l)0.5 (; d)0.5 (dP)0.5 (CR)]TJ
/Span<</ActualText<FEFF2009>>> BDC 
14.453 0 Td
( )Tj
EMC 
0.128 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
0.603 0 Td
( )Tj
EMC 
0.128 0 Td
[(d)0.5 (ro)0.5 (pl)0.5 (e)0.5 (t di)0.5 (gi)0.5 (ta)0.5 (l)0.5 ( po)0.5 (l)0.5 (ym)0.5 (e)0.5 (ra)0.5 (se)3.1 ( )]TJ
0.005 Tc 0.133 Tw -23.267 -1.062 Td
(chain reaction; qPCR)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
8.176 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
0.735 0 Td
[(quantita)-9.9 (tive polymerase chain reaction; PK)]TJ
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
16.625 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
0.735 0 Td
[(pharmacokinetics;)5 ( )]TJ
0 Tc 0 Tw 7.6 0 0 8 575.8799 383.8708 Tm
( )Tj
7.6 0 0 8 323.9999 375.3708 Tm
(T)Tj
-0.012 Tc 0.012 Tw 5.32 0 0 5.6 327.426 374.6308 Tm
(max)Tj
0.048 Tw /Span<</ActualText<FEFF2009>>> BDC 
7.6 0 0 8 335.5941 375.3708 Tm
( )Tj
EMC 
0.113 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
0.701 0 Td
[(time of maximum obser)-17.8 (ved transgene level.)]TJ
0.012 Tw 5.32 0 0 5.6 323.9999 369.5348 Tm
(a)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.015 Tc 0.036 Tw 7.6 0 0 8 328.9999 366.8708 Tm
[(The PK parameters of KarMMa stud)-9.8 (y were determined by time course of transgene copies)-15 ( )]TJ
-0.002 Tc 0.1 Tw 0 -1.062 Td
(per microgram of DNA extracted from CD3)Tj
0 Tc 0 Tw 16.219 0.125 Td
(+)Tj
-0.002 Tc 0.1 Tw 0.598 -0.125 Td
[( sorted cells as quantified by quantita)-10.2 (tive)-2 ( )]TJ
-0.012 Tc 0.048 Tw -16.817 -1.062 Td
(polymerase chain reaction \(qPCR\).)Tj
0.012 Tw 5.32 0 0 5.6 323.9999 344.0348 Tm
(b)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.003 Tc 0.095 Tw 7.6 0 0 8 328.9999 341.3708 Tm
[(The PK parameters of KarMMa-3 Stud)-10.1 (y were determined by time course of transgene)-3 ( )]TJ
-0.011 Tc 0.06 Tw 0 -1.062 Td
[(copies per microgram of DNA extracted from whole blood as quantified by \droplet digital)-11 ( )]TJ
-0.012 Tc 0.048 Tw 0 -1.062 Td
(PCR \(ddPCR\).)Tj
-0.013 Tc 0.036 Tw -0.658 -1.062 Td
[(Note:)37.2 ( )37.2 (The PK parameters should not be directly compared between KarMMa and Kar\MMa-3)-13 ( )]TJ
-0.012 Tc 0.048 Tw 0 -1.062 Td
[(due to different primar)-17.8 (y PK assays used in these two studies.)]TJ
-0.004 Tc 0.114 Tw 8 0 0 8 323.9999 286.1912 Tm
[(ABECMA )0.5 (transgene )0.6 (levels )0.6 (were )0.6 (positively )0.5 (associa)-9.8 (ted )0.5 (with )0.6 (objective )0.6 (tumor )0.5 (response)-3.9 ( )]TJ
-0.003 Tc 0.12 Tw 0 -1.046 Td
[(\(partial response or better\).)36.7 ( )36.8 (Among pa)-10.2 (tients who received )36.8 (ABECMA in KarMMa,)36.8 ( the)-3 ( )]TJ
-0.002 Tc 0.123 Tw 0 -1.046 Td
(median C)Tj
0.002 Tw 5.6 0 0 5.6 352.834 268.7119 Tm
(max)Tj
0.123 Tw 8 0 0 8 361.5999 269.4519 Tm
( levels in responders \(N)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
9.222 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
0.721 0 Td
[(72\) were a)-9.8 (pproxima)-9.8 (tely 4.6-fold higher than)-2 ( )]TJ
-0.012 Tc 0.076 Tw -14.642 -1.046 Td
(the corresponding levels in non-responders \(N)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
17.029 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
0.702 0 Td
[(27\).)36.7 ( Median )37.1 (AUC)]TJ
0.012 Tw 5.6 0 0 5.6 514.6706 260.3423 Tm
(0-28days)Tj
0.076 Tw 8 0 0 8 533.8141 261.0823 Tm
[( in responders)-12 ( )]TJ
-0.021 Tc 0.036 Tw -26.227 -1.046 Td
(\(N)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
0.858 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
0.682 0 Td
[(72\))0.5 ( was )0.5 (a)-9.6 (ppr)0.5 (oxim)0.5 (a)-9.6 (te)0.5 (ly 5)0.5 (.6-fo)0.5 (ld h)0.5 (igher)0.5 ( tha)0.5 (n non)0.5 (-res)0.5 (ponde)0.5 (rs \(N)]TJ
/Span<</ActualText<FEFF2009>>> BDC 
22.096 0 Td
( )Tj
EMC 
0.104 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
0.682 0 Td
[(26)0.5 (\).)37.4 ( )37.4 (Amo)0.5 (ng pa)-9.5 (tien)0.5 (ts)-21 ( )]TJ
-0.024 Tc 0.031 Tw -24.422 -1.046 Td
[(who received )37.4 (ABECMA in )0.5 (KarMMa-3,)37.1 ( the median C)]TJ
0.024 Tw 5.6 0 0 5.6 467.0256 243.603 Tm
(max)Tj
0.031 Tw 8 0 0 8 475.4233 244.343 Tm
[( levels in responders )0.5 (\(N)]TJ
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
8.305 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
0.677 0 Td
[(172\) were)-24 ( )]TJ
-0.014 Tc 0.063 Tw -27.909 -1.046 Td
[(a)-9.8 (pproxima)-9.8 (tely 6.5-fold higher compared to the corresponding levels in non-respond\ers)-14 ( )]TJ
0.009 Tc -0.115 Tw 0 -1.046 Td
(\(N)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
[(35\).)37.4 ( )-291.5 (Median )-254.6 (AUC)]TJ
-0.009 Tw 5.6 0 0 5.6 390.3992 226.8637 Tm
[(0-28da)0.5 (ys)]TJ
0.177 Tw 8 0 0 8 410.4513 227.6037 Tm
[( in r)0.5 (esponders )0.5 (\(N)]TJ
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
7.122 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
0.742 0 Td
[(172\) )0.5 (was a)-9.6 (pprox)0.5 (ima)-9.6 (te)0.5 (ly 6.1-f)0.5 (old)9 ( )]TJ
0 Tc 0 Tw 12.83 0 Td
( )Tj
-0.017 Tc 0.048 Tw -31.5 -1.046 Td
(higher than non-responders \(N)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
11.081 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
0.691 0 Td
(33\).)Tj
-11.771 -1.717 Td
[(T)74.2 (ocilizumab or Siltuximab and Corticosteroid Use)]TJ
0.014 Tc 0.203 Tw 0 -1.631 Td
[(Some pa)-9.9 (tients required tocilizumab or siltuximab and/or corticosteroid for the)14 ( )]TJ
-0.017 Tc 0.042 Tw 0 -1.046 Td
[(mana)-9.7 (gement of CRS.)37.2 ( )37 (ABECMA can continue to expand and persist follo)-9.8 (wing tocilizumab)-17 ( )]TJ
0.048 Tw 0 -1.046 Td
[(or siltuximab or corticosteroid administra)-9.7 (tion )]TJ
/T1_2 1 Tf
[([see )37.2 (W)18.2 (arnings and Precautio)]TJ
(ns \(5.2\)])Tj
/T1_0 1 Tf
0 Tc 0 Tw (.)Tj
-0.005 Tc 0.112 Tw 0 -1.766 Td
[(In KarMMa,)36.6 ( pa)-10.4 (tients with CRS trea)-10.4 (ted with tocilizumab had higher )37.4 (ABECMA cellular)-5 ( )]TJ
-0.017 Tc 0.041 Tw 0 -1.046 Td
[(expansion levels,)37.1 ( as measured by 1.3-fold and 1.6-fold higher median C)]TJ
0.017 Tw 5.6 0 0 5.6 530.9006 152.4661 Tm
(max)Tj
-0.115 Tw 8 0 0 8 539.4146 153.2061 Tm
[( )-155.6 (\(N)]TJ
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
[(67\) )-155.6 (and)-17 ( )]TJ
-0.014 Tc 0.014 Tw -26.927 -1.046 Td
[(A)0.5 (U)0.5 (C)]TJ
5.6 0 0 5.6 336.1157 144.0965 Tm
[(0)0.5 (-)0.5 (2)0.5 (8)0.5 (d)0.5 (a)0.5 (y)0.6 (s)]TJ
0.061 Tw 8 0 0 8 355.1326 144.8365 Tm
[( \()0.5 (N)]TJ
/Span<</ActualText<FEFF2009>>> BDC 
1.055 0 Td
( )Tj
EMC 
0.111 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
0.585 0 Td
( )Tj
EMC 
0.11 0 Td
[(6)0.5 (6)0.5 (\))0.5 (,)37.5 ( r)0.5 (e)0.5 (s)0.5 (p)0.5 (e)0.5 (c)0.5 (t)0.5 (i)0.5 (v)0.5 (e)0.6 (ly)55.6 (,)37.5 ( c)0.5 (o)0.5 (m)0.5 (p)0.6 (a)0.5 (r)0.5 (e)0.5 (d)0.5 ( t)0.6 (o)0.5 ( p)0.5 (a)-9.5 (t)0.6 (i)0.5 (e)0.5 (n)0.5 (t)0.5 (s)0.5 ( w)0.6 (h)0.5 (o)0.5 ( d)0.5 (i)0.5 (d)0.5 ( n)0.5 (o)0.5 (t)0.5 ( r)0.5 (e)0.5 (c)0.5 (e)0.5 (i)0.5 (v)0.5 (e)0.6 ( t)0.5 (o)0.5 (c)0.5 (i)0.5 (l)0.6 (iz)0.6 (u)0.5 (m)0.5 (a)0.5 (b)-14 ( )]TJ
-0.017 Tc -0.115 Tw -5.753 -1.046 Td
(\(N)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
[(59 )-162.8 (for )-162.8 (C)]TJ
0.017 Tw 5.6 0 0 5.6 359.8184 135.7268 Tm
(max)Tj
0.048 Tw 8 0 0 8 368.3324 136.4668 Tm
( and N)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
2.507 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
0.691 0 Td
[(58 for )37.2 (AUC)]TJ
0.017 Tw 5.6 0 0 5.6 424.9812 135.7268 Tm
(0-28days)Tj
8 0 0 8 443.8775 136.4668 Tm
(\).)Tj
-0.009 Tc 0.088 Tw -14.985 -1.766 Td
[(P)18.2 (a)-9.8 (tients with CRS trea)-9.8 (ted with corticosteroids had higher )37.2 (ABECMA cellular expansion)-9 ( )]TJ
-0.019 Tc 0.036 Tw 0 -1.046 Td
[(lev)0.5 (els,)37.4 ( as)0.5 ( mea)0.5 (sured b)0.5 (y 1.7-)0.5 (fold )0.5 (and 2.)0.5 (2-fold)0.5 ( highe)0.5 (r med)0.5 (ian C)]TJ
0.019 Tw 5.6 0 0 5.6 498.7207 113.2275 Tm
[(ma)0.5 (x)]TJ
-0.115 Tw 8 0 0 8 507.1976 113.9675 Tm
[( )-150.6 (\(N)]TJ
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
1.701 0 Td
( )Tj
EMC 
[(18\) )-150.5 (and )-113.6 (AUC)]TJ
0.019 Tw 5.6 0 0 5.6 557.0937 113.2275 Tm
[(0-2)0.5 (8days)]TJ
0 Tc 0 Tw 8 0 0 8 575.9999 113.9675 Tm
( )Tj
-0.017 Tc 0.06 Tw -31.5 -1.046 Td
(\(N)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
0.871 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
0.691 0 Td
[(18\),)36.9 ( respectively)54.9 (,)36.9 ( compared to pa)-10.1 (tients who did not receive corticosteroids \(N)]TJ
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
27.84 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
0.691 0 Td
[(108)-17 ( )]TJ
0.048 Tw -30.094 -1.046 Td
(for C)Tj
0.017 Tw 5.6 0 0 5.6 337.7595 96.4882 Tm
(max)Tj
0.048 Tw 8 0 0 8 346.2735 97.2282 Tm
( and N)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
2.507 0 Td
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
0.691 0 Td
(10)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0.93 0 Td
[(6 for )37.2 (AUC)]TJ
0.017 Tw 5.6 0 0 5.6 406.6603 96.4882 Tm
(0-28days)Tj
8 0 0 8 425.5566 97.2282 Tm
(\).)Tj
0.048 Tw -12.695 -1.766 Td
[(Similar trend was obser)-17.7 (ved in KarMMa-3.)]TJ
0 -1.717 Td
[(Speci\037c P)18.2 (opula)-9.8 (tions)]TJ
/T1_2 1 Tf
0.017 Tw 0 -1.582 Td
[(Geria)-9.7 (tric)]TJ
/T1_0 1 Tf
-0.019 Tc 0.036 Tw 0 -1.541 Td
[(Age \(range:)36.7 ( 30 to 81 years\) had no signi\037cant impact on expansion parameters )]TJ
/T1_2 1 Tf
[([see Use)-19 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.046 Td
[(in Special P)18.2 (opula)-9.7 (tio)]TJ
(ns \(8.5\)])Tj
/T1_0 1 Tf
0 Tc 0 Tw (.)Tj
ET
endstreamendobj32 0 obj<</BaseFont/JHWGPK+Symbol/DescendantFonts 92 0 R/Encoding/Identity-H/Subtype/Type0/ToUnicode 93 0 R/Type/Font>>endobj92 0 obj[94 0 R]endobj93 0 obj<</Filter/FlateDecode/Length 242>>stream
Hâ\PMkƒ Ω˚+Ê∏{X4	›S⁄-9ÙÉ¶˝F'©–®s»øÔhñ-t@·Ò>x3¸“=wŒ&‡Ô—Îå÷ôàã_£Fp≤éU5´”ï_œ*0NÊ~[Œù=k[‡D.)npx4~¿#„o—`¥nÇ√◊•?Ô◊~pFó@Äî`p§†^’å¿ãÌ‘‚m⁄N‰˘S|n°.∏⁄Àhop	JcTnB÷
	ÌïF2tÊﬂÏÆa‘ﬂ*uCj!j!3z∏f‘<UùõùK“Õì3iu∏÷kå‘µ‹ßîÃı¨√˚	É@Æ¸ÿØ  ﬂu$endstreamendobj94 0 obj<</BaseFont/JHWGPK+Symbol/CIDSystemInfo 95 0 R/CIDToGIDMap/Identity/DW 1000/FontDescriptor 96 0 R/Subtype/CIDFontType2/Type/Font/W[3[250]95[631]99[494]]>>endobj95 0 obj<</Ordering(Identity)/Registry(Adobe)/Supplement 0>>endobj96 0 obj<</Ascent 827/CIDSet 97 0 R/CapHeight 700/Descent -299/Flags 4/FontBBox[-167 -299 1094 827]/FontFamily(Symbol)/FontFile2 98 0 R/FontName/JHWGPK+Symbol/FontStretch/Normal/FontWeight 400/ItalicAngle 0/StemV 75/Type/FontDescriptor/XHeight 500>>endobj97 0 obj<</Filter/FlateDecode/Length 16>>stream
Hâö¿ å  o ¢endstreamendobj98 0 obj<</Filter/FlateDecode/Length 3238/Length1 5884>>stream
Hâ‹WˇST◊ˇ‹˜mó∏†Ävºë"¨Ä+ê≠÷∏0àª"CwçD ‚HDê$$eƒRc≈†µ¶UÜ⁄‘R„dÏñ±;÷»»®ôàNé”ôhÍcm~∞∆a¨≤˝º›ì:”?†}o>Ô|ª˜‹sŒ}{œ€ÌÕ≠uòÅ»»˘ÓöÏE]gàÍçol◊C¢xêñ÷7Ω÷íe/eº∂•≠>Æbk7†≤kS›Ü⁄õg¶^ ﬂDEhºÈ
Û65n+,?†}À÷ç\ä.3bπ∆O7º’≤GÂC}Cc›˙>Ûe #¥75◊ÖÌ—Ä˘üêï˜≈è°BëŒH]Tø¢‚·1æqu ˇxATˇ}∂+$7µ5∑Ä¸d@Ì{⁄h˝R≠ëÊ7¶0Û	åb	vcèTÑJ£
˜≈ äΩ∞ã=¥.¡	‚"Q ;™1 „	∆0D¨ì>Âåz‰bÆ4åU®‡®>HR¢‘J}èF¥T$}$˙—'ÌG∞…HWÜÒ^úî·¿1©
õï]L-¯Ä≥,¢Öº$≠í§à^<R
P¢Æ„F˘1ÄF˘ÆTercR¥bn‡ÚP ’†5“ú≈ò8%Æã€¢\∫äÛ‚â•™q◊´@3VO¡*m√)&nE9d/•=åﬂ@=sˇTÌg˛1¡Yπ8Ñ‘B©Íß‘+€â˜P∆;Ér/•NµÁ±ÂS◊¢è∂k’A€)yP8»u™Ö!˜ @,ÓàDÕ	õí.UiªÈÀØJ◊•7—âGRßzR|énuÄıà}jßT#B5YÖru/-≥YÈ:ÓH2™Â¯É∞KÓÕÒÈ⁄|¢ﬁï"•≠˜’	1)≤µ4mPL™ê:1,Ú¥B<Ì¨pj—⁄&Æ[√
Óz'∞„»0±"&Ωob/_é\¥rn∞pâSNæ’üCRKë‰2i™"KY∫≈/•≠®ıªV{ıK>õ=ÎQ∑òt?<˛®6}(x´ÍÛ´œ˚Â4≥_IKΩıﬂå∑ÏY+=^}Hòä›a∑≈’n*◊x…’‘ªÌC0e≠ÇÊÒ˛Và}æ!ÿ5w‚ihê_≠¢Ÿú•Î≈nø®¶ëE≈πÁ≤Ù.URÓMıÈ]z◊ä⁄.ΩDﬂ¥°ñÅ)u]ælÜ∏∆€¿gÖ◊Êw˘¨”lùœ˜˙ôa¯QÇ~∫|Ù∞9Ïas–<Â†»¨ï∫_ûÔÒÆˆ˙;‹VøÀÌ≥⁄lz±ˇú«Î?Á∂⁄|>éäöéî¥ΩaN8Êh∆µÄÃÃê÷¿eı√◊’íRm˛éÆ.kÛÀC8˜åB‡YÖ+¨B–£úV<$:<ASG™Õj(Rm©6∆È3äl1j_ÃHm>;è«˙©•^= ì’ÑWÑMòUIAˆÂœ.Á¬2~y¸rŒ¨[Lö-∆VØ‡Iãl}rg™«=˘†YÀ0Œ 	%Å	Âö|í't&*]˘s¨ÒQHàOZ†Õí#œ≤ á#”˝6kKVÖRa~%skfC∆ñZ|Bf,§E&hsÁeY∆øâIp∆8s◊√Ú≈¢á#˜-&bb©âuÊàÖ"5EãõÔXî/‰haJ‰
q≥µ‘î˘È—¥"o1ã‚f…ˆ}ÕÔÏﬂΩ≥ı]ÒΩUq˘z ™,õ]Kw-+ˆ§≠˛c«˘©ß‚πS˚ó∂B‹;}k¯O7Ü•¡©+ûﬁbüœëﬂºuKÔûwD‹¯«"Èÿ1±8ÿZê>’/ﬂSO`9™]πKùéHD»8iõg-<);„8c¨ˆó-uÃå,\
%I[ñØ•'ÕôôìÔ∂å∞ê#óG,Ç	)Â"{‰À„_ZF.LXnéX&[(◊ô[|83M
%=≠…[l‘‰-ûœí5±EHü*ì8T˝Î5≈%ø|o°g~√€á~ì¯FRÔæØ˛∫º4€û‘ìˇ ˜k∂}˚†~ı|ÁèÙÔOJ±‰˘ºMJE…≤Ùtß[’÷O]˚’á?574˝Ïÿ¸T=%√∑ÃÈ–˛|Û˜‚ÖwS∂Û˜¨(é•K
+CΩà81|eÂ´3ó~%bÃ¡∂Ùã—uÙZı«Oßé?Ì3ü”˙)j·ﬁ≈g®£ô+ßéˇÎ3ÛŒˇËi∆uIÂAn\èçå8é
èµ„ÿ…É∑örQ≠‘b-Ì^bè‰<PÄ%ƒ¢0Ã;àL¢ÇpÂƒÀíGà6Œ7|x*w£ù>+p≠	˘:˙≈!1([Dõ|'8nùzç∆∫·y^•=ÚCÏ†æLÎ·∫µHïr•ZÍ©ª¶‘n”ﬂ}Íìï;»dç˛bÃ„M∞Z9∂Ö}5ÈòH4›AãÉ7W‚#˙)†ø^jªTÆ∂cøz1H≠DÆ2Ü<Â62®ë©N∞«·$_ƒqâ¶D“ãHW3∞ç¥í>≤ï‚b9«¶ÓÇU≥≤Q_ƒ\m;C$J«πc,%“πF¨í…öÄ>⁄¢ç)C~¿&Xãóàvé)ï;Q!wÆ*}ÅI⁄‘œV€ìå£ƒÿ#ÒùÙ{P”–BÿàQb'Û˚DÅ“«˘≥_ö£FﬁœÇÎ≤6nœ˙¥´nîÖmƒQŒÔ÷Óäóπ£^ZèHócq6åù8æîkîÒ}8¿ºÚ0˜Xıd‡}2ñFé…ÂÿÓ0“òÓà"˘°8≈∫¨— _ˇ5UqØ«$ªÅ·y\S<!Fπ◊5L…l·Â(¢åü6Ì®bÌçw'ôπ¥´ÉÇÔ˛3–ﬁFI ˇÙ˝~Ë˙ˇÀ<√.Ò3SC®+Z¯Ì√„ ¥F†y˙§Àü˛íóE)ƒ+‰óáyçºáV(‘|Î√ºÑh~’Öxô˙]a^!ˇÛ0Øë?˝°ûÎtÊÿùN}YS”ñ:}˘÷∆¶÷ÌuÕ˙ä◊7.‘ø∂˛õ˜2çç≤ä¬˘z*[ßîRE,¢¨:äÇ+0(∂Rb’* ã⁄†±uäEPi)≈Eqó Óö ä¨K1ÓK¥Ú7‚.ä+Ó∆•„{ûô$·è1L2œwÓ{ÓΩÁÆﬂwÔ‡ﬁ£ŒõY7Û¬™i58∆îUñé/OTÃÆ9+UΩÎÑŒŒeVi•jbπ>˚Zí5:É¶¨ZgË*õÆgµMSáwùÔ?xtFLDÕñ≈≠C"jâ∫Í rÇ’i∑áF,ûhâ
lãµ⁄J]BFgïnj∆øÛZâ≤æ£¸¨“]Wôkâ:©†WtŸˆä:€Z[¢M÷Ò:£t—Õ"•[◊ÌJû]æì∑);Öœ◊Ì®Ë_§ŸÀK¨è:féã…tN}≥6Q;‘åÂ`G–úñÜmo¯¸˛áø¡_·/g¯¸˛ ∑¡Ô·w[¯¸ö˚ˆV˚“Œ—Õv+)∑É}ÅΩ~?Éü¬O‡«C¯‹ﬂáÔ¡w·;m∏…X±¢m≤>JmD€(ªùΩÖ›ö•+obø_áØio{˚¯2|	æH€_¿~>üÖ-¯4|
>	õÌ	ßv5gRÈV≈w%ÿz[ßΩ”≥àTΩ<Ît}m/Õ=A)Õï`è€Ò1õo!ô÷R[Æ5”sí‘µ‰{îè–÷5∂Zcz∫∂⁄VŸ,•\ÛîGZï≠¡=AÙ÷Ü
ˆeÑ¿˚©Û>&ﬁã}˙›D_â≤"[ﬂ
›,=ÂıπÙ÷ÒrwYRºSsÏJﬂN¥eÿK·mæéÌV;JºÂfx5,¡{#ºÅòãÒ^ØïÏ:Ú,¬{-ºÜ9Ωö<W¡+m†3ΩMmªe!l Æù&mÃÄ¨Q#Ì˝i$G#Û6ü˛4h¸6À”Äß¡6»SoÛ5Ü'à>¬Û¥ŸK§π'à>"Æ¯nıíó¬π6á\s3)‚Ã!◊lîK‡≈pΩæ(ôŸ◊uzŸåV…∫LäíÆõaµÃ˛<µzÂ¯Ï◊2˚µ¥-eXi)f?E€\	v>eŒÖ”a<NÅì·ôpúhÿÎIM†ùg`ü+·iTx
¨`¶N∆«¡ì‡âp,,áeÈè‘“RÍ?Â8vÙ±ÿ£`é§7#∞á√c`	<ÉCU:hÕπ}$<á¿¡“Çä}ÜÈÉÙ)r˚@x h#¶ßß∞B˚c˜É}-.ˆ±û‚˛ZÒ¡ˆCÔ≠1
∂/˘{°cÔ{&3Î`oÿÉÿ{ëkOXªgôØ—)‘I£ü⁄Qà÷Õ
4ö1==bA÷W¿nt;®LÙ≤qvWJÿvÇa∏Ãµ#ƒˆzª„e|£,¿ˆV5G¥™z?UjΩj_¨ˇr˝◊ËøAˇ\ã¢±Mã¢∫ƒn˘ŸÓ	Û˛äˇ` ©s€xendstreamendobj30 0 obj<</Length 31226>>stream
q
/GS0 gs
0 TL/Fm0 Do
Q
0 0 0 1 K
0.5 w 
/GS1 gs
q 1 0 0 1 36 693.0364 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 36 660.7807 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 36 628.525 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 146.88 693.2864 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 217.44 693.2864 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 146.88 693.0364 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 146.88 682.5345 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 217.44 693.0364 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 217.44 682.5345 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 146.88 661.0307 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 217.44 661.0307 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 146.88 660.7807 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 146.88 650.2788 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 217.44 660.7807 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 217.44 650.2788 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 146.88 628.775 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 217.44 628.775 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 146.88 628.525 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 146.88 618.273 cm
0 0 m
0 10.002 l
S
Q
q 1 0 0 1 217.44 628.525 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 217.44 618.273 cm
0 0 m
0 10.002 l
S
Q
1 w 
q 1 0 0 1 36 715.0403 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 146.88 715.0403 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 217.44 715.0403 cm
0 0 m
70.56 0 l
S
Q
0.5 w 
q 1 0 0 1 36 703.7883 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 146.88 703.7883 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 217.44 703.7883 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 36 682.2845 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 146.88 682.2845 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 217.44 682.2845 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 36 671.5326 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 146.88 671.5326 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 217.44 671.5326 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 36 650.0288 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 146.88 650.0288 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 217.44 650.0288 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 36 639.2769 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 146.88 639.2769 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 217.44 639.2769 cm
0 0 m
70.56 0 l
S
Q
1 w 
q 1 0 0 1 36 617.773 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 146.88 617.773 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 217.44 617.773 cm
0 0 m
70.56 0 l
S
Q
0.5 w 
q 1 0 0 1 36 230.8611 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 146.88 230.8611 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 217.44 230.8611 cm
0 0 m
70.56 0 l
S
Q
BT
0 0 0 1 k
/GS2 gs
/T1_0 1 Tf
-0.017 Tc 0.048 Tw 8 0 0 8 36 727.1403 Tm
[(T)74.2 (able 5:)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
5 0 Td
[(Adverse Reactions Obser)-17.8 (ved in at Least 10% of P)24.2 (atients T)74.2 (reated)-17 ( )]TJ
0 -1.062 Td
(with ABECMA in the KarMMa Study)Tj
-0.012 Tc 7.6 0 0 8 36 706.3083 Tm
[(Respirator)-17.7 (y)55.2 (,)37.2 ( thoracic,)37.2 ( and mediastinal disorders)]TJ
/T1_1 1 Tf
0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
0 -1.344 Td
( )Tj
EMC 
(Cough)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 58.1353 698.2205 Tm
(t)Tj
7.6 0 0 8 59.5131 695.5565 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 15.664 0 Td
(23)Tj
0 Tc 0 Tw 9.535 0 Td
(0)Tj
-0.012 Tc 0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
-28.292 -1.344 Td
( )Tj
EMC 
(Dyspnea)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 64.2653 687.4685 Tm
(u)Tj
7.6 0 0 8 66.7285 684.8045 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 14.714 0 Td
(13)Tj
9.187 0 Td
(2.4)Tj
/T1_0 1 Tf
0.048 Tw -27.944 -1.344 Td
(Skin and subcutaneous tissue disorder)Tj
/T1_1 1 Tf
0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
0 -1.344 Td
( )Tj
EMC 
(Rash)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 54.2837 665.9647 Tm
(v)Tj
7.6 0 0 8 56.4435 663.3007 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 16.068 0 Td
(14)Tj
9.187 0 Td
(0.8)Tj
0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
-27.944 -1.344 Td
( )Tj
EMC 
(Xerosis)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 60.4652 655.2128 Tm
(w)Tj
7.6 0 0 8 63.9125 652.5488 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 15.085 0 Td
(11)Tj
0 Tc 0 Tw 9.535 0 Td
(0)Tj
/T1_0 1 Tf
-0.012 Tc 0.048 Tw -28.292 -1.344 Td
[(V)18.2 (ascular disorders)]TJ
/T1_1 1 Tf
0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
0 -1.344 Td
( )Tj
EMC 
(Hypotension)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 74.1617 633.7089 Tm
(x)Tj
7.6 0 0 8 76.3215 631.0449 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 13.452 0 Td
(17)Tj
0 Tc 0 Tw 9.535 0 Td
(0)Tj
-0.012 Tc 0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
-28.292 -1.344 Td
( )Tj
EMC 
(Hypertension)Tj
0.012 Tw 18.758 0 Td
(11)Tj
9.187 0 Td
(3.1)Tj
0.048 Tw -27.944 -1.479 Td
[(CAR=chimeric antigen receptor)74.3 (.)]TJ
0.012 Tw 5.32 0 0 5.6 36 602.6251 Tm
(a)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 41 599.9611 Tm
[(T)74.2 (achycardia inc)20.2 (ludes sinus tachycardia,)37.3 ( tachycardia.)]TJ
0.012 Tw 5.32 0 0 5.6 36 594.1251 Tm
(b)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 41 591.4611 Tm
[(Oral pain inc)20.2 (ludes oral pain,)37.2 ( orophar)-17.8 (yngeal pain,)37.2 ( toothache.)]TJ
0.012 Tw 5.32 0 0 5.6 36 585.6251 Tm
(c)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 41 582.9611 Tm
[(F)20.2 (a)-9.8 (tigue inc)20.2 (ludes asthenia,)37.2 ( fa)-9.7 (tigue,)37.2 ( malaise.)]TJ
0.012 Tw 5.32 0 0 5.6 36 577.1251 Tm
(d)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.004 Tc 0.087 Tw 7.6 0 0 8 41 574.4611 Tm
[(Edema inc)20.3 (ludes edema,)37.4 ( face edema,)37.4 ( fluid overload,)37.3 ( fluid retention,)37.3 ( generalized edema,)33 ( )]TJ
-0.012 Tc 0.048 Tw 0 -1.062 Td
[(peripheral edema,)37.2 ( peripheral s)-9.8 (welling,)37.2 ( scrotal s)-9.8 (welling,)37.2 ( s)-9.8 (welling.)]TJ
0.012 Tw 5.32 0 0 5.6 36 560.1251 Tm
(e)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.022 Tc 0.22 Tw 7.6 0 0 8 41 557.4611 Tm
[(Hypogamma)-10.1 (globulinemia inc)19.8 (ludes pa)-10.1 (tients with adverse events \(21%\) of blood)22 ( )]TJ
-0.015 Tc 0.036 Tw 0 -1.062 Td
[(immunoglobulin G decreased,)36.9 ( hypogamma)-10.1 (globulinemia,)36.9 ( hypoglobulinemia; and/or pa)-10.1 (tients)-15 ( )]TJ
-0.012 Tc 0.048 Tw 0 -1.062 Td
[(with labora)-9.8 (tor)-17.7 (y IgG levels belo)-9.7 (w 500 mg/dL follo)-9.8 (wing )37.2 (ABECMA infusion \(25%\).)]TJ
0.012 Tw 5.32 0 0 5.6 36 534.6251 Tm
(f)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.01 Tc 0.06 Tw 7.6 0 0 8 41 531.9611 Tm
[(Infections and infesta)-9.8 (tions System Organ Class )37.2 (Adverse Events are grouped by pa)-9.8 (thogen)-10 ( )]TJ
-0.012 Tc 0.048 Tw 0 -1.062 Td
[(type and selected c)20.2 (linical syndromes.)]TJ
0.012 Tw 5.32 0 0 5.6 36 517.6251 Tm
(g)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.021 Tc 0.214 Tw 7.6 0 0 8 41 514.9611 Tm
[(Pneumonia inc)19.9 (ludes bronchopulmonar)-18.1 (y aspergillosis,)37 ( lung infection,)36.9 ( pneumonia,)58 ( )]TJ
-0.012 Tc 0.036 Tw 0 -1.062 Td
[(pneumonia aspira)-9.6 (tion,)37.4 ( pneumonia c)20.4 (ytomegaloviral,)37.4 ( pneumonia pneumococcal,)37.4 ( pneumonia)-12 ( )]TJ
0.048 Tw 0 -1.062 Td
[(pseudomonal.)37.2 ( Pneumonias may also be inc)20.2 (luded under pa)-9.7 (thogen ca)-9.8 (tegories.)]TJ
0.012 Tw 5.32 0 0 5.6 36 492.1251 Tm
(h)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.013 Tc 0.036 Tw 7.6 0 0 8 41 489.4611 Tm
[(Upper respira)-9.6 (tor)-17.6 (y tract infection inc)20.3 (ludes lar)-17.7 (yngitis,)37.3 ( nasophar)-17.7 (yngitis,)37.3 ( phar)-17.6 (yngeal er)-17.7 (ythema,)24 ( )]TJ
0.001 Tc 0.114 Tw 0 -1.062 Td
[(phar)-18 (yngitis,)36.9 ( respira)-10 (tor)-18.1 (y tract congestion,)37 ( respira)-10 (tor)-18 (y tract infection,)37 ( rhinitis,)36.9 ( rhinovirus)1 ( )]TJ
0.005 Tc 0.132 Tw 0 -1.062 Td
[(infection,)37.2 ( sinusitis,)37.3 ( upper respira)-9.7 (tor)-17.7 (y tract infection,)37.2 ( upper respira)-9.8 (tor)-17.7 (y tract infection)5 ( )]TJ
0.012 Tc 0.167 Tw 0 -1.062 Td
[(bacterial.)37.2 ( Upper respira)-9.7 (tor)-17.7 (y tract infections may also be inc)20.2 (luded under pa)-9.7 (thogen)11.9 ( )]TJ
-0.012 Tc 0.012 Tw 0 -1.062 Td
[(ca)-9.8 (tegories.)]TJ
5.32 0 0 5.6 36 449.6251 Tm
(i)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 41 446.9611 Tm
[(Decreased a)-9.8 (ppetite inc)20.2 (ludes decreased a)-9.8 (ppetite,)37.2 ( hypopha)-9.8 (gia.)]TJ
0.012 Tw 5.32 0 0 5.6 36 441.1251 Tm
(j)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.016 Tc 0.036 Tw 7.6 0 0 8 41 438.4611 Tm
[(Musculoskeletal pain inc)20.4 (ludes arthralgia,)37.3 ( back pain,)37.3 ( bone pain,)37.3 ( musculoskeletal chest pain,)21 ( )]TJ
0 -1.062 Td
[(mu)0.5 (sculos)0.5 (kelet)0.5 (al di)0.5 (scomf)0.5 (ort)0.5 (,)37.3 ( )0.5 (muscu)0.5 (loske)0.5 (leta)0.5 (l pai)0.5 (n,)37.4 ( mus)0.5 (culos)0.5 (kelet)0.5 (al st)0.5 (iffn)0.5 (ess,)37.4 ( m)0.5 (y)-9.6 (alg)0.5 (ia,)37.4 ( ne)0.5 (ck)-16 ( )]TJ
-0.012 Tc 0.048 Tw 0 -1.062 Td
[(pain,)37.2 ( spinal pain.)]TJ
0.012 Tw 5.32 0 0 5.6 36 415.6251 Tm
(k)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.039 Tw 7.6 0 0 8 41 412.9611 Tm
[(Motor d)-9.8 (ysfunction inc)20.2 (ludes d)-9.8 (ysphonia,)37.2 ( eyelid ptosis,)37.2 ( hypotonia,)37.2 ( motor d)-9.8 (ysfunction,)37.2 ( musc)20.2 (le)-12 ( )]TJ
0.048 Tw 0 -1.062 Td
[(spasms,)37.2 ( muscular weakness,)37.2 ( restless legs syndrome.)]TJ
0.012 Tw 5.32 0 0 5.6 36 398.6251 Tm
(l)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0 Tc 0.111 Tw 7.6 0 0 8 41 395.9611 Tm
[(Encephalopa)-10.3 (thy inc)19.6 (ludes amnesia,)36.6 ( brad)-10.4 (yphrenia,)36.6 ( cognitive disorder)73.6 (,)36.6 ( confusional sta)-10.4 (te,)36.9 ( )]TJ
0.007 Tc 0.143 Tw 0 -1.062 Td
[(depressed level of consciousness,)37.3 ( disturbance in a)-9.8 (ttention,)37.2 ( d)-9.8 (yscalculia,)37.3 ( d)-9.8 (ysgra)-9.8 (phia,)44 ( )]TJ
0.016 Tc 0.188 Tw 0 -1.062 Td
[(encephalopa)-9.7 (thy)55.3 (,)37.2 ( )0.5 (letharg)-9.8 (y)55.3 (,)37.2 ( )0.5 (memor)-17.7 (y )0.5 (impairment,)37.2 ( )0.5 (mental )0.5 (sta)-9.7 (tus )0.5 (changes,)37.2 ( )0.5 (metabolic)16 ( )]TJ
-0.012 Tc 0.048 Tw 0 -1.062 Td
[(encephalopa)-9.8 (thy)55.2 (,)37.2 ( somnolence,)37.2 ( toxic encephalopa)-9.8 (thy)55.2 (.)]TJ
0.012 Tw 5.32 0 0 5.6 36 364.6251 Tm
(m)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 41 361.9611 Tm
[(Headache inc)20.2 (ludes headache,)37.2 ( head discomfort,)37.2 ( sinus headache.)]TJ
0.012 Tw 5.32 0 0 5.6 36 356.1251 Tm
(n)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 41 353.4611 Tm
[(Dizziness inc)20.2 (ludes dizziness,)37.2 ( presyncope,)37.2 ( syncope,)37.2 ( vertigo.)]TJ
0.012 Tw 5.32 0 0 5.6 36 347.6251 Tm
(o)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.006 Tc 0.14 Tw 7.6 0 0 8 41 344.9611 Tm
[(Neuropa)-10.2 (thy peripheral inc)19.8 (ludes carpal tunnel syndrome,)36.8 ( hypoesthesia,)36.8 ( hypoesthesia)6 ( )]TJ
-0.005 Tc 0.086 Tw 0 -1.062 Td
[(oral,)36.7 ( neuralgia,)36.7 ( neuropa)-10.3 (thy peripheral,)36.7 ( paresthesia,)36.7 ( peripheral sensorimotor neuropa)-10.3 (thy)54.7 (,)32 ( )]TJ
-0.012 Tc 0.048 Tw 0 -1.062 Td
[(peripheral sensor)-17.8 (y neuropa)-9.8 (thy)55.2 (,)37.2 ( scia)-9.7 (tica.)]TJ
0.012 Tw 5.32 0 0 5.6 36 322.1251 Tm
(p)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 41 319.4611 Tm
[(T)74.2 (remor inc)20.2 (ludes asterixis,)37.2 ( tremor)74.2 (.)]TJ
0.012 Tw 5.32 0 0 5.6 36 313.6251 Tm
(q)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 41 310.9611 Tm
[(Insomnia inc)20.2 (ludes insomnia,)37.2 ( sleep deficit,)37.2 ( sleep disorder)74.3 (.)]TJ
0.012 Tw 5.32 0 0 5.6 36 305.1251 Tm
(r)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 41 302.4611 Tm
[(Anxiety inc)20.3 (ludes anxiety)55.2 (,)37.3 ( feeling jitter)-17.8 (y)55.2 (,)37.2 ( ner)-17.8 (vousness.)]TJ
0.012 Tw 5.32 0 0 5.6 36 296.6251 Tm
(s)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.002 Tc 0.12 Tw 7.6 0 0 8 41 293.9611 Tm
[(Renal failure inc)19.9 (ludes acute kidney injur)-18.1 (y)54.8 (,)36.8 ( blood crea)-10.1 (tinine increased,)36.8 ( chronic kidney)2 ( )]TJ
-0.012 Tc 0.048 Tw 0 -1.062 Td
[(disease,)37.2 ( renal failure,)37.2 ( renal impairment.)]TJ
0.012 Tw 5.32 0 0 5.6 36 279.6251 Tm
(t)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 41 276.9611 Tm
[(Cough inc)20.2 (ludes cough,)37.2 ( productive cough,)37.2 ( upper)37.2 (-airway cough syndrome.)]TJ
0.012 Tw 5.32 0 0 5.6 36 271.1251 Tm
(u)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.016 Tc 0.036 Tw 7.6 0 0 8 41 268.4611 Tm
[(Dyspnea inc)20 (ludes acute respira)-10 (tor)-17.9 (y failure,)37.1 ( d)-9.9 (yspnea,)37.1 ( d)-9.9 (yspnea exertional,)37 ( respira)-9.9 (tor)-17.9 (y failure.)]TJ
-0.012 Tc 0.012 Tw 5.32 0 0 5.6 36 262.6251 Tm
(v)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.001 Tc 0.101 Tw 7.6 0 0 8 41 259.9611 Tm
[(Ra)0.5 (sh in)0.5 (c)20.4 (lu)0.5 (des)0.5 ( a)0.5 (cne)0.5 (,)37.4 ( d)0.5 (er)0.5 (ma)-9.5 (ti)0.5 (tis)0.5 (,)37.4 ( der)0.5 (ma)-9.5 (ti)0.5 (tis)0.5 ( b)0.5 (ull)0.5 (ous)0.5 (,)37.4 ( e)0.5 (r)-17.5 (yth)0.5 (em)0.5 (a,)37.4 ( ra)0.5 (sh,)37.5 ( ra)0.5 (sh)0.5 ( m)0.5 (acu)0.5 (lar)74.5 (,)37.4 ( r)0.5 (as)0.5 (h)-1 ( )]TJ
-0.012 Tc 0.048 Tw 0 -1.062 Td
[(pa)-9.8 (pular)74.2 (,)37.2 ( urticaria.)]TJ
0.012 Tw 5.32 0 0 5.6 36 245.6251 Tm
(w)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 41 242.9611 Tm
[(Xerosis inc)20.2 (ludes dr)-17.8 (y eye,)37.2 ( dr)-17.7 (y mouth,)37.2 ( dr)-17.7 (y skin,)37.2 ( lip dr)-17.7 (y)55.2 (,)37.2 ( xerosis.)]TJ
0.012 Tw 5.32 0 0 5.6 36 237.1251 Tm
(x)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 41 234.4611 Tm
[(Hypotension inc)20.2 (ludes hypotension,)37.2 ( orthosta)-9.7 (tic hypotension.)]TJ
-0.013 Tc 0.071 Tw 8 0 0 8 36 212.2604 Tm
[(Other c)19.6 (linically important adverse reactions tha)-10.4 (t occurred in less than 10% of pa)-10.4 (tients)-13 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.084 Td
[(trea)-9.7 (ted with )37.3 (ABECMA inc)20.2 (lude the follo)-9.7 (wing:)]TJ
0.017 Tw 1.125 -1.688 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
/T1_2 1 Tf
0.048 Tw 1.125 0 Td
[(Blood and lympha)-9.7 (tic system disorders:)]TJ
/T1_1 1 Tf
-0.198 Tw [(\035)-47.8 (coa)-9.8 (gulopa)-9.8 (thy)]TJ
/Span<</ActualText<FEFF200A200A>>> BDC 
[( )0.6 ( )]TJ
EMC 
0 Tc 0 Tw 5.6 0 0 5.6 205.404 192.7532 Tm
(a)Tj
-0.017 Tc 0.017 Tw 8 0 0 8 207.794 190.0892 Tm
[(\035)-47.8 (\(9%\))]TJ
-20.349 -1.553 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
/T1_2 1 Tf
0.048 Tw 1.125 0 Td
(Cardiac disorders:)Tj
/T1_1 1 Tf
[(\035)-47.8 (a)-9.8 (trial \037brilla)-9.8 (tion \(4.7%\),)37.3 ( cardiomyopa)-9.8 (thy)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.6 0 0 5.6 221.5917 180.3325 Tm
(b)Tj
-0.017 Tc 0.017 Tw 8 0 0 8 224.0882 177.6685 Tm
[(\035)-47.8 (\(1.6%\))]TJ
-22.386 -1.553 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
/T1_2 1 Tf
0.048 Tw 1.125 0 Td
(Gastrointestinal disorders:)Tj
/T1_1 1 Tf
[(\035)-47.8 (gastrointestinal hemorrha)-9.7 (ge)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.6 0 0 5.6 209.9758 167.9118 Tm
(c)Tj
-0.017 Tc 0.017 Tw 8 0 0 8 212.2651 165.2478 Tm
[(\035)-47.8 (\(3.1%\))]TJ
-20.908 -1.553 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
/T1_2 1 Tf
0.048 Tw 1.125 0 Td
(Immune system disorders:)Tj
/T1_1 1 Tf
[(\035)-47.7 (hemopha)-9.8 (goc)20.2 (ytic lymphohistioc)20.2 (ytosis \(3.1%\))]TJ
0.017 Tw -1.125 -1.553 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
/T1_2 1 Tf
0.048 Tw 1.125 0 Td
[(Infections and infesta)-9.8 (tions:)]TJ
/T1_1 1 Tf
[(\035)-47.8 (fungal infections \(8%\),)37.2 ( sepsis)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.6 0 0 5.6 216.4978 143.0705 Tm
(d)Tj
-0.017 Tc 0.017 Tw 8 0 0 8 218.9943 140.4065 Tm
[(\035)-47.8 (\(9%\))]TJ
-21.749 -1.553 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
/T1_2 1 Tf
-0.016 Tc 0.06 Tw 1.125 0 Td
[(Ner)-17.5 (vous sys)0.5 (tem di)0.5 (sorder)0.5 (s:)]TJ
/T1_1 1 Tf
0.016 Tw [(\035)-59.6 (a)-9.6 (pha)0.5 (sia)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.6 0 0 5.6 154.8426 130.6498 Tm
(e)Tj
-0.016 Tc 0.06 Tw 8 0 0 8 157.237 127.9858 Tm
[(\035)-59.6 (\(7%\))0.5 (,)37.4 ( a)-9.6 (ta)0.5 (xia)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.6 0 0 5.6 193.611 130.6498 Tm
(f)Tj
-0.016 Tc 0.06 Tw 8 0 0 8 194.9694 127.9858 Tm
[(\035)-59.6 (\(3.)0.5 (1%\),)37.4 ( par)0.5 (esis)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.6 0 0 5.6 240.3417 130.6498 Tm
(g)Tj
-0.016 Tc 0.06 Tw 8 0 0 8 242.8425 127.9858 Tm
[(\035)-59.6 (\(2.)0.5 (4%\),)37.4 ( sei)0.5 (zure)-16 ( )]TJ
-0.017 Tc 0.017 Tw -23.605 -1.103 Td
(\(1.6%\))Tj
-1.125 -1.553 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
/T1_2 1 Tf
0.048 Tw 1.125 0 Td
[(Psychia)-9.7 (tric disorders:)]TJ
/T1_1 1 Tf
0.017 Tw [(\035)-47.8 (delirium)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.6 0 0 5.6 140.0562 109.4086 Tm
(h)Tj
-0.017 Tc 0.017 Tw 8 0 0 8 142.5527 106.7446 Tm
[(\035)-47.8 (\(6%\))]TJ
-12.194 -1.553 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
/T1_2 1 Tf
-0.021 Tc 0.036 Tw 1.125 0 Td
[(Respira)-9.9 (tor)-17.9 (y)55.1 (,)37.1 ( thoracic,)37.1 ( and mediastinal disorders:)]TJ
/T1_1 1 Tf
[(\035)-35.9 (hypoxia \(2.4%\),)37.1 ( pulmonar)-17.9 (y edema)-21 ( )]TJ
-0.017 Tc 0.017 Tw 0 -1.103 Td
(\(2.4%\))Tj
-1.125 -1.553 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
/T1_2 1 Tf
0.048 Tw 1.125 0 Td
[(V)18.2 (ascular disorders:)]TJ
/T1_1 1 Tf
0.017 Tw [(\035)-47.8 (thrombosis)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.6 0 0 5.6 141.8819 75.7466 Tm
(i)Tj
-0.017 Tc 0.017 Tw 8 0 0 8 142.928 73.0826 Tm
[(\035)-47.8 (\(3.1%\))]TJ
-0.012 Tc 0.012 Tw 5.32 0 0 5.6 36 65.1259 Tm
(a)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.003 Tc 0.092 Tw 7.6 0 0 8 41 62.4619 Tm
[(Coa)-9.6 (gulopa)-9.7 (thy inc)20.4 (ludes activa)-9.6 (ted partial thromboplastin time prolonged,)37.3 ( anticoa)-9.7 (gula)-9.6 (tion)-2.9 ( )]TJ
0.011 Tc 0.165 Tw 0 -1.103 Td
[(drug level above thera)-10.2 (peutic,)36.8 ( dissemina)-10.2 (ted intra)-10.2 (vascular coa)-10.2 (gula)-10.1 (tion,)36.8 ( interna)-10.2 (tional)11 ( )]TJ
-0.012 Tc 0.048 Tw 0 -1.103 Td
[(normalized ra)-9.8 (tio increased.)]TJ
0.012 Tw 5.32 0 0 5.6 36 38.6639 Tm
(b)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 41 35.9999 Tm
[(Cardiomyopa)-9.8 (thy inc)20.2 (ludes stress cardiomyopa)-9.8 (thy)55.2 (,)37.2 ( ventricular hypertrophy)55.2 (.)]TJ
ET
q 1 0 0 1 324 632.5187 cm
0 0 m
71.017 0 l
S
Q
q 1 0 0 1 324 138.0474 cm
0 0 m
94.595 0 l
S
Q
q 1 0 0 1 324 64.8325 cm
0 0 m
41.95 0 l
S
Q
BT
0.012 Tw 5.32 0 0 5.6 324 728.3643 Tm
(c)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.022 Tc 0.218 Tw 7.6 0 0 8 329 725.7003 Tm
[(Gastrointestinal hemorrha)-9.9 (ge inc)20.1 (ludes gastrointestinal hemorrha)-9.8 (ge,)37.1 ( hemorrhoidal)22.1 ( )]TJ
-0.012 Tc 0.048 Tw 0 -1.067 Td
[(hemorrha)-9.8 (ge,)37.2 ( melena.)]TJ
0.012 Tw 5.32 0 0 5.6 324 711.296 Tm
(d)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0 Tc 0.111 Tw 7.6 0 0 8 329 708.632 Tm
[(Sepsis inc)19.7 (ludes bacteremia,)36.7 ( enterococcal bacteremia,)36.7 ( Escherichia bacteremia,)36.6 ( sepsis,)36.9 ( )]TJ
-0.012 Tc 0.048 Tw 0 -1.067 Td
[(septic shock,)37.2 ( Serra)-9.8 (tia bacteremia,)37.2 ( streptococcal bacteremia.)]TJ
0.012 Tw 5.32 0 0 5.6 324 694.2277 Tm
(e)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 329 691.5637 Tm
[(A)-9.8 (phasia inc)20.2 (ludes a)-9.7 (phasia,)37.3 ( d)-9.8 (ysarthria.)]TJ
0.012 Tw 5.32 0 0 5.6 324 685.6935 Tm
(f)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 329 683.0295 Tm
[(Ataxia inc)20.2 (ludes a)-9.7 (taxia,)37.2 ( gait disturbance,)37.2 ( Romberg test positive.)]TJ
0.012 Tw 5.32 0 0 5.6 324 677.1594 Tm
(g)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 329 674.4954 Tm
[(P)18.2 (aresis inc)20.2 (ludes cranial ner)-17.8 (ve disorder)74.2 (,)37.2 ( hemiparesis.)]TJ
0.012 Tw 5.32 0 0 5.6 324 668.6252 Tm
(h)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 329 665.9612 Tm
[(Delirium inc)20.2 (ludes delirium,)37.2 ( disorienta)-9.7 (tion,)37.2 ( hallucina)-9.8 (tion.)]TJ
0.012 Tw 5.32 0 0 5.6 324 660.0911 Tm
(i)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.019 Tc 0.206 Tw 7.6 0 0 8 329 657.4271 Tm
[(Thrombosis inc)19.6 (ludes deep vein thrombosis,)36.7 ( jugular vein thrombosis,)36.7 ( portal vein)19 ( )]TJ
-0.012 Tc 0.048 Tw 0 -1.067 Td
[(thrombosis,)37.2 ( pulmonar)-17.8 (y embolism.)]TJ
-0.017 Tc 0.011 Tw 8 0 0 8 324 633.5187 Tm
[(Labora)-9.8 (tor)-17.8 (y Abnormalities)]TJ
-0.008 Tc 0.095 Tw 0 -1.633 Td
[(T)73.8 (able 6 presents the most common Grade 3 or 4 labora)-10.2 (tor)-18.1 (y abnormalities,)36.8 ( based on)-8 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.048 Td
[(labora)-9.8 (tor)-17.8 (y da)-9.8 (ta,)37.2 ( occurring in a)-9.7 (t least 10% of pa)-9.8 (tients.)]TJ
ET
/GS1 gs
q 1 0 0 1 324 543.2605 cm
0 0 m
105.48 0 l
S
Q
q 1 0 0 1 324 532.8686 cm
0 0 m
105.48 0 l
S
Q
q 1 0 0 1 324 522.4767 cm
0 0 m
105.48 0 l
S
Q
q 1 0 0 1 324 512.0848 cm
0 0 m
105.48 0 l
S
Q
q 1 0 0 1 324 470.5171 cm
0 0 m
105.48 0 l
S
Q
q 1 0 0 1 324 501.6928 cm
0 0 m
105.48 0 l
S
Q
q 1 0 0 1 324 491.3009 cm
0 0 m
105.48 0 l
S
Q
q 1 0 0 1 324 480.909 cm
0 0 m
105.48 0 l
S
Q
q 1 0 0 1 429.48 553.9024 cm
0 0 m
0 28.442 l
S
Q
q 1 0 0 1 324 553.6524 cm
0 0 m
105.48 0 l
S
Q
q 1 0 0 1 429.48 553.6524 cm
0 0 m
146.52 0 l
S
Q
q 1 0 0 1 429.48 543.5105 cm
0 0 m
0 9.892 l
S
Q
q 1 0 0 1 429.48 543.2605 cm
0 0 m
146.52 0 l
S
Q
q 1 0 0 1 429.48 533.1186 cm
0 0 m
0 9.892 l
S
Q
q 1 0 0 1 429.48 532.8686 cm
0 0 m
146.52 0 l
S
Q
q 1 0 0 1 429.48 522.7267 cm
0 0 m
0 9.892 l
S
Q
q 1 0 0 1 429.48 522.4767 cm
0 0 m
146.52 0 l
S
Q
q 1 0 0 1 429.48 512.3348 cm
0 0 m
0 9.892 l
S
Q
q 1 0 0 1 429.48 512.0848 cm
0 0 m
146.52 0 l
S
Q
q 1 0 0 1 429.48 501.9428 cm
0 0 m
0 9.892 l
S
Q
q 1 0 0 1 429.48 501.6928 cm
0 0 m
146.52 0 l
S
Q
q 1 0 0 1 429.48 491.5509 cm
0 0 m
0 9.892 l
S
Q
q 1 0 0 1 429.48 491.3009 cm
0 0 m
146.52 0 l
S
Q
q 1 0 0 1 429.48 481.159 cm
0 0 m
0 9.892 l
S
Q
q 1 0 0 1 429.48 480.909 cm
0 0 m
146.52 0 l
S
Q
q 1 0 0 1 429.48 470.7671 cm
0 0 m
0 9.892 l
S
Q
q 1 0 0 1 429.48 470.5171 cm
0 0 m
146.52 0 l
S
Q
q 1 0 0 1 429.48 460.6252 cm
0 0 m
0 9.642 l
S
Q
1 w 
q 1 0 0 1 324 460.1252 cm
0 0 m
105.48 0 l
S
Q
q 1 0 0 1 429.48 460.1252 cm
0 0 m
146.52 0 l
S
Q
0.5 w 
q 1 0 0 1 324 413.2133 cm
0 0 m
105.48 0 l
S
Q
q 1 0 0 1 429.48 413.2133 cm
0 0 m
146.52 0 l
S
Q
1 w 
q 1 0 0 1 324 582.8444 cm
0 0 m
105.48 0 l
S
Q
q 1 0 0 1 429.48 582.8444 cm
0 0 m
146.52 0 l
S
Q
BT
/GS2 gs
/T1_0 1 Tf
8 0 0 8 324 594.9443 Tm
[(T)74.2 (able 6:)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
5 0 Td
(Grade 3 or 4)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.6 0 0 5.6 402.304 597.6083 Tm
(a)Tj
-0.017 Tc 0.048 Tw 8 0 0 8 404.9011 594.9443 Tm
[(\037)-47.8 (Laborator)-17.8 (y Abnormalities W)18.2 (orsening from Baseline in)-17 ( )]TJ
-5.113 -1.062 Td
[(at Least 10% of P)24.2 (atients T)74.3 (reated with ABECMA in the KarMMa Study)-17 (\037)]TJ
-0.012 Tc 7.6 0 0 8 324 565.3924 Tm
[(Laborator)-17.8 (y Abnormality)]TJ
14.769 1.062 Td
(Dose=[150 to 450 x 10)Tj
0 Tc 0 Tw 5.32 0 0 5.6 503.4979 576.5564 Tm
(6)Tj
-0.012 Tc 0.048 Tw 7.6 0 0 8 505.9865 573.8924 Tm
[( C)18.2 (AR-P)24.2 (ositive T cells])]TJ
0 Tc 0 Tw 7.6 0 0 8 569.4893 573.8924 Tm
( )Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 490.9606 565.3924 Tm
(\(N=127\))Tj
0 Tc 0 Tw 7.6 0 0 8 514.7694 565.3924 Tm
( )Tj
7.6 0 0 8 499.9086 556.8924 Tm
(%)Tj
-0.012 Tc 0.048 Tw -2.833 -1.411 Td
(Grade 3 or 4 \(%\))Tj
/T1_1 1 Tf
-20.312 -1.299 Td
(Neutrophil decreased)Tj
0.012 Tw 23.061 0 Td
(96)Tj
0.048 Tw -23.061 -1.299 Td
[(Leukoc)20.2 (yte decreased)]TJ
0.012 Tw 23.061 0 Td
(96)Tj
0.048 Tw -23.061 -1.299 Td
[(L)37.2 (ymphoc)20.2 (yte decreased)]TJ
0.012 Tw 23.061 0 Td
(92)Tj
0.048 Tw -23.061 -1.299 Td
[(Pla)-9.7 (telet decreased)]TJ
0.012 Tw 23.061 0 Td
(63)Tj
0.048 Tw -23.061 -1.299 Td
(Hemoglobin decreased)Tj
0.012 Tw 23.061 0 Td
(63)Tj
0.048 Tw -23.061 -1.299 Td
[(Phospha)-9.8 (te decreased)]TJ
0.012 Tw 23.061 0 Td
(45)Tj
0.048 Tw -23.061 -1.299 Td
(Sodium decreased)Tj
0.012 Tw 23.061 0 Td
(10)Tj
0.048 Tw -23.061 -1.299 Td
(aPTT increased \(seconds\))Tj
0.012 Tw 23.061 0 Td
(10)Tj
5.32 0 0 5.6 324 453.4773 Tm
(a)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 329 450.8133 Tm
(NCI CTCAE)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
3.951 0 Td
(=)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0.617 0 Td
[(Common )37.2 (T)74.2 (erminolog)-9.8 (y Criteria for )37.2 (Adverse Events version 4.03.)]TJ
0.039 Tc 0.303 Tw -5.226 -1.062 Td
(aPTT)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
2.087 0 Td
(=)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0.719 0 Td
[(activa)-9.9 (ted partial thromboplastin time; CAR=chimeric antigen receptor;)39 ( )]TJ
-0.012 Tc 0.048 Tw -2.806 -1.062 Td
(CTCAE)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
2.432 0 Td
(=)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0.617 0 Td
[(Common )37.2 (T)74.2 (erminolog)-9.8 (y Criteria for )37.3 (Adverse Events; NCI=Na)-9.8 (tional Cancer Institute.)]TJ
0.023 Tc 0.227 Tw -3.05 -1.062 Td
[(Labora)-10.4 (tor)-18.4 (y tests )0.5 (were graded )0.5 (according to NCI CTCAE )37.4 (V)17.6 (ersion )0.5 (4.03.)36.6 ( )0.5 (Labora)-10.4 (tor)-18.4 (y)23 ( )]TJ
-0.012 Tc 0.048 Tw 0 -1.062 Td
[(abnormalities are sorted by decreasing frequenc)20.2 (y in the 150 to 450 x 10)]TJ
0 Tc 0 Tw 5.32 0 0 5.6 524.8918 419.4773 Tm
(6)Tj
-0.012 Tc 0.048 Tw 7.6 0 0 8 527.3805 416.8133 Tm
( column.)Tj
-0.008 Tc 0.096 Tw 8 0 0 8 324.0001 395.0792 Tm
[(Other c)19.6 (linically important Grade 3 or 4 labora)-10.4 (tor)-18.4 (y abnormalities \(based on labora)-10.4 (tor)-18.3 (y)-8 ( )]TJ
-0.001 Tc 0.126 Tw 0 -1.048 Td
[(d)0.5 (a)-9.4 (t)0.6 (a)0.5 (\))0.5 ( t)0.6 (h)0.5 (a)-9.4 (t)0.5 ( o)0.5 (c)0.6 (c)0.5 (u)0.6 (r)0.5 (r)0.6 (e)0.5 (d)0.5 ( i)0.6 (n)0.5 ( l)0.5 (e)0.6 (s)0.5 (s)0.6 ( t)0.6 (h)0.5 (a)0.6 (n)0.5 ( 1)0.5 (0)0.5 (%)0.6 ( o)0.5 (f)0.6 ( p)0.5 (a)-9.4 (t)0.5 (i)0.6 (e)0.5 (n)0.5 (t)0.6 (s)0.5 ( t)0.6 (r)0.5 (e)0.6 (a)-9.5 (t)0.5 (e)0.6 (d)0.6 ( w)0.6 (i)0.5 (t)0.6 (h)0.5 ( )37.3 (A)0.5 (B)0.5 (E)0.6 (C)0.5 (M)0.6 (A)0.5 ( i)0.5 (n)0.5 (c)20.6 (l)0.5 (u)0.6 (d)0.5 (e)0.6 ( t)0.6 (h)0.5 (e)-1 ( )]TJ
-0.008 Tc 0.095 Tw 0 -1.048 Td
[(follo)-10.1 (wing:)37 ( alanine )0.5 (aminotransferase increased,)36.9 ( asparta)-10.1 (te )0.5 (aminotransferase increased,)29 ( )]TJ
0.001 Tc 0.137 Tw 0 -1.048 Td
[(albumin decreased,)37.4 ( alkaline phospha)-9.6 (tase increased,)37.4 ( glucose increased,)37.3 ( potassium)1 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.048 Td
[(decreased,)37.2 ( bilirubin increased,)37.2 ( \037brinogen decreased,)37.2 ( and calcium decreased.)]TJ
/T1_0 1 Tf
0.017 Tw 0 -1.877 Td
(6.2)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3.375 0 Td
(Immunogenicity)Tj
/T1_1 1 Tf
0.06 Tw -3.375 -1.588 Td
[(ABECMA has the potential to induce anti-product antibodies.)36.9 ( In c)19.9 (linical studies,)36.9 ( humoral)-17 ( )]TJ
-0.007 Tc 0.096 Tw 0 -1.048 Td
[(i)0.5 (m)0.5 (m)0.5 (u)0.5 (n)0.5 (o)0.6 (g)0.5 (e)0.5 (n)0.5 (i)0.5 (c)0.5 (i)0.5 (t)0.5 (y)0.6 ( o)0.5 (f)0.5 ( )37.1 (AB)0.6 (E)0.5 (C)0.5 (M)0.5 (A)0.5 ( w)0.5 (a)0.6 (s m)0.5 (e)0.5 (a)0.6 (s)0.5 (u)0.5 (r)0.5 (e)0.5 (d)0.5 ( b)0.6 (y)0.5 ( d)0.5 (e)0.5 (t)0.5 (e)0.6 (r)0.5 (m)0.5 (i)0.5 (n)0.5 (a)-9.5 (t)0.5 (i)0.5 (o)0.6 (n)0.5 ( o)0.5 (f)0.6 ( a)0.5 (n)0.5 (t)0.5 (i)0.5 (-)0.5 (C)0.5 (A)0.6 (R)0.5 ( a)0.5 (n)0.5 (t)0.5 (i)0.5 (b)0.5 (o)0.6 (d)-9.5 (y)0.5 ( i)0.5 (n)-7 ( )]TJ
-0.006 Tc 0.105 Tw 0 -1.048 Td
[(serum pre- and post-administra)-10.1 (tion.)36.9 ( In the c)19.9 (linical studies,)36.9 ( 2.6% of pa)-10.1 (tients \(9/349\))-6 ( )]TJ
-0.005 Tc 0.108 Tw 0 -1.048 Td
[(tested positive for pre-infusion anti-CAR antibodies and trea)-9.9 (tment-induced anti-CAR)-5 ( )]TJ
0.001 Tc 0.139 Tw 0 -1.048 Td
[(antibodies were detected in 53% \(186/349\) of the pa)-9.9 (tients.)37 ( )37.2 (There is no identi\037ed)1 ( )]TJ
-0.011 Tc 0.078 Tw 0 -1.048 Td
[(c)20.1 (linically signi\037cant impact of pre-existing or post-infusion anti-CAR\ antibodies on the)-11 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.048 Td
[(cellular expansion,)37.2 ( safety)55.2 (,)37.2 ( or effectiveness of )37.2 (ABECMA.)]TJ
/T1_0 1 Tf
0.017 Tw 0 -1.877 Td
(6.3)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
[(P)24.2 (ostmarketing Experience)]TJ
/T1_1 1 Tf
-0.018 Tc 0.036 Tw -3.375 -1.588 Td
[(Because adverse events to marketed products are reported voluntarily fro\m a popula)-9.6 (tion)-18 ( )]TJ
-0.021 Tc 0 -1.048 Td
[(of uncertain size,)36.6 ( it is not al)-10.4 (ways possible to reliably estima)-10.4 (te their frequenc)19.6 (y or establish)-21 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.048 Td
[(a causal rela)-9.7 (tionship to product exposure.)]TJ
0 -1.768 Td
[(The follo)-9.8 (wing adverse event has been identi\037ed during postmarketing use of )37.2 (ABECMA:)]TJ
/T1_2 1 Tf
0.037 Tc 0.318 Tw 0 -1.57 Td
[(Ner)-17.8 (vous system disorders:)]TJ
/T1_1 1 Tf
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
11.459 0 Td
[( Immune effector cell-associa)-9.9 (ted neurotoxicity)37.1 ( )]TJ
-0.017 Tc 0.048 Tw -11.459 -1.048 Td
(syndrome \(ICANS\).)Tj
-0.016 Tc 0.06 Tw 0 -1.768 Td
[(The follo)-10.3 (wing adverse event has been identi\037ed during postmarketing use of BCM\A- or)-16 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.048 Td
[(CD19-directed genetically modi\037ed autologous )37.2 (T cell immunothera)-9.7 (pies:)]TJ
/T1_2 1 Tf
0.017 Tw 0 -1.57 Td
(Neoplasms:)Tj
/T1_1 1 Tf
0.048 Tw /Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
4.183 0 Td
[( )37.2 (T cell malignancies.)]TJ
/T1_0 1 Tf
0.017 Tw -4.183 -2.052 Td
(7)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
[(DR)-9.8 (UG INTERACTIONS)]TJ
/T1_1 1 Tf
0.011 Tw -3.375 -1.674 Td
[(Drug/Labora)-9.8 (tor)-17.7 (y T)74.2 (est )-36.8 (Interactions)]TJ
-0.003 Tc 0.117 Tw 0 -1.633 Td
[(HIV and the lentivirus used to make )37.3 (ABECMA ha)-9.6 (ve limited,)37.4 ( short spans of identical)-3 ( )]TJ
-0.008 Tc 0.094 Tw 0 -1.048 Td
[(genetic ma)-10 (terial \(RNA\).)37 ( )36.7 (Therefore,)37 ( some commercial HIV nuc)19.9 (leic acid tests may yield)-8 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.048 Td
[(false-positive results in pa)-9.8 (tients who ha)-9.8 (ve received )37.2 (ABECMA.)]TJ
/T1_0 1 Tf
0.017 Tw 0 -2.052 Td
(8)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
[(USE IN SPECIFIC POPULA)55.2 (TIONS)]TJ
0.017 Tw -3.375 -1.832 Td
(8.1)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3.375 0 Td
[(Pregnanc)10.2 (y)]TJ
/T1_1 1 Tf
0.048 Tw -3.375 -1.539 Td
[(Risk Summar)-17.8 (y)]TJ
0.012 Tc 0.191 Tw 0 -1.633 Td
[(T)0.5 (h)0.6 (e)0.5 (r)0.6 (e)0.5 ( a)0.6 (r)0.5 (e)0.6 ( n)0.5 (o)0.6 ( a)-9.5 (v)0.6 (a)0.5 (i)0.6 (l)0.5 (a)0.5 (b)0.6 (l)0.5 (e)0.6 ( d)0.5 (a)-9.4 (t)0.5 (a)0.5 ( w)0.5 (i)0.5 (t)0.6 (h)0.5 ( )37.2 (A)0.6 (B)0.5 (E)0.5 (C)0.6 (M)0.5 (A)0.5 ( u)0.6 (s)0.5 (e)0.6 ( i)0.5 (n)0.5 ( p)0.5 (r)0.6 (e)0.5 (g)0.5 (n)0.6 (a)0.5 (n)0.5 (t)0.6 ( w)0.5 (o)0.6 (m)0.5 (e)0.6 (n)0.5 (.)37.5 ( N)0.5 (o)0.5 ( a)0.5 (n)0.5 (i)0.6 (m)0.5 (a)0.6 (l)12 ( )]TJ
-0.013 Tc 0.067 Tw 0 -1.048 Td
[(reproductive and developmental toxicity studies ha)-9.6 (ve been conducted with )37.3 (ABECMA to)-13 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.048 Td
(assess whether it can cause fetal harm when administered to a pregnant w\oman.)Tj
/T1_2 1 Tf
0 Tc 0 Tw -36 85.338 Td
(\()Tj
-0.017 Tc 0.017 Tw 0.224 0 Td
(Continued\))Tj
ET
endstreamendobj29 0 obj<</Length 39029>>stream
q
/GS0 gs
0 TL/Fm0 Do
Q
0 0 0 1 K
0.5 w 
/GS1 gs
q 1 0 0 1 36 455.0266 cm
0 0 m
71.017 0 l
S
Q
q 1 0 0 1 36 154.3903 cm
0 0 m
42.334 0 l
S
Q
BT
0 0 0 1 k
/T1_0 1 Tf
-0.013 Tc 0.071 Tw 8 0 0 8 36 727.248 Tm
[(Other c)19.6 (linically important adverse reactions tha)-10.4 (t occurred in less than 10% of pa)-10.4 (tients)-13 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.048 Td
[(trea)-9.7 (ted with )37.3 (ABECMA inc)20.2 (lude the follo)-9.7 (wing:)20 ( )]TJ
0.017 Tw 1.125 -1.651 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
/T1_1 1 Tf
0.048 Tw 1.125 0 Td
(Cardiac disorders:)Tj
/T1_0 1 Tf
[(\035)-47.8 (cardiac arrhythmia \(7%\))]TJ
0.017 Tw -1.125 -1.471 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
/T1_1 1 Tf
0.048 Tw 1.125 0 Td
(Gastrointestinal disorders:)Tj
/T1_0 1 Tf
[(\035)-47.8 (gastrointestinal hemorrha)-9.7 (ge \(0.5%\))]TJ
0.017 Tw -1.125 -1.471 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
/T1_1 1 Tf
0.048 Tw 1.125 0 Td
(Immune system disorders:)Tj
/T1_0 1 Tf
[(\035)-47.7 (hemopha)-9.8 (goc)20.2 (ytic lymphohistioc)20.2 (ytosis \(2.3%\))]TJ
0.017 Tw -1.125 -1.471 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
/T1_1 1 Tf
0.048 Tw 1.125 0 Td
[(Infections and infesta)-9.8 (tions:)]TJ
/T1_0 1 Tf
[(\035)-47.8 (infections - fungal \(5%\),)37.2 ( sepsis)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.6 0 0 5.6 221.3425 673.0081 Tm
(a)Tj
-0.017 Tc 0.017 Tw 8 0 0 8 223.7325 670.3441 Tm
[(\035)-47.8 (\(6%\))]TJ
-22.342 -1.471 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
/T1_1 1 Tf
0.048 Tw 1.125 0 Td
(Musculoskeletal and connective tissue disorders:)Tj
/T1_0 1 Tf
[(\035)-47.8 (motor d)-9.8 (ysfunction)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.6 0 0 5.6 247.6538 661.2372 Tm
(b)Tj
-0.017 Tc 0.017 Tw 8 0 0 8 250.1503 658.5732 Tm
[(\035)-47.8 (\(9%\))]TJ
-25.644 -1.471 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
/T1_1 1 Tf
0.048 Tw 1.125 0 Td
[(Ner)-17.7 (vous system disorders:)]TJ
/T1_0 1 Tf
0.017 Tw [(\035)-47.8 (tremor)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.6 0 0 5.6 151.1342 649.4665 Tm
(c)Tj
-0.017 Tc 0.048 Tw 8 0 0 8 153.4234 646.8025 Tm
[(\035)-47.8 (\(4.1%\),)37.2 ( a)-9.8 (phasia)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.6 0 0 5.6 200.2086 649.4665 Tm
(d)Tj
-0.017 Tc 0.048 Tw 8 0 0 8 202.705 646.8025 Tm
[(\035)-47.8 (\(3.2%\),)37.2 ( a)-9.8 (taxia)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.6 0 0 5.6 244.2838 649.4665 Tm
(e)Tj
-0.017 Tc 0.017 Tw 8 0 0 8 246.6737 646.8025 Tm
[(\035)-47.8 (\(2.3%\),)20 ( )]TJ
0 Tc 0 Tw 3.065 0 Td
( )Tj
-0.017 Tc 0.048 Tw -27.149 -1.066 Td
(seizure \(0.5%\))Tj
0.017 Tw -1.125 -1.471 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
/T1_1 1 Tf
0.048 Tw 1.125 0 Td
[(Psychia)-9.7 (tric disorders:)]TJ
/T1_0 1 Tf
[(\035)-47.8 (anxiety \(4.1%\),)37.2 ( delirium)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.6 0 0 5.6 184.6216 629.1649 Tm
(f)Tj
-0.017 Tc 0.017 Tw 8 0 0 8 185.9756 626.5009 Tm
[(\035)-47.8 (\(7%\))]TJ
-17.622 -1.471 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
/T1_1 1 Tf
0.048 Tw 1.125 0 Td
[(Respira)-9.7 (tor)-17.8 (y)55.2 (,)37.2 ( thoracic,)37.2 ( and mediastinal disorders:)]TJ
/T1_0 1 Tf
[(\035)-47.8 (pulmonar)-17.8 (y edema)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.6 0 0 5.6 245.1112 617.3941 Tm
(g)Tj
-0.017 Tc 0.017 Tw 8 0 0 8 247.6077 614.7301 Tm
[(\035)-47.8 (\(1.4%\))]TJ
-25.326 -1.471 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
/T1_1 1 Tf
0.048 Tw 1.125 0 Td
[(V)18.2 (ascular disorders:)]TJ
/T1_0 1 Tf
0.017 Tw [(\035)-47.8 (thrombosis)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.6 0 0 5.6 141.8819 605.6233 Tm
(h)Tj
-0.017 Tc 0.017 Tw 8 0 0 8 144.3784 602.9593 Tm
[(\035)-47.8 (\(3.2%\))]TJ
-0.012 Tc 0.012 Tw 5.32 0 0 5.6 36 595.6525 Tm
(a)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.003 Tc 0.126 Tw 7.6 0 0 8 41 592.9885 Tm
[(Sepsis inc)19.7 (ludes bacteremia,)36.7 ( bacterial sepsis,)36.7 ( candida sepsis,)36.7 ( citrobacter bacteremia,)40 ( )]TJ
-0.006 Tc 0.081 Tw 0 -1.066 Td
[(c)19.6 (lostridial sepsis,)36.7 ( device rela)-10.4 (ted bacteremia,)36.7 ( enterococcal sepsis,)36.7 ( klebsiella bacteremia,)31.1 ( )]TJ
-0.002 Tc 0.096 Tw 0 -1.066 Td
[(k)0.5 (le)0.5 (bs)0.5 (ie)0.5 (ll)0.5 (a)0.5 ( s)0.5 (ep)0.5 (si)0.5 (s,)37.5 ( mu)0.5 (l)0.5 (ti)0.5 (pl)0.5 (e o)0.5 (rg)0.5 (an)0.5 ( d)-9.6 (y)0.5 (sf)0.5 (un)0.5 (c)0.5 (ti)0.5 (on)0.5 ( sy)0.5 (nd)0.5 (ro)0.5 (me)0.5 (,)37.4 ( n)0.5 (eu)0.5 (tr)0.5 (o)0.5 (pe)0.5 (ni)0.5 (c s)0.5 (ep)0.5 (si)0.5 (s,)37.5 ( pu)0.5 (lm)0.5 (on)0.5 (a)0.5 (r)-17.6 (y)-2 ( )]TJ
0.011 Tc 0.165 Tw 0 -1.066 Td
[(sepsis,)36.9 ( sepsis,)36.9 ( septic shock,)36.9 ( sta)-10.1 (phylococcal bacteremia,)36.9 ( streptococcal bacteremia,)48 ( )]TJ
-0.012 Tc 0.048 Tw 0 -1.066 Td
(streptococcal sepsis.)Tj
0.012 Tw 5.32 0 0 5.6 36 552.9985 Tm
(b)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.009 Tc 0.064 Tw 7.6 0 0 8 41 550.3345 Tm
[(Motor d)-9.9 (ysfunction inc)20 (ludes aka)-9.9 (thisia,)37 ( d)-9.9 (yskinesia,)37.1 ( d)-9.9 (ysphonia,)37.1 ( hypertonia,)37.1 ( musc)20.1 (le spasms,)28 ( )]TJ
-0.012 Tc 0.048 Tw 0 -1.066 Td
[(musc)20.3 (le twitching,)37.2 ( muscular weakness,)37.2 ( restless legs syndrome.)]TJ
0.012 Tw 5.32 0 0 5.6 36 535.937 Tm
(c)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 41 533.2729 Tm
[(T)74.2 (remor inc)20.2 (ludes head tituba)-9.8 (tion,)37.2 ( intention tremor)74.2 (,)37.2 ( resting tremor)74.2 (,)37.2 ( tremor)74.2 (.)]TJ
0.012 Tw 5.32 0 0 5.6 36 527.4061 Tm
(d)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 41 524.7421 Tm
[(A)-9.8 (phasia inc)20.2 (ludes a)-9.7 (phasia,)37.3 ( d)-9.8 (ysarthria,)37.2 ( slo)-9.8 (w speech,)37.3 ( speech disorder)74.2 (.)]TJ
0.012 Tw 5.32 0 0 5.6 36 518.8754 Tm
(e)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 41 516.2114 Tm
[(Ataxia inc)20.2 (ludes a)-9.7 (taxia,)37.2 ( balance disorder)74.2 (,)37.2 ( d)-9.8 (ysmetria,)37.2 ( gait disturbance.)]TJ
0.012 Tw 5.32 0 0 5.6 36 510.3445 Tm
(f)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.005 Tc 0.083 Tw 7.6 0 0 8 41 507.6805 Tm
[(Delirium inc)20.1 (ludes a)-9.8 (gita)-9.9 (tion,)37.1 ( delirium,)37.1 ( disorienta)-9.9 (tion,)37.1 ( hallucina)-9.9 (tion,)37.1 ( hallucina)-9.8 (tion auditor)-17.9 (y)55.1 (,)32 ( )]TJ
-0.012 Tc 0.048 Tw 0 -1.066 Td
[(hallucina)-9.8 (tion visual,)37.2 ( restlessness.)]TJ
0.012 Tw 5.32 0 0 5.6 36 493.283 Tm
(g)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 41 490.619 Tm
[(Pulmonar)-17.8 (y edema inc)20.2 (ludes pulmonar)-17.7 (y congestion and pulmonar)-17.8 (y edema.)]TJ
0.012 Tw 5.32 0 0 5.6 36 484.7522 Tm
(h)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.014 Tc 0.178 Tw 7.6 0 0 8 41 482.0882 Tm
[(Thrombosis inc)20.2 (ludes deep vein thrombosis,)37.1 ( device rela)-9.8 (ted thrombosis,)37.1 ( embolism,)51 ( )]TJ
-0.012 Tc 0.048 Tw 0 -1.066 Td
[(pulmonar)-17.8 (y embolism,)37.2 ( thrombosis,)37.2 ( thrombosis in device.)]TJ
-0.017 Tc 0.011 Tw 8 0 0 8 36 456.0266 Tm
[(Labora)-9.8 (tor)-17.8 (y Abnormalities)]TJ
-0.008 Tc 0.095 Tw 0 -1.633 Td
[(T)73.8 (able 4 presents the most common Grade 3 or 4 labora)-10.2 (tor)-18.1 (y abnormalities,)36.8 ( based on)-8 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.048 Td
[(labora)-9.8 (tor)-17.8 (y da)-9.8 (ta,)37.2 ( occurring in a)-9.7 (t least 10% of pa)-9.8 (tients.)]TJ
ET
/GS2 gs
q 1 0 0 1 36 363.1869 cm
0 0 m
115.92 0 l
S
Q
q 1 0 0 1 36 352.795 cm
0 0 m
115.92 0 l
S
Q
q 1 0 0 1 36 342.4031 cm
0 0 m
115.92 0 l
S
Q
q 1 0 0 1 36 332.0112 cm
0 0 m
115.92 0 l
S
Q
q 1 0 0 1 36 269.6597 cm
0 0 m
115.92 0 l
S
Q
q 1 0 0 1 36 321.6193 cm
0 0 m
115.92 0 l
S
Q
q 1 0 0 1 36 311.2274 cm
0 0 m
115.92 0 l
S
Q
q 1 0 0 1 36 300.8354 cm
0 0 m
115.92 0 l
S
Q
q 1 0 0 1 36 290.4435 cm
0 0 m
115.92 0 l
S
Q
q 1 0 0 1 36 280.0516 cm
0 0 m
115.92 0 l
S
Q
q 1 0 0 1 36 373.5788 cm
0 0 m
115.92 0 l
S
Q
q 1 0 0 1 219.96 373.5788 cm
0 0 m
68.04 0 l
S
Q
q 1 0 0 1 219.96 363.1869 cm
0 0 m
68.04 0 l
S
Q
q 1 0 0 1 219.96 352.795 cm
0 0 m
68.04 0 l
S
Q
q 1 0 0 1 219.96 342.4031 cm
0 0 m
68.04 0 l
S
Q
q 1 0 0 1 219.96 332.0112 cm
0 0 m
68.04 0 l
S
Q
q 1 0 0 1 219.96 321.6193 cm
0 0 m
68.04 0 l
S
Q
q 1 0 0 1 219.96 311.2274 cm
0 0 m
68.04 0 l
S
Q
q 1 0 0 1 219.96 300.8354 cm
0 0 m
68.04 0 l
S
Q
q 1 0 0 1 219.96 290.4435 cm
0 0 m
68.04 0 l
S
Q
q 1 0 0 1 219.96 280.0516 cm
0 0 m
68.04 0 l
S
Q
q 1 0 0 1 219.96 269.6597 cm
0 0 m
68.04 0 l
S
Q
1 w 
q 1 0 0 1 36 259.2678 cm
0 0 m
115.92 0 l
S
Q
q 1 0 0 1 219.96 259.2678 cm
0 0 m
68.04 0 l
S
Q
0.5 w 
q 1 0 0 1 36 229.3559 cm
0 0 m
115.92 0 l
S
Q
q 1 0 0 1 151.92 229.3559 cm
0 0 m
68.04 0 l
S
Q
q 1 0 0 1 219.96 229.3559 cm
0 0 m
68.04 0 l
S
Q
1 w 
q 1 0 0 1 36 403.7423 cm
0 0 m
115.92 0 l
S
Q
q 1 0 0 1 219.96 403.7423 cm
0 0 m
68.04 0 l
S
Q
q 1 0 0 1 151.92 403.7423 cm
0 0 m
68.04 0 l
S
Q
0.5 w 
q 1 0 0 1 151.92 373.8288 cm
0 0 m
0 29.413 l
S
Q
q 1 0 0 1 219.96 373.8288 cm
0 0 m
0 29.413 l
S
Q
q 1 0 0 1 151.92 373.5788 cm
0 0 m
68.04 0 l
S
Q
q 1 0 0 1 151.92 363.4369 cm
0 0 m
0 9.892 l
S
Q
q 1 0 0 1 219.96 363.4369 cm
0 0 m
0 9.892 l
S
Q
q 1 0 0 1 151.92 363.1869 cm
0 0 m
68.04 0 l
S
Q
q 1 0 0 1 151.92 353.045 cm
0 0 m
0 9.892 l
S
Q
q 1 0 0 1 219.96 353.045 cm
0 0 m
0 9.892 l
S
Q
q 1 0 0 1 151.92 352.795 cm
0 0 m
68.04 0 l
S
Q
q 1 0 0 1 151.92 342.6531 cm
0 0 m
0 9.892 l
S
Q
q 1 0 0 1 219.96 342.6531 cm
0 0 m
0 9.892 l
S
Q
q 1 0 0 1 151.92 342.4031 cm
0 0 m
68.04 0 l
S
Q
q 1 0 0 1 151.92 332.2612 cm
0 0 m
0 9.892 l
S
Q
q 1 0 0 1 219.96 332.2612 cm
0 0 m
0 9.892 l
S
Q
q 1 0 0 1 151.92 332.0112 cm
0 0 m
68.04 0 l
S
Q
q 1 0 0 1 151.92 321.8693 cm
0 0 m
0 9.892 l
S
Q
q 1 0 0 1 219.96 321.8693 cm
0 0 m
0 9.892 l
S
Q
q 1 0 0 1 151.92 321.6193 cm
0 0 m
68.04 0 l
S
Q
q 1 0 0 1 151.92 311.4774 cm
0 0 m
0 9.892 l
S
Q
q 1 0 0 1 219.96 311.4774 cm
0 0 m
0 9.892 l
S
Q
q 1 0 0 1 151.92 311.2274 cm
0 0 m
68.04 0 l
S
Q
q 1 0 0 1 151.92 301.0854 cm
0 0 m
0 9.892 l
S
Q
q 1 0 0 1 219.96 301.0854 cm
0 0 m
0 9.892 l
S
Q
q 1 0 0 1 151.92 300.8354 cm
0 0 m
68.04 0 l
S
Q
q 1 0 0 1 151.92 290.6935 cm
0 0 m
0 9.892 l
S
Q
q 1 0 0 1 219.96 290.6935 cm
0 0 m
0 9.892 l
S
Q
q 1 0 0 1 151.92 290.4435 cm
0 0 m
68.04 0 l
S
Q
q 1 0 0 1 151.92 280.3016 cm
0 0 m
0 9.892 l
S
Q
q 1 0 0 1 219.96 280.3016 cm
0 0 m
0 9.892 l
S
Q
q 1 0 0 1 151.92 280.0516 cm
0 0 m
68.04 0 l
S
Q
q 1 0 0 1 151.92 269.9097 cm
0 0 m
0 9.892 l
S
Q
q 1 0 0 1 219.96 269.9097 cm
0 0 m
0 9.892 l
S
Q
q 1 0 0 1 151.92 269.6597 cm
0 0 m
68.04 0 l
S
Q
q 1 0 0 1 151.92 259.7678 cm
0 0 m
0 9.642 l
S
Q
q 1 0 0 1 219.96 259.7678 cm
0 0 m
0 9.642 l
S
Q
1 w 
q 1 0 0 1 151.92 259.2678 cm
0 0 m
68.04 0 l
S
Q
BT
/GS1 gs
/T1_2 1 Tf
8 0 0 8 36 415.8423 Tm
[(T)74.2 (able 4:)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
5 0 Td
(Grade 3 or 4)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.6 0 0 5.6 114.304 418.5063 Tm
(a)Tj
-0.017 Tc 0.048 Tw 8 0 0 8 116.9012 415.8423 Tm
[(\037)-47.8 (Laborator)-17.8 (y Abnormalities W)18.2 (orsening from Baseline in)-17.1 ( )]TJ
-5.113 -1.062 Td
[(at Least 10% of P)24.2 (atients T)74.3 (reated in the KarMMa-3 Study)-17 (\037)]TJ
-0.012 Tc 7.6 0 0 8 36 385.8046 Tm
[(Laborator)-17.8 (y Abnormality)]TJ
0.012 Tw 18.046 1.123 Td
(ABECMA)Tj
0.048 Tw 0.262 -1.062 Td
( N=222)Tj
0.012 Tw 0.748 -1.062 Td
(\(%\))Tj
0.048 Tw 5.829 2.125 Td
[(Standard Regimens)-12 ( )]TJ
0.012 Tw 2.531 -1.062 Td
[(N=126)-12 ( )]TJ
0.61 -1.062 Td
(\(%\))Tj
0.048 Tw -11.519 -1.533 Td
(Grade 3 or 4 \(%\))Tj
8.969 0 Td
(Grade 3 or 4 \(%\))Tj
/T1_0 1 Tf
-25.476 -1.299 Td
[(L)37.2 (ymphoc)20.2 (yte decreased)]TJ
0.012 Tw 19.255 0 Td
(98)Tj
8.969 0 Td
(78)Tj
0.048 Tw -28.224 -1.299 Td
[(Leukoc)20.2 (yte decreased)]TJ
0.012 Tw 19.255 0 Td
(96)Tj
8.969 0 Td
(64)Tj
0.048 Tw -28.224 -1.299 Td
(Neutrophil decreased)Tj
0.012 Tw 19.255 0 Td
(96)Tj
8.969 0 Td
(72)Tj
0.048 Tw -28.224 -1.299 Td
[(Pla)-9.7 (telet decreased)]TJ
0.012 Tw 19.255 0 Td
(59)Tj
8.969 0 Td
(46)Tj
0.048 Tw -28.224 -1.299 Td
(Hemoglobin decreased)Tj
0.012 Tw 19.255 0 Td
(52)Tj
8.969 0 Td
(45)Tj
0.048 Tw -28.224 -1.299 Td
[(Phospha)-9.8 (te decreased)]TJ
0.012 Tw 19.255 0 Td
(45)Tj
8.969 0 Td
(30)Tj
0.048 Tw -28.224 -1.299 Td
[(T)74.2 (riglyceride increased)]TJ
0.012 Tw 19.255 0 Td
(21)Tj
8.969 0 Td
(10)Tj
0.048 Tw -28.224 -1.299 Td
(Alanine aminotransferase increased)Tj
0.012 Tw 19.255 0 Td
(13)Tj
0 Tc 0 Tw 9.203 0 Td
(8)Tj
-0.012 Tc 0.048 Tw -28.458 -1.299 Td
(Sodium decreased)Tj
0.012 Tw 19.255 0 Td
(11)Tj
0 Tc 0 Tw 9.203 0 Td
(7)Tj
-0.012 Tc 0.048 Tw -28.458 -1.299 Td
(Gamma-glutamyltransferase increased)Tj
0.012 Tw 19.255 0 Td
(10)Tj
0 Tc 0 Tw 9.203 0 Td
(6)Tj
-0.009 Tc 0.064 Tw -28.458 -1.456 Td
[(CAR=chimeric antigen receptor; CTCAE=Common )37 (T)74 (erminolog)-10 (y Criteria for )37 (Adverse Events;)-8.9 ( )]TJ
-0.012 Tc 0.048 Tw 0 -1.062 Td
[(NCI=Na)-9.8 (tional Cancer Institute.)]TJ
0.012 Tw 5.32 0 0 5.6 36 235.6199 Tm
(a)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 41 232.9559 Tm
[(Labora)-9.8 (tor)-17.8 (y tests were graded according to NCI CTCAE )37.2 (V)18.2 (ersion 4.03.)]TJ
-0.008 Tc 0.096 Tw 8 0 0 8 36 211.045 Tm
[(Other c)19.6 (linically important Grade 3 or 4 labora)-10.4 (tor)-18.4 (y abnormalities \(based on labora)-10.4 (tor)-18.3 (y)-8 ( )]TJ
-0.001 Tc 0.126 Tw 0 -1.048 Td
[(d)0.5 (a)-9.4 (t)0.6 (a)0.5 (\))0.5 ( t)0.6 (h)0.5 (a)-9.4 (t)0.5 ( o)0.5 (c)0.6 (c)0.5 (u)0.6 (r)0.5 (r)0.6 (e)0.5 (d)0.5 ( i)0.6 (n)0.5 ( l)0.5 (e)0.6 (s)0.5 (s)0.6 ( t)0.6 (h)0.5 (a)0.6 (n)0.5 ( 1)0.5 (0)0.5 (%)0.6 ( o)0.5 (f)0.6 ( p)0.5 (a)-9.4 (t)0.5 (i)0.6 (e)0.5 (n)0.5 (t)0.6 (s)0.5 ( t)0.6 (r)0.5 (e)0.6 (a)-9.5 (t)0.6 (e)0.5 (d)0.6 ( w)0.6 (i)0.5 (t)0.6 (h)0.5 ( )37.3 (A)0.5 (B)0.5 (E)0.6 (C)0.5 (M)0.6 (A)0.5 ( i)0.5 (n)0.6 (c)20.5 (l)0.5 (u)0.6 (d)0.5 (e)0.6 ( t)0.6 (h)0.5 (e)-1 ( )]TJ
0.011 Tc 0.191 Tw 0 -1.048 Td
[(follo)-10.3 (wing:)36.7 ( asparta)-10.3 (te aminotransferase increased,)36.7 ( potassium decreased,)36.7 ( albumin)11 ( )]TJ
-0.001 Tc 0.131 Tw 0 -1.048 Td
[(decreased,)36.6 ( alkaline phospha)-10.3 (tase increased,)36.6 ( calcium decreased,)36.7 ( glucose increased,)36 ( )]TJ
-0.018 Tc 0.036 Tw 0 -1.048 Td
[(activa)-10.1 (ted partial thromboplastin time increased \(seconds\),)36.9 ( \037brinogen decreased,)36.9 ( bilirubin)-18 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.048 Td
[(increased and hypoma)-9.8 (gnesemia.)20 ( )]TJ
/T1_1 1 Tf
0 -1.719 Td
[(KarMMa Stud)-9.8 (y)]TJ
/T1_0 1 Tf
-0.018 Tc 0.036 Tw 0 -1.633 Td
[(The safety da)-10.2 (ta described in this section re\036ect the exposure to )36.7 (ABECMA in the KarMMa)-18 ( )]TJ
0.005 Tc 0.159 Tw 0 -1.048 Td
[(stud)-10 (y)54.9 (,)36.9 ( in which 127 pa)-10 (tients with rela)-10 (psed/refractor)-18 (y multiple myeloma received)5 ( )]TJ
-0.006 Tc 0.102 Tw 0 -1.048 Td
[(ABEC)0.5 (MA )0.5 (acro)0.5 (ss )0.5 (a )0.5 (dos)0.5 (e )0.5 (ran)0.5 (ge )0.5 (of )0.5 (15)0.5 (0 )0.5 (to )0.5 (518 )0.5 (x )0.5 (1)0.5 (0)]TJ
0.006 Tw 5.6 0 0 5.6 185.789 128.2319 Tm
(6 )Tj
0.065 Tw 8 0 0 8 190.32 125.5679 Tm
[(CAR-)0.5 (posi)0.5 (tive)0.5 ( T )-36.5 (ce)0.5 (lls )]TJ
/T1_1 1 Tf
0.006 Tw 7.723 0 Td
[([s)0.5 (ee )]TJ
1.864 0 Td
[(Cli)0.5 (nical)-5.9 ( )]TJ
-0.017 Tc 0.042 Tw -28.877 -1.048 Td
(Studies \(14\))Tj
0 Tc 0 Tw (])Tj
/T1_0 1 Tf
-0.017 Tc 0.042 Tw 4.5 0 Td
[(.)37.2 ( P)18.2 (a)-9.8 (tients with a histor)-17.8 (y of CNS disease \(such as seizure or cerebrovascular)-17 ( )]TJ
0.007 Tc 0.167 Tw -4.5 -1.048 Td
[(ischemia\) or requiring ongoing trea)-9.7 (tment with chronic immunosuppression were)7 ( )]TJ
-0.011 Tc 0.078 Tw 0 -1.048 Td
[(exc)20.1 (luded.)37.2 ( )36.7 (The median dura)-9.8 (tion of follo)-9.9 (w-up was 11.4 months.)37.1 ( )36.8 (The median a)-9.9 (ge of the)-11 ( )]TJ
-0.018 Tc 0.036 Tw 0 -1.048 Td
[(stud)-10.4 (y popula)-10.5 (tion was 61 years \(range:)36.6 ( 33 to 78 years\); 35% were 65 years or older)73.6 (,)36.6 ( and)-18 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.048 Td
[(60% were men.)37.2 ( )37.1 (The Eastern Coopera)-9.8 (tive Oncolog)-9.8 (y Group \(ECOG\) performance sta)-9.7 (tus a)-9.7 (t)-17 ( )]TJ
-0.019 Tc 0.036 Tw 0 -1.048 Td
[(baseline was 0 in 45%,)37.3 ( 1 in 53%,)37.4 ( and 2 in 2% of pa)-9.6 (tients.)37.3 ( Seven percent of the pa)-9.6 (tients)-19 ( )]TJ
-0.017 Tc 0.055 Tw 0 -1.048 Td
[(trea)-9.7 (ted with )37.4 (ABECMA had crea)-9.8 (tinine c)20.2 (learance )0.5 (<45 mL/min.)37.2 ( F)20.2 (or )0.5 (details )0.5 (about )0.5 (the stud)-9.8 (y)-16.9 ( )]TJ
0.048 Tw 0 -1.048 Td
[(popula)-9.7 (tion,)37.2 ( see )]TJ
/T1_1 1 Tf
(Clinical Stud)Tj
(ies \(14\))Tj
/T1_0 1 Tf
-0.037 Tc 0.037 Tw (. )Tj
-0.013 Tc 0.067 Tw 0 -1.768 Td
[(The most common \(grea)-9.7 (ter than or equal to 10%\) Grade 3 or 4 nonlabora)-9.8 (tor)-17.7 (y adverse)-13 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.048 Td
[(reactions were febrile neutropenia \(16%\) and infections \226 pa)-9.7 (thogen unspeci\037ed \(15%\).)20.1 ( )]TJ
-0.007 Tc 0.1 Tw 36 86.406 Td
[(The most common nonlabora)-10.3 (tor)-18.3 (y adverse reactions \(incidence grea)-10.3 (ter than or equal)-7 ( )]TJ
-0.001 Tc 0.131 Tw 0 -1.044 Td
[(to 20%\) inc)19.6 (luded CRS,)36.6 ( infections \226 pa)-10.3 (thogen unspeci\037ed,)36.6 ( fa)-10.3 (tigue,)36.7 ( musculoskeletal)-1 ( )]TJ
-0.013 Tc 0.07 Tw 0 -1.044 Td
[(pain,)36.9 ( hypogamma)-10.1 (globulinemia,)36.9 ( diarrhea,)36.9 ( upper respira)-10.1 (tor)-18.1 (y tract infection,)36.9 ( nausea,)36.9 ( viral)-13 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(infections,)37.2 ( encephalopa)-9.8 (thy)55.2 (,)37.2 ( edema,)37.2 ( pyrexia,)37.2 ( cough,)37.2 ( headache,)37.2 ( and decreased a)-9.8 (ppetite.)]TJ
-0.019 Tc 0.036 Tw 0 -1.764 Td
[(Serious adverse reactions occurred in 67% of pa)-10 (tients.)36.9 ( )37 (The most common nonlabora)-10.1 (tor)-18 (y)-19 ( )]TJ
-0.009 Tc 0.091 Tw 0 -1.044 Td
[(\(grea)-10.4 (ter than or equal to 5%\) serious adverse reactions inc)19.5 (luded CRS \(18%\),)36.5 ( general)-9 ( )]TJ
-0.014 Tc 0.066 Tw 0 -1.044 Td
[(physical health deteriora)-10.3 (tion \(10%\),)36.8 ( pneumonia \(12%\),)36.7 ( )0.5 (infections-pa)-10.3 (thogen )0.5 (unspeci\037ed)-14 ( )]TJ
-0.007 Tc 0.098 Tw 0 -1.044 Td
[(\(19%\),)37.2 ( viral infections \(9%\),)37.2 ( sepsis \(7%\),)37.2 ( and febrile neutropenia \(6%\).)37.2 ( F)20.2 (a)-9.8 (tal adverse)-7 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
(reactions occurred in 6%.)Tj
-0.006 Tc 0.101 Tw 0 -1.764 Td
[(T)74.5 (a)0.5 (b)0.5 (l)0.5 (e)0.5 ( 5)0.5 ( s)0.5 (u)0.5 (m)0.5 (m)0.5 (a)0.5 (r)0.5 (i)0.5 (z)0.5 (e)0.5 (s)0.5 ( t)0.5 (he)0.6 ( ad)0.5 (v)0.5 (e)0.5 (r)0.5 (s)0.5 (e)0.5 ( r)0.5 (e)0.5 (a)0.5 (c)0.5 (t)0.5 (i)0.5 (o)0.5 (n)0.5 (s t)0.6 (ha)-9.5 (t)0.5 ( o)0.5 (c)0.5 (c)0.5 (u)0.5 (r)0.5 (r)0.5 (e)0.5 (d)0.5 ( i)0.5 (n a)-9.4 (t l)0.5 (e)0.5 (a)0.5 (s)0.5 (t)0.5 ( 1)0.5 (0)0.5 (%)0.5 ( o)0.5 (f)0.5 ( p)0.5 (a)-9.5 (t)0.5 (i)0.5 (en)0.6 (ts)-6 ( )]TJ
-0.005 Tc 0.11 Tw 0 -1.044 Td
[(trea)-10.1 (ted )0.5 (with )37.5 (ABECMA.)36.8 ( )37.5 (T)73.9 (able 6 describes )0.5 (the )0.5 (most )0.5 (common Grade )0.5 (3 )0.5 (or )0.5 (4 )0.5 (labora)-10 (tor)-18.1 (y)-5 ( )]TJ
-0.017 Tc 0.017 Tw 0 -1.044 Td
(abnormalities.)Tj
ET
0.5 w 
/GS2 gs
q 1 0 0 1 324 150.6215 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 324 107.6139 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 324 473.179 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 324 462.4271 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 324 451.6751 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 324 440.9232 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 324 408.6675 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 324 397.9156 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 324 387.1636 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 324 376.4117 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 324 344.156 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 324 311.9002 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 324 301.1483 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 324 290.3964 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 324 279.6445 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 324 204.3811 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 324 172.1254 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 324 161.3734 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 324 139.8696 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 434.88 580.7643 cm
0 0 m
0 12.162 l
S
Q
q 1 0 0 1 434.63 580.5143 cm
0 0 m
70.81 0 l
S
Q
q 1 0 0 1 434.88 567.8524 cm
0 0 m
0 12.412 l
S
Q
q 1 0 0 1 505.44 580.5143 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 567.8524 cm
0 0 m
0 12.412 l
S
Q
q 1 0 0 1 434.63 567.6024 cm
0 0 m
70.81 0 l
S
Q
q 1 0 0 1 434.88 537.9404 cm
0 0 m
0 29.412 l
S
Q
q 1 0 0 1 505.44 567.6024 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 537.9404 cm
0 0 m
0 29.412 l
S
Q
q 1 0 0 1 434.88 516.4366 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 505.44 516.4366 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 434.88 494.9328 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 505.44 494.9328 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 434.88 473.429 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 505.44 473.429 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 434.88 473.179 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 434.88 462.6771 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 505.44 473.179 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 462.6771 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 434.88 462.4271 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 434.88 451.9251 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 505.44 462.4271 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 451.9251 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 434.88 451.6751 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 434.88 441.1732 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 505.44 451.6751 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 441.1732 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 434.88 440.9232 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 434.88 430.4213 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 505.44 440.9232 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 430.4213 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 434.88 408.9175 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 505.44 408.9175 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 434.88 408.6675 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 434.88 398.1656 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 505.44 408.6675 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 398.1656 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 434.88 397.9156 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 434.88 387.4136 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 505.44 397.9156 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 387.4136 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 434.88 387.1636 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 434.88 376.6617 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 505.44 387.1636 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 376.6617 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 434.88 376.4117 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 434.88 365.9098 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 505.44 376.4117 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 365.9098 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 434.88 344.406 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 505.44 344.406 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 434.88 344.156 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 434.88 333.6541 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 505.44 344.156 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 333.6541 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 434.88 312.1502 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 505.44 312.1502 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 434.88 311.9002 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 434.88 301.3983 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 505.44 311.9002 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 301.3983 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 434.88 301.1483 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 434.88 290.6464 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 505.44 301.1483 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 290.6464 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 434.88 290.3964 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 434.88 279.8945 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 505.44 290.3964 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 279.8945 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 434.88 279.6445 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 434.88 269.1426 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 505.44 279.6445 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 269.1426 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 434.88 247.6388 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 505.44 247.6388 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 434.88 226.1349 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 505.44 226.1349 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 434.88 204.6311 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 505.44 204.6311 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 434.88 204.3811 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 434.88 193.8792 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 505.44 204.3811 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 193.8792 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 434.88 172.3754 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 505.44 172.3754 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 434.88 172.1254 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 434.88 161.6234 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 505.44 172.1254 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 161.6234 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 434.88 161.3734 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 434.88 150.8715 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 505.44 161.3734 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 150.8715 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 434.88 150.6215 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 434.88 140.1196 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 505.44 150.6215 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 140.1196 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 434.88 139.8696 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 434.88 129.3677 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 505.44 139.8696 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 129.3677 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 434.88 107.8639 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 505.44 107.8639 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 434.88 107.6139 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 434.88 97.1119 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 505.44 107.6139 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 97.1119 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 434.88 75.6082 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 505.44 75.6082 cm
0 0 m
0 10.252 l
S
Q
1 w 
q 1 0 0 1 324 593.4262 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 434.88 593.4262 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 593.4262 cm
0 0 m
70.56 0 l
S
Q
0.5 w 
q 1 0 0 1 324 537.6904 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 434.88 537.6904 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 537.6904 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 324 526.9385 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 434.88 526.9385 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 526.9385 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 324 516.1866 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 434.88 516.1866 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 516.1866 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 324 505.4347 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 434.88 505.4347 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 505.4347 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 324 494.6828 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 434.88 494.6828 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 494.6828 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 324 483.9309 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 434.88 483.9309 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 483.9309 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 324 430.1713 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 434.88 430.1713 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 430.1713 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 324 419.4194 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 434.88 419.4194 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 419.4194 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 324 365.6598 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 434.88 365.6598 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 365.6598 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 324 354.9079 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 434.88 354.9079 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 354.9079 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 324 333.4041 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 434.88 333.4041 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 333.4041 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 324 322.6522 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 434.88 322.6522 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 322.6522 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 324 268.8926 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 434.88 268.8926 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 268.8926 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 324 258.1407 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 434.88 258.1407 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 258.1407 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 324 247.3888 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 434.88 247.3888 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 247.3888 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 324 236.6368 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 434.88 236.6368 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 236.6368 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 324 225.8849 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 434.88 225.8849 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 225.8849 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 324 215.133 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 434.88 215.133 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 215.133 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 324 193.6292 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 434.88 193.6292 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 193.6292 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 324 182.8773 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 434.88 182.8773 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 182.8773 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 324 129.1177 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 434.88 129.1177 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 129.1177 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 324 118.3658 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 434.88 118.3658 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 118.3658 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 324 96.8619 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 434.88 96.8619 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 96.8619 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 324 86.11 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 434.88 86.11 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 86.11 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 324 75.3582 cm
0 0 m
110.88 0 l
S
Q
q 1 0 0 1 434.88 75.3582 cm
0 0 m
70.56 0 l
S
Q
q 1 0 0 1 505.44 75.3582 cm
0 0 m
70.56 0 l
S
Q
BT
/GS1 gs
/T1_2 1 Tf
0.048 Tw 8 0 0 8 324 605.5261 Tm
[(T)74.2 (able 5:)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
5 0 Td
[(Adverse Reactions Obser)-17.8 (ved in at Least 10% of P)24.2 (atients T)74.2 (reated)-17 ( )]TJ
0 -1.062 Td
(with ABECMA in the KarMMa Study)Tj
-0.012 Tc 7.6 0 0 8 324 549.7903 Tm
(System Organ Class)Tj
0 -1.062 Td
[(Preferred T)74.2 (erm)]TJ
14.918 5.353 Td
[(T)74.2 (arget Dose of ABECMA \(C)18.3 (AR-P)24.2 (ositive T Cells\))]TJ
2.297 -1.614 Td
[(An)-9.8 (y Grade)]TJ
7.874 0 Td
(Grade 3 or Higher)Tj
-9.353 -1.614 Td
([150 to 450 x 10)Tj
0 Tc 0 Tw 5.32 0 0 5.6 491.8474 560.9544 Tm
(6)Tj
7.6 0 0 8 494.3361 558.2904 Tm
(])Tj
7.6 0 0 8 496.73 558.2904 Tm
( )Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 458.2556 549.7904 Tm
(\(N=127\))Tj
0 Tc 0 Tw 7.6 0 0 8 482.0644 549.7904 Tm
( )Tj
7.6 0 0 8 467.2036 541.2904 Tm
(%)Tj
-0.012 Tc 0.048 Tw 6.194 2.125 Td
([150 to 450 x 10)Tj
0 Tc 0 Tw 5.32 0 0 5.6 562.5325 560.9544 Tm
(6)Tj
7.6 0 0 8 565.0211 558.2904 Tm
(])Tj
7.6 0 0 8 567.415 558.2904 Tm
( )Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 528.9406 549.7904 Tm
(\(N=127\))Tj
0 Tc 0 Tw 7.6 0 0 8 552.7494 549.7904 Tm
( )Tj
7.6 0 0 8 537.8885 541.2904 Tm
(%)Tj
-0.012 Tc 0.048 Tw -28.143 -1.479 Td
(Blood and lymphatic system disorders)Tj
/T1_0 1 Tf
/Span<</ActualText<FEFF0009>>> BDC 
0 -1.344 Td
( )Tj
EMC 
0.592 0 Td
[(F)24.2 (ebrile neutropenia)]TJ
0.012 Tw 18.166 0 Td
(16)Tj
9.301 0 Td
(16)Tj
/T1_2 1 Tf
0.048 Tw -28.058 -1.344 Td
(Cardiac disorders)Tj
/T1_0 1 Tf
0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
0 -1.344 Td
( )Tj
EMC 
[(T)74.2 (achycardia)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 361.1813 499.8667 Tm
(a)Tj
7.6 0 0 8 363.5433 497.2027 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 13.555 0 Td
(19)Tj
0 Tc 0 Tw 9.535 0 Td
(0)Tj
/T1_2 1 Tf
-0.012 Tc 0.048 Tw -28.292 -1.344 Td
(Gastrointestinal disorders)Tj
/T1_0 1 Tf
0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
0 -1.344 Td
( )Tj
EMC 
(Diarrhea)Tj
0.012 Tw 18.758 0 Td
(35)Tj
9.187 0 Td
(1.6)Tj
0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
-27.944 -1.344 Td
( )Tj
EMC 
(Nausea)Tj
0.012 Tw 18.758 0 Td
(29)Tj
0 Tc 0 Tw 9.535 0 Td
(0)Tj
-0.012 Tc 0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
-28.292 -1.344 Td
( )Tj
EMC 
[(Constipa)-9.8 (tion)]TJ
0.012 Tw 18.758 0 Td
(16)Tj
0 Tc 0 Tw 9.535 0 Td
(0)Tj
-0.012 Tc 0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
-28.292 -1.344 Td
( )Tj
EMC 
[(V)18.2 (omiting)]TJ
0.012 Tw 18.758 0 Td
(15)Tj
0 Tc 0 Tw 9.535 0 Td
(0)Tj
-0.012 Tc 0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
-28.292 -1.344 Td
( )Tj
EMC 
0.592 0 Td
(Oral pain)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 353.4399 435.3552 Tm
(b)Tj
7.6 0 0 8 355.9031 432.6912 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 14.56 0 Td
(12)Tj
0 Tc 0 Tw 9.535 0 Td
(0)Tj
/T1_2 1 Tf
-0.012 Tc 0.048 Tw -28.292 -1.344 Td
(General disorders and administration site conditions)Tj
/T1_0 1 Tf
0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
0 -1.344 Td
( )Tj
EMC 
[(F)20.2 (a)-9.8 (tigue)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 348.6778 413.8514 Tm
(c)Tj
7.6 0 0 8 350.9441 411.1874 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 15.212 0 Td
(45)Tj
9.187 0 Td
(3.1)Tj
0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
-27.944 -1.344 Td
( )Tj
EMC 
(Pyrexia)Tj
0.012 Tw 18.758 0 Td
(25)Tj
9.187 0 Td
(1.6)Tj
0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
-27.944 -1.344 Td
( )Tj
EMC 
0.592 0 Td
[(General physical health deteriora)-9.7 (tion)]TJ
0.012 Tw 18.166 0 Td
(11)Tj
9.301 0 Td
(10)Tj
0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
-28.058 -1.344 Td
( )Tj
EMC 
(Edema)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 347.5333 381.5957 Tm
(d)Tj
7.6 0 0 8 349.9964 378.9317 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 15.337 0 Td
(25)Tj
0 Tc 0 Tw 9.535 0 Td
(0)Tj
-0.012 Tc 0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
-28.292 -1.344 Td
( )Tj
EMC 
(Chills)Tj
0.012 Tw 18.758 0 Td
(11)Tj
0 Tc 0 Tw 9.535 0 Td
(0)Tj
/T1_2 1 Tf
-0.012 Tc 0.048 Tw -28.292 -1.344 Td
(Immune system disorders)Tj
/T1_0 1 Tf
/Span<</ActualText<FEFF0009>>> BDC 
0 -1.344 Td
( )Tj
EMC 
0.592 0 Td
(Cytokine release syndrome)Tj
0.012 Tw 18.166 0 Td
(85)Tj
0 Tc 0 Tw 9.535 0 Td
(9)Tj
-0.012 Tc 0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
-28.292 -1.344 Td
( )Tj
EMC 
[(Hypogamma)-9.7 (globulinemia)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 398.0401 338.588 Tm
(e)Tj
7.6 0 0 8 400.4021 335.924 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 8.705 0 Td
(41)Tj
9.187 0 Td
(0.8)Tj
/T1_2 1 Tf
0.048 Tw -27.944 -1.344 Td
(Infections and infestations)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 402.8638 327.8361 Tm
(f)Tj
7.6 0 0 8 404.4385 325.1721 Tm
(\037)Tj
/T1_0 1 Tf
-0.012 Tc 0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
-10.584 -1.344 Td
( )Tj
EMC 
0.592 0 Td
[(Infections \226 P)18.2 (a)-9.8 (thogen unspecified)]TJ
0.012 Tw 18.166 0 Td
(51)Tj
9.301 0 Td
(15)Tj
0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
-28.058 -1.344 Td
( )Tj
EMC 
0.592 0 Td
(Viral infections)Tj
0.012 Tw 18.166 0 Td
(27)Tj
0 Tc 0 Tw 9.535 0 Td
(9)Tj
-0.012 Tc 0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
-28.292 -1.344 Td
( )Tj
EMC 
0.592 0 Td
(Bacterial infections)Tj
0.012 Tw 18.166 0 Td
(15)Tj
9.187 0 Td
(3.9)Tj
0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
-27.944 -1.344 Td
( )Tj
EMC 
(Pneumonia)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 359.2612 284.8284 Tm
(g)Tj
7.6 0 0 8 361.7243 282.1644 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 13.794 0 Td
(17)Tj
0 Tc 0 Tw 9.535 0 Td
(9)Tj
-0.012 Tc 0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
-28.292 -1.344 Td
( )Tj
EMC 
0.592 0 Td
[(Upper respira)-9.8 (tor)-17.8 (y tract infection)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 415.9947 274.0765 Tm
(h)Tj
7.6 0 0 8 418.4579 271.4125 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 6.329 0 Td
(34)Tj
9.187 0 Td
(1.6)Tj
/T1_2 1 Tf
-27.944 -1.344 Td
(Investigations)Tj
/T1_0 1 Tf
0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
0 -1.344 Td
( )Tj
EMC 
0.592 0 Td
[(W)18.2 (eight decreased)]TJ
0.012 Tw 18.166 0 Td
(13)Tj
9.187 0 Td
(1.6)Tj
/T1_2 1 Tf
0.048 Tw -27.944 -1.344 Td
(Metabolism and nutrition disorders)Tj
/T1_0 1 Tf
/Span<</ActualText<FEFF0009>>> BDC 
0 -1.344 Td
( )Tj
EMC 
0.592 0 Td
[(Decreased a)-9.8 (ppetite)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 381.7883 231.0689 Tm
(i)Tj
7.6 0 0 8 382.8736 228.4049 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 11.011 0 Td
(22)Tj
9.187 0 Td
(0.8)Tj
/T1_2 1 Tf
0.048 Tw -27.944 -1.344 Td
(Musculoskeletal and connective tissue disorders)Tj
/T1_0 1 Tf
/Span<</ActualText<FEFF0009>>> BDC 
0 -1.344 Td
( )Tj
EMC 
0.592 0 Td
(Musculoskeletal pain)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 386.3226 209.565 Tm
(j)Tj
7.6 0 0 8 387.4078 206.901 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 10.414 0 Td
(45)Tj
9.187 0 Td
(3.1)Tj
0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
-27.944 -1.344 Td
( )Tj
EMC 
0.592 0 Td
[(Motor d)-9.8 (ysfunction)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 378.0812 198.8131 Tm
(k)Tj
7.6 0 0 8 380.4432 196.1491 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 11.331 0 Td
(11)Tj
0 Tc 0 Tw 9.535 0 Td
(0)Tj
/T1_2 1 Tf
-0.012 Tc 0.048 Tw -28.292 -1.344 Td
[(Ner)-17.7 (vous system disorders)]TJ
/T1_0 1 Tf
0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
0 -1.344 Td
( )Tj
EMC 
[(Encephalopa)-9.7 (thy)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 371.9529 177.3093 Tm
(l)Tj
7.6 0 0 8 373.0381 174.6453 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 12.305 0 Td
(26)Tj
0 Tc 0 Tw 9.535 0 Td
(6)Tj
-0.012 Tc 0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
-28.292 -1.344 Td
( )Tj
EMC 
(Headache)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 355.8351 166.5574 Tm
(m)Tj
7.6 0 0 8 359.676 163.8934 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 14.063 0 Td
(23)Tj
0 Tc 0 Tw 9.535 0 Td
(0)Tj
-0.012 Tc 0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
-28.292 -1.344 Td
( )Tj
EMC 
(Dizziness)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 354.2074 155.8055 Tm
(n)Tj
7.6 0 0 8 356.6705 153.1415 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 14.459 0 Td
(17)Tj
9.187 0 Td
(0.8)Tj
0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
-27.944 -1.344 Td
( )Tj
EMC 
0.592 0 Td
[(Neuropa)-9.8 (thy peripheral)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 389.528 145.0536 Tm
(o)Tj
7.6 0 0 8 391.89 142.3896 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 9.825 0 Td
(17)Tj
9.187 0 Td
(0.8)Tj
0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
-27.944 -1.344 Td
( )Tj
EMC 
[(T)74.2 (remor)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 347.8583 134.3016 Tm
(p)Tj
7.6 0 0 8 350.3214 131.6376 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 15.294 0 Td
(10)Tj
0 Tc 0 Tw 9.535 0 Td
(0)Tj
/T1_2 1 Tf
-0.012 Tc 0.048 Tw -28.292 -1.344 Td
(Psychiatric disorders)Tj
/T1_0 1 Tf
0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
0 -1.344 Td
( )Tj
EMC 
(Insomnia)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 353.4487 112.7978 Tm
(q)Tj
7.6 0 0 8 355.9119 110.1338 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 14.559 0 Td
(13)Tj
0 Tc 0 Tw 9.535 0 Td
(0)Tj
-0.012 Tc 0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
-28.292 -1.344 Td
( )Tj
EMC 
(Anxiety)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 348.4572 102.0459 Tm
(r)Tj
7.6 0 0 8 350.0318 99.3819 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 15.332 0 Td
(12)Tj
9.187 0 Td
(0.8)Tj
/T1_2 1 Tf
0.048 Tw -27.944 -1.344 Td
[(Renal and urinar)-17.8 (y disorders)]TJ
/T1_0 1 Tf
/Span<</ActualText<FEFF0009>>> BDC 
0 -1.344 Td
( )Tj
EMC 
0.592 0 Td
(Renal failure)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 363.0547 80.5421 Tm
(s)Tj
7.6 0 0 8 365.2199 77.8781 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 13.334 0 Td
(10)Tj
9.187 0 Td
(2.4)Tj
/T1_1 1 Tf
0 Tc 0 Tw 8 0 0 8 541.8843 66.8664 Tm
(\()Tj
-0.017 Tc 0.017 Tw 0.224 0 Td
(Continued\))Tj
ET
endstreamendobj21 0 obj<</Length 53417>>stream
q
/GS0 gs
0 TL/Fm0 Do
Q
0 0 0 1 K
0.5 w 
/GS1 gs
q 1 0 0 1 36 704.178 cm
0 0 m
48.714 0 l
S
Q
BT
0 0 0 1 k
/T1_0 1 Tf
-0.014 Tc 0.064 Tw 8 0 0 8 36 727.248 Tm
[(one randomized,)37.1 ( open-label stud)-9.9 (y )0.5 (with 222 pa)-9.9 (tients in KarMMa-3 and one )0.5 (single-arm,)23 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(open-label stud)-9.7 (y with 127 pa)-9.8 (tients in KarMMa.)]TJ
/T1_1 1 Tf
0 -1.715 Td
[(KarMMa-3 Stud)-9.8 (y)]TJ
/T1_0 1 Tf
0.004 Tc 0.155 Tw 0 -1.629 Td
[(The safety da)-10.2 (ta described in this section reflect the exposure to )36.6 (ABECMA in the)4 ( )]TJ
-0.01 Tc 0.083 Tw 0 -1.044 Td
[(KarMMa-3 stud)-9.9 (y)55.2 (,)37.2 ( in which 222 pa)-9.8 (tients with rela)-9.8 (psed or refractor)-17.8 (y multiple myeloma)-9.9 ( )]TJ
-0.017 Tc 0.038 Tw 0 -1.044 Td
[(received )37.2 (ABECMA across a dose range of 175 to 529 x 10)]TJ
0.017 Tw 5.6 0 0 5.6 202.4901 678.1121 Tm
(6 )Tj
0.038 Tw 8 0 0 8 206.5419 675.4481 Tm
[(CAR-positive )37.2 (T cells \(median)-17 ( )]TJ
-0.014 Tc 0.066 Tw -21.318 -1.044 Td
[(dose:)36.6 ( 445 x 10)]TJ
0.014 Tw 5.6 0 0 5.6 79.9571 669.762 Tm
(6 )Tj
0.029 Tw 8 0 0 8 84.2064 667.098 Tm
[(CAR-positive T )-37.4 (cells\) )]TJ
/T1_1 1 Tf
0.014 Tw 7.692 0 Td
([see )Tj
0.066 Tw 1.792 0 Td
(Clinical Studies \(14\))Tj
0 Tc 0 Tw (])Tj
/T1_0 1 Tf
-0.014 Tc 0.066 Tw 7.422 0 Td
[(.)36.6 ( P)17.6 (a)-10.4 (tients with a histor)-18.4 (y)-14 ( )]TJ
-0.012 Tc 0.076 Tw -22.931 -1.044 Td
[(of CNS disease or requiring ongoing trea)-10.2 (tment with chronic immunosuppression were)-12 ( )]TJ
-0.019 Tc 0.036 Tw 0 -1.044 Td
[(exc)20 (luded.)37 ( )36.9 (The median a)-10 (ge of the safety popula)-10 (tion was 63 years \(range:)37 ( 30 to 81 years\);)-19 ( )]TJ
-0.009 Tc 0.09 Tw 0 -1.044 Td
[(43% were 65 years or older)73.8 (,)36.7 ( and 63% were men.)36.8 ( )36.6 (The Eastern Coopera)-10.2 (tive Oncolog)-10.3 (y)-9 ( )]TJ
-0.013 Tc 0.069 Tw 0 -1.044 Td
[(Group )0.5 (\(ECOG\) performance )0.5 (sta)-9.9 (tus )0.5 (a)-9.9 (t baseline )0.5 (was )0.5 (0 )0.5 (in )0.5 (47%,)37 ( )0.5 (1 )0.5 (in )0.5 (51%,)37.1 ( )0.5 (2 )0.5 (in )0.5 (1.4% )0.5 (and)-13 ( )]TJ
0 Tc 0 Tw 31.5 0 Td
( )Tj
0.005 Tc 0.157 Tw -31.5 -1.044 Td
[(3 in 0.5% of pa)-9.7 (tients.)37.4 ( F)20.4 (our \(1.8%\) pa)-9.7 (tients trea)-9.7 (ted with )37.1 (ABECMA had crea)-9.6 (tinine)5.1 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(c)20.2 (learance <45 mL/min.)37.2 ( F)20.2 (or details about the stud)-9.8 (y popula)-9.8 (tion,)37.2 ( see )]TJ
/T1_1 1 Tf
(Clinical Stud)Tj
(ies \(14\))Tj
/T1_0 1 Tf
-0.037 Tc 0.037 Tw (. )Tj
-0.013 Tc 0.067 Tw 0 -1.764 Td
[(The most common \(grea)-9.7 (ter than or equal to 10%\) Grade 3 or 4 nonlabora)-9.8 (tor)-17.7 (y adverse)-13 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(reactions was febrile neutropenia \(51%\) and an)-9.8 (y infections \(16%\).)]TJ
-0.014 Tc 0.063 Tw 0 -1.764 Td
[(The most common nonlabora)-9.7 (tor)-17.7 (y adverse reactions \(incidence grea)-9.7 (ter than or equal to)-14 ( )]TJ
-0.017 Tc 0.036 Tw 0 -1.044 Td
[(2)0.5 (0)0.5 (%)0.5 (\))0.5 ( )0.5 (i)0.5 (n)0.5 (c)20.4 (l)0.5 (u)0.5 (d)0.5 (e)0.5 (d)0.5 ( )0.5 (C)0.5 (R)0.5 (S)0.5 (,)37.4 ( )0.5 (p)0.5 (y)0.5 (r)0.5 (e)0.5 (x)0.5 (i)0.5 (a)0.5 (,)37.5 ( )0.5 (a)0.5 (n)-9.5 (y)0.5 ( )0.5 (i)0.5 (n)0.5 (f)0.5 (e)0.5 (c)0.5 (t)0.5 (i)0.5 (o)0.5 (n)0.5 (,)37.5 ( )0.5 (fe)0.6 (br)0.5 (i)0.5 (l)0.5 (e)0.5 ( )0.5 (n)0.5 (e)0.5 (u)0.5 (t)0.5 (r)0.5 (o)0.5 (p)0.5 (e)0.5 (n)0.5 (i)0.5 (a)0.5 (,)37.5 ( )0.5 (h)0.5 (y)0.5 (p)0.5 (o)0.5 (ga)0.5 (m)0.6 (m)0.5 (a)-9.5 (gl)0.5 (o)0.6 (b)0.5 (ul)0.5 (i)0.5 (n)0.5 (e)0.5 (m)0.5 (i)0.5 (a)0.5 (,)20 ( )]TJ
0.016 Tc 0.212 Tw 0 -1.044 Td
[(mu)0.5 (scul)0.5 (oske)0.5 (let)0.5 (al )0.6 (pain)0.5 (,)37.4 ( )0.5 (hyp)0.5 (ote)0.5 (nsio)0.5 (n,)37.4 ( )0.5 (i)0.5 (nfec)0.5 (tio)0.5 (ns )0.5 (\226 )0.6 (pa)-9.6 (t)0.5 (hoge)0.5 (n )0.5 (un)0.5 (spec)0.5 (ifie)0.5 (d,)37.4 ( )0.5 (f)0.5 (a)-9.6 (ti)0.5 (gue,)53 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(tachycardia,)37.2 ( diarrhea,)37.2 ( nausea,)37.2 ( headache,)37.2 ( encephalopa)-9.8 (thy)55.3 (,)37.1 ( d)-9.8 (yspnea and edema.)]TJ
-0.019 Tc 0.036 Tw 0 -1.764 Td
[(Serious adverse reactions occurred in 43% of pa)-10 (tients.)36.9 ( )37 (The most common nonlabora)-10.1 (tor)-18 (y)-19 ( )]TJ
-0.014 Tc 0.063 Tw 0 -1.044 Td
[(\(grea)-9.8 (ter than or equal to 5%\) serious adverse reactions inc)20.1 (luded infections \226 pa)-9.9 (thogen)-14 ( )]TJ
-0.016 Tc 0.06 Tw 0 -1.044 Td
[(unspeci\037ed \(10%\),)37.1 ( pneumonia \(9%\),)37.2 ( viral infections \(8%\),)37.1 ( encephalopa)-9.9 (thy \(6%\),)37.2 ( pyrexia)-16 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(\(6%\) and sepsis \(5%\).)37.2 ( F)20.2 (a)-9.8 (tal adverse reactions occurred in 9%.)]TJ
-0.006 Tc 0.101 Tw 0 -1.764 Td
[(T)74.5 (a)0.5 (b)0.5 (l)0.5 (e)0.5 ( 3)0.5 ( s)0.5 (u)0.5 (m)0.5 (m)0.5 (a)0.5 (r)0.5 (i)0.5 (z)0.5 (e)0.5 (s)0.5 ( t)0.5 (he)0.6 ( ad)0.5 (v)0.5 (e)0.5 (r)0.5 (s)0.5 (e)0.5 ( r)0.5 (e)0.5 (a)0.5 (c)0.5 (t)0.5 (i)0.5 (o)0.5 (n)0.5 (s t)0.5 (h)0.5 (a)-9.5 (t)0.5 ( o)0.5 (c)0.5 (c)0.5 (u)0.5 (r)0.5 (r)0.5 (e)0.5 (d)0.5 ( i)0.5 (n a)-9.4 (t l)0.5 (e)0.5 (a)0.5 (s)0.5 (t)0.5 ( 1)0.5 (0)0.5 (%)0.5 ( o)0.5 (f)0.5 ( p)0.5 (a)-9.5 (t)0.5 (ie)0.6 (nt)0.5 (s)-6 ( )]TJ
-0.005 Tc 0.11 Tw 0 -1.044 Td
[(trea)-10.1 (ted )0.5 (with )37.5 (ABECMA.)36.8 ( )37.5 (T)73.9 (able 4 describes )0.5 (the )0.5 (most )0.5 (common Grade )0.5 (3 )0.5 (or )0.5 (4 )0.5 (labora)-10 (tor)-18.1 (y)-5 ( )]TJ
-0.017 Tc 0.017 Tw 0 -1.044 Td
(abnormalities.)Tj
ET
/GS2 gs
q 1 0 0 1 36 336.8689 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 36 326.117 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 36 315.3651 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 36 304.6132 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 36 283.1093 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 36 272.3574 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 36 261.6055 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 36 250.8536 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 36 218.5978 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 36 186.3421 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 36 167.0902 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 36 137.0864 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 36 126.3344 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 121.5 412.3823 cm
0 0 m
0 20.912 l
S
Q
q 1 0 0 1 163.125 412.3823 cm
0 0 m
0 20.912 l
S
Q
q 1 0 0 1 121.5 390.8785 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 163.125 390.8785 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 121.5 380.1266 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 163.125 380.1266 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 121.5 358.6227 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 163.125 358.6227 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 121.5 337.1189 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 163.125 337.1189 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 121.5 336.8689 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 121.5 326.367 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 163.125 336.8689 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 163.125 326.367 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 121.5 326.117 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 121.5 315.6151 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 163.125 326.117 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 163.125 315.6151 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 121.5 315.3651 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 121.5 304.8632 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 163.125 315.3651 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 163.125 304.8632 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 121.5 304.6132 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 121.5 294.1112 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 163.125 304.6132 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 163.125 294.1112 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 121.5 283.1093 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 121.5 272.6074 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 163.125 283.1093 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 163.125 272.6074 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 121.5 272.3574 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 121.5 261.8555 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 163.125 272.3574 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 163.125 261.8555 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 121.5 261.6055 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 121.5 251.1036 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 163.125 261.6055 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 163.125 251.1036 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 121.5 250.8536 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 121.5 240.3517 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 163.125 250.8536 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 163.125 240.3517 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 121.5 218.8478 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 163.125 218.8478 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 121.5 218.5978 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 121.5 208.0959 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 163.125 218.5978 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 163.125 208.0959 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 121.5 186.5921 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 163.125 186.5921 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 121.5 186.3421 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 121.5 167.3402 cm
0 0 m
0 18.752 l
S
Q
q 1 0 0 1 163.125 186.3421 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 163.125 167.3402 cm
0 0 m
0 18.752 l
S
Q
q 1 0 0 1 121.5 167.0902 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 121.5 148.0883 cm
0 0 m
0 18.752 l
S
Q
q 1 0 0 1 163.125 167.0902 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 163.125 148.0883 cm
0 0 m
0 18.752 l
S
Q
q 1 0 0 1 121.5 137.3364 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 163.125 137.3364 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 121.5 137.0864 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 121.5 126.5844 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 163.125 137.0864 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 163.125 126.5844 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 121.5 126.3344 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 121.5 115.8325 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 163.125 126.3344 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 163.125 115.8325 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 121.5 94.3287 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 163.125 94.3287 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 121.5 72.8249 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 163.125 72.8249 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 36 412.1323 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 121.5 412.1323 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 163.125 412.1323 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 204.75 412.1323 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 246.375 412.1323 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 36 401.3804 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 121.5 401.3804 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 163.125 401.3804 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 36 390.6285 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 121.5 390.6285 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 163.125 390.6285 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 36 379.8766 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 121.5 379.8766 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 163.125 379.8766 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 36 369.1246 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 121.5 369.1246 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 163.125 369.1246 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 36 358.3727 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 121.5 358.3727 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 163.125 358.3727 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 36 347.6208 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 121.5 347.6208 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 163.125 347.6208 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 36 293.8612 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 121.5 293.8612 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 163.125 293.8612 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 36 240.1017 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 121.5 240.1017 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 163.125 240.1017 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 36 229.3498 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 121.5 229.3498 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 163.125 229.3498 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 36 207.8459 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 121.5 207.8459 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 163.125 207.8459 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 36 197.094 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 121.5 197.094 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 163.125 197.094 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 36 147.8383 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 121.5 147.8383 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 163.125 147.8383 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 36 94.0787 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 121.5 94.0787 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 163.125 94.0787 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 36 83.3268 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 121.5 83.3268 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 163.125 83.3268 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 204.75 412.3823 cm
0 0 m
0 20.912 l
S
Q
q 1 0 0 1 246.375 412.3823 cm
0 0 m
0 20.912 l
S
Q
q 1 0 0 1 204.75 401.3804 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 204.75 390.8785 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 246.375 401.3804 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 246.375 390.8785 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 204.75 390.6285 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 204.75 380.1266 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 246.375 390.6285 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 246.375 380.1266 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 204.75 379.8766 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 246.375 379.8766 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 204.75 369.1246 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 204.75 358.6227 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 246.375 369.1246 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 246.375 358.6227 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 204.75 358.3727 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 246.375 358.3727 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 204.75 347.6208 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 204.75 337.1189 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 246.375 347.6208 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 246.375 337.1189 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 204.75 336.8689 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 204.75 326.367 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 246.375 336.8689 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 246.375 326.367 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 204.75 326.117 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 204.75 315.6151 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 246.375 326.117 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 246.375 315.6151 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 204.75 315.3651 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 204.75 304.8632 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 246.375 315.3651 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 246.375 304.8632 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 204.75 304.6132 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 204.75 294.1112 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 246.375 304.6132 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 246.375 294.1112 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 204.75 293.8612 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 246.375 293.8612 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 204.75 283.1093 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 204.75 272.6074 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 246.375 283.1093 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 246.375 272.6074 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 204.75 272.3574 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 204.75 261.8555 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 246.375 272.3574 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 246.375 261.8555 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 204.75 261.6055 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 204.75 251.1036 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 246.375 261.6055 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 246.375 251.1036 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 204.75 250.8536 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 204.75 240.3517 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 246.375 250.8536 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 246.375 240.3517 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 204.75 240.1017 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 246.375 240.1017 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 204.75 229.3498 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 204.75 218.8478 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 246.375 229.3498 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 246.375 218.8478 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 204.75 218.5978 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 204.75 208.0959 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 246.375 218.5978 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 246.375 208.0959 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 204.75 207.8459 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 246.375 207.8459 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 204.75 197.094 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 204.75 186.5921 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 246.375 197.094 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 246.375 186.5921 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 204.75 186.3421 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 204.75 167.3402 cm
0 0 m
0 18.752 l
S
Q
q 1 0 0 1 246.375 186.3421 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 246.375 167.3402 cm
0 0 m
0 18.752 l
S
Q
q 1 0 0 1 204.75 167.0902 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 204.75 148.0883 cm
0 0 m
0 18.752 l
S
Q
q 1 0 0 1 246.375 167.0902 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 246.375 148.0883 cm
0 0 m
0 18.752 l
S
Q
q 1 0 0 1 204.75 147.8383 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 204.75 137.3364 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 246.375 147.8383 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 246.375 137.3364 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 204.75 137.0864 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 204.75 126.5844 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 246.375 137.0864 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 246.375 126.5844 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 204.75 126.3344 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 204.75 115.8325 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 246.375 126.3344 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 246.375 115.8325 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 204.75 94.3287 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 246.375 94.3287 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 204.75 94.0787 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 246.375 94.0787 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 204.75 83.3268 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 204.75 72.8249 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 246.375 83.3268 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 246.375 72.8249 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 36 72.5749 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 121.5 72.5749 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 163.125 72.5749 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 204.75 72.5749 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 246.375 72.5749 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 36 115.5825 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 121.5 115.5825 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 163.125 115.5825 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 204.75 115.5825 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 246.375 115.5825 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 36 104.8306 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 121.5 104.8306 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 163.125 104.8306 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 204.75 104.8306 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 246.375 104.8306 cm
0 0 m
41.625 0 l
S
Q
1 w 
q 1 0 0 1 36 454.9561 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 121.5 454.9561 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 163.125 454.9561 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 204.75 454.9561 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 246.375 454.9561 cm
0 0 m
41.625 0 l
S
Q
0.5 w 
q 1 0 0 1 121.5 433.7942 cm
0 0 m
0 20.662 l
S
Q
q 1 0 0 1 204.75 433.7942 cm
0 0 m
0 20.662 l
S
Q
q 1 0 0 1 121.25 433.5442 cm
0 0 m
41.875 0 l
S
Q
q 1 0 0 1 163.125 433.5442 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 204.75 433.5442 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 246.375 433.5442 cm
0 0 m
41.625 0 l
S
Q
BT
/GS1 gs
/T1_2 1 Tf
0.048 Tw 8 0 0 8 36 467.0562 Tm
[(T)74.2 (able 3:)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
5 0 Td
[(Adverse Reactions Obser)-17.8 (ved in at Least 10% of P)24.2 (atients T)74.2 (reated in)-17 ( )]TJ
0 -1.062 Td
(the KarMMa-3 Study)Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 150.3382 445.6442 Tm
(ABECMA)Tj
0 Tc 0 Tw 7.6 0 0 8 175.9119 445.6442 Tm
( )Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 151.2206 437.1442 Tm
(\(N=222\))Tj
0.048 Tw 8.723 1.062 Td
(Standard Regimens)Tj
0 Tc 0 Tw 7.6 0 0 8 275.4815 445.6442 Tm
( )Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 234.5956 437.1442 Tm
(\(N=126\))Tj
0.048 Tw -14.159 -1.614 Td
[(An)-9.8 (y Grade)]TJ
0 Tc 0 Tw 7.6 0 0 8 157.6392 424.2323 Tm
( )Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 137.1993 415.7323 Tm
(\(%\))Tj
0.048 Tw 3.732 1.062 Td
(Grade 3 or 4)Tj
0 Tc 0 Tw 7.6 0 0 8 202.3132 424.2323 Tm
( )Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 178.8243 415.7323 Tm
(\(%\))Tj
0.048 Tw 4.133 1.062 Td
[(An)-9.8 (y Grade)]TJ
0 Tc 0 Tw 7.6 0 0 8 240.8892 424.2323 Tm
( )Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 220.4493 415.7323 Tm
(\(%\))Tj
0.048 Tw 3.748 1.062 Td
(Grade 3 or 4)Tj
0 Tc 0 Tw 7.6 0 0 8 285.6882 424.2323 Tm
( )Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 262.1993 415.7323 Tm
(\(%\))Tj
0.048 Tw -29.763 -1.479 Td
(Blood and lymphatic system disorders)Tj
/T1_0 1 Tf
/Span<</ActualText<FEFF0009>>> BDC 
0 -1.344 Td
( )Tj
EMC 
0.592 0 Td
[(F)24.2 (ebrile neutropenia)]TJ
0.012 Tw 12.922 0 Td
(51)Tj
5.477 0 Td
(51)Tj
5.477 0 Td
(28)Tj
5.493 0 Td
(28)Tj
0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
-29.962 -1.344 Td
( )Tj
EMC 
[(Coa)-9.7 (gulopa)-9.8 (thy)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 77.884 385.0606 Tm
(a)Tj
7.6 0 0 8 80.246 382.3966 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 7.693 0 Td
(14)Tj
5.363 0 Td
(2.7)Tj
5.477 0 Td
(4.8)Tj
5.493 0 Td
(0.8)Tj
/T1_2 1 Tf
0.048 Tw -29.848 -1.344 Td
(Cardiac disorders)Tj
/T1_0 1 Tf
0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
0 -1.344 Td
( )Tj
EMC 
[(T)74.2 (achycardia)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 73.1814 363.5568 Tm
(b)Tj
7.6 0 0 8 75.6445 360.8928 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 8.298 0 Td
(32)Tj
0 Tc 0 Tw 5.711 0 Td
(0)Tj
-0.012 Tc 0.012 Tw 5.243 0 Td
(21)Tj
0 Tc 0 Tw 5.727 0 Td
(0)Tj
/T1_2 1 Tf
-0.012 Tc 0.048 Tw -30.196 -1.344 Td
(Gastrointestinal disorders)Tj
/T1_0 1 Tf
0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
0 -1.344 Td
( )Tj
EMC 
(Diarrhea)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 63.8988 342.0529 Tm
(c)Tj
7.6 0 0 8 66.1651 339.3889 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 9.546 0 Td
(31)Tj
5.363 0 Td
(2.3)Tj
5.591 0 Td
(35)Tj
5.38 0 Td
(3.2)Tj
0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
-29.848 -1.344 Td
( )Tj
EMC 
(Nausea)Tj
0.012 Tw 13.515 0 Td
(27)Tj
5.363 0 Td
(0.9)Tj
5.591 0 Td
(48)Tj
0 Tc 0 Tw 5.727 0 Td
(0)Tj
-0.012 Tc 0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
-30.196 -1.344 Td
( )Tj
EMC 
[(Constipa)-9.8 (tion)]TJ
0.012 Tw 13.515 0 Td
(17)Tj
0 Tc 0 Tw 5.711 0 Td
(0)Tj
-0.012 Tc 0.012 Tw 5.243 0 Td
(15)Tj
0 Tc 0 Tw 5.727 0 Td
(0)Tj
-0.012 Tc 0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
-30.196 -1.344 Td
( )Tj
EMC 
[(V)18.2 (omiting)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 64.3245 309.7972 Tm
(d)Tj
7.6 0 0 8 66.7876 307.1332 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 9.464 0 Td
(14)Tj
0 Tc 0 Tw 5.711 0 Td
(0)Tj
-0.012 Tc 0.012 Tw 5.243 0 Td
(17)Tj
0 Tc 0 Tw 5.727 0 Td
(0)Tj
-0.012 Tc 0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
-30.196 -1.344 Td
( )Tj
EMC 
0.592 0 Td
(Abdominal pain)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 83.2694 299.0453 Tm
(e)Tj
7.6 0 0 8 85.6314 296.3813 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 6.984 0 Td
(10)Tj
5.363 0 Td
(0.5)Tj
5.591 0 Td
(14)Tj
0 Tc 0 Tw 5.727 0 Td
(0)Tj
/T1_2 1 Tf
-0.012 Tc 0.048 Tw -30.196 -1.344 Td
(General disorders and administration site conditions)Tj
/T1_0 1 Tf
0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
0 -1.344 Td
( )Tj
EMC 
(Pyrexia)Tj
0.012 Tw 13.515 0 Td
(91)Tj
0 Tc 0 Tw 5.711 0 Td
(9)Tj
-0.012 Tc 0.012 Tw 5.243 0 Td
(53)Tj
0 Tc 0 Tw 5.727 0 Td
(6)Tj
-0.012 Tc 0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
-30.196 -1.344 Td
( )Tj
EMC 
[(F)20.2 (a)-9.8 (tigue)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 60.678 266.7896 Tm
(f)Tj
7.6 0 0 8 62.0558 264.1255 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 10.086 0 Td
(33)Tj
5.363 0 Td
(1.4)Tj
5.591 0 Td
(48)Tj
0 Tc 0 Tw 5.727 0 Td
(4)Tj
-0.012 Tc 0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
-30.196 -1.344 Td
( )Tj
EMC 
(Edema)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 59.5335 256.0376 Tm
(g)Tj
7.6 0 0 8 61.9967 253.3736 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 10.094 0 Td
(20)Tj
5.363 0 Td
(0.5)Tj
5.591 0 Td
(28)Tj
5.38 0 Td
(2.4)Tj
0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
-29.848 -1.344 Td
( )Tj
EMC 
(Chills)Tj
0.012 Tw 13.515 0 Td
(19)Tj
5.363 0 Td
(0.5)Tj
5.591 0 Td
(13)Tj
0 Tc 0 Tw 5.727 0 Td
(0)Tj
/T1_2 1 Tf
-0.012 Tc 0.048 Tw -30.196 -1.344 Td
(Immune system disorders)Tj
/T1_0 1 Tf
/Span<</ActualText<FEFF0009>>> BDC 
0 -1.344 Td
( )Tj
EMC 
0.592 0 Td
(Cytokine release syndrome)Tj
0.012 Tw 12.922 0 Td
(91)Tj
5.363 0 Td
(4.1)Tj
5.591 0 Td
(40)Tj
5.38 0 Td
(0.8)Tj
0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
-29.848 -1.344 Td
( )Tj
EMC 
[(Hypogamma)-9.8 (globulinemia)]TJ
0.012 Tw 13.515 0 Td
(48)Tj
5.363 0 Td
(0.9)Tj
5.591 0 Td
(25)Tj
0 Tc 0 Tw 5.727 0 Td
(0)Tj
/T1_2 1 Tf
-0.012 Tc 0.048 Tw -30.196 -1.344 Td
(Infections and infestations)Tj
/T1_0 1 Tf
/Span<</ActualText<FEFF0009>>> BDC 
0 -1.344 Td
( )Tj
EMC 
0.592 0 Td
[(An)-9.8 (y infection)]TJ
0.012 Tw 12.922 0 Td
(56)Tj
5.477 0 Td
(16)Tj
5.477 0 Td
(64)Tj
5.493 0 Td
(18)Tj
0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
-29.962 -1.344 Td
( )Tj
EMC 
0.592 0 Td
[(Infections \226 P)18.2 (a)-9.8 (thogen)-12 ( )]TJ
0 Tc 0 Tw 7.6 0 0 8 102.2226 178.1102 Tm
( )Tj
-0.012 Tc 0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
7.6 0 0 8 36 169.6102 Tm
( )Tj
EMC 
(unspecified)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 71.9274 172.2742 Tm
(h)Tj
7.6 0 0 8 74.3906 169.6102 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 8.463 0.531 Td
(35)Tj
0 Tc 0 Tw 5.711 0 Td
(9)Tj
-0.012 Tc 0.012 Tw 5.243 0 Td
(40)Tj
5.493 0 Td
(11)Tj
0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
-29.962 -1.875 Td
( )Tj
EMC 
0.592 0 Td
[(Upper respira)-9.8 (tor)-17.8 (y tract)-12 ( )]TJ
0 Tc 0 Tw 7.6 0 0 8 104.5447 158.8583 Tm
( )Tj
-0.012 Tc 0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
7.6 0 0 8 36 150.3583 Tm
( )Tj
EMC 
(infection)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 63.9504 153.0223 Tm
(i)Tj
7.6 0 0 8 65.0357 150.3583 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 9.694 0.531 Td
(19)Tj
5.363 0 Td
(1.8)Tj
5.591 0 Td
(17)Tj
5.38 0 Td
(0.8)Tj
0.011 Tw /Span<</ActualText<FEFF0009>>> BDC 
-29.848 -1.875 Td
( )Tj
EMC 
0.592 0 Td
[(Infections )-36.8 (\226 Viral)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 86.3411 142.2704 Tm
(h)Tj
7.6 0 0 8 88.8042 139.6064 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 6.567 0 Td
(18)Tj
0 Tc 0 Tw 5.711 0 Td
(5)Tj
-0.012 Tc 0.012 Tw 5.243 0 Td
(28)Tj
0 Tc 0 Tw 5.727 0 Td
(6)Tj
-0.012 Tc 0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
-30.196 -1.344 Td
( )Tj
EMC 
0.592 0 Td
(Infections \226 Bacterial)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 98.639 131.5185 Tm
(h)Tj
7.6 0 0 8 101.1021 128.8545 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 4.949 0 Td
(15)Tj
5.363 0 Td
(4.5)Tj
5.591 0 Td
(19)Tj
0 Tc 0 Tw 5.727 0 Td
(8)Tj
-0.012 Tc 0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
-30.196 -1.344 Td
( )Tj
EMC 
(Pneumonia)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 71.2616 120.7666 Tm
(j)Tj
7.6 0 0 8 72.3468 118.1026 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 8.732 0 Td
(13)Tj
0 Tc 0 Tw 5.711 0 Td
(8)Tj
-0.012 Tc 0.012 Tw 5.243 0 Td
(13)Tj
5.493 0 Td
(11)Tj
/T1_2 1 Tf
0.048 Tw -29.962 -1.344 Td
(Metabolism and nutrition disorders)Tj
/T1_0 1 Tf
/Span<</ActualText<FEFF0009>>> BDC 
0 -1.344 Td
( )Tj
EMC 
0.592 0 Td
[(Decreased a)-9.8 (ppetite)]TJ
0.012 Tw 12.922 0 Td
(17)Tj
5.363 0 Td
(1.8)Tj
5.591 0 Td
(21)Tj
0 Tc 0 Tw 5.727 0 Td
(0)Tj
/T1_2 1 Tf
-0.012 Tc 0.048 Tw -30.196 -1.344 Td
(Musculoskeletal and connective tissue disorders)Tj
/T1_0 1 Tf
/Span<</ActualText<FEFF0009>>> BDC 
0 -1.344 Td
( )Tj
EMC 
0.592 0 Td
(Musculoskeletal pain)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 98.323 77.7589 Tm
(k)Tj
7.6 0 0 8 100.685 75.0949 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 5.003 0 Td
(36)Tj
5.363 0 Td
(1.8)Tj
5.591 0 Td
(49)Tj
0 Tc 0 Tw 5.727 0 Td
(8)Tj
/T1_1 1 Tf
8 0 0 8 253.8843 64.0962 Tm
(\()Tj
-0.017 Tc 0.017 Tw 0.224 0 Td
(Continued\))Tj
ET
/GS2 gs
q 1 0 0 1 324 629.0665 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 324 564.5551 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 324 543.0513 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 324 661.3223 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 324 639.8185 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 324 510.7955 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 409.5 672.5742 cm
0 0 m
0 20.912 l
S
Q
q 1 0 0 1 451.125 672.5742 cm
0 0 m
0 20.912 l
S
Q
q 1 0 0 1 409.5 661.3223 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 409.5 650.8204 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 451.125 661.3223 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 451.125 650.8204 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 409.5 640.0685 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 451.125 640.0685 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 409.5 639.8185 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 409.5 629.3165 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 451.125 639.8185 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 451.125 629.3165 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 409.5 629.0665 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 409.5 618.5646 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 451.125 629.0665 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 451.125 618.5646 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 409.5 597.0608 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 451.125 597.0608 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 409.5 575.557 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 451.125 575.557 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 409.5 564.5551 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 409.5 554.0532 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 451.125 564.5551 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 451.125 554.0532 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 409.5 543.3013 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 451.125 543.3013 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 409.5 543.0513 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 409.5 532.5493 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 451.125 543.0513 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 451.125 532.5493 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 409.5 511.0455 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 451.125 511.0455 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 409.5 510.7955 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 409.5 500.2936 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 451.125 510.7955 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 451.125 500.2936 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 409.5 479.0398 cm
0 0 m
0 10.002 l
S
Q
q 1 0 0 1 451.125 479.0398 cm
0 0 m
0 10.002 l
S
Q
q 1 0 0 1 324 672.3242 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 409.5 672.3242 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 451.125 672.3242 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 492.75 672.3242 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 534.375 672.3242 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 324 650.5704 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 409.5 650.5704 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 451.125 650.5704 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 324 618.3146 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 409.5 618.3146 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 451.125 618.3146 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 324 607.5627 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 409.5 607.5627 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 451.125 607.5627 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 324 596.8108 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 409.5 596.8108 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 451.125 596.8108 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 324 586.0589 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 409.5 586.0589 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 451.125 586.0589 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 324 575.307 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 409.5 575.307 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 451.125 575.307 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 324 553.8032 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 409.5 553.8032 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 451.125 553.8032 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 324 500.0436 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 409.5 500.0436 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 451.125 500.0436 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 324 489.2917 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 409.5 489.2917 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 451.125 489.2917 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 324 532.2993 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 409.5 532.2993 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 451.125 532.2993 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 324 521.5474 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 409.5 521.5474 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 451.125 521.5474 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 492.75 672.5742 cm
0 0 m
0 20.912 l
S
Q
q 1 0 0 1 534.375 672.5742 cm
0 0 m
0 20.912 l
S
Q
q 1 0 0 1 492.75 661.3223 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 492.75 650.8204 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 534.375 661.3223 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 534.375 650.8204 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 492.75 650.5704 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 492.75 640.0685 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 534.375 650.5704 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 534.375 640.0685 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 492.75 639.8185 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 492.75 629.3165 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 534.375 639.8185 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 534.375 629.3165 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 492.75 629.0665 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 492.75 618.5646 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 534.375 629.0665 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 534.375 618.5646 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 492.75 618.3146 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 534.375 618.3146 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 492.75 607.5627 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 492.75 597.0608 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 534.375 607.5627 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 534.375 597.0608 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 492.75 596.8108 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 534.375 596.8108 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 492.75 586.0589 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 492.75 575.557 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 534.375 586.0589 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 534.375 575.557 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 492.75 575.307 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 534.375 575.307 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 492.75 564.5551 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 492.75 554.0532 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 534.375 564.5551 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 534.375 554.0532 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 492.75 553.8032 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 492.75 543.3013 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 534.375 553.8032 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 534.375 543.3013 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 492.75 543.0513 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 492.75 532.5493 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 534.375 543.0513 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 534.375 532.5493 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 492.75 532.2993 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 534.375 532.2993 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 492.75 521.5474 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 492.75 511.0455 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 534.375 521.5474 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 534.375 511.0455 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 492.75 510.7955 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 492.75 500.2936 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 534.375 510.7955 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 534.375 500.2936 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 492.75 500.0436 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 534.375 500.0436 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 492.75 489.2917 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 492.75 479.0398 cm
0 0 m
0 10.002 l
S
Q
q 1 0 0 1 534.375 489.2917 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 534.375 479.0398 cm
0 0 m
0 10.002 l
S
Q
1 w 
q 1 0 0 1 324 478.5398 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 409.5 478.5398 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 451.125 478.5398 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 492.75 478.5398 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 534.375 478.5398 cm
0 0 m
41.625 0 l
S
Q
0.5 w 
q 1 0 0 1 324 40.6279 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 409.5 40.6279 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 451.125 40.6279 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 492.75 40.6279 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 534.375 40.6279 cm
0 0 m
41.625 0 l
S
Q
1 w 
q 1 0 0 1 324 715.1481 cm
0 0 m
85.5 0 l
S
Q
q 1 0 0 1 409.5 715.1481 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 451.125 715.1481 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 492.75 715.1481 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 534.375 715.1481 cm
0 0 m
41.625 0 l
S
Q
0.5 w 
q 1 0 0 1 409.5 693.9861 cm
0 0 m
0 20.662 l
S
Q
q 1 0 0 1 492.75 693.9861 cm
0 0 m
0 20.662 l
S
Q
q 1 0 0 1 409.25 693.7361 cm
0 0 m
41.875 0 l
S
Q
q 1 0 0 1 451.125 693.7361 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 492.75 693.7361 cm
0 0 m
41.625 0 l
S
Q
q 1 0 0 1 534.375 693.7361 cm
0 0 m
41.625 0 l
S
Q
BT
/GS1 gs
/T1_2 1 Tf
0.048 Tw 8 0 0 8 324 727.248 Tm
[(T)74.2 (able 3:)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
5 0 Td
[(Adverse Reactions Obser)-17.8 (ved in at Least 10% of P)24.2 (atients T)74.2 (reated in)-17 ( )]TJ
0 -1.062 Td
(the KarMMa-3 Study)Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 438.3381 705.8361 Tm
(ABECMA)Tj
0 Tc 0 Tw 7.6 0 0 8 463.9119 705.8361 Tm
( )Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 439.2206 697.3361 Tm
(\(N=222\))Tj
0.048 Tw 8.723 1.062 Td
(Standard Regimens)Tj
0 Tc 0 Tw 7.6 0 0 8 563.4815 705.8361 Tm
( )Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 522.5956 697.3361 Tm
(\(N=126\))Tj
0.048 Tw -14.159 -1.614 Td
[(An)-9.8 (y Grade)]TJ
0 Tc 0 Tw 7.6 0 0 8 445.6392 684.4242 Tm
( )Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 425.1993 675.9242 Tm
(\(%\))Tj
0.048 Tw 3.732 1.062 Td
(Grade 3 or 4)Tj
0 Tc 0 Tw 7.6 0 0 8 490.3132 684.4242 Tm
( )Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 466.8243 675.9242 Tm
(\(%\))Tj
0.048 Tw 4.133 1.062 Td
[(An)-9.8 (y Grade)]TJ
0 Tc 0 Tw 7.6 0 0 8 528.8892 684.4242 Tm
( )Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 508.4493 675.9242 Tm
(\(%\))Tj
0.048 Tw 3.748 1.062 Td
(Grade 3 or 4)Tj
0 Tc 0 Tw 7.6 0 0 8 573.6882 684.4242 Tm
( )Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 550.1993 675.9242 Tm
(\(%\))Tj
0.048 Tw -29.763 -1.51 Td
[(Ner)-17.7 (vous system disorders)]TJ
/T1_0 1 Tf
0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
0 -1.344 Td
( )Tj
EMC 
(Headache)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 355.8355 655.7544 Tm
(l)Tj
7.6 0 0 8 356.9208 653.0904 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 9.183 0 Td
(24)Tj
0 Tc 0 Tw 5.711 0 Td
(0)Tj
-0.012 Tc 0.012 Tw 5.243 0 Td
(29)Tj
5.38 0 Td
(1.6)Tj
0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
-29.848 -1.344 Td
( )Tj
EMC 
[(Encephalopa)-9.7 (thy)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 371.9533 645.0025 Tm
(m)Tj
7.6 0 0 8 375.7943 642.3385 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 6.7 0 Td
(22)Tj
5.363 0 Td
(3.6)Tj
5.591 0 Td
(21)Tj
5.38 0 Td
(4.8)Tj
0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
-29.848 -1.344 Td
( )Tj
EMC 
(Dizziness)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 354.2079 634.2505 Tm
(n)Tj
7.6 0 0 8 356.671 631.5865 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 9.216 0 Td
(14)Tj
5.363 0 Td
(1.8)Tj
5.591 0 Td
(18)Tj
5.38 0 Td
(3.2)Tj
0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
-29.848 -1.344 Td
( )Tj
EMC 
[(Neuropa)-9.8 (thy)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 360.0808 623.4987 Tm
(o)Tj
7.6 0 0 8 362.4428 620.8347 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 8.456 0 Td
(10)Tj
0 Tc 0 Tw 5.711 0 Td
(0)Tj
-0.012 Tc 0.012 Tw 5.243 0 Td
(21)Tj
5.38 0 Td
(0.8)Tj
/T1_2 1 Tf
0.048 Tw -29.848 -1.344 Td
(Psychiatric disorders)Tj
/T1_0 1 Tf
/Span<</ActualText<FEFF0009>>> BDC 
0 -1.344 Td
( )Tj
EMC 
0.592 0 Td
(Sleep disorder)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 368.1609 601.9948 Tm
(p)Tj
7.6 0 0 8 370.6241 599.3308 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 7.38 0 Td
(11)Tj
0 Tc 0 Tw 5.711 0 Td
(0)Tj
-0.012 Tc 0.012 Tw 5.243 0 Td
(22)Tj
5.38 0 Td
(2.4)Tj
/T1_2 1 Tf
0.048 Tw -29.848 -1.344 Td
[(Renal and urinar)-17.8 (y disorders)]TJ
/T1_0 1 Tf
/Span<</ActualText<FEFF0009>>> BDC 
0 -1.344 Td
( )Tj
EMC 
0.592 0 Td
(Renal failure)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 363.0552 580.491 Tm
(q)Tj
7.6 0 0 8 365.5184 577.827 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 8.052 0 Td
(13)Tj
0 Tc 0 Tw 5.711 0 Td
(5)Tj
-0.012 Tc 0.012 Tw 5.243 0 Td
(15)Tj
0 Tc 0 Tw 5.727 0 Td
(4)Tj
/T1_2 1 Tf
-0.012 Tc 0.048 Tw -30.196 -1.344 Td
[(Respirator)-17.7 (y)55.2 (,)37.2 ( thoracic,)37.2 ( and mediastinal disorders)]TJ
/T1_0 1 Tf
0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
0 -1.344 Td
( )Tj
EMC 
(Dyspnea)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 352.2653 558.9872 Tm
(r)Tj
7.6 0 0 8 353.84 556.3232 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 9.588 0 Td
(21)Tj
5.363 0 Td
(1.8)Tj
5.591 0 Td
(31)Tj
5.38 0 Td
(2.4)Tj
0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
-29.848 -1.344 Td
( )Tj
EMC 
(Cough)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 346.1353 548.2352 Tm
(s)Tj
7.6 0 0 8 348.3005 545.5712 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 10.317 0 Td
(14)Tj
0 Tc 0 Tw 5.711 0 Td
(0)Tj
-0.012 Tc 0.012 Tw 5.243 0 Td
(21)Tj
0 Tc 0 Tw 5.727 0 Td
(0)Tj
-0.012 Tc 0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
-30.196 -1.344 Td
( )Tj
EMC 
(Hypoxia)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 350.1448 537.4833 Tm
(t)Tj
7.6 0 0 8 351.5226 534.8193 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 9.893 0 Td
(18)Tj
0 Tc 0 Tw 5.711 0 Td
(6)Tj
5.477 0 Td
(8)Tj
-0.012 Tc 0.012 Tw 5.146 0 Td
(1.6)Tj
/T1_2 1 Tf
0.048 Tw -29.848 -1.344 Td
[(V)18.2 (ascular disorders)]TJ
/T1_0 1 Tf
0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
0 -1.344 Td
( )Tj
EMC 
(Hypotension)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 362.1617 515.9795 Tm
(u)Tj
7.6 0 0 8 364.6248 513.3155 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 8.169 0 Td
(36)Tj
5.363 0 Td
(2.3)Tj
5.591 0 Td
(19)Tj
5.38 0 Td
(1.6)Tj
0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
-29.848 -1.344 Td
( )Tj
EMC 
(Hypertension)Tj
0.012 Tw 13.515 0 Td
(14)Tj
0 Tc 0 Tw 5.711 0 Td
(7)Tj
-0.012 Tc 0.012 Tw 5.243 0 Td
(21)Tj
5.493 0 Td
(11)Tj
/T1_2 1 Tf
0.048 Tw -29.962 -1.344 Td
(Skin disorders)Tj
/T1_0 1 Tf
0.364 Tw /Span<</ActualText<FEFF0009>>> BDC 
0 -1.344 Td
( )Tj
EMC 
(Rash)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 342.2837 483.7238 Tm
(v)Tj
7.6 0 0 8 344.4435 481.0598 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 10.825 0 Td
(10)Tj
0 Tc 0 Tw 5.711 0 Td
(0)Tj
-0.012 Tc 0.012 Tw 5.243 0 Td
(19)Tj
5.38 0 Td
(0.8)Tj
0.048 Tw -29.848 -1.479 Td
[(CAR=chimeric antigen receptor)74.3 (.)]TJ
0.012 Tw 5.32 0 0 5.6 324 463.3918 Tm
(a)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.007 Tc 0.077 Tw 7.6 0 0 8 329 460.7278 Tm
[(Coa)-10.4 (gulopa)-10.4 (thy inc)19.6 (ludes activa)-10.4 (ted partial thromboplastin time prolonged,)36.6 ( blood fibrinogen)-7 ( )]TJ
0 Tc 0.106 Tw 0 -1.062 Td
[(de)0.5 (cre)0.5 (as)0.5 (ed,)37.5 ( coa)-9.5 (gul)0.5 (opa)-9.5 (th)0.5 (y)55.4 (,)37.4 ( di)0.5 (sse)0.5 (mi)0.5 (na)-9.6 (t)0.5 (ed)0.5 ( i)0.5 (ntr)0.5 (a)-9.6 (v)0.5 (as)0.5 (cul)0.5 (ar co)0.5 (a)-9.6 (g)0.5 (ula)-9.5 (ti)0.5 (on,)37.5 ( h)0.5 (yp)0.5 (ofi)0.5 (bri)0.5 (nog)0.5 (ene)0.5 (mi)0.5 (a,)37 ( )]TJ
-0.012 Tc 0.048 Tw 0 -1.062 Td
[(interna)-9.8 (tional normalized ra)-9.8 (tio increased,)37.2 ( prothrombin time prolonged.)]TJ
0.012 Tw 5.32 0 0 5.6 324 437.8918 Tm
(b)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 329 435.2278 Tm
[(T)74.2 (achycardia inc)20.2 (ludes heart ra)-9.8 (te increased,)37.2 ( sinus tachycardia,)37.2 ( tachycardia.)]TJ
0.012 Tw 5.32 0 0 5.6 324 429.3918 Tm
(c)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 329 426.7278 Tm
[(Diarrhea inc)20.2 (ludes colitis,)37.2 ( colitis microscopic,)37.2 ( diarrhea,)37.2 ( enterocolitis.)]TJ
0.012 Tw 5.32 0 0 5.6 324 420.8918 Tm
(d)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 329 418.2278 Tm
[(V)18.2 (omiting inc)20.2 (ludes retching,)37.2 ( vomiting.)]TJ
0.012 Tw 5.32 0 0 5.6 324 412.3918 Tm
(e)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.003 Tc 0.094 Tw 7.6 0 0 8 329 409.7278 Tm
[(Abdominal pain inc)20 (ludes abdominal discomfort,)37 ( abdominal pain,)37 ( abdominal pain lo)-10 (wer)74 (,)33.9 ( )]TJ
-0.012 Tc 0.048 Tw 0 -1.062 Td
[(abdominal pain upper)74.2 (,)37.2 ( d)-9.8 (yspepsia.)]TJ
0.012 Tw 5.32 0 0 5.6 324 395.3918 Tm
(f)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 329 392.7278 Tm
[(F)20.2 (a)-9.8 (tigue inc)20.2 (ludes asthenia,)37.2 ( fa)-9.7 (tigue,)37.2 ( malaise,)37.2 ( musc)20.2 (le fa)-9.7 (tigue.)]TJ
0.012 Tw 5.32 0 0 5.6 324 386.8918 Tm
(g)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.009 Tc 0.151 Tw 7.6 0 0 8 329 384.2278 Tm
[(E)0.5 (de)0.5 (ma)0.5 ( in)0.5 (c)20.4 (l)0.5 (ud)0.5 (e)0.5 (s e)0.5 (d)0.5 (em)0.5 (a)0.5 (,)37.4 ( ed)0.5 (e)0.5 (ma)0.5 ( p)0.5 (er)0.5 (i)0.5 (ph)0.5 (e)0.5 (ra)0.5 (l)0.5 (,)37.4 ( g)0.5 (e)0.5 (ne)0.5 (r)0.5 (al)0.5 (iz)0.5 (e)0.5 (d ed)0.5 (e)0.5 (ma)0.5 (,)37.4 ( pe)0.5 (r)0.5 (ip)0.5 (he)0.5 (r)0.5 (al)0.5 ( s)-9.5 (w)0.5 (el)0.5 (li)0.5 (n)0.5 (g,)46 ( )]TJ
-0.014 Tc 0.036 Tw 0 -1.062 Td
[(s)-10.2 (welling,)36.8 ( eyelid edema,)36.8 ( face edema,)36.7 ( fluid retention,)36.8 ( hyper)-18.2 (volemia,)36.8 ( localized edema,)36.7 ( mouth)-14 ( )]TJ
-0.012 Tc 0.048 Tw 0 -1.062 Td
[(s)-9.8 (welling,)37.2 ( periorbital edema,)37.2 ( periorbital s)-9.8 (welling,)37.2 ( s)-9.8 (welling face.)]TJ
0.012 Tw 5.32 0 0 5.6 324 361.3918 Tm
(h)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.06 Tw 7.6 0 0 8 329 358.7278 Tm
[(Infections and infesta)-10.3 (tions System Organ Class )36.6 (Adverse Events are grouped by high level)-12 ( )]TJ
0.048 Tw 0 -1.062 Td
[(grouped term \(HLGT\) pa)-9.8 (thogen type.)25 ( )]TJ
0.012 Tw 5.32 0 0 5.6 324 344.3918 Tm
(i)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.047 Tw 7.6 0 0 8 329 341.7278 Tm
[(Upper respira)-9.8 (tor)-17.8 (y tract infection inc)20.2 (ludes acute sinusitis,)37.2 ( epiglottitis,)37.2 ( HCoV)18.2 (-OC43 infection,)25 ( )]TJ
0.019 Tc 0.206 Tw 0 -1.062 Td
[(nasophar)-18.2 (yngitis,)36.7 ( phar)-18.3 (yngeal inflamma)-10.2 (tion,)36.7 ( phar)-18.2 (yngitis,)36.7 ( phar)-18.3 (yngitis streptococcal,)56 ( )]TJ
-0.012 Tc 0.06 Tw 0 -1.062 Td
[(respira)-9.9 (tor)-17.9 (y tract infection,)37 ( respira)-9.9 (tor)-17.9 (y tract infection bacterial,)37.1 ( rhinitis,)37 ( rhinovirus infection,)25 ( )]TJ
0.048 Tw 0 -1.062 Td
[(sinusitis,)37.2 ( upper respira)-9.8 (tor)-17.8 (y tract infection,)37.2 ( viral upper respira)-9.7 (tor)-17.8 (y tract infection.)]TJ
0.012 Tw 5.32 0 0 5.6 324 310.3918 Tm
(j)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.006 Tc 0.076 Tw 7.6 0 0 8 329 307.7278 Tm
[(P)0.5 (ne)0.5 (u)0.5 (mo)0.5 (n)0.5 (ia)0.5 ( i)0.5 (n)0.5 (c)20.4 (l)0.5 (ud)0.5 (e)0.5 (s br)0.5 (o)0.5 (nc)0.5 (h)0.5 (op)0.5 (u)0.5 (lm)0.5 (o)0.5 (na)0.5 (r)-17.5 (y as)0.5 (p)0.5 (er)0.5 (g)0.5 (il)0.5 (lo)0.5 (s)0.5 (i)0.5 (s,)37.5 ( c)0.5 (or)0.5 (o)0.5 (na)-9.5 (v)0.5 (ir)0.5 (u)0.5 (s pn)0.5 (e)0.5 (um)0.5 (o)0.5 (ni)0.5 (a)0.5 (,)37.4 ( CO)0.5 (VI)0.5 (D)0.5 (-1)0.5 (9)-6 ( )]TJ
0.003 Tc 0.121 Tw 0 -1.062 Td
[(p)0.5 (n)0.5 (e)0.5 (u)0.5 (m)0.5 (o)0.5 (n)0.5 (ia)0.5 (,)37.5 ( o)0.5 (r)0.5 (g)0.5 (a)0.5 (n)0.5 (i)0.5 (z)0.5 (i)0.5 (n)0.5 (g)0.5 ( p)0.5 (ne)0.5 (u)0.5 (m)0.5 (o)0.5 (n)0.5 (i)0.5 (a)0.5 (,)37.5 ( p)0.5 (n)0.5 (e)0.5 (u)0.5 (m)0.5 (o)0.5 (n)0.5 (i)0.5 (a)0.5 (,)37.4 ( p)0.5 (n)0.5 (e)0.5 (u)0.5 (m)0.5 (o)0.5 (n)0.5 (i)0.5 (a)0.5 ( a)0.5 (c)0.5 (i)0.5 (n)0.5 (et)0.6 (o)0.5 (ba)0.5 (c)0.5 (t)0.5 (e)0.6 (r)74.4 (,)37.5 ( p)0.5 (n)0.5 (e)0.5 (u)0.5 (m)0.5 (o)0.5 (n)0.5 (i)0.5 (a)3 ( )]TJ
-0.001 Tc 0.104 Tw 0 -1.062 Td
[(adenoviral,)37.1 ( pneumonia aspira)-9.9 (tion,)37 ( )0.5 (pneumonia )0.5 (bacterial,)37.1 ( pneumonia fungal,)37 ( )0.5 (pneumonia)-1 ( )]TJ
-0.015 Tc 0.036 Tw 0 -1.062 Td
[(in)0.5 (flue)0.5 (nza)0.5 (s,)37.4 ( p)0.5 (neu)0.5 (mon)0.5 (ia )0.5 (legi)0.5 (one)0.5 (lla)0.5 (,)37.4 ( p)0.5 (neum)0.5 (oni)0.5 (a p)0.5 (ara)0.5 (inf)0.5 (luen)0.5 (za )0.5 (vira)0.5 (l,)37.4 ( )0.5 (pne)0.5 (umo)0.5 (nia)0.5 ( pse)0.5 (udo)0.5 (mon)0.5 (al,)22 ( )]TJ
-0.012 Tc 0.048 Tw 0 -1.062 Td
[(pneumonia streptococcal,)37.2 ( pneumonia viral,)37.2 ( pulmonar)-17.8 (y nocardiosis.)]TJ
0.012 Tw 5.32 0 0 5.6 324 267.8918 Tm
(k)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0 Tc 0.11 Tw 7.6 0 0 8 329 265.2278 Tm
[(Musculoskeletal pain inc)19.8 (ludes arthralgia,)36.9 ( back pain,)36.8 ( bone pain,)36.8 ( joint stiffness,)36.9 ( musc)19.8 (le )]TJ
0.001 Tc 0.116 Tw 0 -1.062 Td
[(strain,)36.6 ( musculoskeletal chest pain,)36.6 ( musculoskeletal discomfort,)36.7 ( musculoskeletal pain,)38 ( )]TJ
-0.012 Tc 0.048 Tw 0 -1.062 Td
[(musculoskeletal stiffness,)37.2 ( my)-9.7 (algia,)37.2 ( neck pain,)37.2 ( non-cardiac chest pain.)25 ( )]TJ
0.012 Tw 5.32 0 0 5.6 324 242.3918 Tm
(l)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 329 239.7278 Tm
[(Headache inc)20.2 (ludes headache,)37.2 ( head discomfort.)]TJ
0.012 Tw 5.32 0 0 5.6 324 233.8918 Tm
(m)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.006 Tc 0.078 Tw 7.6 0 0 8 329 231.2278 Tm
[(Encephalopa)-9.8 (thy inc)20.1 (ludes amnesia,)37.2 ( cognitive disorder)74.2 (,)37.1 ( confusional sta)-9.8 (te,)37.2 ( depressed level)-6 ( )]TJ
-0.009 Tc 0.063 Tw 0 -1.062 Td
[(of )0.6 (consciousness,)37.2 ( )0.6 (disturbance )0.6 (in )0.5 (a)-9.7 (ttention,)37.3 ( )0.5 (d)-9.7 (ysgra)-9.7 (phia,)37.3 ( )0.5 (encephalopa)-9.8 (thy)55.3 (,)37.3 ( )0.5 (Immune )0.5 (effector)-9 ( )]TJ
0.061 Tw 0 -1.062 Td
[(c)0.5 (e)0.6 (l)0.6 (l)0.5 (-)0.5 (a)0.6 (s)0.5 (s)0.6 (o)0.5 (c)0.6 (i)0.5 (a)-9.4 (t)0.6 (e)0.5 (d)0.5 ( n)0.6 (e)0.5 (u)0.6 (r)0.5 (o)0.6 (t)0.5 (o)0.6 (x)0.5 (i)0.6 (c)0.5 (i)0.6 (t)0.5 (y)0.6 ( s)0.6 (y)0.5 (n)0.6 (d)0.5 (r)0.6 (o)0.5 (m)0.6 (e)0.5 ( i)0.6 (n)0.5 (c)0.5 (o)0.6 (h)0.5 (e)0.6 (r)0.6 (e)0.5 (n)0.6 (t)0.5 (,)37.5 ( l)0.6 (e)0.5 (t)0.6 (h)0.5 (a)0.6 (r)0.5 (g)-9.4 (y)55.5 (,)37.5 ( m)0.6 (e)0.5 (m)0.6 (o)0.5 (r)-17.4 (y)0.5 ( i)0.6 (m)0.5 (p)0.6 (a)0.5 (i)0.6 (r)0.5 (m)0.6 (e)0.5 (n)0.6 (t)0.5 (,)37.6 ( m)0.6 (e)0.6 (n)0.5 (t)0.6 (a)0.5 (l)-9 ( )]TJ
-0.012 Tc 0.048 Tw 0 -1.062 Td
[(sta)-9.7 (tus changes,)37.2 ( metabolic encephalopa)-9.8 (thy)55.2 (,)37.3 ( somnolence,)37.3 ( stupor)74.2 (,)37.3 ( toxic encephalopa)-9.7 (thy)55.2 (.)]TJ
0.012 Tw 5.32 0 0 5.6 324 199.8918 Tm
(n)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.005 Tc 0.083 Tw 7.6 0 0 8 329 197.2278 Tm
[(Dizziness inc)20.1 (ludes dizziness,)37.1 ( presyncope,)37.1 ( syncope,)37.2 ( vertigo,)37.2 ( vertigo positional,)37.1 ( vestibular)-5 ( )]TJ
-0.012 Tc 0.012 Tw 0 -1.062 Td
[(disorder)74.2 (.)]TJ
5.32 0 0 5.6 324 182.8918 Tm
(o)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.005 Tc 0.083 Tw 7.6 0 0 8 329 180.2278 Tm
[(Neuropa)-9.7 (thy )0.5 (inc)20.2 (ludes carpal )0.5 (tunnel )0.5 (syndrome,)37.2 ( )0.5 (d)-9.8 (ysesthesia,)37.3 ( )0.5 (hyperesthesia,)37.3 ( hypoesthesia,)31.9 ( )]TJ
-0.015 Tc 0.036 Tw 0 -1.062 Td
[(hypoesthesia oral,)37.2 ( mononeuropa)-9.7 (thy)55.3 (,)37.3 ( neuralgia,)37.3 ( neuritis,)37.3 ( neuropa)-9.7 (thy peripheral,)37.3 ( paresthesia,)22 ( )]TJ
0.01 Tc 0.158 Tw 0 -1.062 Td
[(paresthesia oral,)37.1 ( peripheral motor neuropa)-9.9 (thy)55.1 (,)37.1 ( peripheral sensorimotor neuropa)-9.9 (thy)55.1 (,)47 ( )]TJ
-0.009 Tc 0.061 Tw 0 -1.062 Td
[(p)0.5 (er)0.5 (i)0.5 (p)0.5 (he)0.5 (r)0.5 (a)0.5 (l)0.5 ( s)0.5 (e)0.5 (n)0.5 (so)0.5 (r)-17.5 (y)0.5 ( n)0.5 (e)0.5 (u)0.5 (ro)0.5 (p)0.5 (a)-9.5 (t)0.5 (hy)55.5 (,)37.5 ( p)0.5 (e)0.5 (ro)0.5 (n)0.5 (e)0.5 (a)0.5 (l)0.5 ( n)0.5 (e)0.5 (r)-17.6 (v)0.5 (e)0.5 ( pa)0.5 (l)0.5 (s)0.5 (y)55.4 (,)37.5 ( r)0.5 (a)0.5 (d)0.5 (ic)0.5 (u)0.5 (l)0.5 (ar)0.5 ( pa)0.5 (i)0.5 (n)0.5 (,)37.4 ( r)0.5 (ad)0.5 (i)0.5 (c)0.5 (u)0.5 (lo)0.5 (p)0.5 (a)-9.5 (th)0.5 (y)55.5 (,)37.4 ( s)0.5 (ac)0.5 (r)0.5 (a)0.5 (l)-9 ( )]TJ
-0.012 Tc 0.048 Tw 0 -1.062 Td
[(radiculopa)-9.7 (thy)55.2 (,)37.2 ( scia)-9.8 (tica,)37.2 ( sensor)-17.8 (y loss,)37.2 ( toxic neuropa)-9.8 (thy)55.2 (.)]TJ
0.012 Tw 5.32 0 0 5.6 324 140.3918 Tm
(p)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 329 137.7278 Tm
[(Sleep disorder inc)20.2 (ludes hypersomnia,)37.2 ( insomnia,)37.2 ( sleep disorder)74.2 (.)]TJ
0.012 Tw 5.32 0 0 5.6 324 131.8918 Tm
(q)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.002 Tc 0.12 Tw 7.6 0 0 8 329 129.2278 Tm
[(Renal failure inc)19.9 (ludes acute kidney injur)-18.1 (y)54.8 (,)36.8 ( blood crea)-10.1 (tinine increased,)36.8 ( chronic kidney)2 ( )]TJ
0.009 Tc 0.152 Tw 0 -1.062 Td
[(disease,)37.3 ( crea)-9.7 (tinine renal c)20.3 (learance decreased,)37.3 ( glomerular filtra)-9.7 (tion ra)-9.7 (te decreased,)46 ( )]TJ
-0.012 Tc 0.048 Tw 0 -1.062 Td
[(nephropa)-9.8 (thy toxic,)37.2 ( oliguria,)37.2 ( renal failure,)37.2 ( renal impairment,)37.2 ( urine output decreased.)]TJ
0.012 Tw 5.32 0 0 5.6 324 106.3918 Tm
(r)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.014 Tc 0.036 Tw 7.6 0 0 8 329 103.7278 Tm
[(Dyspnea inc)19.8 (ludes d)-10.2 (yspnea,)36.8 ( d)-10.2 (yspnea exertional,)36.8 ( d)-10.2 (yspnea paroxysmal nocturnal,)36.8 ( tachypnea.)]TJ
-0.012 Tc 0.012 Tw 5.32 0 0 5.6 324 97.8918 Tm
(s)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 329 95.2278 Tm
[(Cough inc)20.2 (ludes cough,)37.2 ( productive cough,)37.2 ( upper)37.2 (-airway cough syndrome.)]TJ
0.012 Tw 5.32 0 0 5.6 324 89.3918 Tm
(t)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 329 86.7278 Tm
[(Hypoxia inc)20.2 (ludes hypoxia,)37.2 ( oxygen sa)-9.8 (tura)-9.8 (tion decreased.)]TJ
0.012 Tw 5.32 0 0 5.6 324 80.8918 Tm
(u)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 329 78.2278 Tm
[(Hypotension inc)20.2 (ludes hemod)-9.8 (ynamic instability)55.2 (,)37.2 ( hypotension,)37.2 ( orthosta)-9.8 (tic hypotension.)]TJ
0.012 Tw 5.32 0 0 5.6 324 72.3918 Tm
(v)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.001 Tc 0.111 Tw 7.6 0 0 8 329 69.7278 Tm
[(R)0.5 (a)0.5 (s)0.5 (h)0.5 ( i)0.5 (n)0.5 (c)20.5 (l)0.5 (ud)0.5 (e)0.6 (s a)0.6 (c)0.5 (n)0.5 (e,)37.5 ( c)0.5 (a)-9.5 (t)0.5 (h)0.5 (e)0.5 (t)0.5 (e)0.5 (r)0.5 ( s)0.5 (i)0.5 (t)0.5 (e)0.5 ( d)0.5 (e)0.5 (r)0.5 (m)0.5 (a)-9.5 (t)0.5 (i)0.5 (t)0.5 (i)0.5 (s)0.5 (,)37.5 ( c)0.5 (a)-9.5 (t)0.5 (h)0.5 (e)0.5 (t)0.5 (e)0.5 (r)0.5 ( s)0.5 (i)0.5 (t)0.5 (e)0.5 ( r)0.5 (a)0.5 (s)0.5 (h)0.5 (,)37.5 ( d)0.5 (e)0.5 (r)0.5 (m)0.5 (a)-9.5 (t)0.5 (i)0.5 (t)0.5 (i)0.5 (s)0.5 (,)37.5 ( d)0.5 (e)0.5 (r)0.5 (m)0.5 (a)-9.5 (t)0.5 (i)0.5 (t)0.5 (i)0.5 (s)1 ( )]TJ
0.01 Tc 0.156 Tw 0 -1.062 Td
[(c)0.5 (o)0.5 (nt)0.5 (a)0.5 (c)0.5 (t)0.5 (,)37.4 ( d)0.5 (r)0.5 (ug)0.5 ( e)0.5 (ru)0.5 (p)0.5 (t)0.5 (i)0.5 (on)0.5 (,)37.5 ( ec)0.5 (z)0.5 (e)0.5 (m)0.5 (a)0.5 (,)37.4 ( e)0.5 (r)-17.5 (y)0.5 (th)0.5 (e)0.5 (m)0.5 (a)0.5 (,)37.4 ( p)0.5 (a)-9.5 (pu)0.5 (l)0.5 (o)0.5 (p)0.5 (us)0.5 (t)0.5 (u)0.5 (la)0.5 (r)0.5 ( r)0.5 (o)0.5 (sa)0.5 (c)0.5 (e)0.5 (a)0.5 (,)37.4 ( p)0.5 (h)0.5 (ot)0.5 (o)0.5 (s)0.5 (e)0.5 (ns)0.5 (i)0.5 (t)0.5 (iv)0.5 (i)0.5 (t)0.5 (y)10 ( )]TJ
0.005 Tc 0.134 Tw 0 -1.062 Td
[(reaction,)37 ( rash,)37 ( rash follicular)74 (,)37 ( rash macular)74 (,)37 ( rash maculo-pa)-9.9 (pular)74 (,)37 ( rash pa)-9.9 (pular)74 (,)37 ( rash)5 ( )]TJ
-0.012 Tc 0.048 Tw 0 -1.062 Td
[(pruritic,)37.2 ( skin irrita)-9.8 (tion,)37.2 ( skin lesion,)37.2 ( urticaria.)]TJ
/T1_1 1 Tf
0 Tc 0 Tw 8 0 0 8 324 718.5601 Tm
(\()Tj
-0.017 Tc 0.017 Tw 0.224 0 Td
(Continued\))Tj
ET
endstreamendobj5 0 obj<</ArtBox[0.0 0.0 612.0 792.0]/BleedBox[0.0 0.0 612.0 792.0]/Contents 99 0 R/CropBox[0.0 0.0 612.0 792.0]/MediaBox[0.0 0.0 612.0 792.0]/Parent 14 0 R/Resources<</ExtGState<</GS0 23 0 R>>/Font<</T1_0 27 0 R/T1_1 100 0 R/T1_2 25 0 R/T1_3 26 0 R>>/ProcSet[/PDF/Text]>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page/PieceInfo<</InDesign<</DocumentID<FEFF0078006D0070002E006400690064003A00650064006300330039006600620063002D0030003300320039002D0034003400370062002D0038006500650064002D003400370061006100350031006600300062003500640066>/LastModified<FEFF0044003A00320030003200340030003800300031003100350031003800340030005A>/NumberofPages 1/OriginalDocumentID<FEFF0078006D0070002E006400690064003A00340033003600620065006100360038002D0038003800660039002D0034006600360030002D0039006200370036002D003800360065006600330066003100390033006300310038>/PageTransformationMatrixList<</0[1.0 0.0 0.0 1.0 0.0 0.0]>>/PageUIDList<</0 474>>/PageWidthList<</0 612.0>>>>>>>>endobj6 0 obj<</ArtBox[0.0 0.0 612.0 792.0]/BleedBox[0.0 0.0 612.0 792.0]/Contents 101 0 R/CropBox[0.0 0.0 612.0 792.0]/MediaBox[0.0 0.0 612.0 792.0]/Parent 14 0 R/Resources<</ExtGState<</GS0 23 0 R/GS1 22 0 R>>/Font<</T1_0 27 0 R/T1_1 25 0 R/T1_2 100 0 R/T1_3 26 0 R/T1_4 102 0 R/T1_5 103 0 R/T1_6 104 0 R>>/ProcSet[/PDF/Text]/Properties<</MC0 105 0 R>>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page/PieceInfo<</InDesign<</DocumentID<FEFF0078006D0070002E006400690064003A00650064006300330039006600620063002D0030003300320039002D0034003400370062002D0038006500650064002D003400370061006100350031006600300062003500640066>/LastModified<FEFF0044003A00320030003200340030003800300031003100350031003800340030005A>/NumberofPages 1/OriginalDocumentID<FEFF0078006D0070002E006400690064003A00340033003600620065006100360038002D0038003800660039002D0034006600360030002D0039006200370036002D003800360065006600330066003100390033006300310038>/PageTransformationMatrixList<</0[1.0 0.0 0.0 1.0 0.0 0.0]>>/PageUIDList<</0 573>>/PageWidthList<</0 612.0>>>>>>>>endobj7 0 obj<</ArtBox[0.0 0.0 612.0 792.0]/BleedBox[0.0 0.0 612.0 792.0]/Contents 106 0 R/CropBox[0.0 0.0 612.0 792.0]/MediaBox[0.0 0.0 612.0 792.0]/Parent 14 0 R/Resources<</ExtGState<</GS0 22 0 R/GS1 23 0 R/GS2 24 0 R>>/Font<</T1_0 25 0 R/T1_1 26 0 R/T1_2 27 0 R>>/ProcSet[/PDF/Text]/XObject<</Fm0 28 0 R>>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page/PieceInfo<</InDesign<</DocumentID<FEFF0078006D0070002E006400690064003A00650064006300330039006600620063002D0030003300320039002D0034003400370062002D0038006500650064002D003400370061006100350031006600300062003500640066>/LastModified<FEFF0044003A00320030003200340030003800300031003100350031003800340030005A>/NumberOfPageItemsInPage 2/NumberofPages 1/OriginalDocumentID<FEFF0078006D0070002E006400690064003A00340033003600620065006100360038002D0038003800660039002D0034006600360030002D0039006200370036002D003800360065006600330066003100390033006300310038>/PageItemUIDToLocationDataMap<</0[410.0 0.0 3.0 -270.0 -360.0 -18.0 -346.846 1.0 0.0 0.0 1.0 0.0 0.0]/1[432.0 1.0 3.0 18.0 -359.889 270.0 -346.736 1.0 0.0 0.0 1.0 288.0 0.11058]>>/PageTransformationMatrixList<</0[1.0 0.0 0.0 1.0 0.0 0.0]>>/PageUIDList<</0 678>>/PageWidthList<</0 612.0>>>>>>>>endobj8 0 obj<</ArtBox[0.0 0.0 612.0 792.0]/BleedBox[0.0 0.0 612.0 792.0]/Contents 107 0 R/CropBox[0.0 0.0 612.0 792.0]/MediaBox[0.0 0.0 612.0 792.0]/Parent 14 0 R/Resources<</ExtGState<</GS0 22 0 R/GS1 24 0 R/GS2 23 0 R>>/Font<</T1_0 27 0 R/T1_1 25 0 R/T1_2 26 0 R>>/ProcSet[/PDF/Text]/XObject<</Fm0 28 0 R>>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page/PieceInfo<</InDesign<</DocumentID<FEFF0078006D0070002E006400690064003A00650064006300330039006600620063002D0030003300320039002D0034003400370062002D0038006500650064002D003400370061006100350031006600300062003500640066>/LastModified<FEFF0044003A00320030003200340030003800300031003100350031003800340030005A>/NumberOfPageItemsInPage 2/NumberofPages 1/OriginalDocumentID<FEFF0078006D0070002E006400690064003A00340033003600620065006100360038002D0038003800660039002D0034006600360030002D0039006200370036002D003800360065006600330066003100390033006300310038>/PageItemUIDToLocationDataMap<</0[410.0 0.0 3.0 -270.0 -360.0 -18.0 -346.846 1.0 0.0 0.0 1.0 0.0 0.0]/1[432.0 1.0 3.0 18.0 -359.889 270.0 -346.736 1.0 0.0 0.0 1.0 288.0 0.11058]>>/PageTransformationMatrixList<</0[1.0 0.0 0.0 1.0 0.0 0.0]>>/PageUIDList<</0 730>>/PageWidthList<</0 612.0>>>>>>>>endobj9 0 obj<</ArtBox[0.0 0.0 612.0 792.0]/BleedBox[0.0 0.0 612.0 792.0]/Contents 108 0 R/CropBox[0.0 0.0 612.0 792.0]/MediaBox[0.0 0.0 612.0 792.0]/Parent 14 0 R/Resources<</ExtGState<</GS0 22 0 R/GS1 23 0 R>>/Font<</T1_0 25 0 R/T1_1 27 0 R/T1_2 26 0 R>>/ProcSet[/PDF/Text]/XObject<</Fm0 28 0 R>>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page/PieceInfo<</InDesign<</DocumentID<FEFF0078006D0070002E006400690064003A00650064006300330039006600620063002D0030003300320039002D0034003400370062002D0038006500650064002D003400370061006100350031006600300062003500640066>/LastModified<FEFF0044003A00320030003200340030003800300031003100350031003800340031005A>/NumberOfPageItemsInPage 2/NumberofPages 1/OriginalDocumentID<FEFF0078006D0070002E006400690064003A00340033003600620065006100360038002D0038003800660039002D0034006600360030002D0039006200370036002D003800360065006600330066003100390033006300310038>/PageItemUIDToLocationDataMap<</0[410.0 0.0 3.0 -270.0 -360.0 -18.0 -346.846 1.0 0.0 0.0 1.0 0.0 0.0]/1[432.0 1.0 3.0 18.0 -359.889 270.0 -346.736 1.0 0.0 0.0 1.0 288.0 0.11058]>>/PageTransformationMatrixList<</0[1.0 0.0 0.0 1.0 0.0 0.0]>>/PageUIDList<</0 784>>/PageWidthList<</0 612.0>>>>>>>>endobj108 0 obj<</Length 23850>>stream
q
/GS0 gs
0 TL/Fm0 Do
Q
0 0 0 1 K
0.5 w 
/GS1 gs
q 1 0 0 1 36 234.6829 cm
0 0 m
49.051 0 l
S
Q
BT
0 0 0 1 k
/T1_0 1 Tf
-0.005 Tc 0.108 Tw 8 0 0 8 36 727.248 Tm
[(neurotoxicity)55.2 (.)37.2 ( )37.1 (The manifesta)-9.8 (tions of HLH/MAS inc)20.1 (lude hypotension,)37.2 ( hypoxia,)37.2 ( multiple)-5 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.059 Td
[(organ d)-9.8 (ysfunction,)37.2 ( renal d)-9.8 (ysfunction,)37.3 ( and c)20.2 (ytopenia.)]TJ
-0.016 Tc 0.06 Tw 0 -1.779 Td
[(In KarMMa-3,)37 ( one pa)-10 (tient had Grade 5,)36.9 ( two pa)-10 (tients had Grade 4 and two pa)-10 (tients had)-16 ( )]TJ
-0.017 Tc 0.054 Tw 0 -1.059 Td
[(Grade 3 HLH/MAS.)37.2 ( )36.8 (The pa)-9.8 (tient with Grade 5 HLH/MAS also had Grade 5 candida sepsis)-17.1 ( )]TJ
-0.006 Tc 0.103 Tw 0 -1.059 Td
[(and Grade 5 CRS.)37.2 ( In another pa)-9.8 (tient who died due to stroke,)37.2 ( the Grade 4 HLH/MAS)-6 ( )]TJ
0 Tc 0 Tw 31.5 0 Td
( )Tj
-0.012 Tc 0.075 Tw -31.5 -1.059 Td
[(had resolved prior to dea)-10.1 (th.)36.9 ( )37.3 (T)73.9 (wo cases of Grade 3 and one case of Grade 4 HLH/MAS)-12 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.059 Td
(had resolved.)Tj
0 Tc 0.134 Tw 0 -1.779 Td
[(In KarMMa,)37 ( one pa)-9.9 (tient trea)-10 (ted in the 300 x 10)]TJ
0 Tw 5.6 0 0 5.6 183.8699 659.0715 Tm
(6 )Tj
0.134 Tw 8 0 0 8 188.6527 656.4075 Tm
[(CAR-positive )37 (T cells dose cohort )]TJ
0.016 Tc 0.216 Tw -19.082 -1.059 Td
[(developed fa)-10.3 (tal multi-organ HLH/MAS with )0.5 (CRS.)36.7 ( )0.5 (In another pa)-10.3 (tient with )0.5 (fa)-10.2 (tal)16 ( )]TJ
-0.016 Tc 0.06 Tw 0 -1.059 Td
[(bronchopulmonar)-18.1 (y aspergillosis,)36.9 ( HLH/MAS was contributor)-18 (y to the fa)-10 (tal outcome.)36.9 ( )36.9 (Three)-16 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.059 Td
(cases of Grade 2 HLH/MAS resolved.)Tj
-0.002 Tc 0.123 Tw 0 -1.779 Td
[(HLH/MAS is a potentially life-threa)-9.8 (tening condition with a high mortality ra)-9.8 (te if not)-2 ( )]TJ
0.004 Tc 0.153 Tw 0 -1.059 Td
[(recognized early and trea)-9.7 (ted.)37.2 ( )37.3 (T)74.3 (rea)-9.7 (tment of HLH/MAS should be administered per)4 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.059 Td
(institutional standards.)Tj
/T1_1 1 Tf
0.017 Tw 0 -1.798 Td
(5.5)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
(ABECMA REMS)Tj
/T1_0 1 Tf
-0.014 Tc 0.065 Tw -3.375 -1.599 Td
[(Because of the risk of CRS and neurologic toxicities,)36.8 ( )36.5 (ABECMA is a)-10.2 (vailable only through)-14 ( )]TJ
-0.015 Tc 0.06 Tw 0 -1.059 Td
[(a restricted program under a Risk Evalua)-10.2 (tion and Mitiga)-10.1 (tion Stra)-10.2 (teg)-10.2 (y \(REMS\) called the)-15 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.059 Td
(ABECMA REMS )Tj
/T1_2 1 Tf
[([see Boxed )37.2 (W)18.2 (arning and )37.2 (W)18.2 (arnings and Precautions \(5)]TJ
[(.2,)37.2 ( 5.3\)])]TJ
/T1_0 1 Tf
0 Tc 0 Tw (.)Tj
-0.017 Tc 0.048 Tw 0 -1.779 Td
[(The required components of the )37.2 (ABECMA REMS are:)]TJ
0.017 Tw 1.192 -1.663 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.044 Tw 1.508 0 Td
[(Healthcare facilities tha)-9.8 (t dispense and administer )36.8 (ABECMA must be enrolled and)-17 ( )]TJ
0.048 Tw 0 -1.078 Td
(comply with the REMS requirements.)Tj
0.017 Tw -1.508 -1.528 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.021 Tc 0.036 Tw 1.508 0 Td
[(Certi\037ed healthcare facilities must ha)-9.9 (ve on-site,)37.1 ( immedia)-9.9 (te access to tocilizumab.)]TJ
-0.017 Tc 0.017 Tw -1.508 -1.528 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.031 Tc 0.013 Tw 1.508 0 Td
[(Ensure tha)-9.9 (t a minimum of two doses of tocilizumab are a)-9.9 (vailable for each pa)-10 (tient for)-31 ( )]TJ
0 Tc 0 Tw 28.8 0 Td
( )Tj
-0.017 Tc 0.042 Tw -28.8 -1.078 Td
[(infusion )0.5 (within )0.5 (two )0.5 (hours )0.6 (after )37.5 (ABECMA )0.6 (infusion,)37.2 ( )0.6 (if )0.5 (needed )0.6 (for )0.5 (trea)-9.8 (tment )0.5 (of )0.5 (CRS.)]TJ
0.017 Tw -1.508 -1.528 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.021 Tc 0.24 Tw 1.508 0 Td
[(Further informa)-10.1 (tion is a)-10.1 (vailable a)-10 (t www)36.9 (.AbecmaREMS.com or contact)21 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.078 Td
[(Bristol-Myers Squibb a)-9.8 (t 1-866-340-7332.)]TJ
/T1_1 1 Tf
0.017 Tw -2.7 -1.753 Td
(5.6)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
(Hypersensitivity Reactions)Tj
/T1_0 1 Tf
-0.002 Tc 0.127 Tw -3.375 -1.599 Td
[(Allergic )0.5 (reactions )0.6 (may )0.6 (occur )0.5 (with )0.6 (the )0.5 (infusion )0.6 (of )37.5 (ABECMA.)36.6 ( )0.5 (Serious )0.6 (hypersensitivity)-2 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.059 Td
[(reactions,)37.2 ( inc)20.2 (luding ana)-9.8 (phylaxis,)37.2 ( may be due to dimethyl sulfoxide \(DMSO\) in )37.2 (ABECMA.)]TJ
/T1_1 1 Tf
0.017 Tw 0 -1.888 Td
(5.7)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3.375 0 Td
(Infections)Tj
/T1_0 1 Tf
-0.013 Tc 0.07 Tw -3.375 -1.599 Td
[(ABECMA )0.5 (should )0.5 (not )0.5 (be )0.5 (administered )0.5 (to )0.5 (pa)-10.1 (tients )0.5 (with )0.5 (active )0.5 (infections )0.5 (or )0.5 (in\036amma)-10.1 (tor)-18.1 (y)-13 ( )]TJ
0.011 Tc 0.188 Tw 0 -1.059 Td
[(disorders.)37.1 ( Severe,)37.2 ( life-threa)-9.8 (tening,)37.1 ( or fa)-9.8 (tal infections occurred in pa)-9.9 (tients after)11 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.059 Td
(ABECMA infusion.)Tj
-0.013 Tc 0.071 Tw 0 -1.779 Td
[(In )0.5 (all )0.5 (pa)-10.3 (tients )0.5 (receiving )37.5 (ABECMA )0.6 (in )0.5 (the )0.5 (KarMMa )0.6 (and )0.5 (KarMMa-3,)36.7 ( )0.6 (infections )0.6 (\(all )0.5 (grades\))-13 ( )]TJ
-0.001 Tc 0.127 Tw 0 -1.059 Td
[(occurred in 61% of pa)-9.7 (tients.)37.3 ( Grade 3 or 4 infections occurred in 21% of pa)-9.6 (tients.)36 ( )]TJ
-0.013 Tc 0.068 Tw 0 -1.059 Td
[(Grade 3 or 4 infections with an unspeci\037ed pa)-9.8 (thogen occurred in 12%,)37.2 ( viral infections)-13 ( )]TJ
-0.01 Tc 0.083 Tw 0 -1.059 Td
[(in 7%,)37.1 ( bacterial infections in 4.3%,)37.1 ( and fungal infections in 1.4% of pa)-9.9 (tients.)37.1 ( Overall,)27 ( )]TJ
-0.017 Tc 0.038 Tw 0 -1.059 Td
[(15 pa)-9.7 (tients had Grade 5 infections \(4.3%\); 8 pa)-9.8 (tients \(2.3%\) with infections of pa)-9.8 (thogen)-17 ( )]TJ
0.003 Tc 0.15 Tw 0 -1.059 Td
[(unspecified,)36.9 ( )0.5 (3 )0.5 (pa)-10.1 (tients )0.6 (\(0.9%\) )0.5 (with )0.5 (fungal )0.6 (infections,)37 ( )0.5 (3 )0.6 (pa)-10 (tients )0.5 (\(0.9%\) )0.6 (with )0.6 (viral)3 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.059 Td
[(infections,)37.2 ( and 1 pa)-9.8 (tient \(0.3%\) with bacterial infection.)]TJ
-0.016 Tc 0.06 Tw 0 -1.779 Td
[(Monitor pa)-9.6 (tients for signs and symptoms of infection before and after )37.3 (ABECMA infusion)-16 ( )]TJ
0.008 Tc 0.174 Tw 0 -1.059 Td
[(and trea)-9.9 (t a)-10 (ppropria)-9.9 (tely)55 (.)37.1 ( )37.3 (Administer prophylactic,)37.1 ( pre-emptive,)37 ( and/or thera)-10 (peutic)8 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.059 Td
(antimicrobials according to standard institutional guidelines.)Tj
-0.013 Tc 0.067 Tw 0 -1.779 Td
[(F)24.3 (ebrile neutropenia was obser)-17.7 (ved in 38% \(133/349\) of pa)-9.7 (tients after )36.6 (ABECMA infusion)-13 ( )]TJ
0 Tc 0.131 Tw 0 -1.059 Td
[(a)0.5 (n)0.6 (d)0.5 ( m)0.5 (a)0.6 (y)0.6 ( b)0.5 (e)0.6 ( c)0.6 (o)0.5 (n)0.6 (c)0.5 (u)0.6 (r)0.5 (r)0.6 (e)0.5 (n)0.6 (t)0.5 ( w)0.5 (i)0.5 (t)0.6 (h)0.5 ( C)0.5 (R)0.6 (S)0.5 (.)37.5 ( I)0.5 (n)0.6 ( t)0.6 (h)0.5 (e)0.6 ( e)0.6 (v)0.5 (e)0.6 (n)0.5 (t)0.6 ( o)0.6 (f)0.5 ( f)0.5 (e)0.6 (b)0.5 (r)0.6 (i)0.5 (l)0.6 (e)0.5 ( n)0.5 (e)0.6 (u)0.5 (t)0.6 (r)0.5 (o)0.6 (p)0.5 (e)0.6 (n)0.5 (i)0.5 (a)0.6 (,)37.5 ( e)0.5 (v)0.6 (a)0.5 (l)0.6 (u)0.5 (a)-9.4 (t)0.5 (e)0.6 ( f)0.6 (o)0.6 (r )]TJ
-0.017 Tc 0.06 Tw 0 -1.059 Td
[(infection and mana)-9.8 (ge with broad-spectrum antibiotics,)37.1 ( \036uids,)37.1 ( and other supportive care)-17 ( )]TJ
0.048 Tw 0 -1.059 Td
[(as medically indica)-9.8 (ted.)]TJ
0 -1.731 Td
[(Viral Reactiva)-9.7 (tion)]TJ
0.006 Tc 0.161 Tw 0 -1.644 Td
[(C)0.5 (yt)0.5 (om)0.5 (eg)0.5 (al)0.5 (o)0.5 (vi)0.5 (ru)0.5 (s \()0.5 (CM)0.5 (V\))0.5 ( in)0.5 (fe)0.5 (c)0.5 (ti)0.5 (on)0.5 ( re)0.5 (su)0.5 (lt)0.5 (in)0.5 (g i)0.5 (n p)0.5 (ne)0.5 (u)0.5 (mo)0.5 (ni)0.5 (a a)0.5 (nd)0.5 ( de)0.5 (a)-9.6 (t)0.5 (h)0.5 ( ha)0.5 (s o)0.5 (cc)0.5 (ur)0.5 (r)0.5 (ed)6 ( )]TJ
-0.016 Tc 0.06 Tw 0 -1.059 Td
[(follo)-10.2 (wing )36.8 (ABECMA administra)-10.2 (tion.)36.8 ( Monitor and trea)-10.2 (t for CMV reactiva)-10.2 (tion in accordance)-16 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.059 Td
[(with c)20.1 (linical guidelines.)]TJ
-0.001 Tc 0.128 Tw 0 -1.779 Td
[(Hepa)-9.7 (titis B virus \(HBV\) reactiva)-9.8 (tion,)37.2 ( in some cases resulting in fulminant hepa)-9.8 (titis,)36 ( )]TJ
-0.006 Tc 0.104 Tw 0 -1.059 Td
[(hepa)-10 (tic failure,)37 ( and dea)-10 (th,)37 ( can occur in pa)-10 (tients trea)-10 (ted with drugs directed a)-10 (gainst)-6 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.059 Td
(plasma cells.)Tj
-0.014 Tc 0.065 Tw 0 -1.779 Td
[(P)17.9 (erform screening for CMV)91.8 (,)36.9 ( HBV)91.9 (,)36.9 ( hepa)-10.1 (titis C virus \(HCV\),)36.9 ( and human immunode\037cienc)19.9 (y)-14 ( )]TJ
0.014 Tc 0.202 Tw 0 -1.059 Td
[(virus \(HIV\) in accordance with c)20.4 (linical guidelines before collection of cells fo)0.5 (r)14 ( )]TJ
-0.017 Tc 0.017 Tw 0 -1.059 Td
(manufacturing.)Tj
-0.012 Tc 0.071 Tw 0 -1.779 Td
[(C)0.5 (o)0.5 (n)0.5 (s)0.5 (i)0.6 (d)0.5 (e)0.5 (r)0.5 ( a)0.5 (n)0.5 (t)0.5 (i)0.5 (v)0.6 (i)0.5 (r)0.5 (a)0.5 (l)0.5 ( t)0.5 (h)0.5 (e)0.6 (r)0.5 (a)-9.5 (p)0.5 (y)0.5 ( t)0.5 (o)0.6 ( p)0.5 (r)0.5 (e)0.5 (v)0.5 (e)0.5 (n)0.5 (t)0.6 ( v)0.5 (i)0.5 (r)0.5 (a)0.5 (l)0.5 ( r)0.6 (e)0.5 (a)0.5 (c)0.5 (t)0.5 (i)0.5 (v)0.5 (a)-9.4 (t)0.5 (i)0.5 (o)0.5 (n)0.5 ( p)0.5 (e)0.5 (r)0.6 ( l)0.5 (o)0.5 (c)0.5 (a)0.5 (l)0.5 ( i)0.5 (n)0.6 (s)0.5 (t)0.5 (i)0.5 (t)0.5 (u)0.5 (t)0.5 (i)0.5 (o)0.6 (n)0.5 (a)0.5 (l)0.5 ( g)0.5 (u)0.5 (i)0.5 (d)0.5 (e)0.5 (l)0.6 (i)0.5 (n)0.5 (e)0.5 (s)0.5 (/)]TJ
-0.017 Tc 0.048 Tw 0 -1.059 Td
[(c)20.2 (linical practice.)]TJ
/T1_1 1 Tf
0.017 Tw 0 -1.888 Td
(5.8)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
(Prolonged Cytopenias)Tj
/T1_0 1 Tf
0.039 Tw -3.375 -1.599 Td
[(P)18.2 (a)-9.8 (tients may exhibit )0.5 (prolonged c)20.2 (ytopenias follo)-9.7 (wing lymphodepleting )0.5 (chemothera)-9.8 (py and)-17 ( )]TJ
0.048 Tw 0 -1.059 Td
(ABECMA infusion.)Tj
-0.011 Tc 0.077 Tw 0 -1.779 Td
[(In pa)-9.7 (tients receiving )36.8 (ABECMA in the KarMMa and KarMMa-3 studies,)37.3 ( 40% of pa)-9.7 (tients)-11 ( )]TJ
0.008 Tc 0.172 Tw 0 -1.059 Td
[(\(139/349\) experienced prolonged Grade 3 or 4 neutropenia and 42% \(145\/349\))8 ( )]TJ
-0.014 Tc 0.065 Tw 0 -1.059 Td
[(experienced prolonged Grade 3 or 4 thromboc)19.9 (ytopenia tha)-10.1 (t had not resolved by Month)-14 ( )]TJ
-0.018 Tc 0.036 Tw 0 -1.059 Td
[(1 follo)-10.2 (wing )36.7 (ABECMA infusion.)36.7 ( In 89% \(123/139\) of pa)-10.3 (tients who recovered from Grade 3)-18 ( )]TJ
-0.006 Tc 0.103 Tw 0 -1.059 Td
[(or )0.6 (4 )0.5 (neutropenia )0.6 (after )0.5 (Month )0.6 (1,)37.3 ( )0.5 (the )0.5 (median )0.5 (time )0.5 (to )0.5 (recover)-17.7 (y )0.5 (from )37.5 (ABECMA )0.5 (infusion)-6 ( )]TJ
ET
1 w 4 M 
q 1 0 0 1 31.5 732.96 cm
0 0 m
0 -66.24 l
S
Q
q 1 0 0 1 31.5 377.6521 cm
0 0 m
0 -60.336 l
S
Q
q 1 0 0 1 31.5 281.512 cm
0 0 m
0 -16.92 l
S
Q
q 1 0 0 1 31.5 76.2441 cm
0 0 m
0 -41.684 l
S
Q
0.5 w 10 M 
q 1 0 0 1 324 494.6568 cm
0 0 m
58.632 0 l
S
Q
BT
0.001 Tc 0.137 Tw 8 0 0 8 324 727.248 Tm
[(was 1.9 months.)37.3 ( In 76% \(110/145\) of pa)-9.7 (tients who recovered from Grade 3 or 4)1 ( )]TJ
-0.022 Tc 0.036 Tw 0 -1.045 Td
[(thromboc)19.6 (ytopenia,)36.7 ( the median time to recover)-18.4 (y was 1.9 months.)36.7 ( F)17.6 (ive pa)-10.3 (tients underwent)-22 ( )]TJ
-0.014 Tc 0.061 Tw 0 -1.045 Td
[(s)0.5 (t)0.6 (e)0.6 (m)0.5 ( c)0.5 (e)0.6 (l)0.5 (l)0.6 ( t)0.5 (h)0.6 (e)0.5 (r)0.6 (a)-9.5 (p)0.6 (y)0.5 ( f)0.6 (o)0.5 (r)0.6 ( h)0.5 (e)0.6 (m)0.5 (a)-9.4 (t)0.5 (o)0.6 (p)0.5 (o)0.6 (i)0.5 (e)0.6 (t)0.5 (i)0.6 (c)0.5 ( r)0.6 (e)0.5 (c)0.6 (o)0.5 (n)0.6 (s)0.5 (t)0.6 (i)0.5 (t)0.6 (u)0.5 (t)0.6 (i)0.5 (o)0.6 (n)0.5 ( d)0.5 (u)0.6 (e)0.5 ( t)0.6 (o)0.5 ( p)0.6 (r)0.5 (o)0.6 (l)0.5 (o)0.6 (n)0.5 (g)0.6 (e)0.5 (d)0.6 ( c)20.5 (y)0.5 (t)0.6 (o)0.5 (p)0.6 (e)0.5 (n)0.6 (i)0.5 (a)0.6 (.)37.5 ( )37.3 (T)0.5 (h)0.6 (e)0.5 ( r)0.6 (a)-9.5 (t)0.6 (e)-14 ( )]TJ
-0.008 Tc 0.094 Tw 0 -1.045 Td
[(of Grade 3 or 4 thromboc)20 (ytopenia was 62% \(44/71\) and 56% \(135/241\) for pa)-10 (tients)-8 ( )]TJ
-0.01 Tc 0.082 Tw 0 -1.045 Td
[(trea)-9.7 (ted in dose range of 460 to 510 x 10)]TJ
0.01 Tw 5.6 0 0 5.6 446.3764 696.4805 Tm
(6 )Tj
0.082 Tw 8 0 0 8 450.7554 693.8165 Tm
[(CAR-positive )36.8 (T cells and 300 to 460 x 10)]TJ
0 Tc 0 Tw 5.6 0 0 5.6 573.312 696.4805 Tm
(6 )Tj
-0.017 Tc 0.048 Tw 8 0 0 8 324 685.4586 Tm
[(CAR-positive )37.2 (T cells,)37.2 ( respectively)55.2 (.)20 ( )]TJ
-0.021 Tc 0.036 Tw 0 -1.765 Td
[(M)0.5 (o)0.5 (n)0.5 (i)0.5 (t)0.6 (o)0.5 (r)0.5 ( )0.5 (b)0.5 (l)0.5 (o)0.5 (o)0.5 (d)0.5 ( )0.5 (c)0.5 (o)0.6 (u)0.5 (n)0.5 (t)0.5 (s)0.5 ( )0.5 (p)0.5 (r)0.5 (i)0.5 (o)0.5 (r)0.5 ( )0.6 (t)0.5 (o)0.5 ( )0.5 (a)0.5 (n)0.5 (d)0.5 ( )0.5 (a)0.5 (f)0.6 (t)0.5 (e)0.5 (r)0.5 ( )37.5 (A)0.5 (B)0.5 (E)0.5 (C)0.5 (M)0.5 (A)0.5 ( )0.5 (i)0.5 (n)0.5 (f)0.6 (u)0.5 (s)0.5 (i)0.5 (o)0.5 (n)0.5 (.)37.5 ( )0.5 (M)0.5 (a)0.5 (n)0.5 (a)-9.5 (g)0.5 (e)0.6 ( )0.5 (c)20.5 (y)0.5 (t)0.5 (o)0.5 (p)0.5 (e)0.5 (n)0.5 (i)0.5 (a)0.6 ( )0.5 (w)0.5 (i)0.5 (t)0.5 (h)0.5 ( )0.5 (m)0.5 (y)0.5 (e)0.5 (l)0.5 (o)0.6 (i)0.5 (d)-21 ( )]TJ
-0.003 Tc 0.12 Tw 0 -1.045 Td
[(gro)-10 (wth )0.5 (factor and blood )0.5 (product transfusion )0.5 (support according )0.5 (to local )0.5 (institutional)-2.9 ( )]TJ
-0.017 Tc 0.017 Tw 0 -1.045 Td
(guidelines.)Tj
/T1_1 1 Tf
0 -1.873 Td
(5.9)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3.375 0 Td
(Hypogammaglobulinemia)Tj
/T1_0 1 Tf
0.004 Tc 0.155 Tw -3.375 -1.585 Td
[(Plasma cell a)-10.1 (plasia and hypogamma)-10.2 (globulinemia can occur in pa)-10.1 (tients receiving)4 ( )]TJ
-0.017 Tc 0.011 Tw 0 -1.045 Td
[(trea)-9.7 (tment )-36.7 (with ABECMA.)]TJ
0.032 Tc 0.292 Tw 0 -1.765 Td
[(In all pa)-9.6 (tients receiving )37.2 (ABECMA in the KarMMa and KarMMa-3 studies,)69 ( )]TJ
-0.019 Tc 0.036 Tw 0 -1.045 Td
[(hypogamma)-9.9 (globulinemia was reported as an adverse event in 13% \(46/349\) of pa)-9.9 (tients;)-19 ( )]TJ
-0.012 Tc 0.073 Tw 0 -1.045 Td
[(labora)-9.8 (tor)-17.8 (y IgG levels fell belo)-9.8 (w 500 mg/dL after infusion in 37% \(130/349\) of pa)-9.8 (tients)-12 ( )]TJ
-0.017 Tc 0.011 Tw 0 -1.045 Td
[(trea)-9.7 (ted )-36.8 (with ABECMA.)]TJ
-0.007 Tc 0.097 Tw 0 -1.765 Td
[(Hypogamma)-9.6 (globulinemia either as an adverse reaction or labora)-9.7 (tor)-17.7 (y IgG level belo)-9.6 (w)-7 ( )]TJ
-0.013 Tc 0.066 Tw 0 -1.045 Td
[(5)0.5 (00)0.5 ( m)0.5 (g/)0.5 (dL)0.5 ( a)0.5 (ft)0.5 (e)0.5 (r in)0.5 (fu)0.5 (s)0.5 (io)0.5 (n oc)0.5 (c)0.5 (ur)0.5 (re)0.5 (d)0.5 ( in)0.5 ( 4)0.5 (5%)0.5 ( \()0.5 (15)0.5 (8)0.5 (/3)0.5 (49)0.5 (\) of)0.5 ( p)0.5 (a)-9.6 (t)0.5 (i)0.5 (en)0.5 (t)0.5 (s t)0.5 (r)0.5 (ea)-9.5 (t)0.5 (ed)0.5 ( w)0.5 (it)0.5 (h )36.8 (AB)0.5 (EC)0.5 (MA)0.5 (.)24 ( )]TJ
-0.015 Tc 0.06 Tw 0 -1.045 Td
[(F)20.1 (orty-one percent of pa)-9.8 (tients received intra)-9.8 (venous immunoglobulin \(IVIG\) post-ABECMA)-15 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.045 Td
(for serum IgG <400 mg/dL.)Tj
0 -1.765 Td
[(Monitor immunoglobulin levels after trea)-9.8 (tment with )37.3 (ABECMA and administer IVIG for IgG)-17 ( )]TJ
-0.011 Tc 0.079 Tw 0 -1.045 Td
[(<400 mg/dL.)37 ( Mana)-10 (ge per local institutional guidelines,)36.9 ( inc)20 (luding infection precautions)-11 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.045 Td
(and antibiotic or antiviral prophylaxis.)Tj
0 -1.716 Td
[(Use of Live )37.2 (V)18.2 (accines)]TJ
-0.022 Tc 0.036 Tw 0 -1.63 Td
[(The safety of immuniza)-10.1 (tion with live viral vaccines during or follo)-10.1 (wing )36.8 (ABECMA trea)-10.1 (tment)-22 ( )]TJ
-0.009 Tc 0.086 Tw 0 -1.045 Td
[(h)0.5 (a)0.5 (s)0.5 ( no)0.5 (t)0.5 ( b)0.5 (e)0.5 (e)0.5 (n)0.5 ( st)0.5 (u)0.5 (d)0.5 (i)0.5 (e)0.5 (d)0.5 (.)37.4 ( )36.9 (V)18.5 (a)0.5 (c)0.5 (c)0.5 (in)0.5 (a)-9.5 (t)0.5 (i)0.5 (o)0.5 (n)0.5 ( w)0.5 (i)0.5 (th)0.5 ( l)0.5 (i)0.5 (v)0.5 (e)0.5 ( v)0.5 (ir)0.5 (u)0.5 (s)0.5 ( v)0.5 (a)0.5 (c)0.5 (ci)0.5 (n)0.5 (e)0.5 (s)0.5 ( i)0.5 (s n)0.5 (o)0.5 (t)0.5 ( r)0.5 (e)0.5 (c)0.5 (o)0.5 (m)0.5 (me)0.5 (n)0.5 (d)0.5 (e)0.5 (d)0.5 ( f)0.5 (o)0.5 (r a)-9.4 (t)-9 ( )]TJ
-0.006 Tc 0.106 Tw 0 -1.045 Td
[(least )0.5 (six )0.5 (weeks )0.5 (prior )0.5 (to )0.5 (the )0.5 (start )0.5 (of )0.5 (lymphodepleting )0.5 (chemothera)-10.2 (py)54.8 (,)36.7 ( )0.6 (during )37.5 (ABECMA)-6 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.045 Td
[(trea)-9.7 (tment,)37.2 ( and until immune recover)-17.8 (y follo)-9.8 (wing trea)-9.8 (tment with )37.2 (ABECMA.)]TJ
/T1_1 1 Tf
0.017 Tw 0 -1.873 Td
(5.10)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
[(Secondar)-17.7 (y Malignancies)]TJ
/T1_0 1 Tf
-0.003 Tc 0.121 Tw -3.375 -1.585 Td
[(P)17.6 (a)-10.4 (tients trea)-10.4 (ted with )36.6 (ABECMA may develop secondar)-18.3 (y malignancies.)36.6 ( In KarMMa-3,)34 ( )]TJ
-0.006 Tc 0.105 Tw 0 -1.045 Td
[(myeloid neoplasms \(four cases of myelod)-10.2 (ysplastic syndrome and one case of acute)-6 ( )]TJ
0.004 Tc 0.155 Tw 0 -1.045 Td
[(myeloid leukemia\) occurred in 2.2% \(5/222\) of pa)-10.1 (tients follo)-10.1 (wing trea)-10.1 (tment with)4 ( )]TJ
-0.005 Tc 0.109 Tw 0 -1.045 Td
[(ABECMA compared to none in the standard regimens arm a)-10 (t the time of the safety)-5 ( )]TJ
0.111 Tw 0 -1.045 Td
[(upda)-10.3 (te.)36.7 ( )36.9 (The median time to onset of myeloid neoplasm from )36.9 (ABECMA infusion was)-5 ( )]TJ
-0.008 Tc 0.096 Tw 0 -1.045 Td
[(338 days \(Range:)36.7 ( 277 to 794 days\).)36.7 ( )37.2 (Three of these \037ve pa)-10.3 (tients ha)-10.3 (ve died follo)-10.2 (wing)-8 ( )]TJ
-0.012 Tc 0.072 Tw 0 -1.045 Td
[(the development of myeloid neoplasm.)37.3 ( One out of the \037ve cases of myeloid neoplasm)-12 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.045 Td
[(occurred after initia)-9.8 (tion of subsequent antimyeloma thera)-9.7 (py)55.2 (.)]TJ
-0.004 Tc 0.112 Tw -0.037 -1.765 Td
[(T cell malignancies ha)-9.7 (ve occurred follo)-9.6 (wing trea)-9.7 (tment of hema)-9.6 (tologic malignancies)-4 ( )]TJ
-0.018 Tc 0.036 Tw 0.037 -1.045 Td
[(with BCMA- and CD19-directed genetically modi\037ed autologous )36.8 (T cell immunothera)-10.2 (pies,)19 ( )]TJ
-0.003 Tc 0.117 Tw 0 -1.045 Td
[(inc)20.3 (luding )36.6 (ABECMA.)37.3 ( Ma)-9.8 (ture )36.6 (T cell malignancies,)37.3 ( inc)20.2 (luding CAR-positive tumors,)37.2 ( may)-3 ( )]TJ
-0.021 Tc 0.036 Tw 0 -1.045 Td
[(present as soon as weeks follo)-9.7 (wing infusion,)37.3 ( and may inc)20.3 (lude fa)-9.6 (tal outcomes )]TJ
/T1_2 1 Tf
[([see Boxed)-21 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.045 Td
[(W)18.2 (arning,)37.2 ( )37.2 (Adverse Reactions \(6.3\),)37.2 ( P)18.2 (a)-9.8 (tient Counseling Informa)-9.8 (t)]TJ
(ion \(17\)])Tj
/T1_0 1 Tf
0 Tc 0 Tw (.)Tj
-0.015 Tc 0.06 Tw 0 -1.765 Td
[(Monit)0.5 (or life-)0.5 (long for)0.5 ( seconda)0.5 (r)-17.6 (y mali)0.5 (gnancies.)37.4 ( )0.5 (In)0.5 ( the ev)0.5 (ent tha)-9.6 (t)0.5 ( a seco)0.5 (ndar)-17.6 (y ma)0.5 (lignanc)20.4 (y)-15 ( )]TJ
-0.006 Tc 0.101 Tw 0 -1.045 Td
[(o)0.5 (c)0.6 (c)0.5 (u)0.5 (r)0.5 (s)0.6 (,)37.5 ( c)0.6 (o)0.5 (n)0.5 (t)0.6 (a)0.5 (c)0.5 (t)0.6 ( B)0.6 (r)0.5 (i)0.5 (s)0.5 (t)0.6 (o)0.5 (l)0.5 (-)0.5 (M)0.6 (y)0.5 (e)0.5 (r)0.6 (s)0.5 ( S)0.5 (q)0.5 (u)0.5 (i)0.6 (b)0.5 (b)0.5 ( a)-9.5 (t)0.6 ( 1)0.6 (-)0.5 (8)0.5 (8)0.5 (8)0.6 (-)0.5 (8)0.5 (0)0.5 (5)0.6 (-)0.5 (4)0.5 (5)0.5 (5)0.6 (5)0.5 ( f)0.5 (o)0.5 (r)0.6 ( r)0.5 (e)0.5 (p)0.5 (o)0.6 (r)0.5 (t)0.5 (i)0.5 (n)0.6 (g)0.5 ( a)0.5 (n)0.5 (d)0.6 ( t)0.5 (o)0.5 ( o)0.5 (b)0.6 (t)0.5 (a)0.5 (i)0.6 (n)-6 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.045 Td
[(instructions on collection of pa)-9.8 (tient samples for testing of secondar)-17.7 (y malignanc)20.2 (y)55.2 (.)]TJ
/T1_1 1 Tf
0.017 Tw 0 -1.873 Td
(5.11)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
(Effects on Ability to Drive and Use Machines)Tj
/T1_0 1 Tf
-0.011 Tc 0.078 Tw -3.375 -1.585 Td
[(Due to the potential for neurologic events,)37.3 ( inc)20.2 (luding altered mental sta)-9.8 (tus or seizures,)26 ( )]TJ
0.003 Tc 0.149 Tw 0 -1.045 Td
[(pa)-10 (tients receiving )37 (ABECMA are a)-9.9 (t risk for altered or decreased consciousness or)3 ( )]TJ
-0.009 Tc 0.087 Tw 0 -1.045 Td
[(coordina)-9.6 (tion in the eight weeks follo)-9.6 (wing )37.1 (ABECMA infusion.)37.3 ( )37.2 (Advise pa)-9.6 (tients to refrain)-9 ( )]TJ
-0.006 Tc 0.103 Tw 0 -1.045 Td
[(from driving and enga)-9.7 (ging in hazardous occupa)-9.8 (tions or activities,)37.2 ( such as opera)-9.8 (ting)-6 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.045 Td
[(hea)-9.8 (vy or potentially dangerous machiner)-17.8 (y)55.3 (,)37.2 ( during this initial period.)]TJ
/T1_1 1 Tf
0.017 Tw 0 -2.048 Td
(6)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
(ADVERSE REACTIONS)Tj
/T1_0 1 Tf
-3.375 -1.72 Td
[(The follo)-9.8 (wing adverse reactions are described elsewhere in the labeling:)]TJ
0.017 Tw 1.192 -1.603 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.508 0 Td
[(Early Dea)-9.8 (th )]TJ
/T1_2 1 Tf
[([see )37.2 (W)18.2 (arnings and Precautions \(5.1\),)37.2 ( Clinical Studies \(14\)])]TJ
/T1_0 1 Tf
0.017 Tw -1.508 -1.412 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.508 0 Td
(Cytokine Release Syndrome )Tj
/T1_2 1 Tf
[([see )37.2 (W)18.2 (arnings and Precautions \(5.2\)])]TJ
/T1_0 1 Tf
0.017 Tw -1.508 -1.412 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.011 Tw 1.508 0 Td
[(Neurologic T)74.2 (oxicities )]TJ
/T1_2 1 Tf
0.048 Tw 7.491 0 Td
[([see )37.3 (W)18.1 (arnings and Precautions \(5.3\)])]TJ
/T1_0 1 Tf
0.017 Tw -8.999 -1.412 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.005 Tc 0.109 Tw 1.508 0 Td
[(Hemopha)-10 (goc)20 (ytic L)37 (ymphohistioc)20 (ytosis \(HLH\)/Macropha)-10 (ge )36.9 (Activa)-10 (tion Syndrome)-5 ( )]TJ
-0.017 Tc 0.017 Tw 0 -1.063 Td
(\(MAS\) )Tj
/T1_2 1 Tf
0.048 Tw 2.371 0 Td
[([see )37.2 (W)18.2 (arnings and Precautions \(5.4\)])]TJ
/T1_0 1 Tf
0.017 Tw -3.878 -1.412 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.508 0 Td
(Hypersensitivity Reactions )Tj
/T1_2 1 Tf
[([see )37.2 (W)18.2 (arnings and Precautions \(5.6\)])]TJ
/T1_0 1 Tf
0.017 Tw -1.508 -1.412 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
1.508 0 Td
(Infections )Tj
/T1_2 1 Tf
0.048 Tw 3.672 0 Td
[([see )37.3 (W)18.1 (arnings and Precautions \(5.7\)])]TJ
/T1_0 1 Tf
0.017 Tw -5.179 -1.412 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.508 0 Td
(Prolonged Cytopenias )Tj
/T1_2 1 Tf
[([see )37.2 (W)18.2 (arnings and Precautions \(5.8\)])]TJ
/T1_0 1 Tf
0.017 Tw -1.508 -1.412 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
1.508 0 Td
[(Hypogamma)-9.8 (globulinemia )]TJ
/T1_2 1 Tf
0.048 Tw 9.286 0 Td
[([see )37.3 (W)18.2 (arnings and Precautions \(5.9\)])]TJ
/T1_1 1 Tf
0.017 Tw -11.986 -1.682 Td
(6.1)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
[(Clinical T)74.2 (rials Experience)]TJ
/T1_0 1 Tf
-0.014 Tc 0.066 Tw -3.375 -1.585 Td
[(Because c)19.6 (linical trials are conducted under widely var)-18.4 (ying conditions,)36.6 ( adverse reaction)-14 ( )]TJ
-0.017 Tc 0.045 Tw 0 -1.045 Td
[(ra)-9.8 (tes obser)-17.8 (ved in the c)20.2 (linical trials of a drug cannot be directly compared to ra)-9.8 (tes in the)-17 ( )]TJ
0.048 Tw 0 -1.045 Td
[(c)20.2 (linical trials of another drug and may not re\036ect the ra)-9.7 (tes obser)-17.8 (ved in c)20.1 (linical practice.)]TJ
0.012 Tc 0.193 Tw 0 -1.765 Td
[(The safety da)-9.7 (ta described in the )37.1 (W)18.2 (ARNINGS and PRECAUTIONS section reflect)11.9 ( )]TJ
-0.004 Tc 0.114 Tw 0 -1.045 Td
[(exposure to )37.2 (ABECMA in 349 pa)-10 (tients with rela)-9.9 (psed or refractor)-18 (y multiple myeloma:)33 ( )]TJ
0 Tc 0 Tw 31.5 0 Td
( )Tj
ET
1 w 4 M 
q 1 0 0 1 319.5 732.96 cm
0 0 m
0 -52.56 l
S
Q
q 1 0 0 1 319.5 612 cm
0 0 m
0 -75.6 l
S
Q
q 1 0 0 1 319.5 436.2292 cm
0 0 m
0 -67.248 l
S
Q
q 1 0 0 1 319.5 363.7344 cm
0 0 m
0 -43.632 l
S
Q
endstreamendobj107 0 obj<</Length 25570>>stream
q
/GS0 gs
0 TL/Fm0 Do
Q
0 0 0 0 k
/GS0 gs
36 732.96 252 -10.212 re
36 722.748 50.76 -21.412 re
86.76 722.748 201.24 -21.412 re
36 701.336 50.76 -52.672 re
86.76 701.336 201.24 -52.672 re
36 648.664 50.76 -98.052 re
86.76 648.664 201.24 -98.052 re
36 550.612 50.76 -106.552 re
86.76 550.612 201.24 -106.552 re
36 444.06 50.76 -98.052 re
86.76 444.06 201.24 -98.052 re
36 346.008 252 -12.912 re
f
0 0 0 1 K
0.5 w 
/GS1 gs
q 1 0 0 1 36 333.0966 cm
0 0 m
50.76 0 l
S
Q
q 1 0 0 1 86.76 333.0966 cm
0 0 m
201.24 0 l
S
Q
1 w 
q 1 0 0 1 36 722.748 cm
0 0 m
50.76 0 l
S
Q
q 1 0 0 1 36 346.0085 cm
0 0 m
50.76 0 l
S
Q
0.5 w 
q 1 0 0 1 36 701.3361 cm
0 0 m
50.76 0 l
S
Q
q 1 0 0 1 36 648.6642 cm
0 0 m
50.76 0 l
S
Q
q 1 0 0 1 36 550.6123 cm
0 0 m
50.76 0 l
S
Q
q 1 0 0 1 36 444.0604 cm
0 0 m
50.76 0 l
S
Q
1 w 
q 1 0 0 1 86.76 722.748 cm
0 0 m
201.24 0 l
S
Q
q 1 0 0 1 86.76 346.0085 cm
0 0 m
201.24 0 l
S
Q
0.5 w 
q 1 0 0 1 86.76 701.5861 cm
0 0 m
0 20.662 l
S
Q
q 1 0 0 1 86.76 701.3361 cm
0 0 m
201.24 0 l
S
Q
q 1 0 0 1 86.76 648.9142 cm
0 0 m
0 52.172 l
S
Q
q 1 0 0 1 86.76 648.6642 cm
0 0 m
201.24 0 l
S
Q
q 1 0 0 1 86.76 550.8623 cm
0 0 m
0 97.552 l
S
Q
q 1 0 0 1 86.76 550.6123 cm
0 0 m
201.24 0 l
S
Q
q 1 0 0 1 86.76 444.3104 cm
0 0 m
0 106.052 l
S
Q
q 1 0 0 1 86.76 444.0604 cm
0 0 m
201.24 0 l
S
Q
q 1 0 0 1 86.76 346.5085 cm
0 0 m
0 97.302 l
S
Q
BT
0 0 0 1 k
/GS2 gs
/T1_0 1 Tf
-0.017 Tc 0.048 Tw 8 0 0 8 36 727.248 Tm
[(T)74.2 (able 2:)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
5 0 Td
[(Neurologic T)74.2 (oxicity Grading and Management Guidance)]TJ
-0.012 Tc 0.012 Tw 7.6 0 0 8 36 713.4362 Tm
[(Neurologic)-12 ( )]TJ
0.048 Tw 0 -1.062 Td
[(T)74.2 (oxicity Grade)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 77.8803 707.6002 Tm
(a)Tj
7.6 0 0 8 80.4392 704.9362 Tm
(\037)Tj
-0.012 Tc 0.048 Tw 1.424 0.531 Td
(Corticosteroids and Antiseizure Medications)Tj
-7.271 -4.63 Td
(Grade 1)Tj
/T1_1 1 Tf
7.271 2.485 Td
[(Start non-seda)-9.8 (ting,)37.2 ( antiseizure medicines \(e.g.,)37.2 ( levetiracetam\) for)-12 ( )]TJ
0 -1.062 Td
(seizure prophylaxis.)Tj
0 -1.423 Td
[(If 72 hours or more after infusion,)37.2 ( obser)-17.8 (ve pa)-9.8 (tient.)]TJ
0 -1.423 Td
[(If less than 72 hours after infusion,)37.2 ( consider dexamethasone 10 mg IV)-11.9 ( )]TJ
0 -1.062 Td
[(ever)-17.8 (y 12 to 24 hours for 2 to 3 days.)]TJ
/T1_0 1 Tf
-7.271 -6.935 Td
(Grade 2)Tj
/T1_1 1 Tf
7.271 5.321 Td
[(Start non-seda)-9.8 (ting,)37.2 ( antiseizure medicines \(e.g.,)37.2 ( levetiracetam\) for)-12 ( )]TJ
0 -1.062 Td
(seizure prophylaxis.)Tj
0 -1.423 Td
[(Start dexamethasone 10 mg IV ever)-17.8 (y 12 hours for 2-3 days,)37.2 ( or longer)-12 ( )]TJ
0 -1.062 Td
(for persistent symptoms.)Tj
0 -1.423 Td
[(Consider ta)-9.8 (per for a total corticosteroid exposure of grea)-9.7 (ter than)-12 ( )]TJ
0 -1.062 Td
[(3 days.)37.2 ( Corticosteroids are not recommended for isola)-9.8 (ted Grade 2)-12 ( )]TJ
0.012 Tw 0 -1.062 Td
(headaches.)Tj
0.048 Tw 0 -1.423 Td
[(If no improvement after 24 hours or worsening of neurologic toxicity)55.2 (,)25 ( )]TJ
0 -1.062 Td
[(increase the dose and/or frequenc)20.2 (y of dexamethasone up to a)-12 ( )]TJ
0 -1.062 Td
[(maximum of 20 mg IV ever)-17.7 (y 6 hours.)]TJ
/T1_0 1 Tf
-7.271 -7.466 Td
(Grade 3)Tj
/T1_1 1 Tf
7.271 5.852 Td
[(Start non-seda)-9.8 (ting,)37.2 ( antiseizure medicines \(e.g.,)37.2 ( levetiracetam\) for)-12 ( )]TJ
0 -1.062 Td
(seizure prophylaxis.)Tj
0 -1.423 Td
[(Start dexamethasone 10 to 20 mg IV ever)-17.8 (y 6 to 12 hours.)25 ( )]TJ
0 -1.062 Td
[(Corticosteroids are not recommended for isola)-9.8 (ted Grade 3 headaches.)]TJ
0 -1.423 Td
[(If no improvement after 24 hours or worsening of neurologic toxicity)55.2 (,)25 ( )]TJ
0 -1.062 Td
[(escala)-9.8 (te to methylprednisolone \(2 mg/kg loading dose,)37.2 ( follo)-9.8 (wed by)-12 ( )]TJ
0 -1.062 Td
[(2 mg/kg divided into 4 times a day; ta)-9.7 (per within 7 days\).)]TJ
0 -1.423 Td
[(If cerebral edema is suspected,)37.2 ( consider hyper)-17.7 (ventila)-9.8 (tion and)-12 ( )]TJ
0 -1.062 Td
[(hyperosmolar thera)-9.8 (py)55.3 (.)37.1 ( Give high-dose methylprednisolone \(1-2 g,)25 ( )]TJ
0 -1.062 Td
[(repea)-9.8 (t ever)-17.8 (y 24 hours if needed; ta)-9.7 (per as c)20.2 (linically indica)-9.8 (ted\) and)-12 ( )]TJ
0 -1.062 Td
[(c)20.2 (yc)20.2 (lophosphamide 1.5 g/m)]TJ
0 Tc 0 Tw 5.32 0 0 5.6 165.6794 450.3244 Tm
(2)Tj
7.6 0 0 8 168.168 447.6604 Tm
(.)Tj
/T1_0 1 Tf
-0.012 Tc 0.048 Tw -17.391 -6.935 Td
(Grade 4)Tj
/T1_1 1 Tf
7.271 5.321 Td
[(Start non-seda)-9.8 (ting,)37.2 ( antiseizure medicines \(e.g.,)37.2 ( levetiracetam\) for)-12 ( )]TJ
0 -1.062 Td
(seizure prophylaxis.)Tj
0 -1.423 Td
[(Start dexamethasone 20 mg IV ever)-17.8 (y 6 hours.)]TJ
0 -1.423 Td
[(If no improvement after 24 hours or worsening of neurologic toxicity)55.2 (,)25 ( )]TJ
0 -1.062 Td
[(escala)-9.8 (te to high-dose methylprednisolone \(1-2 g,)37.2 ( repea)-9.8 (t ever)-17.8 (y)-11.9 ( )]TJ
0 -1.062 Td
[(24 hours if needed; ta)-9.8 (per as c)20.2 (linically indica)-9.8 (ted\).)]TJ
0 -1.423 Td
[(If cerebral edema is suspected,)37.2 ( consider hyper)-17.7 (ventila)-9.8 (tion and)-12 ( )]TJ
0 -1.062 Td
[(hyperosmolar thera)-9.8 (py)55.3 (.)37.1 ( Give high-dose methylprednisolone \(1-2 g,)25 ( )]TJ
0 -1.062 Td
[(repea)-9.8 (t ever)-17.8 (y 24 hours if needed; ta)-9.7 (per as c)20.2 (linically indica)-9.8 (ted\),)37.2 ( and)-12 ( )]TJ
0 -1.062 Td
[(c)20.2 (yc)20.2 (lophosphamide 1.5 g/m)]TJ
0 Tc 0 Tw 5.32 0 0 5.6 165.6794 352.2725 Tm
(2)Tj
7.6 0 0 8 168.168 349.6085 Tm
(.)Tj
-0.012 Tc 0.012 Tw 5.32 0 0 5.6 36 339.3606 Tm
(a)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 41 336.6966 Tm
(NCI CTCAE criteria for grading neurologic toxicities version 4.03.)Tj
/T1_0 1 Tf
-0.017 Tc 0.017 Tw 8 0 0 8 36 311.9656 Tm
(3)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
(DOSAGE FORMS AND STRENGTHS)Tj
/T1_1 1 Tf
-3.375 -1.741 Td
[(ABECMA is a cell suspension for intra)-9.7 (venous infusion.)]TJ
-0.004 Tc 0.115 Tw 0 -1.786 Td
[(A single dose of )37.4 (ABECMA contains a cell suspension of 300 to 510 x 10)]TJ
0 Tc 0 Tw 5.6 0 0 5.6 257.2665 286.4076 Tm
(6)Tj
-0.004 Tc 0.115 Tw 8 0 0 8 259.9328 283.7436 Tm
[( chimeric)-4 ( )]TJ
-0.017 Tc 0.054 Tw -27.992 -1.066 Td
[(antigen receptor \(CAR\)-positive )37.3 (T cells in one or more infusion ba)-9.8 (gs )]TJ
/T1_2 1 Tf
[([see Ho)-9.8 (w Supplied/)]TJ
0.048 Tw 0 -1.066 Td
[(Stora)-9.7 (ge and Handl)]TJ
(ing \(16\)])Tj
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
/T1_0 1 Tf
-0.017 Tc 0.017 Tw 0 -2.07 Td
(4)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3.375 0 Td
[(CONTRAINDIC)18.2 (A)55.2 (TIONS)]TJ
/T1_1 1 Tf
-3.375 -1.741 Td
(None.)Tj
/T1_0 1 Tf
0 -2.07 Td
(5)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
[(W)18.2 (ARNINGS AND PREC)18.2 (AUTIONS)]TJ
0.017 Tw -3.375 -1.85 Td
(5.1)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
(Early Death)Tj
/T1_1 1 Tf
0.003 Tc 0.152 Tw -3.375 -1.606 Td
[(In KarMMa-3,)36.5 ( )0.5 (a )0.5 (randomized \(2:1\),)36.5 ( )0.5 (controlled )0.5 (trial,)36.6 ( )0.5 (a higher proportion )0.5 (of )0.5 (pa)-10.4 (tients)3 ( )]TJ
-0.017 Tc 0.049 Tw 0 -1.066 Td
[(experienced dea)-9.8 (th within nine months after randomiza)-9.8 (tion in the )36.7 (ABECMA arm \(45/254;)-17 ( )]TJ
0.036 Tw 0 -1.066 Td
[(1)0.5 (8)0.5 (%)0.6 (\))0.5 ( )0.5 (c)0.6 (o)0.5 (m)0.5 (p)0.5 (a)0.6 (r)0.5 (e)0.5 (d)0.5 ( )0.6 (t)0.5 (o)0.5 ( )0.6 (t)0.5 (h)0.5 (e)0.5 ( )0.6 (s)0.5 (t)0.5 (a)0.5 (n)0.6 (d)0.5 (a)0.5 (r)0.5 (d)0.6 ( )0.5 (r)0.5 (e)0.5 (g)0.6 (i)0.5 (m)0.5 (e)0.5 (n)0.6 (s)0.5 ( )0.5 (a)0.5 (r)0.6 (m)0.5 ( )0.5 (\()0.6 (1)0.5 (5)0.5 (/)0.5 (1)0.5 (3)0.6 (2)0.5 (;)0.5 ( )0.5 (1)0.6 (1)0.5 (%)0.5 (\))0.5 ( )]TJ
/T1_2 1 Tf
0.017 Tw 22.279 0 Td
[([)0.5 (s)0.5 (e)0.6 (e)0.5 ( )]TJ
0.036 Tw 1.742 0 Td
[(C)0.5 (l)0.5 (i)0.6 (n)0.5 (i)0.5 (c)0.5 (a)0.6 (l)0.5 ( )0.5 (S)0.5 (t)0.6 (u)0.5 (d)0.5 (i)0.5 (e)0.5 (s)0.6 ( )0.5 (\()0.5 (1)0.5 (4)0.6 (\))]TJ
0 Tc 0 Tw 7.034 0 Td
(])Tj
/T1_1 1 Tf
-0.037 Tc 0.037 Tw 0.241 0 Td
(. )Tj
-0.012 Tc 0.076 Tw -31.297 -1.066 Td
[(Early dea)-10.3 (ths occurred in 8% \(20/254\) and 0% prior to )36.9 (ABECMA infusion and standard)-12 ( )]TJ
-0.02 Tc 0.036 Tw 0 -1.066 Td
[(r)0.5 (e)0.6 (g)0.5 (i)0.5 (m)0.5 (e)0.6 (n)0.5 ( )0.5 (a)0.6 (d)0.5 (m)0.5 (i)0.5 (n)0.6 (i)0.5 (s)0.5 (t)0.5 (r)0.6 (a)-9.5 (t)0.5 (i)0.6 (o)0.5 (n)0.5 (,)37.5 ( )0.6 (r)0.5 (e)0.5 (s)0.5 (p)0.6 (e)0.5 (c)0.5 (t)0.5 (i)0.6 (v)0.5 (e)0.5 (l)0.6 (y)55.5 (,)37.5 ( )0.5 (a)0.6 (n)0.5 (d)0.5 ( )0.5 (1)0.5 (0)0.6 (%)0.5 ( )0.5 (\()0.6 (2)0.5 (5)0.5 (/)0.5 (2)0.5 (5)0.6 (4)0.5 (\))0.5 ( )0.5 (a)0.6 (n)0.5 (d)0.5 ( )0.5 (1)0.5 (1)0.6 (%)0.5 ( )0.5 (\()0.5 (1)0.6 (5)0.5 (/)0.5 (1)0.5 (3)0.6 (2)0.5 (\))0.5 ( )0.5 (a)0.6 (f)0.5 (t)0.5 (e)0.5 (r)0.6 ( )37.5 (A)0.5 (B)0.5 (E)0.6 (C)0.5 (M)0.5 (A)-20 ( )]TJ
-0.009 Tc 0.09 Tw 0 -1.066 Td
[(infusion and standard )0.5 (regimen administra)-10.1 (tion,)36.9 ( respectively)54.9 (.)36.9 ( Out of the 20 dea)-10 (ths tha)-10.1 (t)-9 ( )]TJ
-0.011 Tc 0.076 Tw 0 -1.066 Td
[(o)0.5 (c)0.6 (c)0.5 (u)0.5 (r)0.6 (r)0.5 (e)0.5 (d)0.6 ( p)0.5 (r)0.5 (i)0.6 (o)0.5 (r)0.5 ( t)0.6 (o)0.5 ( )37.2 (A)0.5 (B)0.5 (E)0.6 (C)0.5 (M)0.5 (A)0.5 ( i)0.6 (n)0.5 (f)0.5 (u)0.6 (s)0.5 (i)0.5 (o)0.6 (n)0.5 (,)37.5 ( 1)0.5 (5)0.6 ( o)0.6 (c)0.5 (c)0.6 (u)0.5 (r)0.5 (r)0.5 (e)0.6 (d)0.5 ( f)0.5 (r)0.6 (o)0.5 (m)0.6 ( d)0.6 (i)0.5 (s)0.5 (e)0.6 (a)0.5 (s)0.6 (e)0.5 ( p)0.5 (r)0.5 (o)0.6 (g)0.5 (r)0.5 (e)0.6 (s)0.5 (s)0.5 (i)0.6 (o)0.5 (n)0.5 (,)37.6 ( 3)0.5 ( o)0.5 (c)0.5 (c)0.6 (u)0.5 (r)0.5 (r)0.6 (e)0.5 (d)-11 ( )]TJ
-0.012 Tc 0.073 Tw 0 -1.066 Td
[(from adverse )0.5 (events )0.5 (and 2 )0.5 (occurred )0.5 (from )0.5 (unkno)-9.7 (wn causes.)37.2 ( )0.5 (Out )0.5 (of )0.5 (the 25 )0.5 (dea)-9.7 (ths tha)-9.7 (t)-12 ( )]TJ
-0.008 Tc 0.097 Tw 0 -1.066 Td
[(occurred after )37.3 (ABECMA infusion,)36.6 ( 10 occurred from disease progression,)36.6 ( 11 occurred)-7.9 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.066 Td
[(from adverse events,)37.2 ( and 4 occurred from unkno)-9.8 (wn causes.)]TJ
/T1_0 1 Tf
0.017 Tw 0 -1.895 Td
(5.2)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
(Cytokine Release Syndrome \(CRS\))Tj
/T1_1 1 Tf
-0.003 Tc 0.121 Tw -3.375 -1.606 Td
[(CRS,)36.6 ( inc)19.7 (luding fa)-10.4 (tal or life-threa)-10.4 (tening reactions,)36.6 ( occurred follo)-10.4 (wing trea)-10.3 (tment with)-3 ( )]TJ
-0.019 Tc 0.036 Tw 0 -1.066 Td
[(ABECMA.)36.9 ( )36.8 (Among pa)-10.1 (tients receiving )36.9 (ABECMA for rela)-10.2 (psed or refractor)-18.1 (y multiple myeloma)-19 ( )]TJ
0.002 Tc 0.142 Tw 0 -1.066 Td
[(in the KarMMa and KarMMa-3 studies \(N=349\),)37.3 ( CRS occurred in 89% \(310/349\),)39 ( )]TJ
-0.012 Tc 0.075 Tw 0 -1.066 Td
[(inc)19.8 (luding \034Grade 3 CRS \(Lee grading system\) in 7% \(23/349\) of pa)-10.1 (tients and Grade 5)-12 ( )]TJ
-0.005 Tc 0.107 Tw 0 -1.066 Td
[(CRS in 0.9% \(3/349\) of pa)-9.6 (tients.)37.4 ( )37 (The median time-to-onset of CRS,)37.4 ( an)-9.7 (y grade,)37.3 ( was)-5 ( )]TJ
-0.011 Tc 0.079 Tw 0 -1.066 Td
[(1 day \(range:)36.9 ( 1 to 27 days\),)36.9 ( and the median dura)-10 (tion of CRS was 5 days \(range:)37 ( 1 to)-11 ( )]TJ
-0.013 Tc 0.069 Tw 0 -1.066 Td
[(63 )0.5 (days\).)37 ( In the )0.5 (pooled studies,)37 ( )0.5 (the ra)-9.9 (te )0.5 (of )0.5 (\034Grade )0.5 (3 )0.5 (CRS was 10% \(7/71\) for pa)-9.9 (tients)-13 ( )]TJ
ET
1 w 4 M 
q 1 0 0 1 31.5 199.2959 cm
0 0 m
0 -87.696 l
S
Q
q 1 0 0 1 31.5 93.8159 cm
0 0 m
0 -59.256 l
S
Q
BT
-0.003 Tc 0.003 Tw 8 0 0 8 324 727.248 Tm
[(trea)-10 (ted )]TJ
0.119 Tw 2.954 0 Td
(in dose range of 460 to 510 x 10)Tj
0.003 Tw 5.6 0 0 5.6 451.313 729.912 Tm
(6 )Tj
0.119 Tw 8 0 0 8 455.9765 727.248 Tm
[(CAR-positive )37.1 (T cells and 5.4% \(13/241\))-3 ( )]TJ
-0.017 Tc 0.048 Tw -16.497 -1.053 Td
[(for pa)-9.8 (tients trea)-9.8 (ted in dose range of 300 to 460 x 10)]TJ
0.017 Tw 5.6 0 0 5.6 476.1112 721.4876 Tm
(6 )Tj
0.011 Tw 8 0 0 8 480.2193 718.8236 Tm
[(CAR-positive T )-36.8 (cells.)]TJ
-0.001 Tc 0.129 Tw -19.527 -1.773 Td
[(The most common manifesta)-10 (tions of CRS \(grea)-10 (ter than or equal to 10%\) inc)20 (luded)-1 ( )]TJ
-0.013 Tc 0.068 Tw 0 -1.053 Td
[(pyrexia \(87%\),)37.2 ( hypotension \(30%\),)37.2 ( tachycardia \(26%\),)37.2 ( chills \(19%\),)37.1 ( and hypoxia \(16%\).)24 ( )]TJ
-0.018 Tc 0.036 Tw 0 -1.053 Td
[(Gr)0.5 (a)0.5 (de)0.5 ( 3)0.5 ( o)0.5 (r)0.5 ( hi)0.5 (gh)0.5 (er)0.5 ( )0.5 (ev)0.5 (en)0.5 (ts)0.5 ( t)0.5 (ha)-9.5 (t)0.5 ( m)0.5 (ay)0.5 ( b)0.5 (e )0.5 (a)0.5 (sso)0.5 (c)0.5 (ia)-9.5 (te)0.5 (d)0.5 ( w)0.5 (it)0.5 (h C)0.5 (R)0.5 (S i)0.5 (nc)20.5 (lu)0.5 (de)0.5 ( h)0.5 (yp)0.5 (o)0.5 (te)0.5 (nsi)0.5 (o)0.5 (n,)37.5 ( h)0.5 (yp)0.5 (ox)0.5 (ia)0.5 (,)19 ( )]TJ
-0.006 Tc 0.105 Tw 0 -1.053 Td
[(hyperbilirubinemia,)36.7 ( hypo\037brinogenemia,)36.7 ( )36.6 (ARDS,)36.8 ( a)-10.2 (trial \037brilla)-10.2 (tion,)36.8 ( hepa)-10.2 (tocellular injur)-18.2 (y)54.8 (,)31 ( )]TJ
0.004 Tc 0.156 Tw 0 -1.053 Td
[(metabolic acidosis,)36.6 ( pulmonar)-18.4 (y edema,)36.6 ( coa)-10.3 (gulopa)-10.4 (thy)54.7 (,)36.6 ( renal failure,)36.6 ( multiple organ)4 ( )]TJ
-0.013 Tc 0.068 Tw 0 -1.053 Td
[(d)-9.8 (ysfunction syndrome and hemopha)-9.7 (goc)20.3 (ytic lymphohistioc)20.2 (ytosis/macropha)-9.8 (ge activa)-9.8 (tion)-13 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.053 Td
(syndrome \(HLH/MAS\) )Tj
/T1_2 1 Tf
0.011 Tw [([see Adverse )-36.8 (Reactio)]TJ
0.048 Tw (ns \(6.1\)])Tj
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
-0.017 Tc 0.06 Tw 0 -1.773 Td
[(Identify CRS based on c)20.1 (linical presenta)-9.9 (tion.)37.1 ( Evalua)-9.9 (te for and trea)-9.9 (t other causes of fever)74.1 (,)20 ( )]TJ
-0.004 Tc 0.112 Tw 0 -1.053 Td
[(hypoxia,)37.2 ( and hypotension.)37.2 ( CRS has been reported to be associa)-9.7 (ted with \037ndings of)-4 ( )]TJ
-0.013 Tc 0.066 Tw 0 -1.053 Td
[(H)0.5 (LH)0.5 (/M)0.5 (AS)0.5 (,)37.4 ( a)0.5 (nd)0.5 ( th)0.5 (e)0.5 ( ph)0.5 (ys)0.5 (io)0.5 (lo)0.5 (g)-9.5 (y o)0.5 (f t)0.5 (h)0.5 (e s)0.5 (yn)0.5 (dr)0.5 (o)0.5 (me)0.5 (s m)0.5 (a)0.5 (y o)0.5 (ve)0.5 (rl)0.5 (a)-9.5 (p.)37.5 ( HL)0.5 (H)0.5 (/M)0.5 (AS)0.5 ( i)0.5 (s)0.5 ( a)0.5 ( p)0.5 (ot)0.5 (en)0.5 (ti)0.5 (a)0.5 (ll)0.5 (y)-13 ( )]TJ
-0.01 Tc 0.084 Tw 0 -1.053 Td
[(life-threa)-9.9 (tening condition.)37.1 ( In pa)-9.9 (tients with progressive symptoms of CRS or refractor)-18 (y)-9.9 ( )]TJ
-0.003 Tc 0.121 Tw 0 -1.053 Td
[(CRS despite trea)-10.3 (tment,)36.7 ( evalua)-10.4 (te for evidence of HLH/MAS.)36.7 ( Please see Section 5.4;)-2.9 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.053 Td
[(Hemopha)-9.8 (goc)20.2 (ytic L)37.2 (ymphohistioc)20.2 (ytosis/Macropha)-9.8 (ge )37.2 (Activa)-9.8 (tion Syndrome.)]TJ
0.052 Tw 0 -1.773 Td
[(Of the 349 pa)-9.7 (tients who received )37.2 (ABECMA in c)20.2 (linical trials,)37.2 ( 226 \(65%\) pa)-9.8 (tients received)-17 ( )]TJ
-0.015 Tc 0.06 Tw 0 -1.053 Td
[(tocilizumab; 39% \(135/349\) received a single dose,)36.8 ( while 26% \(91/349\) received more)-15 ( )]TJ
-0.017 Tc 0.039 Tw 0 -1.053 Td
[(than 1 dose of tocilizumab.)37.2 ( Overall,)37.2 ( 24% \(82/349\) of pa)-9.8 (tients received a)-9.7 (t least 1 dose of)-17 ( )]TJ
0 Tc 0 Tw 31.5 0 Td
( )Tj
-0.017 Tc 0.047 Tw -31.5 -1.053 Td
[(corticosteroids for trea)-9.7 (tment of CRS.)37.2 ( )37.1 (Almost all pa)-9.8 (tients who received corticosteroids for)-17 ( )]TJ
-0.012 Tc 0.072 Tw 0 -1.053 Td
[(CRS also received tocilizumab.)37.3 ( F)20.3 (or pa)-9.7 (tients trea)-9.7 (ted in dose range of 460 to 510 x 10)]TJ
0 Tc 0 Tw 5.6 0 0 5.6 573.312 552.5681 Tm
(6)Tj
8 0 0 8 576 549.9041 Tm
( )Tj
T*
( )Tj
-0.006 Tc 0.104 Tw -31.5 -1.053 Td
[(CAR-positive )37.2 (T cells,)37 ( 76% \(54/71\) of pa)-9.9 (tients received tocilizumab and 35% \(25/71\))-6 ( )]TJ
-0.007 Tc 0.097 Tw 0 -1.053 Td
[(received a)-9.6 (t least 1 dose of corticosteroids for trea)-9.7 (tment of CRS.)37.4 ( F)20.3 (or pa)-9.7 (tients trea)-9.6 (ted)-7 ( )]TJ
-0.004 Tc 0.116 Tw 0 -1.053 Td
(in dose range of 300 to 460 x 10)Tj
0.004 Tw 5.6 0 0 5.6 427.2818 527.2949 Tm
(6 )Tj
0.116 Tw 8 0 0 8 431.9179 524.6309 Tm
[(CAR-positive )37.3 (T cells,)36.8 ( 63% \(152/241\) of pa)-10.3 (tients)-4 ( )]TJ
-0.008 Tc 0.094 Tw -13.49 -1.053 Td
[(received tocilizumab and 20% \(49/241\) received a)-10 (t least 1 dose of corticosteroid for)-8 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.053 Td
[(trea)-9.7 (tment of CRS.)]TJ
-0.001 Tc 0.127 Tw 0 -1.773 Td
[(Ensure tha)-9.7 (t a minimum of two doses of tocilizumab are a)-9.8 (vailable prior to infusion)-1 ( )]TJ
-0.017 Tc 0.011 Tw 0 -1.053 Td
(of ABECMA.)Tj
-0.014 Tc 0.066 Tw 0 -1.773 Td
[(Monitor pa)-10.3 (tients a)-10.3 (t least daily for seven days follo)-10.3 (wing )37.1 (ABECMA infusion a)-10.3 (t the REMS-)]TJ
-0.011 Tc 0.08 Tw 0 -1.053 Td
[(certi\037ed healthcare facility for signs and symptoms of CRS.)36.8 ( Monitor pa)-10.1 (tients for signs)-11 ( )]TJ
-0.004 Tc 0.111 Tw 0 -1.053 Td
[(o)0.5 (r sy)0.5 (mpt)0.5 (o)0.5 (ms)0.5 ( o)0.5 (f CR)0.5 (S f)0.5 (o)0.5 (r a)-9.6 (t)0.5 ( l)0.5 (ea)0.5 (st)0.5 ( f)0.5 (ou)0.5 (r we)0.5 (ek)0.5 (s af)0.5 (t)0.5 (er)0.5 ( i)0.5 (nf)0.5 (usi)0.5 (on)0.5 (.)37.4 ( )36.7 (At)0.5 ( t)0.5 (he)0.5 ( \037)0.5 (rst)0.5 ( s)0.5 (ig)0.5 (n of)0.5 ( C)0.5 (RS)0.5 (,)33 ( )]TJ
-0.014 Tc 0.061 Tw 0 -1.053 Td
[(i)0.5 (n)0.5 (s)0.5 (t)0.5 (it)0.5 (u)0.5 (t)0.5 (e)0.5 ( t)0.5 (r)0.5 (ea)-9.5 (t)0.5 (m)0.5 (e)0.5 (n)0.5 (t)0.5 ( w)0.5 (i)0.5 (th)0.5 ( s)0.5 (u)0.5 (pp)0.5 (o)0.5 (r)0.5 (t)0.5 (i)0.5 (v)0.5 (e)0.5 ( c)0.5 (a)0.5 (r)0.5 (e)0.5 (,)37.5 ( to)0.5 (c)0.5 (i)0.5 (l)0.5 (i)0.5 (z)0.5 (u)0.5 (m)0.5 (a)0.5 (b a)0.5 (n)0.5 (d)0.5 (/o)0.5 (r)0.5 ( c)0.5 (o)0.5 (r)0.5 (t)0.5 (ic)0.5 (o)0.5 (s)0.5 (t)0.5 (e)0.5 (r)0.5 (o)0.5 (i)0.5 (d)0.5 (s)0.5 ( a)0.5 (s)0.5 ( i)0.5 (n)0.5 (d)0.5 (i)0.5 (c)0.5 (a)-9.5 (t)0.5 (e)0.5 (d)-14 ( )]TJ
/T1_2 1 Tf
-0.017 Tc 0.048 Tw 0 -1.053 Td
[([see Dosa)-9.8 (ge and )37.2 (Administra)-9.8 (ti)]TJ
(on \(2.3\)])Tj
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
-0.017 Tc 0.036 Tw 0 -1.773 Td
[(Counsel pa)-9.7 (tients to seek immedia)-9.8 (te medical a)-9.8 (ttention should signs or symptoms of CRS)-17 ( )]TJ
0.048 Tw 0 -1.053 Td
[(occur a)-9.7 (t an)-9.8 (y time )]TJ
/T1_2 1 Tf
[([see P)18.2 (a)-9.8 (tient Counseling Informa)-9.8 (t)]TJ
(ion \(17\)])Tj
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
/T1_0 1 Tf
-0.017 Tc 0.017 Tw 0 -1.792 Td
(5.3)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
[(Neurologic T)74.2 (oxicities)]TJ
/T1_1 1 Tf
-0.008 Tc 0.093 Tw -3.375 -1.593 Td
[(Neurologic toxicities,)37.2 ( inc)20.2 (luding immune-effector cell-associa)-9.8 (ted neurotoxicity \(ICANS\),)29 ( )]TJ
-0.006 Tc 0.107 Tw 0 -1.053 Td
[(which )0.5 (may be )0.5 (severe )0.5 (or )0.5 (life-threa)-10.4 (tening,)36.6 ( )0.5 (occurred concurrently with CRS,)36.5 ( )0.5 (after CRS)-6 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.053 Td
[(resolution,)37.2 ( or in the absence of CRS follo)-9.7 (wing trea)-9.8 (tment with )37.2 (ABECMA.)]TJ
0.002 Tc 0.141 Tw 0 -1.773 Td
[(In)0.5 ( pa)-9.5 (ti)0.5 (ent)0.5 (s r)0.5 (ec)0.5 (eiv)0.5 (ing)0.5 ( )36.6 (ABE)0.5 (CM)0.5 (A in)0.5 ( th)0.5 (e K)0.5 (ar)0.5 (MMa)0.5 ( an)0.5 (d K)0.5 (ar)0.5 (MMa)0.5 (-3 stu)0.5 (die)0.5 (s,)37.5 ( CAR)0.5 ( )36.6 (T c)0.5 (el)0.5 (l-)]TJ
-0.013 Tc 0.067 Tw 0 -1.053 Td
[(associa)-9.7 (ted neurotoxicity occurred in 40% \(139/349\),)37.3 ( inc)20.3 (luding Grade 3 in 4% \(14/349\))-13 ( )]TJ
-0.017 Tc 0.055 Tw 0 -1.053 Td
[(and )0.5 (Grade 4 )0.5 (in 0.6% \(2/349\) of )0.5 (pa)-9.8 (tients.)37.3 ( )37.3 (The median time )0.5 (to onset of neurotoxicity was)-17 ( )]TJ
-0.022 Tc 0.035 Tw 0 -1.053 Td
[(2 )0.6 (da)0.5 (ys)0.5 ( )0.5 (\()0.5 (ra)0.5 (ng)0.5 (e:)37.4 ( )0.6 (1 )0.6 (t)0.5 (o )0.6 (14)0.5 (8 )0.5 (d)0.5 (ay)0.5 (s\))0.5 (.)37.4 ( )37.6 (The)0.5 ( )0.5 (m)0.5 (ed)0.5 (ia)0.5 (n )0.6 (du)0.5 (ra)-9.5 (ti)0.5 (on)0.5 ( )0.5 (o)0.5 (f )0.6 (CAR)0.5 ( )37.5 (T)0.5 ( )0.5 (c)0.5 (el)0.5 (l-)0.5 (as)0.5 (so)0.5 (cia)-9.5 (t)0.5 (ed )0.6 (ne)0.5 (ur)0.5 (ot)0.5 (ox)0.5 (ic)0.5 (it)0.5 (y)-22 ( )]TJ
-0.019 Tc 0.036 Tw 0 -1.053 Td
[(was 8 days \(range:)36.9 ( 1 to 720 days\) in all pa)-10.1 (tients inc)20 (luding those with ongoing neurologic)-19 ( )]TJ
-0.017 Tc 0.06 Tw 0 -1.053 Td
[(events a)-10.4 (t the time of dea)-10.4 (th or da)-10.4 (ta cut off.)36.6 ( CAR )36.6 (T cell-associa)-10.4 (ted neurotoxicity resolved)-17 ( )]TJ
-0.009 Tc 0.091 Tw 0 -1.053 Td
[(in 123 of 139 \(88%\) pa)-10.3 (tients and median time to resolution was 5 days \(range:)36.6 ( 1 to)-9 ( )]TJ
-0.007 Tc 0.102 Tw 0 -1.053 Td
[(245 )0.5 (days\).)36.6 ( )0.6 (One-hundred )0.6 (and )0.6 (thirty )0.6 (four )0.6 (out )0.6 (of )0.5 (349 )0.5 (\(38%\) )0.6 (pa)-10.3 (tients )0.5 (with )0.5 (neurotoxicity)-6.9 ( )]TJ
-0.008 Tc 0.095 Tw 0 -1.053 Td
[(had CRS.)36.9 ( )37.3 (The onset of neurotoxicity during CRS was obser)-18.1 (ved in 93 pa)-10.1 (tients,)36.9 ( before)-7.9 ( )]TJ
-0.007 Tc 0.101 Tw 0 -1.053 Td
[(the onset of CRS in 12 pa)-10.3 (tients,)36.7 ( and after the CRS event in 29 pa)-10.3 (tients.)36.8 ( )37.3 (The ra)-10.2 (te of)-6.9 ( )]TJ
-0.008 Tc 0.093 Tw 0 -1.053 Td
[(Grade 3 or 4 CAR )36.7 (T cell-associa)-9.9 (ted neurotoxicity was 5.6% \(4/71\) and 3.7% \(9/241\))-8 ( )]TJ
-0.013 Tc 0.069 Tw 0 -1.053 Td
[(for pa)-9.9 (tients trea)-10 (ted in dose range of 460 to 510 x 10)]TJ
0.013 Tw 5.6 0 0 5.6 479.733 266.5656 Tm
(6 )Tj
0.069 Tw 8 0 0 8 484.0053 263.9016 Tm
[(CAR-positive )37 (T cells and 300 to)-12.9 ( )]TJ
-0.017 Tc 0.054 Tw -20.001 -1.053 Td
(460 x 10)Tj
0.017 Tw 5.6 0 0 5.6 350.0569 258.1411 Tm
(6 )Tj
0.054 Tw 8 0 0 8 354.2006 255.4771 Tm
[(CAR-positive )36.8 (T cells,)37.2 ( respectively)55.2 (.)37.2 ( )36.9 (The most frequent \(grea)-9.8 (ter than or equal to)-17 ( )]TJ
-0.02 Tc 0.036 Tw -3.775 -1.053 Td
[(5%\) manifesta)-9.6 (t)0.5 (ions of CAR )37.4 (T ce)0.5 (ll-associa)-9.6 (ted neuroto)0.5 (xici)0.5 (ty inc)20.4 (lude )0.5 (encephalopa)-9.6 (thy \(21%\),)17 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.053 Td
[(headache \(15%\),)37.2 ( dizziness \(8%\),)37.2 ( delirium \(6%\),)37.2 ( and tremor \(6%\).)]TJ
-0.003 Tc 0.121 Tw -0.037 -1.773 Td
[(At the safety upda)-10.3 (te for KarMMa-3 stud)-10.3 (y)54.6 (,)36.6 ( one pa)-10.4 (tient developed fa)-10.4 (tal neurotoxicity)-3 ( )]TJ
-0.009 Tc 0.086 Tw 0.037 -1.053 Td
[(4)0.5 (3)0.6 ( d)0.5 (a)0.6 (y)0.5 (s)0.5 ( a)0.6 (f)0.5 (t)0.6 (e)0.5 (r)0.5 ( )37.3 (A)0.5 (B)0.5 (E)0.5 (C)0.6 (M)0.5 (A)0.5 (.)37.6 ( I)0.5 (n)0.5 ( K)0.5 (a)0.5 (r)0.6 (M)0.5 (M)0.5 (a)0.6 (,)37.5 ( o)0.6 (n)0.5 (e)0.5 ( p)0.5 (a)-9.5 (t)0.6 (i)0.5 (e)0.6 (n)0.5 (t)0.5 ( h)0.6 (a)0.5 (d)0.6 ( o)0.5 (n)0.5 (g)0.6 (o)0.5 (i)0.5 (n)0.6 (g)0.5 ( G)0.6 (r)0.5 (a)0.6 (d)0.5 (e)0.5 ( 2)0.6 ( n)0.5 (e)0.6 (u)0.5 (r)0.5 (o)0.6 (t)0.5 (o)0.6 (x)0.5 (i)0.5 (c)0.6 (i)0.5 (t)0.6 (y)0.5 ( a)-9.4 (t)-9 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.053 Td
[(the time of dea)-9.8 (th.)37.2 ( )37.2 (T)74.2 (wo pa)-9.8 (tients had ongoing Grade 1 tremor a)-9.8 (t the time of da)-9.8 (ta cutoff.)]TJ
-0.004 Tc 0.112 Tw 0 -1.773 Td
[(Cerebral edema has been associa)-9.6 (ted with )37.1 (ABECMA in a pa)-9.6 (tient in another stud)-9.7 (y in)-4 ( )]TJ
-0.003 Tc 0.119 Tw 0 -1.053 Td
[(multiple myeloma.)37 ( Grade 3 myelitis and Grade 3 parkinsonism ha)-10 (ve occurred after)-3 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.053 Td
[(trea)-9.7 (tment with )37.2 (ABECMA in another stud)-9.8 (y in multiple myeloma.)]TJ
-0.014 Tc 0.066 Tw 0 -1.773 Td
[(Monitor pa)-10.3 (tients a)-10.3 (t least daily for seven days follo)-10.3 (wing )37.1 (ABECMA infusion a)-10.3 (t the REMS-)]TJ
-0.022 Tc 0.036 Tw 0 -1.053 Td
[(certi\037ed healthcare facility for signs and symptoms of neurologic tox\icities.)36.6 ( Rule out other)-22 ( )]TJ
-0.012 Tc 0.075 Tw 0 -1.053 Td
[(causes of neurologic symptoms.)36.9 ( Monitor pa)-10.1 (tients for signs or symptoms of neurologic)-12 ( )]TJ
-0.008 Tc 0.093 Tw 0 -1.053 Td
[(toxicities for a)-9.8 (t least four weeks after infusion and trea)-9.7 (t promptly)55.1 (.)37.2 ( Neurologic toxicity)-8 ( )]TJ
-0.016 Tc 0.06 Tw 0 -1.053 Td
[(should be mana)-9.7 (ged with supportive care and/or corticosteroids as needed )]TJ
/T1_2 1 Tf
[([see Dosa)-9.6 (ge)-16 ( )]TJ
-0.017 Tc 0.011 Tw 0 -1.053 Td
[(and Administra)-9.8 (ti)]TJ
0.048 Tw (on \(2.3\)])Tj
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
-0.005 Tc 0.108 Tw 0 -1.773 Td
[(Counsel pa)-9.9 (tients to seek immedia)-9.9 (te medical a)-9.8 (ttention should signs or symptoms of)-5 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.053 Td
[(neurologic toxicity occur a)-9.8 (t an)-9.8 (y time )]TJ
/T1_2 1 Tf
[([see P)18.2 (a)-9.8 (tient Counseling Informa)-9.8 (t)]TJ
(ion \(17\)])Tj
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
/T1_0 1 Tf
-0.017 Tc 0.017 Tw 0 -1.882 Td
(5.4)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.011 Tc 0.191 Tw 3.375 0 Td
[(Hemophagoc)9.7 (ytic L)36.6 (ymphohistioc)9.7 (ytosis \(HLH\)/Macrophage Activ)15.7 (ation)11 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.072 Td
(Syndrome \(MAS\))Tj
/T1_1 1 Tf
-0.019 Tc 0.036 Tw -3.375 -1.593 Td
[(In pa)-10.3 (tients receiving )36.7 (ABECMA in the KarMMa and KarMMa-3 studies,)36.7 ( HLH/MAS occurred)-19 ( )]TJ
0.001 Tc 0.138 Tw 0 -1.053 Td
[(in )0.5 (2.9% )0.5 (\(10/349\) )0.5 (of )0.5 (pa)-9.8 (tients.)37.3 ( )37.4 (All )0.5 (events )0.5 (of )0.5 (HLH/MAS )0.5 (had )0.5 (onset )0.5 (within )0.5 (10 )0.5 (days )0.5 (of)1 ( )]TJ
-0.017 Tc 0.06 Tw 0 -1.053 Td
[(receiving )36.9 (ABECMA,)36.9 ( with a median onset of 6.5 days \(range:)36.9 ( 4 to 10 days\) and occurred)-17 ( )]TJ
-0.018 Tc 0.036 Tw 0 -1.053 Td
[(in the setting of ongoing or worsening CRS.)37.3 ( F)18.3 (ive pa)-9.6 (tients with HLH/MAS had overla)-9.6 (pping)-18 ( )]TJ
ET
q 1 0 0 1 319.5 732.96 cm
0 0 m
0 -41.76 l
S
Q
q 1 0 0 1 319.5 589.8831 cm
0 0 m
0 -85.68 l
S
Q
q 1 0 0 1 319.5 394.2 cm
0 0 m
0 -159.48 l
S
Q
q 1 0 0 1 319.5 230.76 cm
0 0 m
0 -8.712 l
S
Q
q 1 0 0 1 319.5 67.752 cm
0 0 m
0 -33.192 l
S
Q
q 1 0 0 1 319.5 41.6519 cm
0 0 m
S
Q
endstreamendobj106 0 obj<</Length 24712>>stream
q
/GS0 gs
0 TL/Fm0 Do
Q
0 0 0 1 K
0.5 w 
/GS1 gs
q 1 0 0 1 36 644.9611 cm
0 0 m
67.631 0 l
S
Q
q 1 0 0 1 36 378.1836 cm
0 0 m
30.313 0 l
S
Q
q 1 0 0 1 36 270.284 cm
0 0 m
97.558 0 l
S
Q
BT
0 0 0 1 k
/T1_0 1 Tf
-0.054 Tc 0.054 Tw 8 0 0 8 45 727.248 Tm
[(9)-36.8 (.)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.017 Tc 0.048 Tw 1.625 0 Td
[(Place the infusion ba)-9.8 (g\(s\) inside a second sterile ba)-9.8 (g per local guidelines.)]TJ
0.017 Tw -1.625 -1.605 Td
(10.)Tj
/Span<</ActualText<FEFF0009>>> BDC 
1.111 0 Td
( )Tj
EMC 
-0.011 Tc 0.081 Tw 0.477 0 Td
[(Tha)-10.3 (w )37.4 (ABECMA )0.5 (infusion )0.5 (ba)-10.2 (g\(s\) )0.5 (a)-10.3 (t a)-10.2 (pproxima)-10.2 (tely 37\260C )0.5 (using an )0.5 (a)-10.3 (pproved )0.5 (tha)-10.3 (w)-11 ( )]TJ
-0.014 Tc 0.067 Tw 0.037 -1.065 Td
[(device )0.5 (or )0.5 (wa)-10.4 (ter ba)-10.5 (th until there is no visible ice in )0.5 (the infusion ba)-10.4 (g.)36.5 ( )0.5 (Gently mix)-14 ( )]TJ
-0.006 Tc 0.103 Tw 0 -1.065 Td
[(the contents of the ba)-9.8 (g to disperse visible c)20.1 (lumps of cellular ma)-9.8 (terial.)37.1 ( Small)-6 ( )]TJ
-0.008 Tc 0.095 Tw 0 -1.065 Td
[(c)19.9 (lumps of )0.5 (cellular ma)-10 (terial may persist despite )0.5 (gentle manual mixing.)36.9 ( Do not)-8 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.065 Td
[(wash,)37.2 ( spin do)-9.8 (wn,)37.2 ( and/or resuspend )37.2 (ABECMA in new media prior to infusion.)]TJ
0.017 Tw -1.625 -1.605 Td
(11.)Tj
/Span<</ActualText<FEFF0009>>> BDC 
1.111 0 Td
( )Tj
EMC 
-0.008 Tc 0.093 Tw 0.514 0 Td
[(ABECMA should be administered within one hour of the initia)-9.9 (tion of the tha)-9.9 (w)-7.9 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.065 Td
[(process.)37.2 ( )37.2 (ABECMA is stable for two hours a)-9.8 (t room tempera)-9.8 (ture once tha)-9.7 (wed.)]TJ
0.011 Tw -2.75 -1.627 Td
[(ABECMA Administra)-9.8 (tion)]TJ
0.017 Tw 1.192 -1.515 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.508 0 Td
[(F)20.2 (or autologous use only)55.2 (.)]TJ
0.017 Tw -1.508 -1.515 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.508 0 Td
[(Do NOT use a leukodepleting \037lter)74.2 (.)]TJ
0.017 Tw -1.508 -1.515 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.014 Tc 0.065 Tw 1.508 0 Td
[(Ensure tha)-10.2 (t a minimum of two doses of tocilizumab and emergenc)19.8 (y equipment)-14 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.065 Td
[(are a)-9.8 (vailable prior to infusion and during the recover)-17.8 (y period.)]TJ
0.017 Tw -1.508 -1.515 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.004 Tc 0.152 Tw 1.508 0 Td
[(Central venous access may be utilized for the infusion of )37.3 (ABECM)0.5 (A and is)4 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.065 Td
[(encoura)-9.8 (ged in pa)-9.7 (tients with poor peripheral access.)]TJ
-0.054 Tc 0.054 Tw 0.05 -1.56 Td
[(1)-36.8 (.)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.005 Tc 0.111 Tw 1.625 0 Td
[(Con\037rm tha)-10.3 (t the pa)-10.3 (tient\222)54.7 (s identity ma)-10.2 (tches the pa)-10.3 (tient identi\037ers on the)-5 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.065 Td
[(ABECMA infusion ba)-9.8 (g\(s\).)]TJ
-0.054 Tc 0.054 Tw -1.625 -1.605 Td
[(2)-36.8 (.)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.005 Tc 0.107 Tw 1.625 0 Td
[(Prime the tubing of the infusion set with normal saline prior to infusio\n.)32 ( )]TJ
-0.009 Tc 0.09 Tw 0 -1.065 Td
[(An )0.5 (infusion )0.5 (set )0.5 (with )0.5 (an )0.5 (in-line \037lter )0.5 (\(non-leukodepleting \037lter )0.5 (with )0.5 (a )0.5 (pore)-8.9 ( )]TJ
-0.017 Tc 0.06 Tw 0 -1.065 Td
[(size range of 170 to 260 \265m\) can be used for tha)-10.1 (wed products with visible)-17 ( )]TJ
0.048 Tw 0 -1.065 Td
[(c)20.2 (lumps of cellular ma)-9.8 (terial tha)-9.8 (t do not disperse after gentle manual mixing.)]TJ
-0.054 Tc 0.054 Tw -1.625 -1.605 Td
[(3)-36.8 (.)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.017 Tc 0.046 Tw 1.625 0 Td
[(Infuse the entire contents of the )37.1 (ABECMA infusion ba)-9.8 (g within one hour after)-17 ( )]TJ
0.048 Tw 0 -1.065 Td
[(start of tha)-9.7 (w by gra)-9.7 (vity \036o)-9.7 (w)37.1 (.)]TJ
-0.054 Tc 0.054 Tw -1.625 -1.605 Td
[(4)-36.8 (.)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.002 Tc 0.123 Tw 1.588 0 Td
[(After the entire content of the infusion ba)-9.8 (g is infused,)37.2 ( rinse the tubing,)35 ( )]TJ
-0.01 Tc 0.083 Tw 0.037 -1.065 Td
[(inc)20.1 (lusive of the in-line \037lter if used,)37.1 ( with 30 to 60 mL of normal saline a)-9.9 (t)-10 ( )]TJ
-0.017 Tc 0.06 Tw 0 -1.065 Td
[(the same infusion ra)-9.9 (te to ensure as man)-9.9 (y cells as possible are infused into)-17 ( )]TJ
0.048 Tw 0 -1.065 Td
[(the pa)-9.8 (tient.)]TJ
-0.054 Tc 0.054 Tw -1.625 -1.605 Td
[(5)-36.8 (.)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.011 Tc 0.076 Tw 1.625 0 Td
[(I)0.5 (f)0.5 ( m)0.5 (o)0.5 (r)0.5 (e)0.5 ( t)0.5 (h)0.5 (an)0.5 ( o)0.5 (ne)0.5 ( in)0.5 (f)0.5 (u)0.5 (si)0.5 (o)0.5 (n)0.5 ( b)0.5 (a)-9.5 (g)0.5 ( i)0.5 (s)0.5 ( r)0.5 (e)0.5 (c)0.5 (e)0.5 (iv)0.5 (e)0.5 (d)0.5 (,)37.4 ( a)0.5 (d)0.5 (mi)0.5 (n)0.5 (i)0.5 (st)0.5 (e)0.5 (r)0.5 ( a)0.5 (l)0.5 (l)0.5 ( b)0.5 (a)-9.5 (g)0.5 (s a)0.5 (s)0.5 ( d)0.5 (i)0.5 (re)0.5 (c)0.5 (t)0.5 (e)0.5 (d,)26 ( )]TJ
-0.014 Tc 0.065 Tw 0 -1.065 Td
[(follo)-10.2 (wing steps 1-4 for each ba)-10.2 (g.)36.8 ( Do not initia)-10.2 (te tha)-10.2 (w of the next ba)-10.2 (g until)-14 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.065 Td
[(infusion of the previous ba)-9.8 (g is complete.)]TJ
-0.003 Tc 0.119 Tw -4.375 -1.676 Td
[(ABECMA contains human blood cells tha)-10.1 (t are genetically modi\037ed with replica)-10 (tion-)]TJ
-0.007 Tc 0.101 Tw 0 -1.046 Td
[(incompetent,)36.6 ( self-inactiva)-10.3 (ting lentiviral vector)73.6 (.)36.7 ( F)19.6 (ollo)-10.3 (w universal precautions and local)-6.9 ( )]TJ
-0.019 Tc 0.036 Tw 0 -1.046 Td
[(biosafety guidelines for handling and disposal of )36.9 (ABECMA to a)-10.1 (void potential transmission)-19 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.046 Td
(of infectious diseases.)Tj
0.017 Tw 0 -1.717 Td
(Monitoring)Tj
1.192 -1.501 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.508 0 Td
[(Administer )37.2 (ABECMA a)-9.8 (t a REMS-certi\037ed healthcare facility)55.3 (.)]TJ
0.017 Tw -1.508 -1.488 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.002 Tc 0.123 Tw 1.508 0 Td
[(Monitor pa)-9.8 (tients a)-9.7 (t least daily for seven days follo)-9.8 (wing )37.3 (ABECMA infusion a)-9.7 (t)-2 ( )]TJ
-0.01 Tc 0.081 Tw 0 -1.065 Td
[(t)0.5 (h)0.5 (e)0.6 ( c)0.5 (e)0.6 (r)0.5 (t)0.5 (i)0.5 (\037)0.5 (e)0.6 (d)0.5 ( h)0.5 (e)0.6 (a)0.5 (l)0.5 (t)0.5 (h)0.6 (c)0.5 (a)0.5 (r)0.5 (e)0.5 ( f)0.5 (a)0.5 (c)0.6 (i)0.5 (l)0.5 (i)0.5 (t)0.5 (y)0.6 ( f)0.5 (o)0.6 (r)0.5 ( s)0.5 (i)0.5 (g)0.6 (n)0.5 (s)0.5 ( a)0.5 (n)0.5 (d)0.5 ( s)0.5 (y)0.5 (m)0.5 (p)0.5 (t)0.6 (o)0.5 (m)0.5 (s)0.5 ( o)0.5 (f)0.5 ( C)0.5 (R)0.5 (S)0.5 ( a)0.5 (n)0.5 (d)0.5 ( n)0.5 (e)0.5 (u)0.5 (r)0.5 (o)0.6 (l)0.5 (o)0.5 (g)0.5 (i)0.6 (c)-10 ( )]TJ
-0.017 Tc 0.017 Tw 0 -1.065 Td
(toxicities )Tj
/T1_1 1 Tf
0.048 Tw 3.356 0 Td
[([see )37.3 (W)18.1 (arnings and Precautions \(5.2,)37.2 ( 5.3\)])]TJ
/T1_0 1 Tf
0 Tc 0 Tw (.)Tj
-0.017 Tc 0.017 Tw -4.863 -1.488 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.016 Tc 0.06 Tw 1.508 0 Td
[(Instruct pa)-10.1 (tients to remain within proximity of the certi\037ed healthcare facility\ for)-16 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.065 Td
[(a)-9.8 (t least four weeks follo)-9.8 (wing infusion.)]TJ
0.017 Tw -1.508 -1.488 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.013 Tc 0.069 Tw 1.508 0 Td
[(Instruct pa)-10 (tients to refrain from driving or hazardous activities for a)-10 (t least eight)-13 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.065 Td
[(weeks follo)-9.8 (wing infusion.)]TJ
/T1_2 1 Tf
0.017 Tw -2.7 -1.726 Td
(2.3)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
(Management of Severe Adverse Reactions)Tj
/T1_0 1 Tf
-3.375 -1.537 Td
(Cytokine Release Syndrome \(CRS\))Tj
0.003 Tc 0.151 Tw 0 -1.631 Td
[(Identify CRS based on c)19.6 (linical presenta)-10.2 (tion )]TJ
/T1_1 1 Tf
[([see )37.1 (W)17.7 (arnings and Precautions \(5.2\)])]TJ
/T1_0 1 Tf
-0.037 Tc 0.037 Tw (. )Tj
-0.017 Tc 0.048 Tw 0 -1.046 Td
[(Evalua)-9.7 (te for and trea)-9.8 (t other causes of fever)74.2 (,)37.2 ( hypoxia,)37.3 ( and hypotension.)]TJ
0 -1.766 Td
[(If CRS is suspected,)37.2 ( mana)-9.8 (ge according to the recommenda)-9.8 (tions in )37.2 (T)74.2 (able 1.)]TJ
-0.019 Tc 0.036 Tw 0 -1.766 Td
[(P)18.5 (a)-9.4 (t)0.5 (i)0.5 (e)0.6 (n)0.5 (t)0.5 (s)0.6 ( )0.5 (w)0.5 (h)0.5 (o)0.6 ( )0.5 (e)0.6 (x)0.5 (p)0.5 (e)0.6 (r)0.5 (i)0.5 (e)0.6 (n)0.5 (c)0.5 (e)0.6 ( )0.5 (C)0.5 (R)0.5 (S)0.5 ( )0.6 (s)0.5 (h)0.5 (o)0.6 (u)0.5 (l)0.5 (d)0.6 ( )0.5 (b)0.5 (e)0.5 ( )0.6 (c)20.5 (l)0.5 (o)0.6 (s)0.5 (e)0.5 (l)0.6 (y)0.5 ( )0.5 (m)0.6 (o)0.5 (n)0.5 (i)0.6 (t)0.5 (o)0.5 (r)0.6 (e)0.5 (d)0.5 ( )0.6 (f)0.5 (o)0.5 (r)0.6 ( )0.5 (c)0.5 (a)0.6 (r)0.5 (d)0.5 (i)0.6 (a)0.5 (c)0.5 ( )0.6 (a)0.5 (n)0.5 (d)0.5 ( )0.6 (o)0.5 (r)0.5 (g)0.6 (a)0.5 (n)0.5 ( )0.6 (f)0.5 (u)0.5 (n)0.6 (c)0.5 (t)0.5 (i)0.5 (o)0.6 (n)-19 ( )]TJ
-0.004 Tc 0.114 Tw 0 -1.046 Td
[(until resolution of symptoms.)37.1 ( Consider antiseizure prophylaxis with levetiracetam in)-4 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.046 Td
[(pa)-9.8 (tients who experience CRS.)]TJ
-0.007 Tc 0.101 Tw 0 -1.766 Td
[(P)17.7 (a)-10.3 (tients who experience Grade 2 or higher CRS \(e.g.,)36.7 ( hypotension not responsive to)-6.9 ( )]TJ
0.006 Tc 0.164 Tw 0 -1.046 Td
[(fluids,)37 ( or hypoxia requiring supplemental oxygena)-9.9 (tion\) should be monitored with)5.9 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.046 Td
[(continuous cardiac telemetr)-17.8 (y and pulse oximetr)-17.8 (y)55.2 (.)]TJ
-0.006 Tc 0.103 Tw 0 -1.766 Td
[(F)20.1 (or severe or life-threa)-9.9 (tening CRS,)37.1 ( consider intensive care unit level monitoring and)-5.9 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.046 Td
[(supportive thera)-9.7 (py)55.2 (.)]TJ
-0.005 Tc 0.111 Tw 0 -1.766 Td
[(F)19.6 (or CRS refractor)-18.3 (y to \037rst line inter)-18.4 (ventions such as tocilizumab or tocilizumab and)-5 ( )]TJ
0.106 Tw 0 -1.046 Td
[(c)0.5 (o)0.5 (r)0.5 (t)0.5 (i)0.5 (c)0.5 (o)0.5 (st)0.6 (er)0.5 (o)0.5 (i)0.5 (d)0.5 (s)0.5 (,)37.5 ( c)0.5 (o)0.5 (n)0.5 (s)0.5 (i)0.5 (d)0.5 (e)0.5 (r)0.5 ( a)0.5 (l)0.5 (t)0.5 (e)0.5 (r)0.5 (n)0.5 (a)-9.5 (t)0.5 (e)0.5 ( t)0.5 (r)0.5 (e)0.5 (a)-9.5 (t)0.5 (m)0.5 (e)0.5 (n)0.5 (t)0.5 ( o)0.5 (p)0.5 (ti)0.6 (on)0.5 (s)0.5 ( \()0.5 (i.)0.5 (e)0.5 (.)0.5 (,)37.5 ( h)0.5 (ig)0.5 (h)0.5 (e)0.5 (r)0.5 ( co)0.6 (rt)0.5 (i)0.5 (c)0.5 (o)0.5 (s)0.5 (t)0.5 (e)0.5 (r)0.5 (o)0.5 (i)0.5 (d)0.5 ( d)0.5 (o)0.5 (s)0.5 (e)0.5 (,)32 ( )]TJ
-0.011 Tc 0.076 Tw 0 -1.046 Td
[(a)0.5 (l)0.5 (t)0.5 (er)0.5 (n)0.5 (a)-9.5 (t)0.5 (i)0.5 (ve)0.5 ( a)0.5 (n)0.5 (ti)0.5 (-)0.5 (c)20.5 (y)0.5 (to)0.5 (k)0.5 (i)0.5 (n)0.5 (e)0.5 ( a)-9.5 (g)0.5 (e)0.5 (n)0.5 (ts)0.5 (,)37.5 ( a)0.5 (nt)0.5 (i)0.5 (-)0.5 (T)0.5 ( c)0.5 (e)0.5 (l)0.5 (l t)0.5 (h)0.5 (e)0.5 (ra)-9.5 (p)0.5 (i)0.5 (e)0.5 (s)0.5 (\).)37.5 ( Re)0.5 (f)0.5 (r)0.5 (a)0.5 (c)0.5 (t)0.5 (or)-17.5 (y)0.5 ( C)0.5 (RS)0.5 ( is)0.5 ( c)0.5 (h)0.5 (ar)0.5 (a)0.5 (c)0.5 (t)0.5 (e)0.5 (r)0.5 (iz)0.5 (e)0.5 (d)-11 ( )]TJ
-0.014 Tc 0.061 Tw 0 -1.046 Td
[(by)0.5 ( fe)0.5 (ve)0.5 (rs)0.5 (,)37.4 ( en)0.5 (d-)0.5 (or)0.5 (ga)0.5 (n to)0.5 (xi)0.5 (ci)0.5 (ty)0.5 ( \(e.)0.5 (g.)0.5 (,)37.4 ( hy)0.5 (po)0.5 (xi)0.5 (a,)37.4 ( h)0.5 (yp)0.5 (ot)0.5 (en)0.5 (si)0.5 (on)0.5 (\) no)0.5 (t im)0.5 (pr)0.5 (ov)0.5 (in)0.5 (g wi)0.5 (th)0.5 (in)0.5 ( 1)0.5 (2 h)0.5 (ou)0.5 (rs)-14 ( )]TJ
0.005 Tc 0.156 Tw 0 -1.046 Td
[(o)0.5 (f)0.6 ( f)0.6 (i)0.5 (r)0.5 (s)0.5 (t)0.6 ( l)0.5 (i)0.6 (n)0.5 (e)0.5 ( i)0.5 (n)0.5 (t)0.6 (e)0.5 (r)-17.5 (v)0.6 (e)0.5 (n)0.5 (t)0.6 (i)0.5 (o)0.6 (n)0.5 (s)0.5 ( o)0.6 (r)0.5 ( d)0.6 (e)0.5 (v)0.6 (e)0.5 (l)0.5 (o)0.5 (p)0.6 (m)0.5 (e)0.5 (n)0.6 (t)0.5 ( o)0.5 (f)0.5 ( h)0.5 (e)0.5 (m)0.6 (o)0.5 (p)0.5 (h)0.6 (a)-9.5 (g)0.5 (o)0.6 (c)20.5 (y)0.5 (t)0.6 (i)0.5 (c)0.5 ( l)0.5 (y)0.5 (m)0.6 (p)0.5 (h)0.5 (o)0.5 (h)0.6 (i)0.5 (s)0.5 (t)0.6 (i)0.5 (o)0.5 (c)20.6 (y)0.5 (t)0.5 (o)0.6 (s)0.5 (i)0.5 (s)0.5 (/)]TJ
-0.017 Tc 0.048 Tw 0 -1.046 Td
[(macropha)-9.8 (ge activa)-9.8 (tion syndrome \(HLH/MAS\).)]TJ
0 -1.766 Td
[(If concurrent neurologic toxicity is suspected during CRS,)37.2 ( administer:)]TJ
0.017 Tw 1.192 -1.636 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.06 Tw 1.508 0 Td
[(Corticosteroids according to the more a)-10 (ggressive inter)-18 (vention based on the CRS)-17 ( )]TJ
0.048 Tw 0 -1.065 Td
[(and neurologic toxicity grades in )37.2 (T)74.2 (ables 1 and 2)]TJ
0.017 Tw -1.508 -1.488 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.508 0 Td
[(T)74.2 (ocilizumab according to the CRS grade in )37.2 (T)74.2 (able 1)]TJ
0.017 Tw -1.508 -1.488 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.508 0 Td
[(Antiseizure medica)-9.8 (tion according to the neurologic toxicity in )37.2 (T)74.2 (able 2)]TJ
ET
1 w 4 M 
q 1 0 0 1 36 720.884 cm
0 0 m
0 -44.64 l
S
Q
q 1 0 0 1 36 553.1709 cm
0 0 m
0 -33.84 l
S
Q
q 1 0 0 1 36 493.3774 cm
0 0 m
0 -37.08 l
S
Q
0.5 w 10 M 
q 1 0 0 1 324 147.8027 cm
0 0 m
52.986 0 l
S
Q
0 0 0 0 k
/GS0 gs
324 732.96 252 -10.212 re
324 722.748 72.36 -12.912 re
396.36 722.748 98.28 -12.912 re
494.64 722.748 81.36 -12.912 re
324 709.836 72.36 -60.812 re
396.36 709.836 98.28 -60.812 re
494.64 709.836 81.36 -60.812 re
324 649.024 72.36 -208.924 re
396.36 649.024 98.28 -106.912 re
494.64 649.024 81.36 -106.912 re
396.36 542.112 179.64 -102.012 re
324 440.1 72.36 -125.224 re
396.36 440.1 98.28 -23.212 re
494.64 440.1 81.36 -23.212 re
396.36 416.888 179.64 -102.012 re
324 314.877 72.36 -105.412 re
396.36 314.877 98.28 -23.212 re
494.64 314.877 81.36 -23.212 re
396.36 291.665 179.64 -82.2 re
324 209.465 252 -38.412 re
f
1 w 
/GS2 gs
q 1 0 0 1 324 722.748 cm
0 0 m
72.36 0 l
S
Q
q 1 0 0 1 494.64 722.748 cm
0 0 m
81.36 0 l
S
Q
q 1 0 0 1 396.36 722.748 cm
0 0 m
98.28 0 l
S
Q
0.5 w 
q 1 0 0 1 396.36 710.0861 cm
0 0 m
0 12.162 l
S
Q
q 1 0 0 1 494.64 710.0861 cm
0 0 m
0 12.162 l
S
Q
q 1 0 0 1 324 709.8361 cm
0 0 m
72.36 0 l
S
Q
q 1 0 0 1 396.36 709.8361 cm
0 0 m
98.28 0 l
S
Q
q 1 0 0 1 396.36 649.2742 cm
0 0 m
0 60.312 l
S
Q
q 1 0 0 1 494.64 709.8361 cm
0 0 m
81.36 0 l
S
Q
q 1 0 0 1 494.64 649.2742 cm
0 0 m
0 60.312 l
S
Q
q 1 0 0 1 324 649.0242 cm
0 0 m
72.36 0 l
S
Q
q 1 0 0 1 396.36 649.0242 cm
0 0 m
98.28 0 l
S
Q
q 1 0 0 1 396.36 542.3623 cm
0 0 m
0 106.412 l
S
Q
q 1 0 0 1 494.64 649.0242 cm
0 0 m
81.36 0 l
S
Q
q 1 0 0 1 494.64 542.3623 cm
0 0 m
0 106.412 l
S
Q
q 1 0 0 1 396.11 542.1123 cm
0 0 m
98.53 0 l
S
Q
q 1 0 0 1 396.36 440.3504 cm
0 0 m
0 101.512 l
S
Q
q 1 0 0 1 494.64 542.1123 cm
0 0 m
81.36 0 l
S
Q
q 1 0 0 1 324 440.1004 cm
0 0 m
72.36 0 l
S
Q
q 1 0 0 1 396.36 440.1004 cm
0 0 m
98.28 0 l
S
Q
q 1 0 0 1 396.36 417.1385 cm
0 0 m
0 22.712 l
S
Q
q 1 0 0 1 494.64 440.1004 cm
0 0 m
81.36 0 l
S
Q
q 1 0 0 1 494.64 417.1385 cm
0 0 m
0 22.712 l
S
Q
q 1 0 0 1 396.11 416.8885 cm
0 0 m
98.53 0 l
S
Q
q 1 0 0 1 396.36 315.1266 cm
0 0 m
0 101.512 l
S
Q
q 1 0 0 1 494.64 416.8885 cm
0 0 m
81.36 0 l
S
Q
q 1 0 0 1 396.36 314.8766 cm
0 0 m
98.28 0 l
S
Q
q 1 0 0 1 494.64 314.8766 cm
0 0 m
81.36 0 l
S
Q
q 1 0 0 1 494.64 291.9146 cm
0 0 m
0 22.712 l
S
Q
q 1 0 0 1 396.11 291.6646 cm
0 0 m
98.53 0 l
S
Q
q 1 0 0 1 494.64 291.6646 cm
0 0 m
81.36 0 l
S
Q
1 w 
q 1 0 0 1 396.36 209.4647 cm
0 0 m
98.28 0 l
S
Q
q 1 0 0 1 494.64 209.4647 cm
0 0 m
81.36 0 l
S
Q
0.5 w 
q 1 0 0 1 324 171.0527 cm
0 0 m
72.36 0 l
S
Q
q 1 0 0 1 396.36 171.0527 cm
0 0 m
98.28 0 l
S
Q
q 1 0 0 1 494.64 171.0527 cm
0 0 m
81.36 0 l
S
Q
q 1 0 0 1 324 314.8766 cm
0 0 m
72.36 0 l
S
Q
q 1 0 0 1 396.36 291.9146 cm
0 0 m
0 22.712 l
S
Q
q 1 0 0 1 396.36 209.9647 cm
0 0 m
0 81.45 l
S
Q
1 w 
q 1 0 0 1 324 209.4647 cm
0 0 m
72.36 0 l
S
Q
BT
0 0 0 1 k
/GS1 gs
/T1_2 1 Tf
8 0 0 8 324 727.248 Tm
[(T)74.2 (able 1:)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
5 0 Td
(CRS Grading and Management Guidance)Tj
-0.012 Tc 7.6 0 0 8 324 713.4362 Tm
(CRS Grade)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 355.5599 716.1002 Tm
(a)Tj
7.6 0 0 8 358.1187 713.4362 Tm
(\037)Tj
-0.012 Tc 0.012 Tw 5.624 0 Td
[(T)74.2 (ocilizumab)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 436.042 716.1002 Tm
(c)Tj
7.6 0 0 8 438.5051 713.4362 Tm
(\037)Tj
-0.012 Tc 0.012 Tw 7.978 0 Td
(Corticosteroids)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 543.7926 716.1002 Tm
(b)Tj
7.6 0 0 8 546.4526 713.4362 Tm
(\037)Tj
-0.012 Tc 0.048 Tw -29.27 -1.726 Td
(Grade 1)Tj
/T1_0 1 Tf
0 -1.512 Td
[(Symptoms require)-11.9 ( )]TJ
0 -1.062 Td
[(symptoma)-9.7 (tic trea)-9.8 (tment)-12 ( )]TJ
0 -1.062 Td
[(only \(e.g.,)37.2 ( fever)74.2 (,)37.2 ( nausea,)25 ( )]TJ
0 -1.062 Td
[(fa)-9.8 (tigue,)37.2 ( headache,)25 ( )]TJ
0 -1.062 Td
[(my)-9.8 (algia,)37.2 ( malaise\).)]TJ
10.113 5.762 Td
[(If onset 72 hours or more after)-12 ( )]TJ
0 -1.062 Td
[(infusion,)37.2 ( trea)-9.8 (t symptoma)-9.8 (tically)55.2 (.)]TJ
0 -1.512 Td
[(If onset less than 72 hours after)-12 ( )]TJ
0 -1.062 Td
[(infusion,)37.2 ( consider tocilizumab)-12 ( )]TJ
0 -1.062 Td
[(8 mg/kg IV over 1 hour \(not to)-12 ( )]TJ
0 -1.062 Td
(exceed 800 mg\).)Tj
12.932 3.413 Td
[(Consider dexamethasone)-11.9 ( )]TJ
0 -1.062 Td
[(10 mg IV ever)-17.8 (y 24 hours.)]TJ
/T1_2 1 Tf
-23.045 -11.096 Td
(Grade 2)Tj
/T1_0 1 Tf
0 -1.512 Td
[(Symptoms require and)-12 ( )]TJ
0 -1.062 Td
[(respond to modera)-9.8 (te)-11.9 ( )]TJ
0.012 Tw 0 -1.062 Td
[(inter)-17.8 (vention.)]TJ
0.048 Tw 0 -1.512 Td
[(Oxygen requirement)-12 ( )]TJ
0 -1.062 Td
[(less than 40% F)18.2 (iO)]TJ
0 Tc 0 Tw 5.32 0 0 5.6 374.5588 533.1164 Tm
(2)Tj
-0.012 Tc 0.048 Tw 7.6 0 0 8 377.0475 533.8564 Tm
[( or)-11.9 ( )]TJ
-6.98 -1.062 Td
[(hypotension responsive)-12 ( )]TJ
0 -1.062 Td
[(to fluids,)37.3 ( or lo)-9.8 (w dose)-12 ( )]TJ
0 -1.062 Td
[(of one vasopressor)74.2 (,)37.2 ( or)-12 ( )]TJ
0 -1.062 Td
[(Grade 2 organ toxicity)55.2 (.)]TJ
10.113 17.369 Td
[(Administer tocilizumab)-12 ( )]TJ
0 Tc 0 Tw 7.6 0 0 8 465.3019 638.8123 Tm
( )Tj
-0.012 Tc 0.048 Tw 7.6 0 0 8 400.86 630.3123 Tm
[(8 mg/kg IV over 1 hour \(not to)-12 ( )]TJ
0 -1.062 Td
(exceed 800 mg\).)Tj
0 -1.512 Td
[(Repea)-9.8 (t tocilizumab ever)-17.8 (y)-12 ( )]TJ
0 -1.062 Td
[(8 hours as needed if not)-12 ( )]TJ
0 -1.062 Td
[(responsive to intra)-9.8 (venous fluids)-12 ( )]TJ
0 -1.062 Td
[(or increasing supplemental)-12 ( )]TJ
0.012 Tw 0 -1.062 Td
(oxygen.)Tj
0.048 Tw 0 -1.512 Td
[(Limit to a maximum of 3 doses)-11.9 ( )]TJ
0 -1.062 Td
[(in a 24-hour period; maximum)-12 ( )]TJ
0 -1.062 Td
(total of 4 doses.)Tj
12.932 6.825 Td
[(Consider dexamethasone)-11.9 ( )]TJ
0 -1.062 Td
[(10 mg IV ever)-17.8 (y)-11.9 ( )]TJ
0 -1.062 Td
[(12-24 hours.)24.9 ( )]TJ
-12.932 -6.539 Td
[(If no improvement within 24 hours or ra)-9.8 (pid progression,)25 ( )]TJ
0 -1.062 Td
[(repea)-9.8 (t tocilizumab and escala)-9.8 (te dose and frequenc)20.3 (y of)-12 ( )]TJ
0 -1.062 Td
[(dexamethasone \(20 mg IV ever)-17.8 (y 6 to 12 hours\).)]TJ
0 -1.512 Td
[(If no improvement within 24 hours or continued ra)-9.8 (pid)-12 ( )]TJ
0 -1.062 Td
[(progression,)37.2 ( s)-9.8 (witch to methylprednisolone 2 mg/kg follo)-9.8 (wed by)-12 ( )]TJ
0 -1.062 Td
[(2 mg/kg divided 4 times per day)55.2 (.)]TJ
0 -1.512 Td
[(After 2 doses of tocilizumab,)37.2 ( consider alterna)-9.8 (tive anti-c)20.2 (ytokine)-12 ( )]TJ
0.012 Tw 0 -1.062 Td
[(a)-9.8 (gents.)]TJ
0.048 Tw 0 -1.512 Td
[(Do not exceed 3 doses of tocilizumab in 24 hours,)37.2 ( or 4 doses)-12 ( )]TJ
0 -1.062 Td
(in total.)Tj
/T1_2 1 Tf
-10.113 -1.921 Td
(Grade 3)Tj
/T1_0 1 Tf
0 -1.512 Td
[(Symptoms require and)-12 ( )]TJ
0 -1.062 Td
[(respond to a)-9.8 (ggressive)-12 ( )]TJ
0.012 Tw 0 -1.062 Td
[(inter)-17.8 (vention.)]TJ
0.048 Tw 0 -1.512 Td
[(F)24.2 (ever)74.2 (,)37.2 ( oxygen)-12 ( )]TJ
0 -1.062 Td
[(requirement grea)-9.8 (ter)-12 ( )]TJ
0 -1.062 Td
[(than or equal to 40%)-11.9 ( )]TJ
-0.03 Tc 0.03 Tw 0 -1.062 Td
[(Fi)-17.8 (O)]TJ
0 Tc 0 Tw 5.32 0 0 5.6 332.7354 361.7925 Tm
(2)Tj
-0.012 Tc 0.048 Tw 7.6 0 0 8 335.2241 362.5325 Tm
[(,)37.2 ( or hypotension)-11.9 ( )]TJ
-1.477 -1.062 Td
[(requiring high-dose or)-12 ( )]TJ
0 -1.062 Td
[(multiple vasopressors,)25 ( )]TJ
0 -1.062 Td
[(or Grade 3 organ)-12 ( )]TJ
0 -1.062 Td
[(toxicity or Grade 4)-12 ( )]TJ
0.012 Tw 0 -1.062 Td
(transaminitis.)Tj
0.048 Tw 10.113 13.201 Td
[(P)18.2 (er Grade 2)-12 ( )]TJ
12.932 0.531 Td
[(Administer dexamethasone)-12 ( )]TJ
0 -1.062 Td
[(10 mg IV ever)-17.8 (y 12 hours.)]TJ
-12.932 -1.839 Td
[(If no improvement within 24 hours or ra)-9.8 (pid progression,)25 ( )]TJ
0 -1.062 Td
[(repea)-9.8 (t tocilizumab and escala)-9.8 (te dose and frequenc)20.3 (y of)-12 ( )]TJ
0 -1.062 Td
[(dexamethasone \(20 mg IV ever)-17.8 (y 6 to 12 hours\).)]TJ
0 -1.513 Td
[(If no improvement within 24 hours or continued ra)-9.8 (pid)-12 ( )]TJ
0 -1.062 Td
[(progression,)37.2 ( s)-9.8 (witch to methylprednisolone 2 mg/kg follo)-9.8 (wed by)-12 ( )]TJ
0 -1.062 Td
[(2 mg/kg divided 4 times per day)55.2 (.)]TJ
0 -1.512 Td
[(After 2 doses of tocilizumab,)37.2 ( consider alterna)-9.8 (tive anti-c)20.2 (ytokine)-12 ( )]TJ
0.012 Tw 0 -1.062 Td
[(a)-9.8 (gents.)]TJ
0.048 Tw 0 -1.512 Td
[(Do not exceed 3 doses of tocilizumab in 24 hours,)37.2 ( or 4 doses)-12 ( )]TJ
0 -1.062 Td
(in total.)Tj
/T1_2 1 Tf
-10.113 -1.839 Td
(Grade 4)Tj
/T1_0 1 Tf
-0.017 Tc 0.017 Tw 8 0 0 8 324.0001 292.7146 Tm
[(Life-threa)-9.8 (tening)-17 ( )]TJ
0 -1.044 Td
(symptoms.)Tj
0 -1.494 Td
[(Requirements)-17 ( )]TJ
0.048 Tw 0 -1.044 Td
[(for ventila)-9.8 (tor)-17 ( )]TJ
0 -1.044 Td
[(support,)37.2 ( continuous)-16.9 ( )]TJ
0.017 Tw 0 -1.044 Td
[(veno-venous)-17 ( )]TJ
0.048 Tw 0 -1.044 Td
[(hemodialysis \(CVVHD\),)20 ( )]TJ
0 -1.044 Td
[(or Grade 4 organ)-17 ( )]TJ
0 -1.044 Td
[(toxicity \(exc)20.2 (luding)-16.9 ( )]TJ
0.017 Tw 0 -1.044 Td
(transaminitis\).)Tj
-0.012 Tc 0.048 Tw 7.6 0 0 8 400.86 300.4146 Tm
[(P)18.2 (er Grade 2)]TJ
12.932 0.531 Td
[(Administer dexamethasone)-12 ( )]TJ
0 -1.062 Td
[(20 mg IV ever)-17.8 (y 6 hours.)]TJ
-12.932 -3.176 Td
[(After 2 doses of tocilizumab,)37.2 ( consider alterna)-9.8 (tive anti-c)20.2 (ytokine)-12 ( )]TJ
0 -1.062 Td
[(a)-9.8 (gents.)37.2 ( Do not exceed 3 doses of tocilizumab in 24 hours,)37.2 ( or)-12 ( )]TJ
0 -1.063 Td
(4 doses in total.)Tj
0 -1.512 Td
[(If no improvement within 24 hours,)37.3 ( consider)-12 ( )]TJ
0 -1.062 Td
[(methylprednisolone \(1-2 g,)37.2 ( repea)-9.8 (t ever)-17.7 (y 24 hours if needed;)-12 ( )]TJ
0 -1.062 Td
[(ta)-9.7 (per as c)20.2 (linically indica)-9.8 (ted\) or other anti-T cell thera)-9.7 (pies.)]TJ
0.012 Tw 5.32 0 0 5.6 324.0001 202.8167 Tm
(a)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 329.0001 200.1527 Tm
[(Lee criteria for grading CRS \(Lee et al.,)37.2 ( 2014\).)]TJ
0.012 Tw 5.32 0 0 5.6 324.0001 194.3167 Tm
(b)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.04 Tw 7.6 0 0 8 329.0001 191.6527 Tm
[(If corticosteroids are initia)-9.7 (ted,)37.2 ( continue corticosteroids for a)-9.8 (t least 3 doses,)37.2 ( and ta)-9.8 (per over)-12 ( )]TJ
0.048 Tw 0 -1.062 Td
(a maximum of seven days.)Tj
0.012 Tw 5.32 0 0 5.6 324.0001 177.3167 Tm
(c)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 329.0001 174.6527 Tm
[(Refer to tocilizumab Prescribing Informa)-9.8 (tion for details.)]TJ
-0.017 Tc 0.011 Tw 8 0 0 8 324.0001 148.8027 Tm
[(Neurologic T)74.2 (oxicity)]TJ
-0.018 Tc 0.036 Tw 0 -1.629 Td
[(Monitor pa)-9.8 (tients for signs and symptoms of neurologic toxicities \(T)74.1 (able 2\).)37.2 ( Rule out other)-18 ( )]TJ
-0.013 Tc 0.072 Tw 0 -1.044 Td
[(causes )0.6 (of )0.5 (neurologic )0.6 (signs )0.5 (or )0.6 (symptoms.)36.6 ( )0.6 (Provide )0.5 (intensive )0.6 (care )0.6 (supportive )0.5 (thera)-10.4 (py )0.6 (for)-13 ( )]TJ
-0.021 Tc 0.036 Tw 0 -1.044 Td
[(severe or life-threa)-10 (tening neurologic toxicities.)37 ( If neurologic toxicity is suspected,)37 ( mana)-10.1 (ge)-21 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(according to the recommenda)-9.8 (tions in )37.2 (T)74.2 (able 2.)]TJ
0 -1.764 Td
[(If concurrent CRS is suspected during the neurologic toxicity event,)37.2 ( administer:)]TJ
0.017 Tw 1.192 -1.647 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.06 Tw 1.508 0 Td
[(Corticosteroids according to the more a)-10 (ggressive inter)-18 (vention based on the CRS)-17 ( )]TJ
0.048 Tw 0 -1.062 Td
[(and neurologic toxicity grades in )37.2 (T)74.2 (ables 1 and 2)]TJ
0.017 Tw -1.508 -1.512 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.508 0 Td
[(T)74.2 (ocilizumab according to CRS grade in )37.3 (T)74.1 (able 1)]TJ
0.017 Tw -1.508 -1.512 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.508 0 Td
[(Antiseizure medica)-9.8 (tion according to neurologic toxicity in )37.2 (T)74.2 (able 2)]TJ
ET
endstreamendobj101 0 obj<</Length 39648>>stream
0 0 0 1 K
0.5 w 
/GS0 gs
q 1 0 0 1 36 127.33 cm
0 0 m
109.652 0 l
S
Q
BT
0 0 0 1 k
/T1_0 1 Tf
-0.017 Tc 0.048 Tw 8 0 0 8 36 643.3819 Tm
[(FULL PRESCRIBING INFORMA)55.1 (TION)]TJ
-0.029 Tc 0.035 Tw 0.962 -3.164 Td
[(W)17.7 (ARNING: )0.5 (CYTOKINE )0.5 (RELEASE )0.5 (SYNDROME,)36.8 ( )0.5 (NEUROLOGIC )0.5 (TOXICITIES,)36.7 ( )0.5 (HLH/MAS,)8 ( )]TJ
-0.023 Tc 0.048 Tw 0.363 -1.062 Td
[(PROLONGED CYTOPENIA,)37.2 ( AND SECOND)34.3 (AR)18.2 (Y HEMA)55.2 (TOLOGIC)18.2 (AL MALIGNANCIES)]TJ
/T1_1 1 Tf
-0.034 Tc 0.034 Tw -0.363 -1.58 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
/T1_0 1 Tf
-0.039 Tc 0.035 Tw 1.125 0 Td
[(Cytokine Release Syndrome \(CRS\),)37.2 ( inc)20.2 (luding f)20.3 (atal or life-threatening reactions,)-2 ( )]TJ
0 Tc 0 Tw 28.45 0 Td
( )Tj
0.132 Tw -28.45 -1.062 Td
[(occurr)0.5 (ed in )0.5 (pati)0.5 (ents )0.5 (followin)0.5 (g tre)0.5 (atment )0.5 (with )0.5 (ABECMA )0.5 (\(idec)0.5 (abtagene )]TJ
-0.005 Tc 0.112 Tw 0 -1.062 Td
[(vic)19.6 (leucel\).)36.6 ( )0.5 (Do )0.5 (not )0.5 (administer )0.5 (ABECMA )0.5 (to )0.5 (patients )0.5 (with )0.6 (active )0.5 (infection)-5.1 ( )]TJ
0.004 Tc 0.155 Tw 0 -1.062 Td
[(or inflammator)-18.1 (y disorders.)36.9 ( T)73.8 (reat severe or life-threatening CRS with)4 ( )]TJ
0.023 Tc 0.25 Tw 0 -1.062 Td
(tocilizumab or tocilizumab and corticosteroids )Tj
/T1_2 1 Tf
[([see Dosage and)23 ( )]TJ
-0.004 Tc 0.115 Tw 0 -1.062 Td
[(Administration \(2.2,)36.9 ( 2.3\),)36.9 ( W)17.8 (arnings and Precautions \(5.2\),)36.9 ( and Adverse)-4 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.062 Td
(Reactions \(6.1\)])Tj
/T1_0 1 Tf
0 Tc 0 Tw (.)Tj
/T1_1 1 Tf
-0.017 Tc 0.017 Tw -1.125 -1.512 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
/T1_0 1 Tf
-0.009 Tc 0.087 Tw 1.125 0 Td
[(Neurologic toxicities,)37.3 ( which may be severe or life-threatening,)37.3 ( occurred)-9 ( )]TJ
0.007 Tc 0.167 Tw 0 -1.062 Td
[(following treatment with ABECMA,)37.3 ( inc)20.3 (luding concurrently with CRS,)44 ( )]TJ
-0.003 Tc 0.117 Tw 0 -1.062 Td
[(after CRS resolution,)37.4 ( or in the absence of CRS.)37.3 ( Monitor for neurologic)-3 ( )]TJ
0.002 Tc 0.142 Tw 0 -1.062 Td
[(events after treatment with ABECMA.)37.3 ( Pro)-9.6 (vide supportive ca)0.5 (re and/or)2 ( )]TJ
-0.012 Tc 0.077 Tw 0 -1.062 Td
[(corticosteroids )0.5 (as )0.6 (needed )]TJ
/T1_2 1 Tf
10.416 0 Td
[([see )0.6 (Dosage )0.5 (and )0.5 (Administration )0.6 (\(2.2,)36.6 ( )0.6 (2.3\) )0.5 (and)-12 ( )]TJ
-0.017 Tc 0.048 Tw -10.416 -1.062 Td
[(W)18.2 (arnings and Precautions \(5.3\)])]TJ
/T1_0 1 Tf
0 Tc 0 Tw (.)Tj
/T1_1 1 Tf
-0.017 Tc 0.017 Tw -1.125 -1.513 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
/T1_0 1 Tf
-0.008 Tc 0.093 Tw 1.125 0 Td
[(Hemophagoc)10.2 (ytic L)37.2 (ymphohistioc)10.1 (ytosis/Macrophage Activ)16.2 (ation Syndrome)-8 ( )]TJ
0.002 Tc 0.146 Tw 0 -1.062 Td
[(\(HLH/MAS\) inc)19.7 (luding f)19.6 (atal and life-threatening reactions,)36.7 ( occurred in)2 ( )]TJ
-0.017 Tc 0.059 Tw 0 -1.062 Td
[(patients following treatment with ABECMA.)37.2 ( HLH/MAS can occur with CRS)-17 ( )]TJ
0.048 Tw 0 -1.062 Td
(or neurologic toxicities )Tj
/T1_2 1 Tf
[([see W)18.2 (arnings and Precautions \(5.4\)])]TJ
/T1_0 1 Tf
0 Tc 0 Tw (.)Tj
/T1_1 1 Tf
-0.017 Tc 0.017 Tw -1.125 -1.512 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
/T1_0 1 Tf
-0.019 Tc 0.036 Tw 1.125 0 Td
[(Prolonged Cytopenia with bleeding and infection,)36.6 ( inc)19.6 (luding f)19.7 (atal outcomes)-19 ( )]TJ
-0.011 Tc 0.078 Tw 0 -1.062 Td
[(following stem cell transplantation for hematopoietic reco)-9.9 (ver)-17.8 (y)55.2 (,)37.2 ( occurred)-11 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.062 Td
(following treatment with ABECMA )Tj
/T1_2 1 Tf
[([see W)18.2 (arnings and Precautions \(5.8\)])]TJ
/T1_0 1 Tf
0 Tc 0 Tw (.)Tj
/T1_1 1 Tf
-0.017 Tc 0.017 Tw -1.125 -1.512 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
/T1_0 1 Tf
-0.004 Tc 0.115 Tw 1.125 0 Td
[(T cell malignancies have occurred following treatment of hematologic)-4 ( )]TJ
0.016 Tc 0.211 Tw 0 -1.062 Td
[(m)0.5 (a)0.5 (l)0.5 (i)0.6 (g)0.5 (n)0.5 (a)0.5 (n)0.5 (c)0.5 (i)0.5 (e)0.5 (s)0.6 ( w)0.5 (i)0.5 (t)0.5 (h)0.6 ( B)0.5 (C)0.5 (M)0.5 (A)0.5 (-)0.5 ( a)0.5 (n)0.5 (d)0.5 ( C)0.5 (D)0.6 (1)0.5 (9)0.5 (-)0.5 (d)0.5 (i)0.5 (r)0.5 (e)0.5 (c)0.6 (t)0.5 (e)0.5 (d)0.5 ( g)0.5 (e)0.5 (n)0.5 (e)0.6 (t)0.5 (i)0.5 (c)0.5 (a)0.5 (l)0.5 (l)0.6 (y)0.5 ( m)0.5 (o)0.5 (d)0.5 (i)0.5 (f)0.6 (i)0.5 (e)0.5 (d)16 ( )]TJ
-0.018 Tc 0.036 Tw 0 -1.062 Td
[(autologous T cell immunotherapies,)36.6 ( inc)19.6 (luding ABECMA )]TJ
/T1_2 1 Tf
[([see W)17.6 (arnings and)-18 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.062 Td
(Precautions \(5.10\)])Tj
/T1_0 1 Tf
0 Tc 0 Tw (.)Tj
/T1_1 1 Tf
-0.017 Tc 0.017 Tw -1.125 -1.513 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
/T1_0 1 Tf
0.001 Tc 0.136 Tw 1.125 0 Td
[(A)0.5 (B)0.5 (E)0.5 (C)0.5 (M)0.5 (A)0.5 ( i)0.5 (s)0.5 ( a)0.5 (v)16.5 (a)0.5 (i)0.5 (l)0.5 (a)0.5 (b)0.5 (l)0.5 (e)0.5 ( o)0.5 (n)0.5 (l)0.5 (y)0.5 ( t)0.5 (h)0.5 (r)0.5 (o)0.5 (u)0.5 (g)0.5 (h)0.5 ( a)0.5 ( r)0.5 (e)0.5 (s)0.5 (t)0.5 (r)0.5 (i)0.5 (c)0.5 (t)0.5 (e)0.5 (d)0.5 ( p)0.5 (r)0.5 (o)0.5 (g)0.5 (r)0.5 (a)0.5 (m)0.5 ( u)0.5 (n)0.5 (d)0.5 (er)0.5 ( a)0.5 ( R)0.5 (i)0.5 (s)0.5 (k)1 ( )]TJ
0.002 Tc 0.146 Tw 0 -1.062 Td
[(Ev)15.7 (aluation and Mitigation Strateg)-10.3 (y \(REMS\) called the ABECMA REMS)2 ( )]TJ
0 Tc 0 Tw 28.45 0 Td
( )Tj
/T1_2 1 Tf
-0.017 Tc 0.048 Tw -28.45 -1.062 Td
[([see W)18.2 (arnings and Precautions \(5.5\)])]TJ
/T1_0 1 Tf
0 Tc 0 Tw (.)Tj
ET
1 w 4 M 
36 350.23 252 281.252 re
S
BT
-0.017 Tc 0.017 Tw 8 0 0 8 36 330.49 Tm
(1)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
[(INDIC)18.2 (A)55.2 (TIONS AND USAGE)]TJ
/T1_1 1 Tf
0.019 Tc 0.229 Tw -3.412 -1.719 Td
[(ABECMA is a B-cell ma)-9.9 (tura)-9.9 (tion antigen \(BCMA\)-directed genetically modified)19 ( )]TJ
-0.003 Tc 0.121 Tw 0.037 -1.044 Td
[(autologous )37.1 (T cell immunothera)-10.3 (py indica)-10.3 (ted for the trea)-10.3 (tment of adult pa)-10.3 (tients with)-3 ( )]TJ
0.004 Tc 0.154 Tw 0 -1.044 Td
[(rela)-9.9 (psed or refractor)-17.9 (y multiple myeloma after two or more prior lines of thera)-9.9 (py)4 ( )]TJ
0.152 Tw 0 -1.044 Td
[(inc)20.3 (luding an immunomodula)-9.6 (tor)-17.7 (y a)-9.7 (gent,)37.3 ( a proteasome inhibitor)74.3 (,)37.3 ( and an anti-CD38)4 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(monoc)20.2 (lonal antibod)-9.8 (y)55.2 (.)]TJ
/T1_0 1 Tf
0.017 Tw 0 -2.048 Td
(2)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
[(DOSAGE AND ADMINISTRA)55.2 (TION)]TJ
-3.375 -1.719 Td
[(For autologous use only)55.2 (.)37.2 ( For intravenous use only)55.2 (.)]TJ
0.017 Tw 0 -1.873 Td
(2.1)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3.375 0 Td
(Dose)Tj
/T1_1 1 Tf
-0.012 Tc 0.073 Tw -3.412 -1.584 Td
[(ABECMA is provided as a single dose for infusion containing a suspension\ of chimeric)-12 ( )]TJ
-0.017 Tc 0.059 Tw 0.037 -1.044 Td
[(antigen receptor \(CAR\)-positive )36.7 (T cells in one or more infusion ba)-9.8 (gs.)37.2 ( )36.7 (The recommended)-17 ( )]TJ
0.048 Tw 0 -1.044 Td
(dose range is 300 to 510 x 10)Tj
0.017 Tw 5.6 0 0 5.6 123.5597 211.524 Tm
(6 )Tj
0.011 Tw 8 0 0 8 127.6678 208.86 Tm
[(CAR-positive T )-36.8 (cells.)]TJ
-0.006 Tc 0.106 Tw -11.458 -1.764 Td
[(See the accompan)-10.3 (ying Release for Infusion Certi\037ca)-10.3 (te \(RFI Certi\037ca)-10.3 (te\) for additional)-6 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(informa)-9.8 (tion pertaining to dose )]TJ
/T1_3 1 Tf
[([see Ho)-9.7 (w Supplied/Stora)-9.8 (ge and Handl)]TJ
(ing \(16\)])Tj
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
/T1_0 1 Tf
-0.017 Tc 0.017 Tw 0 -1.873 Td
(2.2)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3.375 0 Td
(Administration)Tj
/T1_1 1 Tf
0.001 Tc 0.138 Tw -3.375 -1.584 Td
[(ABECMA is for autologous use only)55.1 (.)37.1 ( )36.7 (The pa)-9.8 (tient\222)55.1 (s identity must ma)-9.8 (tch the pa)-9.9 (tient)1 ( )]TJ
-0.015 Tc 0.061 Tw 0 -1.044 Td
[(identi\037ers on the )36.8 (ABECMA cassette\(s\) and infusion ba)-10.3 (g\(s\).)36.6 ( Do not infuse )36.8 (ABECMA if the)-15 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(informa)-9.8 (tion on the pa)-9.7 (tient-speci\037c label\(s\) does not ma)-9.8 (tch the intended pa)-9.8 (tient.)]TJ
0 -1.715 Td
[(Preparing P)18.2 (a)-9.8 (tient for )37.3 (ABECMA Infusion)]TJ
-0.014 Tc 0.065 Tw 0 -1.629 Td
[(Con\037rm the a)-10.1 (vailability of )36.9 (ABECMA prior to starting the lymphodepleting chemothera)-10.2 (py)-14 ( )]TJ
0 Tc 0 Tw 31.5 0 Td
( )Tj
-0.017 Tc 0.017 Tw -31.5 -1.044 Td
(regimen.)Tj
/T1_3 1 Tf
0 -1.715 Td
[(Pretrea)-9.8 (tment)]TJ
/T1_1 1 Tf
-0.015 Tc 0.06 Tw 0 -1.539 Td
[(Administer the lymphodepleting chemothera)-10 (py regimen:)36.9 ( c)20 (yc)20 (lophosphamide 300 mg/m)]TJ
0 Tc 0 Tw 5.6 0 0 5.6 285.312 83.584 Tm
(2)Tj
8 0 0 8 288 80.92 Tm
( )Tj
-0.017 Tc 0.048 Tw -31.5 -1.044 Td
[(intra)-9.7 (venously \(IV\) and \036udarabine 30 mg/m)]TJ
0 Tc 0 Tw 5.6 0 0 5.6 159.6599 75.234 Tm
(2)Tj
-0.017 Tc 0.048 Tw 8 0 0 8 162.2516 72.57 Tm
( IV for three days.)Tj
0.047 Tw -15.781 -1.764 Td
[(See )0.6 (the )0.6 (prescribing )0.5 (informa)-9.8 (tion )0.5 (of )0.5 (c)20.2 (yc)20.2 (lophosphamide )0.6 (and )0.6 (\036udarabine )0.5 (for )0.5 (informa)-9.8 (tion )0.6 (on)-17 ( )]TJ
0.048 Tw 0 -1.044 Td
(dose adjustment in renal impairment.)Tj
0 -1.764 Td
[(Administer )37.2 (ABECMA two days after completion of lymphodepleting chemothera)-9.8 (py)55.2 (.)]TJ
ET
q 1 0 0 1 31.5 324.6413 cm
0 0 m
0 -47.664 l
S
Q
q 1 0 0 1 31.5 232.4373 cm
0 0 m
0 -28.44 l
S
Q
0.5 w 10 M 
q 1 0 0 1 324 515.6953 cm
0 0 m
55.446 0 l
S
Q
q 1 0 0 1 324 407.8074 cm
0 0 m
100.873 0 l
S
Q
BT
0.049 Tw 8 0 0 8 324 643.3819 Tm
[(Delay the infusion of )37.1 (ABECMA \(idecabta)-9.8 (gene vic)20.2 (leucel\) up to seven days if a pa)-9.8 (tient has)-17 ( )]TJ
0.048 Tw 0 -1.071 Td
[(an)-9.8 (y of the follo)-9.8 (wing conditions:)]TJ
0.017 Tw 1.192 -1.675 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.054 Tw 1.508 0 Td
[(unresolved serious adverse events \(especially pulmonar)-17.8 (y events,)37.2 ( cardiac events,)20 ( )]TJ
0.048 Tw 0 -1.09 Td
[(or hypotension\),)37.2 ( inc)20.2 (luding those after preceding chemothera)-9.8 (pies.)]TJ
0.017 Tw -1.508 -1.54 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.042 Tw 1.508 0 Td
[(active infections or in\036amma)-9.8 (tor)-17.8 (y disorders )]TJ
/T1_3 1 Tf
[([see )37.2 (W)18.2 (arnings and Precautions \(5.7\)])]TJ
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
/T1_3 1 Tf
-0.017 Tc 0.017 Tw -2.7 -1.877 Td
[(Premedica)-9.8 (tion)]TJ
/T1_1 1 Tf
0.006 Tc 0.163 Tw 0 -1.566 Td
[(Administer acetaminophen \(650 mg orally\) and diphenhydramine \(12.5 mg\ IV or)6 ( )]TJ
-0.017 Tc 0.056 Tw 0 -1.071 Td
[(25\035)-56 (to\035)-56 (50 mg orally)55.2 (,)37.2 ( or another H)]TJ
0 Tc 0 Tw 5.6 0 0 5.6 416.5338 563.5204 Tm
(1)Tj
-0.017 Tc 0.056 Tw 8 0 0 8 419.1254 564.2604 Tm
[(-antihistamine\) a)-9.8 (pproxima)-9.7 (tely 30 to 60 minutes before)-16.9 ( )]TJ
0.011 Tw -11.891 -1.071 Td
[(infusion )-36.8 (of ABECMA.)]TJ
-0.013 Tc 0.066 Tw 0 -1.791 Td
[(A)0.5 (vo)0.5 (id)0.5 ( p)0.5 (r)0.5 (op)0.5 (hy)0.5 (l)0.5 (ac)0.5 (t)0.5 (ic)0.5 ( u)0.5 (se)0.5 ( o)0.5 (f)0.5 ( d)0.5 (ex)0.5 (a)0.5 (me)0.5 (t)0.5 (ha)0.5 (so)0.5 (n)0.5 (e)0.5 ( or)0.5 ( o)0.5 (t)0.5 (he)0.5 (r)0.5 ( s)0.5 (ys)0.5 (t)0.5 (em)0.5 (i)0.5 (c c)0.5 (o)0.5 (rt)0.5 (i)0.5 (co)0.5 (st)0.5 (e)0.5 (r)0.5 (oi)0.5 (ds)0.5 (,)37.4 ( a)0.5 (s t)0.5 (h)0.5 (e us)0.5 (e)-13 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.071 Td
[(may interfere with the activity of )37.2 (ABECMA.)]TJ
0.011 Tw 0 -2.012 Td
[(Receipt )-36.8 (of ABECMA)]TJ
0.017 Tw 1.192 -1.54 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.018 Tc 0.036 Tw 1.508 0 Td
[(ABECMA is shipped directly to the cell labora)-10.1 (tor)-18.2 (y or c)19.8 (linical pharmac)19.8 (y associa)-10.2 (ted)-18 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.09 Td
[(with the infusion center in the va)-9.7 (por phase of a liquid nitrogen shipper)74.2 (.)]TJ
0.017 Tw -1.508 -1.54 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.508 0 Td
[(Con\037rm the pa)-9.7 (tient\222)55.2 (s identity with the pa)-9.8 (tient identi\037ers on the shipper)74.2 (.)]TJ
0.017 Tw -1.508 -1.54 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.007 Tc 0.098 Tw 1.508 0 Td
[(If the pa)-9.8 (tient is not expected to be read)-9.8 (y for same-day administra)-9.8 (tion before)-7 ( )]TJ
-0.013 Tc 0.069 Tw 0 -1.09 Td
[(the shipper expires and the infusion site is quali\037ed for onsite stor\a)-10 (ge,)36.9 ( transfer)-12.9 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.09 Td
[(ABECMA to onsite va)-9.8 (por phase of liquid nitrogen stora)-9.7 (ge.)]TJ
0.017 Tw -1.508 -1.54 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.046 Tw 1.508 0 Td
[(If the pa)-9.8 (tient is not expected to be read)-9.8 (y for same-day administra)-9.8 (tion before the)-17 ( )]TJ
-0.012 Tc 0.074 Tw 0 -1.09 Td
[(shipper expires and the infusion site is not quali\037ed for onsite stor\a)-9.9 (ge,)37.1 ( contact)-12 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.09 Td
[(Bristol-Myers Squibb a)-9.8 (t 1-888-805-4555 to arrange for return shipment.)]TJ
-2.7 -1.877 Td
[(Prepara)-9.8 (tion of )37.2 (ABECMA for Infusion)]TJ
-0.054 Tc 0.054 Tw 1.125 -1.585 Td
[(1)-36.8 (.)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.012 Tc 0.071 Tw 1.625 0 Td
[(C)0.6 (o)0.5 (o)0.6 (r)0.6 (d)0.5 (i)0.6 (n)0.5 (a)-9.4 (t)0.6 (e)0.5 ( t)0.6 (h)0.5 (e)0.6 ( t)0.6 (i)0.5 (m)0.6 (i)0.5 (n)0.6 (g)0.6 ( o)0.6 (f)0.6 ( )37.3 (A)0.5 (B)0.6 (E)0.5 (C)0.6 (M)0.5 (A)0.6 ( t)0.5 (h)0.6 (a)-9.4 (w)0.5 ( a)0.6 (n)0.5 (d)0.6 ( i)0.5 (n)0.6 (f)0.6 (u)0.5 (s)0.6 (i)0.5 (o)0.6 (n)0.5 (.)37.6 ( C)0.5 (o)0.6 (n)0.6 (\037)0.5 (r)0.6 (m)0.6 ( t)0.6 (h)0.6 (e)0.5 ( i)0.6 (n)0.5 (f)0.6 (u)0.6 (s)0.5 (i)0.6 (o)0.5 (n)0.6 ( t)0.5 (i)0.6 (m)0.6 (e)-12 ( )]TJ
-0.01 Tc 0.085 Tw 0 -1.09 Td
[(in advance and adjust the start time of the tha)-10.1 (w of )37.2 (ABECMA so tha)-10.1 (t it will be)-10 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.09 Td
[(a)-9.8 (vailable for infusion when the pa)-9.8 (tient is read)-9.8 (y)55.2 (.)]TJ
-0.054 Tc 0.054 Tw -1.625 -1.63 Td
[(2)-36.8 (.)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.019 Tc 0.036 Tw 1.625 0 Td
[(Prior to tha)-10.2 (wing the product,)36.7 ( con\037rm tha)-10.2 (t tocilizumab and emergenc)19.7 (y equipment)-19 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.09 Td
[(are a)-9.8 (vailable prior to the infusion and during the recover)-17.7 (y period.)]TJ
-0.054 Tc 0.054 Tw -1.625 -1.63 Td
[(3)-36.8 (.)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.005 Tc 0.108 Tw 1.625 0 Td
[(An )36.9 (ABECMA dose may be contained in one or more pa)-9.8 (tient-speci\037c infusion)-5 ( )]TJ
-0.008 Tc 0.096 Tw 0 -1.09 Td
[(ba)-10.2 (g\(s\).)36.7 ( )37.3 (V)17.7 (erify the number of ba)-10.3 (gs received for the indica)-10.2 (ted dose of )37.2 (ABECMA)-8 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.09 Td
[(prior to prepara)-9.8 (tion of )37.2 (ABECMA for infusion.)]TJ
-0.054 Tc 0.054 Tw -1.625 -1.63 Td
[(4)-36.8 (.)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.006 Tc 0.106 Tw 1.625 0 Td
[(Con\037rm pa)-10.3 (tient identity:)36.6 ( Prior to prepara)-10.3 (tion of )36.8 (ABECMA,)36.6 ( ma)-10.3 (tch the pa)-10.3 (tient\222)54.7 (s)-6 ( )]TJ
-0.011 Tc 0.079 Tw 0 -1.09 Td
[(identity with the pa)-10 (tient identi\037ers on the )37.3 (ABECMA cassette\(s\),)37.1 ( infusion ba)-9.9 (g\(s\),)26 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.09 Td
[(and the RFI Certi\037ca)-9.8 (te.)]TJ
-2.75 -1.701 Td
[(Note:)37.3 ( )37.1 (The pa)-9.8 (tient identi\037er number may be preceded by the letters DIN or )37.2 (A)-9.8 (ph ID.)]TJ
-0.054 Tc 0.054 Tw 1.125 -1.72 Td
[(5)-36.8 (.)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.021 Tc 0.036 Tw 1.625 0 Td
[(D)0.5 (o)0.6 ( )0.5 (n)0.5 (o)0.6 (t)0.5 ( )0.6 (r)0.5 (e)0.5 (m)0.6 (o)0.5 (v)0.5 (e)0.6 ( )0.5 (t)0.6 (h)0.5 (e)0.5 ( )37.5 (A)0.6 (B)0.5 (E)0.5 (C)0.6 (M)0.5 (A)0.5 ( )0.6 (i)0.5 (n)0.5 (f)0.6 (u)0.5 (s)0.5 (i)0.5 (o)0.6 (n)0.5 ( )0.6 (b)0.5 (a)-9.5 (g)0.6 (\()0.5 (s)0.5 (\))0.5 ( )0.6 (f)0.5 (r)0.6 (o)0.5 (m)0.5 ( )0.6 (t)0.5 (h)0.5 (e)0.6 ( )0.5 (c)0.6 (a)0.5 (s)0.5 (s)0.5 (e)0.6 (t)0.5 (t)0.6 (e)0.5 (\()0.5 (s)0.6 (\))0.5 ( )0.5 (i)0.5 (f)0.6 ( )0.5 (t)0.6 (h)0.5 (e)0.5 ( )0.6 (i)0.5 (n)0.5 (f)0.6 (o)0.5 (r)0.5 (m)0.6 (a)-9.5 (t)0.6 (i)0.5 (o)0.6 (n)-21 ( )]TJ
-0.007 Tc 0.098 Tw 0 -1.09 Td
[(on the pa)-9.8 (tient-speci\037c cassette label\(s\) does not ma)-9.9 (tch the intended pa)-9.9 (tient.)30 ( )]TJ
-0.017 Tc 0.06 Tw 0 -1.09 Td
[(Contact Bristol-Myers Squibb a)-10.2 (t 1-888-805-4555 if there are an)-10.1 (y discrepancies)-17 ( )]TJ
0.048 Tw 0 -1.09 Td
[(between the labels and the pa)-9.8 (tient identi\037ers.)]TJ
-0.054 Tc 0.054 Tw -1.625 -1.63 Td
[(6)-36.8 (.)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.005 Tc 0.107 Tw 1.625 0 Td
[(Once pa)-9.7 (tient identity is con\037rmed,)37.3 ( remove the )36.9 (ABECMA infusion ba)-9.6 (g\(s\) from)-5 ( )]TJ
-0.009 Tc 0.087 Tw 0 -1.09 Td
[(the )0.5 (casse)0.5 (tte\(s\) )0.5 (and )0.5 (chec)0.5 (k t)0.5 (ha)-9.6 (t )0.5 (the )0.5 (pa)-9.6 (tie)0.5 (nt i)0.5 (nforma)-9.5 (tion )0.5 (on )0.5 (the )0.5 (casset)0.5 (te )0.5 (label\(s)0.5 (\))-9 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.09 Td
[(ma)-9.8 (tches the pa)-9.8 (tient informa)-9.8 (tion on the ba)-9.8 (g label\(s\).)]TJ
/T1_0 1 Tf
1.875 -1.922 Td
(Figure 1: ABECMA Bag Label\(s\))Tj
ET
/PlacedGraphic /MC0 BDC 
EMC 
BT
/GS1 gs
/T1_4 1 Tf
0 Tc 0 Tw 5.9873 0 0 5.9873 511.1412 145.6792 Tm
(P)Tj
0.01 Tc 0.505 0 Td
(atient Name)Tj
0 Tc -0.505 -1.333 Td
(P)Tj
0.01 Tc 0.505 0 Td
(atient Date of Birt)Tj
0 Tc (h)Tj
-0.505 -1.333 Td
(P)Tj
0.01 Tc 0.505 0 Td
(atient DIN OR Aph ID)Tj
ET
0.299 w 
q 1 0 0 1 539.7417 129.1142 cm
0 0 m
0 0 l
6.778 0 l
h
S
Q
BT
-0.01 Tw 5.9873 0 0 5.9873 511.1412 121.7297 Tm
(JOI)Tj
0 Tc 0 Tw (N)Tj
ET
q
324 99.813 252 93.24 re
W n
0 0 0 0 k
q 1 0 0 1 482.5797 101.2297 cm
0 0 m
-117 0 l
-119.485 0 -121.5 2.015 -121.5 4.5 c
-121.5 85.5 l
-121.5 87.985 -119.485 90 -117 90 c
0 90 l
2.486 90 4.5 87.985 4.5 85.5 c
4.5 4.5 l
4.5 2.015 2.486 0 0 0 c
f
Q
Q
q
360.83 100.98 215.17 90.5 re
W n
0.5 w 
q 1 0 0 1 482.5797 101.2297 cm
0 0 m
-117 0 l
-119.485 0 -121.5 2.015 -121.5 4.5 c
-121.5 85.5 l
-121.5 87.985 -119.485 90 -117 90 c
0 90 l
2.486 90 4.5 87.985 4.5 85.5 c
4.5 4.5 l
4.5 2.015 2.486 0 0 0 c
h
S
Q
Q
q
324 99.813 252 93.24 re
W n
0 0 0 0.794 k
461.037 167.27 -99.727 5.517 re
f
0 0 0 0.691 k
469.634 167.27 -8.598 5.517 re
f
0 0 0 0.223 k
478.221 167.27 -8.599 5.517 re
f
0 0 0 0.471 k
486.826 167.27 -8.599 5.517 re
f
0 0 0 0.665 k
412.505 182.2 -48.068 5.442 re
f
395.144 174.297 -30.707 5.442 re
f
465.956 103.862 -39.08 9.49 re
f
482.779 104.841 -11.232 7.531 re
f
0 0 0 0.405 k
415.259 163.014 -50.125 2.332 re
f
458.769 163.014 -31.031 2.332 re
f
440.024 159.035 -12.285 2.332 re
f
445.594 150.723 -17.856 2.332 re
f
457.974 154.702 -30.236 2.332 re
f
419.743 157.376 -54.609 2.332 re
f
406.418 153.02 -41.284 2.332 re
f
418.654 147.511 -53.52 2.332 re
f
410.39 143.411 -45.256 2.332 re
f
417.693 138.735 -52.559 2.332 re
f
417.693 134.635 -52.559 2.333 re
f
398.282 129.126 -33.148 2.332 re
f
398.282 125.09 -33.148 2.333 re
f
417.629 119.324 -52.495 2.333 re
f
387.712 115.225 -22.578 2.332 re
f
418.141 109.908 -53.007 2.332 re
f
380.602 105.487 -15.468 2.332 re
f
463.124 180.569 -46.991 2.332 re
f
443.542 184.64 -27.409 2.332 re
f
478.453 176.476 -62.32 2.332 re
f
0.665 w 
q 1 0 0 1 488.6627 145.9843 cm
0 0 m
3.069 0 l
3.069 -19.592 l
0 -19.592 l
3.069 -10.137 m
18.298 -10.137 l
S
Q
Q
BT
/T1_5 1 Tf
-0.028 Tc 0.028 Tw 3.5 0 0 3.5 422.8552 143.1025 Tm
(Fi)Tj
-0.01 Tc 0.01 Tw 0.61 0 Td
(rst:)Tj
0 Tc 0 Tw 1.125 0 Td
( )Tj
/T1_4 1 Tf
-0.01 Tc 0.23 0 Td
(FIRST NAME)Tj
/T1_5 1 Tf
0.01 Tw -1.965 -1.2 Td
(Last)Tj
-0.047 Tc 0.047 Tw (: )Tj
/T1_4 1 Tf
-0.01 Tc 0 Tw 1.937 0 Td
(LAST NAM)Tj
0 Tc (E)Tj
/T1_5 1 Tf
-0.01 Tc -1.937 -1.2 Td
(Date of birth:)Tj
0 Tc 4.643 0 Td
( )Tj
/T1_4 1 Tf
-0.01 Tc 0.01 Tw 0.23 0 Td
(DD-MMM-YYYY)Tj
/T1_5 1 Tf
0 Tw -4.874 -1.2 Td
(DIN/Aph ID:)Tj
0 Tc 4.123 0 Td
( )Tj
-0.01 Tc 0.193 0 Td
(W0000 00 000000)Tj
0.01 Tw -4.316 -1.2 Td
(JOIN:)Tj
0 Tw 1.895 0 Td
( XXXX-XXXX)Tj
0 Tc (X)Tj
/T1_6 1 Tf
4.811 0 Td
( )Tj
3.58 0 Td
( )Tj
/T1_5 1 Tf
-0.01 Tc 0.01 Tw -10.286 -1.2 Td
(LOT)Tj
-0.047 Tc 0.047 Tw 1.359 0 Td
(: )Tj
-0.01 Tc 0.01 Tw 0.423 0 Td
(XXXX-XXXXX)Tj
0 Tc 0 Tw (Y)Tj
-0.01 Tc 0.01 Tw -1.782 -1.2 Td
(EXP:)Tj
0 Tw 1.588 0 Td
( DD-MMM-YYY)Tj
0 Tc (Y)Tj
ET
q
324 99.813 252 93.24 re
W n
0.313 w 
485.152 116.022 -63.749 31.473 re
S
Q
BT
-0.01 Tc 3.5 0 0 3.5 470.0882 131.2302 Tm
(Bag ID)Tj
-0.047 Tc 0.047 Tw 2.376 0 Td
(: )Tj
-0.01 Tc 0.01 Tw 0.423 0 Td
(XX)Tj
ET
q
324 99.813 252 93.24 re
W n
0 0 0 0 k
481.851 129.14 -0.353 -0.352 re
480.074 128.785 m
479.956 128.785 479.837 128.786 479.718 128.786 c
479.718 129.14 l
479.365 129.14 l
479.365 128.786 l
479.719 128.786 l
479.719 128.076 l
480.074 128.076 l
480.074 128.786 l
480.428 128.786 l
480.428 129.14 l
480.074 129.14 l
h
480.785 127.719 m
480.785 128.073 l
480.43 128.073 l
480.43 127.719 l
480.076 127.719 l
480.076 127.008 l
480.43 127.008 l
480.43 126.296 l
480.074 126.296 l
480.074 126.653 l
479.717 126.653 l
479.717 127.719 l
479.362 127.719 l
479.362 128.076 l
479.006 128.076 l
479.006 129.14 l
478.651 129.14 l
478.651 128.786 l
478.57 128.786 l
478.479 128.785 478.387 128.785 478.295 128.785 c
478.295 129.14 l
477.941 129.14 l
477.941 128.785 l
477.584 128.785 l
477.584 129.14 l
477.229 129.14 l
477.229 128.786 l
476.873 128.786 l
476.873 129.14 l
476.52 129.14 l
476.52 128.786 l
476.874 128.786 l
476.874 128.43 l
476.52 128.43 l
476.52 128.077 l
476.873 128.077 l
476.873 128.431 l
477.23 128.431 l
477.23 128.076 l
477.585 128.076 l
477.585 128.431 l
477.94 128.431 l
477.94 128.786 l
478.059 128.786 478.177 128.786 478.296 128.785 c
478.296 128.43 l
478.65 128.43 l
478.65 127.719 l
478.296 127.719 l
478.296 128.073 l
477.941 128.073 l
477.941 127.719 l
476.887 127.719 l
476.883 127.719 476.879 127.718 476.873 127.717 c
476.873 127.365 l
476.517 127.365 l
476.517 127.72 l
476.162 127.72 l
476.162 129.14 l
475.808 129.14 l
475.808 121.32 l
483.629 121.32 l
483.629 121.674 l
482.563 121.674 l
482.563 122.03 l
483.628 122.03 l
483.628 122.384 l
482.563 122.384 l
482.563 122.029 l
482.207 122.029 l
482.207 121.676 l
480.785 121.676 l
480.785 122.386 l
481.142 122.386 l
481.142 122.031 l
481.853 122.031 l
481.853 123.095 l
482.209 123.095 l
482.209 122.742 l
483.629 122.742 l
483.629 123.097 l
483.276 123.097 l
483.276 123.453 l
483.628 123.453 l
483.628 123.809 l
483.276 123.809 l
483.276 124.164 l
483.629 124.164 l
483.629 124.519 l
483.276 124.519 l
483.276 124.875 l
483.628 124.875 l
483.628 125.23 l
482.918 125.23 l
482.918 125.587 l
483.629 125.587 l
483.629 125.942 l
482.92 125.942 l
482.92 126.298 l
483.628 126.298 l
483.628 126.653 l
483.276 126.653 l
483.276 127.009 l
483.629 127.009 l
483.629 127.364 l
483.276 127.364 l
483.276 127.72 l
483.628 127.72 l
483.628 128.075 l
483.276 128.075 l
483.276 128.431 l
483.629 128.431 l
483.629 128.786 l
483.273 128.786 l
483.273 129.14 l
482.918 129.14 l
482.918 128.788 l
482.562 128.788 l
482.562 129.14 l
482.209 129.14 l
482.209 128.43 l
482.564 128.43 l
482.564 128.074 l
481.852 128.074 l
481.852 128.43 l
481.734 128.43 l
481.536 128.431 481.339 128.431 481.141 128.431 c
481.141 129.14 l
480.787 129.14 l
480.787 128.432 l
481.142 128.432 l
481.142 128.075 l
481.852 128.075 l
481.852 127.719 l
481.497 127.719 l
481.497 127.363 l
481.14 127.363 l
481.14 127.719 l
h
f
0 0 0 1 k
477.583 127.362 -0.353 -0.353 re
477.583 127.009 m
480.785 122.386 m
480.785 121.676 l
482.207 121.676 l
482.207 122.029 l
482.563 122.029 l
482.563 122.03 l
482.563 121.674 l
483.629 121.674 l
483.629 121.32 l
475.808 121.32 l
475.808 129.14 l
476.162 129.14 l
476.162 127.72 l
476.517 127.72 l
476.517 127.365 l
476.873 127.365 l
476.873 127.717 l
476.879 127.718 476.883 127.719 476.887 127.719 c
477.941 127.719 l
477.94 127.719 l
477.94 127.363 l
478.296 127.363 l
478.296 127.364 l
478.296 127.007 l
478.652 127.007 l
478.652 126.652 l
478.295 126.652 l
478.295 126.297 l
478.266 126.297 l
478.039 126.297 477.812 126.297 477.585 126.296 c
477.585 126.651 l
477.579 126.652 477.576 126.652 477.573 126.652 c
476.873 126.652 l
476.873 127.007 l
476.164 127.007 l
476.164 126.653 l
476.874 126.653 l
476.874 125.941 l
476.52 125.941 l
476.52 125.586 l
476.874 125.586 l
476.874 125.229 l
476.518 125.229 l
476.518 124.874 l
476.164 124.874 l
476.164 124.52 l
476.518 124.52 l
476.518 124.875 l
476.875 124.875 l
476.875 124.518 l
477.939 124.518 l
477.939 124.163 l
477.23 124.163 l
477.23 123.807 l
476.52 123.807 l
476.52 123.452 l
477.23 123.452 l
477.23 123.096 l
476.875 123.096 l
476.875 122.741 l
477.23 122.741 l
477.229 122.705 477.229 122.669 477.229 122.632 c
477.23 122.55 477.23 122.467 477.23 122.384 c
477.114 122.385 476.997 122.385 476.88 122.385 c
476.878 122.385 476.876 122.383 476.874 122.382 c
476.874 122.029 l
476.164 122.029 l
476.164 121.676 l
476.873 121.676 l
476.873 122.03 l
477.23 122.03 l
477.23 122.385 l
477.941 122.385 l
477.941 122.741 l
478.296 122.741 l
478.296 122.029 l
477.942 122.029 l
477.942 121.676 l
478.296 121.676 l
478.296 122.03 l
478.652 122.03 l
478.652 121.676 l
479.007 121.676 l
479.007 122.386 l
479.126 122.385 479.244 122.385 479.363 122.385 c
479.362 122.386 l
479.362 122.029 l
479.719 122.029 l
479.718 122.03 l
479.718 121.676 l
480.074 121.676 l
480.074 122.03 l
480.074 122.029 l
480.43 122.029 l
480.43 122.385 l
480.786 122.385 l
h
f
q 1 0 0 1 482.5632 123.0982 cm
0 0 m
0.354 0 l
0.354 0.709 l
-0.354 0.709 l
-0.354 0.353 l
0 0.353 l
h
0.355 2.132 m
1.065 2.132 l
1.065 1.777 l
0.713 1.777 l
0.713 1.421 l
1.065 1.421 l
1.065 1.066 l
0.713 1.066 l
0.713 0.711 l
1.065 0.711 l
1.065 0.354 l
0.713 0.354 l
0.713 -0.001 l
1.065 -0.001 l
1.065 -0.356 l
-0.354 -0.356 l
-0.354 -0.003 l
-0.711 -0.003 l
-0.711 -1.067 l
-1.422 -1.067 l
-1.422 -0.712 l
-1.779 -0.712 l
-1.777 -0.713 l
-1.777 -0.359 l
-2.49 -0.359 l
-2.49 -1.069 l
-2.489 -1.068 l
-2.845 -1.068 l
-2.844 -1.069 l
-2.844 -0.712 l
-3.201 -0.712 l
-3.2 -0.713 l
-3.2 -0.688 -3.201 -0.663 -3.201 -0.638 c
-3.201 -0.426 -3.201 -0.214 -3.201 -0.001 c
-2.845 -0.001 l
-2.845 0.354 l
-2.727 0.354 -2.608 0.354 -2.49 0.354 c
-2.49 -0.003 l
-1.422 -0.003 l
-1.422 -0.355 l
-1.068 -0.355 l
-1.068 0.708 l
-1.423 0.708 l
-1.423 0.354 l
-1.453 0.354 l
-2.464 0.354 l
-2.473 0.354 -2.482 0.353 -2.49 0.353 c
-2.49 0.356 -2.489 0.359 -2.489 0.361 c
-2.49 0.596 -2.49 0.831 -2.49 1.066 c
-1.777 1.066 l
-1.777 1.422 l
-1.423 1.422 l
-1.423 1.777 l
-1.066 1.777 l
-1.066 1.42 l
-0.711 1.42 l
-0.711 1.421 l
-0.711 1.066 l
0 1.066 l
0 1.777 l
0.356 1.777 l
0.356 2.132 l
h
f
Q
q 1 0 0 1 482.5637 128.0742 cm
0 0 m
0 0.355 l
-0.355 0.355 l
-0.355 1.065 l
-0.001 1.065 l
-0.001 0.713 l
0.355 0.713 l
0.355 1.066 l
0.71 1.066 l
0.71 0.712 l
1.065 0.712 l
1.065 0.357 l
0.712 0.357 l
0.712 0.001 l
1.065 0.001 l
1.065 -0.354 l
0.712 -0.354 l
0.712 -0.71 l
1.065 -0.71 l
1.065 -1.066 l
0.712 -1.066 l
0.712 -1.422 l
1.065 -1.422 l
1.065 -1.776 l
0.357 -1.776 l
0.357 -2.133 l
1.065 -2.133 l
1.065 -2.488 l
0.355 -2.488 l
0.355 -2.845 l
0.356 -2.844 l
-0.711 -2.844 l
-0.711 -2.488 l
-0.712 -2.489 l
-0.002 -2.489 l
-0.002 -2.133 l
-0.712 -2.133 l
-0.711 -2.134 l
-0.711 -1.777 l
-0.712 -1.778 l
-0 -1.778 l
-0 -1.746 l
-0 -1.283 -0 -0.818 0 -0.355 c
-0.001 -0.356 l
0.354 -0.356 l
0.354 0.001 l
-0.001 0.001 l
h
f
Q
q 1 0 0 1 480.0737 126.2962 cm
0 0 m
0.356 0 l
0.355 0.001 l
0.355 -0.712 l
0 -0.712 l
0 -1.067 l
-0.357 -1.067 l
-0.357 -1.423 l
-0.711 -1.423 l
-0.711 -1.776 l
-1.067 -1.776 l
-1.067 -1.422 l
-1.422 -1.422 l
-1.422 -1.422 l
-1.422 -0.71 l
-1.067 -0.71 l
-1.067 0.001 l
-0.948 0 -0.829 0 -0.711 0 c
-0.711 0.001 l
-0.711 -0.354 l
0 -0.354 l
0 0.001 l
h
f
Q
q 1 0 0 1 481.1402 127.3632 cm
0 0 m
0.357 0 l
0.356 0.001 l
0.356 -0.357 l
1.066 -0.357 l
1.066 -0.712 l
0.712 -0.712 l
0.712 -1.067 l
0.712 -1.066 l
0.358 -1.066 l
0.358 -1.423 l
0.712 -1.423 l
0.712 -1.422 l
0.712 -1.778 l
0.712 -1.777 l
0.001 -1.777 l
0.001 -1.751 l
0.001 -1.41 l
0.001 -0.94 0.001 -0.47 0.001 0.001 c
h
f
Q
q 1 0 0 1 478.2952 128.7847 cm
0 0 m
0.091 0.001 0.184 0.001 0.275 0.001 c
0.355 0.001 l
0.355 0.355 l
0.711 0.355 l
0.711 -0.709 l
1.067 -0.709 l
1.067 -1.066 l
1.068 -1.065 l
0.712 -1.065 l
0.712 -1.421 l
0.713 -1.421 l
0.001 -1.421 l
0.001 -1.421 l
0.001 -1.065 l
0.001 -1.066 l
0.355 -1.066 l
0.355 -0.355 l
0.001 -0.355 l
0.001 0.001 l
h
f
Q
q 1 0 0 1 479.3622 127.7187 cm
0 0 m
0.355 0 l
0.355 -1.065 l
0.711 -1.065 l
0.711 -1.422 l
0.712 -1.421 l
0 -1.421 l
0.001 -1.422 l
0.001 -1.066 l
-0.355 -1.066 l
-0.355 -1.057 -0.355 -1.047 -0.355 -1.038 c
-0.355 -0.81 -0.354 -0.582 -0.354 -0.355 c
-0.355 -0.355 l
0.001 -0.355 l
0.001 0.001 l
h
f
Q
q 1 0 0 1 477.9402 128.7862 cm
0 0 m
0 -0.355 l
-0.355 -0.355 l
-0.355 -0.71 l
-0.71 -0.71 l
-0.71 -0.355 l
-1.067 -0.355 l
-1.066 -0.356 l
-1.066 0 l
-1.067 -0.001 l
-0.712 -0.001 l
-0.712 0.354 l
-0.357 0.354 l
-0.357 -0.001 l
0 -0.001 l
h
f
Q
q 1 0 0 1 482.5632 122.0292 cm
0 0 m
0 0.355 l
1.065 0.355 l
1.065 0.001 l
-0 0.001 l
h
f
Q
q 1 0 0 1 481.8517 128.0742 cm
0 0 m
0.712 0 l
0.711 0.001 l
0.711 -0.356 l
0.712 -0.355 l
0 -0.355 l
0 -0.356 l
0 0.001 l
h
f
Q
q 1 0 0 1 480.4297 127.0082 cm
0 0 m
-0.354 0 l
-0.354 0.71 l
0 0.71 l
-0.001 0.711 l
-0.001 -0.001 l
h
f
Q
q 1 0 0 1 479.7182 128.7857 cm
0 0 m
0.118 0 0.238 -0.001 0.356 -0.001 c
0.355 0.001 l
0.355 -0.709 l
0.001 -0.709 l
0.001 0.001 l
h
f
Q
q 1 0 0 1 480.4297 126.2962 cm
0 0 m
0 0.712 l
-0.001 0.711 l
0.354 0.711 l
0.354 0.001 l
-0.001 0.001 l
h
f
Q
q 1 0 0 1 481.1417 128.4317 cm
0 0 m
-0.355 0 l
-0.355 0.709 l
-0 0.709 l
-0 -0.001 l
h
f
Q
q 1 0 0 1 481.8522 128.0752 cm
0 0 m
-0.711 0 l
-0.711 0.356 l
-0.711 0.355 l
-0.513 0.355 -0.316 0.355 -0.118 0.355 c
-0 0.355 l
-0 -0.001 l
h
f
Q
q 1 0 0 1 477.9407 127.7187 cm
0 0 m
0 0.354 l
0.355 0.354 l
0.355 0 l
0.355 0.001 l
-0 0.001 l
h
f
Q
q 1 0 0 1 480.0742 128.7852 cm
0 0 m
0 0.355 l
0.354 0.355 l
0.354 0.001 l
-0 0.001 l
h
f
Q
q 1 0 0 1 479.7187 128.7862 cm
0 0 m
-0.354 0 l
-0.354 0.354 l
-0.001 0.354 l
-0.001 -0.001 l
h
f
Q
481.851 128.787 -0.353 0.352 re
f
q 1 0 0 1 476.8742 128.7862 cm
0 0 m
-0.354 0 l
-0.354 0.354 l
-0.001 0.354 l
-0.001 -0.001 l
h
f
Q
q 1 0 0 1 481.4967 127.3632 cm
0 0 m
0 0.355 l
0.355 0.355 l
0.355 0.356 l
0.355 0.001 l
-0.001 0.001 l
h
f
Q
q 1 0 0 1 480.7847 127.7187 cm
0 0 m
0.355 0 l
0.355 -0.355 l
0.357 -0.355 l
0.001 -0.355 l
0.001 0.001 l
h
f
Q
q 1 0 0 1 476.8732 128.4307 cm
0 0 m
0 -0.354 l
-0.353 -0.354 l
-0.353 -0.001 l
0.001 -0.001 l
h
f
Q
q 1 0 0 1 480.4297 127.7187 cm
0 0 m
0 0.354 l
0.355 0.354 l
0.355 0 l
0.356 0.001 l
-0.001 0.001 l
h
f
Q
q 1 0 0 1 477.9407 128.7852 cm
0 0 m
0 0.355 l
0.354 0.355 l
0.354 -0.001 l
0.355 0 l
0.237 0.001 0.118 0.001 -0 0.001 c
h
f
Q
0 0 0 0 k
q 1 0 0 1 478.6512 124.8747 cm
0 0 m
0.355 0 l
0.355 -0.355 l
0.711 -0.355 l
0.711 -0.001 l
1.066 -0.001 l
1.066 0.355 l
1.423 0.355 l
1.422 0.356 l
1.422 -0.357 l
1.423 -0.355 l
1.067 -0.355 l
1.067 -0.712 l
1.068 -0.711 l
0.711 -0.711 l
0.711 -1.423 l
0.712 -1.422 l
0.355 -1.422 l
0.355 -0.713 l
-0.001 -0.713 l
-0.001 -1.068 l
-0.355 -1.068 l
-0.355 -1.424 l
-0.71 -1.424 l
-0.71 -1.779 l
-0.355 -1.779 l
-0.355 -2.134 l
-0.355 -2.134 l
-0.71 -2.134 l
-0.71 -2.49 l
-1.422 -2.49 l
-1.421 -2.49 l
-1.422 -2.408 -1.422 -2.325 -1.422 -2.242 c
-1.422 -2.206 -1.422 -2.17 -1.422 -2.134 c
-1.423 -2.134 l
-1.068 -2.134 l
-1.068 -1.778 l
-1.423 -1.778 l
-1.422 -1.778 l
-1.422 -1.422 l
-1.423 -1.423 l
-1.068 -1.423 l
-1.068 -1.067 l
-1.423 -1.067 l
-1.422 -1.068 l
-1.422 -0.712 l
-0.713 -0.712 l
-0.713 -0.357 l
-1.776 -0.357 l
-1.776 0 l
-2.134 0 l
-2.133 -0 l
-2.133 0.354 l
-1.778 0.354 l
-1.778 0.711 l
-1.778 0.711 l
-1.421 0.711 l
-1.421 0.001 l
-1.066 0.001 l
-1.066 0.712 l
-0.712 0.712 l
-0.712 1.067 l
-1.066 1.067 l
-1.066 1.423 l
-1.067 1.422 l
-0.84 1.422 -0.612 1.422 -0.385 1.422 c
-0.356 1.422 l
-0.356 1.778 l
0 1.778 l
0 1.778 l
0 1.422 l
0.357 1.422 l
0.355 1.423 l
0.355 0.712 l
0.001 0.712 l
0.001 -0 l
-0.354 -0 l
-0.354 -0.354 l
0 -0.354 l
h
f
Q
q 1 0 0 1 479.0067 122.3857 cm
0 0 m
0 -0.71 l
-0.355 -0.71 l
-0.355 -0.355 l
-0.711 -0.355 l
-0.711 -0.357 l
-0.711 0.355 l
-0.711 0.355 l
-0.355 0.355 l
-0.355 0.355 l
-0.355 -0.001 l
0.001 -0.001 l
h
f
Q
q 1 0 0 1 480.0737 122.0292 cm
0 0 m
0 0.71 l
0.712 0.71 l
0.712 0.356 l
0.357 0.356 l
0.357 0 l
h
f
Q
q 1 0 0 1 479.3622 123.0967 cm
0 0 m
0 -0.212 0 -0.424 0 -0.637 c
0 -0.661 0.001 -0.687 0.001 -0.712 c
-0.118 -0.712 -0.237 -0.712 -0.355 -0.711 c
-0.354 -0.712 l
-0.354 -0.356 l
-0.711 -0.356 l
-0.711 -0.356 l
-0.711 -0 l
0.001 -0 l
h
f
Q
q 1 0 0 1 479.0077 127.3637 cm
0 0 m
0 -0.228 -0.001 -0.455 -0.001 -0.683 c
-0.001 -0.693 -0.001 -0.702 -0.001 -0.712 c
0 -0.711 l
-0.357 -0.711 l
-0.356 -0.712 l
-0.356 -0.357 l
-0.712 -0.357 l
-0.712 0 l
h
f
Q
q 1 0 0 1 476.8737 125.9407 cm
0 0 m
0 0.712 l
-0 0.712 l
0.7 0.712 l
0.703 0.712 0.706 0.711 0.711 0.711 c
0.711 0.356 l
0.712 0.357 l
0.355 0.357 l
0.355 0.001 l
-0 0.001 l
h
f
Q
q 1 0 0 1 476.8732 122.0297 cm
0 0 m
0 -0.354 l
-0.709 -0.354 l
-0.709 -0.001 l
0 -0.001 l
h
f
Q
q 1 0 0 1 477.2297 123.4522 cm
0 0 m
-0.71 0 l
-0.71 0.355 l
0 0.355 l
-0.001 0.355 l
-0.001 -0.001 l
h
f
Q
q 1 0 0 1 476.8737 126.6527 cm
0 0 m
-0.709 0 l
-0.709 0.354 l
-0 0.354 l
-0 -0 l
h
f
Q
q 1 0 0 1 476.8737 125.5857 cm
0 0 m
-0.354 0 l
-0.354 0.355 l
0 0.355 l
-0 0.355 l
-0 -0.001 l
h
f
Q
q 1 0 0 1 476.5177 124.8747 cm
0 0 m
0 -0.355 l
-0.354 -0.355 l
-0.354 -0 l
0.001 -0 l
h
f
Q
477.583 127.009 -0.353 0.353 re
f
q 1 0 0 1 477.2297 122.7412 cm
0 0 m
-0.354 0 l
-0.354 0.355 l
0 0.355 l
-0.001 0.356 l
-0.001 -0 l
h
f
Q
477.94 127.719 0.356 -0.356 re
f
q 1 0 0 1 476.8737 122.0292 cm
0 0 m
0 0.353 l
0.003 0.354 0.005 0.356 0.007 0.356 c
0.123 0.356 0.24 0.356 0.357 0.355 c
0.356 0.356 l
0.356 0.001 l
-0 0.001 l
h
f
Q
479.362 122.386 0.357 -0.357 re
f
q 1 0 0 1 478.2957 122.0302 cm
0 0 m
0 -0.355 l
-0.354 -0.355 l
-0.354 -0.001 l
0 -0.001 l
h
f
Q
479.718 122.03 0.356 -0.355 re
f
q 1 0 0 1 480.4292 127.7192 cm
0 0 m
0.357 0 l
0.357 -0.355 l
0.712 -0.355 l
0.712 -0.826 0.712 -1.296 0.712 -1.766 c
0.712 -2.106 l
0.712 -2.133 l
1.423 -2.133 l
1.423 -2.489 l
2.49 -2.489 l
2.49 -2.844 l
2.134 -2.844 l
2.134 -3.555 l
1.423 -3.555 l
1.423 -3.2 l
1.777 -3.2 l
1.777 -2.846 l
1.423 -2.846 l
1.423 -3.201 l
1.068 -3.201 l
1.068 -2.844 l
0.711 -2.844 l
0.712 -2.845 l
0.712 -2.49 l
0.68 -2.49 l
0.335 -2.489 -0.01 -2.489 -0.355 -2.489 c
-0.355 -2.49 l
-0.355 -2.134 l
0 -2.134 l
0 -1.422 l
0.355 -1.422 l
0.355 -0.712 l
0 -0.712 l
h
f
Q
q 1 0 0 1 480.0732 123.4507 cm
0 0 m
0.008 0 0.017 0.002 0.026 0.002 c
1.037 0.002 l
1.066 0.002 l
1.066 0.355 l
1.422 0.355 l
1.422 -0.708 l
1.068 -0.708 l
1.068 -0.355 l
0 -0.355 l
0 0.001 l
h
f
Q
q 1 0 0 1 481.1402 124.8747 cm
0 0 m
0 -0.355 l
-0.354 -0.355 l
-0.354 -0.711 l
-1.066 -0.711 l
-1.066 -0.712 l
-1.066 -0.355 l
-1.066 -0.357 l
-0.71 -0.357 l
-0.71 -0 l
0.001 -0 l
h
f
Q
q 1 0 0 1 482.5632 123.0982 cm
0 0 m
0 0.353 l
-0.354 0.353 l
-0.354 0.709 l
0.354 0.709 l
0.354 0 l
h
f
Q
q 1 0 0 1 480.0737 124.1637 cm
0 0 m
0 -0.235 0 -0.469 0 -0.704 c
0 -0.707 -0 -0.71 -0 -0.713 c
0 -0.712 l
-0.118 -0.712 -0.237 -0.711 -0.355 -0.711 c
-0.355 -0.712 l
-0.355 0 l
-0.355 -0.001 l
0 -0.001 l
h
f
Q
q 1 0 0 1 479.7182 123.4522 cm
0 0 m
0 -0.356 l
-0.356 -0.356 l
-0.355 -0.356 l
-0.355 0 l
-0.355 -0.001 l
0.001 -0.001 l
h
f
Q
q 1 0 0 1 481.4962 127.3637 cm
0 0 m
0.356 0 l
0.356 0.355 l
1.068 0.355 l
1.067 -0.108 1.067 -0.572 1.067 -1.036 c
1.067 -1.068 l
0.356 -1.068 l
0.356 -0.712 l
0.71 -0.712 l
0.71 -0.357 l
0 -0.357 l
h
f
Q
481.852 125.941 0.71 -0.356 re
f
481.852 125.941 -0.354 0.357 re
f
482.563 128.075 0.354 -0.357 re
f
479.362 126.297 0.712 -0.355 re
f
q 1 0 0 1 479.0067 126.6522 cm
0 0 m
0.356 0 l
0.356 -0.356 l
0.237 -0.356 0.119 -0.356 0 -0.355 c
0.001 -0.356 l
0.001 0 l
h
f
Q
479.363 127.363 -0.356 0.356 re
f
0 0 0 1 k
q 1 0 0 1 479.3632 123.4522 cm
0 0 m
0 -0.356 l
-0.711 -0.356 l
-0.711 -0.712 l
-1.067 -0.712 l
-1.067 -0.357 l
-1.421 -0.357 l
-1.421 -0.001 l
-1.067 -0.001 l
-1.067 0.355 l
-0.712 0.355 l
-0.712 0.709 l
-0.357 0.709 l
-0.357 0 l
h
f
Q
q 1 0 0 1 476.8732 125.5852 cm
0 0 m
0 0.356 l
0.355 0.356 l
0.355 0.712 l
0.712 0.712 l
0.712 0.356 l
1.066 0.356 l
1.066 0.001 l
0.712 0.001 l
0.712 -0.71 l
0.357 -0.71 l
0.357 0 l
h
f
Q
q 1 0 0 1 481.1412 124.8742 cm
0 0 m
-0.711 0 l
-0.711 -0.356 l
-1.068 -0.356 l
-1.068 0.356 l
-0.723 0.356 -0.377 0.356 -0.032 0.355 c
0 0.355 l
h
f
Q
479.719 123.452 -0.356 0.712 re
f
q 1 0 0 1 478.6512 124.8747 cm
0 0 m
0 -0.354 l
-0.354 -0.354 l
-0.354 -0 l
0.001 -0 l
h
f
Q
479.008 126.296 -0.357 0.356 re
f
480.074 124.163 -0.356 0.356 re
f
477.229 123.808 0.355 -0.356 re
f
477.229 123.097 0.355 -0.356 re
f
478.651 122.741 0.357 -0.356 re
f
q 1 0 0 1 481.8522 124.5182 cm
0 0 m
0 0.355 l
0.354 0.355 l
0.354 0.001 l
-0 0.001 l
h
f
Q
Q
BT
3.5 0 0 3.5 461.8317 117.5657 Tm
(XXXX-XXXXXY)Tj
4.959 0 Td
(-X)Tj
0 Tc 0 Tw (X)Tj
/GS0 gs
/T1_1 1 Tf
-0.054 Tc 0.054 Tw 8 0 0 8 333 83.914 Tm
[(7)-36.8 (.)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.019 Tc 0.036 Tw 1.625 0 Td
[(Inspect the infusion ba)-10 (g\(s\) for an)-10.1 (y breaches of container integrity such as breaks)-19 ( )]TJ
-0.011 Tc 0.078 Tw 0 -1.09 Td
[(or cracks before tha)-9.8 (wing.)37.2 ( If the ba)-9.7 (g\(s\) is compromised,)37.2 ( do not administer and)-11 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.09 Td
[(contact Bristol-Myers Squibb a)-9.8 (t 1-888-805-4555.)]TJ
-0.054 Tc 0.054 Tw -1.625 -1.63 Td
[(8)-36.8 (.)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.017 Tc 0.06 Tw 1.625 0 Td
[(If more than one infusion ba)-10.1 (g has been received to achieve the trea)-10.1 (tment dose,)20 ( )]TJ
-0.015 Tc 0 -1.09 Td
[(tha)-10.2 (w each infusion ba)-10.1 (g one a)-10.2 (t a time.)36.9 ( Do not initia)-10.1 (te tha)-10.1 (w of the next ba)-10.2 (g until)-15 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.09 Td
[(infusion of the previous ba)-9.8 (g is complete.)]TJ
ET
1 w 4 M 
q 1 0 0 1 319.5 91.947 cm
0 0 m
0 -28.008 l
S
Q
BT
/T1_0 1 Tf
8 0 0 8 36 744.663 Tm
[(FULL PRESCRIBING INFORMA)55.1 (TION: CONTENTS)]TJ
0 Tc 0 Tw 17.464 0.062 Td
(*)Tj
0.373 -0.062 Td
( )Tj
/T1_3 1 Tf
-0.017 Tc 0.017 Tw 0.271 0 Td
(\(Continued\))Tj
/T1_0 1 Tf
-18.108 -1.602 Td
(13)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.125 0 Td
[(NONCLINIC)18.2 (AL TOXICOLOGY)]TJ
/T1_1 1 Tf
0.017 Tw 0 -1.368 Td
(13.1)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3 0 Td
[(Carcinogenesis,)37.2 ( Muta)-9.8 (genesis,)37.2 ( Impairment of F)24.2 (ertility)]TJ
/T1_0 1 Tf
0.017 Tw -6.125 -1.412 Td
(14)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.125 0 Td
[(CLINIC)18.3 (AL STUDIES)]TJ
0.017 Tw -3.125 -1.423 Td
(15)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3.125 0 Td
(REFERENCES)Tj
32.875 4.213 Td
(16)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.125 0 Td
(HOW SUPPLIED/STORAGE AND HANDLING)Tj
0.017 Tw -3.125 -1.423 Td
(17)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.125 0 Td
[(P)54.2 (A)55.2 (TIENT COUNSELING INFORMA)55.2 (TION)]TJ
/T1_1 1 Tf
-0.005 Tc 0.081 Tw -3.125 -1.805 Td
(*)Tj
/Span<</ActualText<FEFF2009>>> BDC 
0.346 0 Td
( )Tj
EMC 
0.119 0 Td
[(S)0.5 (e)0.5 (c)0.5 (t)0.5 (i)0.5 (o)0.6 (n)0.5 (s)0.5 ( o)0.5 (r)0.5 ( s)0.6 (u)0.5 (b)0.5 (s)0.5 (e)0.5 (c)0.5 (t)0.5 (i)0.5 (o)0.5 (n)0.5 (s)0.5 ( o)0.6 (m)0.5 (i)0.5 (t)0.5 (t)0.5 (e)0.5 (d)0.5 ( f)0.5 (r)0.5 (o)0.5 (m)0.5 ( t)0.5 (h)0.5 (e)0.5 ( f)0.5 (u)0.5 (l)0.5 (l)0.5 ( p)0.5 (r)0.5 (e)0.5 (s)0.5 (c)0.5 (r)0.5 (i)0.5 (b)0.5 (i)0.5 (n)0.5 (g)0.5 ( i)0.5 (n)0.5 (f)0.5 (o)0.5 (r)0.5 (m)0.5 (a)-9.5 (t)0.6 (i)0.5 (o)0.5 (n)0.5 ( a)0.5 (r)0.5 (e)0.6 ( n)0.5 (o)0.5 (t)0.5 ( l)0.5 (i)0.5 (s)0.5 (t)0.5 (e)0.5 (d)0.5 (.)]TJ
ET
q 1 0 0 1 36 683.9123 cm
0 0 m
540 0 l
S
Q
endstreamendobj105 0 obj<</Metadata 109 0 R>>endobj109 0 obj<</Length 12958/Subtype/XML/Type/Metadata>>stream
<?xpacket begin="Ôªø" id="W5M0MpCehiHzreSzNTczkc9d"?>
<x:xmpmeta xmlns:x="adobe:ns:meta/" x:xmptk="Adobe XMP Core 9.1-c002 79.a6a6396, 2024/03/12-07:48:23        ">
   <rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
      <rdf:Description rdf:about=""
            xmlns:xmp="http://ns.adobe.com/xap/1.0/"
            xmlns:dc="http://purl.org/dc/elements/1.1/"
            xmlns:xmpMM="http://ns.adobe.com/xap/1.0/mm/"
            xmlns:stRef="http://ns.adobe.com/xap/1.0/sType/ResourceRef#"
            xmlns:stEvt="http://ns.adobe.com/xap/1.0/sType/ResourceEvent#"
            xmlns:stMfs="http://ns.adobe.com/xap/1.0/sType/ManifestItem#"
            xmlns:xmpTPg="http://ns.adobe.com/xap/1.0/t/pg/"
            xmlns:stDim="http://ns.adobe.com/xap/1.0/sType/Dimensions#"
            xmlns:stFnt="http://ns.adobe.com/xap/1.0/sType/Font#"
            xmlns:xmpG="http://ns.adobe.com/xap/1.0/g/"
            xmlns:illustrator="http://ns.adobe.com/illustrator/1.0/"
            xmlns:pdf="http://ns.adobe.com/pdf/1.3/"
            xmlns:ExtensisFontSense="http://www.extensis.com/meta/FontSense/">
         <xmp:CreatorTool>Adobe Illustrator 28.1 (Macintosh)</xmp:CreatorTool>
         <xmp:CreateDate>2024-01-04T14:53:38-05:00</xmp:CreateDate>
         <xmp:ModifyDate>2024-01-04T14:53:38-05:00</xmp:ModifyDate>
         <xmp:MetadataDate>2024-01-04T14:53:38-05:00</xmp:MetadataDate>
         <dc:format>application/postscript</dc:format>
         <dc:title>
            <rdf:Alt>
               <rdf:li xml:lang="x-default">Abecma_Label_Mockup_v7</rdf:li>
            </rdf:Alt>
         </dc:title>
         <dc:creator>
            <rdf:Seq>
               <rdf:li>(Steve Burgos)</rdf:li>
            </rdf:Seq>
         </dc:creator>
         <xmpMM:DocumentID>xmp.did:e40b906c-a551-4e7d-9b17-4fbb01b90203</xmpMM:DocumentID>
         <xmpMM:InstanceID>xmp.iid:4280ab9a-8b25-4045-80ae-52208d36803f</xmpMM:InstanceID>
         <xmpMM:OriginalDocumentID>xmp.did:39cf100d-aa70-4562-bff5-776ea2fe2e29</xmpMM:OriginalDocumentID>
         <xmpMM:RenditionClass>proof:pdf</xmpMM:RenditionClass>
         <xmpMM:DerivedFrom rdf:parseType="Resource">
            <stRef:instanceID>xmp.iid:c03246dc-6359-451b-bb54-c30c711ae32d</stRef:instanceID>
            <stRef:documentID>xmp.did:04f0f2ff-38a7-4d16-a25a-6a00ba7f0f89</stRef:documentID>
            <stRef:originalDocumentID>xmp.did:39cf100d-aa70-4562-bff5-776ea2fe2e29</stRef:originalDocumentID>
            <stRef:renditionClass>proof:pdf</stRef:renditionClass>
         </xmpMM:DerivedFrom>
         <xmpMM:History>
            <rdf:Seq>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:39cf100d-aa70-4562-bff5-776ea2fe2e29</stEvt:instanceID>
                  <stEvt:when>2020-01-16T11:20:59-05:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator 24.0 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:04f0f2ff-38a7-4d16-a25a-6a00ba7f0f89</stEvt:instanceID>
                  <stEvt:when>2021-03-26T12:49:46-04:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator 25.2 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:e40b906c-a551-4e7d-9b17-4fbb01b90203</stEvt:instanceID>
                  <stEvt:when>2024-01-04T14:53:38-05:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator 28.1 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/postscript to application/vnd.adobe.illustrator</stEvt:parameters>
               </rdf:li>
            </rdf:Seq>
         </xmpMM:History>
         <xmpMM:Manifest>
            <rdf:Seq>
               <rdf:li rdf:parseType="Resource">
                  <stMfs:linkForm>EmbedByReference</stMfs:linkForm>
                  <stMfs:reference rdf:parseType="Resource">
                     <stRef:filePath>/Users/mkemler/Desktop/Unknown.jpeg</stRef:filePath>
                  </stMfs:reference>
               </rdf:li>
            </rdf:Seq>
         </xmpMM:Manifest>
         <xmpMM:Ingredients>
            <rdf:Bag>
               <rdf:li rdf:parseType="Resource">
                  <stRef:filePath>/Users/mkemler/Desktop/Unknown.jpeg</stRef:filePath>
               </rdf:li>
            </rdf:Bag>
         </xmpMM:Ingredients>
         <xmpTPg:NPages>1</xmpTPg:NPages>
         <xmpTPg:HasVisibleTransparency>False</xmpTPg:HasVisibleTransparency>
         <xmpTPg:HasVisibleOverprint>False</xmpTPg:HasVisibleOverprint>
         <xmpTPg:MaxPageSize rdf:parseType="Resource">
            <stDim:w>7.780758</stDim:w>
            <stDim:h>3.201051</stDim:h>
            <stDim:unit>Inches</stDim:unit>
         </xmpTPg:MaxPageSize>
         <xmpTPg:Fonts>
            <rdf:Bag>
               <rdf:li rdf:parseType="Resource">
                  <stFnt:fontName>ITCAvantGardeStd-BkCn</stFnt:fontName>
                  <stFnt:fontFamily>ITC Avant Garde Gothic Std</stFnt:fontFamily>
                  <stFnt:fontFace>Book Condensed</stFnt:fontFace>
                  <stFnt:fontType>Open Type</stFnt:fontType>
                  <stFnt:versionString>Version 2.031;PS 002.000;hotconv 1.0.50;makeotf.lib2.0.16970</stFnt:versionString>
                  <stFnt:composite>False</stFnt:composite>
                  <stFnt:fontFileName>ITCAvantGardeStd-BkCn.otf</stFnt:fontFileName>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stFnt:fontName>HelveticaNeueLTStd-Cn</stFnt:fontName>
                  <stFnt:fontFamily>Helvetica Neue LT Std</stFnt:fontFamily>
                  <stFnt:fontFace>57 Condensed</stFnt:fontFace>
                  <stFnt:fontType>Open Type</stFnt:fontType>
                  <stFnt:versionString>Version 2.035;PS 002.000;hotconv 1.0.51;makeotf.lib2.0.18671</stFnt:versionString>
                  <stFnt:composite>False</stFnt:composite>
                  <stFnt:fontFileName>HelveticaNeueLTStd-Cn.otf</stFnt:fontFileName>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stFnt:fontName>HelveticaNeueLTStd-BdCn</stFnt:fontName>
                  <stFnt:fontFamily>Helvetica Neue LT Std</stFnt:fontFamily>
                  <stFnt:fontFace>77 Bold Condensed</stFnt:fontFace>
                  <stFnt:fontType>Open Type</stFnt:fontType>
                  <stFnt:versionString>Version 2.035;PS 002.000;hotconv 1.0.51;makeotf.lib2.0.18671</stFnt:versionString>
                  <stFnt:composite>False</stFnt:composite>
                  <stFnt:fontFileName>HelveticaNeueLTStd-BdCn.otf</stFnt:fontFileName>
               </rdf:li>
            </rdf:Bag>
         </xmpTPg:Fonts>
         <xmpTPg:PlateNames>
            <rdf:Seq>
               <rdf:li>Black</rdf:li>
            </rdf:Seq>
         </xmpTPg:PlateNames>
         <xmpTPg:SwatchGroups>
            <rdf:Seq>
               <rdf:li rdf:parseType="Resource">
                  <xmpG:groupName>Default Swatch Group</xmpG:groupName>
                  <xmpG:groupType>0</xmpG:groupType>
                  <xmpG:Colorants>
                     <rdf:Seq>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=62 M=0 Y=34 K=0</xmpG:swatchName>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:tint>100.000000</xmpG:tint>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:cyan>61.675400</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>33.896399</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=67 M=83 Y=0 K=0</xmpG:swatchName>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:tint>100.000000</xmpG:tint>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:cyan>66.948998</xmpG:cyan>
                           <xmpG:magenta>82.503998</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=16 M=100 Y=87 K=6</xmpG:swatchName>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:tint>100.000000</xmpG:tint>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:cyan>16.211200</xmpG:cyan>
                           <xmpG:magenta>99.926800</xmpG:magenta>
                           <xmpG:yellow>85.922003</xmpG:yellow>
                           <xmpG:black>5.938800</xmpG:black>
                        </rdf:li>
                     </rdf:Seq>
                  </xmpG:Colorants>
               </rdf:li>
            </rdf:Seq>
         </xmpTPg:SwatchGroups>
         <illustrator:CreatorSubTool>Adobe Illustrator</illustrator:CreatorSubTool>
         <pdf:Producer>Adobe PDF library 15.00</pdf:Producer>
         <ExtensisFontSense:slug>
            <rdf:Bag>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>2061318306</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>Helvetica Neue LT Std</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>OpenType - PS</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>2061318306</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Adobe Systems</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>HelveticaNeueLTStd-Cn</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>1.029</ExtensisFontSense:Version>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>3357634683</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>Helvetica Neue LT Std</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>OpenType - PS</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>3357634683</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Adobe Systems</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>HelveticaNeueLTStd-BdCn</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>2.035</ExtensisFontSense:Version>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>3454135</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>ITC Avant Garde Gothic Std</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>OpenType - PS</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>3454135</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Adobe Systems</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>ITCAvantGardeStd-BkCn</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>2.031</ExtensisFontSense:Version>
               </rdf:li>
            </rdf:Bag>
         </ExtensisFontSense:slug>
      </rdf:Description>
   </rdf:RDF>
</x:xmpmeta>
<?xpacket end="r"?>endstreamendobj100 0 obj<</BaseFont/JHWGPK+HelveticaNeueLTStd-BdCnO/Encoding/WinAnsiEncoding/FirstChar 32/FontDescriptor 110 0 R/LastChar 120/Subtype/Type1/ToUnicode 111 0 R/Type/Font/Widths[240 0 0 0 0 0 0 0 296 296 0 0 240 0 240 0 480 480 480 480 480 480 480 0 480 0 0 0 0 0 0 0 0 556 0 0 574 0 0 0 0 0 0 0 0 0 0 0 519 0 556 519 0 0 0 760 0 0 0 315 0 315 0 0 0 481 500 463 500 463 296 500 0 240 0 0 240 758 500 480 500 0 333 444 296 500 444 704 462]>>endobj102 0 obj<</BaseFont/JHWGPK+HelveticaNeueLTStd-BdCn/Encoding/WinAnsiEncoding/FirstChar 32/FontDescriptor 112 0 R/LastChar 116/Subtype/Type1/Type/Font/Widths[240 0 0 0 0 0 0 0 0 0 0 0 0 370 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 556 556 0 574 481 463 0 0 258 463 0 463 740 574 556 519 0 556 519 480 0 0 0 0 520 0 0 0 0 0 0 0 481 0 0 0 463 296 0 500 240 0 0 0 758 500 480 500 0 333 0 296]>>endobj103 0 obj<</BaseFont/JHWGPK+HelveticaNeueLTStd-Cn/Encoding/WinAnsiEncoding/FirstChar 32/FontDescriptor 113 0 R/LastChar 116/Subtype/Type1/Type/Font/Widths[240 0 0 0 0 0 0 0 0 0 0 0 0 352 0 278 480 0 0 0 0 0 0 0 0 0 240 0 0 0 0 0 0 500 519 0 556 463 444 0 0 204 426 0 444 704 556 556 481 0 0 0 463 0 0 722 481 462 0 0 0 0 0 0 0 444 463 0 0 444 259 463 463 204 0 0 0 0 0 444 463 0 296 407 259]>>endobj104 0 obj<</BaseFont/JHWGPK+ITCAvantGardeStd-BkCn/Encoding/WinAnsiEncoding/FirstChar 32/FontDescriptor 114 0 R/LastChar 32/Subtype/Type1/Type/Font/Widths[241]>>endobj114 0 obj<</Ascent 964/CapHeight 700/CharSet(/space)/Descent -250/Flags 32/FontBBox[-150 -250 1037 964]/FontFile3 115 0 R/FontName/JHWGPK+ITCAvantGardeStd-BkCn/FontStretch/Condensed/FontWeight 400/ItalicAngle 0/StemV 75/Type/FontDescriptor/XHeight 500>>endobj115 0 obj<</Filter/FlateDecode/Length 444/Subtype/Type1C>>stream
Hâlê¡KA∆wt]k›,l‘˙‚°⁄T≠/Bò⁄Çç$“ûÑif6nMv√ÏTÇÇ`c!4óˆoË•ó–Í≈ÉGΩxöâigñˆPÚÊ}èyøÔ„!ÀÓ≥BœüΩ Â_Ã¨≥ô]ÚfÑ8yº≤ìÕáI9Ü§gÀq◊ìÓıHù\æ~= S#?$πoıåçF–t6™’YPﬁÊ0ø¥Ùt÷‘≈YXòõõOÍdHÙÜB°sZça-,E¨1Ã)IC¶RÅd9Fc vÕPáHíA0£¿&¥äŸNëØAú≤Û 
qäııqâBˆ/]è5≤hWF	!m
õÈBÚ⁄[ÉçEÒ^˙~†◊Õ∞äÎ†ˇø]¢åc˝F√‡Ì;ƒ$(õ8˝dµ`¸aıo?©eı!¥æ!«˘´ÉtùÍÙ€≤—Õ˜é8QÁûZÕÒ”Q†æ{¬àﬁ˚¡û≥ïÙbYiÌ»oûÈîQ)qî:hu˜Zä∂Òµy’º±[É˚ÌÓﬁGUnﬂ_ŒƒËŸÕd{Ë·ß‹á√ﬂÓ–≈›À·ãS◊Ωl∫˜˛0 ∞ı»Éendstreamendobj113 0 obj<</Ascent 932/CapHeight 700/CharSet(/space/hyphen/slash/zero/colon/A/B/D/E/F/I/J/L/M/N/O/P/T/W/X/Y/a/b/e/f/g/h/i/o/p/r/s/t)/Descent -212/Flags 32/FontBBox[-164 -212 1000 932]/FontFile3 116 0 R/FontName/JHWGPK+HelveticaNeueLTStd-Cn/FontStretch/Condensed/FontWeight 400/ItalicAngle 0/StemV 75/Type/FontDescriptor/XHeight 500>>endobj116 0 obj<</Filter/FlateDecode/Length 2203/Subtype/Type1C>>stream
HâlU}TWüI2/ÆkßîqòAP¿ä.‡◊™XãéàEj!|*÷uÕF◊œÍ*zv-≠∏ı£ÌZ?p).K‹?≤∞¶ÍâeÍÜ∂∫v◊‚ù¯‚q_B?NœÈôsÊæ;Ô›ﬂ‹˚ªø˜M©M”ìñe≠Yö˜rBñæ“™∑ JWË´ı9ZãÓ≈c`A¥AÀUr‰8^û4.ß·çOû§1ÚîÁÂ‹˛˘ãs°î2 FG”i¶-uf√´-‚åÙÙ‰È‚Ã‰‰ô‚"ùiÉ^‘÷UYÙõ´ƒlcô…º≈d.µËuâ‚¢ J1P%öıUz≥5ÒádDCïX*ZÃ•:˝ÊRÛ&—T.Êå&K›ΩòAPI–´Çk÷ÎDÉQ¥l‘ã´µâbA7ZƒR£N,¯!:∑º‹P¶~‹\Z'íú~]¶7[Jâ5≥XQm6TÈeÉ…Xı=∏±t≥˛g≤0ôE©†í¿´Ù˙ßónﬁêïòî©-8≥Dùæ¸Áâ¶hÚP,EÖ–TEE—TåÇäß©U‘läJSPãi*SEÂ—îVAE∫©ÂT•£©‘ótΩçÓ¢Ô*(ß»P)ˆ)˛ÆWjï&eßÚë*Rı'’Sf9S«|Éb–B‘ÇÓ™√’ıÍ”⁄∫‰˚]4yOÈR⁄Tr≥/œﬂå`Ó·Òÿ«¿0¬"æ¬C¿ÒÔU˚QIp0Òë|ôåp¿c±â°≈M_ÖfÂUh·°Ÿçõã≥˜Z}ı5Ùv∏§‹ﬁ»;4¯Íôlƒ:ùÚêì>#A≠§Ñﬂ4Ú†=:àá≈M∞k±∂	Îp2ûwØ≠Ä<·!yD‘E¶‚v‚hLaj'DCúÜ$`ÅŒz¿´êßﬁë$‰ﬂ•
ˆCá
]‡[MË˘wsGò]ÅBj—%\»x.ï0x,‚ÜØ≈ÚvÙo¸Ä¡àÌµπ¿·Ñ&Whèfo¶ó˚baòˇ›Ï”«en I8îí¡√jqw>ÖIw#≈!ÿ’ú‹Ïl83˛í®¡&$eˇAüü~eV§æQ.ƒ"ˆæÕ%ﬂp—7$8ÏUBí/å˜"òµO√<æû8]H
b#(</Aô`6XãXõˆª¡‚¶{$eOò¸Ç˚°’ç[¡ß‹~±§Ï°◊H0Ù”yºœaıï‘|7Î+IAlE£À7•ÜnÛ¿bI)´|%|ää€∂fnûÂ\èÊrjûzˆÖKòz“úÜm∞π}!ﬂ!»¨Ï!(–BÄU˜Ë^Iû.){	∂ é`ÊS#„S1ˆß*Ú?<·h”Bå‹«ópc„≠Ú DíVŒèJ\1…qïÚ†]u˛Aûd ı∑®qì<Ã`D‚]ÚW.˙Ç⁄	óÔ˚*y\TATîÖ≥:∞ä†®¥Ñ¿¨
–‚"!CÏé”q˙kƒ∞ò}¬!“è√
laÆõ¥ﬁE*É*oêºn†<ww &B)N±-≤—¶ù.ú?}’˙óÖ(¢j´/ƒMC.ëÙªæ≤‹~Ì|X˙4D"¨±A¶øØnüo5WÒaè∑ÒÚ cGHuèL%R$¬¥ˇ6·&VæÕLF±¡1¶âCnmú]ﬁ™Ñx∆„ï¯Q1ƒ¿Yà¬gôàÏögê	èò$Ñ'‡„8é3qà›5L0:x‹!AáÚÂÃ¿¬…xG¬O¥”ËÃÔÖ/≠†pÜ∂K=ê··>ÜPy,ˇ{ı1€ÁﬁkÔãJlı+j5ò10\g¶u”öÖ·	ü‰>Ï∫‹~·Ñ∆é8kÊÓs∂ìé∂›ø€#Ù™õﬂ¸mKSƒVõ£MÄÀÍk∂8è_≥
≥xo·πŒÇ’≈+kœ\Ì<Ï8qTsÊùÅΩÔwåa]˘=rö“jBª=∞N‚.í9¯G≠#˜‹«”ÒxÃ÷§ÃüQ˜Æav∑w—iWóÏ,ÎâÄêK0@UGN™òUÖ∆uµBÏHú0ÀIüñ`5°c<‹‰è´O J8∂$WcTKŸ¸)5® ö\zÈ[qëJNw2å=ˇ™IEeM©sßÿ ‰9~äVπ¬	»EﬂÚ(oÖy‰
Ø3©ùn=¸ÅÊ¨kö≥±téê3?€≠fqé∆∫‰¯û|WËü•≈XÈ·>É≠≤ôø◊:9+Íf'ßæÙå?~«-p_An?qü-mQ‘T|.?GÍ$≥‰ .Ç‰+]'Œ∑
ˆóP˘Ó4Li∏¡ı˙cﬂR?º≠#®Åò%q Ê ë4!rπGŸMrD»}˝ΩÛˇ⁄ïµA„G9D›g{å5kÛ*◊WkFy
rGÕø¶{=d+{‰éTtGÂ˘zîByâìnó†\R∂ì¶‡Ñ3x$A‚Ÿ È	zò@HK‘&h»∆´‰g◊?Ñ10¶ı·›{Gß‚1xL›‘ôãì¨+óú‡c¥…∑ÉMˆ“p†Àc±¶&ùty‰ëfû?è˜¿v;ZwÏºÒBêâÖîµ¿`.ø∏¨¨IhA‹}Á\Bs*IΩ‹”XÛn@;‹uR0x—ˇ8Û—âÕoÌ”páÓ®πÎªwl≥◊G‰nz•∞*Ÿ~+UÕÆ	V˙Gœ"ÃÒ,Òp7eF~ûÔ{k'P89"q˛⁄©Xy£∂øZ‡æËØv6dÑˇz˘Î[“Î>Ì'¢(∞„Xˆü›¿ådø≥¨M√›ÃnÀ~ª/|∞wÔâÎ≠ÂKbŸÈíß9ÉJ˘? h óˇ¯¨=IŸ¸E†g‚Æ°èçñ–äÇÅây_Äú∂˜ÏËÕ.˜07}ô˘^ô˚Tô˜$ô˜•í‚í¸¬ìzú˘^ú˚jó˜•íÔí¸Èó	Õ
ﬂ«ëëëß«£èè¯c¯_ ‹*Ω.endstreamendobj112 0 obj<</Ascent 961/CapHeight 700/CharSet(/space/hyphen/A/B/D/E/F/I/J/L/M/N/O/P/R/S/T/Y/a/e/f/h/i/m/n/o/p/r/t)/Descent -224/Flags 32/FontBBox[-164 -224 1066 961]/FontFile3 117 0 R/FontName/JHWGPK+HelveticaNeueLTStd-BdCn/FontStretch/Condensed/FontWeight 700/ItalicAngle 0/StemV 75/Type/FontDescriptor/XHeight 500>>endobj117 0 obj<</Filter/FlateDecode/Length 2043/Subtype/Type1C>>stream
HâtTPSgæó$ˇ f-ód≤†7◊ãä¨€Rt≠±>∞H¿GT ÉÑ`í&bMu|Ly#‚ñ∆bF≈˙†Íà¨∏¯@Z‘∂®U∆µé€}î-˚0ûõ˛ÈÃû÷n;≥ùÃÕˇ8ˇ˜˝ﬂ9Áªóeî!À≤˙•KV.N{u⁄s±ÀÏ¥‰Á¶òﬂ4'gù¶â¶%ÚëâR4+E*•q·i|∏ñ&PÁ∑ÁøÕTIS.üΩ=.ty£ê…¥ÏDvŒ[iô›R∏÷)˛jˆÏ∏È‚¨∏∏Y‚|ì-œ,ÀN≥’!&ï‰€Ï•6{Æ”läÁãAÄC¥õfªKﬁ¸^éhqàπ¢”ûk2[sÌÎD[Åòl)±9ÀJÕ‚dâEP°yÌfìh)ùkÕbf¨1VLCˆßò[b3æGßXÚÕ¡Mknôàö~åŒ7€ùπ8⁄ê∆.Ωi∑8Lñ|ß≈V‚xJ^ík5ˇ6ªh¡äëæƒa6ˇ/ºÿö∑$vÊ"cÜºx^4ô~™‘ã?FÕ0œ±Ã§&Üef(ô_á0s&ëa±LÀ§(#√d2åÄgñ1)åâiaÏ<v[œfÔ≥˛êC
CNÑ<RºÆ∏©¯órÇÚÄ“ØäWï™v™˛Ifí§ü„πÙñ™.i∏ã≈Có¢J)ï˚”ÂjÈ«:T0H®H/j@^vqíú√<äk"]–»3*Ø‘j6B€mä¯áÜÜAÑqÍª˚]0¬‡å≠rGTI˘Å*%ƒêc0MÈ‰≈!Ü–Â˛]D¯¡?”±örÉﬁQQë®ÔV˘`›§˙"∫¿ q`†ë√K]Zxáèan˜0(ÆÍù˚ÆæÜ„•/ˆù¯d 
∆«w–0ÅÓ `ò†π@æ8f_º§∞tÆ>èLQ^EÿµNGBBñ}ëﬁH‘√U>©“«ˆ {2=Zp0^ıPP„iñûn	]!Ú^çß+‹…SÙØu]¶ïÅœ\LÂ)∫¸9öÔr§F˜b`;é€1ÿ ó¡Ée∏ˆ√≥ZºÒ⁄œ&5µÌw˘s‹≤dk˝9‘]Ç=>àõ›:àî#≠xv„ÂÕÖ+Wn˛®_h¶∫bé*Oƒ¿tò|„*L§wÖ˙§Aw:)Sã75HÉ£Ñ˛~ó‘ˆ"Ë$:≈E-N˙jÅ>(qî˙T5Å>–°1™UdíT≠¢EX≥Që](ß ±£i#æºÜÉWÂ*H@ê.‡© 4QÚ®‘w=>Èêèm√å_C-m‡◊PÎ!≈P|b¡
÷Rà•≈¥∏î∆R´ -Ωw<ŒßFö·Iåè˜‹ÜA›éE<È´OŒ	ûZ∆ì∆˝≠¶>Y˝ÑN÷”ù¡~ıí[≠˘MñtπY≤ªG o‘H	h$º+§«˛ÒuÚY[Q“<ìuë>ïPC`≤u^ ∞kÙut|µ≠∂‘Î˛ƒ’ìRÔ;ß*ˇP”6]˙Â{c–yèÔ5ù¸Ùa®\ïù˜Q∑séh∆ã¢ÇZ £sõ¡°)·®Ó”ó·EÅøq__ái_Ÿ∫)”©ßäs™îÉoÍàjo:˝ô¿t∑òñËAÿG`|l7ç§„‚_°z˙Ã'+ ÚÅˇÀ√¢cé•Q©π∂7^ﬁp¶Oÿœ©k±≠ÉË0tîA—à}¡∑0.0‹çìmxf¥uêÜÒZå√≤¿B=é
ès∞L¬yôBc≥g¿aï∫Œ3îÊí◊É°àV–Q∆¢uº^íB5{∏ˆÊ÷ˆ≥{ÌyÖû∑Ú∂/πT|ÁÙıyyì£ü˝ËÛSﬁÀGÖ¬ªÍ Í\ª7éÒ)oÈäÇè∏·‚Î4ab|.+ºÕÒù∞ìh“^wl:~˙\Û°ÀçBS]ÀÓºc–˚C0˜KàbÇ –oRTkép0ª˙M±—(äUn@CeÅ∂˜&<ªS†cI“∂k≥£WmºzMÜ˚RπüÎzøßªÁ∑Ÿ≥k5M¬B•˝u§‹—?ÿØAJ˚„–o:…o„©›ª´*wc˛ŒÒÉ5vGµ=zV∆∫} ¬79ub”}Ôfœ¢"ä≥à?È=x∏ÛÙ^W¶‡êm"Á[’˘¬Ú,gˆz°ﬁ¢Q#∞Õ˝'ÏœyùóØl√Ìœïàì„p\¶˛z¶/Bfé}"«Òø^Ñ\m˝∞„‘{éó◊‹è÷R4˜Ô5=qKWó§ªÑ
“Ω)˚HrÙÚ5Ó◊÷Í+ØõÍ˛+˝)?*Á~B:ˇª†¯’é%»≈\ì—µû!I=ƒ∂"b*&–
Õözv*Ã©`÷•oöö˝ùSÆß≥2ß“dtÆBÍÔ^øº7[Uña\º„.ÑÍ:”Ò>xÚT $î2å¯fÑ6ˆ^ÈmL•°4tsjj Ê^®XÆ¡cÆ≤ÊpõÎB4®.‹á,=≤Vﬁß™L≥kµU÷9‹#Î§L3t∑LŒüês$¸ËÁn]:pŒªß≤“ãŸs’€∂VoãN7YV⁄‰
ù∏ƒ&ÌIîΩÙEiø‘¶¡¶”+ßÏæ"`é∂÷÷~(<‚*∑n©‹ùøµ©]h¸Ä	¯Õı˙sº4›œy	‹ı’Æ@w∑±…ü”Dã«‡Œ»Æ¿Pc®/Ñgn66÷◊◊7¡±æ°æ>¸g’·jÿ)≠◊¸GÄ Iw}ïendstreamendobj110 0 obj<</Ascent 961/CapHeight 714/CharSet(/space/parenleft/parenright/comma/period/zero/one/two/three/four/five/six/eight/A/D/P/R/S/W/bracketleft/bracketright/a/b/c/d/e/f/g/i/l/m/n/o/p/r/s/t/u/v/w/x)/Descent -271/Flags 96/FontBBox[-171 -271 1116 961]/FontFamily(HelveticaNeueLT Std Cn)/FontFile3 118 0 R/FontName/JHWGPK+HelveticaNeueLTStd-BdCnO/FontStretch/Condensed/FontWeight 700/ItalicAngle -12/StemV 140/Type/FontDescriptor/XHeight 538>>endobj111 0 obj<</Filter/FlateDecode/Length 418>>stream
Hâ\ì¡n£@DÔ|≈ìCÑLw"!K;ë|H≤Zg? C€ã¥–¸˜ô¢¨¨¥H0’U4Mæﬁn∂°ü\˛3ÌŒ&wËCÌ<\bkno«>dÀ¬u};›ÓÊk{j∆,O‚›ı<ŸiCV◊.ˇï6œSº∫ª›∞∑˚,ˇàù≈>››ÔıÓﬁÂªÀ8˛µìÖ…-‹jÂ:;§BoÕ¯ﬁúÃÂ≥Ïa€•˝~∫>$Õø'>Ø£πbæ_2L;tvõ÷béñ’ãt¨\˝öéUf°˚oø∫…ˆáˆO≥∫¿√ãEZ?í¡O‰'öºøê_ó‘ñ–ñKÚ\êpI.¡π{≤Y¿ÃP"C≈öjV‘V–z˙z¯zzyxyzyxy%+¯ô¸ﬁê7âÖııÖuuÑuuÑæ_afAfafAf°ó¿Kÿ7AﬂÑ}ÙMË+≥/{(Ë°ºí”«™ïÔ•x/eEeEeEeEeEeEe?”Ça∏}uåEö^˜=sÌ%∆4nÛàœsÜ	ÎÉ}ˇ„0∫§¬ô}	0 ?‚ÃÓendstreamendobj118 0 obj<</Filter/FlateDecode/Length 3486/Subtype/Type1C>>stream
HâlTPWÌv¶"*ùFÿ∫˝¢é‡àIÑDEe˘ç¸t@1Î'Ûqêô!38dD–?( ƒà
ä‡îeM4]?†Q#ë∏˛à—*◊5	†[Xµ‡m|§vﬂêZS[µ’Ø™ﬂyÔû”˜›Ûn”î|E”¥®éYù¥H£œtË≥MÈ⁄˝:}\≤&[¥PaIt≈åóxZzKæ—sò4÷ì√·¯ËÎóØSi‰H)bÙ›±#∑zS√\b>ÙÑkñ”f2Æ…gÜÖ©¶ã!*Uà∏@gM”ãß=[o∂ã±ñt´-Àj”fÎu¡‚ÇÃLqà`mzªﬁÊp-æIF4ŸE≠òm”ÍÙf≠m≠h5àq&ã5€ô•#àJ0!MD◊¶◊â&ãòΩF/¶kÇ≈$¢n…µùò¸Üùh0ò“ıCãf≠S$9˝/;]oÀ÷í∑ï»ÿƒåu6ì]gJœ6Y-ˆˇä[¥f˝ˇ…¬jM‰ôDﬁb◊Îﬂé6ß≈œà“$ª¿€¢No†(ö<î;Mç†®ë5Q~5û¢&Q‘LäöES°5á¢ÊQ‘BD©)*^Ni5çòä%x’F˝ìfË’t!›5,sÿôøÏê|æ<_ﬁ"ˇ7≥éyç¢ëïπ∫Ìq˚Yë†¯RÒ´˚>˜ãÓ<"=ä=ûè^Í9—”Íy÷ÛóG‰√é¬ÈES|§ÇÅ§¡ªUœÉœËBXƒó8pÅ¡›nÉh’–ÊaÇëtësÕ∞yyâx∂„µO˝åñAœ¿*è¡™˘8»åE˜‡†v¨RÙ£TPnÓòK∆7¿Å(o∏∞F…`:!_¿ ]ò3‚πd,∆v√JBÜ1†∫A'@<	‚fRÉJ·U*˙¨ê=óÅUÃETê˚©¡f4nı€	tY√˝#˝~5‡√E^Ü∞7ë‡ãÍA≈xuÊuKu›t;Äd∞MÚ‰@}¶¶Ì[˛∆Ó4•rÁ1X≠À“ƒÒÒ[ Í¥ÄÍ8\≤¥.¬y0ûáXXﬁ(@…Âµ]8ú«∆∞ßjØŒjáT–à-À‡°LHe∆°πÊXcüèrÇá∆ê,
A.ÌÏ¶•0ò(ìl Áp⁄_ÛÁ3-ßüﬂÛ}~∑Ò⁄°_‡u<˘ox<èï≥‡1VakË˛¡ÍoÔÁ*-IÖ‹ÖŒµÛóD•¯bÔiQogaoÖÉ\GÑç›Nt{∑Å saRàÏ£õêŒÌ,`0om	R€¡≥ßJ`œz∂ÓÊ¨Ú¢bﬂ€ó⁄*ü(ÿá0˙¯¢+¯-ˇaV$Ã©ﬁ≠Ú√Õ7¯¶Y±y¬‚¸åîD~ÖÎDÏ£fÙ∞xq\ûüü≥,íè€~Óq≈P1H‰RJ}N*î¡=ÿ«a¡28Ã#¸˜¡—î¢LË2¶ôt‰L4ÍëR<·«Éâ.≥z°°(ê”`D¬ôt{@Õ2SÉ˙jÕ±æ}ov∑3rå+ÛÒªøo*#Æ°Ì3s÷ó`à·A›Ò
f‘ ?öèÂVÊ÷;Pº√@˘oE´Èá‡nÔÎ0"` T`˚§´“1¸kf=â«˘´±Ø¯P¿åõq|¿C»O?√ªßV∂&´{ÛÒÀÏÜµDu˜)ÜÌ˚◊·ÕekS6
ÿàØs¨ÙºÍ‰È+|[π^ô#ºøﬁë…≥}1≈ﬂ<: %@ÆOj∑wLZ=0a&qÌ≈X¡±}Ô9ã∞,Áa˘{T)T>≥›?†(v˚±Í´ˆΩl'£€0«cn¶∆eŸ¶‘}Í;9änÏãŸπ…ëŒÿ·6«ˆ‹‹_Wﬂƒ7Ud, bÛ÷dhyˆÖ÷Qˇ]π¿ˆÕ¡\G˘âÀÌ|{iJtûìgIVÛÍm≠∑ /"¶*¡Éò9™0«ªP∫ƒv aj%KP&Øi»0∞ä¡QàÌ∫éGq≈dıCú˜Ç¬~ig?-}ìeW| ÅÊ@ŸeÁ∂Ä?^¡„MFå„Æ#∂=øªF¿K”2‚˘EÑÆ ?›f¢†É@YãLD◊·4”â`lﬂ-òR'º:íı
OÊqÈê»5tß*=rÉ∞0w•i…êÇ+˝÷^HÎ˜ñ‹ pLg_¬©ècª:P{mπ◊ÛrWö£¯DÑùÉì9¢Zˆe'∫Zi“|"ÿ∞ˇ6kAVYé®P—gˆÚ“3Â˜˝Í»OÓÚÙ˝ƒä'/‹¨ÓQ∞]§qìn`rÂù◊/’ÙìFú ó0K	ÿgﬂÉù€ja∞Øµ9fÛl'®˙;@Y/T>Õmù⁄4πŸWs|KMŸY{∑ÒÛ„Ì|kÖ.&O Ì_R≈Äˇâ˜Z]Õ96è.ßmxxÛRXMæ¸èåZ{ûZë∏ÒO÷’|¯'_€J™/(ÑÊXï„ªŸ,Åw,ë*H;ö+:Âr. ±_bÕ‡1f™ïéπ0NBıø!ØY8Æw °ónêBe8é'™Óe∆#ò:ê¿ÙπÊÿ˘{Tâ ¯-
4Ø}\{é@Üß˛ö@H^?‰uøˇ#‹r<Èˆæ˛0¸‚I„5Aë‰ŒÌ™`˜‘÷6Ú›oK€,l1:s?‹Í¸hyöc≤""˜`ÿsû=ˇ]cy€Y°±úÖé“ı‰è≤•ÆË»ﬁñkÖ/€Ù¢z}Â'iÒ®èÑÇ|tÿ¿%Â/µx√ßiÿ#î5◊÷\›WYrÏ?ÑWPTU^dﬁs!⁄—}.°◊Òô¢1Œ(FhNZbÉ¨¸0¬¡$›%\TL…]V·+?›RÒπhô0©£ñ£õ$35pswÜŒ[±©?ö˛x≥ÔﬁwﬂyÁ~˜;ﬂw÷d‰äëú1ﬂá0>+¨àTù˘\‰ÉYnµµ∂>b+PS∑tØµöÑ⁄pûÁ≤i$≈%^,◊U⁄ã†Fù8•Ì&¿‹⁄Ö¶#ÒeHdÇ6v;
ƒy–:¡¥°…G]æÉπh+≥]E#å®PL∂ﬁ¢°‹¬MtßÜß)—›o√<ãáÜ·≈Fûz±˛ô©	—dS°f◊Û0£Æ∆vÉ\:©Áˇï˛˜¿sôê˘,uÈ˚GÍ!D˝4u˚”º%/ñrzüjÒ¥;t)’ëÑ2o≠í$è˚äj‚N≠Ütü©æ–é`Kô√ö€0KÚ“π*W1äTÜ&V[rAFWNÁPÔûŒ˘(ù.œ¡òŸƒ”Ï;ªw&Fì˜>πzM‡ML≈m’—jÊ¬±˙^+È-ä^ùÕ+Ê£°n∂?=§SâHÓ!O‰ø]‹Ã¸ÃVŸô ˆÿ9¶…¯Yi+1ô
L<˜cıÔ˜ËHFFQ:Ò€îºDÀÁÜ0$ì`#4¯óW¿˚Ï‹Ë;¶lÄπ˛hço|Œ%q‚z—¢‚ö˜™qﬂ=9Tn'tIı° 4ûF≈µÆÉi§≥´ÆÌ‹vv √µDËS„¬IV∂¡§Áπ]z”A°∏Réß‚õiç7+~Íáç<»ƒÜK¶ø“V,j4wı´a+}!ç_Æ€JBãØˇÄ¬èª¥ËÓÅ;Z\ßÎEiè¿äÈ$ÑÎ*’Çªì*’R˘‚¢é©ES«• ¿a“¶&Å7◊Vz:„Ã’2Kc'i5•«Ï„ÃOﬂ	√ù˛”ú“ªúÖßÜ%!C≠á‚õÇI®F∑5G\ˇq+ ‚¯Ïc‚BX4ı±!ò`leÕÁH{ôvãû_„ò.EΩ+.ƒ®cÊmÁVê–àåw„ùq Æ9„H}ò¬Ór˚∞ Ï√Ó"G„©∫÷äÂ‡7¯Ç[˘6Pß?°á‰‘oùN‡%’öVcæAzåtN™D¨·d„ÒaòvπO}µ∞r∆ù	.∆¬}ÙøÖK≥°ÃREacO4i/˝]µ®ÀSuª%NµM ˇ∑îˇƒa∏:ÂY—õ;ÌƒÅÎÔá!Êf˘ï⁄ÛD(/(@G=]^L—˛}E˚IXÙáë	N o:C¥c]ÄıKÌ ÆIYæ^69Ÿ¶ó!Jò≈µÿ PÖ˝◊ÓΩªa#¯ê?Ó¶ÜØ∏µªÛµ9◊Úz}lyûŸP7˚ÀíSUrR8êk‡πoç9Ö∫¸49Ã`èöë™#Uö:ì–Åo˙eÚ{÷6h“$z’‰UÌ9ê(Á⁄cÛíµqDÛqvL≈ïåb~˛(¸aw˘;-4ãj™|ÇhC]vï%Åå4◊7ÒUèôÇ}˙=â?Xq∆ƒ˜AÁ≥≤lÅeN^:ÖH”)ê(i0Ë)iÃ≥◊“	FΩ79UC∂ÂTwÁá≈È“Ù´â1/Ój◊‹#_[k.∑IB”Ó,óIŸ~ÑHñßóπÇ KUáŸOECΩŸZáÖé<≠ÄnÏ˝)—äJXém §,Kzo/Bªqú”¿O\Ã•Äè®ƒÛŒs(xôÖ,Èe‘Ó
∫g≥«)]¬RÁ®RaË+ÿA\‘Ç†s1äó]·¸Ô+•$ÓRÅ∆—FõpÉ¿(›˙C#vºÇ¥@ë#Lƒ4LÄu∆˚FáµdzV≈DLM*ï„Ã®—a/usáyœîñÜ“fèQ¸5îœy(‡¿,Ò%’_ UÉendstreamendobj99 0 obj<</Length 20463>>stream
BT
0 0 0 1 k
/GS0 gs
/T1_0 1 Tf
-0.017 Tc 0.048 Tw 8 0 0 8 36 750.2881 Tm
[(HIGHLIGHTS OF PRESCRIBING INFORMA)55.2 (TION)]TJ
-0.016 Tc 0.06 Tw 0 -1.197 Td
[(These highlights do not inc)19.9 (lude all the information needed to use ABECMA safely)-15.9 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.062 Td
[(and effectively)55.2 (.)37.2 ( See full prescribing information for ABECMA.)]TJ
0.017 Tw 0 -1.625 Td
(ABECMA)Tj
0 Tc 0 Tw 5.6 0 0 5.6 62.5821 721.8721 Tm
(\256)Tj
-0.017 Tc 0.048 Tw 8 0 0 8 66.9657 719.2081 Tm
[( \(idecabtagene vic)20.1 (leucel\),)37.2 ( suspension for intravenous infusion)]TJ
-3.871 -1.242 Td
[(Initial U.S.)37.2 ( Appro)-9.8 (v)16.3 (al: 2021)]TJ
-0.019 Tc 0.036 Tw 0.625 -2.084 Td
[(W)17.6 (ARNING: CYTOKINE RELEASE SYNDROME,)36.6 ( NEUROLOGIC TOXICITIES,)36.6 ( HLH/MAS,)18 ( )]TJ
-0.017 Tc 0.048 Tw 0.521 -1.062 Td
[(PROLONGED CYTOPENIA,)37.2 ( AND SECOND)34.3 (AR)18.1 (Y HEMA)55.2 (TOLOGIC)18.2 (AL MALIGNANCIES)]TJ
/T1_1 1 Tf
2.864 -1.603 Td
(See full prescribing information for complete boxed warning.)Tj
/T1_0 1 Tf
0.017 Tw -3.385 -1.377 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.011 Tc 0.188 Tw 1.125 0 Td
[(Cytokine Release Syndrome \(CRS\),)37.2 ( inc)20.2 (luding f)20.2 (atal or life-threatening)]TJ
0 Tc 0 Tw 29.125 0 Td
( )Tj
-0.008 Tc 0.095 Tw -29.125 -1.062 Td
[(reactions,)36.9 ( occurred in patients following treatment with ABECMA.)36.8 ( Do not)-8 ( )]TJ
0.007 Tc 0.167 Tw 0 -1.062 Td
[(administer ABECMA to patients with active infection or inflammator)-17.7 (y)7 ( )]TJ
0.017 Tc 0.22 Tw 0 -1.062 Td
[(disorders.)36.8 ( T)73.8 (reat severe or life-threatening CRS with tocilizumab or)17 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.062 Td
[(tocilizumab and corticosteroids \(2.2,)37.2 ( 2.3,)37.3 ( 5.2,)37.2 ( 6.1\).)]TJ
0.017 Tw -1.125 -1.332 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.003 Tc 0.118 Tw 1.125 0 Td
[(Neurologic )0.5 (toxicities,)37.2 ( )0.6 (which )0.5 (may )0.6 (be )0.6 (severe )0.6 (or )0.6 (life-threatening,)37.2 ( )0.6 (occurred)-3.1 ( )]TJ
-0.008 Tc 0.093 Tw 0 -1.062 Td
[(following treatment with ABECMA,)37.2 ( inc)20.2 (luding concurrently with CRS,)37.2 ( after)-8 ( )]TJ
-0.02 Tc 0.036 Tw 0 -1.062 Td
[(CRS resolution,)37.4 ( or i)0.5 (n the absence of CRS.)37.4 ( Monitor for ne)0.5 (ur)0.5 (ol)0.5 (og)0.5 (ic )0.5 (events after)-20 ( )]TJ
-0.014 Tc 0.064 Tw 0 -1.062 Td
[(treatment with ABECMA.)37 ( Pro)-10 (vide supportive care and/or corticosteroids as)-14 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.062 Td
[(needed \(2.2,)37.2 ( 2.3,)37.2 ( 5.3\).)]TJ
0.017 Tw -1.125 -1.333 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0 Tc 0.136 Tw 1.125 0 Td
[(Hemophagoc)9.6 (ytic L)36.6 (ymphohistioc)9.6 (ytosis/Macrophage Activ)15.6 (ation Syndrome )]TJ
0.007 Tc 0.168 Tw 0 -1.062 Td
[(\(HLH/MAS\),)37.2 ( inc)20.2 (luding f)20.2 (atal and life-threatening reactions,)37.1 ( occurred in)7 ( )]TJ
-0.01 Tc 0.082 Tw 0 -1.062 Td
[(patients following treatment with ABECMA.)37.3 ( HLH/MAS can occur with CRS)-10 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.062 Td
(or neurologic toxicities \(5.4\).)Tj
0.017 Tw -1.125 -1.332 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.013 Tc 0.069 Tw 1.125 0 Td
[(Prolonged Cytopenia with bleeding and infection,)37 ( inc)19.9 (luding f)19.9 (atal outcomes)-12.9 ( )]TJ
-0.005 Tc 0.11 Tw 0 -1.062 Td
[(following stem cell transplantation for hematopoietic reco)-10.1 (ver)-18.2 (y)54.8 (,)36.9 ( occurred)-5.1 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.062 Td
(following treatment with ABECMA \(5.8\).)Tj
0.017 Tw -1.125 -1.332 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.003 Tc 0.146 Tw 1.125 0 Td
[(T)0.5 ( ce)0.5 (l)0.5 (l)0.5 ( ma)0.5 (l)0.5 (i)0.5 (gn)0.5 (a)0.5 (n)0.5 (ci)0.5 (e)0.5 (s)0.5 ( ha)0.5 (v)0.5 (e)0.5 ( oc)0.5 (c)0.5 (ur)0.5 (r)0.5 (e)0.5 (d f)0.5 (o)0.5 (l)0.5 (lo)0.5 (w)0.5 (i)0.5 (ng)0.5 ( t)0.5 (r)0.5 (ea)0.5 (t)0.5 (m)0.5 (en)0.5 (t)0.5 ( of)0.5 ( h)0.5 (e)0.5 (ma)0.5 (t)0.5 (o)0.5 (lo)0.5 (g)0.5 (i)0.5 (c)3 ( )]TJ
0.023 Tc 0.249 Tw 0 -1.062 Td
[(malignancies )0.5 (with )0.5 (BCMA- )0.5 (and )0.5 (CD19-directed )0.5 (genetically )0.5 (modified)23 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.062 Td
[(autologous T cell immunotherapies,)37.2 ( inc)20.2 (luding ABECMA \(5.10\).)]TJ
0.017 Tw -1.125 -1.333 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.006 Tc 0.166 Tw 1.125 0 Td
[(ABECMA is av)15.7 (ailable only through a restricted program under a Risk)6 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.062 Td
[(Ev)16.2 (aluation and Mitigation Strateg)-9.8 (y \(REMS\) called the ABECMA REMS \(5.5\).)]TJ
ET
0 0 0 1 K
4 M 
36 465.956 252 237.352 re
S
BT
0.017 Tw 8 0 0 8 36 444.7362 Tm
(------------------------------)Tj
0.048 Tw 10.755 0 Td
(RECENT MAJOR CHANGES)Tj
-0.153 Tw /Span<</ActualText<FEFF002D>>> BDC 
( )Tj
EMC 
10.06 0 Td
(------------------------------)Tj
/T1_2 1 Tf
0.011 Tw -20.815 -1.647 Td
[(Boxed W)18.3 (arning)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
28.908 0 Td
(4/2024)Tj
0.048 Tw -28.908 -1.423 Td
[(Indica)-9.7 (tions and Usa)-9.8 (ge \(1\))]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
28.908 0 Td
(4/2024)Tj
-28.908 -1.423 Td
[(Dosa)-9.7 (ge and )37.2 (Administra)-9.8 (tion \(2.1,)37.2 ( 2.2\))]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
28.908 0 Td
(4/2024)Tj
-28.908 -1.423 Td
[(Dosa)-9.7 (ge and )37.2 (Administra)-9.8 (tion \(2.2\) )]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
28.908 0 Td
(7/2024)Tj
-28.908 -1.423 Td
[(W)18.2 (arnings and Precautions \(5\))]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
28.908 0 Td
(4/2024)Tj
/T1_0 1 Tf
0.017 Tw -28.908 -1.647 Td
(-------------------------------)Tj
0.048 Tw 10.93 0 Td
[(INDIC)18.2 (A)55.2 (TIONS AND USAGE)]TJ
0.022 Tw /Span<</ActualText<FEFF002D>>> BDC 
( )Tj
EMC 
(------------------------------)Tj
/T1_2 1 Tf
0.036 Tw -10.93 -1.647 Td
[(ABECMA is a B-cell ma)-9.8 (tura)-9.7 (tion antigen \(BCMA\)-directed genetically modi\037ed autologous)-17 ( )]TJ
0.003 Tc 0.152 Tw 0 -1.062 Td
[(T cell )0.5 (immunothera)-10.4 (py indica)-10.4 (ted )0.5 (for the trea)-10.4 (tment of adult )0.5 (pa)-10.4 (tients )0.5 (with rela)-10.3 (psed)3 ( )]TJ
-0.006 Tc 0.104 Tw 0 -1.062 Td
[(or refractor)-18 (y multiple myeloma after two or more prior lines of thera)-9.9 (py inc)20 (luding an)-6 ( )]TJ
0.007 Tc 0.17 Tw 0 -1.062 Td
[(immunomodula)-10.1 (tor)-18.1 (y a)-10.2 (gent,)36.8 ( a proteasome inhibitor)73.8 (,)36.8 ( and an anti-CD38 monoc)19.8 (lonal)7 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.062 Td
[(antibod)-9.8 (y \(1\).)]TJ
/T1_0 1 Tf
0.017 Tw 0 -1.647 Td
(---------------------------)Tj
0.048 Tw /Span<</ActualText<FEFF200A>>> BDC 
9.738 0 Td
( )Tj
EMC 
0.024 0 Td
[(DOSAGE AND ADMINISTRA)55.2 (TION)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
-0.112 Tw /Span<</ActualText<FEFF002D>>> BDC 
12 0 Td
( )Tj
EMC 
(---------------------------)Tj
0.048 Tw -21.762 -1.647 Td
[(For autologous use only)55.2 (.)37.2 ( For intravenous use only)55.2 (.)]TJ
/T1_2 1 Tf
0.017 Tw 0 -1.377 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.125 0 Td
(Do NOT use a leukodepleting \037lter \(2.2\).)Tj
ET
0.5 w 10 M 
q 1 0 0 1 333 560.0538 cm
0 0 m
73.791 0 l
S
Q
q 1 0 0 1 333 549.3753 cm
0 0 m
27.517 0 l
S
Q
q 1 0 0 1 333 530.1783 cm
0 0 m
62.389 0 l
S
Q
q 1 0 0 1 333 502.4629 cm
0 0 m
71.59 0 l
S
Q
q 1 0 0 1 333 483.2659 cm
0 0 m
72.754 0 l
S
Q
q 1 0 0 1 333 438.5135 cm
0 0 m
128.898 0 l
S
Q
BT
0.017 Tw 8 0 0 8 324 750.2881 Tm
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0 Tc 0.134 Tw 1.125 0 Td
[(Administer a lymphodepleting chemothera)-10.1 (py regimen of c)20 (yc)20 (lophosphamide and )]TJ
-0.017 Tc 0.048 Tw 0 -1.065 Td
[(\036udarabine before infusion of )37.2 (ABECMA \(idecabta)-9.8 (gene vic)20.2 (leucel\) \(2.2\).)]TJ
0.017 Tw -1.125 -1.335 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.125 0 Td
[(Con\037rm the pa)-9.7 (tient\222)55.2 (s identity prior to infusion \(2.2\).)]TJ
0.017 Tw -1.125 -1.335 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.125 0 Td
[(Premedica)-9.8 (te with acetaminophen and an H)]TJ
0 Tc 0 Tw 5.6 0 0 5.6 456.8146 719.6726 Tm
(1)Tj
-0.017 Tc 0.048 Tw 8 0 0 8 459.4062 720.4126 Tm
(-antihistamine \(2.2\).)Tj
0.017 Tw -16.926 -1.335 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.125 0 Td
(Avoid prophylactic use of dexamethasone or other systemic corticosteroid\s \(2.2\).)Tj
0.017 Tw -1.125 -1.335 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.125 0 Td
[(Con\037rm a)-9.8 (vailability of tocilizumab prior to infusion \(2.2,)37.2 ( 5.2\).)]TJ
0.017 Tw -1.125 -1.335 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.024 Tc 0.032 Tw 1.125 0 Td
[(Dosing of )37.2 (ABECMA is based on the number of chimeric antigen receptor \(CAR\)-posit\ive)-24 ( )]TJ
0 Tc 0 Tw 30.375 0 Td
( )Tj
-0.017 Tc 0.048 Tw -30.375 -1.065 Td
(T cells \(2.1\).)Tj
0.017 Tw -1.125 -1.335 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.125 0 Td
(The recommended dose range is 300 to 510 \327 10)Tj
0.017 Tw 5.6 0 0 5.6 478.1249 671.8442 Tm
(6 )Tj
0.048 Tw 8 0 0 8 482.233 669.1802 Tm
[(CAR-positive )37.2 (T cells \(2.1\).)]TJ
0.017 Tw -19.779 -1.335 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.125 0 Td
[(Administer )37.2 (ABECMA a)-9.8 (t a certi\037ed healthcare facility \(2.2,)37.2 ( 5.2,)37.2 ( 5.3,)37.1 ( 5.4\).)]TJ
/T1_0 1 Tf
0.017 Tw -1.125 -1.605 Td
(--------------------------)Tj
0.048 Tw 9.291 0 Td
(DOSAGE FORMS AND STRENGTHS)Tj
-0.206 Tw /Span<</ActualText<FEFF002D>>> BDC 
( )Tj
EMC 
(--------------------------)Tj
/T1_2 1 Tf
0.017 Tw -9.291 -1.605 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.125 0 Td
[(ABECMA is a cell suspension for intra)-9.7 (venous infusion \(3\).)]TJ
0.017 Tw -1.125 -1.335 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.021 Tc 0.036 Tw 1.125 0 Td
[(A single dose of )36.9 (ABECMA contains a cell suspension of 300 to 510 x 10)]TJ
0.021 Tw 5.6 0 0 5.6 536.0729 624.8102 Tm
(6 )Tj
8 0 0 8 540.0723 622.1462 Tm
[(CAR-positive)-21 ( )]TJ
-0.017 Tc 0.048 Tw -25.884 -1.065 Td
[(T cells in one or more infusion ba)-9.8 (gs \(3\).)]TJ
/T1_0 1 Tf
0.017 Tw -1.125 -1.605 Td
(---------------------------------)Tj
11.731 0 Td
[(CONTRAINDIC)18.2 (A)55.2 (TIONS)]TJ
8.025 0 Td
(---------------------------------)Tj
/T1_2 1 Tf
0.048 Tw -19.757 -1.65 Td
(None \(4\).)Tj
/T1_0 1 Tf
0.017 Tw 0 -1.65 Td
(----------------------------)Tj
0.048 Tw 9.871 0 Td
[(W)18.2 (ARNINGS AND PREC)18.2 (AUTIONS)]TJ
0.021 Tw /Span<</ActualText<FEFF002D>>> BDC 
( )Tj
EMC 
(---------------------------)Tj
/T1_2 1 Tf
0.017 Tw -9.871 -1.605 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.018 Tc 0.036 Tw 1.125 0 Td
(Hypersensitivity Reactions)Tj
(:)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
9.469 0 Td
( Monitor for hypersensitivity reactions during infusion \(5.6\).)Tj
-0.017 Tc 0.017 Tw -10.594 -1.335 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.013 Tc 0.013 Tw 1.125 0 Td
(Infections)Tj
0.067 Tw (:)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
3.695 0 Td
[( Monitor pa)-9.7 (tients for signs and symptoms of infection; trea)-9.7 (t a)-9.7 (ppropria)-9.7 (tely)-13 ( )]TJ
-0.017 Tc 0.017 Tw -3.695 -1.065 Td
(\(5.7\).)Tj
-1.125 -1.335 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.013 Tc 0.068 Tw 1.125 0 Td
(Prolonged Cytopenias)Tj
(:)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
8.054 0 Td
[( P)18.2 (a)-9.7 (tients may exhibit prolonged Grade 3 or higher c)20.2 (ytopenias)-13 ( )]TJ
-0.017 Tc 0.06 Tw -8.054 -1.065 Td
[(follo)-9.8 (wing )37.2 (ABECMA infusion.)37.2 ( Monitor blood counts prior to and after )37.2 (ABECMA infusion)-17 ( )]TJ
0.017 Tw 0 -1.065 Td
(\(5.8\).)Tj
-1.125 -1.335 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.02 Tc 0.02 Tw 1.125 0 Td
[(Hypogamma)-9.6 (globulinemia)]TJ
0.036 Tw (:)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
9.19 0 Td
[( Monitor and consider immunoglobulin replacement thera)-9.6 (py)-20 ( )]TJ
-0.017 Tc 0.017 Tw -9.19 -1.065 Td
(\(5.9\).)Tj
-1.125 -1.335 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.002 Tc 0.124 Tw 1.125 0 Td
[(Secondar)-18 (y Malignancies)]TJ
(:)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
9.372 0 Td
[( )36.9 (T cell malignancies ha)-10 (ve occurred follo)-10 (wing trea)-10 (tment)-2 ( )]TJ
-0.007 Tc 0.098 Tw -9.372 -1.065 Td
[(of hema)-9.8 (tologic malignancies with BCMA- and CD19-directed genetically modi\037ed\)-7 ( )]TJ
-0.017 Tc 0.045 Tw 0 -1.065 Td
[(autologous )37.5 (T )0.5 (cell )0.5 (immunothera)-9.7 (pies,)37.2 ( )0.5 (inc)20.2 (luding )37.5 (ABECMA.)37.2 ( )0.5 (In )0.5 (the )0.5 (event tha)-9.8 (t )0.5 (a )0.5 (secondar)-17.8 (y)-17 ( )]TJ
-0.007 Tc 0.099 Tw 0 -1.065 Td
[(malignanc)19.9 (y occurs after trea)-10 (tment with )36.8 (ABECMA,)37 ( contact Bristol-Myers Squibb a)-10 (t)-7 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.065 Td
(1-888-805-4555 \(5.10\).)Tj
0.017 Tw -1.125 -1.335 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.013 Tc 0.068 Tw 1.125 0 Td
[(Effects on )36.7 (Ability to Drive and Use Machines)]TJ
(:)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
16.368 0 Td
[( )36.7 (Advise pa)-9.9 (tients to refrain from driving)-12.9 ( )]TJ
0.067 Tw -16.368 -1.065 Td
[(or o)0.5 (pera)-9.6 (t)0.5 (ing hea)-9.6 (vy or potentially dangerous machines for a)-9.6 (t least eight weeks after)-13 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.065 Td
[(ABECMA administra)-9.8 (tion \(5.11\).)]TJ
/T1_0 1 Tf
0.017 Tw -1.125 -1.605 Td
(---------------------------------)Tj
0.048 Tw 11.651 0 Td
(ADVERSE REACTIONS)Tj
0.037 Tw /Span<</ActualText<FEFF002D>>> BDC 
( )Tj
EMC 
(--------------------------------)Tj
/T1_2 1 Tf
-0.014 Tc 0.063 Tw -11.651 -1.65 Td
[(The most common nonlabora)-9.7 (tor)-17.7 (y adverse reactions \(incidence grea)-9.7 (ter than or equal to)-14 ( )]TJ
-0.017 Tc 0.038 Tw 0 -1.065 Td
[(20%\) )0.5 (inc)20.2 (lude )0.5 (pyrexia,)37.2 ( CRS,)37.2 ( )0.5 (hypogamma)-9.8 (globulinemia,)37.2 ( )0.5 (infections \226 )0.5 (pa)-9.8 (thogen unspeci\037ed,)20 ( )]TJ
-0.008 Tc 0.096 Tw 0 -1.065 Td
[(musculoskeletal pain,)36.7 ( fa)-10.3 (tigue,)36.6 ( febrile neutropenia,)36.7 ( hypotension,)36.6 ( tachycardia,)36.7 ( diarrhea,)29 ( )]TJ
-0.001 Tc 0.128 Tw 0 -1.065 Td
[(nausea,)37.1 ( headache,)37.2 ( chills,)37.1 ( upper respira)-9.8 (tor)-17.8 (y tract infection,)37.1 ( encephalopa)-9.8 (thy)55.1 (,)37.2 ( edema,)36 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.065 Td
[(d)-9.8 (yspnea and viral infections \(6.1\).)]TJ
-0.01 Tc 0.085 Tw 0 -1.425 Td
[(The most common Grade 3 or 4 labora)-10.1 (tor)-18.1 (y adverse reactions \(incidence grea)-10.2 (ter than)-10 ( )]TJ
0.002 Tc 0.146 Tw 0 -1.065 Td
[(or equal to 50%\) inc)19.7 (lude leukoc)19.7 (yte count decreased,)36.7 ( neutrophil count decreased,)39 ( )]TJ
-0.018 Tc 0.036 Tw 0 -1.065 Td
[(lymphoc)20 (yte count decreased,)37 ( pla)-10 (telet count decreased,)36.9 ( and hemoglobin decreased \(6.1\).)]TJ
/T1_0 1 Tf
0.002 Tc 0.147 Tw 0 -1.537 Td
[(T)73.6 (o report SUSPECTED ADVERSE REACTIONS,)36.5 ( contact Bristol-Myers Squibb )0.5 (at)2.1 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.065 Td
[(1-800-721)60.2 (-5072 or FD)34.2 (A at 1-800-FD)34.3 (A-1088 or www)37.2 (.fda.go)-9.8 (v/medwatch.)]TJ
0 -1.807 Td
[(See 17 for P)54.2 (A)55.2 (TIENT COUNSELING INFORMA)55.2 (TION and Medication Guide)]TJ
25.371 -1.357 Td
(Revised: 7/2024)Tj
-61.371 -4.167 Td
[(FULL PRESCRIBING INFORMA)55.1 (TION: CONTENTS)]TJ
0 Tc 0 Tw 17.464 0.062 Td
(*)Tj
-0.006 Tc 0.104 Tw -17.464 -1.699 Td
[(W)17.9 (ARNING: CYTOKINE RELEASE SYNDROME,)36.9 ( NEUROLOGIC TOXICITIES,)36.9 ( HLH/MAS,)31 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.096 Td
[(PROLONGED CYTOPENIA,)37.1 ( AND SECOND)34.3 (AR)18.1 (Y HEMA)55.2 (TOLOGIC)18.2 (AL MALIGNANCIES)]TJ
0.017 Tw 0 -1.636 Td
(1)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.125 0 Td
[(INDIC)18.2 (A)55.2 (TIONS AND USAGE)]TJ
0.017 Tw -3.125 -1.456 Td
(2)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.125 0 Td
[(DOSAGE AND ADMINISTRA)55.1 (TION)]TJ
/T1_2 1 Tf
0.017 Tw 0 -1.402 Td
(2.1)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3 0 Td
(Dose)Tj
-3 -1.391 Td
(2.2)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3 0 Td
[(Administra)-9.8 (tion)]TJ
-3 -1.391 Td
(2.3)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3 0 Td
[(Mana)-9.7 (gement of Severe )37.2 (Adverse Reactions)]TJ
/T1_0 1 Tf
0.017 Tw -6.125 -1.445 Td
(3)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.125 0 Td
(DOSAGE FORMS AND STRENGTHS)Tj
0.017 Tw -3.125 -1.456 Td
(4)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3.125 0 Td
[(CONTRAINDIC)18.2 (A)55.2 (TIONS)]TJ
-3.125 -1.456 Td
(5)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.125 0 Td
[(W)18.2 (ARNINGS AND PREC)18.2 (AUTIONS)]TJ
/T1_2 1 Tf
0.017 Tw 8 0 0 8.0947 61 128.3783 Tm
(5.1)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3 0 Td
[(Early Dea)-9.8 (th)]TJ
0.017 Tw -3 -1.29 Td
(5.2)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3 0 Td
(Cytokine Release Syndrome \(CRS\))Tj
0.017 Tw -3 -1.29 Td
(5.3)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.011 Tw 3 0 Td
[(Neurologic T)74.2 (oxicities)]TJ
0.017 Tw -3 -1.29 Td
(5.4)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3 0 Td
[(Hemopha)-9.8 (goc)20.2 (ytic L)37.2 (ymphohistioc)20.2 (ytosis \(HLH\)/Macropha)-9.8 (ge )37.2 (Activa)-9.7 (tion)-17 ( )]TJ
0 -1.096 Td
(Syndrome \(MAS\))Tj
0.017 Tw -3 -1.29 Td
(5.5)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3 0 Td
(ABECMA REMS)Tj
0.017 Tw -3 -1.29 Td
(5.6)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3 0 Td
(Hypersensitivity Reactions)Tj
0.017 Tw -3 -1.29 Td
(5.7)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3 0 Td
(Infections)Tj
-3 -1.29 Td
(5.8)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3 0 Td
(Prolonged Cytopenias)Tj
0.017 Tw -3 -1.29 Td
(5.9)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3 0 Td
[(Hypogamma)-9.8 (globulinemia)]TJ
33 25.44 Td
(5.10)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3 0 Td
[(Secondar)-17.8 (y Malignancies)]TJ
0.017 Tw -3 -1.256 Td
(5.11)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3 0 Td
[(Effects on )37.2 (Ability to Drive and Use Machines)]TJ
/T1_0 1 Tf
0.017 Tw 8 0 0 8 324 221.6024 Tm
(6)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.125 0 Td
(ADVERSE REACTIONS)Tj
/T1_2 1 Tf
0.017 Tw 8 0 0 8.0947 349 210.2082 Tm
(6.1)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.011 Tw 3 0 Td
[(Clinical T)74.2 (rials )-36.8 (Experience)]TJ
0.017 Tw -3 -1.275 Td
(6.2)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3 0 Td
(Immunogenicity)Tj
8 0 0 8 349 190.0219 Tm
(6.3)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3 0 Td
[(P)18.2 (ostmarketing Experience)]TJ
/T1_0 1 Tf
0.017 Tw -6.125 -1.412 Td
(7)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.125 0 Td
[(DR)-9.8 (UG INTERACTIONS)]TJ
0.017 Tw -3.125 -1.423 Td
(8)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.125 0 Td
[(USE IN SPECIFIC POPULA)55.2 (TIONS)]TJ
/T1_2 1 Tf
0.017 Tw 8 0 0 8.0947 349 155.9541 Tm
(8.1)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3 0 Td
[(Pregnanc)20.2 (y)]TJ
-3 -1.275 Td
(8.2)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3 0 Td
[(Lacta)-9.8 (tion)]TJ
-3 -1.275 Td
(8.3)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3 0 Td
[(F)24.2 (emales and Males of Reproductive P)18.2 (otential)]TJ
0.017 Tw -3 -1.275 Td
(8.4)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3 0 Td
[(P)18.2 (edia)-9.7 (tric Use)]TJ
0.017 Tw -3 -1.275 Td
(8.5)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3 0 Td
[(Geria)-9.7 (tric Use)]TJ
/T1_0 1 Tf
0.017 Tw 8 0 0 8 324 104.376 Tm
(11)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3.125 0 Td
(DESCRIPTION)Tj
-3.125 -1.423 Td
(12)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.125 0 Td
[(CLINIC)18.2 (AL PHARMACOLOGY)]TJ
/T1_2 1 Tf
0.017 Tw 0 -1.368 Td
(12.1)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.011 Tw 3 0 Td
[(Mechanism )-36.8 (of Action)]TJ
0.017 Tw -3 -1.357 Td
(12.2)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3 0 Td
[(Pharmacod)-9.8 (ynamics)]TJ
-3 -1.357 Td
(12.3)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3 0 Td
(Pharmacokinetics)Tj
/T1_3 1 Tf
0 Tc 0 Tw 21.343 -2.417 Td
(\()Tj
-0.017 Tc 0.017 Tw 0.224 0 Td
(Continued\))Tj
ET
1 w 4 M 
q 1 0 0 1 36 274.4826 cm
0 0 m
540 0 l
S
Q
endstreamendobj119 0 obj<</CreationDate(D:20240801111840-04'00')/Creator(Adobe InDesign 19.5 \(Macintosh\))/ModDate(D:20240801111842-04'00')/Producer(Adobe PDF Library 17.0)/Trapped/False>>endobjxref
0 120
0000000000 65535 f
0000000016 00000 n
0000000124 00000 n
0000010199 00000 n
0000000000 00000 f
0000575887 00000 n
0000576841 00000 n
0000577873 00000 n
0000579065 00000 n
0000580257 00000 n
0000010470 00000 n
0000011662 00000 n
0000012854 00000 n
0000014046 00000 n
0000010259 00000 n
0000010348 00000 n
0000015250 00000 n
0000016494 00000 n
0000017738 00000 n
0000018932 00000 n
0000020047 00000 n
0000522418 00000 n
0000155194 00000 n
0000062490 00000 n
0000208922 00000 n
0000189631 00000 n
0000190359 00000 n
0000189017 00000 n
0000185154 00000 n
0000483337 00000 n
0000452059 00000 n
0000415474 00000 n
0000447692 00000 n
0000322612 00000 n
0000408782 00000 n
0000409182 00000 n
0000381469 00000 n
0000209034 00000 n
0000316162 00000 n
0000316566 00000 n
0000287712 00000 n
0000166159 00000 n
0000155307 00000 n
0000068482 00000 n
0000068611 00000 n
0000069158 00000 n
0000040517 00000 n
0000021188 00000 n
0000062601 00000 n
0000041059 00000 n
0000041562 00000 n
0000041815 00000 n
0000042207 00000 n
0000062638 00000 n
0000130446 00000 n
0000130471 00000 n
0000103922 00000 n
0000104175 00000 n
0000069754 00000 n
0000070001 00000 n
0000070603 00000 n
0000104670 00000 n
0000130966 00000 n
0000131345 00000 n
0000131414 00000 n
0000131674 00000 n
0000131772 00000 n
0000185881 00000 n
0000186390 00000 n
0000186746 00000 n
0000187138 00000 n
0000202857 00000 n
0000202945 00000 n
0000203522 00000 n
0000196292 00000 n
0000196409 00000 n
0000197077 00000 n
0000190845 00000 n
0000191355 00000 n
0000191929 00000 n
0000197769 00000 n
0000204145 00000 n
0000287749 00000 n
0000320039 00000 n
0000316960 00000 n
0000317308 00000 n
0000320379 00000 n
0000381506 00000 n
0000412263 00000 n
0000409588 00000 n
0000409935 00000 n
0000412615 00000 n
0000447820 00000 n
0000447845 00000 n
0000448156 00000 n
0000448327 00000 n
0000448396 00000 n
0000448654 00000 n
0000448738 00000 n
0000720309 00000 n
0000708506 00000 n
0000655729 00000 n
0000708953 00000 n
0000709349 00000 n
0000709751 00000 n
0000695430 00000 n
0000630964 00000 n
0000605341 00000 n
0000581438 00000 n
0000695469 00000 n
0000715796 00000 n
0000716249 00000 n
0000713342 00000 n
0000710711 00000 n
0000709920 00000 n
0000710182 00000 n
0000711053 00000 n
0000713667 00000 n
0000716737 00000 n
0000740824 00000 n
trailer<</Size 120/Root 1 0 R/Info 119 0 R/ID[<64FE36DDB09747E1ABED500009B9112E><9924723426F04A83B3C49B6A0EA6C327>]>>startxref741007%%EOF1 0 obj<</Lang(en-US)/Metadata 2 0 R/Pages 3 0 R/Type/Catalog/ViewerPreferences<</Direction/L2R/DisplayDocTitle true>>>>endobj2 0 obj<</Length 12365/Subtype/XML/Type/Metadata>>stream
<?xpacket begin="Ôªø" id="W5M0MpCehiHzreSzNTczkc9d"?>
<x:xmpmeta xmlns:x="adobe:ns:meta/" x:xmptk="Adobe XMP Core 9.1-c001 79.675d0f7, 2023/06/11-19:21:16        ">
   <rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
      <rdf:Description rdf:about=""
            xmlns:xmp="http://ns.adobe.com/xap/1.0/"
            xmlns:xmpMM="http://ns.adobe.com/xap/1.0/mm/"
            xmlns:stRef="http://ns.adobe.com/xap/1.0/sType/ResourceRef#"
            xmlns:stEvt="http://ns.adobe.com/xap/1.0/sType/ResourceEvent#"
            xmlns:dc="http://purl.org/dc/elements/1.1/"
            xmlns:pdf="http://ns.adobe.com/pdf/1.3/"
            xmlns:ExtensisFontSense="http://www.extensis.com/meta/FontSense/">
         <xmp:CreateDate>2024-08-01T11:18:40-04:00</xmp:CreateDate>
         <xmp:MetadataDate>2024-08-01T12:31:34-04:00</xmp:MetadataDate>
         <xmp:ModifyDate>2024-08-01T12:31:34-04:00</xmp:ModifyDate>
         <xmp:CreatorTool>Adobe InDesign 19.5 (Macintosh)</xmp:CreatorTool>
         <xmpMM:InstanceID>uuid:6bc0952f-c8d1-4f46-b3fc-6dc57494c5f9</xmpMM:InstanceID>
         <xmpMM:OriginalDocumentID>xmp.did:436bea68-88f9-4f60-9b76-86ef3f193c18</xmpMM:OriginalDocumentID>
         <xmpMM:DocumentID>xmp.id:72d583eb-7b08-4af6-831c-a9ade5f0bfe8</xmpMM:DocumentID>
         <xmpMM:RenditionClass>proof:pdf</xmpMM:RenditionClass>
         <xmpMM:DerivedFrom rdf:parseType="Resource">
            <stRef:instanceID>xmp.iid:6245aa2f-9433-4d5a-8905-346a914748fd</stRef:instanceID>
            <stRef:documentID>xmp.did:edc39fbc-0329-447b-8eed-47aa51f0b5df</stRef:documentID>
            <stRef:originalDocumentID>xmp.did:436bea68-88f9-4f60-9b76-86ef3f193c18</stRef:originalDocumentID>
            <stRef:renditionClass>default</stRef:renditionClass>
         </xmpMM:DerivedFrom>
         <xmpMM:History>
            <rdf:Seq>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/x-indesign to application/pdf</stEvt:parameters>
                  <stEvt:softwareAgent>Adobe InDesign 19.5 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
                  <stEvt:when>2024-08-01T11:18:40-04:00</stEvt:when>
               </rdf:li>
            </rdf:Seq>
         </xmpMM:History>
         <dc:format>application/pdf</dc:format>
         <dc:title>
            <rdf:Alt>
               <rdf:li xml:lang="x-default">ABECMA U.S. Prescribing Information</rdf:li>
            </rdf:Alt>
         </dc:title>
         <dc:creator>
            <rdf:Bag>
               <rdf:li>Bristol Myers Squibb</rdf:li>
            </rdf:Bag>
         </dc:creator>
         <pdf:Producer>Adobe PDF Library 17.0</pdf:Producer>
         <pdf:Trapped>False</pdf:Trapped>
         <ExtensisFontSense:slug>
            <rdf:Bag>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>3261192849</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>Helvetica Neue LT Std</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>OpenType - PS</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>3261192849</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Adobe Systems</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>HelveticaNeueLTStd-Cn</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>2.035</ExtensisFontSense:Version>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>3357634683</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>Helvetica Neue LT Std</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>OpenType - PS</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>3357634683</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Adobe Systems</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>HelveticaNeueLTStd-BdCn</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>2.035</ExtensisFontSense:Version>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>3454135</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>ITC Avant Garde Gothic Std</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>OpenType - PS</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>3454135</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Adobe Systems</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>ITCAvantGardeStd-BkCn</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>2.031</ExtensisFontSense:Version>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>3030352917</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>Helvetica Neue LT Std</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>OpenType - PS</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>3030352917</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Adobe Systems</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>HelveticaNeueLTStd-CnO</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>2.035</ExtensisFontSense:Version>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>4073973744</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>Helvetica Neue LT Std</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>OpenType - PS</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>4073973744</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Adobe Systems</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>HelveticaNeueLTStd-BdCnO</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>2.035</ExtensisFontSense:Version>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>3691150952</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>Helvetica Neue LT Std</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>OpenType - PS</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>3691150952</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Adobe Systems</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>HelveticaNeueLTStd-Bd</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>2.035</ExtensisFontSense:Version>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>2068535857</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>Symbol</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>TrueType</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>2068535857</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Apple Computer</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>Symbol</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>6.1</ExtensisFontSense:Version>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>1252007918</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>Arial</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>OpenType - TT</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>1252007918</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Monotype Typography</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>ArialMT</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>5.06</ExtensisFontSense:Version>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>1552261271</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>Arial</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>OpenType - TT</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>1552261271</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Monotype Typography</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>Arial-BoldMT</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>5.01.2</ExtensisFontSense:Version>
               </rdf:li>
            </rdf:Bag>
         </ExtensisFontSense:slug>
      </rdf:Description>
   </rdf:RDF>
</x:xmpmeta>
                                                                                                    
                                                                                                    
                                                                                                    
                                                                                                    
                                                                                                    
                                                                                                    
                                                                                                    
                                                                                                    
                                                                                                    
                                                                                                    
                                                                                                    
                                                                                                    
                                                                                                    
                                                                                                    
                                                                                                    
                                                                                                    
                                                                                                    
                                                                                                    
                                                                                                    
                                                                                                    
                           
<?xpacket end="w"?>endstreamendobj120 0 obj<</Author(Bristol Myers Squibb)/CreationDate(D:20240801111840-04'00')/Creator(Adobe InDesign 19.5 \(Macintosh\))/ModDate(D:20240801123134-04'00')/Producer(Adobe PDF Library 17.0)/Title(ABECMA U.S. Prescribing Information)/Trapped/False>>endobjxref
0 3
0000000000 65535 f
0000743562 00000 n
0000743691 00000 n
120 1
0000756133 00000 n
trailer<</Size 121/Root 1 0 R/Info 120 0 R/ID[<64FE36DDB09747E1ABED500009B9112E><0474B7F5083D49FBB389AE8EAFA3AF0F>]/Prev 741007>>startxref756388%%EOF